Citrus Sinensis ID: 004935
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 723 | 2.2.26 [Sep-21-2011] | |||||||
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.941 | 0.776 | 0.490 | 0.0 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.987 | 0.810 | 0.463 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.943 | 0.800 | 0.457 | 1e-180 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.983 | 0.803 | 0.448 | 1e-179 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.976 | 0.793 | 0.436 | 1e-176 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.970 | 0.801 | 0.436 | 1e-176 | |
| O81069 | 884 | Probable leucine-rich rep | no | no | 0.984 | 0.805 | 0.440 | 1e-174 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.982 | 0.814 | 0.426 | 1e-172 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.990 | 0.796 | 0.441 | 1e-172 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.932 | 0.776 | 0.445 | 1e-172 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/738 (49%), Positives = 472/738 (63%), Gaps = 57/738 (7%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
MYGNYD GK P FD+ L ++WDS+ E+ +TIVTKEII+ + + V+VCLV+K GTP
Sbjct: 113 MYGNYDNLGKAPDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTP 172
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
F+S +ELR LKN+ Y T S SL L+RRWD+G+ RY DDI+DR W+P PN +
Sbjct: 173 FLSVLELRLLKNNIYETASDSLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLIL 232
Query: 121 NTTS--DIISMNDYQGPSTVMQTAVIPTNGS-NSLQLSWEPNDPKFLYYAYLYFSEFENV 177
NT+ D S N + PS VM TAV P N S + + WEP DP + +Y Y++F+E E +
Sbjct: 233 NTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKL 292
Query: 178 QANNQTREIIIYING--IDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPP 235
+N +TRE +++N ID F P + +T+Y P+ + +EF + ST PP
Sbjct: 293 PSN-ETREFSVFLNKEQIDTTSVFRPSYLYTDTLYVQNPV-SGPFLEFVLRQGVKSTRPP 350
Query: 236 ILNAYEIYRAKEFLQFLTNQQD-------------------------AYLWQGLNCSYPE 270
I+NA E YR EFL T+Q D Y WQG+NCSY
Sbjct: 351 IMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTA 410
Query: 271 YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
+PPRI S+NLS SG+ G I P TLT +Q LDLSNN LTG VPDFL+ LP LTELNL+
Sbjct: 411 NNPPRIISVNLSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLE 470
Query: 331 -----GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVS 385
G +P L+E+ K+G LSL V GNPDLC SC + + ++++P VASV
Sbjct: 471 ENKLTGILPEKLLERSKDGSLSLRVGGNPDLCVSDSC---RNKKTERKEYIIPSVASVTG 527
Query: 386 LCVLVTAMAILWSLRRRMQVAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHG 445
L L+ A+ W ++R Q K G + K + + YS ++ ITNNFERVLG GGFG VY+G
Sbjct: 528 LFFLLLALISFWQFKKRQQSVKTGPLDTK-RYYKYSEIVEITNNFERVLGQGGFGKVYYG 586
Query: 446 YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505
L G +VA+KMLS SSAQGYK+F+AEVELL+R+HHKNL L+GYC EG LIYE++ N
Sbjct: 587 VLRGEQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGN 646
Query: 506 GNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGKFQA 552
G L L G+ + ILSWE RL+I+++AA+ VHRDVK TNIL++ K QA
Sbjct: 647 GTLGDYLSGKNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQA 706
Query: 553 KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITS 612
KIADFGLSR+F +EG + V+T +AGT GYLDPE+Y + +EKSDVY+FGVVLLE+IT
Sbjct: 707 KIADFGLSRSFTLEGD-SQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITG 765
Query: 613 KSVI--ERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTS 670
+ VI RT E HI+ VS ML KGDI+SIVDP+L E F+ WK E+A+AC S+++
Sbjct: 766 QPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASEST 825
Query: 671 TKRPTMNQVVMELNESLA 688
R TM+QVV EL ESL
Sbjct: 826 KTRLTMSQVVAELKESLC 843
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/777 (46%), Positives = 490/777 (63%), Gaps = 63/777 (8%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
MYGNYD GK P FD+ L ++WDS+ ++ +TIVTKEIIH + + V+VCLV+K GTP
Sbjct: 114 MYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTP 173
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
F+SA+E+R LK++TY T SL LF+RWD+G + RY DD++DRIW+P P
Sbjct: 174 FLSALEIRLLKSNTYETPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIF 233
Query: 121 NTTSDIISMND--YQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
N + I S N+ +Q VM TA P + S + SWEP DP + Y+ Y++F+E +
Sbjct: 234 NASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELP 293
Query: 179 ANNQTREIIIYINGIDW-FGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPIL 237
+N +TRE + +N + FSP + +T++ P+ + K+EF + T STLPPI+
Sbjct: 294 SN-ETREFKVLLNEKEINMSSFSPRYLYTDTLFVQNPV-SGPKLEFRLQQTPRSTLPPII 351
Query: 238 NAYEIYRAKEFLQFLTNQQDA-------------------------YLWQGLNCSYPEYD 272
NA E YR EFLQ T+QQD Y W+ +NCSY + +
Sbjct: 352 NAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNE 411
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
PRI S+NLSSSG+ G+I S LT + ILDLSNN+LTG +PDFL L LTELNL+G
Sbjct: 412 SPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGN 471
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLC 387
IP L+E+ L+ L ++GNPDLC ASC + ++ N +++P+VASVV +
Sbjct: 472 KLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEK-TKKNVYIIPLVASVVGVL 530
Query: 388 VLVTAMAILWSLRRRMQVA-----KNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTV 442
LV A+A+ ++R + + G + + + YS V+++TNNFERVLG GGFG V
Sbjct: 531 GLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKV 590
Query: 443 YHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502
YHG L+ +VAVK+LS SSAQGYK+F+AEVELL+R+HHKNLT L+GYC EG LIYEF
Sbjct: 591 YHGVLNDDQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEF 650
Query: 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGK 549
MANG L L GE++ +LSWE RL+I+++AA+ V RDVK NIL++ K
Sbjct: 651 MANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEK 710
Query: 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEI 609
QAKIADFGLSR+ ++G+ TT +AGT GYLDPEY+++ +L+EKSD+Y+FGVVLLE+
Sbjct: 711 LQAKIADFGLSRSVALDGNNQD-TTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEV 769
Query: 610 ITSKSVIER---THERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACV 666
++ + VI R T E IHIT V ML GDI IVDP+L E FD S WK E+AMAC
Sbjct: 770 VSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACA 829
Query: 667 SQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSELSPLAR 723
S +S RPTM+ VV EL ES+ +R +A G S + +++ N S + P AR
Sbjct: 830 SSSSKNRPTMSHVVAELKESV----SRARAGGGSGASSVTDPAMT-NFDSGMFPQAR 881
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1634), Expect = e-180, Method: Compositional matrix adjust.
Identities = 341/746 (45%), Positives = 474/746 (63%), Gaps = 64/746 (8%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
MYGNYDG+ P FD+ L ++WD++ + S+IV+KE++++ Q ++VCL NKG GTP
Sbjct: 109 MYGNYDGENGSPEFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTP 168
Query: 61 FISAIELRPL--KNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSE 118
FIS +ELR L N+TY + +G+L RRWD+ S RY DD+YDRIW+P +
Sbjct: 169 FISTLELRFLGNDNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYCR 228
Query: 119 PINTTSDIISMND-YQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENV 177
INT+ + S N+ Y S VM TA+ P N + + ++ E +DP Y+ Y++F+E E++
Sbjct: 229 EINTSLPVTSDNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDL 288
Query: 178 QAN-NQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPI 236
NQTRE I ING+ FSP + NT + + KI FS+ T STLPPI
Sbjct: 289 SLKPNQTREFDISINGVTVAAGFSPKYLQTNTFFLNPE--SQSKIAFSLVRTPKSTLPPI 346
Query: 237 LNAYEIYRAKEFLQFLTNQQDA-------------------------YLWQGLNCSYPEY 271
+NA EIY A F Q LTNQ+D Y+W+GLNCSY
Sbjct: 347 VNALEIYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSL 406
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK- 330
PPRITSLNLSSSG+ G I+ S LT IQ LDLSNN LTG +P+FLS+L FL LNL+
Sbjct: 407 TPPRITSLNLSSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLEN 466
Query: 331 ----GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSL 386
G++P+ L+E+ G SL + NP LC E SC S K V+P+VAS +L
Sbjct: 467 NTLTGSVPSELLERSNTGSFSLRLGENPGLCTEISCRKSNSK-----KLVIPLVASFAAL 521
Query: 387 CVLVTAMAILWSLRRRMQVAKNGSFE----LKNQR---FSYSNVLRITNNFERVLGNGGF 439
+L+ + W +R R + N + + K++ F++++V+++TNNF +VLG GGF
Sbjct: 522 FILLLLSGVFWRIRNRRNKSVNSAPQTSPMAKSENKLLFTFADVIKMTNNFGQVLGKGGF 581
Query: 440 GTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499
GTVYHG+ D +VAVK+LS +SAQG+K+F++EVE+L+R+HH NLT L+GY EG GLI
Sbjct: 582 GTVYHGFYDNLQVAVKLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLI 641
Query: 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILL 546
YEFMANGN+ L G+ LSW RL+IA++AA+ VHRDVK++NILL
Sbjct: 642 YEFMANGNMADHLAGKYQHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILL 701
Query: 547 SGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
+ K +AK+ADFGLSR+F E S +HV+T +AGTPGYLDP + +N L EKSD+Y+FGVVL
Sbjct: 702 NEKNRAKLADFGLSRSFHTE-SRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVL 760
Query: 607 LEIITSKSVIERTH-ERIHITQWV-SFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMA 664
LE+IT K+VI+ + +R+H++ WV S + D+ +++D ++ +DFD+NSVWK VE+A++
Sbjct: 761 LEMITGKTVIKESQTKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALS 820
Query: 665 CVSQTSTKRPTMNQVVMELNESLAIE 690
VSQ + RP M +V LNE L E
Sbjct: 821 SVSQNVSDRPNMPHIVRGLNECLQRE 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1621), Expect = e-179, Method: Compositional matrix adjust.
Identities = 355/791 (44%), Positives = 492/791 (62%), Gaps = 80/791 (10%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG P+F++ L ++W ++ D +EII + + N + VCLV G P
Sbjct: 107 VYGNYDGLNVGPNFNLYLGPNLWTTVSSND----TIEEIILVTRSNSLQVCLVKTGISIP 162
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FI+ +ELRP+K + Y T+SGSL R I S SS R+PDD+YDR W P + +
Sbjct: 163 FINMLELRPMKKNMYVTQSGSLKYLFRGYI-SNSSTRIRFPDDVYDRKWYPLFDDSWTQV 221
Query: 121 NTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQAN 180
T + + Y+ P +VM A P +++L ++W P +Y+Y++ +E + ++AN
Sbjct: 222 TTNLKVNTSITYELPQSVMAKAATPIKANDTLNITWTVEPPTTQFYSYVHIAEIQALRAN 281
Query: 181 NQTREIIIYINGIDWFGPFSPLHFAANTIYSTWP-ILTAEKIEFSINTTESSTLPPILNA 239
+TRE + +NG FGPFSP+ +I P + + T STLPP+LNA
Sbjct: 282 -ETREFNVTLNGEYTFGPFSPIPLKTASIVDLSPGQCDGGRCILQVVKTLKSTLPPLLNA 340
Query: 240 YEIYRAKEFLQFLTNQQDA--------------------------YLWQGLNCSYPEYD- 272
E + +F Q TN+ D LW GLNC +
Sbjct: 341 IEAFTVIDFPQMETNENDVAGIKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDIST 400
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
PP ITSL+LSSSG+ G I I LT +QILDLS+NNLTG VP+FL+ + L +NL G
Sbjct: 401 PPIITSLDLSSSGLTGIITQAIKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGN 460
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGNPD-LCPEASCTADESNGSRDNKFVVPVVASVVSL 386
++P L++K+ + L+VEGNP LC SC + +G + +VPVVAS+ S+
Sbjct: 461 NLSGSVPPSLLQKKG---MKLNVEGNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIASI 517
Query: 387 CVLVTAMAILWSLRR-------------------RMQVAKNGSFELKNQRFSYSNVLRIT 427
VL+ A+ + LR+ R+ + + KN+RFSYS V+ +T
Sbjct: 518 AVLIGALVLFLILRKKRSPKVEGPPPSYMQASDGRLPRSSEPAIVTKNRRFSYSQVVIMT 577
Query: 428 NNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
NNF+R+LG GGFG VYHG+++GTE VAVK+LS SS+QGYKQF+AEVELL+R+HHKNL L
Sbjct: 578 NNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGL 637
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEAD-ILSWEGRLRIAIEAAK----------- 534
VGYCDEG N LIYE+MANG+L+ + G IL+W RL+I IE+A+
Sbjct: 638 VGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKP 697
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
VHRDVK+TNILL+ F+AK+ADFGLSR+F +EG THV+T +AGTPGYLDPEY+ +N
Sbjct: 698 PMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGE-THVSTVVAGTPGYLDPEYHRTNW 756
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
LTEKSDVY+FG++LLEIIT++ VI+++ E+ HI +WV ML KGDI+SI+DP L+ED+D
Sbjct: 757 LTEKSDVYSFGILLLEIITNRHVIDQSREKPHIGEWVGVMLTKGDIQSIMDPSLNEDYDS 816
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISV 712
SVWK VE+AM+C++ +S +RPTM+QVV+ELNE LA E AR A ++ ESK SIE +S+
Sbjct: 817 GSVWKAVELAMSCLNHSSARRPTMSQVVIELNECLASENAR-GGASRDMESKSSIE-VSL 874
Query: 713 NQHSELSPLAR 723
+E+SP AR
Sbjct: 875 TFGTEVSPNAR 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 620 bits (1599), Expect = e-176, Method: Compositional matrix adjust.
Identities = 348/798 (43%), Positives = 492/798 (61%), Gaps = 92/798 (11%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG + PSFD+ + + W S++ + EIIH+ ++ + VCLV G TP
Sbjct: 110 VYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTP 169
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FIS++E+RPL N +Y T+SGSL LF R S SS RY +DI+DR+W NS + E +
Sbjct: 170 FISSLEVRPLNNESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVW--NSFTDDETV 227
Query: 121 NTTSD--IISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
++D I + N Y P +VM+TA +P N S L W ++ Y Y++F+E +N+
Sbjct: 228 WISTDLPIDTSNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLT 287
Query: 179 ANNQTREI-IIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKI-EFSINTTESSTLPPI 236
AN +TRE I Y G+ WF P + + +TI++ + ++ I F+ T +STLPP+
Sbjct: 288 AN-ETREFNITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPL 346
Query: 237 LNAYEIYRAKEFLQFLTNQQDA---------------------------YLWQGLNCSYP 269
LNA EIY + LQ TN+ + Y W+GLNCSYP
Sbjct: 347 LNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYP 406
Query: 270 EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+ + RI SLNL+ S + G I IS LT + +LDLSNN+L+G +P F +++ L +NL
Sbjct: 407 DSEGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINL 466
Query: 330 KG-------TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFV--VPVV 380
G IP+ L ++ + L+L + N L P+ +++K V V +
Sbjct: 467 SGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLTPK-----------KESKKVPMVAIA 515
Query: 381 ASVVSLCVLVTAMAILWSLRRRMQVAK---------------------NGSFELKNQRFS 419
ASV + L+ +AI + ++R+ A N S + ++ +
Sbjct: 516 ASVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKIT 575
Query: 420 YSNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH 479
Y VL++TNNFERVLG GGFGTVYHG LDG EVAVKMLS SSAQGYK+F+AEVELL+R+H
Sbjct: 576 YPEVLKMTNNFERVLGKGGFGTVYHGNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVH 635
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEAAK---- 534
H++L LVGYCD+G N LIYE+MANG+L+ + G+ ++L+WE R++IA+EAA+
Sbjct: 636 HRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEY 695
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
VHRDVK+TNILL+ + AK+ADFGLSR+FP++G HV+T +AGTPGYLDP
Sbjct: 696 LHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGE-CHVSTVVAGTPGYLDP 754
Query: 586 EYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645
EYY +N L+EKSDVY+FGVVLLEI+T++ VI++T ER HI WV FML KGDI+SIVDP+
Sbjct: 755 EYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHINDWVGFMLTKGDIKSIVDPK 814
Query: 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKD 705
L D+D N WK VE+A+ACV+ +S +RPTM VVMELN+ +A+E AR + +E S
Sbjct: 815 LMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENAR-RQGSEEMYSMG 873
Query: 706 SIESISVNQHSELSPLAR 723
S++ S++ S+ +P AR
Sbjct: 874 SVD-YSLSSTSDFAPGAR 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 346/792 (43%), Positives = 486/792 (61%), Gaps = 90/792 (11%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG + PSFD+ + + W S+ E+IH+ +++ + +CLV G TP
Sbjct: 106 IYGNYDGLNQLPSFDLYIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTP 165
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FIS++ELRPL N+TY T+SGSL + R S + RY +D++DRIW+P + +
Sbjct: 166 FISSLELRPLNNNTYVTKSGSLIVVARLYF-SPTPPFLRYDEDVHDRIWIPFLDNKNSLL 224
Query: 121 NTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQAN 180
+T + + N Y P TV +TA +P N + L+++W +D Y Y++F+E EN++AN
Sbjct: 225 STELSVDTSNFYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEAN 284
Query: 181 NQTREI-IIYINGIDWFGPFSPLHFAANTIYSTWPILTAE-KIEFSINTTESSTLPPILN 238
+TRE I Y G +WF F P F T+Y+ + + + F+ + T +ST PP++N
Sbjct: 285 -ETREFNITYNGGENWFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLIN 343
Query: 239 AYEIYRAKEFLQFLTNQQDA---------------------------YLWQGLNCSYPEY 271
EIY+ E Q T Q + Y W+GLNCSYP +
Sbjct: 344 GLEIYQVLELPQLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNF 403
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
PP+I SLNLS S ++G I IS LT ++ LDLSNN+L+G +P S + LT +NL G
Sbjct: 404 APPQIISLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSG 463
Query: 332 ------TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVS 385
++P L ++ N L+L DE+ + N VV + ASV S
Sbjct: 464 NKNLNRSVPETLQKRIDNKSLTL--------------IRDETGKNSTN--VVAIAASVAS 507
Query: 386 LCVLVTAMAILWSLRRRMQVAKNGS--------------------FELKNQRFSYSNVLR 425
+ ++ +AI++ + R+ Q S K ++F+YS VL+
Sbjct: 508 VFAVLVILAIVFVVIRKKQRTNEASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLK 567
Query: 426 ITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
+T NFERVLG GGFGTVYHG LD T+VAVKMLS SSAQGYK+F+AEVELL+R+HH++L
Sbjct: 568 MTKNFERVLGKGGFGTVYHGNLDDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVG 627
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEAAK---------- 534
LVGYCD+G N LIYE+M G+L+ + G+ + ++LSWE R++IA+EAA+
Sbjct: 628 LVGYCDDGDNLALIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCR 687
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRDVK TNILL+ + QAK+ADFGLSR+FPV+G +HV T +AGTPGYLDPEYY +N
Sbjct: 688 PPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGE-SHVMTVVAGTPGYLDPEYYRTN 746
Query: 592 RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
L+EKSDVY+FGVVLLEI+T++ V+ + ER HI +WV FML GDI+SIVDP+L+ED+D
Sbjct: 747 WLSEKSDVYSFGVVLLEIVTNQPVMNKNRERPHINEWVMFMLTNGDIKSIVDPKLNEDYD 806
Query: 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESIS 711
N VWK VE+A+ACV+ +S++RPTM VVMELNE LA+E R + + Y K+S+E S
Sbjct: 807 TNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLALEIERKQGSQATY-IKESVE-FS 864
Query: 712 VNQHSELSPLAR 723
+ S+ SPLAR
Sbjct: 865 PSSASDFSPLAR 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81069|Y2899_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g28990 OS=Arabidopsis thaliana GN=At2g28990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1579), Expect = e-174, Method: Compositional matrix adjust.
Identities = 348/790 (44%), Positives = 493/790 (62%), Gaps = 78/790 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG + P+FDI L + W I+ + E +EIIH + N + +CLV G P
Sbjct: 106 VYGNYDGLNRDPNFDIHLGPNKWKRIDLDGEKEGTREEIIHKARSNSLDICLVKTGETLP 165
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
ISAIE+RPL+N+TY T+SGSL + R + S S + RY DD++DRIW P + + I
Sbjct: 166 IISAIEIRPLRNNTYVTQSGSLMMSFRVYL-SNSDASIRYADDVHDRIWSPFNGSSHTHI 224
Query: 121 NTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQAN 180
T +I + N Y+ P ++QTA IP N S L ++W+P Y Y++F+E + ++AN
Sbjct: 225 TTDLNINNSNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEAN 284
Query: 181 NQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPI-LTAEKIEFSINTTESSTLPPILNA 239
+TR+ + + G FSP T+Y+ P+ +E + T +STLPP++NA
Sbjct: 285 -ETRQFDVILRGNFNHSGFSPTKLKVFTLYTEEPMKCGSEGCYLQLVKTPNSTLPPLINA 343
Query: 240 YEIYRAKEFLQFLTN---------------------QQDAYL-----WQGLNCSYPE-YD 272
E Y EF Q T+ Q D L W+ + C+Y +
Sbjct: 344 IEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQGDPCLPQDLSWESIRCTYVDGST 403
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P I SL+LS SG+ G I + T +Q LDLSNN+LTGPVP FL+ + L+ +NL G
Sbjct: 404 SPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGN 463
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLC 387
++P L++K+K GL+ L +EGNPDLC + C N + NKF++PV+AS SL
Sbjct: 464 NLSGSVPQALLDKEKEGLV-LKLEGNPDLCKSSFC-----NTEKKNKFLLPVIASAASLV 517
Query: 388 VLVTAMAILWSLRRR------------MQVAKNG-------SFELKNQRFSYSNVLRITN 428
++V +A+ + R++ M V+ G SF K RF+YS V +TN
Sbjct: 518 IVVVVVALFFVFRKKKASPSNLHAPPSMPVSNPGHNSQSESSFTSKKIRFTYSEVQEMTN 577
Query: 429 NFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
NF++ LG GGFG VYHG+++ E VAVK+LS SS+QGYK F+AEVELLMR+HH NL +LV
Sbjct: 578 NFDKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLV 637
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEAD-ILSWEGRLRIAIEAA------------- 533
GYCDEG + LIYE+M NG+L+ L G+ +LSWE RL+I ++AA
Sbjct: 638 GYCDEGEHLALIYEYMPNGDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPP 697
Query: 534 KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
VHRD+K+TNILL QAK+ADFGLSR+FP+ G+ +V+T +AGTPGYLDPEYY +N L
Sbjct: 698 MVHRDIKTTNILLDQHLQAKLADFGLSRSFPI-GNEKNVSTVVAGTPGYLDPEYYQTNWL 756
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653
TEKSD+Y+FG+VLLEII+++ +I+++ E+ HI +WVSFM+ KGD+ SI+DP LH+D+DI
Sbjct: 757 TEKSDIYSFGIVLLEIISNRPIIQQSREKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIG 816
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVN 713
SVWK +E+AM+CVS +S +RP M++VV EL E L ET+R+ G++ ESK S+E S +
Sbjct: 817 SVWKAIELAMSCVSLSSARRPNMSRVVNELKECLISETSRI-GEGRDMESKGSME-FSRD 874
Query: 714 QHSELSPLAR 723
++E+ P AR
Sbjct: 875 IYNEVIPQAR 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 607 bits (1564), Expect = e-172, Method: Compositional matrix adjust.
Identities = 330/774 (42%), Positives = 472/774 (60%), Gaps = 64/774 (8%)
Query: 2 YGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTPF 61
YGNYDG + P FDI + W S++ + E+IH+ ++ + +CLV G G PF
Sbjct: 111 YGNYDGLRQVPKFDIHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPF 170
Query: 62 ISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETF-RYPDDIYDRIWLPNSLPNSEPI 120
IS++ELRPL N+TY T+SGSL F R + ++ TF RY +DI+DR+W+ + I
Sbjct: 171 ISSLELRPLNNNTYLTQSGSLIGFAR--VFFSATPTFIRYDEDIHDRVWVRQFGNGLKSI 228
Query: 121 NTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQAN 180
+T + + N Y P V +TA +P+N S L W ++ Y Y++F+E + ++ N
Sbjct: 229 STDLLVDTSNPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDN 288
Query: 181 NQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAE-KIEFSINTTESSTLPPILNA 239
+ I Y G + + P F +T++ + P+ + + S T +STLPP++N
Sbjct: 289 DIREFNITYNGGQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLING 348
Query: 240 YEIYRAKEFLQFLTNQQD---------------------------AYLWQGLNCSYPEYD 272
EIY+ + L+ T+Q + +Y W+GLNCSYP D
Sbjct: 349 LEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSD 408
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
PRI SLNL+ + + G I P IS LT + LDLS N+L+G +P+F + + L +NL G
Sbjct: 409 QPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGN 468
Query: 332 -----TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSL 386
TIP+ + ++ + L L + + G ++P+VASV +
Sbjct: 469 LGLNSTIPDSIQQRLDSKSLIL-------ILSKTVTKTVTLKGKSKKVPMIPIVASVAGV 521
Query: 387 CVLVTAMAILWSLRRRMQVAKNG---SFELKNQRFSYSNVLRITNNFERVLGNGGFGTVY 443
L+ +AI + +RR+ + G S K +R +Y VL++TNNFERVLG GGFGTVY
Sbjct: 522 FALLVILAIFFVVRRKNGESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVY 581
Query: 444 HGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503
HG L+ T+VAVKMLS SSAQGYK+F+AEVELL+R+HH+NL LVGYCD+G N LIYE+M
Sbjct: 582 HGNLEDTQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYM 641
Query: 504 ANGNLQALLLGEEA-DILSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGK 549
ANG+L+ + G+ ++L+WE R++IA+EAA+ VHRDVK+TNILL+ +
Sbjct: 642 ANGDLKENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNER 701
Query: 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEI 609
+ AK+ADFGLSR+FPV+G +HV+T +AGTPGYLDPEYY +N L+EKSDVY+FGVVLLEI
Sbjct: 702 YGAKLADFGLSRSFPVDGE-SHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEI 760
Query: 610 ITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQT 669
+T++ V ++T ER HI +WV ML KGDI+SI+DP+L D+D N WK VE+A+ACV+ +
Sbjct: 761 VTNQPVTDKTRERTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPS 820
Query: 670 STKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSELSPLAR 723
S +RPTM VV ELNE +A+E AR + G+E S + SE SP AR
Sbjct: 821 SNRRPTMAHVVTELNECVALENARRQ--GREEMHTSGYVDFSRSSASEFSPGAR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1560), Expect = e-172, Method: Compositional matrix adjust.
Identities = 350/793 (44%), Positives = 484/793 (61%), Gaps = 77/793 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG PPSFD+ L ++W +++ + +EIIH + VCLV G+ +P
Sbjct: 114 VYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQEIIHKTISKSLQVCLVKTGTSSP 173
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLP--NSLPNSE 118
I+ +ELRPLKN+TY T+SGSL F R+ S S + RYPDD+ DR W P ++ +E
Sbjct: 174 MINTLELRPLKNNTYNTQSGSLKYFFRYYF-SGSGQNIRYPDDVNDRKWYPFFDAKEWTE 232
Query: 119 PINTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
+ T +I S N Y P VM +A P + + SW +Y Y++F+E + ++
Sbjct: 233 -LTTNLNINSSNGYAPPEVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLR 291
Query: 179 ANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAE-KIEFSINTTESSTLPPIL 237
+ + TRE + +NG + +SP A TI+ + P + + T STLPP++
Sbjct: 292 SLD-TREFKVTLNGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLM 350
Query: 238 NAYEIYRAKEFLQFLTNQQDA--------------------------YLWQGLNCS-YPE 270
NA E++ +F Q TN D +LW+GLNC+
Sbjct: 351 NALEVFTVIDFPQMETNPDDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDN 410
Query: 271 YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
PP +TSLNLSSS + G IA I LT +Q LDLSNNNLTG +P+FL+ + L +NL
Sbjct: 411 STPPIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLS 470
Query: 331 GTIPNGLIEK---QKNGLLSLSVEGNPDL-CPEASCTADESNG-SRDNKFVVPVVASVVS 385
G NG I + QK GL L +EGN +L CP+ C NG ++ V+P+VASV
Sbjct: 471 GNNFNGSIPQILLQKKGL-KLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVAF 529
Query: 386 LCVLVTAMAILWSLRR--------------------RMQVAKNGSFELKNQRFSYSNVLR 425
+ VL +A+A + ++ R + + KN+RF+YS V+
Sbjct: 530 VVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEVRTIRSSESAIMTKNRRFTYSEVVT 589
Query: 426 ITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT 484
+TNNFERVLG GGFG VYHG ++ TE VAVKMLS SS+QGYK+F+AEVELL+R+HHKNL
Sbjct: 590 MTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLV 649
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEAAK--------- 534
LVGYCDEG N LIYE+MANG+L+ + G+ IL+WE RL+I +E+A+
Sbjct: 650 GLVGYCDEGENLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGC 709
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
VHRDVK+TNILL+ AK+ADFGLSR+FP+EG THV+T +AGTPGYLDPEYY +
Sbjct: 710 KPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGE-THVSTVVAGTPGYLDPEYYRT 768
Query: 591 NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650
N L EKSDVY+FG+VLLEIIT++ VI ++ E+ HI +WV ML KGDI++I+DP+L+ D+
Sbjct: 769 NWLNEKSDVYSFGIVLLEIITNQLVINQSREKPHIAEWVGLMLTKGDIQNIMDPKLYGDY 828
Query: 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESI 710
D SVW+ VE+AM+C++ +S +RPTM+QVV+ELNE L+ E AR + S+ SIE +
Sbjct: 829 DSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYENAR-GGTSQNMNSESSIE-V 886
Query: 711 SVNQHSELSPLAR 723
S+N +P AR
Sbjct: 887 SMNFDIGATPDAR 899
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1559), Expect = e-172, Method: Compositional matrix adjust.
Identities = 330/741 (44%), Positives = 455/741 (61%), Gaps = 67/741 (9%)
Query: 2 YGNYDGQGKPPSFDIILEADVWDSIE--FEDESTIVTKEIIHIPQKNFVYVCLVNKGSGT 59
YGNYDG P FD+ L ++W S++ D V +EI+H+ + N + +CLV G+ T
Sbjct: 111 YGNYDGLNTSPRFDLFLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTST 170
Query: 60 PFISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEP 119
P ISAIELRPL+ TYT +GSL + + S E RYP+D+YDR+W+P S P
Sbjct: 171 PMISAIELRPLRYDTYTARTGSLKSMAHFYF-TNSDEAIRYPEDVYDRVWMPYSQPEWTQ 229
Query: 120 INTTSDIISMND-YQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
INTT ++ +D Y P V+QTA IPTNGS L +W YAYL+F+E + ++
Sbjct: 230 INTTRNVSGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLK 289
Query: 179 ANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKI-EFSINTTESSTLPPIL 237
N +TRE I NG+D+ ++P F A T+ + P+ + ++ T STLPP++
Sbjct: 290 VN-ETREFKILANGVDYID-YTPWKFEARTLSNPAPLKCEGGVCRVQLSKTPKSTLPPLM 347
Query: 238 NAYEIYRAKEFLQFLTNQQDA--------------------------YLWQGLNCSYPEY 271
NA EI+ +F Q TN + + W G++C+ +
Sbjct: 348 NAIEIFSVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQGDPCVPKQFSWMGVSCNVIDI 407
Query: 272 D-PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL--- 327
PPRI SL+LS SG+ G I+P I LT ++ LDLSNNNLTG VP+FL+ + L +
Sbjct: 408 STPPRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLR 467
Query: 328 --NLKGTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVS 385
NL+G++P L +++KN L L V+ N + ++V +VAS+
Sbjct: 468 GNNLRGSVPQALQDREKNDGLKLFVDPN----------ITRRGKHQPKSWLVAIVASISC 517
Query: 386 LCVLVTAMAILWSLRRRMQVAKN---GSFELKNQRFSYSNVLRITNNFERVLGNGGFGTV 442
+ V + + +++ RRR + S E+KN+RF YS V +TNNFE VLG GGFG V
Sbjct: 518 VAVTIIVLVLIFIFRRRKSSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVVLGKGGFGVV 577
Query: 443 YHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502
YHG+L+ +VAVK+LS SS QGYK+F+ EVELL+R+HH NL +LVGYCDEG + LIYEF
Sbjct: 578 YHGFLNNEQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEF 637
Query: 503 MANGNLQALLLGEEA-DILSWEGRLRIAIEAA-------------KVHRDVKSTNILLSG 548
M NGNL+ L G+ +L+W RL+IAIE+A VHRDVKSTNILL
Sbjct: 638 MENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGL 697
Query: 549 KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLE 608
+F+AK+ADFGLSR+F V GS HV+T +AGT GYLDPEYY+ N LTEKSDVY+FG+VLLE
Sbjct: 698 RFEAKLADFGLSRSFLV-GSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLE 756
Query: 609 IITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQ 668
IT + VIE++ ++ +I +W ML GDIESI+DP LH+D+D +S WK +E+AM C++
Sbjct: 757 SITGQPVIEQSRDKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINP 816
Query: 669 TSTKRPTMNQVVMELNESLAI 689
+ST+RP M +V ELNE L I
Sbjct: 817 SSTQRPNMTRVAHELNECLEI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 723 | ||||||
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.995 | 0.812 | 0.526 | 0.0 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.990 | 0.802 | 0.519 | 0.0 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.975 | 0.770 | 0.511 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.994 | 0.813 | 0.500 | 0.0 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.986 | 0.806 | 0.517 | 0.0 | |
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.977 | 0.800 | 0.503 | 0.0 | |
| 356550478 | 895 | PREDICTED: probable LRR receptor-like se | 0.988 | 0.798 | 0.505 | 0.0 | |
| 356556632 | 884 | PREDICTED: putative leucine-rich repeat | 0.988 | 0.808 | 0.507 | 0.0 | |
| 356556621 | 892 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.802 | 0.509 | 0.0 | |
| 356547364 | 887 | PREDICTED: putative leucine-rich repeat | 0.973 | 0.793 | 0.499 | 0.0 |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/779 (52%), Positives = 523/779 (67%), Gaps = 59/779 (7%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
MYGNYDG + PSFD+ L + W S++ + S V KEIIH P++ +++VCLVN SGTP
Sbjct: 111 MYGNYDGINQRPSFDLYLGPNKWVSVQILNGSIPVRKEIIHHPKRKYIHVCLVNTNSGTP 170
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FISA+ELRPLKN TY +ESGSL+LF R DI S +++T RYPDD+YDR W P I
Sbjct: 171 FISALELRPLKNGTYVSESGSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDI 230
Query: 121 NTTS--DIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
+TT D+ N YQ PSTVM++A P N S+ ++++ DP +YAY +F+E +
Sbjct: 231 STTETIDLGKSNSYQLPSTVMRSAGTPRNSSSPMEVTIAAEDPTLKFYAYFHFAEIVKLD 290
Query: 179 ANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILN 238
AN Q+RE I +NG W+GP + LH+ +T S+ ++ +F I STLPP+LN
Sbjct: 291 AN-QSREFNITLNGDIWYGPIT-LHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLN 348
Query: 239 AYEIYRAKEFLQFLTNQQDAY-------------------------LWQGLNCSYPEYDP 273
A E+Y E LQ T Q+D Y +W+GL C+Y
Sbjct: 349 AVEVYYIVELLQLETKQEDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSAS 408
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT- 332
P I SL+LSSSG+ GD+ P + L S++ LDLSNN+LTGPVPDFLSQL L L+L G
Sbjct: 409 PVIISLDLSSSGLTGDVPPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNK 468
Query: 333 ----IPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLCV 388
IP+ L ++ ++GLL LS GNP+LC SC+ + ++N FVVPVVAS+ +L V
Sbjct: 469 LTGIIPDDLFKRSQSGLLLLSFGGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLV 528
Query: 389 LVTAMAILWSLRRR-MQVAKNGSF---------ELKNQRFSYSNVLRITNNFERVLGNGG 438
+V A+ I+ RRR QVA+N E++N+RF+YS VL++T NFE VLG GG
Sbjct: 529 IVAALTIICCCRRRKQQVARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGG 588
Query: 439 FGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498
FGTVY+GYL EVAVK+LS SS QGYK+F+AEV+LL+R+HHKNLTTLVGYCDEG N L
Sbjct: 589 FGTVYYGYLGDIEVAVKVLSTSSVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMIL 648
Query: 499 IYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNIL 545
IYE+MANGNL+ L GE DILSWEGRL+IA+E A+ VHRDVK+ NIL
Sbjct: 649 IYEYMANGNLRQHLSGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANIL 708
Query: 546 LSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVV 605
L KFQAK+ADFGLSR FP EG GTHV+T +AGTPGYLDPEYY+ N LTEKSDVY+FGVV
Sbjct: 709 LDDKFQAKLADFGLSRMFPAEG-GTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVV 767
Query: 606 LLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMAC 665
LLEIITS+SVI +T E+ H++QWV ML +GDI++IVD RL DFD N+ WK E+AMAC
Sbjct: 768 LLEIITSRSVISQTSEKTHVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMAC 827
Query: 666 VSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSE-LSPLAR 723
VS TST+RP+M+QVVMEL+E L E AR + +S S E +SVN S LSP +R
Sbjct: 828 VSATSTERPSMSQVVMELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1981), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/791 (51%), Positives = 533/791 (67%), Gaps = 75/791 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEII-HIPQKNFVYVCLVNKGSGT 59
MYGNYDG + P FD+ + + W S++ + ST VT+EII P+ +++VCLV K +GT
Sbjct: 109 MYGNYDGLNQLPEFDLHIGPNKWVSVKILNASTSVTEEIIIGSPKSKYIHVCLVTKDTGT 168
Query: 60 PFISAIELRPLKNSTYTTESGSL--SLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNS 117
PFISA+E RPLKN TY TESGSL +LF R D+GS ++ RYP+D+YDR W P
Sbjct: 169 PFISALETRPLKNGTYVTESGSLGLALFTREDVGSLNNRIVRYPNDVYDRRWFPYHFKRG 228
Query: 118 EPINTT--SDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFE 175
I+TT D+ ND+Q PS VM++AVI N S+ L+ + ND + YAY++F+E
Sbjct: 229 TDISTTLTVDLDDHNDFQPPSIVMRSAVISINTSSPLEF-YINNDTTYKLYAYMHFAEIV 287
Query: 176 NVQANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPP 235
++AN Q+R+ I +NG W+GP +P + T+YST I T EFS++ E S LPP
Sbjct: 288 KLEAN-QSRQFNISLNGKIWYGPVTPTYLYTTTVYSTSAI-TDGMYEFSLSKVEGSALPP 345
Query: 236 ILNAYEIYRAKEFLQFLTNQQDA--------------------------YLWQGLNCSYP 269
+LNA E+Y + LQ TNQ+D ++W+GL+C Y
Sbjct: 346 LLNAIELYYVVDLLQPETNQRDVIGIMNIKSTYRISRTNWQGDPCAPEDFVWEGLSCKYN 405
Query: 270 EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
P I SLNLSSSG+ G+IAP I+ L S++ILDLSNNNLT VPDFLSQL L LNL
Sbjct: 406 VTSSPVIISLNLSSSGLHGEIAPDIANLKSLEILDLSNNNLTALVPDFLSQLQSLKFLNL 465
Query: 330 -----KGTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVV 384
GTIP+ L+++ +GL +LSV+GNP+LC SC + ++ F+VPVVASV
Sbjct: 466 TGNRLNGTIPDDLLKRADSGL-TLSVDGNPELCKSVSCNKKKKK-KKNTDFIVPVVASVA 523
Query: 385 SLCVLVTAMAILWSLRRRMQVAK------------------NGSFELKNQRFSYSNVLRI 426
+L V++ + +W L+RR Q + EL ++F+YS+VL+I
Sbjct: 524 ALLVIIVVLTTIWYLKRRKQKGTYLHKYILAGRTEAEAKKTHEPLELNKRQFTYSDVLKI 583
Query: 427 TNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
TNNF VLG GGFGTVYHGYLD EVAVKMLSPSS QGYK+F AEV LL+R+HHKNLTTL
Sbjct: 584 TNNFGSVLGRGGFGTVYHGYLDDVEVAVKMLSPSSVQGYKEFHAEVRLLLRVHHKNLTTL 643
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLG-EEADILSWEGRLRIAIEAAK----------- 534
VGYCDEG N GLIYE+MANGNL+ L G + ILSWEGRL+IA+EAA+
Sbjct: 644 VGYCDEGNNMGLIYEYMANGNLKHHLSGCDHPSILSWEGRLQIALEAAQGLDYLHNGCKP 703
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
VHRDVK+TNILL+ +FQAK+ADFGLSRTFPVE G+HV+T +AGTPGYLDP+YY++N
Sbjct: 704 PIVHRDVKTTNILLNDRFQAKLADFGLSRTFPVE-DGSHVSTVVAGTPGYLDPDYYVTNW 762
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
LTEKSDVY++GVVLLEIITS+ VI RT ++ H++QWV ML KGDI++IVDPRL DFD
Sbjct: 763 LTEKSDVYSYGVVLLEIITSRPVIARTRDKTHVSQWVKAMLDKGDIKNIVDPRLRGDFDN 822
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISV 712
NSVWK E+AMAC+S TS +RP+M+QVVMELN+ L E AR + G+ +S S+E IS+
Sbjct: 823 NSVWKVTELAMACLSTTSGERPSMSQVVMELNDCLTTEMARAR-EGRSTQSSSSVEVISL 881
Query: 713 NQHSELSPLAR 723
+ H+ +SPLAR
Sbjct: 882 HLHTGVSPLAR 892
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/776 (51%), Positives = 525/776 (67%), Gaps = 71/776 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDGQ K P FD+ L + W++++ + + I+TKEIIH+ +++ VCLVN GSGTP
Sbjct: 139 LYGNYDGQNKAPIFDLYLGSSKWETVDTINSTMIITKEIIHLINTSYIDVCLVNTGSGTP 198
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
F+S +ELRP++ S Y+T GSL+ F R D+GS ++ T RY DD+YDRIW PN I
Sbjct: 199 FMSKLELRPIRISAYSTSLGSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEI 258
Query: 121 NT--TSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
+T T D ++ NDY+ PS VM+TA IP N + + +S + D F + Y++F+E ++
Sbjct: 259 STSETIDALAQNDYRPPSIVMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLE 318
Query: 179 ANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILN 238
AN ++R+ I +NG WFGP P + T++S +L+ + EFSI TE+STLPP+LN
Sbjct: 319 AN-ESRQFNISLNGEHWFGPLRPDYLYTTTVFSP-TVLSGGQYEFSIYKTENSTLPPLLN 376
Query: 239 AYEIYRAKEFLQFLTNQQD-------------------------AYLWQGLNCSYPEYDP 273
A EIY + Q +NQ+D AYLW+GLNCSY
Sbjct: 377 AIEIYYILDLSQPQSNQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVM 436
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP-----FLTELN 328
PRI SLNLSSSG+ G+I IS+LTS++ LDLSNN LTG VPDFLSQLP LT
Sbjct: 437 PRIISLNLSSSGLTGEIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNR 496
Query: 329 LKGTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLCV 388
L G++P L+EK + LL LSV GN +LC ++SC + + N VVPVVAS+ + +
Sbjct: 497 LSGSVPPSLVEKSEQNLLVLSVGGNANLCLKSSCKNE-----KKNNVVVPVVASIAGVLI 551
Query: 389 LVTAMA-ILWSLRRRMQVAKN-------GSFELKNQRFSYSNVLRITNNFERVLGNGGFG 440
+++A+A IL++ +RR Q ++ G E K ++F+YS +L ITNNFERVLG GGFG
Sbjct: 552 IISALAAILYTRKRRKQQEEDTKTSNIYGPLESKERQFTYSEILNITNNFERVLGKGGFG 611
Query: 441 TVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500
TVYHGYLD T+VAVK+LSP SAQGYK+F AEV+LL+R+HH+NLT+LVG+C+EGT GLIY
Sbjct: 612 TVYHGYLDDTQVAVKILSPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIY 671
Query: 501 EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILLS 547
E+MANG+L+ LL G +L WE RL IA+EAAK VHRD+K+ NILL+
Sbjct: 672 EYMANGDLEHLLSGRNRHVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLN 731
Query: 548 GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLL 607
+FQA++ADFGLS++FPVEG GTHV+T +AGTPGYLDPEY ++N LTEKSDVY+FGVVLL
Sbjct: 732 DQFQARLADFGLSKSFPVEG-GTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLL 790
Query: 608 EIITSKSVIERTHER-IHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACV 666
+IIT + VI ER IHI+ WVS ++ GDI++++DP L DFDINSVWK VE+AMAC
Sbjct: 791 KIITGRPVIAVIDERSIHISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACT 850
Query: 667 SQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSELSPLA 722
S TS RPTMNQVV EL ESLA ETAR + K + S+ +E +PLA
Sbjct: 851 SPTSAGRPTMNQVVRELIESLAEETARAEEGHK---------TKSIVMMTESTPLA 897
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/775 (50%), Positives = 515/775 (66%), Gaps = 56/775 (7%)
Query: 2 YGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTPF 61
+G+YDG + P FD+ L + W +++ + S V KEIIH P N++++CLVN SG PF
Sbjct: 113 HGDYDGSNELPEFDLHLGPNKWVTVKILNASIPVIKEIIHTPTLNYIHICLVNTDSGMPF 172
Query: 62 ISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPIN 121
ISA+ELRPLKN+TY +SG+L R D+GS +++T RYPDD++DRIW P+ ++
Sbjct: 173 ISALELRPLKNTTYVAQSGALVKSTRLDLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLS 232
Query: 122 TTSDIISMN--DYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQA 179
T + + N D+Q PS VM+TA +PTN S +++ + +D L+Y Y++F+E +QA
Sbjct: 233 TPDTVDAQNHIDFQPPSVVMRTANMPTNASENMEFYIDIDDTTSLFYVYMHFAEIVELQA 292
Query: 180 NNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILNA 239
N Q+R I +NG W+GP P H ++ T+YS +PI+ + FS+ E STLPP+LNA
Sbjct: 293 N-QSRLFNISLNGTIWYGPVIPNHLSSGTVYSQFPIIGGNNM-FSLFKIEGSTLPPLLNA 350
Query: 240 YEIYRAKEFLQFLTNQQD-------------------------AYLWQGLNCSYPEYDPP 274
EIY + Q T+Q D AY+W GLNCSY + DPP
Sbjct: 351 IEIYFVVDLSQSETDQDDVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPP 410
Query: 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG--- 331
+ SLNLSSSG+ G+I I+ L S+++LDLSNN+L+G +PDFLS++ L LNL G
Sbjct: 411 TVKSLNLSSSGLRGEIVSEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKL 470
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNK------FVVPVVASV 383
TIP L E+ + G L LSV GNP+LCP SCT + + F++ V
Sbjct: 471 TGTIPADLFERSQQGSLLLSVSGNPELCPSVSCTKKKKSVVVPVVASVVAFFILAAALVV 530
Query: 384 VSLCVLVTAMAILWSLRRRMQVAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVY 443
+ V + A + + E K ++FSYS +L+ITNNF+++LG GGFGTVY
Sbjct: 531 ILRYFFVRSQAKTNEAKISYETNDEPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVY 590
Query: 444 HGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502
HG L DGT+VAVK+LS SSAQGYK+FQAEV+LL+R+HH+NLTTLVGYC+EGTN GLIYE+
Sbjct: 591 HGTLNDGTQVAVKVLSLSSAQGYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEY 650
Query: 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGK 549
MANGNL+ L + LSWE RLRIA EAA+ VHRDVK+TNILL+ K
Sbjct: 651 MANGNLEDYLSDSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDK 710
Query: 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEI 609
FQAK+ADFGLSR FPV+GS TH++T +AGTPGYLDPEYY++N LT+KSDV++FGVVLLEI
Sbjct: 711 FQAKLADFGLSRIFPVDGS-THISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEI 769
Query: 610 ITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQT 669
IT + I +T ER HI+QWVS ML KGDI IVDPRL+ DF+INSVWK E+AM CVS +
Sbjct: 770 ITGRPAIAQTRERTHISQWVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSAS 829
Query: 670 STKRPTMNQVVMELNESLAIETARLK-AAGKEYESKDSIESISVNQHSELSPLAR 723
S +RPTMNQ V+ELN+ L IE R + + + +SIE ++VN H+E SPLAR
Sbjct: 830 SARRPTMNQAVVELNDCLNIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/782 (51%), Positives = 520/782 (66%), Gaps = 69/782 (8%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+Y NYDG K P FD+ L + W +++ + + V EII+ P N+++VCLVN G GTP
Sbjct: 113 LYRNYDGLSKLPHFDLHLGPNKWITVKILNATIPVITEIIYTPILNYIHVCLVNTGLGTP 172
Query: 61 FISAIELRPLKNSTYTTES-GSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEP 119
FISA+ELRPLKN+TY S G+L+ F R D GS +++T RYPDD+YDRIW P+
Sbjct: 173 FISALELRPLKNTTYEIRSEGALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTD 232
Query: 120 INT--TSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENV 177
++T T D ND+Q PS VM TA +PTN S +Q + D +Y Y++F+E +
Sbjct: 233 LSTPETIDAQFHNDFQPPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKL 292
Query: 178 QANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPIL 237
+AN Q+R+ I +NG +FGP P + +++Y+ PI + FS+ STLPP+L
Sbjct: 293 EAN-QSRQFNISLNGTIFFGPVIPDYLYTSSVYNGLPINAGSNV-FSLFKIGGSTLPPLL 350
Query: 238 NAYEIYRAKEFLQFLTNQQD-------------------------AYLWQGLNCSYPEYD 272
NA EIY + Q T+Q D AY+WQGLNCSY + D
Sbjct: 351 NAIEIYFFVDLSQSQTDQDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDND 410
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332
PP+ITSLNLSSSG+ G+I I+ L S++ LDLSNN+L+GPVPDFLSQ+P L LNL G
Sbjct: 411 PPKITSLNLSSSGLTGEIVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGN 470
Query: 333 -----IPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLC 387
IP L E+ + G L LSV GNP+LCP SC E + VPVVASV S+
Sbjct: 471 KLTGRIPVDLFERTQKGSLLLSVSGNPELCPSVSCKKKEKS------IAVPVVASVASVF 524
Query: 388 VLVTAMAILWSLRRRMQVAKNGS----------FELKNQRFSYSNVLRITNNFERVLGNG 437
+L A+A++ R V++ G ELKN++F+YS VL+ITNNFE+VLG G
Sbjct: 525 ILAAAVAVILRYRILRSVSETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKG 584
Query: 438 GFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR 496
GFGTVY+G L DGT+VAVK+LS SS QGYK+F AEV+LLMR+HH+NLTTLVG C EGTN
Sbjct: 585 GFGTVYYGTLADGTQVAVKILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNM 644
Query: 497 GLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTN 543
GLIYE+MANGNL+ L G + LSWE RLRIA+EA + VHRDVK+TN
Sbjct: 645 GLIYEYMANGNLEDYLSGSNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTN 704
Query: 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFG 603
ILL+ KFQAKI+DFGLSR FP +G GTHV+T +AGTPGYLDPEYY++N LT+KSDVY+FG
Sbjct: 705 ILLNDKFQAKISDFGLSRIFPADG-GTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFG 763
Query: 604 VVLLEIITSKSVI--ERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEI 661
VVLLEIIT + VI R HE HI+QWVS M+ GD+ SI DPRL+ ++++NSVWK VE+
Sbjct: 764 VVLLEIITCRPVIAQNRNHENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVEL 823
Query: 662 AMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSELSPL 721
AM C+S TS +RPTMNQVV+ELNE L E AR + G+ +S SIE ++VN +E SPL
Sbjct: 824 AMECLSTTSARRPTMNQVVIELNECLKTEMARTR-EGQSTQSYYSIELVTVNVDTESSPL 882
Query: 722 AR 723
AR
Sbjct: 883 AR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/791 (50%), Positives = 500/791 (63%), Gaps = 84/791 (10%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+Y NYDG K P+FD+ + + W +++ + KEIIH P N +YVCLV G TP
Sbjct: 109 LYANYDGLNKLPAFDLHIGPNKWVNVQITNPLIYPIKEIIHAPTFNNIYVCLVRTGPWTP 168
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FISA+E+RPL NSTY +SGSLSLF R D+GS +++T RYPDD+YDR+WLP I
Sbjct: 169 FISALEIRPLHNSTYVAQSGSLSLFNRVDVGSLTNQTIRYPDDVYDRMWLPFHFDKGTDI 228
Query: 121 NTTSDIISMNDY-QGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQA 179
+T +I S DY Q PSTVM +A +P N S + L+ + D F Y Y++F+E ++
Sbjct: 229 STKENITSGIDYFQLPSTVMNSATVPLNASEQIILNIDTQDNTFQAYVYIHFAEIVRLEP 288
Query: 180 NNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILNA 239
N Q+R I +NG +GP +P H A T+YS I K FS STLPP+LNA
Sbjct: 289 N-QSRRFNISLNGKILYGPVTPKHLEATTVYSQSAI-PGGKFLFSFYGVGGSTLPPLLNA 346
Query: 240 YEIYRAKEFLQFLTNQQDA-------------------------YLWQGLNCSYPEYDPP 274
E+Y + L TNQ D Y W GLNC+Y P
Sbjct: 347 LELYSVVDLLHSETNQVDVNAITKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASP 406
Query: 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPF----LTELNLK 330
ITSL+ SSSG+ G+I P IS L ++ LDLSNN+LTGPVPDFLSQLP L NL
Sbjct: 407 VITSLDFSSSGLTGEIDPDISNLKWLETLDLSNNSLTGPVPDFLSQLPLKSLNLAGNNLT 466
Query: 331 GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLCVLV 390
GTIP L + ++ LL LSV GNP LC SC +D VPV+ SV +L V++
Sbjct: 467 GTIPADLFNRWQSDLLFLSVSGNPQLCASVSCNSDNKK-----NITVPVIISVTALFVII 521
Query: 391 TAMAI-LWSLRRRMQV----------------------AKNGSFELKNQRFSYSNVLRIT 427
AI LW L++R Q AK EL+ ++ Y +++IT
Sbjct: 522 AGSAIILWRLKKRKQQGTVPNGFCWVMIWPVVGKMEAEAKREPLELQKRQLRYFEIVQIT 581
Query: 428 NNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
NNF+R+LG GGFGTVYHG+LD EVAVKMLSPSSAQGYK+FQ EV+LL+R+HH+NLT+LV
Sbjct: 582 NNFQRILGKGGFGTVYHGHLDDMEVAVKMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLV 641
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------------- 534
GYCDEG LIYE+MANGNL+ L + LSWE RLRIA+EAA+
Sbjct: 642 GYCDEGNKMALIYEYMANGNLRDNLSDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPI 701
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK TNILL+ KFQAK+ADFGLSR PVEG G+HV+T +AGTPGYLDPEYY +N LT
Sbjct: 702 IHRDVKPTNILLNNKFQAKLADFGLSRICPVEG-GSHVSTIVAGTPGYLDPEYYATNWLT 760
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTH--ERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
EKSDV++FGVVLLEIITS VI +T + H++QW S M+ KGDI+SIVDPRL +DFDI
Sbjct: 761 EKSDVFSFGVVLLEIITSGPVISKTRDGDTTHLSQWFSSMVEKGDIQSIVDPRLGDDFDI 820
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISV 712
NS+WK VE+AMACVS TS +RPTMNQVV+EL+E LA ET + + S +S S
Sbjct: 821 NSLWKVVELAMACVSATSAQRPTMNQVVIELSECLATETVKTEGT--------SSQSYST 872
Query: 713 NQHSELSPLAR 723
H+EL+PLAR
Sbjct: 873 VLHTELTPLAR 883
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550478|ref|XP_003543614.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51860-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/794 (50%), Positives = 516/794 (64%), Gaps = 79/794 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG P FDI L A+ W ++ + + KEIIH+P +++V +CLVN G G P
Sbjct: 110 LYGNYDGLNTEPQFDIHLGANRWATVIIYNATIYYAKEIIHVPSQDYVQICLVNTGHGIP 169
Query: 61 FISAIELRPLKNSTYTTESGSLSLF---RRWDIGSRSSETFRYPDDIYDRIWLPNSLPNS 117
FISAIELR LKN TY T+ GSL + R D+GS + +RY DD+YDR W N+
Sbjct: 170 FISAIELRTLKNDTYVTQFGSLETYNDYERCDLGSNTG-GYRYKDDVYDRFW--NTCDFD 226
Query: 118 E---PINTTS---DIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYF 171
E P+ S D + NDY+ P+ V+ TAV P N S L + W P DP +Y Y++F
Sbjct: 227 EDWTPVLNASIPADSLEQNDYEPPAIVLSTAVTPANVSVPLVIKWVPQDPTDQFYVYMHF 286
Query: 172 SEFENVQANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESS 231
E + V A NQTR+ I NG WF SP + + +TIYS + + E+I++S TE+S
Sbjct: 287 LEIQ-VLATNQTRQFSITENGKTWFPNLSPTNQSVDTIYSLRAV-SGEQIKYSFEMTENS 344
Query: 232 TLPPILNAYEIYRAKEFLQFLTNQQDA-------------------------YLWQGLNC 266
TLPPI++A EIYR +F Q T Q D YLW GLNC
Sbjct: 345 TLPPIISAIEIYRVIDFQQSDTFQGDVDAITAIKSVYGVTRDWQGDPCAPIDYLWDGLNC 404
Query: 267 SYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTE 326
+YP D PRIT+LNLSSSG++G I P I LT ++ LDLSNN+L VPDFLSQL L
Sbjct: 405 TYPGNDSPRITTLNLSSSGLSGKIDPSILNLTMLENLDLSNNSLKDEVPDFLSQLQHLKI 464
Query: 327 LNLK-----GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASC---TADESNGSRDNKFVVP 378
LNL+ G+IP+ L+EK K G L+LSV NP LC C ++ G + V P
Sbjct: 465 LNLEKNNLSGSIPSTLVEKSKEGSLALSVGQNPYLCESGQCNQKEKEKEKGKDEKSIVTP 524
Query: 379 VVASVV-SLCVLVTAMAILWSLRRRMQVAKNGS-------------FELKNQRFSYSNVL 424
VVASV ++ +LV +AILW+L+RR K+ S + K Q +SYS+VL
Sbjct: 525 VVASVGGAVILLVVLVAILWTLKRRKSKEKDQSQISLQYTDQDDSFLQSKKQIYSYSDVL 584
Query: 425 RITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT 484
+ITNNF +LG GGFGTVY GY+D T VAVKMLSPSS GY+QFQAEV+LLMR+HHK LT
Sbjct: 585 KITNNFNAILGKGGFGTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKCLT 644
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLRIAIEAAK-------- 534
+LVGYC+EG ++ LIYE+MANGNLQ L G+ + +WE RLRIA++AA
Sbjct: 645 SLVGYCNEGNDKCLIYEYMANGNLQEHLTGKRSKTKFFTWEERLRIAVDAALGLEYLQNG 704
Query: 535 -----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRDVKSTNILL+ FQAK++DFGLS+ P +G THV+T +AGTPGYLDPEY+I
Sbjct: 705 CKPPIIHRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGV-THVSTVVAGTPGYLDPEYFI 763
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649
+NRLTEKSDVY+FGVVLLEIITS+ VI R E IHI++WVS ++ KGDIE+IVDPRL D
Sbjct: 764 TNRLTEKSDVYSFGVVLLEIITSQPVIARKEESIHISEWVSSLIAKGDIEAIVDPRLEGD 823
Query: 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIES 709
FD NSVWK VEIA AC+S KRP + +V+EL ESLA+E AR K +G E++DS+++
Sbjct: 824 FDSNSVWKAVEIATACLSPNMNKRPITSVIVIELKESLAMELARTKYSG--VETRDSVKT 881
Query: 710 ISVNQHSELSPLAR 723
+++N ++E SP AR
Sbjct: 882 VTMNLNTEFSPQAR 895
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556632|ref|XP_003546627.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/785 (50%), Positives = 508/785 (64%), Gaps = 70/785 (8%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG P FD++L A+ W ++ + S EIIH+P + V +CLVN G GTP
Sbjct: 108 LYGNYDGLNMLPQFDLLLGANRWATVTIYNASLDQFNEIIHVPSLDSVQLCLVNTGHGTP 167
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLP---NSLPNS 117
FISA+ELR LKN TY T GSL + RWD+GS ++ +RY D+YDR W N+
Sbjct: 168 FISAVELRTLKNDTYVTRFGSLETYNRWDLGS--NQAYRYNYDVYDRAWFTYGNNNDWTQ 225
Query: 118 EPINTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENV 177
++ + D +S +D++ P+ VM TAV P N S L +SWEP D LYY Y++F+E E V
Sbjct: 226 LNVSISVDSLSQSDFKPPAIVMSTAVTPVNASAPLVISWEPQDQTELYYVYMHFTEVE-V 284
Query: 178 QANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPIL 237
NQTRE I NG W+ SP + A+TIYS + EKI++S+ TE+S LPPI+
Sbjct: 285 LEKNQTREFNINQNGKPWYQNLSPRYQKADTIYSGIGT-SGEKIKYSLEMTENSNLPPII 343
Query: 238 NAYEIYRAKEFLQFLTNQQD-------------------------AYLWQGLNCSYPEYD 272
NA EIYR K+F Q T Q D AYLW GLNC+Y
Sbjct: 344 NAIEIYRLKDFQQSDTYQGDVDVITTIKSVYKVTRDWQGDPCGPVAYLWHGLNCTYAANQ 403
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK-- 330
PRIT+LNLSSSG+ G I P IS L ++ LDLSNN+L G VPDFLSQL L LNL+
Sbjct: 404 SPRITTLNLSSSGLLGKIDPSISKLAMLEKLDLSNNSLNGEVPDFLSQLQHLKILNLEKN 463
Query: 331 ---GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLC 387
G+IP+ L+EK K G LSLSV N LC C + + N V P+VASV +
Sbjct: 464 NLSGSIPSTLVEKSKEGSLSLSVGQNSFLCESDQCNEKQKE-KKKNNIVTPLVASVSGVV 522
Query: 388 VLVTAMA-ILWSLRRRMQVAKNGS-------------FELKNQRFSYSNVLRITNNFERV 433
+L+ MA ILW+L+RR K+ S + K Q +S+S+VL+ITNNF
Sbjct: 523 ILLVVMAAILWTLKRRKSKEKDQSQISPQYTEQDDSLLQFKKQIYSFSDVLKITNNFNTT 582
Query: 434 LGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG 493
LG GGFGTVY G+++ T VAVKMLSPSS GY+QFQAEV+LLMR+HHKNLT+LVGYC+EG
Sbjct: 583 LGKGGFGTVYLGHINDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLTSLVGYCNEG 642
Query: 494 TNRGLIYEFMANGNLQALLLGE--EADILSWEGRLRIAIEAAK-------------VHRD 538
T++GLIYE+MANGNL L G+ + +WE RLRIA++AA +HRD
Sbjct: 643 TSKGLIYEYMANGNLLEHLSGKHGKTKFFTWEERLRIAVDAALGLEYLQNGCKPPIIHRD 702
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
VKSTNILL+ FQAK++DFGLS+ P EG THV+T +AGTPGYLDPEY+I+NRLTEKSD
Sbjct: 703 VKSTNILLNELFQAKLSDFGLSKVIPTEGV-THVSTVVAGTPGYLDPEYFITNRLTEKSD 761
Query: 599 VYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658
VY+FGVVLLEIITS+ VI R E IHI++WVS ++ KGDI++IVD RL +D NSVWK
Sbjct: 762 VYSFGVVLLEIITSQPVIARNQENIHISEWVSSLIMKGDIKAIVDSRLEGAYDTNSVWKA 821
Query: 659 VEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISVNQHSEL 718
VEIA ACVS KRP + +V+EL ESLA+E AR K G ++DS+ S+++N ++E
Sbjct: 822 VEIATACVSPNLNKRPITSVIVVELKESLAMELARTKNRGT--NTRDSVTSVTMNLNTEF 879
Query: 719 SPLAR 723
P AR
Sbjct: 880 IPQAR 884
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556621|ref|XP_003546622.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51880-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/791 (50%), Positives = 511/791 (64%), Gaps = 75/791 (9%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG P FD++L A+ W ++ + S + EII++P ++V++C+V+ G GTP
Sbjct: 109 LYGNYDGLNMLPKFDLLLGANRWLTVNINNASVSLDFEIIYVPSLDYVHICMVDTGHGTP 168
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPI 120
FISAIELR L+ Y T GSL R D+GS + +RY D+YDR W L P+
Sbjct: 169 FISAIELRTLRIDIYETRFGSLETDFRVDLGS--NRGYRYNYDVYDRYWSGADLDTWRPL 226
Query: 121 N--TTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQ 178
N +D + NDY+ P+ VM TA+ P N S L +SW+P+DPK +Y YL+F+E + V
Sbjct: 227 NFPIDADSLVQNDYKPPAVVMSTAITPANVSAPLVISWKPDDPKDSFYVYLHFTEIQ-VL 285
Query: 179 ANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILN 238
A NQTRE I +NG W SP + + NTIYST I + EKI FS TE+STLPPI+N
Sbjct: 286 AKNQTREFNITLNGNPWTENISPRYHSVNTIYSTSGI-SGEKINFSFVMTETSTLPPIIN 344
Query: 239 AYEIYRAKEFLQFLTNQQDA-------------------------YLWQGLNCSYPEYDP 273
A EIYR KEF Q T Q D YLW+GLNC+YP D
Sbjct: 345 AIEIYRVKEFPQPDTYQGDVDAITTIKSVYGVTRDWQGDPCSPKDYLWEGLNCTYPVVDS 404
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK--- 330
PRI +LNLSSSG++G I P I LT ++ LDLSNN+L G VPDFLSQL L LNL+
Sbjct: 405 PRIITLNLSSSGLSGKIDPSILNLTMLEKLDLSNNSLDGEVPDFLSQLQHLKILNLENNN 464
Query: 331 --GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDN---KFVVPVVASVVS 385
G+IP+ L+EK K G LSLSV NP LC C E + V PVVAS
Sbjct: 465 LSGSIPSTLVEKSKEGSLSLSVGQNPHLCESGQCNEKEKEKGEEEDKKNIVTPVVASAGG 524
Query: 386 LCVLVTAMA-ILWSLRRR----MQVAKNGS-------------FELKNQRFSYSNVLRIT 427
+ +L+ A+A IL +L+RR V K+ S + K Q +SYS+VL IT
Sbjct: 525 VVILLLAVAAILRTLKRRNSKASMVEKDQSPISPQYTGQDDSLLQSKKQIYSYSDVLNIT 584
Query: 428 NNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
NNF ++G GG GTVY GY+D T VAVKMLSPSS GY+QFQAEV+LLMR+HHKNL +LV
Sbjct: 585 NNFNTIVGKGGSGTVYLGYIDDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLISLV 644
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLRIAIEAAK----------- 534
GYC+EG N+ LIYE+M NGNLQ + G+ + +WE RLRIA++AA
Sbjct: 645 GYCNEGDNKALIYEYMNNGNLQEHITGKRSKTKFFTWEDRLRIAVDAASGLEYLQNGCKP 704
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRDVKSTNILL+ FQAK++DFGLS+ P +GS THV+T IAGTPGYLDPEYYI+NR
Sbjct: 705 PIIHRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGS-THVSTVIAGTPGYLDPEYYITNR 763
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
LTEKSDVY+FGVVLLEIITSK VI + E+ HI+QWVS ++ KGDI+SIVD RL DFD
Sbjct: 764 LTEKSDVYSFGVVLLEIITSKPVITKNQEKTHISQWVSSLVAKGDIKSIVDSRLEGDFDN 823
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESISV 712
NSVWK VEIA ACVS +RP ++ +V EL ESLA+E AR K G +S+DS++ +++
Sbjct: 824 NSVWKAVEIAAACVSPNPNRRPIISVIVTELKESLAMELARTKYGGP--DSRDSVKPVTM 881
Query: 713 NQHSELSPLAR 723
N ++E SP AR
Sbjct: 882 NLNTEFSPQAR 892
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547364|ref|XP_003542083.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/793 (49%), Positives = 503/793 (63%), Gaps = 89/793 (11%)
Query: 1 MYGNYDGQGKPPSFDIILEADVWDSIEFEDESTIVTKEIIHIPQKNFVYVCLVNKGSGTP 60
+YGNYDG K P FDI L A+ W ++ + ST EII++P +++ +CLV+ GTP
Sbjct: 114 LYGNYDGLNKAPQFDIHLGANRWYTVTISNASTPQANEIIYVPSLDYLQICLVDTDHGTP 173
Query: 61 FISAIELRPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIW----------- 109
FISAIELR LKN TY T+ GSL + RWD+GS +S +RY D+YDR W
Sbjct: 174 FISAIELRTLKNYTYVTQFGSLEYYNRWDLGSNNS--YRYNHDVYDRFWYIYGDNKDWKQ 231
Query: 110 LPNSLPNSEPINTTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYL 169
L S+P +D ++ NDY+ P ++ TAV P N S L +SWEP D LYY Y+
Sbjct: 232 LSASIP--------ADSLNQNDYKPPEIILSTAVTPVNASAPLVISWEPPDQTELYYVYM 283
Query: 170 YFSEFENVQANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKIEFSINTTE 229
+F+E + V A NQTRE I NG W SP + TIYS + +KIE+S+ T+
Sbjct: 284 HFTEIQ-VLAKNQTREFNIAQNGKPWCPNMSPPYQNVTTIYSRLGT-SGKKIEYSLEKTK 341
Query: 230 SSTLPPILNAYEIYRAKEFLQFLTNQQD-------------------------AYLWQGL 264
S+LPPI+NA EIYR F Q T+Q D AYLW GL
Sbjct: 342 DSSLPPIINAIEIYRVINFQQSDTHQGDVDAIATIKSVYGMTRDWQGDPCSPVAYLWNGL 401
Query: 265 NCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFL 324
NC+Y + PRIT+LNLSSS ++G I P IS LT ++ LDLSNNNL G VPDFLS+L L
Sbjct: 402 NCTYRGNENPRITTLNLSSSELSGMIDPSISYLTMLEKLDLSNNNLNGEVPDFLSRLQHL 461
Query: 325 TELNLK-----GTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCTADESNGSRDNKFVVPV 379
+NL G+IP+ L++K K G LSLSV N LC C + + V P+
Sbjct: 462 KIINLDNNNLTGSIPSELVKKSKEGFLSLSVGQNLYLCESGQCNEKK----KKKNIVTPL 517
Query: 380 VASVVSLCVLVTAMA-ILWSLRRRMQVAKNGS-------------FELKNQRFSYSNVLR 425
+ASV + +LV A+A I W+L++R KN S + K Q +S+S+VLR
Sbjct: 518 LASVSGVLILVVAVAAISWTLKKRKPKEKNQSEMSAQCTEQDDSLHQFKKQIYSHSDVLR 577
Query: 426 ITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
ITNNF ++G GGFGTVY GY+DGT VAVKMLS SS GY+QFQAEV+LLMR+HH NLT+
Sbjct: 578 ITNNFNTIVGKGGFGTVYLGYIDGTPVAVKMLSTSSVHGYQQFQAEVKLLMRVHHANLTS 637
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGE--EADILSWEGRLRIAIEAAK--------- 534
LVGYC+EG N+GLIYE+MANGNL L G+ ++ L+WE RLRIA++AA
Sbjct: 638 LVGYCNEGDNKGLIYEYMANGNLHEHLSGKHIKSKFLTWEDRLRIAVDAALGLEYLQTGC 697
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRDVKSTNILL K QAK++DFGLS+ P++G GTHV+T +AGTPGYLDPEYYIS
Sbjct: 698 KPPIIHRDVKSTNILLDEKLQAKLSDFGLSKIIPIDG-GTHVSTVVAGTPGYLDPEYYIS 756
Query: 591 NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650
NRLT+KSD+Y FGVVLLEIIT + VI ER HI QWV ++G GDI+ IVD RL DF
Sbjct: 757 NRLTQKSDIYGFGVVLLEIITCQPVIAWNEERTHIIQWVRSLIGIGDIKGIVDSRLEGDF 816
Query: 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYESKDSIESI 710
DINS WK VEIAMACVS ++RP M +V EL E+LA E AR K +S +SIE +
Sbjct: 817 DINSAWKAVEIAMACVSLNPSERPIMRVIVTELKETLATELARTKHNSA--DSINSIEPV 874
Query: 711 SVNQHSELSPLAR 723
++N +E +PLAR
Sbjct: 875 TMNLDTEFTPLAR 887
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 723 | ||||||
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.435 | 0.353 | 0.572 | 5.2e-149 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.424 | 0.347 | 0.578 | 1.4e-146 | |
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.427 | 0.345 | 0.580 | 8.8e-145 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.430 | 0.351 | 0.556 | 2.6e-143 | |
| TAIR|locus:2017647 | 885 | AT1G51820 [Arabidopsis thalian | 0.424 | 0.346 | 0.603 | 4.3e-143 | |
| TAIR|locus:2195830 | 837 | AT1G51870 [Arabidopsis thalian | 0.435 | 0.376 | 0.563 | 4.3e-143 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.424 | 0.354 | 0.593 | 5.6e-143 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.439 | 0.358 | 0.535 | 8.9e-143 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.426 | 0.345 | 0.584 | 1.3e-139 | |
| TAIR|locus:2078196 | 871 | AT3G46350 [Arabidopsis thalian | 0.430 | 0.357 | 0.537 | 4e-138 |
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 5.2e-149, Sum P(2) = 5.2e-149
Identities = 190/332 (57%), Positives = 253/332 (76%)
Query: 406 AKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGY 465
+ N S + ++ +Y VL++TNNFERVLG GGFGTVYHG LDG EVAVKMLS SSAQGY
Sbjct: 562 SSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNLDGAEVAVKMLSHSSAQGY 621
Query: 466 KQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEG 524
K+F+AEVELL+R+HH++L LVGYCD+G N LIYE+MANG+L+ + G+ ++L+WE
Sbjct: 622 KEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWEN 681
Query: 525 RLRIAIEAAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571
R++IA+EAA+ VHRDVK+TNILL+ + AK+ADFGLSR+FP++G H
Sbjct: 682 RMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGE-CH 740
Query: 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631
V+T +AGTPGYLDPEYY +N L+EKSDVY+FGVVLLEI+T++ VI++T ER HI WV F
Sbjct: 741 VSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHINDWVGF 800
Query: 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691
ML KGDI+SIVDP+L D+D N WK VE+A+ACV+ +S +RPTM VVMELN+ +A+E
Sbjct: 801 MLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALEN 860
Query: 692 ARLKAAGKEYESKDSIESISVNQHSELSPLAR 723
AR + + + Y S S++ S++ S+ +P AR
Sbjct: 861 ARRQGSEEMY-SMGSVD-YSLSSTSDFAPGAR 890
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 1.4e-146, Sum P(2) = 1.4e-146
Identities = 188/325 (57%), Positives = 255/325 (78%)
Query: 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEV 472
KN+RF+YS V+ +TNNF+R+LG GGFG VYHG+++G E VAVK+LS SS+QGYKQF+AEV
Sbjct: 563 KNKRFTYSQVVIMTNNFQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEV 622
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-EEADILSWEGRLRIAIE 531
ELL+R+HHKNL LVGYCDEG N LIYE+MANG+L+ + G IL+WE RL+I I+
Sbjct: 623 ELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVID 682
Query: 532 AAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
+A+ VHRDVK+TNILL+ F+AK+ADFGLSR+FP+ G THV+T +AG
Sbjct: 683 SAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGE-THVSTVVAG 741
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638
TPGYLDPEYY +NRLTEKSDVY+FG+VLLE+IT++ VI+++ E+ +I++WV ML KGDI
Sbjct: 742 TPGYLDPEYYKTNRLTEKSDVYSFGIVLLEMITNRPVIDQSREKPYISEWVGIMLTKGDI 801
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAG 698
SI+DP L+ D+D SVWK VE+AM+C++ +ST+RPTM+QV++ LNE L E +R A
Sbjct: 802 ISIMDPSLNGDYDSGSVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSENSR-GGAS 860
Query: 699 KEYESKDSIESISVNQHSELSPLAR 723
++ +SK S+E +S+ +++SP+AR
Sbjct: 861 RDMDSKSSLE-VSLTFDTDVSPMAR 884
|
|
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 945 (337.7 bits), Expect = 8.8e-145, Sum P(2) = 8.8e-145
Identities = 188/324 (58%), Positives = 245/324 (75%)
Query: 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVE 473
KN++ +Y +V++ITNNFERVLG GGFG VY+G L+ VAVKML+ S+A GYKQF+AEVE
Sbjct: 572 KNRKLTYIDVVKITNNFERVLGRGGFGVVYYGVLNNEPVAVKMLTESTALGYKQFKAEVE 631
Query: 474 LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEA 532
LL+R+HHK+LT LVGYC+EG LIYEFMANG+L+ L G+ IL+WEGRLRIA E+
Sbjct: 632 LLLRVHHKDLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAES 691
Query: 533 AK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579
A+ VHRD+K+TNILL+ KFQAK+ADFGLSR+FP+ G+ THV+T +AGT
Sbjct: 692 AQGLEYLHNGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPL-GTETHVSTIVAGT 750
Query: 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE 639
PGYLDPEYY +N LTEKSDV++FGVVLLE++T++ VI+ E+ HI +WV ML +GDI
Sbjct: 751 PGYLDPEYYRTNWLTEKSDVFSFGVVLLELVTNQPVIDMKREKSHIAEWVGLMLSRGDIN 810
Query: 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGK 699
SIVDP+L DFD N++WK VE AM C++ +S++RPTM QVVM+L E L +E AR +
Sbjct: 811 SIVDPKLQGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNMEMARNMGSRM 870
Query: 700 EYESKDSIESISVNQHSELSPLAR 723
+ DS +S+N +EL+P AR
Sbjct: 871 TDSTNDSSIELSMNFTTELNPGAR 894
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 2.6e-143, Sum P(2) = 2.6e-143
Identities = 183/329 (55%), Positives = 247/329 (75%)
Query: 410 SFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQF 468
SF K RF+YS V +TNNF++ LG GGFG VYHG+++ E VAVK+LS SS+QGYK F
Sbjct: 559 SFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHF 618
Query: 469 QAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD-ILSWEGRLR 527
+AEVELLMR+HH NL +LVGYCDEG + LIYE+M NG+L+ L G+ +LSWE RL+
Sbjct: 619 KAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGKHGGFVLSWESRLK 678
Query: 528 IAIEAA-------------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
I ++AA VHRD+K+TNILL QAK+ADFGLSR+FP+ G+ +V+T
Sbjct: 679 IVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSRSFPI-GNEKNVST 737
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634
+AGTPGYLDPEYY +N LTEKSD+Y+FG+VLLEII+++ +I+++ E+ HI +WVSFM+
Sbjct: 738 VVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSREKPHIVEWVSFMIT 797
Query: 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARL 694
KGD+ SI+DP LH+D+DI SVWK +E+AM+CVS +S +RP M++VV EL E L ET+R+
Sbjct: 798 KGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSRVVNELKECLISETSRI 857
Query: 695 KAAGKEYESKDSIESISVNQHSELSPLAR 723
G++ ESK S+E S + ++E+ P AR
Sbjct: 858 -GEGRDMESKGSME-FSRDIYNEVIPQAR 884
|
|
| TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
Identities = 196/325 (60%), Positives = 255/325 (78%)
Query: 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEV 472
KN+RFSYS V+ +TNNF+R+LG GGFG VYHG+++GTE VAVK+LS SS+QGYKQF+AEV
Sbjct: 564 KNRRFSYSQVVIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEV 623
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-EEADILSWEGRLRIAIE 531
ELL+R+HHKNL LVGYCDEG N LIYE+MANG+L+ + G IL+W RL+I IE
Sbjct: 624 ELLLRVHHKNLVGLVGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIE 683
Query: 532 AAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
+A+ VHRDVK+TNILL+ F+AK+ADFGLSR+F +EG THV+T +AG
Sbjct: 684 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGE-THVSTVVAG 742
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638
TPGYLDPEY+ +N LTEKSDVY+FG++LLEIIT++ VI+++ E+ HI +WV ML KGDI
Sbjct: 743 TPGYLDPEYHRTNWLTEKSDVYSFGILLLEIITNRHVIDQSREKPHIGEWVGVMLTKGDI 802
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAG 698
+SI+DP L+ED+D SVWK VE+AM+C++ +S +RPTM+QVV+ELNE LA E AR A
Sbjct: 803 QSIMDPSLNEDYDSGSVWKAVELAMSCLNHSSARRPTMSQVVIELNECLASENAR-GGAS 861
Query: 699 KEYESKDSIESISVNQHSELSPLAR 723
++ ESK SIE +S+ +E+SP AR
Sbjct: 862 RDMESKSSIE-VSLTFGTEVSPNAR 885
|
|
| TAIR|locus:2195830 AT1G51870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
Identities = 187/332 (56%), Positives = 247/332 (74%)
Query: 406 AKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGY 465
+ N S K+++ +Y VL++TNNFERVLG GGFGTVYHG ++ +VAVKMLS SSAQGY
Sbjct: 509 SSNPSIMRKDRKITYPQVLKMTNNFERVLGKGGFGTVYHGNMEDAQVAVKMLSHSSAQGY 568
Query: 466 KQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEG 524
K+F+AEVELL+R+HH++L LVGYCD+G N LIYE+MANG+L+ +LG+ ++L+WE
Sbjct: 569 KEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMLGKRGGNVLTWEN 628
Query: 525 RLRIAIEAAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571
R++IA+EAA+ VHRDVK+TNILL+ + AK+ADFGLSR+FP++G H
Sbjct: 629 RMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNAQCGAKLADFGLSRSFPIDGE-CH 687
Query: 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631
V+T +AGTPGYLDPEYY +N L+EKSDVY+FGVVLLEI+T++ VI +T ER HI +WV F
Sbjct: 688 VSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVINQTRERPHINEWVGF 747
Query: 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691
ML KGDI+SIVDP+L D+D N WK VE+ +ACV+ +S RPTM VV+ELNE +A E
Sbjct: 748 MLSKGDIKSIVDPKLMGDYDTNGAWKIVELGLACVNPSSNLRPTMAHVVIELNECVAFEN 807
Query: 692 ARLKAAGKEYESKDSIESISVNQHSELSPLAR 723
AR + + + Y + + S SE SP AR
Sbjct: 808 ARRQGSEEMYTRSST--NFSHTSASEFSPGAR 837
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 5.6e-143, Sum P(3) = 5.6e-143
Identities = 193/325 (59%), Positives = 253/325 (77%)
Query: 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQFQAEV 472
KN+RF+YS V +TNNF+R+LG GGFG VYHG+++GTE VAVK+LS SS+QGYK+F+AEV
Sbjct: 544 KNRRFTYSQVAIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKEFKAEV 603
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADI-LSWEGRLRIAIE 531
ELL+R+HHKNL LVGYCDEG N LIYE+MANG+L+ + G L+W RL+I +E
Sbjct: 604 ELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFTLNWGTRLKIVVE 663
Query: 532 AAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
+A+ VHRDVK+TNILL+ FQAK+ADFGLSR+FP+EG THV+T +AG
Sbjct: 664 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIEGE-THVSTVVAG 722
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638
TPGYLDPEYY +N LTEKSDVY+FG+VLLE+IT++ VI+++ E+ HI +WV ML KGDI
Sbjct: 723 TPGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDKSREKPHIAEWVGVMLTKGDI 782
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAG 698
SI+DP L+ED+D SVWK VE+AM+C++ +S +RPTM+QVV+ELNE +A E +R A
Sbjct: 783 NSIMDPNLNEDYDSGSVWKAVELAMSCLNPSSARRPTMSQVVIELNECIASENSR-GGAS 841
Query: 699 KEYESKDSIESISVNQHSELSPLAR 723
++ +SK SIE +S+ +ELSP AR
Sbjct: 842 RDMDSKSSIE-VSLTFDTELSPTAR 865
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 8.9e-143, Sum P(2) = 8.9e-143
Identities = 180/336 (53%), Positives = 236/336 (70%)
Query: 393 MAILWSLRRRMQVAKN---GSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDG 449
+ +++ RRR + S E+KN+RF YS V +TNNFE VLG GGFG VYHG+L+
Sbjct: 543 LVLIFIFRRRKSSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNN 602
Query: 450 TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509
+VAVK+LS SS QGYK+F+ EVELL+R+HH NL +LVGYCD+G + LIYEFM NGNL+
Sbjct: 603 EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLK 662
Query: 510 ALLLGEEAD-ILSWEGRLRIAIEAA-------------KVHRDVKSTNILLSGKFQAKIA 555
L G+ +L+W GRL+IAIE+A VHRDVKSTNILL +F+AK+A
Sbjct: 663 EHLSGKRGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLA 722
Query: 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSV 615
DFGLSR+F V GS THV+T +AGT GYLDPEYY N LTEKSDVY+FG+VLLEIIT + V
Sbjct: 723 DFGLSRSFLV-GSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPV 781
Query: 616 IERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPT 675
IE++ ++ +I +W ML GDIESI+D LH+D+D +S WK +E+AM C++ +ST RP
Sbjct: 782 IEQSRDKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPN 841
Query: 676 MNQVVMELNESLAIETARLKAAGKEYESKDSIESIS 711
M +V ELNE L I + + + SK S +++
Sbjct: 842 MTRVAHELNECLEIYNLTKRRSQDQNSSKSSGHTVT 877
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 1.3e-139, Sum P(2) = 1.3e-139
Identities = 191/327 (58%), Positives = 246/327 (75%)
Query: 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEV 472
KN+RF+YS V+++TNNFE++LG GGFG VYHG + D +VAVKMLSPSS+QGYK+F+AEV
Sbjct: 568 KNRRFTYSEVVKMTNNFEKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEV 627
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIE 531
ELL+R+HHKNL LVGYCDEG N LIYE+MA G+L+ +LG + IL W+ RL+I E
Sbjct: 628 ELLLRVHHKNLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAE 687
Query: 532 AAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
+A+ VHRDVK+TNILL FQAK+ADFGLSR+FP+EG T V T +AG
Sbjct: 688 SAQGLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGE-TRVDTVVAG 746
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638
TPGYLDPEYY +N L EKSDVY+FG+VLLEIIT++ VI ++ E+ HI +WV ML KGDI
Sbjct: 747 TPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHVINQSREKPHIAEWVGVMLTKGDI 806
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAG 698
+SI+DP+ D+D SVW+ VE+AM+CV+ +ST RPTM+QVV+ELNE LA E +R +
Sbjct: 807 KSIIDPKFSGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVIELNECLASENSR-RGMS 865
Query: 699 KEYESKDSIE--SISVNQHSELSPLAR 723
+ ESK SI+ +S N +E +P AR
Sbjct: 866 QNMESKGSIQYTEVSTNFGTEYTPEAR 892
|
|
| TAIR|locus:2078196 AT3G46350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 4.0e-138, Sum P(2) = 4.0e-138
Identities = 177/329 (53%), Positives = 243/329 (73%)
Query: 410 SFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQGYKQF 468
S E+K ++FSYS V+++TNNF+R LG GGFGTVYHG LD ++ VAVK+LS SS QGYK+F
Sbjct: 546 SIEMKRKKFSYSEVMKMTNNFQRALGEGGFGTVYHGDLDSSQQVAVKLLSQSSTQGYKEF 605
Query: 469 QAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLR 527
+AEV+LL+R+HH NL LVGYCDE + LIYE+M+NG+L+ L GE +LSW RLR
Sbjct: 606 KAEVDLLLRVHHINLLNLVGYCDERDHLALIYEYMSNGDLKHHLSGEHGGSVLSWNIRLR 665
Query: 528 IAIEAA-------------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
IA++AA VHRDVKSTNILL F AKIADFGLSR+F + G +HV+T
Sbjct: 666 IAVDAALGLEYLHIGCRPSMVHRDVKSTNILLDENFMAKIADFGLSRSF-ILGGESHVST 724
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634
+AG+ GYLDPEYY ++RL E SDVY+FG+VLLEIIT++ VI++T E+ HIT+W +FML
Sbjct: 725 VVAGSLGYLDPEYYRTSRLAEMSDVYSFGIVLLEIITNQRVIDKTREKPHITEWTAFMLN 784
Query: 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARL 694
+GDI I+DP L+ D++ +SVW+ +E+AM+C + +S RP+M+QVV EL E L E + L
Sbjct: 785 RGDITRIMDPNLNGDYNSHSVWRALELAMSCANPSSENRPSMSQVVAELKECLISENS-L 843
Query: 695 KAAGKEYESKDSIESISVNQHSELSPLAR 723
++ ++ S+ S++ +S+N ++ P AR
Sbjct: 844 RSKNQDMSSQRSLD-MSMNFDTKDVPSAR 871
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034228001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (853 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 723 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-79 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 1e-79
Identities = 108/258 (41%), Positives = 141/258 (54%), Gaps = 20/258 (7%)
Query: 1 MYGNYDGQGK---PPSFDIILEADVWDSIEF-EDESTIVTKE-IIHIPQKNFVYVCLVNK 55
+YGNYDG PPSFD+ L ++W ++ D V KE IIH+ + + + VCLVN
Sbjct: 81 LYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVVKEYIIHVTKSDTLSVCLVNT 140
Query: 56 GSGTPFISAIELRPLKNSTYTTESGS--LSLFRRWDIGSRSSETFRYPDDIYDRIWLPNS 113
G+GTPFISA+ELRPL +S Y + GS L L R + G S T RYPDD+YDRIW P
Sbjct: 141 GTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGG-SEGTIRYPDDVYDRIWEPFF 199
Query: 114 LPNSEPINTTS----DIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYL 169
+TS + Y PS V+QTAV PTN S L +W+ DP F YY YL
Sbjct: 200 SSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNASAPLNFTWDLVDPNFEYYVYL 259
Query: 170 YFSEFENVQANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTA----EKIEFSI 225
+F+E + + +TRE IYING +G SP + +T + S+
Sbjct: 260 HFAEIQ----SLETREFDIYINGKTVYGDVSPKYLGTDTGALYLDFPVNVSGGGLLNISL 315
Query: 226 NTTESSTLPPILNAYEIY 243
T STLPP+LNA EI+
Sbjct: 316 VPTSGSTLPPLLNALEIF 333
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 72/204 (35%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 432 RVLGNGGFGTVYHGYLDG-----TEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTT 485
+ LG G FG VY G L G TEVAVK L S + K F E ++ ++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLL-------GEEADILSWEGRLRIAIEAAK---- 534
L+G C E L+ E+M G+L L E LS + L AI+ AK
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEY 587
VHRD+ + N L+ KI+DFGLSR V + T P ++ PE
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKLPIRWMAPES 178
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
T KSDV++FGV+L EI T
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 24/217 (11%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTLVGYC 490
LG GGFGTVY G +VA+K++ + + E+E+L +++H N+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVK 540
++ + L+ E+ G+L+ LL E LS + LRI ++ + +HRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 541 STNILL-SGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR-LTEKSD 598
NILL S + K+ADFGLS+ S + TI GTP Y+ PE + +EKSD
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLL---TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 599 VYNFGVVLLEIITSKSVIERT-----HERIHITQWVS 630
+++ GV+L E+ K +I + +R + +
Sbjct: 177 IWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKML-SPSSAQGYKQFQAEVELLMRIHHKN 482
+ LG G FG VY G L G EVAVK L +S Q ++F E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C E ++ E+M G+L L LS L A++ A+
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPE 586
+HRD+ + N L+ KI+DFGLSR + G PE
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMA----PE 174
Query: 587 YYISNRLTEKSDVYNFGVVLLEIIT 611
+ T KSDV++FGV+L EI T
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 9e-40
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKN 482
+ LG G FG VY G L G T+VAVK L +++ ++ F E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C +G ++ E+M G+L L + + L+ + L++A++ AK
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISN 591
VHRD+ + N L++ KI+DFGLSR + + P ++ PE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
+ T KSDV++FGV+L EI T
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 430 FERVLGNGGFGTVYHGYLDGT------EVAVKML-SPSSAQGYKQFQAEVELLMRIHHKN 482
+ LG G FG VY G L G EVAVK L +S Q ++F E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C E ++ E+M G+L + L + LS L A++ A+
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG---YLDPEYYI 589
+HRD+ + N L+ KI+DFGLSR G ++ PE
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-----DDYYRKRGGKLPIRWMAPESLK 176
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ T KSDV++FGV+L EI T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 430 FERVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTT 485
R LG+G FGTVY GT VAVK+L S + + + E+ +L R+ H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------V 535
L+ ++ + L+ E+ G+L L LS + +IA++ + +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-T 594
HRD+K NILL KIADFGL++ S TT GTP Y+ PE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSS---SLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 595 EKSDVYNFGVVLLEIITSKSV--IERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
K DV++ GV+L E++T K E +++ + I I+ P L D
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQL------------IRRILGPPLEFDEPK 225
Query: 653 NSVWKTVEIAMA-----CVSQTSTKRPTMNQVV 680
W + C+++ +KRPT +++
Sbjct: 226 ---WSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY-KQFQAEVELLMRIHHKNLTTL 486
LG G FG VY G VA+K++ + ++ E+++L ++ H N+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR-IAIEAAK----------V 535
++ L+ E+ G+L LL ++ LS E R + V
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLS-EDEARFYLRQILSALEYLHSKGIV 119
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
HRD+K NILL K+ADFGL+R TT GTP Y+ PE + +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 596 KSDVYNFGVVLLEIITSKS 614
D+++ GV+L E++T K
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 31/204 (15%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVK--MLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
+LG G FG+VY G +AVK LS S + + + E+ +L + H N+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 488 GYC--DEGTNRGLIYEFMANGNLQALL-----LGEE------ADILSWEG-----RLRIA 529
G +E + E+++ G+L +LL L E IL EG I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL--EGLAYLHSNGI- 122
Query: 530 IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
VHRD+K NIL+ K+ADFG ++ + T ++ GTP ++ PE
Sbjct: 123 -----VHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 590 SNRLTEKSDVYNFGVVLLEIITSK 613
+D+++ G ++E+ T K
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-26
Identities = 117/477 (24%), Positives = 206/477 (43%), Gaps = 86/477 (18%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN----- 328
+ L LS + ++G+I +S+ + LDLS+N L+G +P S++P L++L+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 329 LKGTIPNGL--IEK--QKN-------GLL----------SLSVEGNPDLCPEASCTADES 367
L G IP L +E Q N G L + +V GN DLC D +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG-----DTT 613
Query: 368 NGSRDNKFVVP-------VVASVVSLCVL-VTAMAILWSLRRRMQVAK-----NGSFELK 414
+G K V + ++ + VL + A ++ R K +G++EL+
Sbjct: 614 SGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ 673
Query: 415 --NQRFSYS---NVLRITNNFERVLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQ 467
+ + S S N + + E V+ G G Y G +G + VK ++ ++
Sbjct: 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP--- 730
Query: 468 FQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR 527
+E+ + ++ H N+ L+G C LI+E++ NL +L LSWE R +
Sbjct: 731 -SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRK 784
Query: 528 IAIEAAKVHR-------------DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
IAI AK R ++ I++ GK + + L + T
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-------T 836
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH--ITQWVSFM 632
+ Y+ PE + +TEKSD+Y FG++L+E++T KS + +H I +W +
Sbjct: 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYC 895
Query: 633 LGKGDIESIVDPRLHEDFDINS--VWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
++ +DP + D +N + + + +A+ C + T RP N V+ L +
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 21/196 (10%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+G GGFG VY G EVA+K++ S + ++ E+++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 490 CDEGTNRGLIYEFMANGNLQALLLG-----EEADI-------LSWEGRLRIAIEAAKVHR 537
+ ++ EF + G+L+ LL E+ I L +G L +HR
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELL--KG-LEYLHSNGIIHR 122
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+K+ NILL+ + K+ DFGLS S T T+ GTP ++ PE K+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 598 DVYNFGVVLLEIITSK 613
D+++ G+ +E+ K
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 71/218 (32%), Positives = 97/218 (44%), Gaps = 43/218 (19%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLS-PSSAQGYKQFQAEVELLMRIHHK 481
+R LG G FG V+ G D VAVK L +S K F+ E ELL H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLL--GEEADILSWEGR----------LRIA 529
N+ G C EG +++E+M +G+L L G +A L L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 530 IEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRT------FPVEGSGTHVT 573
++ A VHRD+ + N L+ KI DFG+SR + V G H
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG---HTM 185
Query: 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
I P PE + + T +SDV++FGVVL EI T
Sbjct: 186 LPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 26/198 (13%)
Query: 431 ERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
ER LG G FG V+ G +G T+VAVK L P + + F E +++ ++ H L L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDV 539
C E ++ E+M+ G+L L E L + +A + A+ +HRD+
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129
Query: 540 KSTNILLSGKFQAKIADFGLSRTF------PVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
+ NIL+ KIADFGL+R EG+ + T PE R
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA--------PEAANYGRF 181
Query: 594 TEKSDVYNFGVVLLEIIT 611
T KSDV++FG++L EI+T
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 434 LGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG 493
+G G FG V G G +VAVK L S + F AE ++ + H NL L+G +G
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 494 TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTN 543
++ E+MA G+L L +++ +L A++ + VHRD+ + N
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132
Query: 544 ILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYN 601
+L+S AK++DFGL++ + + V T PE + + KSDV++
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA--------PEALREKKFSTKSDVWS 184
Query: 602 FGVVLLEI 609
FG++L EI
Sbjct: 185 FGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 431 ERVLGNGGFGTVYHG-YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
ER LG+G FG V+ G + + VA+K+L + FQ EV+ L R+ HK+L +L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDV 539
C G +I E M G+L A L E +L + +A + A+ +HRD+
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130
Query: 540 KSTNILLSGKFQAKIADFGLSRTF--PVEGSGTH---VTTTIAGTPGYLDPEYYISNRLT 594
+ NIL+ K+ADFGL+R V S T PE +
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA--------PEAASHGTFS 182
Query: 595 EKSDVYNFGVVLLEIIT 611
KSDV++FG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 425 RITNNFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
R + R LG G FG V+ G + T VAVK L P + K F AE +++ ++ H L
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKL 63
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L C ++ E M G+L L G L + +A + A
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNR 592
+HRD+ + N+L+ K+ADFGL+R + A P + PE + NR
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 593 LTEKSDVYNFGVVLLEIIT 611
+ KSDV++FG++L EI+T
Sbjct: 181 FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 430 FERVLGNGGFGTVYHGYLD------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKN 482
F + LG G FG V D G +VAVK L+ S Q F+ E+E+L + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 483 LTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRL-RIAIEAAK----- 534
+ G C++ R LI E++ +G+L+ L I RL + + K
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSSQICKGMDYL 125
Query: 535 -----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG-YLDPEYY 588
+HRD+ + NIL+ + KI+DFGL++ E + +P + PE
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
+++ + SDV++FGV L E+ T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 67/237 (28%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHK 481
F LG G FG VY G L G T VA+K L + + ++F+ E EL+ + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLL--------------GEEADILSWEGRLR 527
N+ L+G C + +++E++A+G+L L+ L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 528 IAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577
IAI+ A VHRD+ + N L+ KI+DFGLSR + + + + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD--IYSADYYRVQSKS 186
Query: 578 GTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT----------SKSVIERTHERI 623
P ++ PE + + T +SD+++FGVVL EI + ++ VIE R
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 7e-23
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 432 RVLGNGGFGTVY---HGYLDGTEVAVK--MLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ +G G FG VY DG +K LS S + + EV++L +++H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 487 VG-------------YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIE-- 531
Y D G + + + + EE IL W +L +A++
Sbjct: 65 YESFEEKGKLCIVMEYADGGD----LSQKIKKQKKEGKPFPEE-QILDWFVQLCLALKYL 119
Query: 532 -AAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+ K+ HRD+K NI L+ K+ DFG+S+ S + T+ GTP YL PE
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPELCQ 176
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ KSD+++ G VL E+ T
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCT 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.0 bits (245), Expect = 3e-22
Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 25/274 (9%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSP---SSAQGYKQFQAEVELLMRI-HHKNLT 484
R LG G FG VY D VA+K+L+ S ++ ++F E+++L + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALL-LGEEADILSWEGRLRIAIEAAK--------- 534
L + + + L+ E++ G+L+ LL LS L I +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 535 -VHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHV---TTTIAGTPGYLDPEYYI 589
+HRD+K NILL K+ DFGL++ P GS + + +T GTPGY+ PE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 590 SNRL---TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646
L + SD+++ G+ L E++T E +Q + +L + L
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--PSLASPL 239
Query: 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680
++ +++ R + + +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
++G G FG VY G G VA+K +S + K E++LL + H N+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 489 YCDEGTNRGLIYEFMANGNLQALL-----LGEE------ADILSWEGRLRIAIEAAKVHR 537
+ + +I E+ NG+L+ ++ E +L +G L E +HR
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL--QG-LAYLHEQGVIHR 123
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+K+ NIL + K+ADFG++ ++ GTP ++ PE + + S
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATKLNDVSKDDA---SVVGTPYWMAPEVIEMSGASTAS 180
Query: 598 DVYNFGVVLLEIITSK 613
D+++ G ++E++T
Sbjct: 181 DIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 70/224 (31%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 430 FERVLGNGGFGTVYHG-------YLDGTEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
+ R +G G FG V+ Y T VAVKML +SA FQ E L+ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------------------LGEEADILS 521
N+ L+G C G L++E+MA G+L L G LS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 522 WEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV----EG 567
+L IA + A VHRD+ + N L+ KIADFGLSR +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
S ++ PE NR T +SDV+ +GVVL EI +
Sbjct: 189 SENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 35/271 (12%)
Query: 431 ERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLT 484
E+V+G G FG V G L +VA+K L S+ + F E ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
L G + +I E+M NG+L L + + + + A
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
VHRD+ + NIL++ K++DFGLSR +E S TT P + PE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP-RLHEDFDI 652
T SDV++FG+V+ E++ S ER + M + I+++ D RL D
Sbjct: 186 TSASDVWSFGIVMWEVM---SYGERPYWD---------MSNQDVIKAVEDGYRLPPPMDC 233
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683
S ++ + C + +RPT +Q+V L
Sbjct: 234 PSA--LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 431 ERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLT 484
++V+G G FG V+ G L VA+K L P + +Q F +E ++ + H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWE--GRLR-IAI------EAAKV 535
L G + +I E+M NG L L + + S++ G LR IA + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
HRD+ + NIL++ + K++DFGLSR + GT+ T+ + PE + T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 596 KSDVYNFGVVLLEIIT 611
SDV++FG+V+ E+++
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 64/197 (32%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 434 LGNGGFGTVYHGYL---DGTE--VAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLV 487
LG+G FG+V G G E VAVK L A G K+F E ++ ++ H + L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIA-----IEAAK-VHR 537
G C +G L+ E G L L +D+ ++A +E+ VHR
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA--HQVAMGMAYLESKHFVHR 119
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPE--YYISNRLT 594
D+ + N+LL + QAKI+DFG+SR GS + TT P + PE Y + +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGA-GSDYYRATTAGRWPLKWYAPECINY--GKFS 176
Query: 595 EKSDVYNFGVVLLEIIT 611
KSDV+++GV L E +
Sbjct: 177 SKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 25/198 (12%)
Query: 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
F + LG+G FG V+ G G +VA+KM+ A F E +++M++ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 489 YCDEGTNRGLIYEFMANGNL------------QALLLGEEADILSWEGRLRIAIEAAKVH 536
C + ++ E+MANG L LL +D+ L +H
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIH 123
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT---IAGTPGYLDPEYYISNRL 593
RD+ + N L+ K++DFGL+R + ++ T T + P PE + +R
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAP----PEVFDYSRF 178
Query: 594 TEKSDVYNFGVVLLEIIT 611
+ KSDV++FGV++ E+ +
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 430 FERVLGNGGFGTV----YHGYLDGTE--VAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
F + LG G FG+V Y D T VAVK L S+A+ + F+ E+E+L + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 484 TTLVGYCDEGTNR--GLIYEFMANGNLQALLLGEEADI-----LSWEGRLRIAIE--AAK 534
G C R L+ E++ G+L+ L + L + ++ +E +K
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG-----YLDPEY 587
VHRD+ + NIL+ + + KI DFGL++ P + V PG + PE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR-----EPGESPIFWYAPES 182
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
++ + SDV++FGVVL E+ T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 42/216 (19%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEV--AVKMLSP-SSAQGYKQFQAEVELLMRI-HHKNL 483
FE V+G G FG V + DG ++ A+KML +S ++ F E+E+L ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 484 TTLVGYCDEGTNRGLIY---EFMANGNLQALLLGEE--------------ADILSWEGRL 526
L+G C+ NRG +Y E+ GNL L A L+ + L
Sbjct: 66 INLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 527 RIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576
+ A + A +HRD+ + N+L+ +KIADFGLSR G +V T+
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTM 177
Query: 577 AGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ E + T KSDV++FGV+L EI++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 434 LGNGGFGTVY----HGYL---DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
LG G FG V+ H L D VAVK L +S + FQ E ELL + H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLL--GEEADILSWEGR------------LRIAIEA 532
G C EG +++E+M +G+L L G +A IL+ G L IA +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA-GGEDVAPGQLTLGQMLAIASQI 131
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAGT 579
A VHRD+ + N L+ KI DFG+SR + G I
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P PE + + T +SD+++FGVVL EI T
Sbjct: 192 P----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 70/298 (23%), Positives = 123/298 (41%), Gaps = 54/298 (18%)
Query: 418 FSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE-------VAVKMLSPSSAQGYKQ-FQ 469
F SN+ IT LG G FG V+ G E V VK L + + + F+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 470 AEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADI-------LSW 522
E+++ ++ HKN+ L+G C E +I E+ G+L+ L ++ LS
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 523 EGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572
+ ++ + + A VHRD+ + N L+S + + K++ LS+
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 573 TTTIAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631
I P +L PE + + KSDV++FGV++ E+ T E + + ++
Sbjct: 177 NALI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG---ELPFYGLSDEEVLN- 229
Query: 632 MLGKGDIE----SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
L G +E RL+ ++ C + RP+ +++V L E
Sbjct: 230 RLQAGKLELPVPEGCPSRLY------------KLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 71/269 (26%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 433 VLGNGGFGTVYHGYLD-GTEVAVKM--LSPS----SAQGYKQFQAEVELLMRIHHKNLTT 485
VLG G +GTVY G + G +AVK L S + + Y++ Q EV+LL + H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALL--LGEEADILSWEGRLRIAIEAAK------VHR 537
+G C + + EF+ G++ ++L G + + + +I A VHR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEG-SGTH--VTTTIAGTPGYLDPEYYISNRLT 594
D+K N++L K+ DFG +R G GTH + ++ GTP ++ PE +
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186
Query: 595 EKSDVYNFGVVLLEIITSK---SVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
KSD+++ G + E+ T K + ++R +I M PRL + F
Sbjct: 187 RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-----------PRLPDSFS 235
Query: 652 INSVWKTVEIAMACVSQTSTKRPTMNQVV 680
+ ++ +C+++ +RP+ Q++
Sbjct: 236 AAA----IDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 55/189 (29%), Positives = 97/189 (51%), Gaps = 15/189 (7%)
Query: 434 LGNGGFGTVYHGY-LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE 492
+G+G FG V+ GY L+ +VA+K + A + F E +++M++ H L L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 493 GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKST 542
+ L++EFM +G L L + S E L + + + +HRD+ +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 543 NILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNF 602
N L+ K++DFG++R F ++ T T T + PE + ++ + KSDV++F
Sbjct: 130 NCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSKSDVWSF 187
Query: 603 GVVLLEIIT 611
GV++ E+ +
Sbjct: 188 GVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 61/191 (31%), Positives = 85/191 (44%), Gaps = 17/191 (8%)
Query: 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
LG G +G VY G VAVK L ++F E ++ I H NL L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKS 541
+I EFM GNL L ++ L +A + + +HRD+ +
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 542 TNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKSDVY 600
N L+ K+ADFGLSR + T+ A P + PE N+ + KSDV+
Sbjct: 133 RNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189
Query: 601 NFGVVLLEIIT 611
FGV+L EI T
Sbjct: 190 AFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTLVGY 489
+G G FG VY G L TEVAVK + K+ F E E+L + H N+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDV 539
C + ++ E + G+L L ++ L+ + L+++++AA +HRD+
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTH-VTTTIAGTP-GYLDPEYYISNRLTEKS 597
+ N L+ KI+DFG+SR E G + V+ + P + PE R T +S
Sbjct: 120 AARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 598 DVYNFGVVLLEIITSKSVI------ERTHERI 623
DV+++G++L E + ++T ERI
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
+R LG G FG V+ D VAVK L +S K F E ELL + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD-ILSWEGR----------LRIAIE 531
+ G C EG +++E+M +G+L L D +L EG L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 532 AAK----------VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAG 578
A VHRD+ + N L+ KI DFG+SR + G H I
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P PE + + T +SDV++ GVVL EI T
Sbjct: 189 MP----PESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 65/216 (30%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
+R LG G FG V+ D VAVK L + K FQ E ELL + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADI--------------LSWEGRLRI 528
+ G C +G +++E+M +G+L L D L L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTT 575
A + A VHRD+ + N L+ KI DFG+SR + G H
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
I P PE + + T +SDV++FGV+L EI T
Sbjct: 189 IRWMP----PESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 25/192 (13%)
Query: 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
++G G FG V G G +VAVK + +AQ F E ++ ++HHKNL L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI- 68
Query: 492 EGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDV 539
+ GL + E M+ GNL L ++S L+ +++ A+ VHRD+
Sbjct: 69 --LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDV 599
+ NIL+S AK++DFGL+R + + + + PE + + KSDV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDV 180
Query: 600 YNFGVVLLEIIT 611
+++GV+L E+ +
Sbjct: 181 WSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 39/210 (18%)
Query: 432 RVLGNGGFGTVYHG---YLDGT----EVAVKMLSPSSAQGYKQFQAEVELLM------RI 478
R LG+G FG VY G DG +VAVK L S ++ Q E + LM +
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-----QDESDFLMEALIMSKF 66
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAA 533
+H+N+ L+G E R ++ E MA G+L++ L E L+ + L A + A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 534 K----------VHRDVKSTNILLSGKFQ---AKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
K +HRD+ + N LL+ K AKIADFG++R + + + A P
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD--IYRASYYRKGGRAMLP 184
Query: 581 -GYLDPEYYISNRLTEKSDVYNFGVVLLEI 609
++ PE ++ T K+DV++FGV+L EI
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 432 RVLGNGGFGTVY------HGYLDGTEVAVKMLSPSSAQGY-KQFQAEVELLMRIHHKNLT 484
R LG G FG V G G +VAVK L P S + + E+E+L ++H+N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 485 TLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
G C E G LI EF+ +G+L+ L + I + + +L+ A++ K
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-NLKQQLKYAVQICKGMDYLGSR 128
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
VHRD+ + N+L+ + Q KI DFGL++ + V + + PE I ++
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 593 LTEKSDVYNFGVVLLEIIT 611
SDV++FGV L E++T
Sbjct: 189 FYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 72/295 (24%)
Query: 431 ERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKN 482
R LG G FG VY G G T VA+K ++ +++ + +F E ++ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--------ILSWEGRLRIAIEAAK 534
+ L+G G ++ E MA G+L++ L + + + +++A E A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSR--------------TFPVEGSGT 570
VHRD+ + N +++ KI DFG++R PV
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTHERIHITQW 628
++ PE T KSDV++FGVVL E+ T + ++E +
Sbjct: 187 -----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EV 230
Query: 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683
+ F++ G H D N K +E+ C RPT ++V L
Sbjct: 231 LKFVIDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 58/192 (30%), Positives = 98/192 (51%), Gaps = 21/192 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKML-SPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+ +G G FG V G G +VAVK + + ++AQ F AE ++ ++ H NL L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG 66
Query: 489 Y-CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
+E ++ E+MA G+L L +L + L+ +++ + VHR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+ + N+L+S AK++DFGL++ E S T T + + PE + + KS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK--WTAPEALREKKFSTKS 180
Query: 598 DVYNFGVVLLEI 609
DV++FG++L EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 42/215 (19%)
Query: 432 RVLGNGGFGTVYHGYL-----DGTE---VAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
LG+G FG VY G G+ VAVK L ++ Q K+F E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD-----ILSWEGRLRIAIEAAK--- 534
+ L+G C + +I E M G+L + L + +L+ + L I ++ AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 535 -------VHRDVKSTNILLSGKFQA-----KIADFGLSRT------FPVEGSGTHVTTTI 576
+HRD+ + N L+S K KI DFGL+R + EG G +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
A PE + + T +SDV++FGV++ EI+T
Sbjct: 181 A-------PESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 430 FERVLGNGGFGTVYHG--YLDGTE----VAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
F LG FG +Y G YL G + VA+K L ++ Q + +FQ E L+ +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLL---------------GEEADILSWEGRLR 527
+ L+G + +++E++ G+L L+ G L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 528 IAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577
IAI+ A VH+D+ + NIL+ + KI+D GLSR + + + +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--IYSADYYRVQPKS 186
Query: 578 GTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE + + + SD+++FGVVL EI +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+ LGNG FG V+ G +G T+VAVK L P + + F E +++ ++ H L L
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA 68
Query: 489 YCDEG--------TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-VHRDV 539
E ++G + +F+ +G +AL L D+ + IE +HRD+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDV 599
+S NIL+ KIADFGL+R +E + + PE + R T KSDV
Sbjct: 129 RSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 600 YNFGVVLLEIITSKSV 615
++FG++L E++T V
Sbjct: 187 WSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 19/198 (9%)
Query: 432 RVLGNGGFGTVYHGYL---DGTEV--AVKMLSP-SSAQGYKQFQAEVELLMRIHHKNLTT 485
RV+G G FG VYHG L DG ++ AVK L+ + + +QF E ++ H N+ +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 486 LVGYC--DEGTNRGLIYEFMANGNLQALLLGEE-----ADILSWEGRLRIAIE--AAK-- 534
L+G C EG+ ++ +M +G+L+ + E D++ + ++ +E A+K
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSR-TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
VHRD+ + N +L F K+ADFGL+R + E H T ++ E + +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 594 TEKSDVYNFGVVLLEIIT 611
T KSDV++FGV+L E++T
Sbjct: 180 TTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLVGY 489
+G G FG V+ D A+K + S ++ +A E +L ++ + + Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI---IRY 64
Query: 490 CDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEA---------AKV-H 536
+ ++G + E+ NG+L LL + L + R I+ K+ H
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+KS N+ L KI D G+++ T+ TI GTP YL PE EK
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 597 SDVYNFGVVLLEIITSK 613
SDV+ GVVL E T K
Sbjct: 182 SDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 49/289 (16%)
Query: 424 LRITNNFE----RVLGNGGFGTVYHGYL--DG----TEVAVKML-SPSSAQGYKQFQAEV 472
LRI E +VLG+G FGTVY G +G VA+K+L +S + K+ E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL------LGEEADILSWEGRL 526
++ + H ++ L+G C + LI + M G L + +G + +L+W +
Sbjct: 61 YVMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQ-YLLNWC--V 116
Query: 527 RIAI------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
+IA E VHRD+ + N+L+ KI DFGL++ V+ H P
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG--GKVP 174
Query: 581 -GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE 639
++ E + T KSDV+++GV + E++T + + +E I + +L KG+
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA---KPYEGIP-AVEIPDLLEKGE-- 228
Query: 640 SIVDPRLHEDFDINSVWKTVEIAM---ACVSQTSTKRPTMNQVVMELNE 685
RL I T+++ M C + RPT +++ E ++
Sbjct: 229 -----RL-PQPPIC----TIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 32/203 (15%)
Query: 433 VLGNGGFGTVY--HGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+G G FGTV DG + K + + + +Q +EV +L + H N+ V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VR 63
Query: 489 YCDEGTNRG-----LIYEFMANGNLQALL---------LGEEA--DILS------WEGRL 526
Y D +R ++ E+ G+L L+ + EE IL+ +E
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 527 RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
R +HRD+K NI L K+ DFGL++ + G + T GTP Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---ILGHDSSFAKTYVGTPYYMSPE 180
Query: 587 YYISNRLTEKSDVYNFGVVLLEI 609
EKSD+++ G ++ E+
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 42/213 (19%)
Query: 433 VLGNGGFGTVYHGYL--DGTEV--AVKMLSP-SSAQGYKQFQAEVELLMRI-HHKNLTTL 486
V+G G FG V + DG + A+K + +S ++ F E+E+L ++ HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 487 VGYCDEGTNRGLIY---EFMANGNLQALLLGEE--------------ADILSWEGRLRIA 529
+G C+ +RG +Y E+ +GNL L A LS + L A
Sbjct: 62 LGACE---HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 530 IEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579
+ A+ +HRD+ + NIL+ + AKIADFGLSR G +V T+
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 580 P-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ E + T SDV+++GV+L EI++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 42/216 (19%)
Query: 430 FERVLGNGGFGTVYHGYL--DG--TEVAVK-MLSPSSAQGYKQFQAEVELLMRI-HHKNL 483
F+ V+G G FG V + DG + A+K M +S ++ F E+E+L ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 484 TTLVGYCDEGTNRGLIY---EFMANGNLQALL--------------LGEEADILSWEGRL 526
L+G C+ +RG +Y E+ +GNL L A LS + L
Sbjct: 71 INLLGACE---HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 527 RIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576
A + A+ +HRD+ + NIL+ + AKIADFGLSR G +V T+
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 182
Query: 577 AGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ E + T SDV+++GV+L EI++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 432 RVLGNGGFGTVY--HGYLDGTEVAVKM--LSPSSAQGYKQFQAEVELLMRIHHKNLTT-- 485
+ +G G FG +Y D +K L+ + + + EV LL ++ H N+ T
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 486 -----------LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK 534
++ YCD G + M N Q +L E ILSW ++ + ++
Sbjct: 66 ASFQENGRLFIVMEYCDGG-------DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 535 ----VHRDVKSTNILLS--GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+KS NI LS G AK+ DFG++R + T GTP YL PE
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMV-AKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEIC 174
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKSVIE 617
+ K+D+++ G VL E+ T K E
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 423 VLRITNNFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK 481
V R T + LG G FG V+ GY +G T+VA+K L S + F AE L+ ++ H
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHP 61
Query: 482 NLTTLVGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---- 534
L L + IY E+M NG+L L E L+ + +A + A+
Sbjct: 62 RLVRLYAV----VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV------EGSGTHVTTTIAGTPGY 582
+HRD+++ NIL+S KIADFGL+R EG+ + T
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA------ 171
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
PE T KSDV++FG++L EI+T
Sbjct: 172 --PEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
E LG G FG V+ G +GT VA+K L P + + F E +++ ++ H+ L L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 68
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
E ++ E+M+ G+L L GE L + +A + A VHRD
Sbjct: 69 VVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKS 597
+++ NIL+ K+ADFGL+R + A P + PE + R T KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 598 DVYNFGVVLLEIITSKSV 615
DV++FG++L E+ T V
Sbjct: 185 DVWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 16/192 (8%)
Query: 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYC 490
+ LG G FG V+ GY + T+VAVK L P + + F E L+ + H L L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVK 540
+ +I E+MA G+L L +E + + + + A+ +HRD++
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130
Query: 541 STNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKSDV 599
+ N+L+S KIADFGL+R V + A P + PE T KSDV
Sbjct: 131 AANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 600 YNFGVVLLEIIT 611
++FG++L EI+T
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 31/263 (11%)
Query: 432 RVLGNGGFG--TVYHGYLDGTEVAVKM--LSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
RVLG G FG T+Y D + V K L+ S + + E+ +L + H N+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 488 GYCDEGTNRGLIYEFMANGNL------QALLLGEEADILSWEGRLRIAI----EAAKVHR 537
+ + + E+ G L Q L EE +L + ++ A+ +A +HR
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+K+ NI L+ K+ DFG+S+ + GS + T+ GTP Y+ PE + KS
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182
Query: 598 DVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657
D++ G VL E++T K + T+ + + V +G+ +V E
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIV-----QGNYTPVVSVYSSE--------- 228
Query: 658 TVEIAMACVSQTSTKRPTMNQVV 680
+ + + + Q KRPT ++V+
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 432 RVLGNGGFGTVYHGYL---DGT--EVAVKM--LSPSSAQGYKQFQAEVELLMRIHHKNLT 484
++LG G FG+V G L DG+ +VAVK L + ++F +E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 485 TLVGYCDEGTNRG------LIYEFMANGNLQALLL----GEEADILSWEGRLRIAIEAAK 534
L+G C E ++ +I FM +G+L + LL G + L + L+ ++ A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYL 583
+HRD+ + N +L +ADFGLS+ + + IA P ++
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGDYYRQGRIAKMPVKWI 182
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
E T KSDV+ FGV + EI T
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-17
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 33/195 (16%)
Query: 449 GTEVAVKML---SPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-TNRGL---IYE 501
G EVA+K+L +P +F+ E L R++H N+ L+ D G GL ++E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFE 59
Query: 502 FMANGNLQALLLGEEADILSWEGRLRI----AIEAAK----VHRDVKSTNILLS---GKF 550
++ L+ +L + A GRL + A+ A VHRD+K NI++S +
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 551 QAKIADFGLSRTFPVEGSGTH--------VTTTIAGTPGYLDPEYYISNRLTEKSDVYNF 602
AK+ DFG+ P G TT + GTP Y PE +T SD+Y +
Sbjct: 120 HAKVLDFGIGTLLP----GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 603 GVVLLEIITSKSVIE 617
G++ LE +T + V++
Sbjct: 176 GLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQ-FQAEVELLMRI-HH 480
F + LG G FG V G +VAVKML P++ ++ +E++++ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+N+ L+G C G +I E+ G+L L + L+ E L + + AK
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYI 589
+HRD+ + N+LL+ KI DFGL+R + +V A P ++ PE
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARD--IMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ T +SDV+++G++L EI +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 433 VLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLVGYC 490
+LG G FG V+ G L D T VAVK Q K +F +E +L + H N+ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVK 540
+ ++ E + G+ + L ++ D L + ++ A++AA +HRD+
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 541 STNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKSDV 599
+ N L+ KI+DFG+SR E G + ++ + P + PE R + +SDV
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQ---EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 600 YNFGVVLLEIIT 611
+++G++L E +
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 38/205 (18%)
Query: 434 LGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTT 485
LG G FG V L G A+K+L K+ + E +L RI+H +
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 486 LVGYCDEGTNRGL--IYEFMANGNL-----QALLLGEE------ADI---LSWEGRLRIA 529
L + T L + E+ G L + EE A+I L + L I
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI- 114
Query: 530 IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
++RD+K NILL K+ DFGL++ EGS T T GTP YL PE +
Sbjct: 115 -----IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLL 166
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKS 614
+ D ++ GV+L E++T K
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ---FQA--EVELLMRIHHKN 482
+ LG G + VY G VA+K + + K F A E++LL + H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQAL-----LLGEEADILSWEGRLRIAIEAAK--- 534
+ L+ +N L++EFM +L+ + ++ ADI S+ +E
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE-YYISNR 592
+HRD+K N+L++ K+ADFGL+R+F GS T T Y PE + +
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 593 LTEKSDVYNFGVVLLEII 610
D+++ G + E++
Sbjct: 180 YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 37/218 (16%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQA---EVELLMRI-HHKNL 483
F +++G G F TV E A+K+L K+ + E E+L R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 484 TTLVGYC---DEGTNRGLIYEFMANGNLQALL--LG--EEADILSWEGRLRIAIE--AAK 534
L Y DE N + E+ NG L + G +E + + +A+E +K
Sbjct: 65 IKL--YYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFP---VEGSGTHVTTTIA------------ 577
+HRD+K NILL KI DFG ++ S T I
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 578 --GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
GT Y+ PE + SD++ G ++ +++T K
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 428 NNFERV--LGNGGFGTVYHGYLDGT--EVAVKML-SPSSAQGYKQFQAEVELLMRIHHKN 482
++ ERV LG G G VY T A+K + + KQ E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 483 LTTLVG-YCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRIAIEAAK-- 534
+ G + EG ++ E+M G+L LL + E +L+ IA + K
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPE--PVLA-----YIARQILKGL 112
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
+HRD+K +N+L++ K + KIADFG+S+ +E + T GT Y+ P
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD-QCNTFVGTVTYMSP 169
Query: 586 EYYISNRLTEKSDVYNFGVVLLEIITSK 613
E + +D+++ G+ LLE K
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 58/193 (30%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 434 LGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE 492
LG G FG V+ G +GT +VA+K L P + + F E +++ ++ H L L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 493 G--------TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-VHRDVKSTN 543
+G + +F+ G+ + L L + D+ + IE +HRD+++ N
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAAN 132
Query: 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKSDVYNF 602
IL+ KIADFGL+R + A P + PE + R T KSDV++F
Sbjct: 133 ILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 603 GVVLLEIITSKSV 615
G++L E++T V
Sbjct: 190 GILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 45/222 (20%)
Query: 432 RVLGNGGFGTVYHGY---LDG----TEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNL 483
+ LG G FG V L G T VAVKML +++ + +E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLL------------------------GEEA-- 517
L G C + LI E+ G+L++ L E A
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 518 --DILS--WE---GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570
D++S W+ G +A E VHRD+ + N+L++ + KI+DFGLSR E S
Sbjct: 126 MGDLISFAWQISRGMQYLA-EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182
Query: 571 HVTTTIAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+V + P ++ E + T +SDV++FGV+L EI+T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 431 ERVLGNGGFGTVYHGYLD-----GTEVAVKML-SPSSAQGYKQFQAEVELLMRIHHKNLT 484
E V+G G FG V G L VA+K L S + + + F +E ++ + H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLR-IAI------EAAKV 535
L G + +I EFM NG L + L + ++ G LR IA E V
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT-P-GYLDPEYYISNRL 593
HRD+ + NIL++ K++DFGLSR + S T+++ G P + PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 594 TEKSDVYNFGVVLLEIIT 611
T SDV+++G+V+ E+++
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 72/249 (28%), Positives = 105/249 (42%), Gaps = 64/249 (25%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTE------------------VAVKMLSPSSAQGYKQ-FQ 469
NF LG G FG V+ DG + VAVK+L P ++ ++ F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 470 AEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL---------LGEEADIL 520
EV++L R+ N+ L+G C +I E+M NG+L L L + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 521 SWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRT------FP 564
S+ L +A + A VHRD+ + N L+ + KIADFG+SR +
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 565 VEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEI-----------ITS 612
V+G A P ++ E + + T KSDV+ FGV L EI +T
Sbjct: 188 VQGR--------APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 613 KSVIERTHE 621
+ VIE
Sbjct: 240 QQVIENAGH 248
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 432 RVLGNGGFGTVYHGYL---DGT--EVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLT 484
R+LG G FG+V L DG+ +VAVKML S+ ++F E + H N+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 485 TLVGYCDEGTNRG------LIYEFMANGNLQALLL----GEEADILSWEGRLRIAIEAAK 534
L+G +G +I FM +G+L LL GEE L + +R I+ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRT-----FPVEGSGTHVTTTIAGT 579
+HRD+ + N +L+ +ADFGLS+ + +G + +
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK---- 180
Query: 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+L E N T SDV+ FGV + EI+T
Sbjct: 181 --WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 432 RVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQA---EVELLMRIHHKNLTTL 486
RV+G G FG V+ D V +K + P + A E ++L + H N+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNI--- 61
Query: 487 VGYCD---EGTNRGLIYEFMANGNLQALL------LGEEADILSWEGRLRIAIEAAK--- 534
+ Y + E ++ E+ G L + L +E IL + ++ +A+
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 535 -VHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRD+K+ NILL K KI DFG+S+ S T+ GTP Y+ PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYISPELCEGKP 177
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIE 617
+KSD++ G VL E+ + K E
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 434 LGNGGFGTVYHGYLDGTE-------VAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLT 484
LG G FG V G + VAVKML + + +E+E++ I HKN+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEEA---------------DILSWEG 524
L+G C + ++ E+ A+GNL+ L GE A D++S+
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 525 RLRIAIE--AAK--VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
++ +E A+K +HRD+ + N+L++ KIADFGL+R + + TT P
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD--IHHIDYYRKTTNGRLP 197
Query: 581 -GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
++ PE T +SDV++FGV+L EI T
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 431 ERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLT 484
E+V+G G FG V G L VA+K L + + + F +E ++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLRIAIEAAK-------V 535
L G + ++ E+M NG+L A L + ++ G LR K V
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
HRD+ + NIL++ K++DFGLSR + + T + PE + T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 596 KSDVYNFGVVLLEIIT 611
SDV+++G+V+ E+++
Sbjct: 189 ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 40/208 (19%)
Query: 434 LGNGGFGTVYHGY-LDGTEV-AVKM--LSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG- 488
+G G FG VY LD E+ AVK + + + K+ E+++L + H NL G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 489 ------------YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI----EA 532
YC GT + E + +G + +E I + +L +
Sbjct: 68 EVHREKVYIFMEYCSGGT----LEELLEHGRIL-----DEHVIRVYTLQLLEGLAYLHSH 118
Query: 533 AKVHRDVKSTNILLSGKFQAKIADFG----LSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
VHRD+K NI L K+ DFG L G ++AGTP Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ---SLAGTPAYMAPEVI 175
Query: 589 ISNRLTEK---SDVYNFGVVLLEIITSK 613
+ +D+++ G V+LE+ T K
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 36/204 (17%)
Query: 428 NNFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
N E+ +G G G VY G EVA+K + Q + E+ ++ H N+
Sbjct: 22 KNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 486 LVG-YCDEGTNRGLIYEFMANGNLQALLLGEEADILSW------EGRL-RIAIE------ 531
Y ++ E+M G+L DI++ E ++ + E
Sbjct: 80 YYDSYLVGDE-LWVVMEYMDGGSL--------TDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 532 ----AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT-TTIAGTPGYLDPE 586
+HRD+KS NILLS K+ADFG F + + ++ GTP ++ PE
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 587 YYISNRLTEKSDVYNFGVVLLEII 610
K D+++ G++ +E+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 52/274 (18%)
Query: 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
F + LG G FG V +G G +VA+KM+ S +F E +++M++ H+ L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLG-----EEADILSWEGRLRIAIEAAK----VHRDV 539
C + ++ E+M+NG L L + + +L + + + +HRD+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126
Query: 540 KSTNILLSGKFQAKIADFGLSR-------------TFPVEGSGTHVTTTIAGTPGYLDPE 586
+ N L+ + K++DFGLSR FPV S PE
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------------PE 171
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646
+ ++ + KSDV+ FGV++ E+ S+ + +ER + ++ + +G + P L
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVY---SLGKMPYERFNNSE-TVEKVSQG--LRLYRPHL 225
Query: 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680
+ K I +C + + +RPT Q++
Sbjct: 226 ASE-------KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-15
Identities = 110/481 (22%), Positives = 179/481 (37%), Gaps = 95/481 (19%)
Query: 3 GNYDGQGKPPSFDIILEADVWDSIEF---EDESTIVTKEIIHIPQKNFVYVCLVNKGSGT 59
P FD+ +E S++ + + + ++ + +C + G G
Sbjct: 104 VAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFL-TDGSASICFHSTGHGD 162
Query: 60 PFISAIELRPLKNSTYTTESGS-----LSLFRRWDIGSRSSE-TFRYPDDIY--DRIWLP 111
P I +IE+ + + Y L +R G+ S+ Y D + DR W
Sbjct: 163 PAILSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNR 222
Query: 112 NSLPNS---EPINTTSDI----ISMNDYQGPSTVMQTAVIPTNGSNSL--QLSWEPNDPK 162
S + I+T + I + N Y P ++ Q+A++ T+ L + +PN
Sbjct: 223 MQTFGSGSDQAISTENVIKKASNAPNFY--PESLYQSALVSTDTQPDLSYTMDVDPNRN- 279
Query: 163 FLYYAYLYFSEFENVQANNQTREIIIYINGIDWF----------GPFSPLHFAANTIYST 212
Y +L+F+E +N R + ING F ++ L T+ +
Sbjct: 280 --YSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNK-TVAVS 336
Query: 213 WPILT------------AEKIE-FSINTTESSTLPPILNAYEIYRAKEFLQFLTN----- 254
LT IE F I T ES TL ++A + K L
Sbjct: 337 GRTLTIVLQPKKGTHAIINAIEVFEIITAESKTLLEEVSA--LQTLKSSLGLPLRFGWNG 394
Query: 255 -----QQDAYLWQGLNCSYPEY----------------------DPPR---ITSLNLSSS 284
QQ + W G +C + D + + S+NLS +
Sbjct: 395 DPCVPQQ--HPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGN 452
Query: 285 GIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG 344
I G+I P + ++TS+++LDLS N+ G +P+ L QL L LNL G +G + G
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
Query: 345 LL----SLSVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLCVLVTAMAILWSLR 400
L S + N LC A + S K + SV L +++ AM W R
Sbjct: 513 RLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAM--CWWKR 570
Query: 401 R 401
R
Sbjct: 571 R 571
|
Length = 623 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 425 RITNNFERVLGNGGFGTVYHG-YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
R + E+ LG G FG V+ Y T+VAVK + P S + F AE ++ + H L
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKL 63
Query: 484 TTLVGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
L + IY EFMA G+L L +E + + + A+
Sbjct: 64 VKL----HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYI 589
+HRD+++ NIL+S KIADFGL+R + A P + PE
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAIN 176
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
T KSDV++FG++L+EI+T
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKM--LSPSSAQGYKQ-------FQAEVELLMRIHHK 481
++G+G FG+VY G G +AVK L SA + E+ LL + H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIAIEAAK--- 534
N+ +G + + + E++ G++ ALL EE + ++ ++ +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-----TIAGTPGYLDPEYY 588
+HRD+K NIL+ K KI+DFG+S+ +E + T ++ G+ ++ PE
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKK--LEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSK 613
T K+D+++ G +++E++T K
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 432 RVLGNGGFGT---VYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT--- 485
RV+G G FG V H D ++ P S+ + + E LL ++ H N+
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 486 ----------LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI----E 531
++ YCD G + M LQ L E IL W ++ + + E
Sbjct: 66 SFEADGHLYIVMEYCDGG-------DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+KS NI L+ + K+ DFG +R T P + T+V GTP Y+ PE +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPYYVPPEIWE 173
Query: 590 SNRLTEKSDVYNFGVVLLEIITSK 613
+ KSD+++ G +L E+ T K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 434 LGNGGFGT--VYHGYLDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLVGY 489
+G G FG + DG + +K ++ S ++ ++ EV +L + H N+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 490 CDEGTNRGLIYEFMANGNL------QALLLGEEADILSWEGRLRIAIEAAK----VHRDV 539
+E N ++ ++ G+L Q +L E IL W ++ +A++ +HRD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDI 127
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDV 599
KS NI L+ K+ DFG++R V S + T GTP YL PE + KSD+
Sbjct: 128 KSQNIFLTKDGTIKLGDFGIAR---VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 600 YNFGVVLLEIITSKSVIE 617
+ G VL E+ T K E
Sbjct: 185 WALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 432 RVLGNGGFGTV----YHGYLDGTE--VAVKML----SPSSAQGYKQFQAEVELLMRIHHK 481
RVLG G FG V Y DGT VAVK L + G+K+ E+ +L ++H+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHE 66
Query: 482 NLTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEE---ADILSWEGRLRIAIEAAK-- 534
N+ G C E +G LI E++ G+L+ L + A +L + ++ +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY-LDPEYYISN 591
+HRD+ + N+LL KI DFGL++ P EG + +P + E N
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 592 RLTEKSDVYNFGVVLLEIIT----SKSVIERTHERIHITQ 627
+ + SDV++FGV L E++T +S ++ E I Q
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVK--MLSPSSAQGY---KQFQAEVELLMRIHHKNLT 484
+LG+G FG+VY G DG AVK L+ G KQ + E+ LL ++ H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALL--LGE--EADILSWEGRLRIAIE----AAKVH 536
+G E N + E + G+L LL G E I + ++ + +E VH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-----TIAGTPGYLDPEYYIS- 590
RD+K NIL+ K+ADFG+++ V + G+P ++ PE
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 591 NRLTEKSDVYNFGVVLLEIITSK 613
+D+++ G +LE+ T K
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLV 487
ER+ G G FG V+ G L D T VAVK + K +F E +L + H N+ L+
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G C + ++ E + G+ L E L + +++ AA +HR
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-TIAGTP-GYLDPEYYISNRLTE 595
D+ + N L++ K KI+DFG+SR E G + +T + P + PE R +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE---EEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 596 KSDVYNFGVVLLEIITSKSV 615
+SDV++FG++L E + +V
Sbjct: 176 ESDVWSFGILLWEAFSLGAV 195
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 434 LGNGGFGTVYHGYLDG---------TEVAVKML-SPSSAQGYKQFQAEVELLMRI-HHKN 482
LG G FG V G T+VAVKML S ++ + +E+E++ I HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA--------------DILSWEGRLRI 528
+ L+G C + +I E+ + GNL+ L + LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
A + A+ +HRD+ + N+L++ KIADFGL+R + + TT
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYKKTTNGR 203
Query: 579 TP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE T +SDV++FGV+L EI T
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
F + LG+G FG V+ G +VA+K ++ A + F E +++M++ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
C + ++ EFM NG L L + LS + L + + + +HRD
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKS 597
+ + N L+S K++DFG++R + ++ + +++ A P + PE + ++ + KS
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR-YVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 598 DVYNFGVVLLEIIT 611
DV++FGV++ E+ T
Sbjct: 183 DVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 432 RVLGNGGFGTVYHGY-LD-GTEVAVKM-----LSPSSAQGYKQFQAEVELLMRIHHKNLT 484
++LG G FG VY Y +D G E+AVK SP + + + E++LL + H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL---------RIAIEAAK- 534
G + + E+M G+++ D L G L R +E +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVK--------DQLKAYGALTETVTRKYTRQILEGVEY 119
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
VHRD+K NIL K+ DFG S+ S ++ GTP ++ PE
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSK 613
K+DV++ G ++E++T K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 54/198 (27%), Positives = 80/198 (40%), Gaps = 25/198 (12%)
Query: 434 LGNGGFGTVYHGYLDGT-----EVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTLV 487
LG+G FG V G + VAVK L F E ++ + H+NL L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILS----WEGRLRIA-----IEAAK-VHR 537
G ++ E G+L L + + ++IA +E+ + +HR
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEG----SGTHVTTTIAGTPGYLDPEYYISNRL 593
D+ + NILL+ + KI DFGL R P H+ A PE +
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA----PESLRTRTF 177
Query: 594 TEKSDVYNFGVVLLEIIT 611
+ SDV+ FGV L E+ T
Sbjct: 178 SHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 432 RVLGNGGFGTVYHGY-LD-GTEVAVKML-----SPSSAQGYKQFQAEVELLMRIHHKNLT 484
++LG G FG VY Y +D G E+A K + SP +++ + E++LL + H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 485 TLVGYCDEGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRL-RIAIEAAK------- 534
G + + L E+M G+++ L A S + R +E
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRD+K NIL K+ DFG S+ T + G+G ++ GTP ++ PE
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPEVISGE 184
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
K+DV++ G ++E++T K
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 73/298 (24%), Positives = 118/298 (39%), Gaps = 65/298 (21%)
Query: 430 FERVLGNGGFGTVYHGYLDGTE----------------VAVKMLSPSSAQGYKQ-FQAEV 472
+ LG G FG V+ +G VAVKML + + F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD----------ILSW 522
+++ R+ + N+ L+G C +I E+M NG+L L E + +S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 523 EGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572
L +A++ A VHRD+ + N L+ + KIADFG+SR G +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL-YSGDYYRI 187
Query: 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEI-----------ITSKSVIERTHE 621
++ E + + T SDV+ FGV L E+ ++ + VIE T E
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
Query: 622 RIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
F +G + L + V+ ++ M C S+ RPT N++
Sbjct: 248 ---------FFRNQGRQIYLSQTPLCP----SPVF---KLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 434 LGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV-GYC 490
LG+G FG VY G A K++ S + + F E+++L H N+ L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA----IEAAK-------VHRDV 539
E ++ EF G L +++L E + E ++R +EA +HRD+
Sbjct: 73 YEN-KLWILIEFCDGGALDSIMLELERGLT--EPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY-----YISNRLT 594
K+ NILL+ K+ADFG+S T GTP ++ PE + N
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRD---TFIGTPYWMAPEVVACETFKDNPYD 186
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646
K+D+++ G+ L+E+ + +E H ++ + V + K + ++ P
Sbjct: 187 YKADIWSLGITLIEL----AQMEPPHHELNPMR-VLLKILKSEPPTLDQPSK 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 29/258 (11%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTLVGYC 490
+G G FG V+ G + T+ VA+K++ A+ + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA-------AKVHRDVKSTN 543
+GT +I E++ G+ LL D L+ ++ K+HRD+K+ N
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAAN 131
Query: 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVT-TTIAGTPGYLDPEYYISNRLTEKSDVYNF 602
+LLS + K+ADFG++ + T + T GTP ++ PE + K+D+++
Sbjct: 132 VLLSEQGDVKLADFGVAGQL----TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187
Query: 603 GVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIA 662
G+ +E+ E + +H + V F++ K + P L +F E
Sbjct: 188 GITAIELAKG----EPPNSDMHPMR-VLFLIPKNN-----PPTLTGEFSKP----FKEFI 233
Query: 663 MACVSQTSTKRPTMNQVV 680
AC+++ + RPT +++
Sbjct: 234 DACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 429 NF--ERVLGNGGFGTVYHG--YLDGTEVAVK---MLSPSSAQGYKQFQAEVELLMRIHHK 481
NF E+ +G G F VY LDG VA+K + A+ E++LL +++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------LGEEADILSWEGRLRIAIEAA 533
N+ E ++ E G+L ++ L E + + +L A+E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 534 K----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+K N+ ++ K+ D GL R F + + H ++ GTP Y+ PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMSPERIH 179
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKS 614
N KSD+++ G +L E+ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQAEVELLMRIHH---KNLTTL 486
++G G +G VY G G VA+K+++ + Q EV LL ++ N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------VHRDV 539
G +G +I E+ G+++ L+ +R + A K +HRD+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE-KSD 598
K+ NIL++ K+ DFG++ + +T GTP ++ PE + + K+D
Sbjct: 128 KAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184
Query: 599 VYNFGVVLLEIIT 611
+++ G+ + E+ T
Sbjct: 185 IWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 431 ERVLGNGGFGTVYHG--YLDGTEVAVK---MLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
E+ +G G F VY LD VA+K + A+ + E++LL +++H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALL--------LGEEADILSWEGRLRIAIEAAK--- 534
+ E ++ E G+L ++ L E + + +L A+E
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
+HRD+K N+ ++ K+ D GL R F + + H ++ GTP Y+ PE N
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGY 183
Query: 594 TEKSDVYNFGVVLLEIITSKS 614
KSD+++ G +L E+ +S
Sbjct: 184 NFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 432 RVLGNGGFGTVYHGYLDGTE--VAVK-MLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG G G V T +AVK + + KQ E+++L + + + G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 489 YCDEGTNRGLIYEFMANGNLQALL------LGEEADILSWEGRLRIAI--------EAAK 534
+ + E+M G+L +L + E IL G++ +A+ E K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--RIL---GKIAVAVLKGLTYLHEKHK 121
Query: 535 V-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA----GTPGYLDPEYYI 589
+ HRDVK +NIL++ + Q K+ DFG+S + ++A GT Y+ PE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS---------GQLVNSLAKTFVGTSSYMAPERIQ 172
Query: 590 SNRLTEKSDVYNFGVVLLEIITSK 613
N + KSD+++ G+ L+E+ T +
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 39/204 (19%)
Query: 431 ERVLGNGGFGTVYHGYLDGT--EVAVKMLS-PSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
+G G FG VY T VA+K++ + + Q E++ L + +T
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 488 GYCDEGTNRGLIYEFMANGNLQALL----LGEEADILSWEGRLRIAI------------- 530
G +G+ +I E+ G+ LL L E IA
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAFILREVLLGLEYLH 115
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT---TIAGTPGYLDPEY 587
E K+HRD+K+ NILLS + K+ADFG V G T + T GTP ++ PE
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG------VSGQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
+ EK+D+++ G+ +E+
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDGTE------------------VAVKMLSPSSAQGYKQ-FQA 470
F+ LG G FG V+ + + VAVK+L P + + + F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 471 EVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD------------ 518
EV++L R+ N+ L+G C + +I E+M NG+L L D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 519 -----ILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTF 563
+S+ L +A++ A VHRD+ + N L+ KIADFG+SR
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
G + ++ E + + T SDV+ FGV L EI+
Sbjct: 189 -YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 432 RVLGNGGFGTVYHGY-LD-GTEVAVKML-----SPSSAQGYKQFQAEVELLMRIHHKNLT 484
++LG G FG VY Y D G E+AVK + SP +++ + E++LL + H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 485 TLVGYCDEGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRL-RIAIEAAK------- 534
G + R L E M G+++ L A + + R +E
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRD+K NIL K+ DFG S+ T + G+G ++ GTP ++ PE
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG---MKSVTGTPYWMSPEVISGE 184
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
K+D+++ G ++E++T K
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLVGY 489
+G G +G VY L G VA+K + A E++LL ++H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIE----AAKVHRDVK 540
+ L++EFM + +L L+ E+ I S+ +L + +HRD+K
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 541 STNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-TEKSDV 599
N+L++ + K+ADFGL+R+F GS T T Y PE + ++ + D+
Sbjct: 126 PENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 600 YNFGVVLLEIITSKSVIERTHERIHITQW 628
++ G + E+++ + + E I Q
Sbjct: 183 WSVGCIFAELLSRRPLFPGKSE---IDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 434 LGNGGFGTVYHGYLDGTE---------VAVKMLSPSSA-QGYKQFQAEVELLMRI-HHKN 482
LG G FG V G + VAVKML + + +E+E++ I HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA--------------DILSWEGRLRI 528
+ L+G C + ++ E+ + GNL+ L + L+++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
A + A+ +HRD+ + N+L++ KIADFGL+R V + TT
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD--VHNIDYYKKTTNGR 197
Query: 579 TP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE T +SDV++FGV+L EI T
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 45/269 (16%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGY-KQFQAEVELLMRIHHKNLTTLVGYC 490
LG G G+V L T A+K ++ KQ E+E+ + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 491 --DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR------LRIAIEAAK-------- 534
+ ++ G+ E+ G+L ++ + GR +IA K
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRD+K +NILL+ K Q K+ DFG+S +GT GT Y+ PE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKP 179
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV----DPRLHE 648
+ SDV++ G+ LLE+ R LG ++ S + +P L +
Sbjct: 180 YSITSDVWSLGLTLLEV---------AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 649 DFDINSVW-KTVEIAMA-CVSQTSTKRPT 675
+ W + + + C+ + T+RPT
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 56/293 (19%)
Query: 429 NFERVLGNGGFGTVYHG----YLDG---TEVAVKMLSPSSAQGYK-QFQAEVELLMRIHH 480
R LG G FG VY G + G T VAVK ++ S++ + +F E ++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--------LRIAIEA 532
++ L+G +G ++ E MA+G+L++ L + + GR +++A E
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSRT------FPVEGSGTHVTTTI 576
A VHRD+ + N +++ F KI DFG++R + G G +
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG 636
A PE T SD+++FGVVL EI S+ E+ ++ + Q + F++ G
Sbjct: 189 A-------PESLKDGVFTTSSDMWSFGVVLWEI---TSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 637 --DIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
D R+ ++ C RPT ++V L + L
Sbjct: 239 YLDQPDNCPERVT------------DLMRMCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 40/239 (16%)
Query: 432 RVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNL 483
R LG G FG VY G G T VA+K ++ +++ + +F E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--------LRIAIEAAK- 534
L+G +G +I E M G+L++ L ++ + + +++A E A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG---- 581
VHRD+ + N +++ F KI DFG++R G G
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPV 185
Query: 582 -YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE 639
++ PE T SDV++FGVVL EI T + E+ ++ + Q + F++ G ++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGMSNEQVLRFVMEGGLLD 241
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 434 LGNGGFGTVYHGYLDGTE---------VAVKMLSPSSAQ-GYKQFQAEVELLMRI-HHKN 482
LG G FG V G + VAVKML + + +E+E++ I HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEE---------------ADILSW 522
+ L+G C + +I E+ + GNL+ L G E D++S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 523 EGRLRIAIE--AAK--VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
++ +E A++ +HRD+ + N+L++ KIADFGL+R V + TT
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VNNIDYYKKTTNGR 200
Query: 579 TP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE T +SDV++FGV++ EI T
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 50/241 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDGTE------------------VAVKML-SPSSAQGYKQFQA 470
F+ LG G FG V+ +G E VAVKML ++ F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 471 EVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL---------LGEEADILS 521
E++++ R+ N+ L+ C +I E+M NG+L L + +S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 522 WEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571
+ + +A + A VHRD+ + N L+ + KIADFG+SR G
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYR 187
Query: 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-----------SKSVIERTH 620
+ ++ E + + T SDV+ FGV L EI+T + VIE T
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 621 E 621
E
Sbjct: 248 E 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 434 LGNGGFGTVYHGYLDGTE---------VAVKMLSP-SSAQGYKQFQAEVELLMRI-HHKN 482
LG G FG V G + VAVKML ++ + +E+EL+ I HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA--------------DILSWEGRLRI 528
+ L+G C + +I E+ A GNL+ L + LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
A + A+ +HRD+ + N+L++ KIADFGL+R V + T+
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG--VHDIDYYKKTSNGR 197
Query: 579 TP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE T +SDV++FG+++ EI T
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 34/208 (16%)
Query: 429 NFERVLGNGGFGTVYHGY-LDGTE-VAVKMLSPSSAQGYKQFQAEVELLMR-------IH 479
V+G G VY L E VA+K + ++ Q V+ L + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRID------LEKCQTSVDELRKEVQAMSQCN 57
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-------LGEEADILSWEGRLRIAIEA 532
H N+ G L+ +++ G+L ++ +EA I + L+ ++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV---LKEVLKG 114
Query: 533 -------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH-VTTTIAGTPGYLD 584
++HRD+K+ NILL KIADFG+S + G T V T GTP ++
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 585 PEYYISNR-LTEKSDVYNFGVVLLEIIT 611
PE K+D+++FG+ +E+ T
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELAT 202
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 424 LRITNNFE----RVLGNGGFGTVYHG-YLDGTE-----VAVKMLSPSSA-QGYKQFQAEV 472
LRI E +VLG+G FGTVY G ++ E VA+K+L+ ++ + +F E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA 532
++ + H +L L+G C T + L+ + M +G L + E D + + L ++
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQI 118
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-G 581
AK VHRD+ + N+L+ KI DFGL+R +EG P
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL--LEGDEKEYNADGGKMPIK 176
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
++ E + T +SDV+++GV + E++T
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 432 RVLGNGGFGTVYHGYL--DGTE----VAVKMLSP-SSAQGYKQFQAEVELLMRIHHKNLT 484
+VLG+G FGTVY G DG VA+K+L +S + K+ E ++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALL------LGEEADILSWEGRLRIAI----EAAK 534
L+G C T + L+ + M G L + +G + D+L+W ++ + E
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQ-DLLNWCVQIAKGMSYLEEVRL 130
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
VHRD+ + N+L+ KI DFGL+R ++ + H P ++ E + R
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG--GKVPIKWMALESILHRRF 188
Query: 594 TEKSDVYNFGVVLLEIIT 611
T +SDV+++GV + E++T
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 427 TNNF--ERVLGNGGFGTVYHG--YLDGTEVAVK------MLSPSSAQGYKQFQAEVELLM 476
NF E+ +G G F VY LDG VA+K M+ + Q + E++LL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------LGEEADILSWEGRLRI 528
++ H N+ + E ++ E G+L ++ L E I + +L
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 529 AIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
A+E +HRD+K N+ ++ K+ D GL R F + + H ++ GTP Y+
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMS 174
Query: 585 PEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
PE N KSD+++ G +L E+ +S
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 29/258 (11%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTLVGYC 490
+G G FG V+ G + T+ VA+K++ A+ + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA-------AKVHRDVKSTN 543
+ T +I E++ G+ LL D LR ++ K+HRD+K+ N
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 131
Query: 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVT-TTIAGTPGYLDPEYYISNRLTEKSDVYNF 602
+LLS + K+ADFG++ + T + T GTP ++ PE + K+D+++
Sbjct: 132 VLLSEHGEVKLADFGVAGQL----TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 603 GVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIA 662
G+ +E+ E H +H + V F++ K + P L ++ E
Sbjct: 188 GITAIELAKG----EPPHSELHPMK-VLFLIPKNN-----PPTLEGNYSK----PLKEFV 233
Query: 663 MACVSQTSTKRPTMNQVV 680
AC+++ + RPT +++
Sbjct: 234 EACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 430 FERVLGNGGFGTV--YHGYLDGTEVAVKMLS--PSSAQGYKQFQAEVELLMRIHHKNLTT 485
F RV+G G +G V DG + +K L+ +S + K + E +LL ++ H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 486 --------------LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI- 530
++G+C+ G +Y + + L E ++ W ++ +A+
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP---ENQVVEWFVQIAMALQ 116
Query: 531 ---EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
E +HRD+K+ N+ L+ K+ D G++R V + + +T+ GTP Y+ PE
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR---VLENQCDMASTLIGTPYYMSPEL 173
Query: 588 YISNRLTEKSDVYNFGVVLLEIITSK 613
+ + KSDV+ G + E+ T K
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 66/274 (24%), Positives = 120/274 (43%), Gaps = 47/274 (17%)
Query: 434 LGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
LG+G FG VY T V A K++ S + + + E+++L H N+ L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI-----------EAAKVHRDVK 540
N ++ EF A G + A++L E + E ++R+ E +HRD+K
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLT--EPQIRVVCKQTLEALNYLHENKIIHRDLK 130
Query: 541 STNILLSGKFQAKIADFGLS----RTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE- 595
+ NIL + K+ADFG+S RT S GTP ++ PE + +
Sbjct: 131 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-------FIGTPYWMAPEVVMCETSKDR 183
Query: 596 ----KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP-RLHEDF 650
K+DV++ G+ L+E+ + IE H ++ + V + K + ++ P R +F
Sbjct: 184 PYDYKADVWSLGITLIEM----AQIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSSEF 238
Query: 651 ----------DINSVWKTVEIAMACVSQTSTKRP 674
++++ W T ++ ++ +P
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 432 RVLGNGGFGTVYHG--YLDGTEVAVKMLS----PSSAQG--YKQFQAEVELLMRIHHKNL 483
+ LG G F + Y GT +AVK ++ SS Q + + E+ L+ R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIAI----EAAKV 535
++G E ++ L E+MA G++ LL +EA I+++ +L + E +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 536 HRDVKSTNILLSGKFQ-AKIADFGLSRTFPVEGSGT-HVTTTIAGTPGYLDPEYYISNRL 593
HRDVK N+L+ Q +IADFG + +G+G + GT ++ PE +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185
Query: 594 TEKSDVYNFGVVLLEIITSK 613
DV++ G V++E+ T+K
Sbjct: 186 GRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNL 483
F + LG G FG V G+ A+K+LS + KQ + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEE------ADILSWEGRLRIAIE- 531
L G + +N L+ E++ G L + L E A ++ +A+E
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV-------LALEY 116
Query: 532 ---AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
V+RD+K N+LL KI DFG ++ V+G T T+ GTP YL PE
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGR----TYTLCGTPEYLAPE-I 169
Query: 589 ISNRLTEKS-DVYNFGVVLLEII 610
I ++ K+ D + G+++ E++
Sbjct: 170 ILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 425 RITNNFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQG-YKQFQAEVELLMRIHHK 481
+ ER+ G G FG VY G + T+ VA+K++ A+ + Q E+ +L +
Sbjct: 4 ELFTKLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG---EEADILSWEGRLRIAIE----AAK 534
+T G +GT +I E++ G+ LL EE I + + ++ K
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 122
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT-TTIAGTPGYLDPEYYISNRL 593
+HRD+K+ N+LLS + K+ADFG++ + T + T GTP ++ PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQL----TDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 594 TEKSDVYNFGVVLLEI 609
K+D+++ G+ +E+
Sbjct: 179 DFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 427 TNNFER-VLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
N ER VLG G +G VY T+V A+K + ++ + E+ L + H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALL------LGEEADILSWEGR-----LRIAIEA 532
+G E + E + G+L ALL L + + + + L+ +
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 533 AKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGTH-VTTTIAGTPGYLDPEYY 588
VHRD+K N+L+ SG KI+DFG S+ +G + T T GT Y+ PE
Sbjct: 128 QIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRL----AGINPCTETFTGTLQYMAPE-V 180
Query: 589 ISNRLT---EKSDVYNFGVVLLEIITSK 613
I +D+++ G ++E+ T K
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 432 RVLGNGGFGTVYHGY-LD-GTEVAVKML--SPSSAQGYKQFQA---EVELLMRIHHKNLT 484
++LG G FG VY Y D G E+AVK + P S + K+ A E++LL + H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 485 TLVGYCDEGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRL-RIAIEAAK------- 534
G + + L E+M G+++ L A + R R ++
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRD+K NIL K+ DFG S+ T + G+G ++ GTP ++ PE
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG---IKSVTGTPYWMSPEVISGE 184
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
K+DV++ ++E++T K
Sbjct: 185 GYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 431 ERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLT 484
ER+LG G FG + G L VA+ L S + + F AE L + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWE---------GRLRIAIEAAKV 535
L G G ++ E+M+NG L + L E +++ + ++ E V
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL--DPEYYISNRL 593
H+ + + +L++ KI+ F + E + TT++G L PE +
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA----IYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 594 TEKSDVYNFGVVLLEIIT 611
+ SDV++FG+V+ E+++
Sbjct: 186 SSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 432 RVLGNGGFGTVYHGYLDGTE----VAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTT 485
+ LG G FG+V G L+ + VAVK + + + + F +E + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 486 LVGYCDEGTNRG------LIYEFMANGNLQALLL----GEEADILSWEGRLRIAIEAAK- 534
L+G C + +I FM +G+L + LL G+ L + ++ + A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLD 584
+HRD+ + N +L+ +ADFGLS+ + + IA P ++
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK--IYNGDYYRQGRIAKMPVKWIA 182
Query: 585 PEYYISNRLTEKSDVYNFGVVLLEIIT 611
E T KSDV++FGV + EI T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 39/203 (19%)
Query: 434 LGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLVGY 489
LG G +G+VY D A+K + S ++ A E+ +L ++H N+ + Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 490 CD---EGTNRGLIYEFMANGNLQALL--------LGEEADILSWEGRLRIAIEAAK---- 534
+ +G ++ E+ G+L + L E +I W RI I+ +
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI--W----RIFIQLLRGLQA 118
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+KS NILL KI D G+S+ T I GTP Y+ PE +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQI-GTPHYMAPEVW 173
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
+ KSD+++ G +L E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 34/204 (16%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTLVG 488
+ G +G V+ T A+K++ + Q E ++L + + L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 489 YCDEGT-NRGLIYEFMANGNLQALL-----LGEE------ADILSWEGRLRIAIEAAK-- 534
Y +G N L+ E++ G+L +LL L E+ A+I+ +A+E
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIV-------LALEYLHSN 112
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE-----GSGTHVTTTIAGTPGYLDPEY 587
+HRD+K NIL+ K+ DFGLS+ V I GTP Y+ PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
+ ++ D ++ G +L E +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 43/208 (20%)
Query: 432 RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTL 486
R +G+G FG VY T VA+K +S S Q +++Q EV L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 487 VG-YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA------------ 533
G Y E T L+ E+ LG +DIL + +E A
Sbjct: 81 KGCYLREHT-AWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 534 -----KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
++HRD+K+ NILL+ K+ADFG S + GTP ++ PE
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFG-------SASLVSPANSFVGTPYWMAPEVI 183
Query: 589 IS---NRLTEKSDVYNFGVVLLEIITSK 613
++ + K DV++ G+ +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 40/200 (20%)
Query: 433 VLGNGGFGTVYHG-YLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG-- 488
LG G +G+VY + + G VA+K++ + ++ E+ +L + + G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 489 -----------YCDEG--------TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA 529
YC G TN+ L E +A L L G L + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA-AILYQTLKG-----LEYLHSNK-- 119
Query: 530 IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
K+HRD+K+ NILL+ + QAK+ADFG+S T+ GTP ++ PE
Sbjct: 120 ----KIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 590 SNRLTEKSDVYNFGVVLLEI 609
K+D+++ G+ +E+
Sbjct: 173 EIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 429 NFE--RVLGNGGFGTVYH-GYLDGTEV-AVKMLSPS---SAQGYKQFQAEVELLMRIHHK 481
+FE RV+G G FG V D ++ A+K ++ + E +L ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 482 NLTTL-VGYCDEGTNRGLIYEFMANGNL-----QALLLGEEADILSWEGRLRIAIEAAK- 534
L L + DE N L+ + + G+L Q + EE + W + +A+E
Sbjct: 61 FLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-VKFWICEIVLALEYLHS 118
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K NILL + I DF ++ +TT+ +GTPGY+ PE
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT----PDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
+ D ++ GV E + K
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 424 LRITNNFE----RVLGNGGFGTVYHGYL--DGTE----VAVKML-SPSSAQGYKQFQAEV 472
LRI E +VLG+G FGTVY G +G + VA+K L +S + K+ E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA 532
++ + + ++ L+G C T + LI + M G L + E D + + L ++
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQI 118
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-G 581
AK VHRD+ + N+L+ KI DFGL++ + H P
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG--GKVPIK 176
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
++ E + T +SDV+++GV + E++T
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 19/205 (9%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG GGFG V + T A K L +G + E ++L ++ + + +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 489 YCDEGTNRGLIYEFMANGNLQALL--LGE----EADILSWEGRLRIAIEAAK----VHRD 538
+ + L+ M G+L+ + +GE EA + + ++ +E V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+K N+LL +I+D GL+ VE G AGTPGY+ PE D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 599 VYNFGVVLLEIITSKSVIERTHERI 623
+ G L E+I +S + E++
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 59/263 (22%), Positives = 108/263 (41%), Gaps = 43/263 (16%)
Query: 442 VYHGYLDGTEVAVKMLSPSSAQGYK----QFQAEVELLMRIHHKNLTTLVGY----CDEG 493
+Y G + EV ++ +G+K + E++ L RI N+ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 494 TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA-----------KVHRDVKST 542
LI E+ G L+ +L E+ LS++ +L +AI+ K ++++ S
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 543 NILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY--ISNRLTEKSDVY 600
+ L++ ++ KI GL + +V + Y + I + T K D+Y
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPF-KNVNFMV-----YFSYKMLNDIFSEYTIKDDIY 206
Query: 601 NFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVE 660
+ GVVL EI T K E + K + I++ ++ +
Sbjct: 207 SLGVVLWEIFTGKIPFEN-------------LTTKEIYDLIINKNNSLKLPLDCPLEIKC 253
Query: 661 IAMACVSQTSTKRPTMNQVVMEL 683
I AC S S KRP + +++ L
Sbjct: 254 IVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRD+KS NILL K+ DFG S+ + S V T GTP Y+ PE + +
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-VGRTFCGTPYYVAPEIWRRKPYS 223
Query: 595 EKSDVYNFGVVLLEIITSKSVI--ERTHERIHIT 626
+K+D+++ GV+L E++T K E E +H T
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 408 NGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSAQGY 465
+ S + S S + R+ +G+G GTVY T A+K++ +
Sbjct: 61 SASGSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV 115
Query: 466 K-QFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE---ADI-- 519
+ Q E+E+L ++H N+ D ++ EFM G+L+ + +E AD+
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175
Query: 520 -----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF-----PVEGSG 569
+++ R I VHRD+K +N+L++ KIADFG+SR P S
Sbjct: 176 QILSGIAYLHRRHI------VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 570 THVTTTIAGTPGYLDPEYYISNRLTE------KSDVYNFGVVLLE 608
GT Y+ PE I+ L D+++ GV +LE
Sbjct: 229 -------VGTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 429 NFERV--LGNGGFGTVYHGY--LDGTEVAVKML-------SPSSAQGYKQFQAEVELLMR 477
NF+++ LG G + TVY G G VA+K + +PS+A E+ L+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKE 54
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFM---------ANGNLQALLLGEEADILSWEGRLRI 528
+ H+N+ L L++E+M +G AL + + S+ +L
Sbjct: 55 LKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL---DPNTVKSFTYQLLK 111
Query: 529 AI----EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF--PVEGSGTHVTTTIAGTPGY 582
I E +HRD+K N+L++ + + K+ADFGL+R F PV V T Y
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL-----WY 166
Query: 583 LDPEYYISNRLTEKS-DVYNFGVVLLEIITSK 613
P+ + +R S D+++ G ++ E+IT +
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 9e-11
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 430 FERV--LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEVELLMR 477
+E++ LG G +G VY G VA+K + PS+A E+ LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKE 54
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRIAIEA 532
+ H N+ L+ L++E+ +L+ L I S +L +
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 533 AK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K NIL++ K+ADFGL+R F + T + T Y PE
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVV-TLWYRAPEIL 170
Query: 589 ISNRLTEKS-DVYNFGVVLLEIITSK 613
+ ++ + D+++ G + E+IT K
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 43/208 (20%)
Query: 432 RVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTL 486
R +G+G FG VY VA+K +S S Q +++Q EV+ L RI H N
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 487 VG-YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKV---------- 535
G Y E T L+ E+ LG +D+L + +E A +
Sbjct: 91 KGCYLREHT-AWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 536 -------HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
HRD+K+ NILL+ Q K+ADFG S + GTP ++ PE
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFG-------SASIASPANSFVGTPYWMAPEVI 193
Query: 589 IS---NRLTEKSDVYNFGVVLLEIITSK 613
++ + K DV++ G+ +E+ K
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 36/199 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTL 486
++ +LG+G GTVY Y L +AVK++ + + KQ +E+E+L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 487 VGYCDEGTNRGLIYEFMANGNLQAL------LLGEEADILSWEGRLRIAIEAAK------ 534
G + EFM G+L +LG RIA+ K
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG------------RIAVAVVKGLTYLW 112
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRDVK +N+L++ + Q K+ DFG+S + T GT Y+ PE
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKTYVGTNAYMAPERISG 167
Query: 591 NRLTEKSDVYNFGVVLLEI 609
+ SDV++ G+ +E+
Sbjct: 168 EQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 20/195 (10%)
Query: 432 RVLGNGGFGTVYHG-YLD----GTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTT 485
R +G G FG VY G Y+ VAVK ++ ++ F E ++ + H ++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------V 535
L+G E ++ E G L++ L L + + + + V
Sbjct: 72 LIGVITENPVW-IVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
HRD+ + N+L+S K+ DFGLSR +E + + ++ PE R T
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 596 KSDVYNFGVVLLEII 610
SDV+ FGV + EI+
Sbjct: 188 ASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 45/203 (22%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
+G+G +G VY G VA+K++ ++ Q E+ +L H N+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGR----LRIAI-------------EAAK 534
++ E+ G+LQ DI L+IA E K
Sbjct: 71 RRDKLWIVMEYCGGGSLQ--------DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGYLDPEYY 588
+HRD+K NILL+ K+ADFG+S +T TIA GTP ++ PE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS---------AQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 589 ISNRL---TEKSDVYNFGVVLLE 608
R K D++ G+ +E
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 430 FERV--LGNGGFGTVYHGY--LDGTEVAVKMLSPSSA-QGYKQFQA-EVELLMRIHHKNL 483
+E++ +G G +G VY G VA+K + + +G+ E++LL ++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 484 TTLVG-YCDEGTNR-GLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIE----A 532
L +G +++E+M + +L LL E+ I + +L ++
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 533 AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI-SN 591
+HRD+K +NIL++ K+ADFGL+R + S + I T Y PE + +
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGAT 177
Query: 592 RLTEKSDVYNFGVVLLEIITSKSV 615
R + D+++ G +L E+ K +
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 21/194 (10%)
Query: 430 FERVLGNGGFGTVYHGYLD---GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
FE++ G G GTVY +D G EVA+K ++ Q K+ L+MR +KN +
Sbjct: 24 FEKI-GQGASGTVYTA-IDIATGQEVAIKQMNLQQ-QPKKELIINEILVMR-ENKN-PNI 78
Query: 487 VGYCDE---GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------VH 536
V Y D G ++ E++A G+L ++ D R ++A +H
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+KS NILL K+ DFG E S +T+ GTP ++ PE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 597 SDVYNFGVVLLEII 610
D+++ G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 43/206 (20%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTLVG 488
+G+G FG VY T VAVK +S S Q +++Q EV+ L ++ H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 489 -YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA-------------- 533
Y E T L+ E+ LG +D+L + +E A
Sbjct: 89 CYLKEHT-AWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 534 ---KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRD+K+ NILL+ Q K+ADFG S + + GTP ++ PE ++
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFG-------SASKSSPANSFVGTPYWMAPEVILA 191
Query: 591 ---NRLTEKSDVYNFGVVLLEIITSK 613
+ K DV++ G+ +E+ K
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 434 LGNGGFGTVYHGYLDGTE----VAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLV 487
LG+G FGTV G + VAVK+L + + E ++ ++ + + ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAI----EAAKVHRDV 539
G C E + L+ E G L L E +I ++ + + E VHRD+
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDV 599
+ N+LL + AKI+DFGLS+ + + T + PE + + KSDV
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181
Query: 600 YNFGVVLLE 608
++FGV++ E
Sbjct: 182 WSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 13/99 (13%)
Query: 249 LQFLTN---QQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDL 305
L++L+N D LWQG+ C+ + R+ S++LS I+G I+ I L IQ ++L
Sbjct: 45 LKYLSNWNSSADVCLWQGITCN----NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100
Query: 306 SNNNLTGPVPDFLSQLPF------LTELNLKGTIPNGLI 338
SNN L+GP+PD + L+ N G+IP G I
Sbjct: 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSI 139
|
Length = 968 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG GGFG V + T A K L+ +GY+ E +L ++H + + +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 489 YCDEGTNRGLIYEFMANGNLQALL--LGEE-------------ADILSWEGRL---RIAI 530
T+ L+ M G+L+ + + EE A I+S L RI
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI-- 118
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE-GSGTHVTTTIAGTPGYLDPEYYI 589
++RD+K N+LL +I+D GL+ VE G T AGTPG++ PE
Sbjct: 119 ----IYRDLKPENVLLDNDGNVRISDLGLA----VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI 623
D + GV L E+I ++ E++
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 23/193 (11%)
Query: 435 GNGGFGTVYHGYLDGTEVAVKML---SPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
GNGG + GT +A K++ + SS + KQ E++++ + + G
Sbjct: 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYGAFL 73
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-----------VHRDVK 540
N + EFM G+L + ++ + E +IA+ + +HRD+K
Sbjct: 74 NENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK 131
Query: 541 STNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVY 600
+NIL++ + Q K+ DFG+S + T GT Y+ PE + T KSDV+
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELI-----NSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 601 NFGVVLLEIITSK 613
+ G+ ++E+ K
Sbjct: 187 SLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMR-IHHKNLTTL 486
FE++ G G GTVY G EVA+K ++ Q K+ L+MR H N+
Sbjct: 24 FEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNI--- 78
Query: 487 VGYCDE---GTNRGLIYEFMANGNLQALLLGEEADILSWEGRL----RIAIEAAK----- 534
V Y D G ++ E++A G+L ++ D EG++ R ++A +
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHSN 134
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRD+KS NILL K+ DFG E S +T+ GTP ++ PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 191
Query: 593 LTEKSDVYNFGVVLLEII 610
K D+++ G++ +E++
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 434 LGNGGFGTVYHGYL----DGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLVG 488
LG+G FG V G +VA+K+L + + + + E E++ ++ + + ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADI-------LSWEGRLRIAIEAAK--VHRDV 539
C E L+ E + G L L G++ +I L + + + K VHRD+
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 540 KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDV 599
+ N+LL + AKI+DFGLS+ + S + + PE + + +SDV
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 600 YNFGVVLLE 608
+++G+ + E
Sbjct: 182 WSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 59/192 (30%), Positives = 84/192 (43%), Gaps = 23/192 (11%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTLV- 487
LG G FG V GT A+K L KQ Q E +LM + H + ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 488 GYCDEGTNR-GLIYEFMANGNLQALL--LGEEADILS--WEGRLRIAIEAAK----VHRD 538
+ DE NR + EF+ G L L G + ++ + L +A E ++RD
Sbjct: 86 SFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+K N+LL K K+ DFG ++ P T T+ GTP YL PE S + D
Sbjct: 144 LKPENLLLDNKGHVKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVD 197
Query: 599 VYNFGVVLLEII 610
+ GV+L E I
Sbjct: 198 WWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 21/189 (11%)
Query: 437 GGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHHKNLTTLVGYC- 490
G FG+VY G A+K+L S Q +AE ++M + Y
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 491 DEGTNRGLIYEFMANGNLQALL--LG--EEADILSWEGRLRIAIEAAK----VHRDVKST 542
L+ E++ G+ +L+ LG E + + + +E +HRD+K
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 543 NILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNF 602
N+L+ K+ DFGLSR GTP YL PE + + SD ++
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-------GLENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 603 GVVLLEIIT 611
G V+ E +
Sbjct: 180 GCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 49/278 (17%)
Query: 434 LGNGGFGTVYHGY----LDGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVG 488
+GNG FG V G + V VK L S+ F EV+ ++H N+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 489 YCDEGTNRGLIYEFMANGNLQALL---LGEEADILSWEGRLRIAIEAAK----------V 535
C E L+ EF G+L+ L G A + + R+A E A +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 536 HRDVKSTNILLSGKFQAKIADFGLS--------------RTFPVEGSGTHVTTTIAGTPG 581
H D+ N L+ KI D+GL+ P+ +
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG---- 178
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641
+ + T+KS++++ GV + E+ T+ + + + Q + ++ + DI+ +
Sbjct: 179 ----QDLLPKDQTKKSNIWSLGVTMWELFTAAD---QPYPDLSDEQVLKQVVREQDIK-L 230
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
P+L D + W E+ C RPT +V
Sbjct: 231 PKPQL--DLKYSDRW--YEVMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 434 LGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
LG+G FG VY T A K++ S + + + E+E+L +H + L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI----AIEAAK-------VHRDVK 540
++ EF G + A++L E D E ++++ +EA + +HRD+K
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137
Query: 541 STNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-----TIAGTPGYLDPEYYISNRLTE 595
+ N+LL+ K+ADFG+ S +V T + GTP ++ PE + + +
Sbjct: 138 AGNVLLTLDGDIKLADFGV--------SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 596 -----KSDVYNFGVVLLEIITSKSVIERTHERIH 624
K+D+++ G+ L+E+ + IE H ++
Sbjct: 190 TPYDYKADIWSLGITLIEM----AQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 434 LGNGGFGTV----YHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH---HKNLTTL 486
LG G +G V + VA+K ++ ++ +A EL + H HKN+T L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 487 VGY--CDEGTNRGL-IYEFMANGNLQALLLG----EEADILSWEGRLRIA---IEAAKV- 535
G L +YE + +L ++ +A S+ ++ I +A V
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVL 127
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTF---PVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
HRD+K N+L++ + KI DFGL+R F P E +G +T +A T Y PE +S +
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVA-TRWYRAPEIMLSFQ 185
Query: 593 LTEKS-DVYNFGVVLLEIITSKSVIE 617
K+ DV++ G +L E++ K V +
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 39/124 (31%), Positives = 67/124 (54%), Gaps = 13/124 (10%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRD+KS NI L K+ DFG S+ + + V ++ GTP YL PE + R +
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---------IESIVDPR 645
+K+D+++ GV+L E++T + +R I Q V + GK D +++++DP
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQV--LYGKYDPFPCPVSSGMKALLDPL 306
Query: 646 LHED 649
L ++
Sbjct: 307 LSKN 310
|
Length = 478 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 37/209 (17%)
Query: 433 VLGNGGFGTVYHG-YLDGT-----EVAVKMLSPSSAQGYKQFQ-----AEVELLMRIHHK 481
+L G FG +++G +D EV VK + + Q E LL + H+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 482 NLTTLVGYCDEGTNRGLI-YEFMANGNLQALL----LGEE--ADILSWEGRLRIAIEAAK 534
N+ ++ C E + Y +M GNL+ L LGE LS + + +AI+ A
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSR-TFPVEGSGTHVTTTIAGTP-GY 582
+H+D+ + N ++ + Q KI D LSR FP H P +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP---MDYHCLGDNENRPVKW 185
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ E ++ + SDV++FGV+L E++T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 432 RVLGNGGFGTVYHGYL----DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI---HHKNLT 484
++LG+G FGTV+ G D ++ V + + G + FQ + ++ + H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
L+G C G + L+ + G+L + + D L + L ++ AK
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHR++ + NILL +IADFG++ + + + ++ E + R T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMALESILFGRYT 189
Query: 595 EKSDVYNFGVVLLEIIT 611
+SDV+++GV + E+++
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 433 VLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGY 489
++GNG +G VY G G A+K++ + + ++ + E+ +L + HH+N+ T G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 490 CDEGTNRG------LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
+ G L+ EF G++ L+ + + L E I E +
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
+HRD+K N+LL+ + K+ DFG+S T GTP ++ PE +
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 594 TE-----KSDVYNFGVVLLEI 609
+ KSD+++ G+ +E+
Sbjct: 189 PDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 19/193 (9%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
FE++ G G GTVY G EVA++ ++ Q K+ L+MR +KN +V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMR-ENKN-PNIV 80
Query: 488 GYCDE---GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------VHR 537
Y D G ++ E++A G+L ++ D R ++A + +HR
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+KS NILL K+ DFG E S +T+ GTP ++ PE K
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 598 DVYNFGVVLLEII 610
D+++ G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 432 RVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLV 487
+G G G V+ T VA+K ++ +G QA E++ L H + L+
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--LRIAIEAAK-------VHRD 538
G+ L+ E+M + L +L EE + + + +R+ ++ +HRD
Sbjct: 66 DVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE-YYISNRLTEKS 597
+K N+L+S KIADFGL+R F E + + T Y PE Y + +
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLY--SHQVATRWYRAPELLYGARKYDPGV 182
Query: 598 DVYNFGVVLLEII 610
D++ G + E++
Sbjct: 183 DLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 427 TNNFERVLGNGGFGTVYHGYLDGTE-------VAVKMLSPSSAQGYKQ-FQAEVELLMRI 478
T F LG FG VY G+L GT VA+K L + ++ F+ E + R+
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG--------------------EEAD 518
H N+ L+G + +I+ + ++ +L L+ E AD
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 519 ILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
+ ++ +E VH+D+ + N+L+ K KI+D GL R V + +
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE--VYAADYYKLM 183
Query: 575 TIAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ P ++ PE + + + SD++++GVVL E+ +
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/199 (27%), Positives = 80/199 (40%), Gaps = 31/199 (15%)
Query: 434 LGNGGFGTVYHGYLDGT-----------EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
LG G FGTVY D E+ V L+P+ Q E +LL ++ H
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNL--------QALLLGEEADILSWEGRLRIAIEAAK 534
+ E +I E+ +L E + W +L + +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 535 V----HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
HRD+K+ NI L KI DFG+SR + GS + TT GTP Y+ PE
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGS-CDLATTFTGTPYYMSPEALKH 179
Query: 591 NRLTEKSDVYNFGVVLLEI 609
KSD+++ G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 61/236 (25%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLS----PSSAQGYKQFQAEV--------EL-LMR- 477
LG G +G V Y L G VA+K + + +Q EL +M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 478 IHHKNLTTLVG-YCDEG-TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK- 534
I H+N+ LV Y + N L+ + MA +L+ ++ + ++R+ K
Sbjct: 77 IKHENIMGLVDVYVEGDFIN--LVMDIMA-SDLKKVV----------DRKIRLTESQVKC 123
Query: 535 -----------------VHRDVKSTNILLSGKFQAKIADFGLSRTF---PVEGSGTHVT- 573
+HRD+ NI ++ K KIADFGL+R + P + +
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 574 -------TTIAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEIITSKSVIERTHE 621
T+ T Y PE + + + D+++ G + E++T K + +E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGY-KQFQAEVELLMRIHHKNLTTLV 487
+ +G+G G V + + G VAVK LS P Q + K+ E+ LL ++HKN+ +L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 488 GY------CDEGTNRGLIYEFMANGNLQALLLGEEADILSWE-----GRLRIAIEAAKVH 536
+E + L+ E M Q + + + + +S+ ++ A +H
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIH 146
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+K +NI++ KI DFGL+RT + T T Y PE + E
Sbjct: 147 RDLKPSNIVVKSDCTLKILDFGLART----ACTNFMMTPYVVTRYYRAPEVILGMGYKEN 202
Query: 597 SDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
D+++ G ++ E++ + + T HI QW
Sbjct: 203 VDIWSVGCIMGELVKGSVIFQGTD---HIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 432 RVLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQA-----EVELLMRI-HHKNL 483
+ LG+G FG+VY G VA+K + + + ++ EV+ L ++ H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR-----IAIEAAKV--- 535
L E ++E+M GNL L+ + S E +R I A +
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKH 118
Query: 536 ---HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE------ 586
HRD+K N+L+SG KIADFGL+R + + T T Y PE
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY--TDYVSTRWYRAPEILLRST 174
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSK 613
Y S D++ G ++ E+ T +
Sbjct: 175 SYSS-----PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
+G G GTV+ G EVA+K ++ + E+ ++ + + N+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------VHRDVKSTNI 544
G ++ E++A G+L ++ D R ++A + +HRD+KS N+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 545 LLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGV 604
LL K+ DFG E S +T+ GTP ++ PE K D+++ G+
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 605 VLLEII 610
+ +E++
Sbjct: 204 MAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 432 RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQAEVELLM---RI-----HHK 481
++LG G FG V+ L GT A+K L +VE M R+ H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL----MDDDVECTMVEKRVLSLAWEHP 56
Query: 482 NLTTLVGYCDEGTNRGLIY--EFMANGNLQALLLG------EEADILSWEGRLRIAIEAA 533
LT L YC T L + E++ G+L + A + E + +
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 534 K--VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
K V+RD+K NILL KIADFG+ + + G T T GTP Y+ PE +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---GDAKTCTFCGTPDYIAPEILLGQ 171
Query: 592 RLTEKSDVYNFGVVLLEIITSKS 614
+ D ++FGV+L E++ +S
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 55/231 (23%)
Query: 428 NNFERV--LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE + +G G FG V+ T A+K+L S Q +AE ++L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEE------ADILSWEGRLRIA 529
+ L + + L+ E+M G+L LL EE A+++ +A
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV-------LA 113
Query: 530 IEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT----------- 574
+++ +HRD+K NIL+ K+ADFGL + +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 575 ---------------TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
+ GTP Y+ PE + D ++ GV+L E++
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 24/198 (12%)
Query: 432 RVLGNGGFGTVY-----HGYLDGTEVAVKMLSPSSAQGYKQFQAEVE--LLMRIHHKNLT 484
+VLG G FG V+ G G A+K+L ++ + + + ++E +L ++H +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 485 TL-VGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEAAK----V 535
L + EG LI +F+ G+L L E E D+ + L +A++ +
Sbjct: 62 KLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-- 593
+RD+K NILL + K+ DFGLS+ ++ + GT Y+ PE + NR
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK--AYSFCGTVEYMAPE--VVNRRGH 175
Query: 594 TEKSDVYNFGVVLLEIIT 611
T+ +D ++FGV++ E++T
Sbjct: 176 TQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 28/202 (13%)
Query: 432 RVLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVG 488
V+GNG +G VY G G A+K++ + + ++ + E+ +L + HH+N+ T G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYG 80
Query: 489 YCDEGTNRG------LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ + G L+ EF G++ L+ + + L + I E +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRD+K N+LL+ + K+ DFG+S T GTP ++ PE +
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 593 LTE-----KSDVYNFGVVLLEI 609
+ +SD+++ G+ +E+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 35/240 (14%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQ-AEVELLMRIHHKNLTTL-- 486
+G G +G V G +VA+K +SP Q + Q E+++L R H+N+ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 487 ---VGYCDEGTNRGLIYEFMANGNLQALLLGEEA----------DILSWEGRLRIAIEAA 533
+ + ++ E M +L L+ + IL R I +A
Sbjct: 71 IIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQIL----RGLKYIHSA 125
Query: 534 KV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
V HRD+K +N+LL+ KI DFGL+R E T T T Y PE ++++
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK 185
Query: 593 LTEKS-DVYNFGVVLLEIITSKSVI---ERTHERIHITQWVSFMLG---KGDIESIVDPR 645
K+ D+++ G +L E+++++ + + H+ I +LG + D+ I+ R
Sbjct: 186 GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG----VLGTPSQEDLNCIISLR 241
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 34/201 (16%)
Query: 434 LGNGGFGTVYHGYLDGTEVAVKM----LSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
LG G +G+VY T V + M L ++ + Q E+++L H +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDIL---HKAVSPYIVDF 64
Query: 490 CDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRL-RIAIEAAK----------- 534
G +Y E+M G+L L G A E L RI K
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK TN+L++G Q K+ DFG+S + T++ G Y+ PE S
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPN 179
Query: 595 E------KSDVYNFGVVLLEI 609
+ +SDV++ G+ +LE+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 43/208 (20%)
Query: 432 RVLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNLTTL 486
R +G+G FG VY + VA+K +S S Q +++Q EV L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 487 VG-YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKV---------- 535
G Y E T L+ E+ LG +D+L + +E A V
Sbjct: 81 RGCYLREHT-AWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 536 -------HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
HRDVK+ NILLS K+ DFG S GTP ++ PE
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWMAPEVI 183
Query: 589 IS---NRLTEKSDVYNFGVVLLEIITSK 613
++ + K DV++ G+ +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 432 RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQAE-VE---LLMRIHHKNLTT 485
+VLG G FG V L GT A+K L + VE L + H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 486 LVGYCDEGTNRGLIY--EFMANGNL----QALLLGEE-------ADILSWEGRLRIAIEA 532
L +C T L + E++ G+L Q+ +E A+I+ L+ +
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC---GLQFLHKK 115
Query: 533 AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
++RD+K N+LL KIADFG+ + +G +T GTP Y+ PE +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 593 LTEKSDVYNFGVVLLEIITSKS 614
E D ++FGV+L E++ +S
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 31/204 (15%)
Query: 432 RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQAEVELLM---RI-----HHK 481
+VLG G FG V L GT+ AVK+L + +VE M R+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK----KDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 482 NLTTLVGYCDEGTNRGLIY--EFMANGNL----QALLLGEEADILSWEGRLRIAI----E 531
LT L + T L + E++ G+L Q +E + + + + E
Sbjct: 57 FLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-TIAGTPGYLDPEYYIS 590
++RD+K N+LL + KIADFG+ + EG VTT T GTP Y+ PE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 591 NRLTEKSDVYNFGVVLLEIITSKS 614
D + GV+L E++ +S
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 44/145 (30%), Positives = 64/145 (44%), Gaps = 18/145 (12%)
Query: 434 LGNGGFGTVYHGY----LDGTEVAVKML-SPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+GNG FG V G +V VK L +S Q +F E + + H NL +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGRL--RIAIEAAK----------V 535
C E T L+ EF G+L+ L A++++ + R+A E A +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 536 HRDVKSTNILLSGKFQAKIADFGLS 560
H D+ N LL+ KI D+GLS
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 433 VLGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTL-- 486
+G G +G VY G VA+K + + + A E+++L +++H+N+ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 487 -----VGYCDEGTNRG---LIYEFMAN---GNLQALLLG-EEADILSWEGRLRIAIEAAK 534
D ++G L++E+M + G L++ L+ E I S+ +L +
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRD+K +NILL+ K Q K+ADFGL+R + E S + I T Y PE +
Sbjct: 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TLWYRPPELLLG 191
Query: 591 N-RLTEKSDVYNFGVVLLEIITSKSVIERTHE 621
R DV++ G +L E+ T K + + E
Sbjct: 192 EERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 21/195 (10%)
Query: 434 LGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHHKNLTTLVG 488
LG GGFG V A+K + Q +E E+L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILS-WEGRLRIA--IEAAK-------VHRD 538
+ ++ E+ G L +L + + + R IA + A + ++RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+K N+LL K+ DFG ++ SG T T GTP Y+ PE ++ D
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK---KLKSGQK-TWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 599 VYNFGVVLLEIITSK 613
++ G++L E++T +
Sbjct: 175 YWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 61/213 (28%), Positives = 83/213 (38%), Gaps = 42/213 (19%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQF---QAEVELLM------- 476
VLG G FG V T A+K L K + EVE LM
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIFE 54
Query: 477 ---RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-------- 525
H L L + + E+ A G+ L++ D+ S E R
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGD---LMMHIHTDVFS-EPRAVFYAACV 110
Query: 526 ---LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-TIAGTPG 581
L+ E V+RD+K N+LL + KIADFGL + EG G T T GTP
Sbjct: 111 VLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPE 166
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
+L PE T D + GV++ E++ +S
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 34/270 (12%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKM--LSPSSAQGYKQFQ--------AEVELLMRIHH 480
++G G +G VY G +AVK L + A + Q +E+E L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSW-----EGRLRIAIE 531
N+ +G+ + E++ G++ + L EE + + EG L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG-LAYLHS 126
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K+ N+L+ KI+DFG+S+ + ++ G+ ++ PE S
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 592 R--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649
+ K D+++ G V+LE+ + R + F LG P + D
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGR----RPWSDEEAIAAM-FKLGN----KRSAPPIPPD 236
Query: 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+N ++ AC + RPT ++
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 35/170 (20%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLS-PSSAQGYKQFQA-EVELLMRI---HHKNLTTL 486
+G G +GTVY G VA+K + P S +G E+ LL ++ H N+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 487 VGYC-----DEGTNRGLIYEFMANGNLQALL-------LGEEA------DILSWEGRL-- 526
+ C D L++E + + +L L L E +L L
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 527 -RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575
RI VHRD+K NIL++ Q KIADFGL+R + E + T V T
Sbjct: 126 HRI------VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVK-MLSPSSAQGYK-QFQAEVELLMRIHHKNLTTL--- 486
LG G FG VY G VA+K +L + G+ E+++L ++ H N+ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 487 -VGYCDEGTN-RGLIY---EFMANGNLQALLLG-----EEADILSW-----EGRLRIAIE 531
V D+ RG +Y +M + +L LL E+ I + EG + E
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH-E 133
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE--------GSGTHVTTTIAGTPGYL 583
+HRD+K+ NIL+ + KIADFGL+R + G GT T + T Y
Sbjct: 134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193
Query: 584 DPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIE 617
PE + R T D++ G V E+ T + +++
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 432 RVLGNGGFGTVY-----HGYLDGTEVAVKMLSPS----SAQGYKQFQAEVELLMRIHHKN 482
+VLG GG+G V+ G G A+K+L + + + +AE +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIE----AAK 534
+ L+ G LI E+++ G L L E E + + +A+E
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K NILL + K+ DFGL + EG+ TH T GT Y+ PE + +
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTIEYMAPEILMRSGHG 178
Query: 595 EKSDVYNFGVVLLEIIT 611
+ D ++ G ++ +++T
Sbjct: 179 KAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 44/225 (19%)
Query: 434 LGNGGFGTVYHGYLD---GTEVAVKMLSPSSAQGYKQFQA---------EVELLMRIHHK 481
+G+G +GTV LD G +VA+K L Y+ FQ+ E+ LL + H+
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 482 NLTTLVGY------CDEGTNRGLIYEFMANGNLQALL----LGEE-ADILSWE--GRLRI 528
N+ L+ D + L+ FM +L L+ L E+ L ++ L+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 529 AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
A +HRD+K N+ ++ + KI DFGL+R E +G VT Y PE
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW------YRAPEVI 187
Query: 589 IS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM 632
++ T+ D+++ G ++ E++T K + + H+ H+ Q + M
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLF-KGHD--HLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQA---EVELLMRIHHKNLTTL 486
RVLG G FG V L G AVK+L + E +L + T
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 487 VGYCDEGTNR-GLIYEFMANGNL----QALLLGEEADILSWEGRLRIAI----EAAKVHR 537
+ C + +R + EF+ G+L Q +EA + + A+ + ++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+K N+LL + K+ADFG+ + G T+T GTP Y+ PE
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---TTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 598 DVYNFGVVLLEIITSKSVIERTHE 621
D + GV+L E++ + E +E
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 58/282 (20%)
Query: 429 NFERV--LGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT 484
+FE + +G+G +G VY G A+K++ + + Q E+ ++ H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEG---RLRIAI----------- 530
G + EF G+LQ DI G +IA
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQ--------DIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 531 --EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGY 582
K+HRD+K NILL+ K+ADFG+S +T TIA GTP +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS---------AQITATIAKRKSFIGTPYW 172
Query: 583 LDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE 639
+ PE R + D++ G+ +E+ + + H + F++ K + +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMTKSNFQ 227
Query: 640 SIVDPRLHEDFD-INSVWKTVEIAMACVSQTSTKRPTMNQVV 680
P+L + NS V++A+ ++ KRPT +++
Sbjct: 228 P---PKLKDKMKWSNSFHHFVKMAL---TKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 27/204 (13%)
Query: 428 NNFER--VLGNGGFGTVYHGYLDGTE--VAVKML--SPSSAQGYKQFQAEVELLMRIHHK 481
N +E V+G G +G V T VA+K S K EV++L ++ H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQAL------LLGEEADILSWEGRLRIAIEAAK- 534
N+ L L++E++ L+ L L + W+ ++A
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ-----LLQAIAY 115
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K NIL+S K+ DFG +R + +T +A T Y PE
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVA-TRWYRAPELL 173
Query: 589 ISNRLTEKS-DVYNFGVVLLEIIT 611
+ + K DV+ G ++ E++
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 429 NFERV--LGNGGFGTVYHG--YLDGTEVAVKMLS--------PSSAQGYKQFQAEVELLM 476
NF++V +G G +G VY L G VA+K + PS+A E+ LL
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLLK 54
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-- 534
++H N+ L+ L++EF+ + +L+ + D G I + K
Sbjct: 55 ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-----DASPLSG---IPLPLIKSY 105
Query: 535 ----------------VHRDVKSTNILLSGKFQAKIADFGLSRTF--PVEGSGTHVTTTI 576
+HRD+K N+L++ + K+ADFGL+R F PV + TH T+
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTL 164
Query: 577 AGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSV 615
Y PE + + + D+++ G + E++T +++
Sbjct: 165 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 449 GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508
G +VAVKM+ Q + EV ++ H+N+ + G ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 509 QALL----LGEEADILSWEGRLRIAI---EAAKVHRDVKSTNILLSGKFQAKIADFG--- 558
++ L EE E L+ +HRD+KS +ILL+ + K++DFG
Sbjct: 106 TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165
Query: 559 -LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
+S+ P S + GTP ++ PE + D+++ G++++E++
Sbjct: 166 QISKDVPKRKS-------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 429 NFERVLGNGGFGTV--YHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
NF ++ G G G V G +VAVK + Q + EV ++ H N+ +
Sbjct: 23 NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL---RIA------------IE 531
G ++ EF+ G L DI++ R+ +IA +
Sbjct: 82 YSSYLVGDELWVVMEFLEGGAL--------TDIVT-HTRMNEEQIATVCLAVLKALSFLH 132
Query: 532 AAKV-HRDVKSTNILLSGKFQAKIADFG----LSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
A V HRD+KS +ILL+ + K++DFG +S+ P S + GTP ++ PE
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-------LVGTPYWMAPE 185
Query: 587 YYISNRL---TEKSDVYNFGVVLLEII 610
IS RL TE D+++ G++++E++
Sbjct: 186 -VIS-RLPYGTE-VDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNL 483
NF VLG G FG V GT+ A+K+L + E +L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 484 TTLVGYCDEGTNR-GLIYEFMANGNL----QALLLGEEADILSWEGRLRIAI----EAAK 534
T + C + +R + E++ G+L Q + +E + + + I +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K N++L + KIADFG+ + +G T T GTP Y+ PE
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---TTKTFCGTPDYIAPEIIAYQPYG 179
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHE 621
+ D + FGV+L E++ ++ E E
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 41/171 (23%)
Query: 532 AAK--VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYY 588
A+K +HRDV + N+LL+ AKI DFGL+R + +V A P ++ PE
Sbjct: 229 ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD--IMNDSNYVVKGNARLPVKWMAPESI 286
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI-VDPRLH 647
T +SDV+++G++L EI F LGK I V+ + +
Sbjct: 287 FDCVYTVQSDVWSYGILLWEI---------------------FSLGKSPYPGILVNSKFY 325
Query: 648 E-----------DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
+ DF ++ I C + T+RPT +Q+ + L
Sbjct: 326 KMVKRGYQMSRPDFAPPEIYS---IMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K N++L KIADFG+ + G + +T GTP Y+ PE + T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 595 EKSDVYNFGVVLLEIITSKS 614
D ++FGV+L E++ +S
Sbjct: 175 FSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 19/207 (9%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTL 486
RVLG GGFG V + G A K L +G E ++L +++ + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLG------EEADILSWEGRLRIAIE----AAKVH 536
+ L+ M G+L+ + EE L + + +E V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+K NILL +I+D GL+ P G + + GT GY+ PE + R T
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRV-GTVGYMAPEVLNNQRYTLS 181
Query: 597 SDVYNFGVVLLEIITSKSVIERTHERI 623
D + G ++ E+I +S E++
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTTL 486
R++G GG G VY Y + VA+K + ++ K+F E ++ + H + +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLG-EEADILSWE--------GRLRI------AIE 531
C +G ++ L++LL + + LS E L I IE
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 532 AAK----VHRDVKSTNILLSGKF-QAKIADFG------------LSRTFPVEGSGTHVTT 574
+HRD+K NILL G F + I D+G L T
Sbjct: 128 YVHSKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 575 T---IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
I GTP Y+ PE + +E +D+Y GV+L +++T
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTL 486
RVLG GGFG V + G A K L +G E ++L +++ + + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALL--LGE----EADILSWEGRLRIAIEAAK----VH 536
+ L+ M G+L+ + +GE E + + + +E V+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI---AGTPGYLDPEYYISNRL 593
RD+K NILL +I+D GL+ P EG TI GT GY+ PE + R
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVP-EGQ------TIKGRVGTVGYMAPEVVKNERY 178
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERI 623
T D + G +L E+I +S ++ ++I
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 64/226 (28%)
Query: 427 TNNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHK 481
T FE V+G G +G VY G VA+K++ + ++ + E +L + +H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHP 63
Query: 482 NLTTLVG-------------------YCDEGTNRGLIYEFMANG-----NLQALLLGEEA 517
N+ T G C G+ L+ G A +L E
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 518 DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577
L++ ++ +HRD+K NILL+ + K+ DFG+S + +T+
Sbjct: 124 RGLAYLHENKV------IHRDIKGQNILLTKNAEVKLVDFGVSA---------QLDSTLG 168
Query: 578 ------GTPGYLDPE---------YYISNRLTEKSDVYNFGVVLLE 608
GTP ++ PE R SDV++ G+ +E
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDAR----SDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 449 GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508
G +VAVK + Q + EV ++ HH+N+ + G ++ EF+ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 509 QALL----LGEE---ADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFG--- 558
++ + EE LS L +HRD+KS +ILL+ + K++DFG
Sbjct: 107 TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166
Query: 559 -LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
+S+ P S + GTP ++ PE + D+++ G++++E+I
Sbjct: 167 QVSKEVPKRKS-------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 11/118 (9%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFP--VEGSGTHVTTTIAGTPGYLDPEYYI-SN 591
+HRD+K +NILL+ + K+ADFGL+R+ E V T T Y PE + S
Sbjct: 129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST 188
Query: 592 RLTEKSDVYNFGVVLLEIITSKSVIERTH-----ERIHITQWVSFMLGKGDIESIVDP 644
R T+ D+++ G +L E++ K + T E+I I V DIESI P
Sbjct: 189 RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI-IE--VIGPPSAEDIESIKSP 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 47/192 (24%), Positives = 87/192 (45%), Gaps = 13/192 (6%)
Query: 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
+NF ++ G G G V + G VAVK + Q + EV ++ H+N+
Sbjct: 23 DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALL----LGEE---ADILSWEGRLRIAIEAAKVHRD 538
+ G ++ EF+ G L ++ + EE A L+ L + +HRD
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+KS +ILL+ + K++DFG E ++ GTP ++ PE + D
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 599 VYNFGVVLLEII 610
+++ G++++E++
Sbjct: 199 IWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 30/201 (14%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEVELLMRIHHKNL 483
+G G +G VY G G VA+K + PS+A E+ LL + H N+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLKELQHPNI 61
Query: 484 TTLVGYCDEGTNRGLIYEFMA---NGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
L + + LI+EF++ L +L G+ D + L ++
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI-SNR 592
+HRD+K N+L+ K K+ADFGL+R F G V T T Y PE + S R
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 593 LTEKSDVYNFGVVLLEIITSK 613
+ D+++ G + E+ T K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 410 SFELKNQRFSYSNVLRITNNFERVLGNGGFGTV---YHGYLDGTEVAVKMLS-PSSAQGY 465
S E+ + F+ VL+ N + +G+G G V Y LD VA+K LS P Q +
Sbjct: 5 SVEVGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTH 59
Query: 466 -KQFQAEVELLMRIHHKNLTTLVGY------CDEGTNRGLIYEFMANGNLQALLLGEEAD 518
K+ E+ L+ ++HKN+ +L+ +E + L+ E M Q + + + +
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE 119
Query: 519 ILSWE-GRLRIAIE----AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573
+S+ ++ I+ A +HRD+K +NI++ KI DFGL+RT + +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMM 175
Query: 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
T T Y PE + E D+++ G ++ E++ K + R +I QW
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP---GRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 427 TNNFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSA---QGYKQFQAEVELLMRIHHK 481
NF VLG G FG V GT+ A+K+L + E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 482 NLTTLVGYCDEGTNR-GLIYEFMANGNL----QALLLGEEADILSWEGRLRIAI----EA 532
T + C + +R + E++ G+L Q + +E + + + + +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 533 AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
++RD+K N++L + KIADFG+ + V+G T T GTP Y+ PE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFCGTPDYIAPEIIAYQP 177
Query: 593 LTEKSDVYNFGVVLLEIITSK 613
+ D + +GV+L E++ +
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 429 NFERV--LGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHK 481
+ ER+ +G G FG V+ + A+K+++ KQ Q E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL-----------LGEEADILSWEGRLRIAI 530
+ L + ++ E++ G L + L L ++I+ A+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC-------AL 114
Query: 531 EAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
E V+RD+K NILL + K+ DFG ++ T T+ GTP YL PE
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPE 168
Query: 587 YYISNRLTEKSDVYNFGVVLLEII 610
S + D + G+++ E++
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 429 NFE--RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQ-----FQAEVELLMRIHHK 481
+FE +V+G G FG V L + M + + K+ F+ E ++L+ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-----LRIAIEAAK-- 534
+TTL + N L+ ++ G+L LL E + R + IAI++
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS-- 590
VHRD+K NIL+ ++ADFG + GT ++ GTP Y+ PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 591 ---NRLTEKSDVYNFGVVLLEIITSKS 614
+ + D ++ GV + E++ ++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 432 RVLGNGGFGTVYHGYLDGT-EV-AVKMLSPSSAQGYKQFQAEVELLM---RI-----HHK 481
+VLG G FG V L GT EV A+K+L +V+ M RI H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ----DDDVDCTMTEKRILALAAKHP 56
Query: 482 NLTTLVGYCDEGTNRGLIY--EFMANGNL----QALLLGEEADILSWEGRLRIAIEAAKV 535
LT L +C T L + E++ G+L Q +E + + +A+
Sbjct: 57 FLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 536 H----RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
H RD+K NILL + K+ADFG+ + + G TTT GTP Y+ PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIAPEILQEL 171
Query: 592 RLTEKSDVYNFGVVLLEIITSKSVIERTHE 621
D + GV++ E++ + E +E
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 64/213 (30%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLS--------PSSAQGYKQFQAEVELLMRIHHKN- 482
+G G +GTV+ VA+K + PSSA E+ LL + HKN
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 61
Query: 483 ------------LTTLVGYCDE----------GT-NRGLIYEFMANGNLQALLLGEEADI 519
LT + YCD+ G + ++ FM L+ L ++
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLLKGLAFCHSHNV 120
Query: 520 LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF--PVEGSGTHVTTTIA 577
L HRD+K N+L++ + K+ADFGL+R F PV V T
Sbjct: 121 L---------------HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL-- 163
Query: 578 GTPGYLDPEYYISNRLTEKS-DVYNFGVVLLEI 609
Y P+ +L S D+++ G + E+
Sbjct: 164 ---WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 432 RVLGNGGFGTVYHGYLD---GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN------ 482
R LG G G V+ +D VAVK + + Q K E++++ R+ H N
Sbjct: 11 RPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 483 --------LTTLVGYCDEGTNRGLIYEFM----ANGNLQALLLGEEADILSWEGRLR--I 528
LT VG E + ++ E+M AN Q L E A + ++ LR
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ-LLRGLK 128
Query: 529 AIEAAKV-HRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
I +A V HRD+K N+ ++ + KI DFGL+R S + T Y P
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 587 YYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHE 621
+S N T+ D++ G + E++T K + HE
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL- 593
+HRD+K++N+LL+ + KI DFGL+R + GS T + T Y PE + +
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 594 TEKSDVYNFGVVLLEIITSK 613
+ D+++ G + E++T K
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 409 GSFELKNQRFSYSNVLRITNNFERV--LGNGGFGTVYH--GYLDGTEVAVKMLSPSSAQG 464
G F + ++ T+ +E + +G G +G VY DG+ AVK+L P S
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD 62
Query: 465 YKQFQAEVELLMRI-HHKNLTTLVGY---CDE--GTNRGLIYEFMANGNLQALLLGEEAD 518
++ +AE +L + +H N+ G D+ G L+ E G++ L+ G
Sbjct: 63 -EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---- 117
Query: 519 ILSWEGRLRIAIEA----------------AKVHRDVKSTNILLSGKFQAKIADFGLSRT 562
+L RL A+ + +HRDVK NILL+ + K+ DFG+S
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS-----DVYNFGVVLLEI 609
S T GTP ++ PE + + S DV++ G+ +E+
Sbjct: 178 LT---STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTL 486
RVLG GGFG V + G A K L +G E +L +++ + + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 487 VGYCDEGTNR-GLIYEFMANGNLQALL--LG----EEADILSWEGRLRIAIEAAK----V 535
Y E + L+ M G+L+ + +G +E + + L +E + V
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
+RD+K NILL + +I+D GL+ P G V + GT GY+ PE + + T
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRV-GTVGYMAPEVINNEKYTF 180
Query: 596 KSDVYNFGVVLLEIITSKSVIERTHERI 623
D + G ++ E+I +S + ER+
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 59/248 (23%)
Query: 423 VLRITNNFERV--LGNGGFGTVYHG--YLDGTEVAVKM---------LSPSSAQGYKQFQ 469
R FE++ +G G +G VY G VA+K + SS +
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR------ 55
Query: 470 AEVELLMRIHHKNLTTL---------------VGYCDEGTNRGLIYEFMA-------NGN 507
E+ LL+ + H N+ L + YC++ L+
Sbjct: 56 -EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLAS-LLDNMPTPFSESQVKCL 113
Query: 508 LQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567
+ LL G L+ E +HRD+K +N+LL+ K KIADFGL+RT+
Sbjct: 114 MLQLLRG-----------LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GL 160
Query: 568 SGTHVTTTIAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHIT 626
+T + T Y PE + T D++ G +L E++ K ++ E I
Sbjct: 161 PAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQL 218
Query: 627 QWVSFMLG 634
+ +LG
Sbjct: 219 DLIIQLLG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 59/200 (29%), Positives = 83/200 (41%), Gaps = 31/200 (15%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTT- 485
+V+G G FG V DG AVK+L + + K AE +L+ KN+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL----KNVKHP 56
Query: 486 -LVGYCDEGTNRGLIY---EFMANGNLQALLLGEE-----------ADILSWEGRLRIAI 530
LVG +Y +++ G L L E A+I S G L
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--- 113
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
++RD+K NILL + + DFGL + +E S T T+T GTP YL PE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKT--TSTFCGTPEYLAPEVLRK 170
Query: 591 NRLTEKSDVYNFGVVLLEII 610
D + G VL E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 28/235 (11%)
Query: 410 SFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTE--VAVKMLS-PSSAQGY- 465
S E+ + F+ VL+ N + +G+G G V Y E VA+K LS P Q +
Sbjct: 12 SVEIGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 67
Query: 466 KQFQAEVELLMRIHHKNLTTLVGY------CDEGTNRGLIYEFMANGNL----QALLLGE 515
K+ E+ L+ ++HKN+ L+ +E + ++ E M + NL Q L E
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHE 126
Query: 516 EADILSWEGRLRIAI--EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573
L ++ I A +HRD+K +NI++ KI DFGL+RT G+ +T
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMT 183
Query: 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
+ T Y PE + E D+++ G ++ E+I + T HI QW
Sbjct: 184 PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD---HIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 29/159 (18%)
Query: 432 RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTTL 486
++LG G G V+ L GT A+K+L K+ E E+L + H L TL
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALL-------LGEE------ADILSWEGRLRIAIE-- 531
T L+ ++ G L LL L EE A++L +A+E
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL-------LALEYL 119
Query: 532 --AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568
V+RD+K NILL ++DF LS+ VE
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 30/78 (38%), Positives = 43/78 (55%), Gaps = 3/78 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
+HRD+ + NILLS KI DFGL+R + +V A P ++ PE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 594 TEKSDVYNFGVVLLEIIT 611
T +SDV++FGV+L EI +
Sbjct: 253 TTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 420 YSNVLRITNNFERV--LGNGGFGTVYHGY--LDGTEVAVK-MLSP-SSAQGYKQFQAEVE 473
+ V ITN + + +G G FG V L G VA+K ++ P S+ K+ E++
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 474 LLMRIHHKNLTTLVG-YCDEGTNRGLIYEFMANGNLQALLLGEEAD----------ILSW 522
LL + H+N+ +L + + + E + +L LL + IL
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILR- 119
Query: 523 EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
L+ A VHRD+K +NIL++ KI DFGL+R T T Y
Sbjct: 120 --GLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMTGYVSTRYY 171
Query: 583 LDPEYYIS-NRLTEKSDVYNFGVVLLEIITSK 613
PE ++ + + D+++ G + E++ K
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 29/201 (14%)
Query: 434 LGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVG-Y 489
+G G +G V+ +G++ AVK+L P ++ +AE +L + H N+ G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 490 CDEGTNRG----LIYEFMANGNLQALLLG--EEADILSWEGRLRIAIEA----------A 533
+ G L+ E G++ L+ G + + + I EA
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 534 KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY----- 588
+HRDVK NILL+ + K+ DFG+S S T GTP ++ PE
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---STRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 589 ISNRLTEKSDVYNFGVVLLEI 609
+ + + DV++ G+ +E+
Sbjct: 202 LDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K NILL + + DFGL + + T T GTP YL PE + + T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 595 EKSDVYNFGVVLLEIIT 611
+ D + GV+L E++T
Sbjct: 172 KAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 58/195 (29%), Positives = 80/195 (41%), Gaps = 21/195 (10%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLMR-IHHKNLTT 485
+V+G G FG V LDG AVK+L + + K AE +L++ + H L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------VH 536
L Y + T + NG L E R A A+ V+
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEG-SGTHVTTTIAGTPGYLDPEYYISNRLTE 595
RD+K NILL + + DFGL + EG + + TTT GTP YL PE
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 596 KSDVYNFGVVLLEII 610
D + G VL E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 42/156 (26%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT------PGYLDPEYY 588
+HRDVK +NILL K+ DFG+S + +IA T P Y+ PE
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDAGCRP-YMAPERI 179
Query: 589 ISNRLTE---KSDVYNFGVVLLEIITSK-------SVIERTHERIHITQWVSFMLGKGDI 638
+ +SDV++ G+ L E+ T K SV ++ +TQ V KGD
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ------LTQVV-----KGD- 227
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRP 674
P L + V C+ + +KRP
Sbjct: 228 ----PPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
+HRD+ + NILLS KI DFGL+R + +V A P ++ PE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE-DFDI 652
T +SDV++FGV+L EI S+ + + I + L +G R+ D+
Sbjct: 259 TIQSDVWSFGVLLWEIF---SLGASPYPGVKIDEEFCRRLKEGT-------RMRAPDYTT 308
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
+++T+ + C ++RPT +++V L L
Sbjct: 309 PEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 56/226 (24%)
Query: 429 NFERVLGNGGFGTVYHGYL----DGTEVAVKMLSPSSAQGYKQFQA---EVELLMRIHHK 481
E +G G +G VY DG E A+K Q Q+ E+ LL + H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 482 NLTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGR-LRIAIEAAKV--- 535
N+ +LV E ++ L++++ + Q I+ + + R++I + V
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQ---------IIKFHRQAKRVSIPPSMVKSL 113
Query: 536 -----------------HRDVKSTNILLSGKFQA----KIADFGLSRTF------PVEGS 568
HRD+K NIL+ G+ KI D GL+R F +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 569 GTHVTTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSK 613
V TI Y PE + R T+ D++ G + E++T +
Sbjct: 174 P--VVVTI----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 19/205 (9%)
Query: 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQ---GYKQFQAEVELLMRIHHKNLTTLVG 488
LG GGFG V + G A K L + G K E E+L +++ + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLG------EEADILSWEGRLRIAI----EAAKVHRD 538
+ T+ L+ M G+L+ + E ++ + ++ I V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+K N+LL + +++D GL+ VE T AGT GY+ PE + D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176
Query: 599 VYNFGVVLLEIITSKSVIERTHERI 623
+ G + E++ ++ + E++
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK +NILL K+ DFG+S V+ S T AG Y+ PE
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS-GRLVD-SKAK--TRSAGCAAYMAPERIDPPDPN 192
Query: 595 EK----SDVYNFGVVLLEIITSK 613
K +DV++ G+ L+E+ T +
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 429 NFE--RVLGNGGFGTVY-----HGYLDGTEVAVKMLSPSS----AQGYKQFQAEVELLMR 477
NFE RVLG G +G V+ G+ G A+K+L ++ A+ + + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 478 IHHKN-LTTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIAIEA 532
+ L TL T LI +++ G L L E+++ + + +A++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 533 AK----VHRDVKSTNILLSGKFQAKIADFGLSRTF-PVEGSGTHVTTTIAGTPGYLDPEY 587
++RD+K NILL + + DFGLS+ F E + + GT Y+ PE
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPE- 176
Query: 588 YISNRLT----EKSDVYNFGVVLLEIITSKS 614
+ + + D ++ GV+ E++T S
Sbjct: 177 -VIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 429 NFE--RVLGNGGFGTVY-----HGYLDGTEVAVKMLSPSS----AQGYKQFQAEVELLMR 477
NFE +VLG G +G V+ G+ G A+K+L ++ A+ + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 478 IHHKNLTTLVGYC-DEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIAIEA 532
I + Y T LI +++ G L L +E ++ + G + +A+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 533 AK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
++RD+K NILL + DFGLS+ F + + GT Y+ P+
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVERAYSFCGTIEYMAPDIV 178
Query: 589 ISNRLTEKS--DVYNFGVVLLEIITSKS 614
D ++ GV++ E++T S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHRD+ NI+L + I DFGL++ + T++ GT Y PE +
Sbjct: 136 VHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTILYSCPEIVKNEPYG 191
Query: 595 EKSDVYNFGVVLLEIIT 611
EK+DV+ FG +L ++ T
Sbjct: 192 EKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 429 NFERVLGNGGFGTVYHGYLDGT--EVAVKMLS-P-SSAQGYKQFQAEVELLMRIHHKNLT 484
+G+G +G V + T +VA+K LS P SA K+ E+ LL + H+N+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 485 TLVG-YCDEGTNRG-----LIYEFMANGNLQALL----LGEEA------DILSWEGR-LR 527
L+ + + L+ M +L ++ L ++ IL R L+
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 528 IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
A +HRD+K +NI ++ + KI DFGL+R E +G +V T Y PE
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-YVATR-----WYRAPE- 185
Query: 588 YISNRL--TEKSDVYNFGVVLLEIITSK 613
+ N + + D+++ G ++ E++T K
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 44/203 (21%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
+G+G +G VY G AVK++ + Q E+ ++ H N+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEG---RLRIAI-------------EAAKV 535
+ E+ G+LQ DI G L+IA K+
Sbjct: 77 SREKLWICMEYCGGGSLQ--------DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGYLDPEYYI 589
HRD+K NILL+ K+ADFG++ +T TIA GTP ++ PE
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA---------AKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 590 SNR---LTEKSDVYNFGVVLLEI 609
+ + D++ G+ +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 27/202 (13%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQA-EVELLMRIH---HKNLTTL 486
+G G +GTVY G VA+K + ++ G EV LL R+ H N+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 487 VGYC-----DEGTNRGLIYEFMANGNLQALLLGEEADILSWE----------GRLRIAIE 531
+ C D T L++E + + +L+ L L E L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRD+K NIL++ Q K+ADFGL+R + + + T V T+ Y PE + +
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL----WYRAPEVLLQS 182
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
D+++ G + E+ K
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 31/238 (13%)
Query: 425 RITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKM-LSPSSAQGYKQFQA--EVELLMR 477
+ +E++ +G G FG V+ VA+K L + +G+ A E+++L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALREIKILQL 67
Query: 478 IHHKNLTTLVGYCD---EGTNRG-----LIYEFMANGNLQALL--------LGEEADILS 521
+ H+N+ L+ C NR L++EF + +L LL L E ++
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126
Query: 522 WEGRLRIAIEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTF--PVEGSGTHVTTTIAG 578
I K+ HRD+K+ NIL++ K+ADFGL+R F T +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 579 TPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635
T Y PE + R D++ G ++ E+ T +S I + + H +S + G
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQLCGS 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 43/278 (15%)
Query: 429 NFERVLGNGGFGTVY--HGYLDGTEVAVKML--SPSSAQGYKQFQAEVELLMRIHHKNLT 484
N V G G +G V G VA+K S K E+ +L ++ H+NL
Sbjct: 5 NLGLV-GEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI-------AIEAAK--- 534
L+ L++EF+ + L L E+ E R+R IE
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-R 592
+HRD+K NIL+S K+ DFG +RT + G T +A T Y PE + + +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVA-TRWYRAPELLVGDTK 177
Query: 593 LTEKSDVYNFGVVLLEIIT------SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646
D++ G ++ E++T S I++ + HI + + ++ PR
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY---HIIKCLGNLI----------PRH 224
Query: 647 HEDFDINSVWKTVEIAMACVSQTSTKR-PTMNQVVMEL 683
E F N ++ + + + KR P ++ +V++L
Sbjct: 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDL 262
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 34/259 (13%)
Query: 432 RVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQ---GYKQFQAEVELLMRIHHKNLTTL 486
RVLG GGFG V G A K L + G E ++L +++ + + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALL--LG----EEADILSWEGRLRIAIEAAK----VH 536
+ L+ M G+L+ + +G +E + + + +E V+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+K NILL +I+D GL+ P G + + GT GY+ PE + R T
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRV-GTVGYMAPEVVKNERYTFS 181
Query: 597 SDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656
D + G ++ E+I KS + E++ + V+ R+ ED + S
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREE--------------VERRVKEDQEEYSE- 226
Query: 657 KTVEIAMACVSQTSTKRPT 675
K E A + Q TK P
Sbjct: 227 KFSEAARSICRQLLTKDPG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 429 NFE--RVLGNGGFGTV--YHGYLDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHHK 481
+FE +V+G G FG V G A+K+L + +Q +AE ++L+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWE------GRLRIAIEAAK- 534
+ + + N LI EF+ G++ LL+ + D L+ E +AI++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSR----------------------TFPVEGSG 569
+HRD+K N+LL K K++DFGL TF S
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 570 THVTT----------TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
T + GTP Y+ PE ++ + D ++ GV++ E++
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 60/238 (25%)
Query: 428 NNFE--RVLGNGGFGTV--YHGYLDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE +V+G G FG V G A+K L S +Q +AE ++L +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 481 KNLTTLVGYC---DEGTNRGLIYEFMANGNLQALLLGEEADILSWEG-RLRI-----AIE 531
+ L Y DE LI E++ G++ LL+ + D + E R I AI+
Sbjct: 61 PWVVKL--YYSFQDE-NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAID 115
Query: 532 AAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFP-----------VEGSGTHVTTTI 576
+ +HRD+K N+LL K K++DFGL ++ I
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 577 A------------------------GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
+ GTP Y+ PE ++ ++ D ++ GV++ E++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 20/196 (10%)
Query: 429 NFERVLGNGGFGTVYHG-YLDGT--EVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKN 482
NF R LG G FG V Y + VA+K S KQ +E ++L I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA---DI-LSWEGRLRIAIEAAK---- 534
L G + + L+ EF+ G L + D+ + ++ + E +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
V+RD+K N+LL K+ DFG ++ T T+ GTP Y+ PE ++
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHG 206
Query: 595 EKSDVYNFGVVLLEII 610
+ +D + G+ + EI+
Sbjct: 207 KAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 25/77 (32%), Positives = 43/77 (55%), Gaps = 5/77 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK +NIL++ + + K+ DFG+S + + V GT Y+ PE T
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYT 176
Query: 595 EKSDVYNFGVVLLEIIT 611
+SD+++ G+ L+E+
Sbjct: 177 VQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 5/77 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K N++L + KIADFG+ + G T T GTP Y+ PE I+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAPE-IIAYQPY 178
Query: 595 EKS-DVYNFGVVLLEII 610
KS D + FGV+L E++
Sbjct: 179 GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG-SGTHVTTTIAGTPGYLDPEYYISNRL 593
V+RD+K N++L KI DFGL + EG S T GTP YL PE N
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 594 TEKSDVYNFGVVLLEIITSK-SVIERTHERI 623
D + GVV+ E++ + + HE++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 252 LTNQQDAYLWQG-LNCSYPE--YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNN 308
L N Q +L+Q L+ P + ++ SL+LS + ++G+I + L +++IL L +N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 309 NLTGPVPDFLSQLPFLTEL-----NLKGTIPNGLIEKQKNGLLSLSVEGNPDLCPEASCT 363
N TG +P L+ LP L L G IP L + +L LS PE C+
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 364 A 364
+
Sbjct: 379 S 379
|
Length = 968 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 429 NFE--RVLGNGGFGTVY-----HGYLDGTEVAVKMLSPSS----AQGYKQFQAEVELLMR 477
NFE +VLG G +G V+ G+ G A+K+L ++ A+ + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 478 IHHKN-LTTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIAIEA 532
+ L TL LI ++++ G + L E ++ + G + +A+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 533 AK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
V+RD+K NILL + + DFGLS+ F E T + GT Y+ PE
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEII 178
Query: 589 ISNRLTEKS-DVYNFGVVLLEIITSKSVIERTHER 622
K+ D ++ G+++ E++T S ER
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 29/201 (14%)
Query: 428 NNFERV----LGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHKN 482
++FER+ GNGG T G +A K++ + Q E+++L H N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL---HECN 61
Query: 483 LTTLVGYCDEGTNRGLI---YEFMANGNLQALLLGEEADILSWE--GRLRIAI------- 530
+VG+ + G I E M G+L +L +EA + E G++ IA+
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 531 --EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+ +HRDVK +NIL++ + + K+ DFG+S + + GT Y+ PE
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERL 174
Query: 589 ISNRLTEKSDVYNFGVVLLEI 609
+ +SD+++ G+ L+E+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 428 NNFE--RVLGNGGFGTV--YHGYLDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE +V+G G FG V G A+K+L + +Q +AE ++L+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWE------GRLRIAIEAAK 534
+ + + N LI EF+ G++ LL+ + D LS E +AI+A
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFG----------------LSRTFPVEGSGTHVTT 574
+HRD+K N+LL K K++DFG L+ P + S ++ +
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 575 ----------------TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610
+ GTP Y+ PE ++ + D ++ GV++ E++
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 30/78 (38%), Positives = 43/78 (55%), Gaps = 3/78 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
+HRD+ + NILLS KI DFGL+R + +V A P ++ PE
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 594 TEKSDVYNFGVVLLEIIT 611
T +SDV++FGV+L EI +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 67/232 (28%)
Query: 434 LGNGGFGTVYHG--YLDGTEVAVKMLSPSSAQGYKQFQ--------AEVELLMRI-HHKN 482
+G G F V G A+K + K F+ E++ L R+ H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 483 LTTL--VGYCDEGTNR-GLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIEAAK 534
+ L V + D T R L++E M + NL L+ G E + S+ +L +++
Sbjct: 60 ILRLIEVLF-DRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
HRD+K NIL+ K+ADFG R I P Y + YIS
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCR-------------GIYSKPPYTE---YIS 160
Query: 591 NR--------LTE-----KSDVYNFGVVLLEIITSKSVIERTHE-----RIH 624
R LT+ K D++ G V EI++ + T+E +IH
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-TIAGTPGYLDPEYYISNRL 593
V+RD+K N++L KI DFGL + EG T T GTP YL PE N
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 594 TEKSDVYNFGVVLLEIITSK-SVIERTHERI 623
D + GVV+ E++ + + HER+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLVGYC 490
LG G + TV+ G TE VA+K + +G EV LL + H N+ TL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 491 DEGTNRGLIYEFMAN---------GNLQA----------LLLGEEADILSWEGRLRIAIE 531
L++E++ + GNL + LL G LS+ + +I
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRG-----LSYCHKRKI--- 124
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+K N+L++ K + K+ADFGL+R + P + V T Y P+ +
Sbjct: 125 ---LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-----WYRPPDVLL 176
Query: 590 -SNRLTEKSDVYNFGVVLLEIITSK 613
S + D++ G +L E+ T +
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSP--SSAQGYKQFQAEVELLMRIHHKNLT 484
+ +G+G +G V G +VA+K +S K+ E++LL + H+N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 485 TL--VGYCDEGTNRGLIY---EFMANGNLQALLLGEEAD---ILSWEGRLRIA------- 529
L + + +Y E M E D ++ L
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM------------ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 530 --------IEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
+ +A V HRD+K +NIL++ KI DFGL+R + T T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 581 GYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSK 613
Y PE +S +R T+ D+++ G + E++T K
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 35/152 (23%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLTTLVG 488
LG G + TVY G L G VA+K + +G F A E LL + H N+ TL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 489 YCDEGTNRGLIYEFM----------ANGNLQ---------ALLLGEEADILSWEGRLRIA 529
L++E++ G L LL G L++ + R+
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRG-----LAYCHQRRV- 124
Query: 530 IEAAKVHRDVKSTNILLSGKFQAKIADFGLSR 561
+HRD+K N+L+S + + K+ADFGL+R
Sbjct: 125 -----LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKN---- 482
+G+G +G V G +VA+K + + K+ E+++L H N
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLG----EEADILSWEGRLRIA---IEAAKV 535
L + + ++ + M + +L ++ E I + +L I +A V
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANV 128
Query: 536 -HRDVKSTNILLSGKFQAKIADFGLSR---TFPVEGSGTHVTTTIAGTPGYLDPEYYIS- 590
HRD+K +N+L++ + +I DFG++R + P E +T +A T Y PE +S
Sbjct: 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE-HKYFMTEYVA-TRWYRAPELLLSL 186
Query: 591 NRLTEKSDVYNFGVVLLEII 610
T D+++ G + E++
Sbjct: 187 PEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS-----PSSAQ-GYKQFQAEVELLMR-IHHKN 482
+ +G+G G V Y + G VA+K LS + A+ Y++ +LM+ ++HKN
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL-----VLMKLVNHKN 76
Query: 483 LTTLVGY------CDEGTNRGLIYEFMANGNL----QALLLGEEADILSWEGRLRIAIE- 531
+ L+ +E + L+ E M + NL Q L E L ++ + I+
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLYQ--MLCGIKH 133
Query: 532 ---AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
A +HRD+K +NI++ KI DFGL+RT G+ +T + T Y PE
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVV-TRYYRAPEVI 189
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
+ E D+++ G ++ E+I + T HI QW
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD---HIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 31/197 (15%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+G GG+G V+ T VA+K + S + E ++L + L L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 489 YCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRIA--IEAAK------- 534
+ L E++ G+ + LL L E+ R +A EA
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED------HARFYMAEMFEAVDALHELGY 122
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRD+K N L+ K+ DFGLS+ ++ G+P Y+ PE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMAPEVLRGKGYD 176
Query: 595 EKSDVYNFGVVLLEIIT 611
D ++ G +L E +
Sbjct: 177 FTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHRD+K NIL++ Q K+ADFGL+R + + + T V T+ Y PE + +
Sbjct: 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL----WYRAPEVLLQSSYA 187
Query: 595 EKSDVYNFGVVLLEIITSK 613
D+++ G + E+ K
Sbjct: 188 TPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 14/95 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDGTE-------VAVKMLSP-SSAQGYKQFQAEVELLMRI-HH 480
+ LG G FG V G E VAVKML ++A YK E+++L+ I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 481 KNLTTLVGYCDEGTNRG---LIYEFMANGNLQALL 512
N+ L+G C G +I E+ GNL L
Sbjct: 71 LNVVNLLGACT--KPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLVGYC 490
LG G + TVY G T+ VA+K + +G EV LL + H N+ TL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 491 DEGTNRGLIYEFMAN---------GNL-----QALLLGEEADILSWEGRLRIAIEAAKVH 536
+ L++E++ GN L L + L++ R ++ +H
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV------LH 127
Query: 537 RDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYI-SNRL 593
RD+K N+L++ + + K+ADFGL+R + P + V T Y P+ + S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL-----WYRPPDILLGSTDY 182
Query: 594 TEKSDVYNFGVVLLEIITSKSVI--ERTHERIH 624
+ + D++ G + E+ T + + E++H
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
E V+RD+K N++L KI DFGL + +G+ T GTP YL PE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLED 170
Query: 591 NRLTEKSDVYNFGVVLLEIITSK-SVIERTHERI 623
N D + GVV+ E++ + + HE++
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 20/197 (10%)
Query: 432 RVLGNGGFGTVYHGYLDGTEVAVKM--LSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+ + + T VAVK L S + K Q E+ ++ H N+ V
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 490 CDEGTNRGLIYEFMANGNLQALL-------LGEEADILSWEGRLRIAIEAAK----VHRD 538
+ ++ MA G+ + LL L E A + L A++ +HR
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLN-ALDYIHSKGFIHRS 126
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV----TTTIAGTPGYLDPEYYISNRL- 593
VK+++ILLSG + ++ S + G V + +L PE N
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 594 -TEKSDVYNFGVVLLEI 609
EKSD+Y+ G+ E+
Sbjct: 187 YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 32/207 (15%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHKNLT 484
N E+ LG G + TVY G ++G VA+K++S + +G F A E LL + H N+
Sbjct: 9 NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66
Query: 485 TLVGYCDEGTNRGLIYEFMAN----------GNLQA----LLLGEEADILSWEGRLRIAI 530
L ++E+M G L L + + L++ I
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI-- 124
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K N+L+S + K+ADFGL+R + P + + V T P L
Sbjct: 125 ----LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKSV 615
S+ L D++ G + +E++ +
Sbjct: 181 YSSAL----DIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 58/237 (24%)
Query: 428 NNFERV--LGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYK-----QFQAEVELLMRIHH 480
N +E + +GNG FG V+ T+ S +G K Q EV ++ + H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQ-EFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 481 KNLTTLVGYCDEGTNRG-----LIYEFMANGNLQA------LLLG--EEADILSWEGRLR 527
KN+ V Y D N+ ++ EF G+L + G EE I+ +L
Sbjct: 72 KNI---VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 528 IAIEAAK-----------VHRDVKSTNILLS-----------------GKFQAKIADFGL 559
A+ +HRD+K NI LS G+ AKI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYI--SNRLTEKSDVYNFGVVLLEIITSKS 614
S+ +E S H + GTP Y PE + + +KSD++ G ++ E+ + K+
Sbjct: 189 SKNIGIE-SMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/194 (28%), Positives = 80/194 (41%), Gaps = 19/194 (9%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ---FQAEVELLMR-IHHKNLTT 485
+V+G G FG V DG+ AVK+L + K+ AE +L++ + H L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------VH 536
L + +++ G L L E L R A A+ ++
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+K NILL + + DFGL + VE T T+T GTP YL PE
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKE-GVEPEET--TSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 597 SDVYNFGVVLLEII 610
D + G VL E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK+ NI ++ Q I D G ++ FPV +AGT PE ++
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFL---GLAGTVETNAPEVLARDKYN 234
Query: 595 EKSDVYNFGVVLLEIITSKSVI 616
K+D+++ G+VL E++ S I
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 428 NNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA--EVELLMRIHHK 481
+++E++ LG G + TVY G ++G VA+K++ +G F A E LL + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQ--------------ALLLGEEADILSWEGRLR 527
N+ L L++E++ Q L L + LS+ +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 528 IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
I +HRD+K N+L+S + K+ADFGL+R V +H + T Y P+
Sbjct: 124 I------LHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDV 174
Query: 588 YISNRLTEKS---DVYNFGVVLLEII 610
+ + TE S D++ G + +E+I
Sbjct: 175 LLGS--TEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK N+LL K+ADFG ++ +G T GTP Y+ PE S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 595 ----EKSDVYNFGVVLLEII 610
+ D ++ GV L E++
Sbjct: 222 GYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 10/84 (11%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK +N+L++ Q K+ DFG+S + T AG Y+ PE I+ L
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKPYMAPE-RINPELN 180
Query: 595 E-----KSDVYNFGVVLLEIITSK 613
+ KSDV++ G+ ++E+ T +
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT-TIAGTPGYLDPEYYISNRL 593
V+RD+K N++L KI DFGL + EG T T GTP YL PE N
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 594 TEKSDVYNFGVVLLEIITSK-SVIERTHERI 623
D + GVV+ E++ + + HE++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 23/196 (11%)
Query: 432 RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSS---AQGYKQFQAEVELLMR-IHHKNLTT 485
+V+G G FG V E AVK+L + + K +E +L++ + H L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI-AIEAAK---------- 534
L + +++ G L L E + E R R A E A
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYLHSLNI 117
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
V+RD+K NILL + + DFGL + +E +GT T+T GTP YL PE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGT--TSTFCGTPEYLAPEVLHKQPYD 174
Query: 595 EKSDVYNFGVVLLEII 610
D + G VL E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE +V+G G FG V + TE A+K+L+ + F+ E +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILS-----WEGRLRIAIEAAK- 534
+ +TTL + L+ ++ G+L LL E + + + +AI +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS- 590
VHRD+K N+LL ++ADFG + GT ++ GTP Y+ PE +
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 591 ----NRLTEKSDVYNFGVVLLEII 610
+ + D ++ GV + E++
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 434 LGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYK-QFQAEVELLMRIHHKNLTTLVGYC 490
LG G + TV+ G TE VA+K + +G EV LL + H N+ TL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 491 DEGTNRGLIYEFMAN---------GNLQA-----LLLGEEADILSWEGRLRIAIEAAKVH 536
+ L++E++ GN+ + + L + L++ R ++ +H
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV------LH 127
Query: 537 RDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYI-SNRL 593
RD+K N+L++ + + K+ADFGL+R + P + V T Y P+ + S+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL-----WYRPPDVLLGSSEY 182
Query: 594 TEKSDVYNFGVVLLEIITSK 613
+ + D++ G + E+ + +
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 518 DILSWEGRLRIAIE--AAK--VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573
D+LS+ ++ +E A+K VHRD+ + N+LL+ KI DFGL+R + +V+
Sbjct: 238 DLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARD--IMHDSNYVS 295
Query: 574 TTIAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P ++ PE N T SDV+++G++L EI +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 23/75 (30%), Positives = 42/75 (56%), Gaps = 5/75 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRDVK +NIL++ + + K+ DFG+S + + GT Y+ PE +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQGTHYS 180
Query: 595 EKSDVYNFGVVLLEI 609
+SD+++ G+ L+E+
Sbjct: 181 VQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 4/76 (5%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR-L 593
V+RD+K NILL + DFGLS+ + T T GT YL PE + +
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKA---NLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 594 TEKSDVYNFGVVLLEI 609
T+ D ++ GV++ E+
Sbjct: 175 TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 23/146 (15%)
Query: 434 LGNGGFGTVYHG--YLD--GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+GNG FG V Y D V VK L + S++ +F + + + H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEE-----ADILSWEGRLRIAIEAAK--------- 534
C E L++E+ G+L++ L E+ + +L + R+A E A
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKHN 119
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGL 559
+H D+ N L+ K+ D+G+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
+HRD+ + NILL+ KI DFGL+R + +V A P ++ PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARD--IRNDSNYVVKGNARLPVKWMAPESIFNCVY 293
Query: 594 TEKSDVYNFGVVLLEIIT 611
T +SDV+++G++L EI +
Sbjct: 294 TFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 17/140 (12%)
Query: 487 VGYCD-EGTNRGLIYE---FMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
V Y D E +N Y+ A + L E+ LS+ + + + A
Sbjct: 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK 258
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISN 591
VHRD+ + N+L+ KI DFGL+R + +++ P ++ PE +N
Sbjct: 259 NCVHRDLAARNVLICEGKLVKICDFGLARD--IMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
T SDV++FG++L EI T
Sbjct: 317 LYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 4/115 (3%)
Query: 530 IEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
I A V HRD+K NIL + + KI DFGL+R + T T Y PE
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 589 IS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641
S ++ T D+++ G + E++T K + +H ++ +LG E+I
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDLITDLLGTPSPETI 232
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 28/201 (13%)
Query: 434 LGNGGFGTVYHGYLD---GTEVAVKMLS-PSSAQGY-KQFQAEVELLMRIHHKNL----- 483
+G+G +G+V +D G +VA+K LS P ++ + K+ E+ LL + H+N+
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 484 --TTLVGYCDEGTNRGLIYEFMANGNLQAL----LLGEEADILSWE--GRLRIAIEAAKV 535
T+ V DE + L+ +M +LQ + L ++ L ++ L+ A +
Sbjct: 82 VFTSAVSG-DEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGII 139
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLT 594
HRD+K N+ ++ + KI DFGL+R E +G VT Y PE ++
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW------YRAPEVILNWMHYN 193
Query: 595 EKSDVYNFGVVLLEIITSKSV 615
+ D+++ G ++ E++T K++
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTL 214
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT-HVTTTIAGTPGYLDPEYYI 589
E ++RD+K N+LL K+ D+G+ + EG G T+T GTP Y+ PE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKS 614
D + GV++ E++ +S
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 433 VLGNGGFGTVY--HGYLDGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLV 487
++G G FG V G A+K++ S + + F+ E ++L + + L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 488 GYCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRIAI----EAAKVHRD 538
+ N L+ E+ G+L +LL +E + L +AI + VHRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI-AGTPGYLDPEYYISNRLTEKS 597
+K N+L+ K+ADFG + V + + GTP Y+ PE + K
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANK---MVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 598 ------DVYNFGVVLLEIITSKS 614
D ++ GV+ E+I +S
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE +V+G G FG V + T A+K+L+ + F+ E ++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 481 KNLTTL-VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI-----AIEAAK 534
+ +T L + DE N L+ ++ G+L LL E + R + AI++
Sbjct: 61 RWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
VHRD+K N+LL ++ADFG + GT + GTP Y+ PE
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 530 IEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH-VTTTIAGTPGYLDPEY 587
I +A V HRD+K +N+LL+ KI DFGL+RT S T T Y PE
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLART----TSEKGDFMTEYVVTRWYRAPEL 179
Query: 588 YIS-NRLTEKSDVYNFGVVLLEIITSKSV 615
++ + T DV++ G + E++ K +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 31/78 (39%), Positives = 41/78 (52%), Gaps = 7/78 (8%)
Query: 281 LSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP-----FLTELNLKGTIPN 335
L + ++G+I I LTS+ LDL NNLTGP+P L L FL + L G IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 336 GLIEKQKNGLLSLSVEGN 353
+ QK L+SL + N
Sbjct: 279 SIFSLQK--LISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)
Query: 432 RVLGNGGFGTVYHGYLDGTE-------VAVKMLSP-SSAQGYKQFQAEVELLMRI-HHKN 482
+VLG+G FG V G + VAVKML ++A +K +E+++L+ I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 483 LTTLVGYCDEGTNRGL-IYEFMANGNLQALLLGEEADILSW-------EGRLRIAIEAAK 534
+ L+G C + + I EF GNL L + + GR R +E ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 535 VHRDVKS 541
V R +++
Sbjct: 133 VDRRIEA 139
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHRD+K N+L+S K+ DFG +R EGS + T +A T Y PE +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVA-TRWYRSPELLLGAPYG 179
Query: 595 EKSDVYNFGVVLLEI 609
+ D+++ G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI-S 590
A +HRD+K N+L++ KI DFGL+R + S H+T + T Y PE + S
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVV-TQYYRAPEILMGS 179
Query: 591 NRLTEKSDVYNFGVVLLEIITSK 613
T D+++ G + E++ +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 498 LIYEFMANGNLQALLLG---EEADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKF 550
++ E+M G+L L+ E + + +A++A +HRDVK N+LL
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179
Query: 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN----RLTEKSDVYNFGVVL 606
K+ADFG ++ +G T GTP Y+ PE S + D ++ GV L
Sbjct: 180 HLKLADFG--TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 607 LEIITSKS 614
E++ +
Sbjct: 238 FEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 12/88 (13%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSR-------TFPVEGSGTHVT-----TTIAGTPGY 582
VHRD+K N+L++ K+ DFGLS+ T EG T + GTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEII 610
+ PE + + D + G++L E +
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-RL 593
+HRDVK NIL++ + Q K+ DFG +R + G G T +A T Y PE + + +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVA-TRWYRAPELLVGDTQY 178
Query: 594 TEKSDVYNFGVVLLEIITS 612
DV+ G V E++T
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 11/125 (8%)
Query: 498 LIYEFMANGNL------QALLLGEEADILSWEGRLRIAI--EAAKVHRDVKSTNILLSGK 549
+ E++ G+L Q L E A S E L + E ++RD+K N+LL +
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132
Query: 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEI 609
K+ D+G+ + G T+T GTP Y+ PE D + GV++ E+
Sbjct: 133 GHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 610 ITSKS 614
+ +S
Sbjct: 190 MAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 12/76 (15%)
Query: 498 LIYEFMANGNLQALLLGEEADILS------WEGRLRIAIEAAK----VHRDVKSTNILLS 547
LI EF+ G+L +L+ + D S + +AIEA +HRD+K NIL+
Sbjct: 78 LIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID 135
Query: 548 GKFQAKIADFGLSRTF 563
K++DFGLS F
Sbjct: 136 RGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 13/126 (10%)
Query: 498 LIYEFMANGNL------QALLLGEEADILSWEGRLRIAI--EAAKVHRDVKSTNILLSGK 549
+ EF++ G+L Q L E A S E L + E ++RD+K N+LL +
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132
Query: 550 FQAKIADFGLSRTFPVEGSGT-HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLE 608
K+ D+G+ + EG T+T GTP Y+ PE D + GV++ E
Sbjct: 133 GHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188
Query: 609 IITSKS 614
++ +S
Sbjct: 189 MMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 13/85 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----N 328
PR+ L L S+ +G+I + ++ +LDLS NNLTG +P+ L L +L +
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 329 LKGTIPNGL--------IEKQKNGL 345
L+G IP L + Q N
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSF 416
|
Length = 968 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 7/80 (8%)
Query: 535 VHRDVKSTNILL-SGKFQAKIADFGLSRTFPVE-GSGTHVTTTIAGTPGYLDPEYYI-SN 591
+HRD+K N+L+ K KIAD GL R F + S TH T+ Y PE + S
Sbjct: 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL----WYRAPEVLLGST 187
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
+ D+++ G + E+
Sbjct: 188 HYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSP--SSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+G+G +G+V + G VAVK LS S K+ E+ LL + H+N+ +G
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV---IGL 81
Query: 490 CDEGTNRGLIYEF--------MANGNLQAL-----LLGEEADILSWE--GRLRIAIEAAK 534
D T + EF + +L + L + L ++ L+ A
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRL 593
+HRD+K +N+ ++ + KI DFGL+R E +G T Y PE ++
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG------YVATRWYRAPEIMLNWMHY 195
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQ 627
+ D+++ G ++ E++T +++ T HI Q
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 9/83 (10%)
Query: 535 VHRDVKSTNILLSGKFQA-KIADFGLSRTF--PVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K N+L+ + A K+ADFGL+R F PV + TH T+ Y PE + +
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTL----WYRAPEILLGS 178
Query: 592 R-LTEKSDVYNFGVVLLEIITSK 613
R + D+++ G + E++ K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 5/94 (5%)
Query: 535 VHRDVKSTNILLSG----KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRD+K NIL+ G + + KIAD G +R F + T Y PE +
Sbjct: 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189
Query: 591 NR-LTEKSDVYNFGVVLLEIITSKSVIERTHERI 623
R T+ D++ G + E++TS+ + E I
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 279 LNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP-----FLTELNLKGTI 333
L+L + + G I ++ LTS++ L L++N L G +P L Q+ +L NL G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 334 PNGLIEKQKNGLLSLS 349
P + GL SL+
Sbjct: 229 PY-----EIGGLTSLN 239
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQ-FQAEVELLMRI-HH 480
F + LG G FG V G VAVKML S+ ++ +E+++L + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNL 508
KN+ L+G C G +I E+ G+L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 432 RVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQ-FQAEVELLMRI-HHKN 482
R+LG+G FG V G G +VAVKML P++ KQ +E++++ + H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNL 508
+ L+G C + +I E+ G+L
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDL 128
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQ-FQAEVELLMRI-HH 480
F + LG G FG V G VAVKML PS+ ++ +E+++L + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNL 508
N+ L+G C G +I E+ G+L
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDL 126
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 2/59 (3%)
Query: 275 RITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332
+ SL+LS++ + I L ++++LDLS NNLT P+ S LP L L+L G
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 5/94 (5%)
Query: 535 VHRDVKSTNILLSG----KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRD+K NIL+ G + + KIAD G +R F + T Y PE +
Sbjct: 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189
Query: 591 NR-LTEKSDVYNFGVVLLEIITSKSVIERTHERI 623
R T+ D++ G + E++TS+ + E I
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 430 FERV--LGNGGFGTVYHG--YLDGTEVAVKMLS--------PSSAQGYKQFQAEVELLMR 477
+++V +G G +G VY L G VA+K + PS+A E+ LL
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKE 54
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-------LGEEADILSWEGRLRIAI 530
++H N+ L+ L++EF+ + +L+ + L I S+ +L I
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPL-IKSYLYQLLQGI 112
Query: 531 ---EAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTF--PVEGSGTHVTTTIAGTPGYLD 584
+ +V HRD+K N+L+ + K+ADFGL+R F PV TH T+ Y
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVVTL----WYRA 167
Query: 585 PEYYISNRLTEKS-DVYNFGVVLLEIITSK 613
PE + +R D+++ G + E++ +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 52/239 (21%), Positives = 92/239 (38%), Gaps = 57/239 (23%)
Query: 432 RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQF---QAEVELLMRIHHKNLTTL 486
+ LG G FG V T A+K L Q +AE ++L ++ + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEA--DILS--WEGRLRIAIEAAK----VHRD 538
+ N + +++ G++ +LL+ E ++L+ + L +AIE+ +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 539 VKSTNILLSGKFQAKIADFGLSRTF------PVEGSGTHV-------------------- 572
+K NIL+ K+ DFGL F G+H+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 573 ------------------TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
++ GTP Y+ PE + T+ D ++ GV+L E++ +
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 6/84 (7%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN--- 591
+HRDVK N+LL K+ADFG EG T GTP Y+ PE S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR--CDTAVGTPDYISPEVLKSQGGD 221
Query: 592 -RLTEKSDVYNFGVVLLEIITSKS 614
+ D ++ GV L E++ +
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 25/144 (17%)
Query: 437 GGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
G FG VY G + AVK++ + + Q QAE + L + L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 492 EGTNRGLIYEFMANGNLQALL--------------LGEEADILSWEGRLRIAIEAAKVHR 537
N L+ E++ G++++LL + E A L + R I +HR
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI------IHR 128
Query: 538 DVKSTNILLSGKFQAKIADFGLSR 561
D+K N+L+S + K+ DFGLS+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
V+RD+K NILL +I+D GL+ F + V GT GY+ PE
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGTAY 173
Query: 595 EKS-DVYNFGVVLLEIITSKS 614
+ S D ++ G +L +++ S
Sbjct: 174 DSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 723 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.59 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.58 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.53 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.51 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.51 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.5 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.5 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.49 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.45 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.44 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.31 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.29 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.27 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.27 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.12 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.96 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 98.87 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.59 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.55 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.08 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.06 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 97.99 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.94 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 97.94 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 97.89 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.88 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.85 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.85 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.82 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.71 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.69 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.63 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.54 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.31 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.31 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.12 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.08 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 97.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 96.88 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 96.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 96.82 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 96.81 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 96.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 96.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.73 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 96.54 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 96.54 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.5 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.47 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=528.16 Aligned_cols=355 Identities=24% Similarity=0.375 Sum_probs=281.9
Q ss_pred CCCCCCCCCCCCcEEEEEcCeEEEEEec--CCCCccEEEEEEEecCCCcEEEEEEecCCCCcceeeeeeeeCCCCCCcCC
Q 004935 1 MYGNYDGQGKPPSFDIILEADVWDSIEF--EDESTIVTKEIIHIPQKNFVYVCLVNKGSGTPFISAIELRPLKNSTYTTE 78 (723)
Q Consensus 1 ~ygnyd~~~~~p~Fd~~~~~~~w~~v~~--~~~~~~~~~e~i~~~~~~~~~vCl~~~~~~~Pfis~lel~~l~~~~y~~~ 78 (723)
+|||||+++++|.|||++|+|+|.+|+. +.++..+++|+|++++++.++|||+++++|+||||+||||||++++|...
T Consensus 102 ~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~~~y~~~ 181 (623)
T PLN03150 102 GLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFG 181 (623)
T ss_pred ecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCccccccc
Confidence 6999999999999999999999999975 44556788999999999999999999999999999999999999999743
Q ss_pred -----CCceeEEEEEecCCCCC-CCccCCCCCC--CceEecCCC---CCCccccCcccccc--CCCCCCchhhhhhceec
Q 004935 79 -----SGSLSLFRRWDIGSRSS-ETFRYPDDIY--DRIWLPNSL---PNSEPINTTSDIIS--MNDYQGPSTVMQTAVIP 145 (723)
Q Consensus 79 -----~~~l~~~~r~~~g~~~~-~~~rypdD~~--dR~W~~~~~---~~~~~~~t~~~i~~--~~~~~~P~~v~~tA~~~ 145 (723)
+..|++++|.|+|+... ..+|||||+| ||+|.|+.. ..|..+++...|.. .+.+.+|+.|||||+++
T Consensus 182 ~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~ 261 (623)
T PLN03150 182 PSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVS 261 (623)
T ss_pred ccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccc
Confidence 33599999999998643 3699999999 999998765 45778888877764 34577899999999998
Q ss_pred cCCCCceEEeeCCCCCccceEEEeeeecccccccCCcceEEEEEEcCccccCCccccee-----eeEEEEeeeeecccce
Q 004935 146 TNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQANNQTREIIIYINGIDWFGPFSPLHF-----AANTIYSTWPILTAEK 220 (723)
Q Consensus 146 ~~~~~~~~~~w~~~~~~~~y~~~lhF~e~~~~~~~~~~R~f~i~ln~~~~~~~~~p~~l-----~~~~~~~~~p~~~~~~ 220 (723)
.++...+++.|+ +++...|+|+|||||++......+.|+|+|++||+.+...+++... ...+....... .++.
T Consensus 262 ~~~~~~lty~~~-v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~-~~g~ 339 (623)
T PLN03150 262 TDTQPDLSYTMD-VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAV-SGRT 339 (623)
T ss_pred cCCCCceEEEee-cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEee-cCCe
Confidence 875555555554 6788899999999999853323478999999999987766654321 12222222223 2467
Q ss_pred EEEEEEcCCCCCcchhhhhhhhhhhhccccc----------------------cccCCCce-----eecCccCCCCCC--
Q 004935 221 IEFSINTTESSTLPPILNAYEIYRAKEFLQF----------------------LTNQQDAY-----LWQGLNCSYPEY-- 271 (723)
Q Consensus 221 ~~lsl~~~~~s~lPp~inale~~~~~~~~~~----------------------~~~~~~~~-----~w~g~~c~~~~~-- 271 (723)
++|++.+..++ ||+|||+|+|+....... .+. .++| .|.|+.|+....
T Consensus 340 l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~-g~~C~p~~~~w~Gv~C~~~~~~~ 416 (623)
T PLN03150 340 LTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWN-GDPCVPQQHPWSGADCQFDSTKG 416 (623)
T ss_pred EEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCC-CCCCCCcccccccceeeccCCCC
Confidence 88999997654 799999999986442110 112 3456 699999963211
Q ss_pred -----------------------CCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEE
Q 004935 272 -----------------------DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328 (723)
Q Consensus 272 -----------------------~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~ 328 (723)
..++|+.|+|++|+|+|.||+.+++|++|+.|+|++|+|+|.+|..+++|++|+.|+
T Consensus 417 ~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~ 496 (623)
T PLN03150 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496 (623)
T ss_pred ceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence 125788899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCchhhcccC----ccccccCCCCCCCCCC
Q 004935 329 LKGTIPNGLIEKQKNG----LLSLSVEGNPDLCPEA 360 (723)
Q Consensus 329 l~~n~~~g~~p~~~~~----~~~l~~~~n~~lc~~~ 360 (723)
|++|.++|.+|..+.. +..+.+.+|+++|+.+
T Consensus 497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 9999999999987654 2357789999999754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=439.06 Aligned_cols=274 Identities=48% Similarity=0.830 Sum_probs=240.2
Q ss_pred cccccCHHHHHHHHHHhh--hhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEE
Q 004935 414 KNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYC 490 (723)
Q Consensus 414 ~~~~~~~~~l~~~t~~f~--~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 490 (723)
....|++.++.++|++|. ++||+|+||.||+|.+++ ..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999997 799999999999999976 79999988766543146699999999999999999999999
Q ss_pred ecCC-ceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc-------------cccCCCCCCEEEcCCCcEEEEe
Q 004935 491 DEGT-NRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 491 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~-------------vH~Dlk~~NILl~~~~~~kl~D 556 (723)
.+.+ +++||||||++|+|+++|+......++|.+|++||+++|+ |||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 5999999999999999999865437899999999999987 9999999999999999999999
Q ss_pred ccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc--ccccHHHHHHHHhc
Q 004935 557 FGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH--ERIHITQWVSFMLG 634 (723)
Q Consensus 557 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~--~~~~~~~~~~~~~~ 634 (723)
||+|+..+.. . .+......||.+|+|||++..+..++|+|||||||+|+||+||+.+.+... ....+..|+...+.
T Consensus 221 FGLa~~~~~~-~-~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG-D-TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc-c-cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999776531 1 222221189999999999999999999999999999999999999887543 44458999999999
Q ss_pred CCCcccccCCccc-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 635 KGDIESIVDPRLH-EDFDI-NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 635 ~~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
++.+.+++||++. +.+.. +++.++..+|.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999997 55554 6899999999999999999999999999999665543
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=428.18 Aligned_cols=244 Identities=46% Similarity=0.794 Sum_probs=209.1
Q ss_pred CCCCCCCCC-----CCCcEEEEEcCeEEEEEecCCCC-ccEEEE-EEEecCCCcEEEEEEecCCCC-cceeeeeeeeCCC
Q 004935 1 MYGNYDGQG-----KPPSFDIILEADVWDSIEFEDES-TIVTKE-IIHIPQKNFVYVCLVNKGSGT-PFISAIELRPLKN 72 (723)
Q Consensus 1 ~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~-~~~~~e-~i~~~~~~~~~vCl~~~~~~~-Pfis~lel~~l~~ 72 (723)
+||||||++ .+|.|||++|+|.|.+|++++.. .++++| +|++.+++.++|||+++++|+ ||||+||||||++
T Consensus 84 ~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~lp~ 163 (347)
T PF12819_consen 84 YYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRPLPD 163 (347)
T ss_pred ccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEECCc
Confidence 699999984 37889999999999999988721 358889 666666899999999999999 9999999999999
Q ss_pred CCCcC----CCCceeEEEEEecCCCCCCCccCCCCCCCceEecCC-CCCCccccCccccc-c--CCCCCCchhhhhhcee
Q 004935 73 STYTT----ESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNS-LPNSEPINTTSDII-S--MNDYQGPSTVMQTAVI 144 (723)
Q Consensus 73 ~~y~~----~~~~l~~~~r~~~g~~~~~~~rypdD~~dR~W~~~~-~~~~~~~~t~~~i~-~--~~~~~~P~~v~~tA~~ 144 (723)
++|+. .+.+|.+++|+|+|+..+ .||||||+|||+|+|+. .+.|..++|+.+++ . .+.|.+|..|||||++
T Consensus 164 ~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~ 242 (347)
T PF12819_consen 164 SLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTART 242 (347)
T ss_pred cceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhc
Confidence 99952 245699999999998744 49999999999999985 57799999987775 2 5689999999999999
Q ss_pred ccCCCCceEEeeCCCCCccceEEEeeeecccccccCCcceEEEEEEcCccccCCcccceeeeEEE--Eeeeeec--ccce
Q 004935 145 PTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQANNQTREIIIYINGIDWFGPFSPLHFAANTI--YSTWPIL--TAEK 220 (723)
Q Consensus 145 ~~~~~~~~~~~w~~~~~~~~y~~~lhF~e~~~~~~~~~~R~f~i~ln~~~~~~~~~p~~l~~~~~--~~~~p~~--~~~~ 220 (723)
+.+.+.+++++|..++++..|||+|||||++....+.+.|+|+|+|||+.+.+++.|.++..... +...+.. .++.
T Consensus 243 ~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 322 (347)
T PF12819_consen 243 PSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGF 322 (347)
T ss_pred ccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCE
Confidence 99988889999999999999999999999999765545799999999999888999987766544 4444333 3457
Q ss_pred EEEEEEcCCCCCcchhhhhhhhhhh
Q 004935 221 IEFSINTTESSTLPPILNAYEIYRA 245 (723)
Q Consensus 221 ~~lsl~~~~~s~lPp~inale~~~~ 245 (723)
++|+|.++.++++||+|||+|+|++
T Consensus 323 ~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 323 LNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EEEEEEeCCCCCcCceeEeeeeEeC
Confidence 8899999999999999999999873
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=473.46 Aligned_cols=436 Identities=24% Similarity=0.408 Sum_probs=310.4
Q ss_pred EEEEc-CCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 223 FSINT-TESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 223 lsl~~-~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
+.+.. ...+.+|..+..+..++.+.+..+...+..|..+.+ .++|+.|+|++|.++|.+|..++.|++|+
T Consensus 480 L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 550 (968)
T PLN00113 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS---------CKKLVSLDLSHNQLSGQIPASFSEMPVLS 550 (968)
T ss_pred EECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcC---------ccCCCEEECCCCcccccCChhHhCcccCC
Confidence 44433 233456666666666666665555444444333222 25789999999999999999999999999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc--cCccccccCCCCCCCCCC------CCCCCCCCCCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK--NGLLSLSVEGNPDLCPEA------SCTADESNGSRDN 373 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~--~~~~~l~~~~n~~lc~~~------~c~~~~~~~~~~~ 373 (723)
.|||++|+++|.+|..+.++++|+.|++++|.+.|.+|... ..+...++.||+.+|+.. +|.. ..+..
T Consensus 551 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~----~~~~~ 626 (968)
T PLN00113 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR----VRKTP 626 (968)
T ss_pred EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc----ccccc
Confidence 99999999999999999999999999999999999998652 244456789999999754 2321 11111
Q ss_pred ceEEEEEEeeehhHHHHHHHhhhhhhhhccc-ccc-----CCcccc------cccccCHHHHHHHHHHhhhhccccCcEE
Q 004935 374 KFVVPVVASVVSLCVLVTAMAILWSLRRRMQ-VAK-----NGSFEL------KNQRFSYSNVLRITNNFERVLGNGGFGT 441 (723)
Q Consensus 374 ~~~v~iv~~vv~l~vl~~~~~~~~~~rrr~~-~~~-----~~~~~~------~~~~~~~~~l~~~t~~f~~~lG~G~~g~ 441 (723)
...+.+++.+++++++++++++++++++|+. ..+ .+..+. ....+++.++.... ...+.||+|+||.
T Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ig~G~~g~ 705 (968)
T PLN00113 627 SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL-KEENVISRGKKGA 705 (968)
T ss_pred eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhC-CcccEEccCCCee
Confidence 1222222222222222222222222232221 111 111110 01223444443321 2346899999999
Q ss_pred EEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCCC
Q 004935 442 VYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADI 519 (723)
Q Consensus 442 Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~ 519 (723)
||+|.. ++..||||++...... ...|++.+++++|||||+++|+|.+.+..++|||||++|+|.++++.
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----- 776 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----
Confidence 999997 5679999998754322 23568899999999999999999999999999999999999999963
Q ss_pred CCHHHHHHHHHhccc-------------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccccc
Q 004935 520 LSWEGRLRIAIEAAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586 (723)
Q Consensus 520 l~~~~~l~i~~~~a~-------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE 586 (723)
+.|.++..++.++|. +||||||+||+++.++.+++. ||....... .....++..|+|||
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE 848 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-------DTKCFISSAYVAPE 848 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-------CCCccccccccCcc
Confidence 677777776665543 899999999999999988876 665543211 11235789999999
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHcCCCccccCc-ccccHHHHHHHHhcCCCcccccCCcccCC--CCHHHHHHHHHHHH
Q 004935 587 YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH-ERIHITQWVSFMLGKGDIESIVDPRLHED--FDINSVWKTVEIAM 663 (723)
Q Consensus 587 ~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~ 663 (723)
++.+..++.++|||||||++|||+||+.|++... ....+.+|++..........++|+.+... .+.+++..+.+++.
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence 9999999999999999999999999999986432 33467788877766666667778777543 34567788999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 664 ACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 664 ~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+||+.+|++||||+||+++|+++.+.
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=362.40 Aligned_cols=245 Identities=36% Similarity=0.532 Sum_probs=201.9
Q ss_pred hhhccccCcEEEEEEEECCce-EEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEecCC-ceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLDGTE-VAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDEGT-NRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~-vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~g 506 (723)
.+.||+|+||+||+|.+.|.. ||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999999997 999999875422 2568999999999999999999999999887 799999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc-----------cccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK-----------VHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~-----------vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|.++++......++|..++.+|+++|+ |||||||+||||+.++ ++||+|||+++...... ...+
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~ 202 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TSMT 202 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---cccc
Confidence 9999998865667889888888888776 9999999999999997 99999999998754321 2234
Q ss_pred cccCCCccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 575 TIAGTPGYLDPEYYI--SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~--~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
...||+.|||||.+. ...++.|+|||||||+||||+||+.||..... . +.+......+. +...+.
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~---~~~~~v~~~~~---------Rp~~p~ 269 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V---QVASAVVVGGL---------RPPIPK 269 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H---HHHHHHHhcCC---------CCCCCc
Confidence 478999999999999 56899999999999999999999999987654 2 22222221211 112222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
++...+..++.+||+.+|.+||++.+++..|+.+...-.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 245578899999999999999999999999998876443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.30 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=204.4
Q ss_pred HHHhhhhccccCcEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 427 TNNFERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...+.+.||+|.||.||.|.+++. .||+|.++.... ....|.+|+++|++|+|+|||+++|+|...+..+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345678999999999999999887 999999987643 347899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.++|+......+...+.+.++.++|. |||||.++||||+++..+||+|||+|+....+ .-.....
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~~~ 363 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTASEG 363 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC--ceeecCC
Confidence 99999999877788899999999988887 99999999999999999999999999954322 1233344
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..-...|.|||.+..++++.|||||||||+||||+| |+.|+.++.. .+.+... ..| .+-..+..+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~l-e~G---------yRlp~P~~C 429 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELL-ERG---------YRLPRPEGC 429 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHH-hcc---------CcCCCCCCC
Confidence 455679999999999999999999999999999999 7888776543 2222222 222 222233345
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+..+.+++..||+.+|++|||++.+...|++....
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 66889999999999999999999999988877643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=363.10 Aligned_cols=246 Identities=29% Similarity=0.453 Sum_probs=203.4
Q ss_pred HhhhhccccCcEEEEEEEEC-------CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.|.+.||+|.||+||+|+.. ..-||||.++..... ...+|++|+++|+.++|||||+|+|.|.+++..+||+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 34578999999999999873 236999999987654 7789999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCC--------CC----CCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEecc
Q 004935 501 EFMANGNLQALLLGEE--------AD----ILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~--------~~----~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
|||..|+|.++|+.+. .+ .|+-.+.+.||.++|. |||||.++|+|+.++..+||+|||
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccc
Confidence 9999999999997541 22 3888899999999887 999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
+++..-..+. -+......-..+|||||.+..+++|++||||||||+|||+++ |+.|+.+.... .|-..++.++
T Consensus 649 LsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-----EVIe~i~~g~ 722 (774)
T KOG1026|consen 649 LSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-----EVIECIRAGQ 722 (774)
T ss_pred cchhhhhhhh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-----HHHHHHHcCC
Confidence 9997643322 111112234569999999999999999999999999999998 89999876542 2333444444
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+. ..+.+++..+.+|+..||+.+|++||+++||-..|+...+.
T Consensus 723 lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 723 LL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 32 23445677899999999999999999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.96 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=196.5
Q ss_pred ccCHHHHHHHHHHhhhhccccCcEEEEEEEEC--CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC
Q 004935 417 RFSYSNVLRITNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG 493 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 493 (723)
.++.+|+++. +.||+|..|+|||+.+. +..+|+|.+... .....+++.+|++++++.+||+||.++|.|...
T Consensus 75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 4566666553 47999999999999994 668999999654 345568999999999999999999999999988
Q ss_pred C-ceEEEEEeCCCCCHHHHhccCCCC--------CCCHHHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 494 T-NRGLIYEFMANGNLQALLLGEEAD--------ILSWEGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 494 ~-~~~lV~Ey~~~gsL~~~l~~~~~~--------~l~~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
. ...++||||++|||++++.....- .....+.|.++++ ...|||||||+|||++..|++||||||.++.+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 8 499999999999999999853211 2344556677775 44599999999999999999999999999987
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccC-cccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERT-HERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
... ......||..|||||.+.+..|+.++||||||+.++|+.+|+-|+... .....+.+.+.....+.
T Consensus 230 vnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p------ 298 (364)
T KOG0581|consen 230 VNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP------ 298 (364)
T ss_pred hhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC------
Confidence 422 445678999999999999999999999999999999999999999765 22234444443333221
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
-|++... .....+.+++..|+++||.+||+++|+++
T Consensus 299 pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1344333 23446889999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.23 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=213.6
Q ss_pred cccCHHHHHHHHHHhh-----------hhccccCcEEEEEEEEC--C---ceEEEEEecCCC-hhhHHHHHHHHHHHHhc
Q 004935 416 QRFSYSNVLRITNNFE-----------RVLGNGGFGTVYHGYLD--G---TEVAVKMLSPSS-AQGYKQFQAEVELLMRI 478 (723)
Q Consensus 416 ~~~~~~~l~~~t~~f~-----------~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l 478 (723)
..++|+|.-++...|. ++||.|.||.||+|.++ + ..||||.++... .+...+|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 3578888777777663 68999999999999983 3 379999999875 44567899999999999
Q ss_pred cCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC
Q 004935 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG 548 (723)
Q Consensus 479 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~ 548 (723)
.||||++|.|........++|.|||++|+|+.+|+.+..+ +.|.+.+.++-++| .|||||.++|||++.
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS 766 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc
Confidence 9999999999999999999999999999999999988765 66665555555444 399999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHH
Q 004935 549 KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQ 627 (723)
Q Consensus 549 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~ 627 (723)
+..+|++|||+++.+..+.........-.-..+|.|||.+...+++.++||||||||+||+++ |.+|+-.+.+.+-+.
T Consensus 767 nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk- 845 (996)
T KOG0196|consen 767 NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK- 845 (996)
T ss_pred ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-
Confidence 999999999999988655432233333344569999999999999999999999999999987 899987765533221
Q ss_pred HHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 628 WVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 628 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
.+. ..++-..+.+++..+.+|++.||++|-.+||.+.+++..|+.++......
T Consensus 846 ----aIe---------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 846 ----AIE---------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred ----HHH---------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 111 12222334567889999999999999999999999999999988666554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.12 Aligned_cols=186 Identities=28% Similarity=0.492 Sum_probs=158.6
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||+||+|++ ++..||||.+... .....+.+..|+++|+.++|||||.+++++..++..+||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45699999999999998 4569999999776 5566677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCC------CcEEEEeccCccccCCCCCCcee
Q 004935 507 NLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGK------FQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 507 sL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~------~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+|.++++.+... . .+....++++++...|||||||+||||+.. -.+||+|||+|+.+.. ...
T Consensus 95 DLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~----~~~ 170 (429)
T KOG0595|consen 95 DLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP----GSM 170 (429)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc----hhH
Confidence 999999876321 2 233344444555555999999999999864 4689999999999853 334
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH 620 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~ 620 (723)
....+|++-|||||.+...+|+.|+|+||.|+||||+++|+.||+...
T Consensus 171 a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 171 AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 566889999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.70 Aligned_cols=240 Identities=22% Similarity=0.364 Sum_probs=189.4
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh-------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ-------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
+-..+.||+|+||.|-+|.. +++.||||++++.-.. .....++|+++|++++|||||++.+++...+..||
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 34468999999999999987 5779999999764211 12335799999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCC--------CCCCHHHHHHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCC
Q 004935 499 IYEFMANGNLQALLLGEEA--------DILSWEGRLRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~--------~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~ 567 (723)
|||||++|.|.+.+-.+.. -..+....++++|+...+||||||+|||+..+ ..+||+|||+|+...
T Consensus 254 VlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g--- 330 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG--- 330 (475)
T ss_pred EEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc---
Confidence 9999999999998865421 12456677888888888999999999999866 789999999999864
Q ss_pred CCceeeecccCCCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
........+||+.|.|||.+.+.. +..++|+||+||||+-+++|.+||........+.+ .+..|+..
T Consensus 331 -~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G~y~----- 400 (475)
T KOG0615|consen 331 -EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKGRYA----- 400 (475)
T ss_pred -cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcCccc-----
Confidence 244567789999999999998664 33488999999999999999999987655443322 22222211
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+...+..+++.++|..||++|||+.|+++
T Consensus 401 -f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 401 -FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 011112234457789999999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.17 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=200.2
Q ss_pred HhhhhccccCcEEEEEEEEC---Cc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD---GT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~---~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|.||.||+|... +. .||||.+.... .+...+|.+|..+|++++|||||+++|.|.+....++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 44578999999999999983 22 59999998764 566788999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccC-----CCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 501 EFMANGNLQALLLGE-----EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~-----~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
|||++|+|..+|++. ....+.....+.+++++|+ |||||.++|+||+....+||+|||+|+.+..
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~ 854 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYD 854 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence 999999999999875 2446888899999999998 9999999999999999999999999995533
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.+. ........-...|||||.+..+.++.|+|||||||+|||++| |..||...... +.+......+++.
T Consensus 855 ~~y-yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~~~~~ggRL~----- 924 (1025)
T KOG1095|consen 855 KDY-YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLLDVLEGGRLD----- 924 (1025)
T ss_pred chh-eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHHHHHhCCccC-----
Confidence 221 111111233468999999999999999999999999999999 77788655432 2222233333221
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.+..++.++.+++..||+.+|++||++..++++++.+.+...
T Consensus 925 -----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 925 -----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 122355588899999999999999999999999988876553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=298.30 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=186.0
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEE-EecCCc-eEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGY-CDEGTN-RGLIYE 501 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~-~~~~~~-~~lV~E 501 (723)
+.+.++||+|+||.|||+.. ++..||.|.+.-. +.+...+..+|+.+|++++|||||+++++ +.+.++ ..+|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 45578999999999999976 7889999998754 34556779999999999999999999984 444444 789999
Q ss_pred eCCCCCHHHHhccC--CC------CCCCHHHHHHHHHhccc--------cccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 502 FMANGNLQALLLGE--EA------DILSWEGRLRIAIEAAK--------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 502 y~~~gsL~~~l~~~--~~------~~l~~~~~l~i~~~~a~--------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
|+..|+|.+.+..- +. .++....+|..|+..+| +||||||.||+|+++|.+||+|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 99999999988642 11 12223334444444443 8999999999999999999999999998753
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
. ........|||.||+||.+....|+.|+||||+||+++||+.-++||.+. .+.+. ...+..++.. +
T Consensus 181 ~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L-~~KI~qgd~~-----~ 247 (375)
T KOG0591|consen 181 K---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSL-CKKIEQGDYP-----P 247 (375)
T ss_pred h---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHH-HHHHHcCCCC-----C
Confidence 2 34556678999999999999999999999999999999999999999876 22222 2223333221 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+. +......+..|+..|+..||..||+.-..++.++.
T Consensus 248 ~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 21 12345578899999999999999996555555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.13 Aligned_cols=235 Identities=22% Similarity=0.418 Sum_probs=188.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.-.++||+|||+.||+++. .|..||+|++.+.. ....+...+||++.+.|+|||||++++||++.++.|||.|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3457899999999999998 57799999997642 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC----C----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEA----D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~----~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|+|..+++.+.. + ..+....+..+|+...+|||||..|+||++++++||+|||+|..+..++ .....
T Consensus 101 ~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~---Erk~T 177 (592)
T KOG0575|consen 101 HRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG---ERKKT 177 (592)
T ss_pred CCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc---cccce
Confidence 99999999985421 1 1234455666677777999999999999999999999999999886442 34556
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.+|||.|+|||++.....+..+||||+|||||-|++|++||+...-...... ....+ ..-|. .-.
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~---Ik~~~-----Y~~P~-------~ls 242 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK---IKLNE-----YSMPS-------HLS 242 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH---HHhcC-----ccccc-------ccC
Confidence 8999999999999999999999999999999999999999986532211111 11111 11111 112
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+|+.++|+.+|.+|||+++|+.
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 24569999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.20 Aligned_cols=235 Identities=23% Similarity=0.371 Sum_probs=183.3
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhh---HHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~ 504 (723)
..||+|++|.||+|.++++.||||.++...... .+.|.+|+.+|++++||||++++|++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 479999999999999999999999997653322 4678899999999999999999999876 346789999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhcc-----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEAA-----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~a-----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+|+|.+++.... .++|...+.++.+++ .+||||||+|||+++++.+||+|||+++.+... .
T Consensus 106 ~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~------~ 177 (283)
T PHA02988 106 RGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP------P 177 (283)
T ss_pred CCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc------c
Confidence 999999997642 355555554444333 289999999999999999999999999865321 1
Q ss_pred ecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 574 TTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+........+.. +.+ +
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~~~-----~~~----~ 244 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINKNNS-----LKL----P 244 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcCCC-----CCC----C
Confidence 23457889999999876 6899999999999999999999999976532 1222222111110 111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
......+.+++.+||+.+|++|||++|+++.|++.-
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 123346789999999999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.13 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=199.5
Q ss_pred HhhhhccccCcEEEEEEEECC-ceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.|.++||+|-||.|......+ ..||||+++..... ..++|.+|+++|.+++||||+.|+|.|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 456899999999999999977 69999999987544 4589999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..++.+.++-...+.|+.++|. |||||.++|+|+|.++++||+|||+++.+-..+. .+.....
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-y~vqgr~ 699 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-YRVQGRA 699 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc-eeeecce
Confidence 9999999886554444444555555443 9999999999999999999999999997643332 3444455
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc--CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
.-...|||||.+..++++.++|||+||++|||+++ ...||....++ ...+-...++..+....++ ..+.-+
T Consensus 700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~~~~~~l------~~P~~c 772 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQGRQVVL------SRPPAC 772 (807)
T ss_pred eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCCCcceec------cCCCcC
Confidence 56789999999999999999999999999999865 67788766543 2233333333333222211 112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
..++.+++++||..+..+||+++++...|++.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 55788999999999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.16 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=195.2
Q ss_pred hhhccccCcEEEEEEEEC---C--ce-EEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYLD---G--TE-VAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~---~--~~-vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.++||+|.||.||+|.+. + .. ||||..+.. .....++|++|+++|++++|||||+++|++......++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 478999999999999983 2 13 899999852 35667899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|++|+|.++|.+... .+++.+++.+++++|. |||||.++|+|++.++.+||+|||+++..... ..
T Consensus 242 l~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~---~~ 317 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY---VM 317 (474)
T ss_pred ecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce---ee
Confidence 9999999999987654 6888899888888876 99999999999999999999999998864210 11
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......-...|+|||.+....++.++|||||||++||+++ |..|+.+.... ...+++ ...+. +...
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI---~~~~~---------r~~~ 384 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKI---VKNGY---------RMPI 384 (474)
T ss_pred ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHH---HhcCc---------cCCC
Confidence 1112235679999999999999999999999999999999 78898776432 112221 12111 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
+...+..+..+..+||..+|++||+|.++.+.|+.+.....+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112334566777899999999999999999999988866543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.12 Aligned_cols=247 Identities=30% Similarity=0.428 Sum_probs=183.4
Q ss_pred HHhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCC-ceE
Q 004935 428 NNFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGT-NRG 497 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-~~~ 497 (723)
+.+.+.||+|+||.||+|.. .+..||||++.... ....+.+.+|+++++++ +||||++++++|...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 34567899999999999975 13479999997543 33456799999999999 8999999999987644 578
Q ss_pred EEEEeCCCCCHHHHhccCC------------------------------------------------------------C
Q 004935 498 LIYEFMANGNLQALLLGEE------------------------------------------------------------A 517 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------~ 517 (723)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999986431 1
Q ss_pred CCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccc
Q 004935 518 DILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587 (723)
Q Consensus 518 ~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 587 (723)
..+++...+.++.++ ..+||||||+|||++.++.+||+|||+++....... ........++..|+|||.
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCccccCcHH
Confidence 124444444433333 339999999999999999999999999986532211 111223346678999999
Q ss_pred cccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhcc
Q 004935 588 YISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACV 666 (723)
Q Consensus 588 ~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl 666 (723)
+.+..++.++|||||||+||||++ |+.||........+. . ....+.. ..... .....+.+++.+||
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~---~-~~~~~~~-----~~~~~----~~~~~l~~li~~cl 314 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC---Q-RLKDGTR-----MRAPE----NATPEIYRIMLACW 314 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH---H-HHhcCCC-----CCCCC----CCCHHHHHHHHHHc
Confidence 999999999999999999999997 999987543221111 1 1112111 11111 12336789999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhhh
Q 004935 667 SQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 667 ~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+|++|||+.|+++.|++++.
T Consensus 315 ~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 315 QGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.84 Aligned_cols=245 Identities=30% Similarity=0.488 Sum_probs=192.3
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||+||+|++.| .||||++.... ....+.|.+|+..+++-||.||+-++|||..... ++|..+|++-+|
T Consensus 397 ~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSL 474 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSL 474 (678)
T ss_pred cceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchh
Confidence 5689999999999999976 79999998664 4456789999999999999999999999998887 999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
+.+++..+ ..+...+-++||.++|+ ||||||+.||+|.+++++||+|||++..-..- ..........|
T Consensus 475 Y~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w-~g~~q~~qp~g 552 (678)
T KOG0193|consen 475 YTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW-SGEQQLEQPHG 552 (678)
T ss_pred hhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee-ccccccCCCcc
Confidence 99998765 34566666666666654 99999999999999999999999998753221 11222334457
Q ss_pred CCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 579 TPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 579 t~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
...|||||++.. ..|+..+||||||||+|||+||..||... ..+. +-.+.+.|.+ . |++. ....++.
T Consensus 553 silwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq----IifmVGrG~l--~--pd~s-~~~s~~p 622 (678)
T KOG0193|consen 553 SLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ----IIFMVGRGYL--M--PDLS-KIRSNCP 622 (678)
T ss_pred chhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh----eEEEeccccc--C--ccch-hhhccCH
Confidence 889999999874 46899999999999999999999999832 2211 1122223211 1 1110 1122456
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..+.+|+..||..++++||.+.+++..|++++..
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 6788999999999999999999999999988864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.63 Aligned_cols=240 Identities=27% Similarity=0.457 Sum_probs=192.4
Q ss_pred ccCHHHHHHHHHHhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce
Q 004935 417 RFSYSNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR 496 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 496 (723)
.+.|+++.+. +-||.|+.|.||.|++.++.||||+++.. =..+|+-|++|+|+||+.+.|+|......
T Consensus 120 eiPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4556655443 35999999999999999999999987532 24678999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCC----CCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 497 GLIYEFMANGNLQALLLGEEA----DILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~----~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
++|||||+.|-|...|+.... ...+|.+.+.-.+.+.| ||||||+-|||+..+..+||+|||-++.....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 999999999999999987632 23577776655555554 99999999999999999999999999876422
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.....++||..|||||.+.....++|+||||||||||||+||.-||.......- ..+-| .-.|.-
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGVG------sNsL~L 330 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGVG------SNSLHL 330 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEecc------CCcccc
Confidence 334568899999999999999999999999999999999999999865432110 01111 112223
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+..++..+.-|+++||+..|..||++++++..|+-
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3344566678889999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.88 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=191.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||.|..+.||+|+. .+..||||++.... ....+.+++|+..|+.++||||++.+..|..+..+++||.||.+
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 4467899999999999987 56799999998653 33468899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCC----------CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee-e
Q 004935 506 GNLQALLLGEEADI----------LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT-T 574 (723)
Q Consensus 506 gsL~~~l~~~~~~~----------l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~-~ 574 (723)
||+.+++...-..- ....+.|.++|+..+||||||+.||||+++|.+||+|||.+..+-..+...... .
T Consensus 109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~ 188 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFN 188 (516)
T ss_pred CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeec
Confidence 99999997653221 234456788888889999999999999999999999999987775544322223 5
Q ss_pred cccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 575 TIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
...||+.|||||.+.. ..|+.|+|||||||..+||.+|..||........+. ..+... .....-..+..+...
T Consensus 189 tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl----~tLqn~-pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 189 TFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL----LTLQND-PPTLLTSGLDKDEDK 263 (516)
T ss_pred cccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH----HHhcCC-CCCcccccCChHHhh
Confidence 6689999999999643 469999999999999999999999998665322221 122111 110000011111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++..|++.||++|||++++++
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22346789999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=286.52 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=184.9
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.++|+|+||.|||.+. +|+.||||++.... ....+-.++|+++|++++|+|+|.|+..|.......||+||++.--
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 4799999999999988 57799999997654 3344567999999999999999999999999999999999999855
Q ss_pred HHHHhccCCC--------CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 508 LQALLLGEEA--------DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 508 L~~~l~~~~~--------~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
|.++-+.... ...+...++..++....|||||||+|||++.++.+||||||.|+.+... ...-+....|
T Consensus 88 L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p---gd~YTDYVAT 164 (396)
T KOG0593|consen 88 LHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP---GDNYTDYVAT 164 (396)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC---cchhhhhhhh
Confidence 5554332211 1244555666666666699999999999999999999999999988532 2234556789
Q ss_pred Ccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH----------hcCC-CcccccCCccc
Q 004935 580 PGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM----------LGKG-DIESIVDPRLH 647 (723)
Q Consensus 580 ~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~-~~~~i~d~~l~ 647 (723)
..|+|||.+.+ .+|...+||||.||++.||++|.+.|.+..+.+.+-.+++.. .... ....+.-|...
T Consensus 165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~ 244 (396)
T KOG0593|consen 165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE 244 (396)
T ss_pred hhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence 99999999988 679999999999999999999999888766544333322221 1111 11111111111
Q ss_pred CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 ED-----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ..+....-+++++..|++.||.+|++-+|++.
T Consensus 245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 11122346789999999999999999998875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.19 Aligned_cols=238 Identities=32% Similarity=0.513 Sum_probs=183.7
Q ss_pred hhhccccCcEEEEEEEEC------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYLD------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||.|.||.||+|.+. +..|+||+++... ....+.|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999997 4589999997643 345788999999999999999999999999888899999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.......+++..++.++.+++. +|+||+++||++++++.+||+|||+++....... ....
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-~~~~ 162 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-YKND 162 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-EEES
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 9999999999886667888888888887776 8999999999999999999999999987622211 2223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
........|+|||.+....++.++||||||+++|||++ |+.|+..... .+..... ..+.... ...
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~-~~~~~~~---------~~~ 228 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL-KQGQRLP---------IPD 228 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH-HTTEETT---------SBT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc-cccccce---------ecc
Confidence 33457779999999999999999999999999999999 6788765422 2222222 2221111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
.....+.+++.+||+.+|.+||+|+++++.|
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1233678999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.66 Aligned_cols=228 Identities=23% Similarity=0.374 Sum_probs=178.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.++||+|+||+||+++. .++.+|+|++++.. ....+...+|..+|.+++||.||+++-.+.+.++++||+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 57899999999999987 46689999998753 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC----CCCCCHHHHHHHHH----hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEE----ADILSWEGRLRIAI----EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~----~~~l~~~~~l~i~~----~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.|..+|.+.. ..+--|..-+..|+ +...|||||||+|||||++|+++|+|||+++.....+ ..+...+
T Consensus 110 GeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~---~~t~tfc 186 (357)
T KOG0598|consen 110 GELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG---DATRTFC 186 (357)
T ss_pred ccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC---Ccccccc
Confidence 99999998542 12223334444444 4444999999999999999999999999999653332 2344589
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|||||.+.+..|+..+|.||+||++|||++|.+||...+. .++....... ++. .-|. -. ...
T Consensus 187 GT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~-k~~--~~p~---~l----s~~ 252 (357)
T KOG0598|consen 187 GTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKG-KLP--LPPG---YL----SEE 252 (357)
T ss_pred CCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcC-cCC--CCCc---cC----CHH
Confidence 99999999999999999999999999999999999999986542 3333332222 100 0011 01 124
Q ss_pred HHHHHHhccCCCCCCCCC
Q 004935 658 TVEIAMACVSQTSTKRPT 675 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPs 675 (723)
..+++.+.+..+|++|-.
T Consensus 253 ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHHHHhccCHHHhcC
Confidence 568999999999999963
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.45 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=186.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~ 504 (723)
.++||+|.||.||+|+. +|+.||+|+++... .....-..+||.+|++|+||||++|.+...+. ...|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 46899999999999998 57799999998664 33445678999999999999999999998776 78999999999
Q ss_pred CCCHHHHhccC-----CCCCCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGE-----EADILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~-----~~~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
. +|..++... ..++..++++ +..+|....+|||||.+|||||.+|.+||+|||+|+++.... ....+.
T Consensus 202 h-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~--~~~~T~ 278 (560)
T KOG0600|consen 202 H-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG--SAPYTS 278 (560)
T ss_pred c-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC--Cccccc
Confidence 8 888888764 2233334444 445555555999999999999999999999999999875443 233566
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-cccccC-Cc---cc--
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-IESIVD-PR---LH-- 647 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~i~d-~~---l~-- 647 (723)
...|+.|+|||.+.|. .|+.+.|+||.||||.||++|++.+.+..+...+..+.+.+-.+.. .....+ |. +.
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~ 358 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ 358 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence 7789999999999875 6999999999999999999999999887765555444443322211 000000 10 00
Q ss_pred CCCC--H-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 EDFD--I-----NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ~~~~--~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+. . .-....++|+..+|..||.+|.|+.++++
T Consensus 359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 0 11345678999999999999999999886
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.43 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=182.6
Q ss_pred HhhhhccccCcEEEEEEEEC------------------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD------------------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGY 489 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 489 (723)
.+.+.||+|+||.||++.+. +..||+|.+.... .....+|.+|++++.+++||||++++++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 45678999999999999752 2269999987653 3345679999999999999999999999
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCC-----------------CCCCCHHHHHHHHHhc----------cccccCCCCC
Q 004935 490 CDEGTNRGLIYEFMANGNLQALLLGEE-----------------ADILSWEGRLRIAIEA----------AKVHRDVKST 542 (723)
Q Consensus 490 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~ 542 (723)
+...+..++||||+++|+|.+++.... ...++|...+.++.++ ..+||||||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~ 167 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchh
Confidence 999999999999999999999986431 1134454444444433 3399999999
Q ss_pred CEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc--CCCccccCc
Q 004935 543 NILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTH 620 (723)
Q Consensus 543 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt--g~~p~~~~~ 620 (723)
|||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ +..|+....
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred heEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 99999999999999999986532211 122233445788999999988899999999999999999987 556776543
Q ss_pred ccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 621 ERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.. .....+......... ... ..........+.+++.+||+.+|++||||++|++.|++
T Consensus 247 ~~-~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 247 DE-QVIENAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HH-HHHHHHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 22 222222222211110 000 00111233467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.64 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=184.9
Q ss_pred HHhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
..+.+.||+|+||.||+|.. .+..||||+++... ....+.+.+|+++++.+ +||||++++++|...+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34578999999999999974 23489999997543 33456789999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC--------------------------------------------------------------
Q 004935 499 IYEFMANGNLQALLLGEE-------------------------------------------------------------- 516 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~-------------------------------------------------------------- 516 (723)
||||+++|+|.+++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999886421
Q ss_pred -----------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 517 -----------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 517 -----------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
...++|...+.++.+++ .+||||||+|||++.++.+||+|||+++....... ......
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~ 275 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YVVKGN 275 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-ccccCC
Confidence 01345555555554443 39999999999999999999999999986543221 111222
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+.+..++.++|||||||+++||++ |..||........+.+++. .+.. ...+. ..
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~--~~~~~-------~~ 342 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYR--MLSPE-------CA 342 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCcc--CCCCC-------CC
Confidence 345668999999999999999999999999999998 8888865543322222222 1110 00011 11
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
...+.+++.+|++.+|++||+|.||++.|++.
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 23678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.70 Aligned_cols=242 Identities=29% Similarity=0.390 Sum_probs=195.1
Q ss_pred hhhhccccCcEEEEEEEECC--ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
...+||-|.||.||.|.++. ..||||.++.... ..++|++|+.+|+.++|||+|+|+|+|......|+|.|||.+|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 35789999999999999964 4899999987654 45899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc------c----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA------K----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a------~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|-++|+......+.-.-.+.+|.+++ . |||||.++|+|+.++-.+||+|||+++++..+-. .......
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY--TAHAGAK 427 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY--TAHAGAK 427 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce--ecccCcc
Confidence 99999987655444333444444333 2 9999999999999999999999999999853322 1122233
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
-...|.|||.+....++.|+|||+|||+|||+.| |..|+.+.. +.+ +..++. ...+.+.+..|+.
T Consensus 428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lSq-VY~LLE---------kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQ-VYGLLE---------KGYRMDGPEGCPP 493 (1157)
T ss_pred CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HHH-HHHHHh---------ccccccCCCCCCH
Confidence 4568999999999999999999999999999988 777876542 222 333332 3333444555777
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
++.+|+.+||+.+|++||++.|+-+.++.+.+
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999988763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=298.24 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=199.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.|.+.||+|+|++|++|+. .++.+|||++.+... ...+-...|-.+|.+| .||.|++|+-.|.+...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 4678999999999999987 567999999976532 2234567888999999 899999999999999999999999
Q ss_pred CCCCCHHHHhccCCCC--------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-----
Q 004935 503 MANGNLQALLLGEEAD--------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG----- 569 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~--------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~----- 569 (723)
.++|+|-+++++...- +-.+...+..+|+...|||||||+|||||+||++||+|||.|+.+......
T Consensus 156 A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~ 235 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPV 235 (604)
T ss_pred cCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCcc
Confidence 9999999999875221 123445667777777799999999999999999999999999988643221
Q ss_pred -----ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 570 -----THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 570 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
......+.||..|.+||.+..+..+..+|+|+|||+||+|+.|++||...++-..+.+++. +|-
T Consensus 236 ~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-----------l~y 304 (604)
T KOG0592|consen 236 DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-----------LDY 304 (604)
T ss_pred CcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-----------hcc
Confidence 1112457899999999999999999999999999999999999999988766433333222 122
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-------HHHhhhhHhhhhhc
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME-------LNESLAIETARLKA 696 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~-------L~~~~~~~~~~~~~ 696 (723)
.+.+.++ ..+.+|+.+.|..||.+|+|.+++.+. .+++++...+++..
T Consensus 305 ~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~p 359 (604)
T KOG0592|consen 305 EFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQP 359 (604)
T ss_pred cCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccC
Confidence 3334444 356799999999999999999888774 35566666665554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=273.73 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=187.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.-.+.||+|.||.||+|++ +++.||||+++..... -.....+|++.|+.++|+||+.+++.+...+...||+|||+
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence 3357899999999999998 5779999999876432 23467899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCC-----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGEEA-----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~~~-----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
. +|+..++.... ++..|. +.+..+|..-.+||||||.|+|++.++.+||+|||+|+.+..... ..+.
T Consensus 85 t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~---~~~~ 160 (318)
T KOG0659|consen 85 T-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR---IQTH 160 (318)
T ss_pred c-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---cccc
Confidence 7 99999887532 223343 334555555559999999999999999999999999999865432 2233
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccc------ccC-----
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES------IVD----- 643 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------i~d----- 643 (723)
...|..|+|||.+.|. .|+...|+||.|||+.||+-|.+-|.+..+.+.+....+. ++...-.. +-|
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~-LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA-LGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH-cCCCCcccCccccccccHHHHh
Confidence 3678999999998875 5999999999999999999999877776654444444333 22211111 111
Q ss_pred ----CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 644 ----PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 644 ----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+.+.. .-.......+++...++..+|.+|+|++|++++
T Consensus 240 ~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00111 111233456899999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.35 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=186.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--ceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--NRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~Ey~~~ 505 (723)
..+.||+|+||.||.+... +...|||..........+.+.+|+++|.+++|||||+.+|...... ...++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3578999999999999985 5799999987664444677999999999999999999999865555 58899999999
Q ss_pred CCHHHHhccCCCCCC----------CHHHHHHHHHhccccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCceeee
Q 004935 506 GNLQALLLGEEADIL----------SWEGRLRIAIEAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 506 gsL~~~l~~~~~~~l----------~~~~~l~i~~~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|+|.+++.+... .+ +....+..+|....|||||||+|||++. ++.+||+|||+++.............
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~ 179 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSEL 179 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccc
Confidence 999999987643 22 2334566666666799999999999999 79999999999987643122223344
Q ss_pred cccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...||+.|||||.+..+ ....++||||+||++.||+||++||.... ...+++-........ |.+...
T Consensus 180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---~~~~~~~~ig~~~~~-----P~ip~~---- 247 (313)
T KOG0198|consen 180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---EEAEALLLIGREDSL-----PEIPDS---- 247 (313)
T ss_pred cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---chHHHHHHHhccCCC-----CCCCcc----
Confidence 57899999999999863 33459999999999999999999997641 112222222212111 222222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
-.....+++.+|+..+|++|||++++++.---..+.
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 223567999999999999999999999866544433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.88 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=183.8
Q ss_pred HHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
..+.+.||+|+||.||+|... +..||||+++... ......+.+|+++++++ +|+||++++++|...+..++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 345688999999999998851 2379999997643 33446789999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC--------------------------------------------------------------
Q 004935 499 IYEFMANGNLQALLLGEE-------------------------------------------------------------- 516 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~-------------------------------------------------------------- 516 (723)
||||+++|+|.+++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999885421
Q ss_pred ------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 517 ------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 517 ------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
...+++...+.++.++ ..+||||||+|||+++++.+||+|||+++....... ........++.
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~ 278 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLPV 278 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccCCCCcc
Confidence 0124444444444433 339999999999999999999999999986532211 11222234567
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
.|+|||.+.+..++.++|||||||+++||++ |+.||............+ ..+. ....+. .....+.
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~--~~~~~~-------~~~~~l~ 345 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGY--QMSRPD-------FAPPEIY 345 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----Hccc--CccCCC-------CCCHHHH
Confidence 8999999998899999999999999999997 999987543322221211 1110 000111 1123678
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 660 EIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
+++.+|++.+|++|||+.+|++.|++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=294.55 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=190.3
Q ss_pred HHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh-hHHHHHHHHHHHHhcc-CCceeeEEEEEecCC-ceEEEE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIH-HKNLTTLVGYCDEGT-NRGLIY 500 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~ 500 (723)
.++...+.||.|.||.||+|+- ++..||||+++..-.. ..--=++|++.|+++. ||||++|.+.+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 3456678999999999999987 5779999999765332 1122379999999998 999999999998887 999999
Q ss_pred EeCCCCCHHHHhccCCCCCCC----------HHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILS----------WEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~----------~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
|||+. +|.++++.+ ...++ ..+.|..+|.....|||+||+|||+.....+||+|||+||.... .
T Consensus 90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S----k 163 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS----K 163 (538)
T ss_pred Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc----C
Confidence 99987 999999887 33333 33445555555559999999999999999999999999998642 2
Q ss_pred eeeecccCCCccccccccc-cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc--------
Q 004935 571 HVTTTIAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI-------- 641 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i-------- 641 (723)
..-+....|..|+|||++. .+-|+.+.|+||+|||++|+.+-++.|.+..+.+.+-++.. .++.......
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~-VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE-VLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH-HhCCCccccchhHHHHHH
Confidence 2345567899999999976 56799999999999999999999999988877655544333 3332211111
Q ss_pred -cCCcccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 642 -VDPRLHE-------DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 642 -~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+.-++.. ..-.......++++.+|++.||.+|||++|+++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111110 0112345678899999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.98 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=184.4
Q ss_pred HHHhhhhccccCcEEEEEEEEC-----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
...+.+.||+|+||.||+|.+. +..||+|+++... ......|.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 3445688999999999999863 3489999988653 334467999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++.... ..+++...+.++.+++ .+||||||+|||++.++.+|++|||.+....... .
T Consensus 86 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~--~ 162 (266)
T cd05064 86 EYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA--I 162 (266)
T ss_pred EeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc--h
Confidence 9999999999987643 2455665555444433 3999999999999999999999999876532111 1
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.......++..|+|||.+.+..++.++|||||||+++|+++ |+.||...... +.... ...+.. ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~-~~~~~~-----~~~--- 229 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKA-VEDGFR-----LPA--- 229 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH-HHCCCC-----CCC---
Confidence 11112335678999999999999999999999999999875 99999755322 11111 111110 011
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.......+.+++.+||+.+|.+||+++++.+.|+..
T Consensus 230 -~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 -PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112334678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.22 Aligned_cols=236 Identities=23% Similarity=0.313 Sum_probs=179.0
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||++.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 56899999999999987 57799999987543 22334678999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+.+...+.++.+ ...+||||||+|||+++++.+||+|||++...... .....
T Consensus 85 g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~ 160 (285)
T cd05631 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRG 160 (285)
T ss_pred CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC----CeecC
Confidence 99998886543334555544444333 33499999999999999999999999999875321 11234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|+..|+|||.+.+..++.++|||||||+++||++|+.||.............. ...... ..+... ..
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~------~~~~~~----~s 229 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-RVKEDQ------EEYSEK----FS 229 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-Hhhccc------ccCCcc----CC
Confidence 5689999999999999999999999999999999999999976543222111111 111110 011111 22
Q ss_pred HHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+|++.+|.+||+ ++++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 35779999999999999997 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.08 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=183.9
Q ss_pred HhhhhccccCcEEEEEEEEC-------CceEEEEEecCCCh-hhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSA-QGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|... +..||||++..... ...+.|.+|+++++++. ||||++++++|.+.+..++|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 34678999999999999862 23699999976433 33467999999999996 99999999999999999999
Q ss_pred EEeCCCCCHHHHhccCC---------------------------------------------------------------
Q 004935 500 YEFMANGNLQALLLGEE--------------------------------------------------------------- 516 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~--------------------------------------------------------------- 516 (723)
|||+++|+|.+++....
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 99999999999886421
Q ss_pred -------------------------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEE
Q 004935 517 -------------------------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 517 -------------------------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
...+.+...+.++.+++ .+||||||+|||+++++.+||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~ 279 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEE
Confidence 01244444444444433 3999999999999999999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhc
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||........+...+ .
T Consensus 280 DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~----~ 354 (400)
T cd05105 280 DFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI----K 354 (400)
T ss_pred eCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH----h
Confidence 9999986533221 111223346778999999998899999999999999999997 889987543222221111 1
Q ss_pred CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 635 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.+.. +. ........+.+++.+||+.+|++||++.+|++.|++++
T Consensus 355 ~~~~-----~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 355 SGYR-----MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cCCC-----CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1100 00 11122346789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=285.98 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=186.5
Q ss_pred HHHhhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...+.+.||+|++|.||+|... ++.||+|.++.... ..++|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 3455689999999999999984 45899999876542 356799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.......++|.....++.+++ .+||||||+||++++++.+||+|||+++....... .....
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 163 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--EAREG 163 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--cccCC
Confidence 9999999765544566666555544443 39999999999999999999999999987642211 11111
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+..|+|||.+.+..++.++||||||++++||+| |+.||....... ........... ......
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~----------~~~~~~ 229 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQVDQGYRM----------PCPPGC 229 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCC----------CCCCcC
Confidence 223458999999999999999999999999999999 998986543211 11111111100 011122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
...+.+++.+|++.+|.+||+|.++++.|++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=285.92 Aligned_cols=241 Identities=28% Similarity=0.384 Sum_probs=186.2
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|++|.||+|... ++.||+|++.... ...+++.+|++++++++|+||++++++|...+..+++|||++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 34578999999999999984 6689999987543 34567999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+.+..++.++.+++ .+||||||+||++++++.+||+|||+++....... ......
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~ 165 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGA 165 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee--eccCCC
Confidence 999999765545566666555544443 39999999999999999999999999987542211 111122
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..+..|+|||.+.+..++.++|||||||+++||++ |..|+..... .+...... .+. .+ .......
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~-~~~-----~~----~~~~~~~ 231 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE-KGY-----RM----ERPEGCP 231 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH-CCC-----CC----CCCCCCC
Confidence 34568999999999999999999999999999998 8888865322 11111111 110 01 1111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
..+.+++.+|++.+|++||++.+++++|+++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=289.41 Aligned_cols=242 Identities=28% Similarity=0.500 Sum_probs=184.2
Q ss_pred HhhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||.||+|...+ ..|++|.+.... .....+|.+|++++++++||||+++++++......+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 346789999999999998732 369999987543 334567999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEe
Q 004935 501 EFMANGNLQALLLGEEA--------------DILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~D 556 (723)
||+++|+|.+++..... ..+++...+.++. +...+||||||+||++++++.+||+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECC
Confidence 99999999999865311 2344444444333 33339999999999999999999999
Q ss_pred ccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcC
Q 004935 557 FGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 557 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
||+++....... ........+++.|+|||.+.+..++.++|||||||+++||++ |..||...... .+.. .+..
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~~~----~i~~ 241 (283)
T cd05048 168 FGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVIE----MIRS 241 (283)
T ss_pred Ccceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHHc
Confidence 999986532211 112233456788999999998899999999999999999998 99998754332 1111 1222
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.... ........+.+++.+||+.+|.+||+++||++.|+.
T Consensus 242 ~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 RQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 21111 112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.11 Aligned_cols=235 Identities=21% Similarity=0.364 Sum_probs=189.6
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+.||+|..|.||.|.. .+..||||++........+-+.+|+.+|+..+|+|||.++..+..+++++.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 5799999999999987 56699999998877666677899999999999999999999999999999999999999999
Q ss_pred HHhccCC---CC----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcc
Q 004935 510 ALLLGEE---AD----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582 (723)
Q Consensus 510 ~~l~~~~---~~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y 582 (723)
+.+.... .+ .....+.|.++|..+.+|||||++||||+.++.+||+|||+|..+..... ......||+.|
T Consensus 359 DvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYW 435 (550)
T KOG0578|consen 359 DVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYW 435 (550)
T ss_pred hhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---ccccccCCCCc
Confidence 9987652 11 12344567777777889999999999999999999999999987754322 34567899999
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHH
Q 004935 583 LDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIA 662 (723)
Q Consensus 583 ~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~ 662 (723)
||||......|.+|.||||||++++||+-|.+||-.... +.. +......|. |.+.. ...-...+.++.
T Consensus 436 MAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrA-lyLIa~ng~------P~lk~--~~klS~~~kdFL 503 (550)
T KOG0578|consen 436 MAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRA-LYLIATNGT------PKLKN--PEKLSPELKDFL 503 (550)
T ss_pred cchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHH-HHHHhhcCC------CCcCC--ccccCHHHHHHH
Confidence 999999999999999999999999999999999975322 111 111111111 22211 111233677999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 004935 663 MACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 663 ~~Cl~~~p~~RPsm~evl~ 681 (723)
.+||+.|+.+||+++|+++
T Consensus 504 ~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcchhcCCCHHHHhc
Confidence 9999999999999999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.86 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=185.8
Q ss_pred HHHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEec-CCce
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE-GTNR 496 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-~~~~ 496 (723)
.+.+.+.||+|+||.||+|... ++.||+|+++... ....+.+..|++++.++ +|+||++++++|.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 3456789999999999999752 3579999987543 33456788999999999 89999999998865 4567
Q ss_pred EEEEEeCCCCCHHHHhccCCC-----------------------------------------------------------
Q 004935 497 GLIYEFMANGNLQALLLGEEA----------------------------------------------------------- 517 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 517 (723)
++++||+++|+|.+++.....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 899999999999998854211
Q ss_pred CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccc
Q 004935 518 DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587 (723)
Q Consensus 518 ~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 587 (723)
..++|.....++.+++ .+||||||+|||+++++.+||+|||+++.+..... ........++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCccccCcHH
Confidence 2456665555554444 39999999999999999999999999987633221 111223445678999999
Q ss_pred cccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhcc
Q 004935 588 YISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACV 666 (723)
Q Consensus 588 ~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl 666 (723)
+.+..++.++|||||||+|+||++ |+.||........+.. ....+... .. +......+.+++.+|+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~-----~~----~~~~~~~~~~l~~~cl 313 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR----RLKEGTRM-----RA----PEYATPEIYSIMLDCW 313 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH----HHhccCCC-----CC----CccCCHHHHHHHHHHc
Confidence 999999999999999999999998 9999865432222211 11121110 00 1112346789999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhhh
Q 004935 667 SQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 667 ~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+|++||++.|+++.|+++++
T Consensus 314 ~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 314 HNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.10 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=183.7
Q ss_pred HhhhhccccCcEEEEEEEE------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 499 (723)
.+.+.||+|+||.||++.. ++..||+|.+.... ......|.+|++++++++||||++++++|... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3457899999999988653 35589999987653 23456789999999999999999999998654 357899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++... .+++.....++.+++ .+||||||+|||+++++.+||+|||+++........
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 9999999999998753 255555555444433 399999999999999999999999999876432221
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc-cHHHHHHHHhcCCCcccccCCcccC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI-HITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
........++..|+|||.+....++.++||||||++++||+||+.|+....... ................+.++.....
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 111222345667999999988889999999999999999999999975432110 0000000000000111111111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.........+.+++.+|++.+|++|||++++++.|+++.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 122233457889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.78 Aligned_cols=238 Identities=25% Similarity=0.349 Sum_probs=192.2
Q ss_pred hhhccccCcEEEEEEEEC---Cc--eEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLD---GT--EVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~---~~--~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.++||+|.||.|++|.++ |+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|...+ ....||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 478999999999999984 33 8999999877544 67899999999999999999999999877 77889999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
.|+|.+.|++.....+-......++.++|. |||||.++|+||...-.+||+|||+.+.++...+.-....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p 273 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAP 273 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecC
Confidence 999999999865556665555566666554 9999999999999999999999999999876554333334
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...-...|.|||.+...+++.++|||+|||+||||+| |..||.+-.. .++++. +|.+-+-..+..
T Consensus 274 ~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~----------iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 274 QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKN----------IDAGERLPRPKY 339 (1039)
T ss_pred CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHh----------ccccccCCCCCC
Confidence 4556779999999999999999999999999999999 6678865433 121111 222212223445
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
+...+.++++.||..+|++|||+.++.+.+
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 677899999999999999999999998554
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=282.59 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=188.6
Q ss_pred HHhhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.+.||.|+||.||+|... +..+++|.+.........++..|++++++++|+||+++++++......++||||+++|
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 445689999999999999984 5689999998776656678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+.+.....++ |+...+||||||+||++++++.+||+|||.+....... ......
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~---~~~~~~ 164 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV---YLSSDK 164 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc---ccccCC
Confidence 99999987554455555544443 33334999999999999999999999999998753221 112233
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||.+....++.++||||||++++||++ |+.||...... +.......... ........
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~----------~~~~~~~~ 230 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQITAGYR----------MPCPAKCP 230 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHHhCCc----------CCCCCCCC
Confidence 45678999999988899999999999999999998 88898654321 11111111100 01111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+.+++.+|++.+|++|||++++++.|+.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=285.12 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=188.5
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHh--ccCCceeeEEEEEecCC----ceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMR--IHHKNLTTLVGYCDEGT----NRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~lV~Ey~ 503 (723)
+.++||+|+||.||||.++++.||||++... ....|++|-++.+. ++|+||++++++-..++ +..||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 4578999999999999999999999999754 34578888877765 58999999999977666 789999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhccc-------------------cccCCCCCCEEEcCCCcEEEEeccCccccC
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFP 564 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~-------------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 564 (723)
++|+|.++|..+ .++|....+++..+++ +|||||++||||.+|+++.|+|||+|..+.
T Consensus 291 ~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999864 6789888887776654 899999999999999999999999999886
Q ss_pred CCCCCceeeecccCCCccccccccccCC-CC-----ChhhHHHHHHHHHHHHcCCCcccc--------C-----cccccH
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNR-LT-----EKSDVYNFGVVLLEIITSKSVIER--------T-----HERIHI 625 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DV~SfGvvL~elltg~~p~~~--------~-----~~~~~~ 625 (723)
.... ........||.+|||||.+.+.. +. .+.||||+|.|||||+++....+. . .....+
T Consensus 368 p~~~-~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 368 PGKP-QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred CCCC-CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 5433 22233478999999999997642 22 368999999999999997654421 0 011111
Q ss_pred HHHHHHHhcCCCcccccCCcccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 626 TQWVSFMLGKGDIESIVDPRLHE-DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 626 ~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.+.-....++.. .|.+.. ......+..+.+.+..||..||+.|.|+.=|-+.+.++.-...
T Consensus 447 e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111111111111 122211 1112456788899999999999999999999998887765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.64 Aligned_cols=233 Identities=25% Similarity=0.374 Sum_probs=191.7
Q ss_pred hhhhccccCcEEEEEEEECC--ceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
..+.||+|+||+||||+-++ +.||+|.+.+.. .+..+.+.+|++++++++||||+.++++|+...+.++|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 35789999999999998754 589999987653 44567899999999999999999999999999999999999988
Q ss_pred CCHHHHhccCCCC--------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD--------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~--------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+|..+|.....- ..+....+..++...++|||+||+||||+..+++|++|||+|+.+.. ++.+.+.+.
T Consensus 86 -~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~t~vltsik 161 (808)
T KOG0597|consen 86 -DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---NTSVLTSIK 161 (808)
T ss_pred -hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---Cceeeeecc
Confidence 999999865321 23344455666666669999999999999999999999999998753 467788899
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|||||...+..|+..+|.||+||||||+++|++||... .+.+.++....+. +.. +.+....
T Consensus 162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~-------v~~----p~~~S~~ 226 (808)
T KOG0597|consen 162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDP-------VKP----PSTASSS 226 (808)
T ss_pred CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCC-------CCC----cccccHH
Confidence 999999999999999999999999999999999999999643 3455555444332 111 1133446
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+..++...+.+||.+|.|..+++.
T Consensus 227 f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHhhcChhhcccHHHHhc
Confidence 778999999999999999988875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.96 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=196.2
Q ss_pred HHHHHHhhhhccccCcEEEEEEEEC----Cc--eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce
Q 004935 424 LRITNNFERVLGNGGFGTVYHGYLD----GT--EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR 496 (723)
Q Consensus 424 ~~~t~~f~~~lG~G~~g~Vy~~~~~----~~--~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 496 (723)
.+..-...++||+|.||.||+|... |. .||||..+.+. ....+.|+.|.-+|++++||||++|+|.|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3333345689999999999999872 22 69999998754 4556789999999999999999999999976 467
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 497 GLIYEFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++|||.++.|-|..+|..+.. .++....+.++.+ .-.|||||.++|||+....-+||+|||+++.+..+
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 899999999999999987533 2444333333333 33399999999999999999999999999998543
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.. ...+...-...|||||.+...+++.++|||.|||.+||+++ |..||.+-...+-+. .+. ..
T Consensus 545 ~y--YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iE---------nG 608 (974)
T KOG4257|consen 545 AY--YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIE---------NG 608 (974)
T ss_pred ch--hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----Eec---------CC
Confidence 32 22334455679999999999999999999999999999976 899998654322110 111 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
-+...++.++..+..+..+||+.+|.+||++.++...|+++++.|+.
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 12234556777899999999999999999999999999999986654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=284.78 Aligned_cols=245 Identities=28% Similarity=0.431 Sum_probs=185.7
Q ss_pred HHHHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 497 (723)
.+..+.+.||+|+||.||+|... +..||||.++..... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 34556789999999999999862 358999999765444 4578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCC------------CCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEE
Q 004935 498 LIYEFMANGNLQALLLGEE------------ADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
+||||+++|+|.+++.... ...+.+.....+ +|+...+||||||+||+++.++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 9999999999999997532 123444443333 333334999999999999999999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhc
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |+.||...... +.+... .
T Consensus 165 d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~~-~ 238 (280)
T cd05049 165 DFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIECI-T 238 (280)
T ss_pred CcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH-H
Confidence 9999976432211 111223345678999999999999999999999999999998 99998654322 111111 1
Q ss_pred CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 635 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.+.... . .......+.+++.+||+.+|++||++.||++.|++
T Consensus 239 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRLLQ-----R----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 211111 0 11123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=286.45 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=182.2
Q ss_pred HHhhhhccccCcEEEEEEEECC----------------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG----------------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYC 490 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~----------------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 490 (723)
+.+.+.||+|+||.||++...+ ..||+|.++... ......|.+|++++++++|+|++++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3456789999999999987632 258999987653 33456799999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCCHHHHhccCC----------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCC
Q 004935 491 DEGTNRGLIYEFMANGNLQALLLGEE----------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKF 550 (723)
Q Consensus 491 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~ 550 (723)
......++||||+++++|.+++.... ...+.|...+.++.++ ..+||||||+||++++++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~ 166 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC
Confidence 99999999999999999999986432 1124555554444433 339999999999999999
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc--CCCccccCcccccHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTHERIHITQW 628 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt--g~~p~~~~~~~~~~~~~ 628 (723)
.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |..||........+...
T Consensus 167 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 245 (295)
T cd05097 167 TIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245 (295)
T ss_pred cEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence 999999999976532211 112223345678999999998899999999999999999998 55677654332222111
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.......+...... ........+.+++.+|++.+|++||+|.+|++.|++
T Consensus 246 ~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 246 GEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000 111123478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=296.03 Aligned_cols=244 Identities=26% Similarity=0.384 Sum_probs=183.2
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.||+|+||.||+|++.+ ..||||+++... ....+.+.+|+++|.++. ||||++++++|...+..++|+
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 45799999999999998632 479999997653 233457899999999997 999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCC---------------------------------------------------------------
Q 004935 501 EFMANGNLQALLLGEEA--------------------------------------------------------------- 517 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 517 (723)
||+++|+|.++++....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999864311
Q ss_pred ---------------------------------CCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEE
Q 004935 518 ---------------------------------DILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 518 ---------------------------------~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl 554 (723)
..++|...+.++.+ ...+||||||+|||+++++.+||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL 280 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEE
Confidence 12444444444433 33399999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |+.|+.......... ..+
T Consensus 281 ~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~----~~~ 355 (401)
T cd05107 281 CDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY----NAI 355 (401)
T ss_pred EecCcceecccccc-cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH----HHH
Confidence 99999986532211 111122346788999999998889999999999999999998 888886543221111 111
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
..+.. +. .+......+.+++.+||+.+|.+||+++|+++.|++++
T Consensus 356 ~~~~~-----~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 356 KRGYR-----MA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11110 00 11112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=282.26 Aligned_cols=239 Identities=28% Similarity=0.444 Sum_probs=183.0
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|... +..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 3578999999999999884 45899999875433 356899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.++. +...+||||||+||++++++.+||+|||+++...... ........+
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~ 166 (261)
T cd05072 89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKF 166 (261)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc--eeccCCCcc
Confidence 9999765444455554444333 3333999999999999999999999999998754221 111223345
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||++.+..++.++|||||||+++||+| |+.||....... ... .. ..+... +. .. .....
T Consensus 167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~---~~-~~~~~~----~~-~~----~~~~~ 232 (261)
T cd05072 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMS---AL-QRGYRM----PR-ME----NCPDE 232 (261)
T ss_pred ceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHH---HH-HcCCCC----CC-CC----CCCHH
Confidence 678999999988889999999999999999998 999986543211 111 11 111100 11 11 12235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.+++.+|++.+|++||+++++.+.|++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 7899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=285.88 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=189.5
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|... +..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 3568999999999999752 336999998877766667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEecc
Q 004935 503 MANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 503 ~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
+++++|.+++.... ...++|..++.++.+++. +||||||+||+++.++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg 168 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 168 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCC
Confidence 99999999986532 123666666665555443 999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
+++....... ........++..|+|||.+.+..++.++|||||||+++||+| |+.||...... +.... ...+.
T Consensus 169 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~-~~~~~ 242 (291)
T cd05094 169 MSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIEC-ITQGR 242 (291)
T ss_pred cccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH-HhCCC
Confidence 9976532211 112233446788999999999999999999999999999999 99998654321 11111 11221
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
... . .......+.+++.+|++.+|++||++++|+++|+++..
T Consensus 243 ~~~-----~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 243 VLE-----R----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCC-----C----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111 0 11123467899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=284.85 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=187.8
Q ss_pred HhhhhccccCcEEEEEEEE-------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||++.. ++..+|+|.+........+.+.+|++++++++|+||++++++|...+..++|||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 3467899999999999975 123699999887666667789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC-----------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCc
Q 004935 502 FMANGNLQALLLGEE-----------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLS 560 (723)
Q Consensus 502 y~~~gsL~~~l~~~~-----------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla 560 (723)
|+++++|.+++.... ...+++...+.++.+++ .+||||||+||++++++.+||+|||++
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 167 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCcc
Confidence 999999999986432 12356655555444333 399999999999999999999999999
Q ss_pred cccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcc
Q 004935 561 RTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIE 639 (723)
Q Consensus 561 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 639 (723)
+....... ........++..|+|||.+.+..++.++|||||||+++||++ |+.||....... . .. ....+...
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~---~~-~i~~~~~~ 241 (288)
T cd05093 168 RDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-V---IE-CITQGRVL 241 (288)
T ss_pred ccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-H---HH-HHHcCCcC
Confidence 86532211 111222345678999999998899999999999999999998 888886543221 1 11 11121111
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 640 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..... ....+.+++.+|++.+|.+|||+++|++.|+++...
T Consensus 242 -----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 242 -----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 223678999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=285.46 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=186.6
Q ss_pred HhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|.. .+..||||+++... ....+.+.+|+++++++ +|+||++++++|...+..++|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 3467899999999999975 13379999987653 33456789999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+||+++|+|.+++.......+.+...+.++.+++ .+|+||||+|||++.++.+||+|||+++.......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 196 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN- 196 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCc-
Confidence 9999999999999765444456665555544433 39999999999999999999999999986643221
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
........++..|+|||.+.+..++.++|||||||+++||++ |+.|+............. ..+.. +
T Consensus 197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~~~-----~---- 263 (302)
T cd05055 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEGYR-----M---- 263 (302)
T ss_pred eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcCCc-----C----
Confidence 112223345678999999999899999999999999999998 999987554322222211 11110 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111223678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=282.23 Aligned_cols=243 Identities=26% Similarity=0.427 Sum_probs=183.7
Q ss_pred hhhhccccCcEEEEEEEEC--Cc---eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GT---EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~---~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
..+.||+|+||.||+|... ++ .+++|.+.... ....+++..|++++++++|+|++++++++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 3578999999999999873 32 69999987653 344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++++|.+++.... ..+++...+.++. +...+||||||+||++++++.+||+|||++.............
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 167 (268)
T cd05063 89 ENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167 (268)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceec
Confidence 9999999987543 2345544444333 3334999999999999999999999999998764322211111
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+........... + ...
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~~~~-----~-----~~~ 233 (268)
T cd05063 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGFRL-----P-----APM 233 (268)
T ss_pred cCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcCCCC-----C-----CCC
Confidence 12233457999999988889999999999999999997 9999865432 1222222111110 1 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
+....+.+++.+|++.+|++||+|++|++.|++++
T Consensus 234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 23346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.76 Aligned_cols=242 Identities=19% Similarity=0.312 Sum_probs=183.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC-----ceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT-----NRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~ 503 (723)
.+++|.|+||.||+|.+ +++.||||+.-.... --.+|+++|+++.|||||+|+-++.... ...||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 46899999999999998 456999999865543 2257999999999999999999885432 345899999
Q ss_pred CCCCHHHHhcc-----CCCC-------CCCHHHHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCc
Q 004935 504 ANGNLQALLLG-----EEAD-------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 504 ~~gsL~~~l~~-----~~~~-------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 570 (723)
|. +|.+.++. ..-. ..+..+.+..++....+||||||+|+|+|.+ +.+||||||.|+.+.....
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep-- 181 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP-- 181 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC--
Confidence 98 99988873 1111 2456677888888778999999999999976 8999999999998754332
Q ss_pred eeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--Ccc-------c
Q 004935 571 HVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--DIE-------S 640 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~-------~ 640 (723)
......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+......+..+++..-.+. ++. +
T Consensus 182 --niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 182 --NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred --ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 2445678899999998875 699999999999999999999999988766655555554322111 011 1
Q ss_pred ccCCccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IVDPRLH-----EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...|.+. .-.........++++.++++.+|.+|.++.|++.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1112221 1122234456789999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.50 Aligned_cols=236 Identities=22% Similarity=0.393 Sum_probs=182.9
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC----Ch-hhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS----SA-QGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.+.||+|+||+|+.|.. ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++....+.++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 34567899999999999987 5789999977653 11 23456678999999998 99999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC----CC----CCHHHHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCc
Q 004935 500 YEFMANGNLQALLLGEEA----DI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~----~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 570 (723)
|||+.+|+|.+++..... .. .+....+..+|....+||||||+|||++.+ +++||+|||++.... ...
T Consensus 99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~---~~~ 175 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP---GED 175 (370)
T ss_pred EEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC---CCC
Confidence 999999999999987321 12 233344555555555999999999999999 999999999999863 112
Q ss_pred eeeecccCCCccccccccccCC-CC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNR-LT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......+||+.|+|||++.+.. |+ .++||||+||+|+.|++|+.||+.... ....+. +..+.. .+..
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~k-i~~~~~------~~p~ 244 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRK-IRKGEF------KIPS 244 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHH-HhcCCc------cCCC
Confidence 3455678999999999999877 86 789999999999999999999987432 111111 222211 1111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
... ...+..++.+|+..+|.+|+|+.+++
T Consensus 245 ~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 245 YLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 110 34678999999999999999999999
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=280.38 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=185.5
Q ss_pred HhhhhccccCcEEEEEEEEC-----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|.+. ...||||.++... .....+|.+|+.++++++|+||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 34678999999999999873 2379999987653 33456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++++|.+++..... .+++...+.++.+ ...+||||||+||++++++.+||+|||+++....... ...
T Consensus 87 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (266)
T cd05033 87 MENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYT 164 (266)
T ss_pred CCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc-cee
Confidence 999999999876432 3555555444433 3339999999999999999999999999987642211 122
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|+|||.+.+..++.++||||||++++||++ |..||...... +..... ..+... +. .
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~-~~~~~~----~~-----~ 230 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAV-EDGYRL----PP-----P 230 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHH-HcCCCC----CC-----C
Confidence 223345678999999998899999999999999999998 99998644321 111111 111100 00 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
......+.+++.+|++.+|++||++++|++.|++++
T Consensus 231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 122346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=291.59 Aligned_cols=244 Identities=20% Similarity=0.275 Sum_probs=178.4
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.||+|+||.||++... +..||+|++.... ....+++.+|+++|++++|+||+++++++...+..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 468999999999999984 5689999987653 3345679999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHH----------HHHHHHHhcc-ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 508 LQALLLGEEADILSWE----------GRLRIAIEAA-KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~----------~~l~i~~~~a-~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
|.+++..... +.+. ..+..+|+.. .+||||||+|||++.++.+||+|||+++..... .....
T Consensus 90 L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~ 162 (331)
T cd06649 90 LDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSF 162 (331)
T ss_pred HHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-----ccccC
Confidence 9999875432 2222 2233333332 389999999999999999999999998765321 12335
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccc--------------
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IES-------------- 640 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-------------- 640 (723)
.++..|+|||.+.+..++.++|||||||+++||+||+.||...... .+..........+. ...
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCccccccccccc
Confidence 6899999999999999999999999999999999999999643321 11111111000000 000
Q ss_pred ------------------ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 641 ------------------IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 641 ------------------i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
++...............+.+++.+||+.+|++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000123467899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=285.05 Aligned_cols=242 Identities=26% Similarity=0.459 Sum_probs=182.1
Q ss_pred HhhhhccccCcEEEEEEEE------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||+|.. .+..|++|.+.... ......|.+|++++++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 3467899999999999985 34589999997543 3445689999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC---------------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEe
Q 004935 502 FMANGNLQALLLGEE---------------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 502 y~~~gsL~~~l~~~~---------------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~D 556 (723)
|+++|+|.+++.... ...+++...+.++.++ ..+||||||+|||+++++.+||+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecc
Confidence 999999999985321 1234555444444433 339999999999999999999999
Q ss_pred ccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcC
Q 004935 557 FGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 557 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |..||...... .+.+ ....
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-~~~~----~~~~ 241 (283)
T cd05090 168 LGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIE----MVRK 241 (283)
T ss_pred ccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHHc
Confidence 999986533221 122233345678999999988889999999999999999998 88888654321 1112 1111
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.... .... .....+.+++.+|++.+|++||++.++++.|+.
T Consensus 242 ~~~~-----~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQLL-----PCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCcC-----CCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 0111 123467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=284.40 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=184.4
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.... ..+++|.+.... .....++.+|+.++++++||||+++++.|...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 35789999999999998632 368999887554 3345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC----------------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCC
Q 004935 502 FMANGNLQALLLGEE----------------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGK 549 (723)
Q Consensus 502 y~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~ 549 (723)
|+++|+|.+++.... ...+.+...+.++.+++ .+||||||+|||++++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~ 163 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG 163 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCC
Confidence 999999999986421 12345555555444443 3999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQW 628 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~ 628 (723)
+.+||+|||+++....... ........++..|+|||.+.+..++.++||||||++++||+| |+.||...... .+.+
T Consensus 164 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~- 240 (290)
T cd05045 164 RKMKISDFGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFN- 240 (290)
T ss_pred CcEEeccccccccccCccc-hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH-
Confidence 9999999999986532221 111122345678999999988889999999999999999999 99998654321 1111
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
....+. .... .......+.+++.+|++.+|++||+++++++.|++++.
T Consensus 241 ---~~~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 ---LLKTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHhCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 0011 11123467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=285.89 Aligned_cols=233 Identities=27% Similarity=0.420 Sum_probs=187.8
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.||+|+||.||||.. .++.||+|++..... ....+.++|+.+|..++++||.+.+|.+..+..+.++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6899999999999998 466999999986643 4457889999999999999999999999999999999999999999
Q ss_pred HHHhccCCC---CCC-----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 509 QALLLGEEA---DIL-----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 509 ~~~l~~~~~---~~l-----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
.+.+..... ... .....+.+.|....+|||||+.|||+..+|.+||+|||.+..+..... ......||+
T Consensus 99 ~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~---rr~tfvGTP 175 (467)
T KOG0201|consen 99 LDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK---RRKTFVGTP 175 (467)
T ss_pred hhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---ccccccccc
Confidence 999976532 111 223345555555569999999999999999999999999987754322 235678999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHH
Q 004935 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVE 660 (723)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 660 (723)
.|||||++.+..|+.|+||||+|++.+||.+|.+|+.......- ... +.+-.-|.+.+.+ ...+.+
T Consensus 176 fwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lfl-----Ipk~~PP~L~~~~----S~~~kE 241 (467)
T KOG0201|consen 176 FWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LFL-----IPKSAPPRLDGDF----SPPFKE 241 (467)
T ss_pred cccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EEe-----ccCCCCCcccccc----CHHHHH
Confidence 99999999988999999999999999999999999876543110 001 1222234455433 346789
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 004935 661 IAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 661 l~~~Cl~~~p~~RPsm~evl~ 681 (723)
++..|+..+|+.||++.++++
T Consensus 242 FV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhh
Confidence 999999999999999999986
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=277.70 Aligned_cols=236 Identities=26% Similarity=0.441 Sum_probs=179.3
Q ss_pred hhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||++...+ ..+|+|.+.... ...++|.+|++++++++||||++++++|......++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 45789999999999999854 489999876443 2346789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++..... .++|...+.++ |+...+||||||+||++++++.+||+|||.++...... ........+
T Consensus 87 ~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~ 163 (256)
T cd05114 87 LNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKF 163 (256)
T ss_pred HHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--eeccCCCCC
Confidence 999875432 24554444443 33334999999999999999999999999988653211 111122335
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++||||||++++||++ |+.||..... .+.+..... +. ....+.. ....
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~-~~--~~~~~~~-------~~~~ 229 (256)
T cd05114 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISR-GF--RLYRPKL-------ASMT 229 (256)
T ss_pred chhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC-CC--CCCCCCC-------CCHH
Confidence 568999999988889999999999999999999 8989865432 122222111 11 1111111 1236
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
+.+++.+||+.+|++||+|+++++.|
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhh
Confidence 78999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=281.88 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=181.0
Q ss_pred HhhhhccccCcEEEEEEEE------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 500 (723)
.+.+.||+|+||.||++.. .+..||+|.+........+.|.+|++++++++|+||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 3457899999999999975 356899999987776667889999999999999999999998754 34678999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++.... ..+.+...+.++.+ ...+||||||+||++++++.+||+|||+++.........
T Consensus 87 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (284)
T cd05081 87 EYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY 165 (284)
T ss_pred EecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcce
Confidence 9999999999986542 23455554444433 333999999999999999999999999998764332211
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-------cccccC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-------IESIVD 643 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~i~d 643 (723)
.......++..|+|||.+.+..++.++|||||||+++||++|..++..... .+......... +.+.+.
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-----EFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-----hhhhhcccccccccchHHHHHHHh
Confidence 111222344569999999888899999999999999999998776532211 00000000000 000000
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
..............+.+++.+||+.+|++||||+||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000011112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=288.76 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=182.6
Q ss_pred hhhhccccCcEEEEEEEE--CCc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
..+.||+|+||.||+|.+ ++. .||+|+++... ....++|..|+.+++.++|+||++++|+|... ...+++||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 357899999999999986 333 48999987543 34557899999999999999999999999765 56799999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++..... .+.+...+.++ |+...+||||||+|||+++++.+||+|||+++....... ...
T Consensus 90 ~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 167 (316)
T cd05108 90 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK-EYH 167 (316)
T ss_pred CCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc-cee
Confidence 999999999876432 23444333333 333339999999999999999999999999987643221 111
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......+..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .++.. ....+... ..+
T Consensus 168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~~-~~~~~~~~--~~~------- 233 (316)
T cd05108 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISS-ILEKGERL--PQP------- 233 (316)
T ss_pred ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHH-HHhCCCCC--CCC-------
Confidence 122334678999999999999999999999999999998 9999865422 11111 11111100 001
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
..+...+.+++.+||+.+|.+||++.+++..|..+.....
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 1122367899999999999999999999999998875553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=282.48 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=181.0
Q ss_pred HhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||.||+|... +..||||.+.... .....+|.+|+.++++++|+||+++++++......++||
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 88 (277)
T cd05062 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 88 (277)
T ss_pred eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEE
Confidence 34678999999999999863 2479999986543 334567999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCC--------CCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 501 EFMANGNLQALLLGEE--------ADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
||+++|+|.+++.... ...+.|...+.++.+ ...+||||||+||++++++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 168 (277)
T cd05062 89 ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168 (277)
T ss_pred ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccc
Confidence 9999999999986531 122445544444333 3339999999999999999999999999876
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
...... ........++..|+|||.+.+..++.++|||||||+++||++ |..||...... +...... .+....
T Consensus 169 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~~-~~~~~~- 241 (277)
T cd05062 169 IYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFVM-EGGLLD- 241 (277)
T ss_pred cCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH-cCCcCC-
Confidence 532211 111122345678999999998899999999999999999999 68888654321 2122111 111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.. ......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 242 ----~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 242 ----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=302.89 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=195.1
Q ss_pred hhhhccccCcEEEEEEEEC-C-ceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEE-Ee---c---CCceEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD-G-TEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGY-CD---E---GTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~---~---~~~~~lV 499 (723)
+++.|.+|||+.||.|... + .++|+|++-..+....+...+||++|++|+ |+|||.+++. .. . .-+.+|+
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 3578999999999999983 3 699999998888888899999999999996 9999999993 21 1 2356799
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc------------cccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
||||++|+|-+++..+....|+-...|+|..++++ ||||||-+||||+.+++.||||||.+.......
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 99999999999998775555777777777776665 999999999999999999999999987532221
Q ss_pred CCcee------eecccCCCcccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc
Q 004935 568 SGTHV------TTTIAGTPGYLDPEYY---ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 568 ~~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
..... .....-|+.|+|||.+ .+...++|+|||++||+||-|+....||+....
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------------- 263 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------------- 263 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------------
Confidence 11110 1123479999999987 466789999999999999999999999986532
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
..|++....-.-.......+-+||..||+.+|.+||++.+|+..+.++...+-.
T Consensus 264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 122233322222245667889999999999999999999999999998866643
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=276.82 Aligned_cols=236 Identities=28% Similarity=0.421 Sum_probs=187.2
Q ss_pred HhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.+.||.|+||.||+|...++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred cceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 4467899999999999999999999999986654 567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+.+.....++.+++ .+||||||+||+++.++.+||+|||.++...... .....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------~~~~~ 161 (256)
T cd05039 88 VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------DSGKL 161 (256)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc------ccCCC
Confidence 9999766544566666655555443 3999999999999999999999999998753211 12334
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+....++.++||||||++++|+++ |+.||...... . +......+... . ........
T Consensus 162 ~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~-~~~~~~~~~~~-----~----~~~~~~~~ 227 (256)
T cd05039 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----D-VVPHVEKGYRM-----E----APEGCPPE 227 (256)
T ss_pred cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----H-HHHHHhcCCCC-----C----CccCCCHH
Confidence 568999999988889999999999999999997 99988654221 1 11111111100 0 11112346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.+++.+|+..+|++||++.|++++|+.
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=293.97 Aligned_cols=238 Identities=22% Similarity=0.309 Sum_probs=175.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 356899999999999998 46799999986543 334567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcc
Q 004935 507 NLQALLLGEEADILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y 582 (723)
+|.+...........+ ...+..+|+...+||||||+|||+++++.+||+|||+++.+.... .......|+..|
T Consensus 158 ~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~y 234 (353)
T PLN00034 158 SLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---DPCNSSVGTIAY 234 (353)
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---ccccccccCccc
Confidence 9976543222222223 334445555555999999999999999999999999998753221 112345689999
Q ss_pred cccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 583 LDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 583 ~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+|||.+.. ...+.++|||||||++|||++|+.||...... ............ . .+... ......
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~-~-----~~~~~----~~~~~~ 303 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMS-Q-----PPEAP----ATASRE 303 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhcc-C-----CCCCC----CccCHH
Confidence 99998743 23456899999999999999999999733221 111111111100 0 01111 122346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+++.+||+.+|++||++.|+++
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 789999999999999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=304.39 Aligned_cols=239 Identities=22% Similarity=0.300 Sum_probs=181.5
Q ss_pred HHhhhhccccCcEEEEEEEE--C-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--D-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||+|.. + +..||+|.+..........+..|+.+|++++||||++++++|...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 34567899999999999987 2 45789998766655555678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccC--CCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 505 NGNLQALLLGE--EADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 505 ~gsL~~~l~~~--~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+|+|.+++... ....+++... +..+|+...+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-~~~ 227 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-LDV 227 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-ccc
Confidence 99999887643 2223333332 3333333449999999999999999999999999987643211 122
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+....... +... + +..
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~~~~-~~~~----~-~~~---- 293 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLY-GKYD----P-FPC---- 293 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCCC----C-CCc----
Confidence 3445699999999999999999999999999999999999999965432 222222211 1111 0 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++||++.+++.
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12235789999999999999999999875
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=276.68 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=184.4
Q ss_pred hhccccCcEEEEEEEECC---c--eEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLDG---T--EVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~---~--~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|++|.||+|.+.. + .||||.+..... ...+.|.+|++++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998732 2 699999987765 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+.|.....++.++ ..+||||||+||+++.++.+||+|||+++.+............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 999999976542345665554444433 3399999999999999999999999999876543221122223
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+.+..++.++|||||||+++||++ |+.|+...... +............. .....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~---------~~~~~ 226 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDKEGERLE---------RPEAC 226 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHhcCCcCC---------CCccC
Confidence 457789999999998899999999999999999999 99998654322 22222211111000 01112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
...+.+++.+|++.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=275.72 Aligned_cols=238 Identities=24% Similarity=0.331 Sum_probs=178.2
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.||+|+||.||+|.. +++.||+|...... ......|.+|++++++++|+||++++++|......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999988 57789999876543 34456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..+.+...+.++ |+...+||||||+||+++.++.+||+|||++........ .........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-ASTGGMKQI 158 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-cccCCCCCC
Confidence 99986532 234444443333 333349999999999999999999999999876432111 001111223
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++|||||||+++||++ |..|+....... ......... ...........
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~ 224 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQGV---------RLPCPELCPDA 224 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcCC---------CCCCcccCCHH
Confidence 457999999998899999999999999999998 888886443211 111111110 00111122346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.+++.+|++.+|++|||+.++.++|++
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 7899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.10 Aligned_cols=237 Identities=24% Similarity=0.382 Sum_probs=177.4
Q ss_pred hccccCcEEEEEEEE----CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 433 VLGNGGFGTVYHGYL----DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.||+|+||.||+|.+ ++..+|+|+++... ....+++..|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 35689999986543 334568999999999999999999999985 45678999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+++...+.++.++ ..+||||||+||+++.++.+||+|||+++...............
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999986542 23444444433333 33999999999999999999999999998764332211111223
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||.+....++.++|||||||+++||++ |+.||...... .+.+ .+..+.. +..... ..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~----~i~~~~~-----~~~~~~----~~ 224 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQ----MIESGER-----MECPQR----CP 224 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHCCCC-----CCCCCC----CC
Confidence 34578999999988889999999999999999998 99998754321 1222 1222211 111111 22
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
..+.+++.+|++.+|++||+|++|++.|++.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 4677999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=278.33 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=183.2
Q ss_pred HHhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.+.||+|+||.||+|...+ ..||+|+++.... ..++|.+|++++++++|+||+++++++. ....++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 4567889999999999998854 4899999875432 3467899999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+++...+.++.++ ..+||||||+||++++++.+||+|||.++....... ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--~~~~~~ 163 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQGA 163 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc--ccccCC
Confidence 99999976543445555544444333 339999999999999999999999999986543221 111233
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||...+..++.++|||||||+++||+| |+.||...... +.......... . ....+..
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~------~----~~~~~~~ 229 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYR------M----PCPPECP 229 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhcCCC------C----CCccccC
Confidence 46678999999988899999999999999999999 78788654321 11111111100 0 1112234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
..+.+++.+|++.+|++||+++++++.|++..
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 56789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=284.22 Aligned_cols=229 Identities=20% Similarity=0.351 Sum_probs=176.1
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||.++- +|..+|+|++++... ...+....|-.+|....++.||+|+-.|.+.+.+||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 6899999999999987 577999999988754 33456789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHH--------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCC------------
Q 004935 507 NLQALLLGEEADILSWEG--------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE------------ 566 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~--------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~------------ 566 (723)
++..+|.....-.-+|.+ .+..+|+...|||||||+|+|||..|++||+||||+.-+...
T Consensus 227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~ 306 (550)
T KOG0605|consen 227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQM 306 (550)
T ss_pred cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhh
Confidence 999999876544444443 233444555599999999999999999999999998643110
Q ss_pred ---------CCCc----ee-------------------eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCC
Q 004935 567 ---------GSGT----HV-------------------TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614 (723)
Q Consensus 567 ---------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~ 614 (723)
.... .. .-...|||-|||||++.+..|+..+|.||+|||++||+.|-+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyP 386 (550)
T KOG0605|consen 307 QINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYP 386 (550)
T ss_pred hhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCC
Confidence 0000 00 012369999999999999999999999999999999999999
Q ss_pred ccccCcccccH---HHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 004935 615 VIERTHERIHI---TQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPT 675 (723)
Q Consensus 615 p~~~~~~~~~~---~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 675 (723)
||......... ..|......+ ..........++|.+|+. ||.+|--
T Consensus 387 PF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 387 PFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred CCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99876543322 2222211111 111112466799999999 9999976
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=286.42 Aligned_cols=250 Identities=29% Similarity=0.423 Sum_probs=188.4
Q ss_pred HHHhhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCc
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTN 495 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 495 (723)
.+.+.+.||+|+||.||++... ...+|+|.+.... .....++..|+++++++ +|+||++++++|...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3455789999999999999752 2369999998643 34456788999999999 79999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCc
Q 004935 496 RGLIYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQ 551 (723)
Q Consensus 496 ~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~ 551 (723)
.++||||+++|+|.+++.... ...++|...+.++.+++ .+||||||+||+++.++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc
Confidence 999999999999999997532 12466665555544443 399999999999999999
Q ss_pred EEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHH
Q 004935 552 AKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVS 630 (723)
Q Consensus 552 ~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~ 630 (723)
+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |+.|+.... ..+...
T Consensus 179 ~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~~~~~~ 253 (307)
T cd05098 179 MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFK 253 (307)
T ss_pred EEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHH
Confidence 99999999876532111 111112234568999999988889999999999999999998 888885432 122222
Q ss_pred HHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 631 FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.. ..+... .........+.+++.+|++.+|++||+|.+|++.|+++++...
T Consensus 254 ~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 254 LL-KEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HH-HcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 21 111110 1111223467789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=276.86 Aligned_cols=238 Identities=26% Similarity=0.403 Sum_probs=179.2
Q ss_pred hhccccCcEEEEEEEEC--C---ceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--G---TEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|... + ..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999862 2 5799999886554 34567999999999999999999999876 4567999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... .+++...+.++.+++ .+||||||+|||++.++.+||+|||+++..............
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999997653 344444444443333 299999999999999999999999999876433221111112
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+.+..++.++|||||||+++||++ |+.||...... .+..++. ..... ......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~----~~~~~---------~~~~~~ 223 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE----SGERL---------PRPEEC 223 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH----cCCcC---------CCCCCC
Confidence 224567999999998899999999999999999998 99998754321 1222221 11100 011112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
...+.+++.+|+..+|++||++.++++.|++.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 34678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=265.91 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=187.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 501 (723)
.+.+.||+|||+.||.++. +++.+|+|++.-...++.+..++|++..++++|||++++++++..+ ...+|+++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 4567899999999999875 6779999999887777788899999999999999999999987443 34899999
Q ss_pred eCCCCCHHHHhccC--CCCCCCHHHHHHHHHhccc------------cccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 502 FMANGNLQALLLGE--EADILSWEGRLRIAIEAAK------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 502 y~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~~a~------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
|...|+|.+.+... +...++-.+.+.+..++++ +||||||.|||+.+.+.++|.|||.+...+..-
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 99999999998754 3334454454444444433 899999999999999999999999998754322
Q ss_pred CCcee------eecccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc
Q 004935 568 SGTHV------TTTIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 568 ~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
.+.+. ......|..|+|||.+. +...++++|||||||+||+|+.|..||+...+...-.+
T Consensus 184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----------- 252 (302)
T KOG2345|consen 184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----------- 252 (302)
T ss_pred echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----------
Confidence 21111 12345899999999986 44578999999999999999999999975432211110
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
..+..+.+.-.........+.+++.+|++.||.+||++.+++..+++..
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111222211111124457889999999999999999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=278.41 Aligned_cols=237 Identities=21% Similarity=0.307 Sum_probs=178.3
Q ss_pred ccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||.||++.. +++.||+|.+..... ...+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 467999999864321 2234567799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+.+...+.++ |+...+||||||+||+++.++.++|+|||++...... .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQRAG 156 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ceeeccCC
Confidence 998865544445555444333 3333399999999999999999999999998765321 12234568
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|+|||.+.+..++.++|||||||++|||++|+.||..........+........ ... .. ... ....+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~-~~~----~~~~~ 226 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EVK----FE-HQN----FTEES 226 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-ccc----cc-ccc----CCHHH
Confidence 899999999998889999999999999999999999997543322222222222111 110 00 011 22357
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+++.+|++.+|++||+++|+++.+.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhh
Confidence 89999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-33 Score=295.12 Aligned_cols=234 Identities=23% Similarity=0.349 Sum_probs=185.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+-|.|-.|++ +|+.+|||++.+.. ......+.+|+-+|+.+.|||++.+++.+.+..++|||.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 357899999999999998 68899999997652 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC----CCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEE----ADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~----~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|-|.+++..+. .++.....++-+++..+| +||||||+|+|||...++||+|||+|..-.. .......
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~----gklLeTS 171 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP----GKLLETS 171 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC----Ccccccc
Confidence 999999987652 334444445444444444 9999999999999999999999999986432 2345567
Q ss_pred cCCCccccccccccCCCC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
+|++.|.|||.+.+.+|. .++||||.||||+.|+||+.||++.+ +..... ....|... .+.+..
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLl-KV~~G~f~----------MPs~Is 236 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLL-KVQRGVFE----------MPSNIS 236 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHH-HHHcCccc----------CCCcCC
Confidence 899999999999999985 78999999999999999999998543 222221 12222111 111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.+|+.+|+..||++|.|++||.+.
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhC
Confidence 467799999999999999999999873
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=276.26 Aligned_cols=238 Identities=22% Similarity=0.388 Sum_probs=177.6
Q ss_pred hccccCcEEEEEEEEC----CceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLD----GTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||+|+||.||+|.+. +..||+|++..... ...+.|.+|+.++++++|+||++++++|. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999763 33699999876543 34467999999999999999999999985 457889999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..+++...+.++.++ ..+||||||+|||++.++.+||+|||+++................
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 999986532 234555444444333 339999999999999999999999999986543322111112223
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
++..|+|||.+.+..++.++|||||||+++|+++ |+.||...... .... ....+.. ...+.....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~-~~~~~~~---------~~~~~~~~~ 225 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMS-FIEQGKR---------LDCPAECPP 225 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH-HHHCCCC---------CCCCCCCCH
Confidence 4578999999988889999999999999999996 99998755321 1111 1111111 111122334
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 677999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=282.15 Aligned_cols=246 Identities=29% Similarity=0.418 Sum_probs=183.8
Q ss_pred HhhhhccccCcEEEEEEEEC--Cc--eEEEEEecCC-ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GT--EVAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|... +. .+++|.++.. .....+.|.+|+++++++ +||||+++++++...+..++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 34678999999999999873 22 5788888753 334556799999999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCC--------------CCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEecc
Q 004935 503 MANGNLQALLLGEE--------------ADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 503 ~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
+++|+|.+++.... ...+.+...+.++ |+...+||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcC
Confidence 99999999986531 1134455444433 33333999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
++...... ........+..|+|||.+.+..++.++|||||||+++||++ |+.||...... +...... .+.
T Consensus 165 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~~~~~-~~~ 235 (297)
T cd05089 165 LSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYEKLP-QGY 235 (297)
T ss_pred CCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHh-cCC
Confidence 98643211 01111223457999999998899999999999999999997 99998654321 1111111 110
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.+... ......+.+++.+|++.+|.+||+++++++.|+++++..++
T Consensus 236 -----~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 -----RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -----CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 01111 11224678999999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=286.11 Aligned_cols=188 Identities=23% Similarity=0.308 Sum_probs=151.9
Q ss_pred HHHhhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.+.||+|+||.||++... +..+|+|++.... ......+.+|++++++++|+||++++++|...+..++||||+
T Consensus 6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence 3445678999999999999984 5689999887643 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC----CCCH----HHHHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 504 ANGNLQALLLGEEAD----ILSW----EGRLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~----~l~~----~~~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++|+|.+++...... ...+ ...+..+|+. ..+||||||+|||++.++.+||+|||++...... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-----~~~ 160 (333)
T cd06650 86 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MAN 160 (333)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-----ccc
Confidence 999999998754221 1112 2233334433 2489999999999999999999999998765321 123
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccC
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERT 619 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~ 619 (723)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 346889999999999888999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=275.71 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=182.2
Q ss_pred HHhhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.+.||+|+||.||+|... +..||+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 456788999999999999874 45899999876443 3467999999999999999999999885 45678999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+++...+.++.+ ...+||||||+||++++++.++|+|||++..+..... ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 163 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--TARQGA 163 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc--ccccCC
Confidence 9999997654444566555444433 3349999999999999999999999999987543211 111222
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||.+.+..++.++||||||++++||++ |+.||...... +.......... + .......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~------~----~~~~~~~ 229 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGYR------M----PCPQDCP 229 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCC------C----CCCCcCC
Confidence 35568999999988899999999999999999999 88888654321 11221111100 1 1111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+.+++.+|+..+|++|||++++.+.|++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=280.38 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=182.6
Q ss_pred HHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
..+.+.||+|+||.||+|... +..||+|+++..... ....|.+|+.++++++|+||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455788999999999999873 357999999865432 346689999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEE
Q 004935 500 YEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
+||+++++|.+++.... ...+.+...+.++.++ ..+||||||+||++++++.+||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence 99999999999985321 1234444443333333 33999999999999999999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhc
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
|||+++....... ........+++.|+|||.+.+..++.++|||||||+++||++ |..|+..... .++.....
T Consensus 167 Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~i~- 240 (283)
T cd05091 167 DLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIEMIR- 240 (283)
T ss_pred ccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH-
Confidence 9999886532221 122233445778999999988889999999999999999998 7788765432 22222221
Q ss_pred CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 635 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.+.... . .......+.+++.+|++.+|.+||+++++++.|+.
T Consensus 241 ~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLP-----C----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCC-----C----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211111 1 11233457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=287.23 Aligned_cols=230 Identities=23% Similarity=0.281 Sum_probs=174.9
Q ss_pred ccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||.||++... +..||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999984 568999998653 233456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++..... +.+. ..+..+|+...+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCG 155 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---CccccccC
Confidence 999865422 3332 33444444445999999999999999999999999998642221 22334568
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
|+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+........ . ..+... ....+
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~~~-~------~~~~~~----~~~~~ 220 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKILQE-P------LRFPDG----FDRDA 220 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHHHcC-C------CCCCCc----CCHHH
Confidence 9999999999999999999999999999999999999975432 2222222211 1 111111 12356
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
.+++.+|++.+|.+||++..+.+.|
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 7999999999999998754444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.60 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=189.5
Q ss_pred HHHHhhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCC
Q 004935 426 ITNNFERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGT 494 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 494 (723)
....+.+.||+|+||.||+|... +..||+|.+.... ....+++.+|+.+++.+ +|+||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 33445688999999999999741 2369999987543 34457899999999999 8999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCC
Q 004935 495 NRGLIYEFMANGNLQALLLGEE--------------ADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKF 550 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~ 550 (723)
..++||||+++|+|.+++.... ...++|...+.++ |+...+||||||+||++++++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 9999999999999999987532 1234554444433 333349999999999999999
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWV 629 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~ 629 (723)
.+||+|||+++....... ........++..|+|||.+.+..++.++||||||++++||++ |..|+.... ..+..
T Consensus 175 ~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~ 249 (304)
T cd05101 175 VMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELF 249 (304)
T ss_pred cEEECCCccceecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----HHHHH
Confidence 999999999987643221 111223345678999999988889999999999999999998 777875432 22222
Q ss_pred HHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 630 SFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 630 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.... .+... .........+.+++.+||+.+|++||+|.|+++.|++++.....
T Consensus 250 ~~~~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 250 KLLK-EGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 2221 11110 01112334678999999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=276.87 Aligned_cols=236 Identities=26% Similarity=0.395 Sum_probs=182.3
Q ss_pred HhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe-cCCceEEEEEeCCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD-EGTNRGLIYEFMANGN 507 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gs 507 (723)
.+.+.||+|+||.||++...+..|++|.++... ..+.|.+|+.++++++|+|++++++++. .++..++++||+++|+
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 346789999999999999999999999987543 2467899999999999999999999764 5567899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.......+.+...+.++.+++ .+||||||+||++++++.+||+|||+++...... ....
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~ 160 (256)
T cd05082 87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGK 160 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC------CCCc
Confidence 99999765544455655555444433 3999999999999999999999999987643211 2233
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.+..|+|||++.+..++.++|||||||+++||++ |+.|+.... ..+...... .+.. +.. ......
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~-~~~~-----~~~----~~~~~~ 226 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVE-KGYK-----MDA----PDGCPP 226 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHh-cCCC-----CCC----CCCCCH
Confidence 4568999999988899999999999999999997 898886432 222222211 1110 111 112234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.+.+++.+|++.+|++|||++++++.|+++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=272.97 Aligned_cols=236 Identities=24% Similarity=0.354 Sum_probs=178.9
Q ss_pred hhccccCcEEEEEEEEC-CceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
++||+|+||.||+|... +..+|+|.++.... .....|.+|++++++++|+||++++++|...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999874 55899999876543 33456899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 510 ALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 510 ~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
+++..... .+.+...+.++.++ ..+||||||+||+++.++.+||+|||++....... ........++
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGLKQIP 157 (250)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc--cccCCCCCCc
Confidence 99865432 34555554444433 33999999999999999999999999987542211 1111122345
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
..|+|||++.+..++.++||||||++++|+++ |..||...... .... ....+... .........+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~-~~~~~~~~---------~~~~~~~~~~ 223 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QARE-QVEKGYRM---------SCPQKCPDDV 223 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH-HHHcCCCC---------CCCCCCCHHH
Confidence 68999999998899999999999999999998 89898654321 1111 11111100 1111223478
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+++.+|++.+|++||++.|++++|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=280.75 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=184.4
Q ss_pred HhhhhccccCcEEEEEEEECC------------------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG------------------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGY 489 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~------------------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 489 (723)
.+.+.||+|+||.||++...+ ..||+|++.... ....++|.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 456789999999999988632 358999988654 3455789999999999999999999999
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCC---------CCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCC
Q 004935 490 CDEGTNRGLIYEFMANGNLQALLLGEE---------ADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKF 550 (723)
Q Consensus 490 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~ 550 (723)
|..++..++++||+++++|.+++.... ...+.+...+.++. +...+||||||+||+++.++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC
Confidence 999999999999999999999987543 11345555444443 33349999999999999999
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc--CCCccccCcccccHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTHERIHITQW 628 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt--g~~p~~~~~~~~~~~~~ 628 (723)
.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |..|+...... ...+.
T Consensus 168 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-~~~~~ 245 (296)
T cd05051 168 TIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-QVIEN 245 (296)
T ss_pred ceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-HHHHH
Confidence 999999999986532211 122234456778999999988899999999999999999998 66777544321 11222
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.............. .........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 246 ~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 246 AGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22111111111110 0111123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=290.30 Aligned_cols=230 Identities=23% Similarity=0.308 Sum_probs=176.4
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||++.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 46699999987532 233456889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+.+ ...+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTF 155 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccccce
Confidence 9999886542 2232 233444555555999999999999999999999999987532211 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ........ +. ..+... ...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~-~~------~~~p~~----~~~ 220 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM-EE------IRFPRT----LSP 220 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHc-CC------CCCCCC----CCH
Confidence 6899999999999999999999999999999999999999654321 11111111 11 111111 223
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
.+.+++.+|++.+|++|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 577999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=292.87 Aligned_cols=240 Identities=19% Similarity=0.309 Sum_probs=180.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. .++.||||++.... ....+.+..|++++.+++||||+++++++...+..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 357899999999999998 46799999987542 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|+|.+++..... ... +....+..+|+...+||||||+|||++.++.+||+|||+++.... .....
T Consensus 85 g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~ 158 (333)
T cd05600 85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSV 158 (333)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc------ccCCc
Confidence 9999999865421 111 222334444555559999999999999999999999999986532 22345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||+++||++|+.||........... +... ..... .+... ........
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~--~~~~~---~~~~~-~~~~~~s~ 231 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-LKYW--KETLQ---RPVYD-DPRFNLSD 231 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-HHhc--ccccc---CCCCC-ccccccCH
Confidence 689999999999999999999999999999999999999975432211111 1100 00000 11110 00011234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.+.+++.+|+..+|.+||+++++++.
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 67789999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=279.17 Aligned_cols=240 Identities=27% Similarity=0.422 Sum_probs=182.6
Q ss_pred hhhhccccCcEEEEEEEE-------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||++.. ++..+++|.+..........|.+|++++++++|+||+++++++...+..++++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 357899999999999964 2447999998877766677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC-------------CCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccC
Q 004935 503 MANGNLQALLLGEEA-------------DILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGL 559 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~-------------~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGl 559 (723)
+++|+|.+++..... ..+++...+.++.++ ..+||||||+|||+++++.+||+|||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~ 168 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCc
Confidence 999999999875421 235555554443333 339999999999999999999999999
Q ss_pred ccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCc
Q 004935 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 560 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
++....... ........+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... +...........
T Consensus 169 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~~ 243 (280)
T cd05092 169 SRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIECITQGREL 243 (280)
T ss_pred eeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHHHHHcCccC
Confidence 976532211 111222335678999999999999999999999999999998 89888654321 111111111100
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.... .....+.+++.+||+.+|.+||+++||++.|+
T Consensus 244 ------~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 244 ------ERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0001 12235779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.35 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=178.6
Q ss_pred hhccccCcEEEEEEEECC--c--eEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLDG--T--EVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--~--~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.+.+ . .+++|.++... ....+.+.+|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999843 2 57888887543 44556899999999999 899999999999999999999999999
Q ss_pred CCHHHHhccCC--------------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 506 GNLQALLLGEE--------------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 506 gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
|+|.+++.... ...+++...+.++.++ ..+||||||+||++++++.+||+|||+++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986532 1234555544443333 33999999999999999999999999986
Q ss_pred ccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIES 640 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (723)
..... ........+..|+|||++....++.++|||||||+++||++ |..||...... ............
T Consensus 161 ~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~-- 230 (270)
T cd05047 161 GQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLPQGYRL-- 230 (270)
T ss_pred ccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHHHhCCCCC--
Confidence 42211 01111234567999999988889999999999999999997 99998654321 112211111000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.. .......+.+++.+|++.+|.+|||+.++++.|++++
T Consensus 231 ----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ----EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 01 1112235789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=276.87 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=183.6
Q ss_pred HhhhhccccCcEEEEEEEEC--C---ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD--G---TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|... + ..+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 45678999999999999872 2 279999987543 33456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++..... .+++...+.++. +...+||||||+|||++.++.++|+|||+++...........
T Consensus 87 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd05066 87 MENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165 (267)
T ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeee
Confidence 999999999976432 355555544443 333499999999999999999999999999876433221111
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|+|||.+.+..++.++||||||++++|+++ |+.||...... .... ........ + . .
T Consensus 166 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~---~~~~~~~~-----~-~----~ 231 (267)
T cd05066 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIK---AIEEGYRL-----P-A----P 231 (267)
T ss_pred cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHH---HHhCCCcC-----C-C----C
Confidence 122233568999999998899999999999999999887 99998654321 1111 11111000 1 1 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
......+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=274.37 Aligned_cols=237 Identities=27% Similarity=0.425 Sum_probs=179.3
Q ss_pred HhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.+.||+|+||.||+|...+ ..+|+|++..... ...+|.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 356789999999999998854 4899999865432 23578899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++..... .+++...+.++.+ ...+||||||+||++++++.+||+|||+++...... ........
T Consensus 86 L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~ 162 (256)
T cd05059 86 LLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTK 162 (256)
T ss_pred HHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc--ccccCCCC
Confidence 9999875432 3555554444433 334999999999999999999999999987653211 11111222
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. .... ..+. .... ......
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~---~~~~-~~~~-----~~~~----~~~~~~ 228 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EV---VESV-SAGY-----RLYR----PKLAPT 228 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HH---HHHH-HcCC-----cCCC----CCCCCH
Confidence 4457999999999999999999999999999999 78888654321 11 1111 1110 0111 111334
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
.+.+++.+|++.+|++||||.|+++.|
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=278.54 Aligned_cols=241 Identities=22% Similarity=0.382 Sum_probs=179.9
Q ss_pred hhhccccCcEEEEEEEE--CCc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||+|+||.||+|.+ ++. .+++|.+.... .....++..|+..+++++|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence 56899999999999987 343 47888876443 2344678889999999999999999999864 5578899999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++..... .+++...+.++.+++ .+||||||+|||+++++.+||+|||+++....... ....
T Consensus 91 ~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 168 (279)
T cd05111 91 PLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFY 168 (279)
T ss_pred CCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc-cccc
Confidence 99999999975422 345554444444333 39999999999999999999999999987543221 1222
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+ .+..+... ..+..
T Consensus 169 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~--~~~~~------ 235 (279)
T cd05111 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPD----LLEKGERL--AQPQI------ 235 (279)
T ss_pred CCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHHCCCcC--CCCCC------
Confidence 33456778999999998899999999999999999998 99998654321 1111 12222111 11111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
....+.+++.+|+..+|++|||+.|+++.|+.+.+
T Consensus 236 -~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 -CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 12356788999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=272.99 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=175.7
Q ss_pred hhccccCcEEEEEEEEC-----CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEe-cCCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCD-EGTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~~ 504 (723)
+.||+|+||.||+|... ...||+|.+... .....+.+.+|+.++++++||||++++++|. ..+..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999862 237999998643 3345578899999999999999999999875 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc-eee
Q 004935 505 NGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT-HVT 573 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~ 573 (723)
+|+|.+++..... .+.+...+ ..+|+...+||||||+|||+++++.+||+|||+++......... ...
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999875422 12333333 33333344999999999999999999999999997653221100 111
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||+++||++|+ +|+.... ..+.......... +....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~------~~~~~---- 225 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRR------LLQPE---- 225 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHhcCCC------CCCCC----
Confidence 2334567899999998889999999999999999999964 4554332 1222222221111 00111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11236789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=285.15 Aligned_cols=231 Identities=20% Similarity=0.249 Sum_probs=176.1
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 4578999999999999984 6799999986532 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|+|.+++.....- .. +....+..+|+...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------~~~~ 158 (291)
T cd05612 85 GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTL 158 (291)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------cccc
Confidence 99999998754211 11 2223334444444599999999999999999999999999865321 1234
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||+++||++|+.||...... ....... .+.. .+.... ..
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~-~~~~------~~~~~~----~~ 223 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKIL-AGKL------EFPRHL----DL 223 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCc------CCCccC----CH
Confidence 6899999999999888999999999999999999999999754321 1111111 1110 111111 23
Q ss_pred HHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
.+.+++.+|++.||.+||+ ++|+++
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 5679999999999999995 666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.83 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=180.1
Q ss_pred hhhhccccCcEEEEEEEEC--C---ceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc------e
Q 004935 430 FERVLGNGGFGTVYHGYLD--G---TEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN------R 496 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~ 496 (723)
+.+.||+|+||.||+|... + ..||+|+++... ......+.+|++.+++++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999873 2 479999987542 3345679999999999999999999999866554 7
Q ss_pred EEEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 497 GLIYEFMANGNLQALLLGE----EADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
++++||+++|+|..++... ....+++...+.++ |+...+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceee
Confidence 8999999999999988543 22234544433333 333349999999999999999999999999987
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
...... .........+..|+|||.+.+..++.++|||||||+++||++ |..||..... .+........ ..
T Consensus 163 ~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~~-~~--- 233 (273)
T cd05035 163 IYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRHG-NR--- 233 (273)
T ss_pred cccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC-CC---
Confidence 543221 111122335678999999988889999999999999999999 8888865432 1222222111 11
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
+.. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 234 --~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 --LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 112334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.99 Aligned_cols=238 Identities=26% Similarity=0.408 Sum_probs=181.3
Q ss_pred HhhhhccccCcEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.+.||+|+||.||+|...+. .+|+|.+..... ...+|.+|+.++++++||||++++++|......++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 3457899999999999988654 799999875432 34679999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++..... .+++...+.++.+++. +|+||||+||++++++.+||+|||+++...... ........
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~ 162 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSK 162 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--eeecCCCc
Confidence 9999875432 4565555554444333 999999999999999999999999988653221 11112234
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
++..|+|||.+.+..++.++|||||||+++||++ |+.||...... +........... .... ....
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~~----~~~~ 228 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVSQGLRL------YRPH----LASE 228 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHhcCCCC------CCCC----CCCH
Confidence 5678999999988889999999999999999999 99998654321 111111111110 0001 1134
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+.+++.+||+.+|.+||++.++++.|+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 6789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=286.68 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=182.7
Q ss_pred HHHhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC-Cce
Q 004935 427 TNNFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG-TNR 496 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~ 496 (723)
.+.+.+.||+|+||.||+|.. .++.||||+++... ......+.+|+.++.++ +|+||++++++|... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 345678999999999999974 34589999997643 33456788999999999 789999999988654 457
Q ss_pred EEEEEeCCCCCHHHHhccCCC-----------------------------------------------------------
Q 004935 497 GLIYEFMANGNLQALLLGEEA----------------------------------------------------------- 517 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 517 (723)
++||||+++|+|.+++.....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 899999999999999864210
Q ss_pred ------CCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCc
Q 004935 518 ------DILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581 (723)
Q Consensus 518 ------~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~ 581 (723)
..++|...+.++.++ ..+||||||+|||+++++.+||+|||+++....... ........++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCCCCcc
Confidence 124444444444443 339999999999999999999999999986532211 111122345678
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHH
Q 004935 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVE 660 (723)
Q Consensus 582 y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 660 (723)
|+|||.+.+..++.++||||||++++||++ |..|+........+. .....+... ...... ...+.+
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~~-----~~~~~~----~~~~~~ 313 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGTRM-----RAPDYT----TPEMYQ 313 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHHhccCCC-----CCCCCC----CHHHHH
Confidence 999999988899999999999999999997 888886543221111 111121111 011111 235789
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 661 IAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 661 l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
++.+||+.+|++|||+.|+++.|+.+++.
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.32 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=179.0
Q ss_pred hhhhccccCcEEEEEEEECCc----eEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceE
Q 004935 430 FERVLGNGGFGTVYHGYLDGT----EVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~----~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~ 497 (723)
+.+.||+|+||.||+|..... .||+|.++.. .....+.|..|++++++++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999998432 6999988754 344457899999999999999999999988432 2468
Q ss_pred EEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 498 LIYEFMANGNLQALLLGE----EADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
+++|||++|+|.+++... ....+++...+.++ |+...+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccccc
Confidence 999999999999887432 22335555444333 3333499999999999999999999999999876
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........++..|+|||...+..++.++|||||||++|||++ |+.||..... .+.... ...+....
T Consensus 163 ~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~-~~~~~~~~-- 234 (272)
T cd05075 163 YNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDY-LRQGNRLK-- 234 (272)
T ss_pred Ccccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH-HHcCCCCC--
Confidence 43211 111122345678999999999899999999999999999999 7888865322 111121 12221110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
. .......+.+++.+||+.+|++|||+.++++.|++++
T Consensus 235 ---~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 235 ---Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1 1112345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=281.09 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=175.0
Q ss_pred HhhhhccccCcEEEEEEEE---CCceEEEEEecCCCh--hhHHHHHHHHHHHHhc---cCCceeeEEEEEe-----cCCc
Q 004935 429 NFERVLGNGGFGTVYHGYL---DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRI---HHKNLTTLVGYCD-----EGTN 495 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~~~~ 495 (723)
.+.+.||+|+||.||+|.. .+..||+|+++.... .....+.+|+.+++++ +||||++++++|. ....
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 3457899999999999987 245899999865432 2234566788777766 6999999999985 2456
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 496 RGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 496 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
.++|+||++ ++|.+++.......+++.....++.++ ..+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence 889999997 599999876544445555544444333 339999999999999999999999999986532
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--Ccc----
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--DIE---- 639 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~---- 639 (723)
. .......+++.|+|||.+.+..++.++|||||||+++||++|++||........+...+....... ...
T Consensus 163 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 163 Q----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred C----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 2 122345689999999999888999999999999999999999999976544333332222111000 000
Q ss_pred ---cccCCcccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 ---SIVDPRLHE---DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ---~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.-.. .........+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 000112235679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.73 Aligned_cols=243 Identities=28% Similarity=0.442 Sum_probs=183.3
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCC-ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.||+|+||.||++...+ ..+|+|++... ......++.+|++++.++ +|+||++++++|...+..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 45789999999999998632 47999998764 334456789999999999 8999999999999999999999
Q ss_pred EeCCCCCHHHHhccC--------------CCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEe
Q 004935 501 EFMANGNLQALLLGE--------------EADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~D 556 (723)
||+++|+|.+++... ....+++...+.++.+ ...+||||||+||++++++.+||+|
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~D 175 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCc
Confidence 999999999998642 1233555544444433 3339999999999999999999999
Q ss_pred ccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcC
Q 004935 557 FGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 557 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..|+..... .+..... ..
T Consensus 176 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~-~~ 249 (293)
T cd05053 176 FGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----EELFKLL-KE 249 (293)
T ss_pred cccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----HHHHHHH-Hc
Confidence 999987643221 111222335678999999988899999999999999999998 8888864422 1111111 11
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
+... .........+.+++.+|+..+|++||||+|+++.|++++
T Consensus 250 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 250 GYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1100 111122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=267.99 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=186.9
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChh-h-HHHHHHHHHHHHhccCCceeeEEEEEe--cCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ-G-YKQFQAEVELLMRIHHKNLTTLVGYCD--EGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~~~ 505 (723)
+.|++|.||.||+|++ +++.||+|+++..... + .-.-++||.+|.+++|||||.+-.... +-+..+||||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 5799999999999998 4669999999865321 1 124589999999999999999988764 34679999999998
Q ss_pred CCHHHHhccCCCC---------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 506 GNLQALLLGEEAD---------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 506 gsL~~~l~~~~~~---------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|..++...... .++..+.++++|+.-.+|||||++|+|++..|.+||+|||+|+.+... ....+..
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp---~k~~T~l 237 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP---LKPYTPL 237 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC---cccCcce
Confidence 899988765432 245566677777777799999999999999999999999999987543 2334567
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-c-ccccC-C--------
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-I-ESIVD-P-------- 644 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~i~d-~-------- 644 (723)
..|..|+|||.+.+. .|++..|+||+|||+.||+++++.|.+..+.+.+..+++.+-.+.+ + ..... |
T Consensus 238 VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~ 317 (419)
T KOG0663|consen 238 VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFS 317 (419)
T ss_pred EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccC
Confidence 789999999999875 5999999999999999999999999888776666555554322211 0 00000 0
Q ss_pred -----cccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 -----RLHEDFDIN-SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 -----~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.++..+... -...-+++....+..||.+|.|++|.++
T Consensus 318 ~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 318 EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 011111111 1245678899999999999999999886
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=277.09 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=187.5
Q ss_pred HHhhhhccccCcEEEEEEEECC------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV 499 (723)
+.+.+.||+|+||.||+|...+ ..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....+++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 3456889999999999999843 589999987543 3445678999999999999999999999866 5678999
Q ss_pred EEeCCCCCHHHHhccCCC------CCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 500 YEFMANGNLQALLLGEEA------DILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~------~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
+||+++|+|.+++..... ..+.+...+.++.+++. +||||||+||++++++.+||+|||+++.+
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 999999999999865421 45667666665555443 99999999999999999999999999865
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........++..|+|||.+.+..++.++|||||||+++|+++ |+.||..... .++...........
T Consensus 168 ~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~--- 239 (280)
T cd05043 168 FPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKDGYRLA--- 239 (280)
T ss_pred cCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHcCCCCC---
Confidence 33221 111223345678999999988889999999999999999999 9999865422 12222111111110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
. .......+.+++.+|++.+|++|||+.++++.|+++..
T Consensus 240 ---~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 ---Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 11123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=287.75 Aligned_cols=230 Identities=23% Similarity=0.318 Sum_probs=175.0
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||++.. ++..||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999987 46799999987542 234456789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|..++.... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTF 155 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---Cccccc
Confidence 9998886542 233333 3333444444999999999999999999999999987532211 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ . ..+.... ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~~~~~-~------~~~p~~~----~~ 220 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILME-E------IRFPRTL----SP 220 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHhcC-C------CCCCCCC----CH
Confidence 68999999999999999999999999999999999999996543221 11111111 1 1111112 23
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
.+.+++.+|++.+|.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 567999999999999998 7777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=277.56 Aligned_cols=234 Identities=22% Similarity=0.315 Sum_probs=174.5
Q ss_pred ccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||.||++.. +++.||+|.+..... ...+.+..|++++++++|+||+++.+++......++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 467999999875432 2345678999999999999999999999999999999999999999
Q ss_pred HHHhccC--CCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 509 QALLLGE--EADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 509 ~~~l~~~--~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
.+++... ....+++...+.+ +|+...+||||||+||+++.++.+||+|||+++.+.... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---cccccc
Confidence 9887532 2233444444333 333344999999999999999999999999997654321 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||+++||++|+.||................... . ..+ ......
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~------~~~----~~~~~~ 226 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-S------VTY----PDKFSP 226 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-C------CCC----cccCCH
Confidence 68999999999999999999999999999999999999997543322222211111111 0 011 111234
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
.+.+++.+|++.+|++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 577999999999999999 4455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=280.29 Aligned_cols=237 Identities=23% Similarity=0.305 Sum_probs=178.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||++.. +++.||+|++..... .....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 356899999999999987 467999999875432 223567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.......+++..... .+|+...+||||||+||++++++.++|+|||+++...... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~ 159 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIR 159 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----ccc
Confidence 99999888654333345444433 3444444999999999999999999999999998753221 112
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||..........+ +...+.... .......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~ 228 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-VERRVKEDQ----------EEYSEKF 228 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-HHHHhhhcc----------cccCccc
Confidence 34688999999999988899999999999999999999999976433221111 111111110 0111122
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 33577999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=272.74 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=182.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|.. ++..|++|.+... .....+.+.+|++++++++|||++++++++...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 457899999999999988 4679999998643 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.......+.+.....++.+ ...+||||||+||+++.++.+||+|||+++...... .....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~ 160 (256)
T cd08529 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANT 160 (256)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc---chhhc
Confidence 99999997653344555444444433 333999999999999999999999999988764322 12233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..+++.|+|||+..+..++.++|||||||+++||++|+.||...... ....... .+.. +.+.. ...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~-----~~~~~----~~~ 226 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILKII-RGVF-----PPVSQ----MYS 226 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCCC-----CCCcc----ccC
Confidence 46788999999999989999999999999999999999999755421 1111111 1111 11111 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.+++.+|++.+|++||+|.++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=273.55 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=185.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. ++..++||.+... ......+|.+|++++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 4567899999999999996 5779999987653 2334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 504 ANGNLQALLLGE--EADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++++|.+++... ....+++.....++.+ ...+|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---T 161 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC---c
Confidence 999999988642 2234555554444333 333999999999999999999999999987654221 1
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......++..|+|||.+.+..++.++||||||++++||++|..||...... ......... . ...+.+..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~-----~~~~~~~~--- 230 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE-Q-----CDYPPLPS--- 230 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhh-c-----CCCCCCCc---
Confidence 122346888999999998888999999999999999999999998644321 112111111 1 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
......+.+++.+|++.+|++||||.+|++.++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 12334678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=274.82 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=183.8
Q ss_pred HHhhhhccccCcEEEEEEEEC--C---ceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--G---TEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
..+.+.||+|+||.||+|... + ..||||.+... .....++|..|+.++++++||||+++++++..+...++|+|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 345788999999999999873 2 26999998765 34456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++..... .+++...+.++. +...+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 86 FMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred cCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 9999999999875432 345554444443 33349999999999999999999999999886543222111
Q ss_pred eeeccc--CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 572 VTTTIA--GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 572 ~~~~~~--gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
...... .+..|+|||.+.+..++.++|||||||+++|+++ |..||...... ....++. ..... ..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i~---~~~~~------~~-- 232 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIE---QDYRL------PP-- 232 (269)
T ss_pred cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHHH---cCCcC------CC--
Confidence 111111 2457999999999999999999999999999987 99998654321 1222221 11000 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
..+.+..+.+++.+|++.+|++||+|++++..|+.+
T Consensus 233 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 --PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=273.06 Aligned_cols=240 Identities=25% Similarity=0.387 Sum_probs=181.5
Q ss_pred HHhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
..+.+.||+|++|.||+|...+ ..+|+|.+..... ..+.|.+|++++++++|+|++++++++. .+..+++|||+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 3456789999999999999855 4899998865432 3467899999999999999999999875 45688999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......++|...+.++.++ ..+||||||+||++++++.++|+|||+++....... ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 163 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--TARQGA 163 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--cccCCC
Confidence 99999976544445665554444333 339999999999999999999999999976532211 111223
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||...+..++.++||||||++++||+| |+.||....... . ......... +. ......
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~---~~~~~~~~~------~~----~~~~~~ 229 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-V---LEQVERGYR------MP----CPQGCP 229 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-H---HHHHHcCCC------CC----CCcccC
Confidence 45678999999988899999999999999999999 888886543221 1 111111100 01 111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+.+++.+|++.+|.+||++++|++.|++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=273.30 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=173.4
Q ss_pred hhccccCcEEEEEEEECC----ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYLDG----TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||+|...+ ..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998632 379999987654 334457899999999999999999999999999999999999999
Q ss_pred CHHHHhccCC---CCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 507 NLQALLLGEE---ADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 507 sL~~~l~~~~---~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+|.+++.... .....+...+.+ +|+...+||||||+||+++.++++||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce-eecC
Confidence 9999987532 112333332222 3333339999999999999999999999999875432211 1112
Q ss_pred ecccCCCccccccccccC-------CCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 574 TTIAGTPGYLDPEYYISN-------RLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~-------~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
....++..|+|||.+.+. .++.++||||||++++||++ |+.||......... ..... +......++.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~ 234 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYTVR-EQQLKLPKPR 234 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HHHhh-cccCCCCCCc
Confidence 234567889999988542 35789999999999999996 99999654332111 11111 1112222333
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
+..... ..+.+++.+|+ .+|++|||++||++.|+
T Consensus 235 ~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 322222 24567888998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=289.17 Aligned_cols=232 Identities=23% Similarity=0.311 Sum_probs=177.4
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 3467899999999999998 46689999987532 233457899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCC--------CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEADI--------LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~--------l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|+|.+++....... .+....+..+|+...+||||||+|||++.++.+||+|||+++..... ...
T Consensus 101 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------~~~ 174 (329)
T PTZ00263 101 VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------TFT 174 (329)
T ss_pred CCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC------cce
Confidence 9999999987543211 12223344555555599999999999999999999999999865321 123
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.... +..+.. .+.... .
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~-i~~~~~------~~p~~~----~ 239 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEK-ILAGRL------KFPNWF----D 239 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHHH-HhcCCc------CCCCCC----C
Confidence 4689999999999999999999999999999999999999965432 111111 112111 111111 2
Q ss_pred HHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+||+.||.+||+ +++++.
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 25679999999999999997 566653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=278.24 Aligned_cols=240 Identities=30% Similarity=0.451 Sum_probs=181.1
Q ss_pred hhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.||+|++|.||+|...+ ..|++|.+.... ......|..|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 5789999999999998843 478999887543 33456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCC-----CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC---cEEEEeccCccccC
Q 004935 503 MANGNLQALLLGEE-----ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF---QAKIADFGLSRTFP 564 (723)
Q Consensus 503 ~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~---~~kl~DfGla~~~~ 564 (723)
+++|+|.+++.... ...++|...+.++.+++ .+||||||+||+++.++ .+||+|||+++...
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 99999999986542 12466666665555444 39999999999998654 69999999998753
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
.... .........+..|+|||.+.+..++.++|||||||+++||++ |+.||...... +...........
T Consensus 171 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~----- 240 (277)
T cd05036 171 RASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVTGGGRL----- 240 (277)
T ss_pred Cccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCCcC-----
Confidence 2111 111112233568999999998899999999999999999997 99998754321 222222111111
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 241 -----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 241 -----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0111123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=274.73 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=183.2
Q ss_pred HHhhhhccccCcEEEEEEEE------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGL 498 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 498 (723)
+...+.||+|+||.||++.. .+..||+|.++... ......+.+|++++++++|+|++++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 34457899999999999975 35589999987553 34456799999999999999999999998775 56789
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
||||+++++|.+++..... .++|..++.++.++ ..+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 9999999999999865422 34555544444333 339999999999999999999999999987643322
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc-----------ccccHHHHHHHHhcCCC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH-----------ERIHITQWVSFMLGKGD 637 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~-----------~~~~~~~~~~~~~~~~~ 637 (723)
.........++..|+|||.+.+..++.++|||||||+++||+|++.|..... ........+.. ...+.
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LEEGK 243 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HHcCc
Confidence 1122233456778999999988889999999999999999999876643211 00111111111 11111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.. .........+.+++.+|++.+|.+||+++++++.|++++
T Consensus 244 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 244 RL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred cC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 00 011123347889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=273.52 Aligned_cols=244 Identities=28% Similarity=0.388 Sum_probs=184.4
Q ss_pred HHHHHHhhhhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 424 LRITNNFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 424 ~~~t~~f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
...+..+.+.||+|+||.||+|.. +++.||+|.+..... ...+|.+|+.++++++|+|++++++++. .+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 344556678999999999999998 456999999875543 3467899999999999999999999874 4578999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++.......+++...+.++.++ ..+||||||+||++++++.++|+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--YTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC--ccc
Confidence 999999999876544445555444433332 23999999999999999999999999997754221 111
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||..... .+...... .+.. .....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~-~~~~-----~~~~~--- 226 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLE-RGYR-----MPRPD--- 226 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHH-cCCC-----CCCCC---
Confidence 223345678999999988889999999999999999999 9999865432 11122111 1100 01111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.....+.+++.+|++.+|++||++++++..|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 122368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=278.10 Aligned_cols=248 Identities=18% Similarity=0.219 Sum_probs=177.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+++.. +..||+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 4578999999999999984 5689999987542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+.+..+.... ..+++... +..+|+...+||||||+||+++.++.+||+|||+++....... .....
T Consensus 85 ~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 160 (287)
T cd07848 85 NMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTE 160 (287)
T ss_pred CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--ccccc
Confidence 8777654332 12333322 3333333449999999999999999999999999987643211 11233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH-----------HHhcCCCcccccCC
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS-----------FMLGKGDIESIVDP 644 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~i~d~ 644 (723)
..+++.|+|||.+.+..++.++|||||||+++||++|+.||.............. .............+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 5689999999999988899999999999999999999999976543222211111 00001001111011
Q ss_pred cccCCC------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDF------DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...... .......+.+++.+|++.+|++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110000 0112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=286.27 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=174.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. ++..||||++... ......++.+|++++++++||||+++++++... ...++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 457899999999999997 4679999998743 223446789999999999999999999988543 2479999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
|||. ++|.+++.... .+++... +..+|+...+||||||+|||++.++.+||+|||+++.........
T Consensus 84 e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 84 ELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred ecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 9996 68988886542 2333333 344444444999999999999999999999999998653322212
Q ss_pred eeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC-----------C
Q 004935 571 HVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG-----------D 637 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 637 (723)
.......+++.|+|||.+.+ ..++.++|||||||+++||+||+.||........ ...+....... .
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhhhhh
Confidence 22234568999999999865 6789999999999999999999999965432111 11111111000 0
Q ss_pred cccc---cCC----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 638 IESI---VDP----RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 638 ~~~i---~d~----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.... +.+ .+.... ......+.+++.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000 000000 0112356799999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=275.37 Aligned_cols=247 Identities=25% Similarity=0.437 Sum_probs=184.9
Q ss_pred HhhhhccccCcEEEEEEEEC------CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD------GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 499 (723)
.+.+.||+|+||.||+|..+ +..||||++...... ..+.|.+|++++++++|+||+++++++.. ....+++
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 44578999999999999873 458999999866543 56789999999999999999999999977 5678999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+||+++++|.+++..... .+++...+.++.+ ...+||||||+||+++.++.++|+|||++.........
T Consensus 87 ~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165 (284)
T ss_pred EecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence 999999999999976432 3455544444333 33399999999999999999999999999876532221
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc-----------cHHHHHHHHhcCCCc
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI-----------HITQWVSFMLGKGDI 638 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-----------~~~~~~~~~~~~~~~ 638 (723)
........++..|+|||.+.+..++.++||||||++++||+||+.|+....... ....+.. .+..+.
T Consensus 166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 243 (284)
T cd05038 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKEGE- 243 (284)
T ss_pred eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HHHcCC-
Confidence 122222345567999999988899999999999999999999999876432211 0111111 111111
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
...........+.+++.+|++.+|++||||+||+++|+.+
T Consensus 244 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 --------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred --------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0001112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=272.51 Aligned_cols=243 Identities=22% Similarity=0.352 Sum_probs=183.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|+. +++.||||.+... .......|.+|++++++++||||+++++++...+..++++||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 467899999999999987 5679999987642 23344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC--CCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 505 NGNLQALLLGE--EADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 505 ~gsL~~~l~~~--~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+|+|.+++... ....++.... +..+|+...+||||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~ 162 (267)
T cd08228 86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TA 162 (267)
T ss_pred CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh---HH
Confidence 99999888532 1222333322 333333334999999999999999999999999988754221 11
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....+.... .... .+.. ...
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~-~~~~-----~~~~---~~~ 231 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKI-EQCD-----YPPL---PTE 231 (267)
T ss_pred HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHHHHH-hcCC-----CCCC---Chh
Confidence 1234578899999999888899999999999999999999999864322 222222221 1111 1111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 2234678999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.02 Aligned_cols=222 Identities=25% Similarity=0.367 Sum_probs=174.9
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhh---HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||.|+||+|..++. .+.-+|+|++++...-. .+...+|..+|+.+.||.+++|.+.|.+.+..+|||||+++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 46899999999999987 46699999998765433 34567899999999999999999999999999999999999
Q ss_pred CCHHHHhccCC----CCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEE----ADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~----~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|-|..++++.. ..+.-.+..+..|++..| ++|||||+|||||.+|.+||.|||.|+... ..+...+
T Consensus 129 GElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~------~rT~TlC 202 (355)
T KOG0616|consen 129 GELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS------GRTWTLC 202 (355)
T ss_pred ccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec------CcEEEec
Confidence 99999998742 223334445555555554 999999999999999999999999999863 2356789
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..+..++|-|||||++|||+.|.+||..... +..+-+....+-.....+ . ..
T Consensus 203 GTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP~~f--------s----~~ 267 (355)
T KOG0616|consen 203 GTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFPSYF--------S----SD 267 (355)
T ss_pred CCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCCccc--------C----HH
Confidence 99999999999999999999999999999999999999986654 222222222221111111 1 24
Q ss_pred HHHHHHhccCCCCCCC
Q 004935 658 TVEIAMACVSQTSTKR 673 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~R 673 (723)
+.+|+...++.|-.+|
T Consensus 268 ~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHhhhhHhh
Confidence 4577777777777777
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=279.76 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=183.4
Q ss_pred HhhhhccccCcEEEEEEEEC--Cc--eEEEEEecCC-ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GT--EVAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|... +. .+++|.+... .....++|.+|++++.++ +|+||+++++++...+..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 34678999999999999873 33 4688877654 334556889999999999 899999999999999999999999
Q ss_pred CCCCCHHHHhccCC--------------CCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEecc
Q 004935 503 MANGNLQALLLGEE--------------ADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 503 ~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
+++|+|.+++.... ...+++...+.++ |+...+||||||+|||+++++.+||+|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccc
Confidence 99999999986532 1234444444433 33334999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
+++...... .......+..|+|||.+.+..++.++|||||||+++||+| |..||...... +...... .+.
T Consensus 170 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~-~~~ 240 (303)
T cd05088 170 LSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLP-QGY 240 (303)
T ss_pred cCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHHHh-cCC
Confidence 986432110 1111234567999999988889999999999999999998 99998644321 1111111 110
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
+. .........+.+++.+|++.+|++||+++++++.|++++.....-
T Consensus 241 -------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 241 -------RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred -------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 00 011112235789999999999999999999999999887666543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.78 Aligned_cols=241 Identities=27% Similarity=0.427 Sum_probs=182.9
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|...+ ..||+|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 45789999999999998742 479999987553 3445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC--------CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 502 FMANGNLQALLLGEE--------ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 502 y~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
|+++|+|.+++.... ...+.|...+.++.++ ..+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~ 169 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhh
Confidence 999999999986532 1234555544444433 3399999999999999999999999999865
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........++..|+|||.+.+..++.++|||||||+++|++| |+.||...... +...... .+...
T Consensus 170 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~~-~~~~~--- 240 (277)
T cd05032 170 YETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFVI-DGGHL--- 240 (277)
T ss_pred ccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHHh-cCCCC---
Confidence 43221 112233446788999999988889999999999999999998 88888643321 1111111 11111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..... ....+.+++.+|++.+|++|||+.++++.|++
T Consensus 241 --~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 241 --DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 23467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=277.01 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=181.1
Q ss_pred HhhhhccccCcEEEEEEEEC------------------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD------------------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGY 489 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 489 (723)
.+.+.||+|+||.||++... +..||+|++.... .....+|.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34678999999999998532 2368999997653 3445689999999999999999999999
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCCC---------CCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCC
Q 004935 490 CDEGTNRGLIYEFMANGNLQALLLGEEA---------DILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKF 550 (723)
Q Consensus 490 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~ 550 (723)
+...+..++||||+++|+|.+++..... ..+++...+.++.+ ...+||||||+|||++.++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC
Confidence 9999999999999999999999875421 23444444444433 3349999999999999999
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc--CCCccccCcccccHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT--SKSVIERTHERIHITQW 628 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt--g~~p~~~~~~~~~~~~~ 628 (723)
.++|+|||+++.+..... ........++..|++||...++.++.++|||||||++|||++ |..|+........ ...
T Consensus 168 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~-~~~ 245 (296)
T cd05095 168 TIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-IEN 245 (296)
T ss_pred CEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH-HHH
Confidence 999999999986532211 111122334678999999888889999999999999999998 6678764432211 111
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.......... ....+. .......+.+++.+|++.+|.+||+|.+|++.|++
T Consensus 246 ~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 246 TGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111110 000111 11123577899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=285.79 Aligned_cols=230 Identities=23% Similarity=0.320 Sum_probs=175.7
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||++.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999987 46799999997542 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+.+... +..+|....+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---AATMKTF 155 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc---ccccccc
Confidence 9998886542 2333333 33334444499999999999999999999999998753221 1122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+........ . ..+.... ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~~~-~------~~~p~~~----~~ 220 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME-D------IKFPRTL----SA 220 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHHhccC-C------ccCCCCC----CH
Confidence 689999999999988999999999999999999999999965432 1212211111 1 1111112 23
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
.+.+++.+|++.+|++|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 567899999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.42 Aligned_cols=239 Identities=28% Similarity=0.451 Sum_probs=180.6
Q ss_pred hhccccCcEEEEEEEECC--------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 432 RVLGNGGFGTVYHGYLDG--------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.||+|+||.||+|+..+ ..+|+|.+.... ......|.+|++++++++||||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998742 469999886543 23456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCC-----CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC-----cEEEEeccCccc
Q 004935 503 MANGNLQALLLGEE-----ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF-----QAKIADFGLSRT 562 (723)
Q Consensus 503 ~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~-----~~kl~DfGla~~ 562 (723)
+++|+|.+++.... ...++|...+.++.+++ .+|+||||+||+++.+. .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 99999999987531 23356666555554433 39999999999999877 899999999976
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
...... ........++..|+|||.+.+..++.++|||||||+++||+| |+.||...... +...........
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~~--- 232 (269)
T cd05044 161 IYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHVTAGGRL--- 232 (269)
T ss_pred cccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHHhcCCcc---
Confidence 532211 111223345678999999999999999999999999999998 99998644321 111111111100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 -------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111223467899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=258.20 Aligned_cols=232 Identities=26% Similarity=0.362 Sum_probs=186.4
Q ss_pred hhhhccccCcEEEEEEEECC--ceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|.||.||.|+.+. ..||+|++.+.. .+..+++.+|+++-+.++||||+++++|+.+....+|++||.+
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 46899999999999999854 489999987643 2345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC------CCCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGE------EADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~------~~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|.|...|... +...-....++.-|+..++ |||||||+|+|++.++..||+|||-+..-+ .....
T Consensus 106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-----~~kR~ 180 (281)
T KOG0580|consen 106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SNKRK 180 (281)
T ss_pred CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-----CCCce
Confidence 99999999843 2233344455555555555 999999999999999999999999987643 22335
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..+||.-|.|||...+...+.++|+|++|++.+|++.|.+||..........+..+ .++.+| ...
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--------~~~~~p-------~~i 245 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--------VDLKFP-------STI 245 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--------ccccCC-------ccc
Confidence 67899999999999999999999999999999999999999987653333222222 111222 122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|+..+|.+|.+..||++
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhh
Confidence 335679999999999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=279.75 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=175.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|.. +++.||||++..... .....+.+|++++++++||||+++++++......++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 3467899999999999998 467999999875432 223467899999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCC-----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 506 GNLQALLLGEEAD-----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 506 gsL~~~l~~~~~~-----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
++|.+++...... +. +....+..+|+...+||||||+|||+++++.+||+|||+++...... ......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 163 (303)
T cd07869 87 TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---HTYSNE 163 (303)
T ss_pred cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---ccCCCC
Confidence 5787777643211 11 22233444455555999999999999999999999999987542211 122335
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc---cc-----ccCC-cc
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI---ES-----IVDP-RL 646 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-----i~d~-~l 646 (723)
.+++.|+|||.+.+ ..++.++||||+||+++||++|+.||..........+.+......... .. ..++ .+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 67899999998865 458899999999999999999999997653322222212111111000 00 0000 00
Q ss_pred c--CCCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 H--EDFDIN-------SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~--~~~~~~-------~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ...... ....+.+++.+|++.+|++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 000000 1235679999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=272.29 Aligned_cols=239 Identities=21% Similarity=0.373 Sum_probs=190.6
Q ss_pred HHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 424 LRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 424 ~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
++-.+.|.+.||+|.||+|-+|.. .|+.||||.+++.. .++.-.+.+|+++|..++||||+.++.+|.+.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345567788999999999999976 68899999998754 3445568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC----CCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 499 IYEFMANGNLQALLLGEE----ADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||||..+|.|.+++..+. .+.-.+.+++..|+.++| +|||||.+|||||+++++||+|||++-.+.. .
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~----~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD----K 206 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----c
Confidence 999999999999998753 233344445555555555 9999999999999999999999999987642 3
Q ss_pred eeeecccCCCccccccccccCCCC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.....++|++-|.+||...+..|. +.+|-||+||+||.|+.|..||++..- ...+++ +..|...+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQ-Is~GaYrE--------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQ-ISRGAYRE--------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHH-hhcccccC---------
Confidence 345678999999999999998885 789999999999999999999987543 222322 22222211
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
++.+....-++.+++..+|++|.|+.+|...
T Consensus 273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 --PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1122245678999999999999999998763
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=273.46 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=184.5
Q ss_pred HHhhhhccccCcEEEEEEEECC-----ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
..+.+.||+|+||.||+|...+ ..|+||...... ....+.|.+|+.++++++|+||++++++|.. ...++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3456789999999999998732 269999987655 4456789999999999999999999999875 45789999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++..... .+.+...+.++.++ ..+||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~ 163 (270)
T cd05056 87 LAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES--YY 163 (270)
T ss_pred cCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc--ce
Confidence 9999999999975432 35555554444333 33999999999999999999999999998654321 11
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......++..|+|||.+....++.++||||||++++|+++ |+.||........ .... ..+.. .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~----~~~~~-----~~~~~-- 231 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRI----ENGER-----LPMPP-- 231 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH----HcCCc-----CCCCC--
Confidence 1222334568999999988889999999999999999986 9999875543211 1111 11110 01111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.....+.+++.+|+..+|.+|||+.++++.|+++...+
T Consensus 232 --~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 232 --NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 12346789999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=275.71 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=176.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. ++..||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 457899999999999988 466999999875432 2345678999999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+.+ ...+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 88 ~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---~~~~~~ 163 (288)
T cd07871 88 DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---KTYSNE 163 (288)
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---ccccCc
Confidence 89988865422 2222 233444444445999999999999999999999999997643221 112334
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----------CCcccccCC
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----------GDIESIVDP 644 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~i~d~ 644 (723)
.+++.|+|||.+.+ ..++.++||||+||+++||+||+.||........+....+..-.. ........+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 67899999998865 568999999999999999999999997654322222221111000 000111111
Q ss_pred cccCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDF----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...... .........+++.+|++.+|.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110000 0011235679999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=295.65 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=178.6
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--------ce
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--------NR 496 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------~~ 496 (723)
.+.+.||+|+||.||+|.. +++.||||++... .......+.+|+..+..++|+|++++...+...+ ..
T Consensus 35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 4467899999999999987 5779999998654 3344567899999999999999999988764432 25
Q ss_pred EEEEEeCCCCCHHHHhccCC--CCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccC
Q 004935 497 GLIYEFMANGNLQALLLGEE--ADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFP 564 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 564 (723)
++||||+++|+|.+++.... ...+.... .+..+|....+||||||+|||++.++.+||+|||+++.+.
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~ 194 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence 79999999999999986532 22333332 3333444444999999999999999999999999998754
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+..... +...
T Consensus 195 ~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----~~~~~~~~~~-~~~~----- 263 (496)
T PTZ00283 195 ATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLA-GRYD----- 263 (496)
T ss_pred cccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHhc-CCCC-----
Confidence 3221 122334578999999999999999999999999999999999999997542 2222222221 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.. .....+.+++.+||+.+|.+||++.++++
T Consensus 264 ~~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 264 PLPP----SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111 12346789999999999999999999876
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.46 Aligned_cols=232 Identities=24% Similarity=0.362 Sum_probs=176.0
Q ss_pred hhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 432 RVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.||+|+||.||+++. .++.||||++.... ......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999986 35689999987532 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 503 MANGNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|+|.+++...... . .+....+..+|+...+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 158 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTH 158 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---Cccc
Confidence 9999999998654221 1 122334455555555999999999999999999999999987542221 1223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...|++.|+|||.+.+..++.++|||||||+++||++|+.||...... +...... .+.. .+... .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~-~~~~------~~~~~----~ 223 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTIDKIL-KGKL------NLPPY----L 223 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHH-cCCC------CCCCC----C
Confidence 456899999999999888999999999999999999999999754322 1122221 1111 11111 1
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 23567999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=271.79 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=183.9
Q ss_pred HhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.+.||+|+||.||+|...+ ..||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++++
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 446789999999999998854 5899999876443 34679999999999999999999999999899999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.......+.+...+.++.++ ..+|+||||+||++++++.+||+|||+++.+.... ........
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~ 165 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAK 165 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh--hhhhhccC
Confidence 9999987654456665554444333 33999999999999999999999999988754211 11111223
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.+..|+|||.+.+..++.++||||||++++|+++ |+.||........ ......... ... +.....
T Consensus 166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----~~~~~~~~~------~~~----~~~~~~ 231 (261)
T cd05034 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV----LEQVERGYR------MPR----PPNCPE 231 (261)
T ss_pred CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCCC------CCC----CCCCCH
Confidence 4568999999998889999999999999999999 9999865432211 111111100 000 111134
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.+.+++.+|++.+|++||+++++.+.|++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=276.36 Aligned_cols=241 Identities=31% Similarity=0.455 Sum_probs=180.9
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||++... +..||+|++.... ....++|.+|+.++++++|+||++++++|..+...++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 3578999999999999863 4589999987653 3445679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC--------------------CCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCc
Q 004935 502 FMANGNLQALLLGEEA--------------------DILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQ 551 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~--------------------~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~ 551 (723)
|+++|+|.+++..... ..+.+...+.++.++ ..+||||||+||++++++.
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~ 168 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV 168 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCc
Confidence 9999999999864311 123444444443333 3399999999999999999
Q ss_pred EEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHH
Q 004935 552 AKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVS 630 (723)
Q Consensus 552 ~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~ 630 (723)
+||+|||+++....... .........+..|+|||.+.+..++.++|||||||+++||++ |..||..... .+...
T Consensus 169 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----~~~~~ 243 (288)
T cd05050 169 VKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----EEVIY 243 (288)
T ss_pred eEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 99999999876432211 111122234667999999998899999999999999999997 8888764322 22222
Q ss_pred HHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 631 FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
. ...+.... ... .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 244 ~-~~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 Y-VRDGNVLS-----CPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-HhcCCCCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2 22222111 111 123468899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=267.64 Aligned_cols=238 Identities=31% Similarity=0.452 Sum_probs=185.3
Q ss_pred hhccccCcEEEEEEEEC-----CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|... +..|++|.++..... ..+.+.+|++.+++++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999985 569999999876543 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 506 GNLQALLLGEE-------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 506 gsL~~~l~~~~-------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
++|.+++.... ...+++.....++.+++ .+||||||+||++++++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 99999997652 23456655555444433 39999999999999999999999999987654321
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
........++..|+|||.+....++.++||||+|++++||++ |+.||..... .+....... +.. ...
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~-~~~-----~~~- 228 (262)
T cd00192 161 -YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRK-GYR-----LPK- 228 (262)
T ss_pred -cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc-CCC-----CCC-
Confidence 122334557889999999988899999999999999999999 5888876532 122222211 110 011
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 ---PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.87 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=181.3
Q ss_pred HHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 345678999999999999753 2379999987543 23345688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCC--------CCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 500 YEFMANGNLQALLLGEE--------ADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
|||+++|+|.+++.... .....+... +..+|+...+||||||+||++++++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccc
Confidence 99999999999996531 112233222 333344444999999999999999999999999998
Q ss_pred ccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIES 640 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (723)
....... ........++..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+........+ ..
T Consensus 168 ~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~-~~- 240 (288)
T cd05061 168 DIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFVMDGG-YL- 240 (288)
T ss_pred ccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCC-CC-
Confidence 6532221 111122234678999999998899999999999999999998 7888864322 12222222111 11
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.... .....+.+++.+|++.+|++|||+.++++.|++.+
T Consensus 241 ----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 ----DQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 12346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=282.65 Aligned_cols=230 Identities=20% Similarity=0.313 Sum_probs=171.7
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||++.. +++.||+|+++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 4568999998754 223445678899998877 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|..++..... +.+. ..+..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTST 155 (329)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---Ccccc
Confidence 999988865422 2222 23334444444999999999999999999999999987532211 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc----cccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE----RIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
..||..|+|||.+.+..++.++|||||||+++||++|+.||..... ......++......... .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~--- 226 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR--- 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC---
Confidence 5789999999999999999999999999999999999999963211 11222233222222111 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
.....+.+++.+|++.+|++||+.
T Consensus 227 -~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 -SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122356799999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=274.07 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=181.2
Q ss_pred hhhhccccCcEEEEEEEE--CCc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.. ++. .||+|++.... ....+++.+|+.+++.++|+||++++++|.. ...++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 357899999999999986 333 48999987543 3445678999999999999999999999975 457799999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++..... .+.+...+.++.+++ .+||||||+|||+++++.+||+|||+++....... ...
T Consensus 90 ~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~-~~~ 167 (279)
T cd05109 90 MPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET-EYH 167 (279)
T ss_pred CCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc-eee
Confidence 999999999876432 344444444444333 39999999999999999999999999987643221 111
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|+|||...+..++.++|||||||++|||++ |..|+...... .+..++. .+... .. .
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~-----~~----~ 233 (279)
T cd05109 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE----KGERL-----PQ----P 233 (279)
T ss_pred cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH----CCCcC-----CC----C
Confidence 122334678999999998899999999999999999998 88888654321 1222221 11110 00 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
......+.+++.+|++.+|++||++.++++.|+++....
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 112346789999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.67 Aligned_cols=234 Identities=24% Similarity=0.285 Sum_probs=176.8
Q ss_pred HHhhhhccccCcEEEEEEEEC--C-ceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--G-TEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~-~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.+.||+|+||.||+|... + ..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 345688999999999999863 2 479999986432 2334578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+++|+|.+++.....- .. +....+..+|+...+||||||+|||++.++.+||+|||+++..... .
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~------~ 185 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------T 185 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC------c
Confidence 99999999998764321 11 1222334444555599999999999999999999999999865321 1
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ..... +..+.. .+.....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~-i~~~~~------~~p~~~~-- 252 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQK-ILEGII------YFPKFLD-- 252 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHHH-HhcCCC------CCCCCCC--
Confidence 2356899999999999888999999999999999999999999754321 11111 111111 1111111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRP-----TMNQVVME 682 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~ 682 (723)
..+.+++.+|++.+|++|+ +++++++.
T Consensus 253 --~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 253 --NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2467999999999999995 78877653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=285.33 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=193.6
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc-eEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN-RGLIYEF 502 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~Ey 502 (723)
+...+.+|+|+||.++..+. ++..+++|.+.... ....+....|+.++++++|||||.+.+.+.+++. .++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 34567899999999987766 56699999987543 3334568999999999999999999999988888 9999999
Q ss_pred CCCCCHHHHhccCC------CCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEE------ADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~------~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
++||+|.+.+.... ..+..|..++..++...| +|||||+.||+++.+..+||+|||+|+.+.... ..
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~---~~ 162 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED---SL 162 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch---hh
Confidence 99999999987653 345678777777777666 999999999999999999999999999986443 24
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....||+.|++||.+.+.+|..|+||||+||+++||++-+++|...+....+.+..+... . ..+.
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~---------~-----Plp~ 228 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY---------S-----PLPS 228 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC---------C-----CCCc
Confidence 5567899999999999999999999999999999999999999987654333333222221 1 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+..++..|++.+|..||++.+++..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 234467789999999999999999999987
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=281.51 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=188.8
Q ss_pred HHHHHhhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC
Q 004935 425 RITNNFERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG 493 (723)
Q Consensus 425 ~~t~~f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 493 (723)
...+.+.+.||+|+||.||++... +..||+|.+.... ....+++.+|+++++++ +|+||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 344556789999999999999752 1268999887543 34457899999999999 899999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCC
Q 004935 494 TNRGLIYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGK 549 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~ 549 (723)
+..++++||+++|+|.+++.... ...+.|...+.++.+++ .+||||||+|||++++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999987531 23456655555444443 3999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQW 628 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~ 628 (723)
+.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+++||++ |..||..... .+.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~ 245 (334)
T cd05100 171 NVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----EEL 245 (334)
T ss_pred CcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHH
Confidence 9999999999986532211 111122334567999999999999999999999999999998 8888865422 222
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
..... .+.... ........+.+++.+|++.+|.+||+|.|+++.|+++.....
T Consensus 246 ~~~~~-~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 246 FKLLK-EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHH-cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 22221 111110 111223467899999999999999999999999999885543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.82 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=185.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 3567899999999999998 4779999988642 2333567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 504 ANGNLQALLLGE--EADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++|+|.+++... ....+.+...+.++ |+...+||||||+||+++.++.++|+|||+++...... .
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---T 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC---c
Confidence 999999988642 22334444443333 33334999999999999999999999999987653221 1
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......++..|+|||.+.+..++.++|||||||+++||++|+.|+..... ...+..... ..+... ... .
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~-----~~~---~ 230 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKI-EKCDYP-----PLP---A 230 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhh-hcCCCC-----CCC---h
Confidence 12234578899999999888899999999999999999999999864331 222222211 111111 111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
......+.+++.+|+..+|++||++.+++++|+++
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 12334678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=302.09 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=183.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. .++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 357899999999999988 46799999987542 2335679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC---------CCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 505 NGNLQALLLGEE---------ADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 505 ~gsL~~~l~~~~---------~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
+|+|.+++.... ....++...+ ..+|+...+||||||+|||++.++.+||+|||+++....
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~ 165 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence 999999886420 1123333333 333444449999999999999999999999999987521
Q ss_pred CCCC---------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH
Q 004935 566 EGSG---------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS 630 (723)
Q Consensus 566 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~ 630 (723)
.... ........||+.|+|||.+.+..++.++|||||||+++||+||+.||........ . ..
T Consensus 166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-~--~~ 242 (932)
T PRK13184 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-S--YR 242 (932)
T ss_pred ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-h--hh
Confidence 1100 0111234689999999999999999999999999999999999999965322110 0 00
Q ss_pred HHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhh
Q 004935 631 FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRP-TMNQVVMELNESLAI 689 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~~~ 689 (723)
.. + .++.-... ..+....+.+++.+|++.+|++|| +++++++.|+..++.
T Consensus 243 ~~-----i---~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 243 DV-----I---LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh-----c---cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 01100000 011234577999999999999995 688888888887764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.78 Aligned_cols=246 Identities=29% Similarity=0.413 Sum_probs=182.9
Q ss_pred HhhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceE
Q 004935 429 NFERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 497 (723)
.+.+.||+|+||.||++... ...+|+|+++... ......+..|+++++++ +|+||++++++|......+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 35688999999999999752 3369999987543 34456789999999999 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEE
Q 004935 498 LIYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~k 553 (723)
+++||+++|+|.+++.... ...++|...+.++.+ ...+||||||+|||++.++.+|
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~k 174 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEE
Confidence 9999999999999996532 123555544443333 3339999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHH
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~ 632 (723)
|+|||+++........ .......++..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+... .
T Consensus 175 L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~-~ 248 (314)
T cd05099 175 IADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----EELFK-L 248 (314)
T ss_pred Eccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----HHHHH-H
Confidence 9999999865422110 11111234467999999988889999999999999999999 8888864322 11111 1
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
...+.... ........+.+++.+|++.+|++||++.++++.|+++...
T Consensus 249 ~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 249 LREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111110 1112233677999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.01 Aligned_cols=227 Identities=26% Similarity=0.376 Sum_probs=170.4
Q ss_pred hccccCcEEEEEEEEC--------------------------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeE
Q 004935 433 VLGNGGFGTVYHGYLD--------------------------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 486 (723)
.||+|+||.||+|.+. ...|++|++..........|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999751 12589999876655555678999999999999999999
Q ss_pred EEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC------
Q 004935 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF------ 550 (723)
Q Consensus 487 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~------ 550 (723)
+++|......++||||+++|+|..++.... ..+.+..++.++.+++ .+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 999999999999999999999999986532 2345555555544443 39999999999998643
Q ss_pred -cEEEEeccCccccCCCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHH-cCCCccccCcccccHHH
Q 004935 551 -QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEII-TSKSVIERTHERIHITQ 627 (723)
Q Consensus 551 -~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~ell-tg~~p~~~~~~~~~~~~ 627 (723)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+...... ....
T Consensus 161 ~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~ 232 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-EKER 232 (274)
T ss_pred ceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-HHHH
Confidence 3899999988653211 12346788999998865 56899999999999999995 789888654321 1111
Q ss_pred HHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 628 WVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 628 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
... .. ..+.... ...+.+++.+||+.+|++||||+++++.|
T Consensus 233 ~~~---~~--------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 FYE---KK--------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---hc--------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 00 0111111 12578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.21 Aligned_cols=229 Identities=23% Similarity=0.369 Sum_probs=171.2
Q ss_pred hhccccCcEEEEEEEECC--------------ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceE
Q 004935 432 RVLGNGGFGTVYHGYLDG--------------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 497 (723)
+.||+|+||.||+|+... ..|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998521 258999987665555667899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCc-------EEEEeccCc
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQ-------AKIADFGLS 560 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~-------~kl~DfGla 560 (723)
+||||+++|+|..++..... .+++...+.++.+++ .+||||||+|||++.++. +|++|||++
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 99999999999998865422 345554444444333 399999999999987654 899999998
Q ss_pred cccCCCCCCceeeecccCCCccccccccc-cCCCCChhhHHHHHHHHHHHH-cCCCccccCcccccHHHHHHHHhcCCCc
Q 004935 561 RTFPVEGSGTHVTTTIAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEII-TSKSVIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 561 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SfGvvL~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+..... .+... .. .+..
T Consensus 160 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~-~~-~~~~ 226 (262)
T cd05077 160 ITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AEKER-FY-EGQC 226 (262)
T ss_pred ccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hHHHH-HH-hcCc
Confidence 764211 2235778899999886 466899999999999999998 57777754321 11111 11 1110
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
... . .....+.+++.+||+.+|.+||+++++++.|+
T Consensus 227 -~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 -MLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -cCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 11235789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=268.56 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=185.8
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEec--CCChhhHHHHHHHHHHHHhccCCceeeEEEEEec-----CCceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLS--PSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-----GTNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~lV~E 501 (723)
.+.||+|++|.|+.+.. ++..||||++. -......++-.+|+++|+.++|+||+.+...+.. -+..++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 35799999999999988 56799999987 3455566888999999999999999999998754 457899999
Q ss_pred eCCCCCHHHHhccCCCC--------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEAD--------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~--------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+|+. +|.+.++..... ..+..+.++..|++..+||||||+|+|++.+...||+|||+|+..... ......
T Consensus 107 lMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~m 184 (359)
T KOG0660|consen 107 LMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFM 184 (359)
T ss_pred HHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-Ccccch
Confidence 9954 899988765411 245667778888888899999999999999999999999999987543 223344
Q ss_pred ecccCCCccccccccc-cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---ccccc-------
Q 004935 574 TTIAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIV------- 642 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~-~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~------- 642 (723)
+....|..|+|||.+. ...|+...||||.||||.||++|++-|.+...-.. .+.+...++... +..+-
T Consensus 185 TeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~lI~~~lGtP~~e~l~~i~s~~ar~y 263 (359)
T KOG0660|consen 185 TEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQLILELLGTPSEEDLQKIRSEKARPY 263 (359)
T ss_pred hcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHHHHHhcCCCCHHHHHHhccHHHHHH
Confidence 6667899999999875 56799999999999999999999998876543211 122222222111 00000
Q ss_pred -C--CcccC-C---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 -D--PRLHE-D---FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 -d--~~l~~-~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. |.... . .-+..-...+++..+++..||.+|+|++|+++
T Consensus 264 i~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 264 IKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000 0 00122335689999999999999999999886
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=274.61 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=178.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. ++..||+|++... .....+.|.+|++++++++||||+++++++...+..++|+||+++|
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 457899999999999987 5668999998654 3344567999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcc
Q 004935 507 NLQALLLGEEADI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582 (723)
Q Consensus 507 sL~~~l~~~~~~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y 582 (723)
+|..+........ .+....+..+|+...+|+||||+|||++.++.+||+|||++...... ......++..|
T Consensus 85 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y 159 (279)
T cd06619 85 SLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAY 159 (279)
T ss_pred ChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----cccCCCCChhh
Confidence 9976543221111 12233344555555599999999999999999999999999765321 12335688999
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccccc---HHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 583 LDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH---ITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 583 ~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
+|||.+.+..++.++||||||++++||++|+.||........ ..+......... .+.+... .....+.
T Consensus 160 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~ 230 (279)
T cd06619 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLPVG---QFSEKFV 230 (279)
T ss_pred cCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCCCC---cCCHHHH
Confidence 999999998999999999999999999999999965332111 111111111110 1111111 1123577
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+++.+|++.+|.+||+++|+++.
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=269.85 Aligned_cols=234 Identities=26% Similarity=0.412 Sum_probs=179.1
Q ss_pred HhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.+.||+|+||.||++...++.||+|+++... ....+.+|+.++++++|+|++++++++... ..++||||+++|+|
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 456789999999999999999999999987543 235789999999999999999999998654 47999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+.+...+.++.+ ...+||||||+||+++.++.+||+|||+++..... ......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~ 159 (254)
T cd05083 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG------VDNSKL 159 (254)
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc------CCCCCC
Confidence 99997654444555544443333 33399999999999999999999999998764221 112234
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+... ....+... + ........
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~-~~~~~~~~---~------~~~~~~~~ 225 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKE-CVEKGYRM---E------PPEGCPAD 225 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHH-HHhCCCCC---C------CCCcCCHH
Confidence 568999999988899999999999999999997 8988865432 11111 11111100 0 01122346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.+++.+|++.+|.+||+++++++.|++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=283.00 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=176.7
Q ss_pred hhhhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.||+|+||.||+++. .++.||+|++.... ....+.+..|++++.++ +|+||+++++++...+..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 457899999999999876 35689999986432 22345688999999999 599999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 500 YEFMANGNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|||+++|+|.+++..... ... +....+..+|+...+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~--~ 161 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--E 161 (332)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC--C
Confidence 999999999999865422 111 223334445555559999999999999999999999999986532221 1
Q ss_pred eeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......||+.|+|||.+.+. .++.++|||||||+++||+||+.||................... ++.+....
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 234 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-------DPPFPSFI 234 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-------CCCCCCCC
Confidence 22345689999999998865 47889999999999999999999997544332322222222211 12222211
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++++++
T Consensus 235 ----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 235 ----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 23567999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=276.63 Aligned_cols=234 Identities=21% Similarity=0.310 Sum_probs=179.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
..+.||+|++|.||+|.. +++.|++|.+..........+.+|+.+++.++|+|++++++++......++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 346799999999999987 467999999987665556788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++... .+.+...+. .+|+...+||||||+||+++.++.+||+|||++....... .......
T Consensus 104 L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 177 (296)
T cd06654 104 LTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMV 177 (296)
T ss_pred HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc---cccCccc
Confidence 99998643 234433333 3333344999999999999999999999999987653221 1122346
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+++.|+|||.+.+..++.++|||||||+++||++|+.||........+. . ....+ . +.+. ........
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---~-~~~~~-~-----~~~~--~~~~~~~~ 245 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---L-IATNG-T-----PELQ--NPEKLSAI 245 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---H-HhcCC-C-----CCCC--CccccCHH
Confidence 8889999999998889999999999999999999999996543221111 1 11111 0 0110 01112245
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+++.+|+..+|++||++.++++
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhh
Confidence 778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=267.90 Aligned_cols=239 Identities=23% Similarity=0.383 Sum_probs=177.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||+|++|.||++.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 57899999999999987 46799999986432 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC----CCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEAD----ILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~----~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++++|.+++...... ...+. ..+..+|+...+||||||+||++++++.++|+|||+++..............
T Consensus 87 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (263)
T cd06625 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166 (263)
T ss_pred CCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccC
Confidence 999999988654221 11222 2233344444499999999999999999999999999765332111111123
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...... .+.+.. ...
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~-~~~~~~-----~~~~~~----~~~ 233 (263)
T cd06625 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFK-IATQPT-----NPQLPS----HVS 233 (263)
T ss_pred CCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHH-HhccCC-----CCCCCc----cCC
Confidence 45778999999999989999999999999999999999998654221 11111 111110 011111 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.+++.+|+..+|.+|||+.++++.
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 357799999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=271.71 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=178.3
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|.. +++.||+|++..........+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 34567899999999999997 5668999999766545556788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... .+++.. .+..+|+...+||||||+||++++++.+||+|||+++...... .....
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---~~~~~ 165 (267)
T cd06646 91 GSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI---AKRKS 165 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc---cccCc
Confidence 99999886432 233333 2333444444999999999999999999999999998653221 11223
Q ss_pred ccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 576 IAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 576 ~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
..++..|+|||.+. ...++.++|||||||+++||++|+.|+........... .... ....+.+.. ..
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-----~~~~---~~~~~~~~~--~~ 235 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-----MSKS---NFQPPKLKD--KT 235 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-----eecC---CCCCCCCcc--cc
Confidence 46788999999874 34578899999999999999999999854322111000 0000 001111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+.+++.+|++.+|++||+++++++.
T Consensus 236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 123467899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.55 Aligned_cols=241 Identities=29% Similarity=0.426 Sum_probs=181.7
Q ss_pred HHHhhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...+.+.||+|+||.||+|... +..+++|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 3455788999999999999874 4589999887543 234678999999999999999999999887 778999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+++...+.++.+++ .+||||||+||+++.++.+||+|||.+....... ......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 162 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREG 162 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC--cccccC
Confidence 9999999765444455554444333332 2999999999999999999999999997653221 111222
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+....++.++|||||||+++|++| |+.||...... ..... +..+... + . ....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~----~~~~~~~----~-~----~~~~ 228 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA----LERGYRM----P-R----PENC 228 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHH----HhCCCCC----C-C----cccC
Confidence 345678999999998889999999999999999999 88888654321 11111 1111100 0 0 1112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=265.91 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=178.4
Q ss_pred hhccccCcEEEEEEEEC-CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+.||+|+||.||++... ++.|++|.+...... ....|.+|+++++++.|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999985 679999998765443 5578999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 510 ALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 510 ~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
+++..... .+++... +..+|+...+||||||+||+++.++.+||+|||+++....... .........+
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~ 158 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIP 158 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eeccccCcce
Confidence 99865422 2333333 3333444449999999999999999999999999976531110 0111122345
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
..|+|||.+.+..++.++|||||||+++||+| |..||....... ... ...... . . .........+
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-~~~----~~~~~~--~---~----~~~~~~~~~~ 224 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRE----RIESGY--R---M----PAPQLCPEEI 224 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-HHH----HHhcCC--C---C----CCCccCCHHH
Confidence 67999999988899999999999999999999 788876543211 111 111110 0 0 0111223468
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+++.+|++.+|.+|||+.|+++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 89999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=281.12 Aligned_cols=230 Identities=25% Similarity=0.333 Sum_probs=173.7
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|+.. ++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999984 5689999987542 23345678899999876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|..++.... .+.+.. .+..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTT 155 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---ccccc
Confidence 99998886542 233322 3334444444999999999999999999999999987542211 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ . ...|. . ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~i~~~-~---~~~p~---~----~~ 220 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFESILHD-D---VLYPV---W----LS 220 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHHHHcC-C---CCCCC---C----CC
Confidence 568999999999998899999999999999999999999997654322 11212111 1 00111 1 12
Q ss_pred HHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRP-------TMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RP-------sm~evl~ 681 (723)
..+.+++.+|++.+|++|| +++++++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3567999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=273.32 Aligned_cols=229 Identities=22% Similarity=0.364 Sum_probs=172.2
Q ss_pred hhccccCcEEEEEEEEC---------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 432 RVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.||+|+||.||+|... ...|++|.+........+.|.+|+.+++.++|+|++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999863 225888888766555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCc--------EEEEeccCccccC
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQ--------AKIADFGLSRTFP 564 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~--------~kl~DfGla~~~~ 564 (723)
+++|+|.+++..... .+++...+.++.++ ..+||||||+||+++.++. ++++|||++....
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999976532 34555444444333 3399999999999987765 6999999887542
Q ss_pred CCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHHHHHHhcCCCccccc
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
. .....++..|+|||.+.+ ..++.++|||||||+++||++|. .|+...... ..........
T Consensus 160 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~------ 222 (258)
T cd05078 160 P-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQFYEDRH------ 222 (258)
T ss_pred C-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHHHHHccc------
Confidence 1 123457889999999876 45799999999999999999995 454432211 1111111110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+.. .....+.+++.+|++.+|++|||++++++.|+
T Consensus 223 --~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 --QLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --cCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111 11235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.29 Aligned_cols=235 Identities=23% Similarity=0.337 Sum_probs=175.5
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
..||+|+||.||+|... +..|++|.+........+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999873 4589999988777667788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCC-CCH----------HHHHHHHHhccccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 510 ALLLGEEADI-LSW----------EGRLRIAIEAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 510 ~~l~~~~~~~-l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+++....... ..+ ...+..+|+...+||||||+||+++. ++.+||+|||++....... .......
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~ 170 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFT 170 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC---CccccCC
Confidence 9987542111 122 22333444444499999999999986 6799999999987653221 1122345
Q ss_pred CCCccccccccccCC--CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 578 GTPGYLDPEYYISNR--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 578 gt~~y~aPE~~~~~~--~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
++..|+|||.+.... ++.++||||||++++||++|+.|+....... ...+...... ..+.+ +....
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------~~~~~----~~~~~ 238 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMFKVGMFK-------IHPEI----PESLS 238 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-hhHhhhhhhc-------cCCCC----CcccC
Confidence 788999999986643 7899999999999999999999986432211 1111000000 01111 11223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|++|||+.|++.
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 35779999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.42 Aligned_cols=235 Identities=20% Similarity=0.308 Sum_probs=175.2
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||++.. ++..||+|+++... ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999998 46699999997542 23345688999999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... .+.+... +..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTST 155 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC---Ccccc
Confidence 99998886532 2333333 333344444999999999999999999999999987532111 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc----cccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE----RIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||+.... ......+.......... .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~-- 227 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRS-- 227 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCC--
Confidence 5789999999999999999999999999999999999999963221 11222333322222211 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPT------MNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPs------m~evl~ 681 (723)
....+.+++.+|++.+|.+||+ ++++++
T Consensus 228 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 --LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1235779999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.47 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=171.0
Q ss_pred hccccCcEEEEEEEEC----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLD----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||+|+||.||+|... ...+++|.+.... ......|.+|+++++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999762 2378899876543 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC---CCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 508 LQALLLGEEA---DILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 508 L~~~l~~~~~---~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|.+++..... ....+... +..+|+...+||||||+|||+++++.+||+|||+++....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh-eeccC
Confidence 9999876421 22223322 3333333449999999999999999999999999875432211 11112
Q ss_pred cccCCCcccccccccc-------CCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 575 TIAGTPGYLDPEYYIS-------NRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-------~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
...++..|+|||.+.. ..++.++|||||||++|||++ |..||........ ......... ..+.++.+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~ 235 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----LKQVVREQD-IKLPKPQL 235 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHhhccC-ccCCCCcc
Confidence 3345678999998642 356889999999999999999 7778765432211 112222211 11222222
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.... ...+.+++..|+ .+|++|||+++|++.|.
T Consensus 236 ~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 DLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222 234557778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=273.81 Aligned_cols=233 Identities=23% Similarity=0.303 Sum_probs=175.9
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|.. +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 46799999999999998 466999999875432 2334578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+.+...+.++.++ ..+||||||+||++++++.+||+|||++....... ....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~ 160 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRG 160 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----cccC
Confidence 999988865443345555544444333 33999999999999999999999999987653211 1223
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|+..|+|||.+.+..++.++|||||||+++||++|+.||...........+.. ...... ...... ..
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-~~~~~~------~~~~~~----~~ 229 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-RVLETE------EVYSAK----FS 229 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhhccc------cccCcc----CC
Confidence 4689999999999988999999999999999999999999975433222112111 111111 011111 22
Q ss_pred HHHHHHHHhccCCCCCCCCCHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~e 678 (723)
..+.+++.+|++.+|++||++.+
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 230 EEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred HHHHHHHHHHccCCHhHcCCCcc
Confidence 35679999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=283.22 Aligned_cols=230 Identities=23% Similarity=0.312 Sum_probs=175.4
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||++.. ++..||+|++.... ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56799999987532 233456789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCH----------HHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEEADILSW----------EGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~----------~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|..++.... .+.+ ...+..+|+ ...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKT 155 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---ccccc
Confidence 9998886542 2333 233444454 345999999999999999999999999987542221 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++|||||||+++||+||+.||...... +...... ... ..+.... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~-~~~------~~~p~~~----~ 220 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL-MEE------IRFPRTL----S 220 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHHh-cCC------CCCCCCC----C
Confidence 56899999999999999999999999999999999999999654321 1111111 111 1111111 2
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
..+.+++.+|++.+|++|+ +++++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 3567999999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=289.60 Aligned_cols=241 Identities=20% Similarity=0.318 Sum_probs=173.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|.. ++..||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46899999999999988 45699999997542 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----CCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC--------
Q 004935 506 GNLQALLLGEEAD----ILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-------- 569 (723)
Q Consensus 506 gsL~~~l~~~~~~----~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------- 569 (723)
|+|.+++...... ...+. ..+..+|....+||||||+|||++.++++||+|||+++.+......
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~ 165 (381)
T cd05626 86 GDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165 (381)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccc
Confidence 9999998654211 11122 2344444445599999999999999999999999998643110000
Q ss_pred ------------------------------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC
Q 004935 570 ------------------------------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613 (723)
Q Consensus 570 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~ 613 (723)
........||+.|+|||.+.+..++.++|||||||+++||+||+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~ 245 (381)
T cd05626 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245 (381)
T ss_pred ccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCC
Confidence 00012346999999999999888999999999999999999999
Q ss_pred CccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHh--ccCCCCCCCCCHHHHHHH
Q 004935 614 SVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMA--CVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 614 ~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPsm~evl~~ 682 (723)
.||........... ......... -+. ..... ..+.+++.+ |+..++.+||++.+++..
T Consensus 246 ~Pf~~~~~~~~~~~---i~~~~~~~~---~~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 246 PPFLAPTPTETQLK---VINWENTLH---IPP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCcCCCHHHHHHH---HHccccccC---CCC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99975432211111 111011100 000 00112 245566665 666777789999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=293.42 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=192.4
Q ss_pred hhhccccCcEEEEEEEE--CCc----eEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.++||.|+||+||||.+ +++ +||+|++... ..+..++|+.|+-+|.+++|||+++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 46899999999999988 333 7999998765 4456789999999999999999999999998776 88999999
Q ss_pred CCCCHHHHhccCCC-----CCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 504 ANGNLQALLLGEEA-----DILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 504 ~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+.|+|.++++.+.. ..+.|.-++.-++.+.+ |||||.++|||+..-..+||.|||+++.+..++. .....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~-ey~~~ 858 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK-EYSAP 858 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc-ccccc
Confidence 99999999987533 23455444443333333 9999999999999999999999999999876654 23333
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...-.+.|||-|.+....++.++|||||||.+||++| |..|+++.... -+...++.++ +-..++.
T Consensus 859 ~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----eI~dlle~ge---------RLsqPpi 924 (1177)
T KOG1025|consen 859 GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----EIPDLLEKGE---------RLSQPPI 924 (1177)
T ss_pred ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----HhhHHHhccc---------cCCCCCC
Confidence 4456678999999999999999999999999999998 88898765421 1222232322 1122334
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+...+..++.+||..|+..||+++++...+.+.+..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 556788999999999999999999999999887643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=279.91 Aligned_cols=231 Identities=23% Similarity=0.310 Sum_probs=171.4
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|... ++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 5589999987532 22334566777777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++...... . .+....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Ccccccc
Confidence 9999988654221 1 122233444555555999999999999999999999999997643221 2233456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ .+.+... ....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~-------~~~~~~~----~~~~ 222 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSILND-------RPHFPRW----ISKE 222 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcC-------CCCCCCC----CCHH
Confidence 899999999999989999999999999999999999999754331 111211111 0111111 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
+.+++.+|++.+|++||++.+.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 67899999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=277.18 Aligned_cols=247 Identities=17% Similarity=0.228 Sum_probs=176.6
Q ss_pred hhhhcccc--CcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNG--GFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.++||+| +|++||++.. ++..||+|++.... ....+.+.+|+++++.++||||++++++|...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999988 46799999987542 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce--
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH-- 571 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-- 571 (723)
++|+|.+++.......+++...+.++.+ ...+||||||+|||++.++.++++||+.............
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 9999999997654344555544444333 3339999999999999999999999987554321111000
Q ss_pred --eeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc-----
Q 004935 572 --VTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV----- 642 (723)
Q Consensus 572 --~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~----- 642 (723)
......++..|+|||.+.+ ..++.++|||||||+++||++|+.||.............. +......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 236 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-----GTVPCLLDTTTI 236 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-----CCccccccccch
Confidence 1122346778999999876 4589999999999999999999999975432211111111 0000000
Q ss_pred --------------CCccc-----------------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 --------------DPRLH-----------------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 --------------d~~l~-----------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+..+. ..........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 0011122346789999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=269.37 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=178.5
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
...+.||+|+||.||+|... +..+++|.+........+.+.+|++++++++|+|++++++++...+..++|+||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34578999999999999984 4588999987766666778999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|..++.... ..+++.....+ +|+...+||||||+||+++.++.+||+|||++...... .......
T Consensus 88 ~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~ 163 (282)
T cd06643 88 AVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQRRDSF 163 (282)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc---ccccccc
Confidence 9998876432 23455444443 33434499999999999999999999999998764321 1122345
Q ss_pred cCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 577 AGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 577 ~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.++..|+|||.+. +..++.++|||||||++|||++|+.||...... +.+...... ....+..+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~------- 231 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKS-EPPTLAQP------- 231 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHhhc-CCCCCCCc-------
Confidence 6889999999974 345788999999999999999999998654321 111111111 10011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112236789999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=280.36 Aligned_cols=227 Identities=26% Similarity=0.335 Sum_probs=171.2
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|+.. ++.||||++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 6689999987532 23345678899998877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++...... .. +....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---Ccccccc
Confidence 9999988654221 11 12233344444444999999999999999999999999987542211 1223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +....... +.. .+... ....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~-~~~------~~~~~----~~~~ 222 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILN-DEV------VYPTW----LSQD 222 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhc-CCC------CCCCC----CCHH
Confidence 899999999999889999999999999999999999999755322 22222211 111 11111 1235
Q ss_pred HHHHHHhccCCCCCCCCCH
Q 004935 658 TVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm 676 (723)
+.+++.+|++.+|.+||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 6799999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=280.35 Aligned_cols=227 Identities=24% Similarity=0.328 Sum_probs=169.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHH---HhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELL---MRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.. +++.||||+++... ....+.+..|++++ ++++||||+++++++..++..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 357899999999999988 46799999997532 22334566676655 56689999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|..++... .+++... +..+|+...+||||||+|||++.++.+||+|||+++...... .
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---~ 156 (324)
T cd05589 83 YAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---D 156 (324)
T ss_pred CCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC---C
Confidence 99999999888653 2344333 333444444999999999999999999999999987532211 1
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......|++.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ . +.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~-~------~~~p~~-- 223 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFDSIVND-E------VRYPRF-- 223 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC-C------CCCCCC--
Confidence 223457899999999999999999999999999999999999999754322 111111111 1 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
....+.+++.+|++.+|.+||++.
T Consensus 224 --~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 224 --LSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCC
Confidence 123567999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=270.85 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=183.8
Q ss_pred HhhhhccccCcEEEEEEEEC--Cc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||+|... +. .+|+|.+.... ......+.+|+.++++++|+||++++++|.. ...++|+|
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 34578999999999999873 22 68999887654 3445679999999999999999999999987 78899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++..... .+++...+.++.+++ .+||||||+||++++++.+||+|||+++....... ..
T Consensus 89 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~ 166 (279)
T cd05057 89 LMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-EY 166 (279)
T ss_pred cCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc-ce
Confidence 9999999999876432 245555444444333 39999999999999999999999999987643221 11
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......++..|+|||.+....++.++||||||++++|+++ |+.||..... .++.... ..+.. .-.+.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~-~~~~~--~~~~~----- 234 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLL-EKGER--LPQPP----- 234 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHH-hCCCC--CCCCC-----
Confidence 1112234568999999988889999999999999999999 9999875432 1222211 12111 00011
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.+...+.+++.+||..+|.+||++.++++.|++++..
T Consensus 235 --~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 235 --ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1223577999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.38 Aligned_cols=227 Identities=25% Similarity=0.368 Sum_probs=171.6
Q ss_pred hhccccCcEEEEEEEECCc------------eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 432 RVLGNGGFGTVYHGYLDGT------------EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.||+|+||.||+|.+.+. .|++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999998433 4788887655433 6789999999999999999999999988 778999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCC-------cEEEEeccCccc
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKF-------QAKIADFGLSRT 562 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~-------~~kl~DfGla~~ 562 (723)
+||+++|+|.+++..... .+++..++.++.++ ..+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999876432 34554444444333 339999999999999887 799999999986
Q ss_pred cCCCCCCceeeecccCCCccccccccccC--CCCChhhHHHHHHHHHHHHcC-CCccccCcccccHHHHHHHHhcCCCcc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISN--RLTEKSDVYNFGVVLLEIITS-KSVIERTHERIHITQWVSFMLGKGDIE 639 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SfGvvL~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 639 (723)
... .....++..|+|||++.+. .++.++|||||||+++||++| ..|+...... .+.........
T Consensus 158 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~~~~~-- 224 (259)
T cd05037 158 VLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQDQHR-- 224 (259)
T ss_pred ccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHhcCCC--
Confidence 532 1223466789999998876 789999999999999999994 6666544211 11111111110
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 640 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
+.. .....+.+++.+|+..+|.+|||+.++++.|+
T Consensus 225 ------~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 ------LPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------CCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 01147789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.35 Aligned_cols=229 Identities=24% Similarity=0.346 Sum_probs=171.4
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|... ++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999984 5689999987542 22345567788888765 999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... .+++... +..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCT 155 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---Cceee
Confidence 99999987532 2333322 333444444999999999999999999999999987532211 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +...... .. .+.+.... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~-~~------~~~~~~~~----~ 220 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIR-MD------NPCYPRWL----T 220 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hC------CCCCCccC----C
Confidence 56899999999999989999999999999999999999999754321 1111111 11 01111111 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHH-HHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMN-QVV 680 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~-evl 680 (723)
..+.+++.+|++.+|++||++. ++.
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 2567899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.69 Aligned_cols=230 Identities=25% Similarity=0.324 Sum_probs=174.2
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||++... +..||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999984 5689999987542 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|..++.... .+++... +..+|+...+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTST 155 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---Ccccc
Confidence 99998886542 2344333 333344444999999999999999999999999987532211 12233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|+..|+|||.+.+..++.++|||||||+++||++|+.||..... .+........ . ..+... ..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i~~~-~------~~~~~~----~~ 220 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DELFQSILED-E------VRYPRW----LS 220 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcC-C------CCCCCc----CC
Confidence 4689999999999999999999999999999999999999975432 1111211111 1 111111 22
Q ss_pred HHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTM-----NQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm-----~evl~ 681 (723)
..+.+++.+|++.+|.+||++ .++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 357899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=269.04 Aligned_cols=234 Identities=24% Similarity=0.357 Sum_probs=179.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+...+.||+|+||.||+|.. .+..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 34457899999999999987 45689999987543 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++... .+.+..... .+|+...+|+||+|+||++++++.++|+|||++..+.... ....
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---~~~~ 159 (277)
T cd06642 86 GGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRN 159 (277)
T ss_pred CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---hhhh
Confidence 99999988653 233333333 3333344999999999999999999999999997654221 1122
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.+..++.++|||||||+++||++|+.|+........ .. ....+. .+.+.+ ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~-~~~~~~-----~~~~~~----~~ 225 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----LF-LIPKNS-----PPTLEG----QY 225 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----Hh-hhhcCC-----CCCCCc----cc
Confidence 34578899999999988999999999999999999999999864432111 11 111111 111211 23
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++||+|.++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 346789999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=266.01 Aligned_cols=239 Identities=22% Similarity=0.355 Sum_probs=179.1
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 44568899999999999988 4669999998876555566788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... .++.. ..+..+|+...+|+||||+||+++.++.+||+|||++...... ......
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~ 165 (267)
T cd06645 91 GSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---IAKRKS 165 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---cccccc
Confidence 99999886542 23333 3334444444599999999999999999999999998765321 112234
Q ss_pred ccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 576 IAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 576 ~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
..|+..|+|||.+. ...++.++|||||||+++||++|+.|+........... .. .... ..+.+....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~----~~-~~~~---~~~~~~~~~-- 235 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MT-KSNF---QPPKLKDKM-- 235 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh----hh-ccCC---CCCcccccC--
Confidence 56889999999874 45688999999999999999999999864432111111 11 1110 011111100
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++||+++++++
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11235679999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=266.89 Aligned_cols=236 Identities=24% Similarity=0.411 Sum_probs=175.4
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC------CceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG------TNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------~~~~lV 499 (723)
...+.||+|+||.||+|.. .++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...+++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 3457899999999999988 45689999986543 3346788999999998 799999999998653 457899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++.......+++.....++.++ ..+||||||+||++++++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-- 165 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-- 165 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc--
Confidence 999999999999886544455655444444333 33999999999999999999999999998653211
Q ss_pred ceeeecccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.|+...... .... ...........+.
T Consensus 166 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~--~~~~~~~~~~~~~ 239 (272)
T cd06637 166 -GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALF--LIPRNPAPRLKSK 239 (272)
T ss_pred -ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHH--HHhcCCCCCCCCC
Confidence 1223456889999999986 335788999999999999999999998643321 1111 1111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|.+|||+.++++
T Consensus 240 --------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 240 --------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 12235789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=270.61 Aligned_cols=239 Identities=25% Similarity=0.323 Sum_probs=181.5
Q ss_pred HHhhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||++... +..||+|++.... ....+++.+|+++++.++|+||+++++++...+..++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 445688999999999999984 6789999886543 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+++|.+++.... .+.+... +..+|+ ...+||||||+||++++++.++|+|||++...... ..
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-----~~ 159 (284)
T cd06620 87 CGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-----IA 159 (284)
T ss_pred CCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-----cc
Confidence 999999886542 2333333 223333 23499999999999999999999999998754221 11
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc-------ccHHHHHHHHhcCCCcccccCCcc
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER-------IHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
....++..|+|||.+.+..++.++|||||||+++||+||+.||...... ..+..+........ .+.+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC
Confidence 2346889999999998889999999999999999999999999754321 11122222222111 1111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.. .+....+.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 234 PS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred Cc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 1133467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=262.89 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=185.6
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChh--hHHHHHHHHHHHHhccCCc-eeeEEEEEecCC------ceEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKN-LTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------~~~lV 499 (723)
.++||+|.||+||+|+. +|..||+|+++..... ......+|+.+|++++|+| ||.|++++...+ ..+||
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 45699999999999987 6779999999765432 2345689999999999999 999999998877 78899
Q ss_pred EEeCCCCCHHHHhccCCC--------CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 500 YEFMANGNLQALLLGEEA--------DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~--------~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+||++. +|..++..... .+. +....+..+|+...+||||||+|||++++|.+||+|||+|+.....
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip- 173 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP- 173 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC-
Confidence 999987 89998876432 122 2334455555666699999999999999999999999999976432
Q ss_pred CCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-----cccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-----IESI 641 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~i 641 (723)
....+...+|..|+|||.+.+. .|+...||||+|||+.||+++++-|.+..+...+....+..-.++. ....
T Consensus 174 --~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 174 --MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred --cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 2224456788999999999887 6999999999999999999999999887765444444443322211 1111
Q ss_pred cCC--cccCCC---CH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 642 VDP--RLHEDF---DI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 642 ~d~--~l~~~~---~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.+- ...... +. .-.....+++.+|++.+|.+|.|++.++..
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 111111 00 011357899999999999999999999885
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.46 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=176.6
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||++.. .++.||+|.+.... ....+.+.+|+.++++++|++++++++.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 46799999999999988 46699999986542 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+.....+.+ +|+...+||||||+||++++++.++|+|||++....... ....
T Consensus 85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~ 160 (285)
T cd05630 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKG 160 (285)
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----cccC
Confidence 99999886543333444333333 333333999999999999999999999999987653221 1123
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..|+..|+|||.+.+..++.++|||||||+++||++|+.||........... ........ . ...... ..
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~~--~----~~~~~~----~~ 229 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEV--Q----EEYSEK----FS 229 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhhh--h----hhcCcc----CC
Confidence 4689999999999998999999999999999999999999975432211111 11111110 0 011111 22
Q ss_pred HHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+|++.+|++||| ++|+++
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 35679999999999999999 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=265.40 Aligned_cols=241 Identities=21% Similarity=0.307 Sum_probs=172.6
Q ss_pred hccccCcEEEEEEEEC-Cc---eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLD-GT---EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~-~~---~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||+|+||.||+|... +. .+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999762 22 56777776543 3455789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC--CCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 508 LQALLLGEEA--DILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 508 L~~~l~~~~~--~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|.+++..... ....+ ...+..+|+...+||||||+|||++.++.+||+|||++........ ......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-hhcccC
Confidence 9999875421 11222 2233444444449999999999999999999999999864321110 111223
Q ss_pred ccCCCcccccccccc-------CCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 576 IAGTPGYLDPEYYIS-------NRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-------~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
..++..|+|||++.. ..++.++|||||||+++||++ |..|+..... .+........ ......++.+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~-~~~~~~~~~~~ 235 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNHVIKD-QQVKLFKPQLE 235 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhh-cccccCCCccC
Confidence 457889999998743 245789999999999999997 4667754332 1222222222 22333444444
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
..+. ..+.+++..|+ .+|.+||++++|++.|.
T Consensus 236 ~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333 35667888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=286.92 Aligned_cols=240 Identities=21% Similarity=0.294 Sum_probs=179.8
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... ++.||||++.... ......+..|++++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 4578999999999999985 7799999987542 2344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC--------
Q 004935 505 NGNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-------- 568 (723)
Q Consensus 505 ~gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-------- 568 (723)
+|+|.+++...... . .+....+..+|....+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 164 (350)
T cd05573 85 GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164 (350)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccc
Confidence 99999998765211 1 1222334444444459999999999999999999999999987543220
Q ss_pred ------------------CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH
Q 004935 569 ------------------GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS 630 (723)
Q Consensus 569 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~ 630 (723)
.........||+.|+|||.+.+..++.++|||||||+|+||++|+.||....... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----~~~ 240 (350)
T cd05573 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE----TYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH----HHH
Confidence 0011234568999999999999999999999999999999999999997654211 111
Q ss_pred HHhc-CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 004935 631 FMLG-KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPT-MNQVVME 682 (723)
Q Consensus 631 ~~~~-~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~evl~~ 682 (723)
.... .... .-|... . ....+.+++.+|+. +|.+||+ ++++++.
T Consensus 241 ~i~~~~~~~---~~p~~~-~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 241 KIINWKESL---RFPPDP-P----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHhccCCcc---cCCCCC-C----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111 0000 001110 0 23357789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=265.87 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=179.1
Q ss_pred hhhhccccCcEEEEEEEECC---ceEEEEEecCC----------ChhhHHHHHHHHHHHHh-ccCCceeeEEEEEecCCc
Q 004935 430 FERVLGNGGFGTVYHGYLDG---TEVAVKMLSPS----------SAQGYKQFQAEVELLMR-IHHKNLTTLVGYCDEGTN 495 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~ 495 (723)
+.+.||+|+||.||+|...+ ..+|+|.+... ......++..|+.++.+ ++|+||+++++++...+.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45789999999999999854 58999987532 22234567889998875 799999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHhcc-----------ccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 496 RGLIYEFMANGNLQALLLGE--EADILSWEGRLRIAIEAA-----------KVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 496 ~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~~a-----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
.+++|||+++++|.+++... ....+++...+.++.+++ .+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceee
Confidence 99999999999999987542 223344444443333221 28999999999999999999999999987
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .+.....
T Consensus 164 ~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~- 233 (269)
T cd08528 164 KQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSLATKIV-EAVYEPL- 233 (269)
T ss_pred ccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHHHHHHh-hccCCcC-
Confidence 53221 23345688899999999988899999999999999999999999864422 11111111 1111111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
... .....+.+++.+|++.+|++||++.||.+++++
T Consensus 234 ---~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 234 ---PEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---Ccc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 011 122367899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=272.31 Aligned_cols=242 Identities=20% Similarity=0.302 Sum_probs=177.1
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||++... +..+|+|.+.... .....++.+|++++++++||||++++++|...+..++|+||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 3578999999999999884 5688999887543 334467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHH----------HHHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEEADILSWE----------GRLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~----------~~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|.+++..... +.+. ..+..+|+. ..+||||||+|||++.++.+||+|||++...... ....
T Consensus 85 ~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~ 157 (308)
T cd06615 85 SLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANS 157 (308)
T ss_pred cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----cccc
Confidence 99999876422 2222 233344432 3499999999999999999999999998765321 1233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccc---------------
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES--------------- 640 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 640 (723)
..++..|+|||.+.+..++.++|||||||+++||++|+.||..... .....+............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 5688899999999888899999999999999999999999864321 111111111000000000
Q ss_pred -----c-------cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 641 -----I-------VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 641 -----i-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
. ..+.+... .....+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000 122357899999999999999999998875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=284.95 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=177.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 3457899999999999988 4669999998643 2233456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC---C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 504 ANGNLQALLLGEEAD---I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~---~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
++|+|.+++...... . .+....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 126 ~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~--~~~~~~~ 203 (370)
T cd05596 126 PGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG--MVRCDTA 203 (370)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC--cccCCCC
Confidence 999999998754211 1 122233444555555999999999999999999999999998653221 1122345
Q ss_pred cCCCccccccccccC----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 577 AGTPGYLDPEYYISN----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ........... .+ .+.. ..
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~--~~---~~~~--~~ 272 (370)
T cd05596 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIMDHKN--SL---TFPD--DI 272 (370)
T ss_pred CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCC--cC---CCCC--cC
Confidence 699999999998653 4789999999999999999999999764321 11111111100 00 0111 01
Q ss_pred HHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTK--RPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~ 682 (723)
.....+.+++.+|++.+|.+ ||++.|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 12346678999999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=289.31 Aligned_cols=243 Identities=17% Similarity=0.277 Sum_probs=168.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC--------CceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--------TNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~~~lV 499 (723)
+.+.||+|+||.||+|.. .++.||||++.... ....+|+.+|++++|+||+++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 467899999999999998 46699999886432 2345799999999999999999876432 235689
Q ss_pred EEeCCCCCHHHHhccC--CCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCC
Q 004935 500 YEFMANGNLQALLLGE--EADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVE 566 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~--~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~ 566 (723)
|||+++ +|.+++... ....+.+ ...+..+|+...+||||||+|||++.++ .+||+|||+++.+...
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 999985 676666431 2222333 3334455555559999999999999664 7999999999875422
Q ss_pred CCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC---------
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--------- 636 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 636 (723)
. ......+|+.|+|||.+.+. .++.++|||||||+|+||++|++||........+...+...-...
T Consensus 225 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 225 Q----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred C----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 1 12235679999999998764 689999999999999999999999976543333333222111000
Q ss_pred Cccc-----ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 DIES-----IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 ~~~~-----i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+ +....+...++......+.+++.+||+.+|.+|||+.|+++
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 00011111111112346789999999999999999999884
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=283.87 Aligned_cols=237 Identities=20% Similarity=0.280 Sum_probs=177.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 457899999999999987 46699999987542 2344668899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCC----------HHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILS----------WEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~----------~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++..... .+. ....+..+|+...+||||||+|||++.++.+||+|||+++.+.... .....
T Consensus 85 ~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 161 (330)
T cd05601 85 GGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK--MVNSK 161 (330)
T ss_pred CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC--ceeee
Confidence 9999999876421 122 2233444444455999999999999999999999999998764322 12233
Q ss_pred cccCCCccccccccc------cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 575 TIAGTPGYLDPEYYI------SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~------~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
...||+.|+|||.+. ...++.++|||||||+++||++|+.||...... ............... +.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~--~~--- 232 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNIMNFQRFLKF--PE--- 232 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHHHcCCCccCC--CC---
Confidence 456899999999986 456789999999999999999999999754322 112222111111110 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.+++.+|++ +|.+||+++++++
T Consensus 233 --~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 --DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 01122356788899997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=265.09 Aligned_cols=234 Identities=24% Similarity=0.392 Sum_probs=180.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||.|++|.||+|.. +++.||+|++.... ......+.+|++++++++|+|++++++++.+....++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 4467899999999999998 46699999987553 34456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++... .+.+..... .+++...+||||+|+||++++++.++|+|||+++...... .....
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~~~~ 157 (274)
T cd06609 84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---SKRNT 157 (274)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---ccccc
Confidence 9999998764 334333333 3333334999999999999999999999999998764321 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..++..|+|||.+.+..++.++||||||+++|||+||+.||...... .... ....... +.+... ...
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~-~~~~~~~-----~~~~~~---~~~ 224 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLF-LIPKNNP-----PSLEGN---KFS 224 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHH-HhhhcCC-----CCCccc---ccC
Confidence 46788999999999888999999999999999999999999654321 1111 1111111 111111 022
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|+..+|++|||++++++
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 35779999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=263.80 Aligned_cols=237 Identities=26% Similarity=0.462 Sum_probs=179.2
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|... +..+|+|.+..... ...+|.+|++++++++|||++++++++......++|+||+++++|
T Consensus 8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 4578999999999999884 67899999875433 245789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++..... .+.+.... ..+|+...+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 87 ~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~ 163 (256)
T cd05112 87 SDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKF 163 (256)
T ss_pred HHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--ccccCCCcc
Confidence 999875432 23333332 23333344999999999999999999999999987653221 111122335
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+.+|+|||.+.+..++.++||||||++++||++ |+.||...... ...... ..+ .....++. ....
T Consensus 164 ~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~-~~~--~~~~~~~~-------~~~~ 229 (256)
T cd05112 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVETI-NAG--FRLYKPRL-------ASQS 229 (256)
T ss_pred chhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHH-hCC--CCCCCCCC-------CCHH
Confidence 678999999998899999999999999999998 89998654321 122211 111 11112222 1246
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
+.+++.+|++.+|++||++.++++.|+
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=283.72 Aligned_cols=229 Identities=24% Similarity=0.310 Sum_probs=179.5
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
|.++||+|+||+|+.+.+. ++.+|||++++.. ....+..+.|.+++... +||.|+.|+.++...++.+.||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 4689999999999999984 4589999998864 34567788899888877 5999999999999999999999999
Q ss_pred CCCCHHHHhccCC---CCCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 504 ANGNLQALLLGEE---ADIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 504 ~~gsL~~~l~~~~---~~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
.+|++..+.+... ..+- ...-.|+++|+...|+||||.+|||||.+|++||+|||+++...-. ...+..+
T Consensus 452 ~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~---g~~TsTf 528 (694)
T KOG0694|consen 452 AGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ---GDRTSTF 528 (694)
T ss_pred CCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC---CCccccc
Confidence 9999554444221 1111 1223455566666699999999999999999999999999975322 2345678
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
+||+.|||||.+.+..|+..+|-|||||+||||+.|..||.+.+++.....++ .+ |+.... -...
T Consensus 529 CGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d-------~~~yP~----~ls~ 593 (694)
T KOG0694|consen 529 CGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----ND-------EVRYPR----FLSK 593 (694)
T ss_pred cCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cC-------CCCCCC----cccH
Confidence 99999999999999999999999999999999999999998776654332221 11 122222 2233
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 004935 657 KTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm 676 (723)
..++|+.+.+..+|++|--+
T Consensus 594 ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHhccCcccccCC
Confidence 56788999999999999877
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=272.94 Aligned_cols=233 Identities=19% Similarity=0.319 Sum_probs=180.1
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||.|++|.||+|.. +++.|++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 46799999999999986 5679999998766555567889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++... .+++...+.++ |+...+||||||+||+++.++.+||+|||++........ ......+
T Consensus 104 ~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~ 177 (296)
T cd06655 104 TDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVG 177 (296)
T ss_pred HHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---cCCCcCC
Confidence 9988653 24555444433 333349999999999999999999999999886543221 1223467
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|+|||.+.+..++.++|||||||+++||++|+.||......... .... ...... +.. .......+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~~~-~~~~~~-----~~~--~~~~~~~~ 245 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIA-TNGTPE-----LQN--PEKLSPIF 245 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH-hcCCcc-----cCC--cccCCHHH
Confidence 88999999999888999999999999999999999999765332111 1111 111101 100 11122357
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+++.+|+..+|++||++.++++
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhh
Confidence 78999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=264.64 Aligned_cols=234 Identities=23% Similarity=0.347 Sum_probs=180.6
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...+.||.|+||.||+|.. .+..||+|.+.... ......+.+|++++++++|+||+++++++......++||||+++
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 3456899999999999987 46699999987543 34557899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... +.+... +..+|+...+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 87 ~~L~~~i~~~~---l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 160 (277)
T cd06640 87 GSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNT 160 (277)
T ss_pred CcHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---ccccc
Confidence 99999987532 233222 233333344999999999999999999999999997654321 12233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..++..|+|||.+.+..++.++|||||||+++||+||+.|+....... ... ....+ ..........
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~-~~~~~---------~~~~~~~~~~ 226 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF-LIPKN---------NPPTLTGEFS 226 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh-hhhcC---------CCCCCchhhh
Confidence 457889999999988889999999999999999999999986543211 111 11111 0111222345
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=265.53 Aligned_cols=235 Identities=23% Similarity=0.368 Sum_probs=180.4
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|... +..+++|.+..... .+++.+|++++++++|+||+++++++......++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 34678999999999999984 56999999875533 678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++.....++.+ ...+||||+|+||++++++.+||+|||++........ .....
T Consensus 84 ~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 159 (256)
T cd06612 84 SVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---KRNTV 159 (256)
T ss_pred cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc---ccccc
Confidence 9999986432 23454444444333 3349999999999999999999999999987643221 22334
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.++..|+|||.+.+..++.++|||||||+++||++|+.|+........... .... ..+.+. .......
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~~~-----~~~~~~--~~~~~~~ 227 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNK-----PPPTLS--DPEKWSP 227 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hccC-----CCCCCC--chhhcCH
Confidence 578899999999988999999999999999999999999875432211110 0000 001111 1111234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+++.+|++.+|++|||++||++
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhc
Confidence 6789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.77 Aligned_cols=227 Identities=22% Similarity=0.293 Sum_probs=171.0
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccC-CceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHH-KNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|... ++.||||++.... ....+.+..|++++..++| ++|+.+++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 4678999999999999984 4589999987532 2345678899999999966 46888999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++..... +.+. ..+..+|+...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 84 ~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~ 158 (324)
T cd05587 84 NGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTT 158 (324)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC---Cce
Confidence 99999998865422 2222 23344444444999999999999999999999999987532111 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+++||+||+.||........ ..... ... +.+...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~-~~~------~~~~~~---- 223 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIM-EHN------VSYPKS---- 223 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHH-cCC------CCCCCC----
Confidence 345689999999999999999999999999999999999999975533211 11111 111 111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
....+.+++.+|++.+|.+|++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCC
Confidence 12356799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=272.39 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=180.2
Q ss_pred hhhccccCcEEEEEEEE--CCc----eEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||+|+||.||+|.. ++. .||+|.+..... ....++.+|+.++++++|+||++++|+|... ...+++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 46899999999999987 333 579998876543 3345789999999999999999999999754 467999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++..... .+.+...+.+ +|+...+||||||+||++++++.+||+|||+++....... ....
T Consensus 91 ~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 168 (303)
T cd05110 91 PHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-EYNA 168 (303)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc-cccc
Confidence 99999999875422 2333333333 3333339999999999999999999999999987643221 1112
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ...+++ ..+... ..+ .
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~--~~~-------~ 234 (303)
T cd05110 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLL----EKGERL--PQP-------P 234 (303)
T ss_pred CCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HCCCCC--CCC-------C
Confidence 22345678999999998899999999999999999997 88888654211 122221 111110 001 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.....+.+++.+|+..+|++||+|+++++.|+++...+..
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~ 274 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 274 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence 1234678999999999999999999999999987655543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=296.64 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=193.8
Q ss_pred hhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
+.+.||+|.||.|++|... ...||||+++... ....+.+..|+++|+.+ +|+||+.++|+|..++..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 4568999999999999862 2379999998654 34567899999999999 69999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC------------C--CCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE------------A--DILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl 554 (723)
|+||++.|+|.++|+.+. . ..+.....+.++.++|. |||||.++|||+.++..+||
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kI 459 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKI 459 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEE
Confidence 999999999999998654 0 23777778888888876 99999999999999999999
Q ss_pred EeccCccccCCCCCCceeeeccc--CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHH
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIA--GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~ 631 (723)
+|||+++....... ....... -...|||||.+....++.|+|||||||+||||+| |..|+.+......+.+
T Consensus 460 aDFGlar~~~~~~~--y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~---- 533 (609)
T KOG0200|consen 460 ADFGLARDHYNKDY--YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE---- 533 (609)
T ss_pred ccccceeccCCCCc--eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH----
Confidence 99999997544332 1112122 3446999999999999999999999999999998 7778865321122222
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.+.+|.. .+.+..+...+.+++..||+.+|++||++.++++.|+..++.
T Consensus 534 ~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 534 FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 3434322 112223445778999999999999999999999999996543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=284.54 Aligned_cols=191 Identities=23% Similarity=0.395 Sum_probs=151.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. .++.||||++.... ......+..|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 357899999999999988 46699999997532 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-------
Q 004935 505 NGNLQALLLGEEA----DILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG------- 569 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~------- 569 (723)
+|+|.+++..... ....+ ...+..+|+...+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 164 (363)
T cd05628 85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164 (363)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccc
Confidence 9999999875422 11112 22334444444499999999999999999999999998764321100
Q ss_pred -------------------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc
Q 004935 570 -------------------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH 620 (723)
Q Consensus 570 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~ 620 (723)
........||+.|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 001123469999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=285.64 Aligned_cols=240 Identities=20% Similarity=0.323 Sum_probs=174.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 357899999999999998 46799999997532 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce-----
Q 004935 505 NGNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH----- 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~----- 571 (723)
+|+|.+++..... .+. +....+..+|+...+||||||+|||++.++.+||+|||+++.+........
T Consensus 85 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 164 (364)
T cd05599 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164 (364)
T ss_pred CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence 9999999875422 111 222334444444559999999999999999999999999876432110000
Q ss_pred ------------------------------eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc
Q 004935 572 ------------------------------VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE 621 (723)
Q Consensus 572 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~ 621 (723)
......||+.|+|||.+....++.++|||||||+++||++|+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~ 244 (364)
T cd05599 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244 (364)
T ss_pred ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH
Confidence 01124589999999999999999999999999999999999999975432
Q ss_pred cccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 004935 622 RIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPT---MNQVVM 681 (723)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~evl~ 681 (723)
. +......... .....+ ... .....+.+++.+|+. +|.+|++ ++|+++
T Consensus 245 ~----~~~~~i~~~~--~~~~~~---~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 245 Q----ETYRKIINWK--ETLQFP---DEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred H----HHHHHHHcCC--CccCCC---CCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 1 1111111110 000001 100 112245688888886 8999998 777766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=265.16 Aligned_cols=236 Identities=22% Similarity=0.377 Sum_probs=179.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||++.. ++..+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++++||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 457899999999999987 4669999998643 3345577899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCC------HHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILS------WEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~------~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+. |... +..+|+...+|+||||+||++++++.++|+|||++....... ......
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 160 (255)
T cd08219 84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTY 160 (255)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc---cccccc
Confidence 999988654333233 2222 233333334999999999999999999999999997654321 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.++..|+|||.+.+..++.++||||||+++++|++|+.||..... ....... ..+.... +.. ....
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~-----~~~----~~~~ 226 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLILKV-CQGSYKP-----LPS----HYSY 226 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHHHHH-hcCCCCC-----CCc----ccCH
Confidence 688899999999888899999999999999999999999975432 1111111 1111111 111 1223
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.+.+++.+||+.+|.+||++.+++..
T Consensus 227 ~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 227 ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 57799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=280.80 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=184.9
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-C-----CceeeEEEEEecCCceEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-H-----KNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 498 (723)
++...+.||+|.||.|-|+.. +++.||||+++... .-..+-+.|+.+|.+|+ | -|+|++++|+...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 344578999999999999998 46699999998653 33466789999999996 4 389999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCC--CcEEEEeccCccccCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGK--FQAKIADFGLSRTFPVE 566 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~--~~~kl~DfGla~~~~~~ 566 (723)
|+|.+.. +|.++++.+....++.. +.|..+++...||+||||+||||.+. ..+||+|||+|.....
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q- 343 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ- 343 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC-
Confidence 9999976 99999998765544433 34455555556999999999999754 4799999999987532
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH-------HhcCC-Cc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF-------MLGKG-DI 638 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~-~~ 638 (723)
.. ....-+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|.+..+.+.+..++.. ++..+ +.
T Consensus 344 ----~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 344 ----RV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred ----cc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 11 1455678999999999999999999999999999999998888776665444333322 11000 00
Q ss_pred ccccCC--------------------------------c-cc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 004935 639 ESIVDP--------------------------------R-LH-------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 639 ~~i~d~--------------------------------~-l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 678 (723)
...++. . .. .......-..+++++++|+..||.+|+|..+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 000000 0 00 0011133456799999999999999999999
Q ss_pred HHH
Q 004935 679 VVM 681 (723)
Q Consensus 679 vl~ 681 (723)
+++
T Consensus 499 al~ 501 (586)
T KOG0667|consen 499 ALN 501 (586)
T ss_pred Hhc
Confidence 986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=280.84 Aligned_cols=241 Identities=17% Similarity=0.174 Sum_probs=171.4
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||++.. .++.||+|... ...+.+|++++++++||||+++++++......++|+|++. +
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 3457899999999999998 46699999753 2357899999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+.+... +..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 168 ~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~~ 243 (391)
T PHA03212 168 DLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--ANKYYGW 243 (391)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc--ccccccc
Confidence 8888876532 2333333 333344444999999999999999999999999997542211 1122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc-------cccHHHHHHHHhcCCC----------cc
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-------RIHITQWVSFMLGKGD----------IE 639 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~----------~~ 639 (723)
.||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ...+...+.. ..... +.
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~-~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR-SGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH-hcCChhhcCcchhHHHH
Confidence 799999999999999999999999999999999999988643211 0111111111 00000 00
Q ss_pred cc---------cCCcccCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SI---------VDPRLHEDF--DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i---------~d~~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ..+...... .......+.+++.+|++.+|.+|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000000 0112346789999999999999999999985
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=268.57 Aligned_cols=238 Identities=22% Similarity=0.331 Sum_probs=178.4
Q ss_pred HHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|... +..|++|++........+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 345678999999999999984 569999999877777778899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|..++.... ..+++...+.++ |+...+||||||+||+++.++.+||+|||++...... ......
T Consensus 94 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~ 169 (292)
T cd06644 94 GAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---LQRRDS 169 (292)
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---ccccce
Confidence 99998875432 224444433333 3333399999999999999999999999998754221 111233
Q ss_pred ccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..++..|+|||.+. ...++.++|||||||++|||++|+.|+...... +........ .. +.+. .
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~-----~~~~--~ 237 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKS-EP-----PTLS--Q 237 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHhcC-CC-----ccCC--C
Confidence 45788999999985 344688999999999999999999998654321 111111111 10 1110 0
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.+++.+|++.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1112235779999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=284.47 Aligned_cols=229 Identities=23% Similarity=0.317 Sum_probs=172.3
Q ss_pred hhccccCcEEEEEEEE-----CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.||+|+||.||+++. .++.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 456899999875432 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|+|.+++..... ....|. ..+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KKAYSF 158 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---Cceecc
Confidence 9999999865421 112222 22333444444999999999999999999999999988653221 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||+++||++|+.||...... +....... ... .+... ...
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i~~-~~~------~~p~~----~~~ 223 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMILK-AKL------GMPQF----LSP 223 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHHHc-CCC------CCCCC----CCH
Confidence 7899999999999888999999999999999999999999754321 11111111 110 11111 123
Q ss_pred HHHHHHHhccCCCCCCCCCHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~e 678 (723)
.+.+++.+|++.+|++||++.+
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCC
Confidence 5678999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=275.98 Aligned_cols=231 Identities=23% Similarity=0.306 Sum_probs=172.0
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.. ++..||+|+++... ......+..|..++... +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998 45689999987532 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++.....- . .+....+..+|+...+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---DNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---CCceeccC
Confidence 9999988654221 1 12223344444444599999999999999999999999998753211 12234467
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +...... .. .+.+.... ...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~-~~------~~~~~~~~----~~~ 222 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIR-VD------TPHYPRWI----TKE 222 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hC------CCCCCCCC----CHH
Confidence 899999999999999999999999999999999999999754322 1111111 11 11111111 235
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 004935 658 TVEIAMACVSQTSTKRPTMN-QVV 680 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~-evl 680 (723)
+.+++.+|++.+|++||++. ++.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 67899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=277.44 Aligned_cols=227 Identities=23% Similarity=0.299 Sum_probs=170.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|... +..||+|++.... ....+.+..|..++..+ +|++|+.+++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 4578999999999999884 4589999987542 22334577788888877 5899999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++..... +++... +..+|+...+||||||+|||+++++.+||+|||+++...... ...
T Consensus 84 ~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~---~~~ 158 (323)
T cd05616 84 NGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTT 158 (323)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC---Ccc
Confidence 99999988865422 333333 333344444999999999999999999999999997543211 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ...... ... ..+...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~-~~~------~~~p~~---- 223 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIM-EHN------VAYPKS---- 223 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHHHHH-hCC------CCCCCc----
Confidence 34568999999999999999999999999999999999999997654321 111111 111 011111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
....+.+++.+|++.+|++|++.
T Consensus 224 ~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 224 MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCHHHHHHHHHHcccCHHhcCCC
Confidence 22356799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=264.58 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=185.4
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc--cCCceeeEEEEEecC----CceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI--HHKNLTTLVGYCDEG----TNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~lV~Ey~~ 504 (723)
.+.||+|.||.||+|.+.|+.||||++..... +.+.+|.++.+.+ ||+||+.+++.-..+ .+++||.+|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 46899999999999999999999999986543 5677888888764 999999999986444 35789999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhccc------------------cccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEAAK------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~------------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
.|||.|+|... .++....+++++..|. .|||||+.|||+..++.+.|+|+|+|......
T Consensus 293 ~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 293 HGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred CCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 99999999863 4555555555554432 89999999999999999999999999876543
Q ss_pred CCC-ceeeecccCCCccccccccccCC------CCChhhHHHHHHHHHHHHcC----------CCccccCcccccHHHHH
Q 004935 567 GSG-THVTTTIAGTPGYLDPEYYISNR------LTEKSDVYNFGVVLLEIITS----------KSVIERTHERIHITQWV 629 (723)
Q Consensus 567 ~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SfGvvL~elltg----------~~p~~~~~~~~~~~~~~ 629 (723)
... ........||.+|||||.+...- --..+||||||.|+||+..+ +.||.+....+.-.+.+
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 221 12234567999999999986432 12369999999999999763 35665443333222323
Q ss_pred HHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 630 SFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 630 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+...-..++.-.++.+ ....+.+..+.+++..||..+|.-|-|+--+.+.|.++.+.
T Consensus 450 rkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 450 RKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred hcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 3222222222222222 23456788899999999999999999999999999887753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=267.79 Aligned_cols=239 Identities=22% Similarity=0.330 Sum_probs=176.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh--------------hHHHHHHHHHHHHhccCCceeeEEEEEec-
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--------------GYKQFQAEVELLMRIHHKNLTTLVGYCDE- 492 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~- 492 (723)
+.+.||+|.||.|-+|+. +++.||||++.+.... ..+...+|+.+|++++|+|||+|+.+..+
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 457899999999999998 5779999999753211 12468899999999999999999999865
Q ss_pred -CCceEEEEEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 493 -GTNRGLIYEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 493 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
.+..|||+|||..|.+...-.... .+... ..|.++|-...|||||||+|+||++++++||+|||.+.
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~ 258 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSN 258 (576)
T ss_pred ccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceee
Confidence 567999999999988754422211 13322 33455555556999999999999999999999999998
Q ss_pred ccCCCCC--CceeeecccCCCccccccccccCC----CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC
Q 004935 562 TFPVEGS--GTHVTTTIAGTPGYLDPEYYISNR----LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 562 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
..+.... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||...........
T Consensus 259 ~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K-------- 330 (576)
T KOG0585|consen 259 EFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK-------- 330 (576)
T ss_pred ecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH--------
Confidence 7643211 111223467999999999987743 35789999999999999999999976543222211
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
|+...|.-....+.-..+.+|++++|++||++|.+..+|....
T Consensus 331 -----Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 331 -----IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2222222222223344677999999999999999999987644
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=272.86 Aligned_cols=235 Identities=20% Similarity=0.311 Sum_probs=180.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.. +++.||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 3457899999999999987 57799999998765555677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... +.+.. .+..+|+...+||||||+|||++.++.++|+|||++........ .....
T Consensus 102 ~L~~~~~~~~---~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 175 (297)
T cd06656 102 SLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 175 (297)
T ss_pred CHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcc
Confidence 9999986532 23333 33444444459999999999999999999999999876533221 12234
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.+++.|+|||.+.+..++.++|||||||++++|++|+.||........+.. .. .... +.+. .......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~-~~~~-----~~~~--~~~~~~~ 243 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IA-TNGT-----PELQ--NPERLSA 243 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----ec-cCCC-----CCCC--CccccCH
Confidence 678899999999998899999999999999999999999965432111000 00 0000 0110 0111223
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+++.+|++.+|++||+++++++
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 5678999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=287.48 Aligned_cols=190 Identities=22% Similarity=0.358 Sum_probs=150.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|.. .++.||+|++.... ......+.+|++++++++|+||+++++.+.+.+..++|||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 57899999999999988 45689999987542 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----CCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC--------
Q 004935 506 GNLQALLLGEEAD----ILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-------- 569 (723)
Q Consensus 506 gsL~~~l~~~~~~----~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------- 569 (723)
|+|.+++...... ...|. ..+..+|+...+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~ 165 (382)
T cd05625 86 GDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165 (382)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccc
Confidence 9999998654211 11222 3344455555599999999999999999999999997543110000
Q ss_pred ------------------------------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC
Q 004935 570 ------------------------------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613 (723)
Q Consensus 570 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~ 613 (723)
........||+.|+|||.+.+..++.++|||||||+|+||++|+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 245 (382)
T cd05625 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245 (382)
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCC
Confidence 00012346899999999999999999999999999999999999
Q ss_pred CccccCc
Q 004935 614 SVIERTH 620 (723)
Q Consensus 614 ~p~~~~~ 620 (723)
.||....
T Consensus 246 ~Pf~~~~ 252 (382)
T cd05625 246 PPFLAQT 252 (382)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=263.68 Aligned_cols=236 Identities=25% Similarity=0.367 Sum_probs=182.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||.|+||.||.+.. ++..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 457899999998888876 5679999987654 344557789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+++.....++. +...+||||+|+||++++++.+||+|||++........ ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~~ 160 (256)
T cd08221 84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAET 160 (256)
T ss_pred CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---cccc
Confidence 9999999765434455554444433 33338999999999999999999999999987643221 2234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..++..|+|||.+.+..++.++||||||++++||++|+.||..... .+...... .+..... .....
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~-~~~~~~~---------~~~~~ 226 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----LNLVVKIV-QGNYTPV---------VSVYS 226 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-cCCCCCC---------ccccC
Confidence 5688999999999888899999999999999999999999865432 22222222 1111111 01123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.+++.+|++.+|.+||+++++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 227 SELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 357799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=269.52 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=172.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhc---cCCceeeEEEEEec-----CCceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRI---HHKNLTTLVGYCDE-----GTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~~~~ 497 (723)
+.+.||+|+||.||+|.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ....+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 456899999999999988 466899999875422 1224566777777665 79999999998854 34578
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+|+||+++ +|.+++.......+++.... ..+|+...+||||||+|||++.++.+||+|||+++......
T Consensus 84 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd07863 84 LVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM 162 (288)
T ss_pred EEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcc
Confidence 99999985 89888876443334444333 33333344999999999999999999999999998653221
Q ss_pred CCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cc------
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IE------ 639 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~------ 639 (723)
......++..|+|||.+.+..++.++|||||||+++||++|++||........+.+.......... ..
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 163 ----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred ----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 123346788999999999889999999999999999999999998755433322222221110000 00
Q ss_pred -cccCCccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 -SIVDPRLH---EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 -~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+... .....+....+.+++.+|++.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000112345679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=284.94 Aligned_cols=241 Identities=21% Similarity=0.275 Sum_probs=174.1
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||++... ++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999984 568999998642 2223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC---CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 504 ANGNLQALLLGEEA---DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 504 ~~gsL~~~l~~~~~---~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
++|+|.+++..... ... +....+..+|+...+||||||+|||+++++.+||+|||+++...... .......
T Consensus 126 ~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~--~~~~~~~ 203 (370)
T cd05621 126 PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--MVRCDTA 203 (370)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC--ceecccC
Confidence 99999999865421 111 22233444444455999999999999999999999999998753221 1122345
Q ss_pred cCCCccccccccccC----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 577 AGTPGYLDPEYYISN----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.||+.|+|||.+.+. .++.++||||+||+|+||++|+.||........ ........... .+.. ..
T Consensus 204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~-----~~p~--~~ 272 (370)
T cd05621 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT----YSKIMDHKNSL-----NFPE--DV 272 (370)
T ss_pred CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCccc-----CCCC--cc
Confidence 799999999998754 378899999999999999999999975432211 11111111000 0111 11
Q ss_pred HHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTK--RPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~ 682 (723)
.....+.+++.+|+...+.+ ||++.|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11234567888888755543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=267.74 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=178.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHH--HHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYK--QFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||++... ++.+|+|++......... ....|+.++++++|+||+++++++......++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 4578999999999999995 447999999887654332 345699999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++... ..+++... +..+|+...+|+||||+||++++++.++|+|||.+..... .......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~~~~~~ 157 (260)
T PF00069_consen 83 GSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NNENFNP 157 (260)
T ss_dssp EBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TTSEBSS
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc
Confidence 9999999722 22333333 3334444449999999999999999999999999976411 1233445
Q ss_pred ccCCCccccccccc-cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYI-SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+. +...+.++||||+|+++++|++|+.|+......... .......... . ...... ....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~-~----~~~~~~--~~~~ 229 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRP-L----PSSSQQ--SREK 229 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTH-H----HHHTTS--HTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhh-hhhhhccccc-c----cccccc--cchh
Confidence 67899999999998 888999999999999999999999999865211111 1111111100 0 000000 0001
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 257889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=263.19 Aligned_cols=236 Identities=23% Similarity=0.384 Sum_probs=179.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 503 (723)
.+.+.||+|++|.||++.. +++.||+|.+.... ....+.+..|++++++++|+|++++++.+.. ....+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 3467899999999999987 45689999986542 3445678999999999999999999998764 44578999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++++|.+++.......+.+...+.++.+ ...+||||||+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~ 159 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DMA 159 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---Ccc
Confidence 9999999987654444555555444433 333999999999999999999999999998763221 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....+++.|+|||.+.+..++.++||||||++++||++|+.||..... ........ .+... .+. ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~-~~~~~-----~~~----~~ 225 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVYRII-EGKLP-----PMP----KD 225 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHH-hcCCC-----CCc----cc
Confidence 345678899999999999999999999999999999999999864432 22222221 11111 111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.58 Aligned_cols=228 Identities=25% Similarity=0.324 Sum_probs=170.3
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHH-HHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVE-LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.. +++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999998 56799999987532 222345555555 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|..++...... . .+....+..+|+...+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---SKTTSTFC 157 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---CCcccccc
Confidence 9999988654211 1 12233344455555599999999999999999999999998753221 11233456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+........ . ..+.... ...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~-~------~~~~~~~----~~~ 222 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMYDNILNK-P------LRLKPNI----SVS 222 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HHHHHHHHcC-C------CCCCCCC----CHH
Confidence 89999999999999999999999999999999999999975432 2222222211 1 1111111 235
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 004935 658 TVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~ 677 (723)
+.+++.+|++.+|.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 77999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=281.86 Aligned_cols=234 Identities=24% Similarity=0.377 Sum_probs=189.2
Q ss_pred hccccCcEEEEEEEECCc--eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHH
Q 004935 433 VLGNGGFGTVYHGYLDGT--EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQA 510 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 510 (723)
+||+|.||+||.|++... .+|||-+........+.+..|+.+.++++|+|||+.+|.|.+++..-+.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999998544 789999988777777789999999999999999999999999999999999999999999
Q ss_pred HhccCC------CC-----CCCHHHHHHHHHhccccccCCCCCCEEEc-CCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 511 LLLGEE------AD-----ILSWEGRLRIAIEAAKVHRDVKSTNILLS-GKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 511 ~l~~~~------~~-----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
+|+..= .. ..++...++++|+.-+||||||-+|||++ -.|.+||+|||-++.+.-- ..++..+.|
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---nP~TETFTG 738 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---NPCTETFTG 738 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---Ccccccccc
Confidence 998641 11 13455667788888889999999999997 4689999999999876321 345567889
Q ss_pred CCccccccccccC--CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 579 TPGYLDPEYYISN--RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 579 t~~y~aPE~~~~~--~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
|+.|||||.+..+ .|..++|||||||.+.||.||++||...... +-+.+..+- -+..+..+.+-..
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAAMFkVGm--------yKvHP~iPeelsa 806 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAAMFKVGM--------YKVHPPIPEELSA 806 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHhhhhhcc--------eecCCCCcHHHHH
Confidence 9999999999765 4899999999999999999999999765432 111111111 1123344455566
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+...++++|+.++|.+||+++++++
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhcc
Confidence 7789999999999999999999886
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=274.69 Aligned_cols=231 Identities=20% Similarity=0.309 Sum_probs=172.5
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||++.. .++.||+|+++... ....+.+..|+.++.++ +|+||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999998 45689999997642 23345688999999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|..++.... .+.+... +..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTST 155 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cceec
Confidence 99998886432 2333333 333344444999999999999999999999999987532111 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc--ccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER--IHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
..||+.|+|||.+.+..++.++|||||||+|+||++|+.||...... ....++.......... .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~---- 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRF---- 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCC----
Confidence 57899999999999999999999999999999999999999643221 1222222222222111 11111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
....+.+++.+|++.+|++||+++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 123567999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=263.81 Aligned_cols=235 Identities=22% Similarity=0.384 Sum_probs=170.4
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E 501 (723)
.+.||+|+||.||+|.. .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 57899999999999987 46699999886432 2234568999999999999999999998865 356789999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++++|.+++.... .+++...+.+ +|....+||||||+||+++.++.+||+|||+++..........
T Consensus 87 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd06651 87 YMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164 (266)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCC
Confidence 999999999987542 2343333333 3333339999999999999999999999999986532111111
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......++..|+|||.+.+..++.++|||||||+++||++|+.||..... .+.+....... ..+.+...
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~~-----~~~~~~~~-- 233 (266)
T cd06651 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQP-----TNPQLPSH-- 233 (266)
T ss_pred ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcCC-----CCCCCchh--
Confidence 12234578899999999988899999999999999999999999875422 11112111111 11222111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++ +|+..+|++||+|+||+.
T Consensus 234 --~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 234 --ISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --cCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112334444 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=283.02 Aligned_cols=244 Identities=20% Similarity=0.229 Sum_probs=173.4
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||++... ++.||||... ...+.+|+++|++++|+||+++++++..++..++|||++. ++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 3568999999999999984 5689999643 2346789999999999999999999999999999999995 68
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..++|...+.++.+++ .+||||||+|||++.++.+||+|||+++....... ........
T Consensus 246 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~~ 323 (461)
T PHA03211 246 LYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-TPFHYGIA 323 (461)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-cccccccC
Confidence 888876532 2466666655555443 39999999999999999999999999987532211 11223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc-------ccHHHHHHHHhcC-CCcccccCCcc---
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER-------IHITQWVSFMLGK-GDIESIVDPRL--- 646 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~i~d~~l--- 646 (723)
||..|+|||++.+..++.++|||||||+||||++|..++...... ..+.+.++..... .........++
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 999999999999999999999999999999999988765322110 1122222211100 00000000000
Q ss_pred ---------cCCCC---H----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 647 ---------HEDFD---I----NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 647 ---------~~~~~---~----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..... . .....+.+++.+|++.||.+|||+.|+++.
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0 011246789999999999999999999863
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=286.73 Aligned_cols=241 Identities=20% Similarity=0.321 Sum_probs=173.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 357899999999999987 56799999986532 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-------
Q 004935 505 NGNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG------- 569 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~------- 569 (723)
+|+|.+++..... ....|. ..+..+|+...+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 164 (377)
T cd05629 85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164 (377)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence 9999999865422 111222 3344444445599999999999999999999999999643211000
Q ss_pred ----c---------------------------------eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcC
Q 004935 570 ----T---------------------------------HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITS 612 (723)
Q Consensus 570 ----~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg 612 (723)
. .......||+.|+|||.+.+..++.++|||||||+++||++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG 244 (377)
T cd05629 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244 (377)
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC
Confidence 0 000124689999999999998999999999999999999999
Q ss_pred CCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 004935 613 KSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKR---PTMNQVVME 682 (723)
Q Consensus 613 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~evl~~ 682 (723)
+.||........ ......... .+ .+... ......+.+++.+|+. +|.+| +++.|+++.
T Consensus 245 ~~Pf~~~~~~~~----~~~i~~~~~--~~---~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 245 WPPFCSENSHET----YRKIINWRE--TL---YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCCCCHHHH----HHHHHccCC--cc---CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999975432211 111111000 00 01110 0112356788999997 66665 588888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.89 Aligned_cols=234 Identities=25% Similarity=0.314 Sum_probs=172.7
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHH-HHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVE-LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.. +++.||+|++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 46799999986532 223345666665 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|..++...... .. +....+..+|+...+||||||+|||+++++.+||+|||+++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---SDTTTTFC 157 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---CCCccccc
Confidence 9999888654221 11 2223344445555599999999999999999999999998753211 11223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
|++.|+|||.+.+..++.++|||||||+++||++|+.||..... .+........ .. .+... ....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~~~~~-~~------~~~~~----~~~~ 222 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----AEMYDNILHK-PL------VLRPG----ASLT 222 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----HHHHHHHHcC-Cc------cCCCC----CCHH
Confidence 89999999999999999999999999999999999999975432 1222222211 10 11111 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
+.+++.+|++.+|.+||++++.++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 67899999999999999987554444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=262.47 Aligned_cols=238 Identities=29% Similarity=0.465 Sum_probs=181.7
Q ss_pred hhhhccccCcEEEEEEEECC------ceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||.|+||.||++...+ ..||+|++...... ..+.+..|++.+++++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 35789999999999999854 68999999766543 567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++++|.+++.......+.+.....++.++ ..+||||||+||++++++.++|+|||+++....... ..
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 160 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY--YK 160 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc--cc
Confidence 999999999876543325555544444333 239999999999999999999999999987643311 11
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|+|||.+.+..++.++||||+|++++||++ |+.|+..... .......... ... ....
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~~~-~~~-----~~~~--- 227 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLKKG-YRL-----PKPE--- 227 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhcC-CCC-----CCCC---
Confidence 112336789999999988889999999999999999998 7788765321 2222222111 110 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
.....+.+++.+|+..+|++|||+.|+++.|
T Consensus 228 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 -NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1234678899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.92 Aligned_cols=236 Identities=24% Similarity=0.303 Sum_probs=173.4
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHH-HHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVE-LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+++.. ++.||+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999984 5589999987532 122334455544 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++...... . .+....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---GTTSTFC 157 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC---CCccccc
Confidence 9999988754221 1 122333445555555999999999999999999999999997542211 1223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ .. .+... ....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~-~~------~~~~~----~~~~ 222 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNK-PL------QLKPN----ITNS 222 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----HHHHHHHhC-Cc------CCCCC----CCHH
Confidence 899999999999999999999999999999999999999754322 111111111 10 11111 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
+.+++.+|++.+|.+||++.+.+..+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 6799999999999999998865554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=264.11 Aligned_cols=236 Identities=24% Similarity=0.397 Sum_probs=177.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh---------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ---------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
+.+.||+|++|.||+|.. +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 456899999999999987 4569999988654221 22568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
|+||+++++|.+++..... +++. ..+..+|+...+||||+|+||++++++.+||+|||+++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 84 FLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 9999999999999965421 2222 223344444449999999999999999999999999987642211
Q ss_pred Cc---eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 569 GT---HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 569 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.. .......++..|+|||.+.+..++.++|||||||+++||++|+.||........ +.... . ...+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~-----~~~~~ 231 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----IFKIG-E-----NASPE 231 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----HHHHh-c-----cCCCc
Confidence 11 111234578899999999988899999999999999999999999975432111 11111 1 11112
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.. .....+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 232 IPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 211 22346779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=263.06 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=180.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.+|++.. +++.||+|.+... .....+++.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 457899999999999987 5679999998643 233456899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.......+++...+.++.+++ .+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 160 (256)
T cd08218 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---ELART 160 (256)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch---hhhhh
Confidence 9999998754333344444443333333 2999999999999999999999999997653221 11223
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..+++.|+|||.+.+..++.++|||||||+++||++|+.|+..... ...+...... .. +.. .....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~~~-~~-----~~~----~~~~~ 226 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----KNLVLKIIRG-SY-----PPV----SSHYS 226 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----HHHHHHHhcC-CC-----CCC----cccCC
Confidence 4578899999999988999999999999999999999999865422 2222222211 11 111 11223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|.+||+|.+|++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 227 YDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 46789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=275.35 Aligned_cols=229 Identities=22% Similarity=0.316 Sum_probs=171.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
++.+.||+|+||.||+|.. +++.||+|++.... ....+.+..|..+++.+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 3567899999999999987 46699999987532 233456788999998885 57788899999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++.... .+++...+.+ +|+...+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~---~~ 157 (323)
T cd05615 83 VNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VT 157 (323)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC---cc
Confidence 99999999986542 2344433333 333334999999999999999999999999987543221 12
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +....... ... .+...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~-~~~------~~p~~--- 223 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIME-HNV------SYPKS--- 223 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh-CCC------CCCcc---
Confidence 23456899999999999889999999999999999999999999765332 11121111 111 11111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
....+.+++.+|++.+|.+|++..
T Consensus 224 -~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 224 -LSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCHHHHHHHHHHcccCHhhCCCCC
Confidence 123567899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=279.04 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=174.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC-----ceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT-----NRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E 501 (723)
.+.||+|+||.||++.. +++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 57899999999999997 5779999998653 2334567899999999999999999999998776 7899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+. ++|.+.+.... .+.+. ..+..+|....+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~--~ 159 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES--K 159 (372)
T ss_pred ccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--c
Confidence 997 57877775432 23332 333444444449999999999999999999999999986532211 1
Q ss_pred eeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccc----------
Q 004935 572 VTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES---------- 640 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 640 (723)
......++..|+|||.+.+. .++.++|||||||+++||++|+.||........+.. +....+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL-ITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHcCCCCHHHHHHhhHHHHH
Confidence 22334578899999998774 479999999999999999999999975543211111 111111000000
Q ss_pred -c----cC-CcccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 641 -I----VD-PRLHE--DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 641 -i----~d-~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+ .. +.... .........+.+++.+|++.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00 00000 0011123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=265.52 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=180.2
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||.|+||.||+|.. ++..||+|.+........+.|..|++++++++|+|++++++++......++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 34567899999999999998 4669999999877766677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++..... .+++.... ..+|+...+||||||+||+++.++.++|+|||++....... .....
T Consensus 87 ~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~~~~ 162 (280)
T cd06611 87 GALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---QKRDT 162 (280)
T ss_pred CcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---cccce
Confidence 999999865322 23333333 33344444999999999999999999999999987653221 12233
Q ss_pred ccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..++..|+|||.+. ...++.++||||||+++|||++|+.||...... +...... .+.. +.+..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~-----~~~~~-- 230 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKIL-KSEP-----PTLDQ-- 230 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHh-cCCC-----CCcCC--
Confidence 46888999999875 344778999999999999999999998654321 1111111 1111 11110
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+......+.+++.+|++.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11122357799999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=276.74 Aligned_cols=228 Identities=23% Similarity=0.309 Sum_probs=169.4
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHH-HHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVE-LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|+. ++..||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 46689999987532 122344555654 57889999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|..++...... . .++...+..+|+...+||||||+||+++.++.+||+|||+++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---EETTSTFC 157 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---CCcccccc
Confidence 9999888653211 1 12233344455555599999999999999999999999998753211 11223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ . ..+.. .....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~-~------~~~~~----~~~~~ 222 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQMYDNILHK-P------LQLPG----GKTVA 222 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HHHHHHHhcC-C------CCCCC----CCCHH
Confidence 89999999999988999999999999999999999999975432 2222222111 1 01111 12235
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 004935 658 TVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~ 677 (723)
+.+++.+|++.+|.+||+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 77999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=263.00 Aligned_cols=237 Identities=26% Similarity=0.456 Sum_probs=176.8
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCC------hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSS------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||+|+||.||+|.. +++.+|+|.+.... ......+.+|++++++++|+||++++++|.+.+..++++||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999987 56689999886432 123356899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC---Cc
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS---GT 570 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---~~ 570 (723)
++++|.+++..... +.+.. .+..+|+...+|+||+|+||++++++.+||+|||++........ ..
T Consensus 85 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (265)
T cd06631 85 PGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162 (265)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccc
Confidence 99999999865321 22222 23333444449999999999999999999999999876532111 11
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......++..|+|||.+.+..++.++|||||||+++||++|+.||.......... ........ .+.+...
T Consensus 163 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~-----~~~~~~~- 233 (265)
T cd06631 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGAHRGL-----MPRLPDS- 233 (265)
T ss_pred ccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---HhhhccCC-----CCCCCCC-
Confidence 11233468889999999998889999999999999999999999996543211111 11111011 1122222
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|++||++.+++.
T Consensus 234 ---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 234 ---FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2335789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.56 Aligned_cols=239 Identities=24% Similarity=0.380 Sum_probs=180.8
Q ss_pred hhhccccCcEEEEEEEEC-------CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.||+|+||.||+|+.. ...|++|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999862 347999998765433 456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC-------CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 503 MANGNLQALLLGEEA-------DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~-------~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
+++|+|.+++..... ..+++..++.++.+++ .+||||||+||+++.++.++|+|||+++....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~ 169 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCc
Confidence 999999999875431 1466666655544443 39999999999999999999999999875422
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.. ........++..|+|||.+.+...+.++||||||++++||++ |..||...... +.+... ..+.....
T Consensus 170 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~-~~~~~~~~--- 239 (275)
T cd05046 170 SE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRL-QAGKLELP--- 239 (275)
T ss_pred cc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHH-HcCCcCCC---
Confidence 11 111122345677999999988889999999999999999999 77788543321 111211 11111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
........+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 -----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01112346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=269.43 Aligned_cols=185 Identities=22% Similarity=0.306 Sum_probs=139.9
Q ss_pred hhccccCcEEEEEEEEC----CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD----GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 505 (723)
..||+|+||.||+|... +..||+|.+..... ...+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999873 35899999875432 2467899999999999999999998853 5567899999885
Q ss_pred CCHHHHhccC-------CCCCCCHHHHH----------HHHHhccccccCCCCCCEEE----cCCCcEEEEeccCccccC
Q 004935 506 GNLQALLLGE-------EADILSWEGRL----------RIAIEAAKVHRDVKSTNILL----SGKFQAKIADFGLSRTFP 564 (723)
Q Consensus 506 gsL~~~l~~~-------~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl----~~~~~~kl~DfGla~~~~ 564 (723)
+|.+++... ....+.+.... ..+|+...+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 777766422 11224443333 33333334999999999999 566799999999998764
Q ss_pred CCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERT 619 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~ 619 (723)
.............+|+.|+|||.+.+. .++.++|||||||+++||+||+.||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 332212222345688999999998764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=264.80 Aligned_cols=237 Identities=26% Similarity=0.391 Sum_probs=177.2
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
++.+.||+|+||.||++... +..||+|.+... .......+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45678999999999999984 679999988754 334456899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-CCCCCHHHHHHHH----------Hh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEE-ADILSWEGRLRIA----------IE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~-~~~l~~~~~l~i~----------~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|.+++.... ...+++.....++ |. ...+||||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~ 158 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-----LA 158 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-----cc
Confidence 99999887642 2234444433333 32 13389999999999999999999999998765321 12
Q ss_pred ecccCCCccccccccccCC------CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 574 TTIAGTPGYLDPEYYISNR------LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~------~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
....++..|+|||.+.+.. ++.++|||||||+++||++|+.||....... ......... .+. .+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~-~~~-----~~~~~ 231 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLSAIV-DGD-----PPTLP 231 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHHHHh-hcC-----CCCCC
Confidence 2345788999999986543 5889999999999999999999996543211 111111111 111 01111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|++||++++++.
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 232 ----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 123346779999999999999999998886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.47 Aligned_cols=186 Identities=22% Similarity=0.318 Sum_probs=140.9
Q ss_pred hhhccccCcEEEEEEEEC----CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLD----GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 504 (723)
.+.||+|+||.||+|... +..||+|.+..... ...+.+|++++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999863 35899999875432 2457889999999999999999998854 456789999987
Q ss_pred CCCHHHHhccCC-------CCCCCHH----------HHHHHHHhccccccCCCCCCEEE----cCCCcEEEEeccCcccc
Q 004935 505 NGNLQALLLGEE-------ADILSWE----------GRLRIAIEAAKVHRDVKSTNILL----SGKFQAKIADFGLSRTF 563 (723)
Q Consensus 505 ~gsL~~~l~~~~-------~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl----~~~~~~kl~DfGla~~~ 563 (723)
+ +|.+++.... ...+... ..+..+|+...+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5 7877765321 1123222 23344444445999999999999 45678999999999876
Q ss_pred CCCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccC
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERT 619 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~ 619 (723)
..............+|+.|+|||.+.+. .++.++||||+||+++||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 4322212223345789999999998764 5899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=260.77 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=177.7
Q ss_pred hhhhccccCcEEEEEEEEC-----CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ce
Q 004935 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NR 496 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 496 (723)
+.+.||+|+||.||+|.+. +..||||++... .....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999862 458999998754 3345677899999999999999999999886542 23
Q ss_pred EEEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 497 GLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
++++||+++|+|.+++... ....+++...+.++.++ ..+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccc
Confidence 6889999999999887532 11234554444444333 339999999999999999999999999986
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
...... ........++..|++||.+....++.++|||||||+++||++ |+.|+...... .+. ..........
T Consensus 163 ~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-~~~---~~~~~~~~~~-- 235 (273)
T cd05074 163 IYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIY---NYLIKGNRLK-- 235 (273)
T ss_pred ccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-HHH---HHHHcCCcCC--
Confidence 532211 111122345678999999988889999999999999999999 88888644321 111 1111111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
. .......+.+++.+|++.+|++||+++++++.|+++
T Consensus 236 ----~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 ----Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=270.81 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=174.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
..+.||+|+||.||+|.. .++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 357899999999999987 456899999875432 2334678999999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+.+. ..+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 89 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 164 (309)
T cd07872 89 DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---KTYSNE 164 (309)
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc---cccccc
Confidence 88887764322 23332 33344444445999999999999999999999999997643221 112234
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC------------cccccC
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD------------IESIVD 643 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~i~d 643 (723)
.+++.|+|||.+.+ ..++.++|||||||+++||+||+.||........+....+ ...... ......
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR-LLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHHHHhhhcchhhhhhhhc
Confidence 57889999998865 4689999999999999999999999975543222222111 111000 000000
Q ss_pred CcccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+..... ........+.+++.+|++.+|.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 00012235679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=268.30 Aligned_cols=236 Identities=23% Similarity=0.394 Sum_probs=171.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEe-----cCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCD-----EGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-----~~~~~~lV~Ey 502 (723)
.+.||+|+||.||++.. .++.+|+|++..... ...++.+|+.+++++ +|+||+++++++. .++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 47899999999999988 466899998865332 235688999999999 6999999999884 34568999999
Q ss_pred CCCCCHHHHhccC--CCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 503 MANGNLQALLLGE--EADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 503 ~~~gsL~~~l~~~--~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
+++++|.+++... ....+.+. ..+..+|+...+||||||+||++++++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--- 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--- 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC---
Confidence 9999999987532 12233332 23333444444999999999999999999999999988653221
Q ss_pred eeeecccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 571 HVTTTIAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.......++..|+|||.+.. ..++.++|||||||+++||++|+.|+........+.. ..........++.
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~ 253 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-----IPRNPPPTLHQPE 253 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-----ccccCCCcccCCC
Confidence 12233468899999998753 4578899999999999999999999865432111111 0011101111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
. ....+.+++.+|++.+|++|||+.|+++.
T Consensus 254 ~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 254 L-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred C-------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 12357899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=269.85 Aligned_cols=233 Identities=21% Similarity=0.307 Sum_probs=177.5
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
..||+|+||.||++.. ++..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 4699999999999987 46699999987666556677999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 510 ALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 510 ~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
+++... .+.+..... .+|....+||||||+||++++++.+||+|||++........ ......++
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~ 181 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKSLVGT 181 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---cCceeecC
Confidence 988543 233333333 33333349999999999999999999999999876532211 12234578
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
..|+|||.+.+..++.++||||||++++||++|+.||...... +...... . ...+.+.... .....+.
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~-~-----~~~~~~~~~~--~~~~~~~ 249 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIR-D-----NLPPRVKDSH--KVSSVLR 249 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-h-----cCCCcccccc--ccCHHHH
Confidence 8999999998888999999999999999999999998654321 1111111 0 1111111110 1122567
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+++.+|+..+|++|||++++++.
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 89999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=285.63 Aligned_cols=241 Identities=18% Similarity=0.282 Sum_probs=172.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+++. .++.||||++.... ......+.+|+++|++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 357899999999999987 46699999986532 1234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC--------
Q 004935 505 NGNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-------- 568 (723)
Q Consensus 505 ~gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-------- 568 (723)
+|+|.+++...... .. +....+..+|+...+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~ 164 (376)
T cd05598 85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164 (376)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccc
Confidence 99999998764321 11 222334445555559999999999999999999999999753210000
Q ss_pred --------------------------------CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 569 --------------------------------GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 569 --------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
.........||+.|+|||.+.+..++.++|||||||+++||++|+.||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf 244 (376)
T cd05598 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244 (376)
T ss_pred ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCC
Confidence 000012346999999999999999999999999999999999999999
Q ss_pred ccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 004935 617 ERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRP---TMNQVVME 682 (723)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---sm~evl~~ 682 (723)
........ ......... ....+. .... ...+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 245 ~~~~~~~~----~~~i~~~~~--~~~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 245 LADTPAET----QLKVINWET--TLHIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCHHHH----HHHHhccCc--cccCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 76542211 111111000 000010 0111 224556777765 4999999 77888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=260.10 Aligned_cols=238 Identities=24% Similarity=0.376 Sum_probs=181.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|.. +++.+++|.+........+.+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 457899999999999998 456899999987665567889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..++. ...+..+|+...+||||||+||++++++.+||+|||++....... .......
T Consensus 87 l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~ 162 (262)
T cd06613 87 LQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---AKRKSFI 162 (262)
T ss_pred HHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---hcccccc
Confidence 999886541 12222 233344444444999999999999999999999999987653221 1223356
Q ss_pred CCCccccccccccC---CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 578 GTPGYLDPEYYISN---RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 578 gt~~y~aPE~~~~~---~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
++..|+|||.+.+. .++.++|||||||+++||+||+.|+........... ...... ..+.+. .....
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~~~---~~~~~~--~~~~~ 232 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKSNF---PPPKLK--DKEKW 232 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhccC---CCcccc--chhhh
Confidence 78899999998776 889999999999999999999999875432211111 111100 001111 11223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|.+|||+++|+.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=260.59 Aligned_cols=237 Identities=21% Similarity=0.344 Sum_probs=171.1
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 501 (723)
.+.||+|+||.||+|.. ++..||||.+.... ....+.+.+|++++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 57899999999999987 46699999875321 22346788999999999999999999988663 45779999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+++++|.+++..... ..+.|.. .+..+|+...+|+||||+||+++.++.++|+|||+++............
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 166 (265)
T cd06652 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166 (265)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccccccc
Confidence 9999999999865422 1122222 2233333334999999999999999999999999988653211111112
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....++..|+|||.+.+..++.++|||||||+++||++|+.||...... .. ......... .+ ..+..
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~-~~~~~~~~~-----~~----~~~~~ 233 (265)
T cd06652 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AA-IFKIATQPT-----NP----VLPPH 233 (265)
T ss_pred ccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HH-HHHHhcCCC-----CC----CCchh
Confidence 2345888999999998888999999999999999999999998654221 11 111111110 11 11222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|+. +|++||+++|+++
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 33466788888885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=278.84 Aligned_cols=246 Identities=19% Similarity=0.220 Sum_probs=175.4
Q ss_pred HHHhhhhccccCcEEEEEEEEC----CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD----GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.+.||+|+||.||++... +..||+|.+... +.+.+|+++|++++|+||+++++++......++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 3455678999999999999763 347999988643 3456899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+. ++|.+++... ..+.+...+.+ +|+...+||||||+|||++.++.+||+|||+++....... ...
T Consensus 168 ~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~-~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-TPQ 243 (392)
T ss_pred cC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-ccc
Confidence 96 5888887432 23444444433 3333349999999999999999999999999976543221 122
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccccc---HHHHHHHHhcCCCcccc--------
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH---ITQWVSFMLGKGDIESI-------- 641 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~i-------- 641 (723)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ +...++ .+......-.
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccchhHH
Confidence 2345789999999999999999999999999999999999999965432211 111111 1111000000
Q ss_pred -----cCCcccCCCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 642 -----VDPRLHEDFDI-------NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 642 -----~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+..... .....+.+++.+|+..+|++|||+.|++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 112356788999999999999999999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=269.17 Aligned_cols=233 Identities=20% Similarity=0.294 Sum_probs=177.3
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
..||+|+||.||++.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999987 56799999987655455567899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 510 ALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 510 ~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
+++... .+++.... ..+|+...+||||||+||+++.++.+||+|||++....... .......++
T Consensus 107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~ 180 (297)
T cd06659 107 DIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKRKSLVGT 180 (297)
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---ccccceecC
Confidence 987543 23333333 33333334999999999999999999999999987653221 112335688
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
..|+|||.+.+..++.++|||||||+++||++|+.||...... +........ .. +.... .......+.
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~-----~~~~~--~~~~~~~l~ 248 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLRDS-PP-----PKLKN--AHKISPVLR 248 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcc-CC-----CCccc--cCCCCHHHH
Confidence 9999999999888999999999999999999999998644321 111111111 00 00000 001123567
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+++.+|++.+|++||+++++++.
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=262.19 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=175.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh----------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA----------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~----------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
.+.||+|+||.||+|.. +++.||+|.+..... ...+.+..|++++++++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46899999999999987 467999998764211 113467889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
|+||+++|+|.+++.... .+.+... +..+|+...+||||+|+||+++.++.++|+|||+++.......
T Consensus 86 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 163 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD 163 (272)
T ss_pred EEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccc
Confidence 999999999999987652 2333332 2333333349999999999999999999999999986532211
Q ss_pred CceeeecccCCCccccccccccCC--CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNR--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
........++..|+|||.+.... ++.++||||||++++|+++|+.|+...... ..... .. .......+++..
T Consensus 164 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~-~~-~~~~~~~~~~~~ 237 (272)
T cd06629 164 -NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFK-LG-NKRSAPPIPPDV 237 (272)
T ss_pred -ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHH-hh-ccccCCcCCccc
Confidence 11223456788999999987654 889999999999999999999998643221 11111 11 111111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+....+.+++.+|++.+|++||++.+|++
T Consensus 238 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 238 ----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1122346789999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=276.00 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=174.0
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 498 (723)
.+.+.||+|+||.||++.. .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 3457899999999999987 4668999998753 233456788999999999999999999987543 35689
Q ss_pred EEEeCCCCCHHHHhccCCC--CC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 499 IYEFMANGNLQALLLGEEA--DI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~--~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
||||+++ +|.+.+...-. .. .+....+..+|....+||||||+|||++.++.+||+|||+++..... ..
T Consensus 107 v~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~ 181 (364)
T cd07875 107 VMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FM 181 (364)
T ss_pred EEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC----Cc
Confidence 9999976 67766643211 11 12223344444444599999999999999999999999999865321 12
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh------------------c
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML------------------G 634 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~------------------~ 634 (723)
.....+|..|+|||.+.+..++.++|||||||+++||++|+.||............+.... .
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (364)
T cd07875 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261 (364)
T ss_pred ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHh
Confidence 2345689999999999999999999999999999999999999975433222111111000 0
Q ss_pred C-CCcccc----cCCcc----cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 635 K-GDIESI----VDPRL----HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 635 ~-~~~~~i----~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
. ...... ..+.. ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000 00000 000011123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=274.41 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=174.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV 499 (723)
..+.||+|+||.||++.. .++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 357899999999999987 4679999998754 233456788999999999999999999988543 346899
Q ss_pred EEeCCCCCHHHHhccCCC--C----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 500 YEFMANGNLQALLLGEEA--D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~--~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|||+++ +|.+.+...-. . ..+....+..+|+...+||||||+|||++.++.+||+|||+++..... ...
T Consensus 101 ~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~ 175 (355)
T cd07874 101 MELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMM 175 (355)
T ss_pred hhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc----ccc
Confidence 999976 66666543211 1 112233344445555599999999999999999999999999864321 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH------------------hcC
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM------------------LGK 635 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~------------------~~~ 635 (723)
....+|..|+|||.+.+..++.++|||||||+++||++|+.||............+... ...
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (355)
T cd07874 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255 (355)
T ss_pred CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhc
Confidence 34568999999999999899999999999999999999999997543221111111110 000
Q ss_pred -CCcccccCCccc--------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 636 -GDIESIVDPRLH--------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 636 -~~~~~i~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+..+... ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00111123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=274.59 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=173.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV 499 (723)
..+.||+|+||.||++.. .+..||||++... .......+.+|+.+++.++||||+++++++.... ..++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 357899999999999987 4679999998653 2334567889999999999999999999986443 46899
Q ss_pred EEeCCCCCHHHHhccCC--CC----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 500 YEFMANGNLQALLLGEE--AD----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~--~~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|||+++ +|.+.+...- .. ..+....+..+|+...+||||||+|||++.++.+||+|||+++..... ...
T Consensus 105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~----~~~ 179 (359)
T cd07876 105 MELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN----FMM 179 (359)
T ss_pred EeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC----ccC
Confidence 999986 5665554321 11 122334445555555599999999999999999999999999764221 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH------------------HhcC
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF------------------MLGK 635 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~------------------~~~~ 635 (723)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||............... ....
T Consensus 180 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (359)
T cd07876 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259 (359)
T ss_pred CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhh
Confidence 3456889999999999999999999999999999999999999754322111111110 0000
Q ss_pred -CCcc-----cccCCcc-c--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 -GDIE-----SIVDPRL-H--EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 -~~~~-----~i~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... +....-. . ..........+.+++.+|++.+|++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 0 0000111345789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=280.22 Aligned_cols=241 Identities=22% Similarity=0.270 Sum_probs=174.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||++.. .++.+|+|++... .....+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 3457899999999999998 4568999998642 2223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC---CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 504 ANGNLQALLLGEEAD---IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~---~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
++|+|.+++...... .. +....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 126 ~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~--~~~~~~~ 203 (371)
T cd05622 126 PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTA 203 (371)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC--cccccCc
Confidence 999999998654211 11 22233444555555999999999999999999999999998754221 1222345
Q ss_pred cCCCccccccccccC----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 577 AGTPGYLDPEYYISN----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ................+ ..
T Consensus 204 ~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~-------~~ 272 (371)
T cd05622 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIMNHKNSLTFPD-------DN 272 (371)
T ss_pred ccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCcccCCC-------cC
Confidence 799999999998754 3789999999999999999999999754321 11122211111011100 01
Q ss_pred HHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTK--RPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~ 682 (723)
.....+.+++.+|+...+.+ ||+++|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 12235668899999844433 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.44 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=174.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|+. ++..||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 346799999999999998 46699999986542 2234678899999999999999999999999999999999998
Q ss_pred CCHHHHhccCC-CCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 506 GNLQALLLGEE-ADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 506 gsL~~~l~~~~-~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++|.+++.... ...+++.... ..+|+...+||||||+||+++.++.+||+|||++....... ....
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 159 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYT 159 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---cccc
Confidence 68988876432 2334443333 33333333999999999999999999999999997653221 1122
Q ss_pred cccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC-----------C----c
Q 004935 575 TIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG-----------D----I 638 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~----~ 638 (723)
...+++.|+|||.+.+. .++.++|||||||+++||+||+.||.................... . .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 33568899999988654 578999999999999999999999975433222211111110000 0 0
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.. ........+.+++.+|++.+|++|||+++|+.
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 240 PKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00012235679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=259.67 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=182.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||.|+||.||+|.. ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 3467899999999999987 45689999987543 33567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC-CCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc-eee
Q 004935 506 GNLQALLLGEEA-DILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT-HVT 573 (723)
Q Consensus 506 gsL~~~l~~~~~-~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~ 573 (723)
++|.+++..... ..+.+.. .+..+++...+||||||+||++++++.+||+|||++..+....... ...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 163 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccc
Confidence 999999875422 2333333 2334444444999999999999999999999999998765432211 122
Q ss_pred ecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC-
Q 004935 574 TTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD- 651 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~- 651 (723)
....++..|+|||.+... .++.++|||||||+++||++|+.||..........+... .. .+.+.....
T Consensus 164 ~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~------~~~~~~~~~~ 233 (267)
T cd06610 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----ND------PPSLETGADY 233 (267)
T ss_pred ccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CC------CCCcCCcccc
Confidence 334688899999998776 789999999999999999999999975543222222111 10 111111110
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 122346789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=261.68 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=177.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 456899999999999998 46799999986442 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|..+..... .+.+...+.++.+++ .+||||||+||+++.++.+||+|||++........ ....
T Consensus 85 ~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 159 (286)
T cd07847 85 TVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTD 159 (286)
T ss_pred cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---cccC
Confidence 99988765432 245554444444333 39999999999999999999999999987643221 1223
Q ss_pred ccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh----------cCCC-cccccC
Q 004935 576 IAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML----------GKGD-IESIVD 643 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~-~~~i~d 643 (723)
..++..|+|||.+.+ ..++.++||||||++++||++|+.||........+........ .... ......
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 457789999999876 4578999999999999999999999975543222211111100 0000 000001
Q ss_pred CcccCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+........ .....+.+++.+|++.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 111100110 11345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=259.49 Aligned_cols=235 Identities=24% Similarity=0.372 Sum_probs=179.9
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||+|.. ++..||+|++.... ....+.|.+|++++++++|+||+++++++..++..++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 34467899999999999987 46699999986543 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++... .+++.....++ |+...+|+||||+||+++.++.++|+|||++....... ....
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---~~~~ 159 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRN 159 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch---hhhc
Confidence 99999998653 24444443333 33333999999999999999999999999987653221 1122
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.+...+.++|||||||+++||++|+.|+...... ...... ..... +.+.+ ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~-~~~~~-----~~~~~----~~ 225 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVLFLI-PKNNP-----PTLEG----NY 225 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHHHHH-hcCCC-----CCCCc----cc
Confidence 345788999999998888999999999999999999999998654321 111111 11111 11211 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...+.+++.+|++.+|.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3457799999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.65 Aligned_cols=233 Identities=24% Similarity=0.399 Sum_probs=177.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
..+.||+|++|.||+|.. ++..|++|.+.... ....+.+..|++++++++|+||+++++++..+...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 346899999999999998 46799999986533 23456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++++|.+++.... .+.+.. .+..+|....+|+||+|+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~ 157 (258)
T cd06632 84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----F 157 (258)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----c
Confidence 99999999987542 233333 3333444444999999999999999999999999988653222 2
Q ss_pred eecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....++..|++||.+.... ++.++|+||||++++||++|+.||......... .......... .+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~-----~~~~--- 225 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSKELP-----PIPD--- 225 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcccCC-----CcCC---
Confidence 23456888999999987766 899999999999999999999998654321111 1111101111 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++||++.+++.
T Consensus 226 -~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 -HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12235678999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=264.45 Aligned_cols=235 Identities=23% Similarity=0.370 Sum_probs=187.0
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+++++.||+|.|+.|-.|++ .|..||||++.+... -....+.+|++-|+.++|||||+|+.+......+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45678899999999998876 899999999976543 34457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC-----CCCHHHHHHHHHhcc----ccccCCCCCCEEE-cCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEAD-----ILSWEGRLRIAIEAA----KVHRDVKSTNILL-SGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~-----~l~~~~~l~i~~~~a----~vH~Dlk~~NILl-~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.+++.. +..+..++-.|+.++ .|||||||+||.+ .+-|-+||.|||++-.+.+. ...
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG----~kL 175 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG----KKL 175 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----chh
Confidence 999999999876432 223334444444444 4999999999766 45688999999999876433 334
Q ss_pred ecccCCCccccccccccCCCC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
...+|++.|-|||.+.+..|+ +++||||+|||||-|++|++||+..++...+.. ++|-... .+.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-------------ImDCKYt--vPs 240 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-------------IMDCKYT--VPS 240 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-------------hhccccc--Cch
Confidence 567899999999999999986 689999999999999999999987765443332 2332221 223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++..|+..||.+|.+.++|+.
T Consensus 241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 241 HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 34456789999999999999999998874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=267.17 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=179.5
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|++|.||++... +..||+|.+..... ...+.+..|++++++++|+||+++++.+...+..++||||+++
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 468999999999999984 57999999976532 2456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc-----
Q 004935 506 GNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT----- 570 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~----- 570 (723)
++|.+++.......+.+.... ..+|....+||||||+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 165 (316)
T cd05574 86 GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165 (316)
T ss_pred CCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccc
Confidence 999999876543444444333 33333334999999999999999999999999987643221100
Q ss_pred ---------------------eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHH
Q 004935 571 ---------------------HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWV 629 (723)
Q Consensus 571 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~ 629 (723)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~-- 243 (316)
T cd05574 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN-- 243 (316)
T ss_pred cccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH--
Confidence 001123578899999999988899999999999999999999999975543221111
Q ss_pred HHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 630 SFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 630 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.... . ..+.. .......+.+++.+|++.+|++||+++..+++|-.
T Consensus 244 --~~~~-~------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 244 --ILKK-E------VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred --HhcC-C------ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 0 00111 11133468899999999999999995555444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=258.41 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=178.9
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||.||+|.. +++.|++|.+..... ...+.+..|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 46899999999999987 467999999876544 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee-eec
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV-TTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-~~~ 575 (723)
+|.+++.... .+.+... +..+|+...+|+||+|+||++++++.+||+|||++............ ...
T Consensus 85 ~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 162 (264)
T cd06626 85 TLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162 (264)
T ss_pred cHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence 9999987642 1233333 33333334499999999999999999999999999876433221111 123
Q ss_pred ccCCCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 576 IAGTPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
..++..|+|||.+.+.. .+.++||||||++++|+++|+.||....... ....... .+. .+.+....
T Consensus 163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~-~~~-----~~~~~~~~-- 231 (264)
T cd06626 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVG-AGH-----KPPIPDSL-- 231 (264)
T ss_pred CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHh-cCC-----CCCCCccc--
Confidence 46788999999998766 8999999999999999999999996543211 1111111 111 11111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|.+||++.|++.
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11335679999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=264.33 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=173.1
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC-----CceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG-----TNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-----~~~~lV~Ey 502 (723)
.+.||+|+||.||++.. +++.+|+|.+..... ...++.+|+.+++++ +|+|++++++++... +..++|+||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 46899999999999998 466899999865432 235678899999999 899999999998653 357899999
Q ss_pred CCCCCHHHHhccC--CCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 503 MANGNLQALLLGE--EADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 503 ~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
+++|+|.+++... ....+.+.....++.+ ...+||||||+||++++++.+||+|||+++......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--- 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--- 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc---
Confidence 9999999988642 2233555554444433 333999999999999999999999999988654221
Q ss_pred eeeecccCCCccccccccccC-----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 571 HVTTTIAGTPGYLDPEYYISN-----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.......++..|+|||.+... .++.++|||||||+++||++|+.|+........+.+ . ..+....+.++
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~- 256 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK----I-PRNPPPTLLHP- 256 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH----H-hcCCCCCCCcc-
Confidence 112234678899999987643 368999999999999999999999875432211111 1 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|++||++.|+++
T Consensus 257 ------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 257 ------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 112235789999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=258.16 Aligned_cols=234 Identities=24% Similarity=0.373 Sum_probs=178.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||++.. ++..+|+|.+.... ....+.+..|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 457899999999999987 46689999986542 33456899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCceeee
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++|.+++.......+++...+.++. +...+||||||+||+++++ ..+||+|||.+....... ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~----~~~ 159 (256)
T cd08220 84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----KAY 159 (256)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----ccc
Confidence 9999999765444445444443333 3333999999999999855 468999999998764321 122
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ..+...... .... +.. ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~~-~~~~-----~~~----~~ 225 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIMSG-TFAP-----ISD----RY 225 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHHhc-CCCC-----CCC----Cc
Confidence 345788999999999888999999999999999999999998654321 112211111 1111 111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||+.|+++
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 235779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=265.33 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=178.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh-----hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ-----GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|++|.||+|.. +++.|+||.+...... ....+..|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 456899999999999997 4679999999765322 335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+ +|+|.+++.... ..+++...+.++.+++ .+||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~ 158 (298)
T cd07841 84 M-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---K 158 (298)
T ss_pred c-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc---c
Confidence 9 899999997654 2455555554444433 38999999999999999999999999987643211 1
Q ss_pred eecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC--------CCcccccC
Q 004935 573 TTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK--------GDIESIVD 643 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~i~d 643 (723)
.....++..|+|||.+.+ ..++.++|||||||+++||++|.++|........+.......... ........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 223346778999998865 457899999999999999999988776543322221211111000 00000000
Q ss_pred CcccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
........ ......+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000111 122456789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=266.66 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=177.7
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|++++++++|+||+++++++......++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4578999999999999984 66999999865422 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|..+..... .++|...+.++.+++ .+||||+|+||++++++.++|+|||++....... .....
T Consensus 85 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 159 (286)
T cd07846 85 TVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYTD 159 (286)
T ss_pred cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---cccCc
Confidence 99988765432 256665555554444 3999999999999999999999999988653322 12223
Q ss_pred ccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH----------HhcCCCc-ccccC
Q 004935 576 IAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF----------MLGKGDI-ESIVD 643 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~-~~i~d 643 (723)
..++..|+|||.+.+ ..++.++||||||++++||++|++||............... ......+ .....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 457889999999875 45788999999999999999999988644321111111100 0000000 00000
Q ss_pred CcccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+...... .......+.+++.+|++.+|++||+|+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 1110000 0112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=258.53 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=181.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|++|.||++... ++.|++|.+.... ....+++.+|++++++++|+||+++++++...+..++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4578999999999999985 6689999987653 345577999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCC----------CHHHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEEADIL----------SWEGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~~l----------~~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|.+++.... ..+ ++...+..+|. ...+||||||+||++++++.++|+|||.+....... ...
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----~~~ 158 (265)
T cd06605 85 SLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKT 158 (265)
T ss_pred cHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----hhc
Confidence 9999987542 112 22333444555 445999999999999999999999999987653211 112
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc-cccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-RIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+..... .....+.++....... +.+... ..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---~~ 229 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------PRLPSG---KF 229 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------CCCChh---hc
Confidence 5678899999999998999999999999999999999999865421 1222233332222110 111111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|+..+|++|||+.+++.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 345789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=266.21 Aligned_cols=244 Identities=18% Similarity=0.268 Sum_probs=180.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++... ++.|++|.+..... ...+.+.+|+++++.++|+||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3578999999999999984 56899999876532 334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC------
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS------ 568 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~------ 568 (723)
+++|.+++.... .+.+.. .+..+|+...+||||||+||+++.++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (305)
T cd05609 85 GGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162 (305)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccc
Confidence 999999996542 233332 23333444449999999999999999999999999874211100
Q ss_pred ------CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 569 ------GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 569 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
.........++..|+|||.+....++.++|||||||+++||++|+.||.+... .+........ .. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~~~~-~~---~ 234 (305)
T cd05609 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISD-DI---E 234 (305)
T ss_pred ccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc-cc---C
Confidence 00011224578899999999888899999999999999999999999864322 2222221111 11 1
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.+.... .....+.+++.+|++.+|++||++.++.+.|+...
T Consensus 235 ~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 235 WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 111111 12235689999999999999999888888777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=264.13 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=176.4
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||.|++|.||+|+. ++..||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 46799999999999988 46799999987543 2234578999999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+++.....++.+ ...+||||+|+||++++++.+||+|||+++...... ......
T Consensus 84 ~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 160 (284)
T cd07860 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHE 160 (284)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc---cccccc
Confidence 8998887654444555444443333 333999999999999999999999999987653221 112233
Q ss_pred cCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---------------ccc
Q 004935 577 AGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---------------IES 640 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~ 640 (723)
.++..|+|||.+.+.. ++.++|||||||+++||+||+.||....+.....+..+..-.... ...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence 4678999999887654 688999999999999999999999755433222222221111000 000
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.. ........+.+++.+|++.+|++|||++++++
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 241 WARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 00011234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=262.48 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=178.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|.. ++..|++|++.... ....+.+.+|+.++++++|+||+++++++......++|+||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 457899999999999997 46799999987654 333567999999999999999999999999999999999999 9
Q ss_pred CCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... ..+.+.....+ +|+...+|+||||+||+++.++.++|+|||++........ .....
T Consensus 83 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 159 (286)
T cd07832 83 SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RLYSH 159 (286)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--Ccccc
Confidence 99999986543 23444444333 3333349999999999999999999999999987643221 11223
Q ss_pred ccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC------------ccccc
Q 004935 576 IAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD------------IESIV 642 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~i~ 642 (723)
..++..|+|||.+.+.. ++.++||||+|++++||+||+++|........+.. +........ ...+.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI-VFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH-HHHHcCCCChHHHhhccCcchhhccc
Confidence 46888999999987544 68999999999999999999877765433221111 111111100 00000
Q ss_pred CCccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLH----EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.-. .....+....+.+++.+|++.+|++||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 0000122367889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=257.76 Aligned_cols=242 Identities=23% Similarity=0.314 Sum_probs=176.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~~ 505 (723)
.+.||.|++|.||++.. .++.+|+|.+..... ....++.+|++++++++|+||++++++|... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 46899999999999998 456999999875432 4457799999999999999999999998653 467999999999
Q ss_pred CCHHHHhccC--CCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGE--EADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~--~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|.+++... ....++... .+..+|+...+|+||+|+||+++.++.++|+|||++....... .
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~ 160 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----A 160 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-----c
Confidence 9999887532 122233332 3333444444999999999999999999999999987643221 1
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc-ccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER-IHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ....+........ ....+.+ .... ..
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~--~~ 236 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKD-EPGN--GI 236 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cchhhcc-CCCC--CC
Confidence 2345788999999999889999999999999999999999999755221 1112222211111 1111100 0000 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++||||.|+++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 12346789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=264.83 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=174.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 356899999999999988 46689999987543 2233567899999999999999999999999999999999998 5
Q ss_pred CHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+.+. ..+..+|+...+||||||+||++++++.+||+|||++....... ......
T Consensus 89 ~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 164 (301)
T cd07873 89 DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---KTYSNE 164 (301)
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---Cccccc
Confidence 89888865422 22332 23334444444999999999999999999999999997643221 112234
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---CCccccc---------C
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---GDIESIV---------D 643 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i~---------d 643 (723)
.+++.|+|||.+.+. .++.++|||||||+++||+||+.||........... +...... .....+. .
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF-IFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCChhhchhhhcccccccccc
Confidence 568899999988654 578899999999999999999999975432211111 1111110 0000000 0
Q ss_pred CcccCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDF----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+...... .......+.+++.+|++.+|.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110000 0112335679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=258.52 Aligned_cols=233 Identities=20% Similarity=0.285 Sum_probs=178.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|++|.||++.. +++.+++|.+........+.+.+|+.++++++|+||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 35899999999999987 4568999998766555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++... .+++.. .+..+|+...+||||+|+||+++.++.++|+|||.+....... .......+
T Consensus 104 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~ 177 (285)
T cd06648 104 TDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---PRRKSLVG 177 (285)
T ss_pred HHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC---cccccccC
Confidence 9998763 233332 2333444444999999999999999999999999887653221 11233458
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|+|||.+.+..++.++|||||||+++||++|+.||..... .......... .. +.+.. .......+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~~~-~~-----~~~~~--~~~~~~~l 245 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIRDN-LP-----PKLKN--LHKVSPRL 245 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHhc-CC-----CCCcc--cccCCHHH
Confidence 8999999999888899999999999999999999999865322 1222211111 10 11111 01122468
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+++.+|++.+|++||++.++++
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHcc
Confidence 89999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=279.37 Aligned_cols=190 Identities=23% Similarity=0.411 Sum_probs=151.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||++.. .++.||+|++.... ......+..|+.++.+++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 47899999999999988 46699999987532 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC----CCCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC--------
Q 004935 506 GNLQALLLGEEA----DILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-------- 569 (723)
Q Consensus 506 gsL~~~l~~~~~----~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------- 569 (723)
|+|.+++..... ....|..+ +..+|+...+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~ 165 (360)
T cd05627 86 GDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165 (360)
T ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccccccc
Confidence 999999875422 11223333 33444444599999999999999999999999998754321100
Q ss_pred ------------------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc
Q 004935 570 ------------------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH 620 (723)
Q Consensus 570 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~ 620 (723)
........||+.|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 001123468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-31 Score=251.73 Aligned_cols=239 Identities=24% Similarity=0.376 Sum_probs=181.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.+.||+|.|+.||+... .|+..|+|++... +..+.+.+.+|+++.+.++|||||+|.....+....+||+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 44567899999999999876 5778888887533 3446788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC----CCC----CCCHHHHHHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCCCcee
Q 004935 504 ANGNLQALLLGE----EAD----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 504 ~~gsL~~~l~~~----~~~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
.+|.|..-+-.+ +.. ..+....+..+|.-..||||+||+|+||... --+||+|||++..+. ....
T Consensus 93 ~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~----~g~~ 168 (355)
T KOG0033|consen 93 TGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN----DGEA 168 (355)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC----Cccc
Confidence 999997554332 111 2234445566666666999999999999643 348999999999875 2345
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....|||+|||||.+...+|+..+|||+.||||+-|+.|.+||.+........+ +..+.. + ++++...
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~-----I~~g~y-d-~~~~~w~---- 237 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ-----IKAGAY-D-YPSPEWD---- 237 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-----Hhcccc-C-CCCcccC----
Confidence 5678899999999999999999999999999999999999999986433222222 111111 1 1121111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+++.+|+..||++|.|+.|++.
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 12234568999999999999999998874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=261.62 Aligned_cols=232 Identities=25% Similarity=0.367 Sum_probs=174.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||+|.. ++..||+|.+.... ....+++.+|++++++++|+|+++++++|...+..++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 456899999999999987 46699999986432 2344678999999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|+|.+.+.... ..++|.....++.++ ..+||||+|+||+++.++.+||+|||++..... ..
T Consensus 109 -g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-------~~ 179 (317)
T cd06635 109 -GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------AN 179 (317)
T ss_pred -CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-------cc
Confidence 47877765432 235555554444333 339999999999999999999999999876432 12
Q ss_pred cccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 575 TIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
...++..|+|||.+. .+.++.++|||||||+++||++|+.|+........+.. ....+. +... .
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~---~ 246 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNES------PTLQ---S 246 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccC------CCCC---C
Confidence 345788999999974 45689999999999999999999999865432111111 111110 0111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
......+.+++.+|++.+|.+||++.++++.+
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11233578999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.07 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=189.3
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh---hHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ---GYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.+.||+|.||.||++.. +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.+.+.++.....++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 345568999999999999998 4679999999775432 3468899999999998 999999999999999999999
Q ss_pred EeCCCCCHHHHhccC-CC--C----CCCHHHHHHHHHhccccccCCCCCCEEEcCC----CcEEEEeccCccccCCCCCC
Q 004935 501 EFMANGNLQALLLGE-EA--D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK----FQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~-~~--~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~----~~~kl~DfGla~~~~~~~~~ 569 (723)
|++.+|.|.+.+... -. + ..+....++++|....+||||||+|+|+... +.+|++|||++.....
T Consensus 116 EL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---- 191 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---- 191 (382)
T ss_pred EecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC----
Confidence 999999999988765 11 1 1233344566666666999999999999643 4799999999998754
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.......+||+.|+|||.+....|+..+||||.||++|.|++|.+||....+.....+ +..++. +.-++.+
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~~~~-~f~~~~w--- 262 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILRGDF-DFTSEPW--- 262 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHcCCC-CCCCCCc---
Confidence 2345678899999999999999999999999999999999999999987764433332 112211 1111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+-+++..|+..||.+|+|+.++++
T Consensus 263 --~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 263 --DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred --cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 122345679999999999999999999998
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=272.32 Aligned_cols=229 Identities=24% Similarity=0.356 Sum_probs=180.1
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+-||.|+||.||-|+. +...||||+++... ...+.++.+|++.|.+++|||++.+-|||......+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 5699999999999988 45689999998654 44577899999999999999999999999999999999999964
Q ss_pred CHHHHhccCCCC---------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 507 NLQALLLGEEAD---------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 507 sL~~~l~~~~~~---------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|-.+++.-.... ...-.+.+.++|....||||||+.||||.+.|.+||+|||.|.... ....+.
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-------PAnsFv 183 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-------PANSFV 183 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------chhccc
Confidence 777777543221 1223345666666667999999999999999999999999997753 234578
Q ss_pred CCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 578 GTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 578 gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
|||.|||||++. .+.|+-|+||||+||+..||.-+++|...++....+-.+ ...+ .|.|.. .+=
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNe-------sPtLqs---~eW 250 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNE-------SPTLQS---NEW 250 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcC-------CCCCCC---chh
Confidence 999999999986 467999999999999999999999998766543222211 1111 133331 123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++..|++.-|.+|||.++++.
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 346789999999999999999988764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=258.12 Aligned_cols=233 Identities=23% Similarity=0.419 Sum_probs=177.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|.. ++..||+|.+.... .....++.+|++++++++ |+|++++++++..+...++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 457899999999999997 46799999987543 344567899999999997 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++++|.+++... .+.+... +..+|+...+||||+|+||++++++.++|+|||++....... ...
T Consensus 85 ~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---~~~ 158 (277)
T cd06917 85 EGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---SKR 158 (277)
T ss_pred CCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---ccc
Confidence 999999998654 3444333 333444444999999999999999999999999998764332 122
Q ss_pred ecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.++ .++.++|||||||++|||++|+.||..... ...... .... ..+.+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~-~~~~-----~~~~~~~~--- 225 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMML-IPKS-----KPPRLEDN--- 225 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhhc-cccC-----CCCCCCcc---
Confidence 334688899999988654 468999999999999999999999965422 111111 1110 11122211
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++||++.+++.
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 12346789999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=261.93 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=178.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
..+.||.|++|.||+|.. ++..||+|++.... ....+.+.+|++++++++|+|++++++++...+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 356799999999999987 57799999987543 2233578899999999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.......+++...+.++.+++ .+||||+|+||+++.++.++|+|||+++...... .....
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~ 158 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTH 158 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---cccCc
Confidence 6899998765434456665555544433 3999999999999999999999999997653221 11122
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---------------cc
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---------------IE 639 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~ 639 (723)
..++..|+|||.+.+. .++.++||||||+++|||++|+.||........+.+..+....... ..
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3467899999987664 5789999999999999999999998755432222222221110000 00
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+... .........+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 239 KWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 001112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.67 Aligned_cols=233 Identities=23% Similarity=0.352 Sum_probs=173.9
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+...+.||+|+||.||+|.. +++.||+|.+.... ....+++.+|++++++++||||++++++|...+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 34567899999999999987 46799999986432 33446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
++ |++.+++.... ..+++.....++ |....+||||+|+||++++++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------ 168 (307)
T cd06607 97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------ 168 (307)
T ss_pred hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC------
Confidence 97 57777665332 224444443333 3333399999999999999999999999998764321
Q ss_pred eecccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 573 TTTIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
....++..|+|||.+. ...++.++||||||+++|||+||+.|+....... ..... ..... +.+.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~~-~~~~~-----~~~~-- 235 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHI-AQNDS-----PTLS-- 235 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHHH-hcCCC-----CCCC--
Confidence 2345788999999874 3568899999999999999999999986543211 11111 11111 1111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.......+.+++.+||+.+|++||+|.+++..
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11123467899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=279.64 Aligned_cols=244 Identities=18% Similarity=0.265 Sum_probs=168.0
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCC------ceeeEEEEEecC-CceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK------NLTTLVGYCDEG-TNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~------nIv~l~g~~~~~-~~~~lV 499 (723)
.+.+.||+|+||.||+|.. .++.||||+++... ...+.+..|++++.+++|. +++.+++++... .+.++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 3457899999999999988 45689999996532 2234567788888777554 588999988654 567889
Q ss_pred EEeCCCCCHHHHhccCCCC--------CCCHHHHHHHHHh-ccccccCCCCCCEEEcCCC----------------cEEE
Q 004935 500 YEFMANGNLQALLLGEEAD--------ILSWEGRLRIAIE-AAKVHRDVKSTNILLSGKF----------------QAKI 554 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~--------~l~~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~----------------~~kl 554 (723)
||++ +++|.+++...... ..+....+..+|. ...|||||||+|||++.++ .+||
T Consensus 211 ~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl 289 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289 (467)
T ss_pred Eecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence 9988 67888887654210 1122334455554 3559999999999998765 4999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
+|||.+.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........+.. +...+.
T Consensus 290 ~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-i~~~~g 362 (467)
T PTZ00284 290 CDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL-MEKTLG 362 (467)
T ss_pred CCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHcC
Confidence 9999886432 123346789999999999999999999999999999999999999976543222111 111110
Q ss_pred C---------------------CCcccccCCcc----cC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 635 K---------------------GDIESIVDPRL----HE---DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 635 ~---------------------~~~~~i~d~~l----~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. +.+....++.. .. .........+.+++.+||+.||.+|||++|+++
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 00000001100 00 000011245779999999999999999999986
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=291.18 Aligned_cols=236 Identities=23% Similarity=0.342 Sum_probs=173.4
Q ss_pred HHhhhhccccCcEEEEEEEEC--CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYE 501 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E 501 (723)
+.+.+.||+|+||.||++... +..||+|.+... .......|..|+.++++++||||+++++++.. ....+||||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 344678999999999999984 558999998754 23345678999999999999999999998754 456889999
Q ss_pred eCCCCCHHHHhccCC--CCCCCH----------HHHHHHHHhcc-------ccccCCCCCCEEEcC--------------
Q 004935 502 FMANGNLQALLLGEE--ADILSW----------EGRLRIAIEAA-------KVHRDVKSTNILLSG-------------- 548 (723)
Q Consensus 502 y~~~gsL~~~l~~~~--~~~l~~----------~~~l~i~~~~a-------~vH~Dlk~~NILl~~-------------- 548 (723)
|+++|+|.+++.... ...+.+ ...|..+|... .|||||||+||||+.
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 999999999986531 122332 23344455433 499999999999964
Q ss_pred ---CCcEEEEeccCccccCCCCCCceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccc
Q 004935 549 ---KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERI 623 (723)
Q Consensus 549 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~ 623 (723)
...+||+|||+++.+.... ......||+.|+|||.+.+ ..++.++|||||||+||||+||+.||.....
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-- 248 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-- 248 (1021)
T ss_pred cCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--
Confidence 2358999999998653221 2234568999999999864 4588999999999999999999999975432
Q ss_pred cHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 624 HITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 624 ~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+...... +.+... .....+.+++..||+.+|.+||++.|++.
T Consensus 249 -~~qli~~lk~~--------p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 -FSQLISELKRG--------PDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -HHHHHHHHhcC--------CCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22222222111 111100 11235789999999999999999999984
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.83 Aligned_cols=241 Identities=21% Similarity=0.300 Sum_probs=170.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||+|++... .....+.|.+|+.++.+++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 457899999999999998 4669999998642 22234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC-----CCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGEEAD-----ILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~~~~-----~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|+|.+++...... ...+ ...+..+|+...+||||||+|||++.++.+||+|||++....... ......
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 162 (331)
T cd05597 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNV 162 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC--Cccccc
Confidence 99999998653211 1122 233444444445999999999999999999999999987653221 112223
Q ss_pred ccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..||+.|+|||.+.. ..++.++|||||||++|||++|+.||..... .+.............+ +.....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~- 235 (331)
T cd05597 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEHFQF--PPDVTD- 235 (331)
T ss_pred eeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCcccC--CCccCC-
Confidence 468999999999863 4578899999999999999999999965432 2222222211111111 111111
Q ss_pred CHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 004935 651 DINSVWKTVEIAMACVS--QTSTKRPTMNQVVME 682 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~--~~p~~RPsm~evl~~ 682 (723)
....+.+++.+|+. .++..||+++++++.
T Consensus 236 ---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 236 ---VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 12245566666554 444458898888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=270.04 Aligned_cols=176 Identities=23% Similarity=0.303 Sum_probs=141.0
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|... +..||+|+.... ....|+.++++++|+||+++++++......++|+||+. +
T Consensus 69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 44678999999999999985 458999985433 23569999999999999999999999999999999995 5
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+.+...+.++.+++ .+||||||+|||++.++.+||+|||+++..... ......
T Consensus 142 ~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~ 216 (357)
T PHA03209 142 DLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA----PAFLGL 216 (357)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC----cccccc
Confidence 8888876532 2345554444443333 399999999999999999999999999753211 112345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
.||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 6899999999999999999999999999999999876554
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=260.59 Aligned_cols=236 Identities=22% Similarity=0.333 Sum_probs=182.2
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|++|.||+|... +..|++|.+..... ..+.+.+|++.+++++|+|++++++++......++|+||++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 34578999999999999985 67999999986654 5577899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++...+.++.+++ .+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 101 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~ 176 (286)
T cd06614 101 SLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---SKRNSV 176 (286)
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---hhhccc
Confidence 9999998754 3456655555444433 3999999999999999999999999987653221 112234
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.++..|+|||.+.+..++.++|||||||+++||++|+.|+........ ..... ........++ .....
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~-------~~~~~ 244 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----LFLIT-TKGIPPLKNP-------EKWSP 244 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH-hcCCCCCcch-------hhCCH
Confidence 578899999999888899999999999999999999999865432111 11111 1111111110 11223
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+++.+|++.+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhh
Confidence 6779999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=255.31 Aligned_cols=235 Identities=23% Similarity=0.368 Sum_probs=177.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~ 503 (723)
+.+.||.|+||.||++.. ++..||+|.+... .....+++..|++++++++|+||+++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 456899999999999987 4568999998754 23445678999999999999999999998754 45578999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHH----------HHHHH-----hccccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 504 ANGNLQALLLGE--EADILSWEGR----------LRIAI-----EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~----------l~i~~-----~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++++|.+++... ....+++... +..+| +...+|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999998653 1233444333 33344 333489999999999999999999999999876432
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
. .......++..|+|||.+.+..++.++||||||+++++|++|+.|+..... .+... ....+.. +.+
T Consensus 164 ~---~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~-----~~~ 230 (265)
T cd08217 164 S---SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLAS-KIKEGKF-----RRI 230 (265)
T ss_pred c---ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHH-HHhcCCC-----CCC
Confidence 2 112334688999999999988899999999999999999999999975432 11111 1112111 111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.+++.+|++.+|++||++++|++
T Consensus 231 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 231 ----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1123346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=259.97 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=173.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||.||++.. .++.||+|.+.... ......+.+|+.++.++. |+||+++++++......++++||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 46899999999999998 46699999987543 344567899999999996 99999999999999999999999875
Q ss_pred CHHHHh---ccCCCCCCCHHH----------HHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 507 NLQALL---LGEEADILSWEG----------RLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 507 sL~~~l---~~~~~~~l~~~~----------~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
++.++. .......+.+.. .+..+++. ..+||||||+||+++.++.+||+|||+++...... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~ 163 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----A 163 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC----c
Confidence 554432 222222233332 23333332 44999999999999999999999999997653221 1
Q ss_pred eecccCCCccccccccccC---CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 573 TTTIAGTPGYLDPEYYISN---RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~---~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||.... ...+.+...... . .+.+...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~-~-----~~~~~~~ 234 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKG-D-----PPILSNS 234 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCC-C-----CCcCCCc
Confidence 1234578899999998766 68999999999999999999999986543 111212211111 0 1222222
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
........+.+++.+|++.+|++|||+++|++.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222234568899999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=251.42 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=187.4
Q ss_pred hhhccccCcEEEEEEEECC--ceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||.|.-|+||.+.+.+ ...|+|++.+.. .+...+.+.|-+||+.+.||.++.|++.++.....+|+||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4689999999999999976 589999998764 34456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCH------HHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCC---------
Q 004935 506 GNLQALLLGEEADILSW------EGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE--------- 566 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~------~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~--------- 566 (723)
|+|..+++++....++- ..-+-.|+++.| |.|||||+||||.++|++.|+||.++......
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~ 241 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSP 241 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCC
Confidence 99999998875544432 233344444444 99999999999999999999999998654210
Q ss_pred -----------------------CCC---------------------ceeeecccCCCccccccccccCCCCChhhHHHH
Q 004935 567 -----------------------GSG---------------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNF 602 (723)
Q Consensus 567 -----------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~Sf 602 (723)
... ...+....||-.|+|||.+.+...+.++|.|+|
T Consensus 242 ~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtf 321 (459)
T KOG0610|consen 242 RSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTF 321 (459)
T ss_pred CCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHH
Confidence 000 011123469999999999999999999999999
Q ss_pred HHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 603 GVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 603 GvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
||+||||+.|+.||.+.+....+...+.+- +.+.+ ..+....+.+||.+.|.+||++|...+.=++.
T Consensus 322 GIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-----------l~Fp~--~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 322 GIFLYEMLYGTTPFKGSNNKETLRNIVGQP-----------LKFPE--EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred HHHHHHHHhCCCCcCCCCchhhHHHHhcCC-----------CcCCC--CCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 999999999999999887665554433321 11211 22445577899999999999999984433333
Q ss_pred HHH
Q 004935 683 LNE 685 (723)
Q Consensus 683 L~~ 685 (723)
+++
T Consensus 389 IK~ 391 (459)
T KOG0610|consen 389 IKR 391 (459)
T ss_pred hhc
Confidence 433
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.59 Aligned_cols=235 Identities=24% Similarity=0.381 Sum_probs=180.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 457899999999999998 46689999986542 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCceeee
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++|.+++.......+++...+.++.+++ .+|+||||+||++++++ .+||+|||.+....... ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 160 (257)
T cd08225 84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---ELAY 160 (257)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---cccc
Confidence 9999998765444456655554444433 39999999999999885 56999999998764321 1222
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.+..++.++||||||++++||++|+.|+.... ..+++...... .... ... ..
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~-----~~~----~~ 226 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQG-YFAP-----ISP----NF 226 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc-cCCC-----CCC----CC
Confidence 3458889999999988889999999999999999999999986432 22333322211 1111 111 11
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||+.|+++
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 235789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=262.66 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=178.5
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+.+.||+|+||.||+|... ++.|++|.++... ....+.+.+|++++++++|+||+++++++..++..++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 34578999999999999984 5689999987542 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++.+..+..... .+++.. .+..+|+...+||||+|+||++++++.+||+|||++........ ....
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~~~~ 159 (288)
T cd07833 84 RTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--SPLT 159 (288)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--cccc
Confidence 987776665432 133333 33334444449999999999999999999999999987643321 1223
Q ss_pred cccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc------------CCCcc--
Q 004935 575 TIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG------------KGDIE-- 639 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~~~-- 639 (723)
...++..|+|||.+.+. .++.++||||||++++||++|+.||........+..... ... .....
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK-CLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCCHHHhhhcccCcccccc
Confidence 35678899999999888 789999999999999999999999875433221111111 100 00000
Q ss_pred ---cccCCc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 ---SIVDPR-LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ---~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...++. +...........+.+++.+|+..+|++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000011112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.24 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=175.4
Q ss_pred hhcccc--CcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNG--GFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
..||+| +||+||++.. .++.||+|++.... ....+.+.+|+.+++.++|+||++++++|..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 9999999988 67899999987543 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee---
Q 004935 506 GNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV--- 572 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~--- 572 (723)
|+|.+++.......+.+.. .+..+|+...+||||||+|||++.++.++++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999998764333333333 333344444499999999999999999999999865433221111100
Q ss_pred -eecccCCCccccccccccC--CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH-----------------
Q 004935 573 -TTTIAGTPGYLDPEYYISN--RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM----------------- 632 (723)
Q Consensus 573 -~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~----------------- 632 (723)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 1112345679999998764 47899999999999999999999997543221111111000
Q ss_pred ---------------hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 633 ---------------LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 633 ---------------~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+....+.+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000111111222222334567899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=264.15 Aligned_cols=236 Identities=21% Similarity=0.317 Sum_probs=179.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||++.. ++..|++|.+........+.+.+|+.++++++|||+++++++|...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 3457899999999999986 56689999987655555677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... +.+.... ..+|+...+||||||+||+++.++.+||+|||++........ .....
T Consensus 102 ~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~ 175 (293)
T cd06647 102 SLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 175 (293)
T ss_pred cHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---ccccc
Confidence 9999987532 3333333 333444449999999999999999999999999876543221 12234
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.+++.|+|||.+....++.++||||||+++||+++|+.||........+.. ....+. +.+. .......
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~------~~~~--~~~~~~~ 243 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGT------PELQ--NPEKLSA 243 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCC------CCCC--CccccCH
Confidence 688899999999888899999999999999999999999975432111110 000000 1111 0111233
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.+.+++.+||+.+|++||++.+++..
T Consensus 244 ~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 244 IFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 57789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.26 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=184.0
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|++|.||+|... ++.|+||++..... ...+.+.+|++.+.+++|+|++++++++...+..++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 3578999999999999984 67999999887654 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC----CC----CCHHHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 507 NLQALLLGEEA----DI----LSWEGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 507 sL~~~l~~~~~----~~----l~~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+|.+++..... .. .+....+..+|+ ...+||||+|+||+++.++.++|+|||++........ ......
T Consensus 85 ~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~ 161 (264)
T cd06623 85 SLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---QCNTFV 161 (264)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---ccccee
Confidence 99999975421 11 122334455555 5559999999999999999999999999987643222 112345
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
++..|+|||.+.+..++.++||||||++++||+||+.|+...... ...+........ .. +.+... .....
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~-~~-----~~~~~~---~~~~~ 231 (264)
T cd06623 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDG-PP-----PSLPAE---EFSPE 231 (264)
T ss_pred ecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcC-CC-----CCCCcc---cCCHH
Confidence 788999999999888999999999999999999999998765421 122222222211 11 111111 02347
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+.+++.+|++.+|++||++.++++.
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 8899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.72 Aligned_cols=235 Identities=21% Similarity=0.289 Sum_probs=174.9
Q ss_pred ccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||+||++.. +++.||+|.+.... ......+..|++++++++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999987 46799999986532 22345678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.+ +|+...+||||+|+||++++++.+||+|||++...... .......+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAG 156 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----CccccccC
Confidence 99987654444555444433 33333499999999999999999999999998765321 11223457
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|+|||.+.+..++.++|||||||+++||++|+.||................. .. ....... ....+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------~~~~~~~----~~~~~ 225 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EM------AVEYPDK----FSPEA 225 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cc------cccCCcc----CCHHH
Confidence 7899999999888899999999999999999999999965443222111111110 00 0111111 13357
Q ss_pred HHHHHhccCCCCCCCCCHHH-HHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQ-VVMEL 683 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~e-vl~~L 683 (723)
.+++.+|++.+|++||+.++ .+..|
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHH
Confidence 79999999999999996555 44444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=245.30 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=182.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hh---hHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQ---GYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~---~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.||.|..+.|-+... .+++.|+|++.... .. -.+.-.+|+.+|+++ .||+|+.+.+++......++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 56899999999988877 46689999885421 11 123457899999998 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccC----CCCCCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 500 YEFMANGNLQALLLGE----EADILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~----~~~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|.|+.|.|.++|... +.+.-..+++ +..+|....|||||||+|||+|+++++||+|||.++.++...
T Consensus 102 Fdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---- 177 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---- 177 (411)
T ss_pred hhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch----
Confidence 9999999999999764 2222223333 334444444999999999999999999999999999875432
Q ss_pred eeecccCCCcccccccccc------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 572 VTTTIAGTPGYLDPEYYIS------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.....+||++|+|||.+.. ..|+...|.|+.|||++.|+.|.+||....... +..++.+|.. +.-.|.
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----MLR~ImeGky-qF~spe 251 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----MLRMIMEGKY-QFRSPE 251 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----HHHHHHhccc-ccCCcc
Confidence 3456789999999999864 358889999999999999999999996432211 1223333321 111122
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhhhhHh
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM--ELNESLAIET 691 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~--~L~~~~~~~~ 691 (723)
+. +....+-+++.+|++.||.+|.|.+|+++ .+..+++.+.
T Consensus 252 Wa-----dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 252 WA-----DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred hh-----hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 21 22335669999999999999999999987 3444544443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.29 Aligned_cols=235 Identities=23% Similarity=0.418 Sum_probs=171.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEec------CCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE------GTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. .+..+|+|++.... ....++..|+.+++++ +|+||+++++++.. ....+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 357899999999999998 45689999986543 2345788999999999 79999999999853 45679999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++.......+.+.. .+..+|+...+||||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--- 175 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--- 175 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc---
Confidence 999999999998754333333322 2333333344999999999999999999999999987643211
Q ss_pred eeeecccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 571 HVTTTIAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.......++..|+|||.+. ...++.++|||||||+++||++|+.||........... ..... .+.
T Consensus 176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-----~~~~~-----~~~ 245 (282)
T cd06636 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRNP-----PPK 245 (282)
T ss_pred cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-----HhhCC-----CCC
Confidence 1123356888999999876 34578899999999999999999999865432111110 10100 111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.. ......+.+++.+||+.+|.+||++.|+++
T Consensus 246 ~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 246 LKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Ccc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111 112346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=260.45 Aligned_cols=237 Identities=21% Similarity=0.368 Sum_probs=182.4
Q ss_pred hhhhccccCcEEEEEEEECC-ceEEEEEecCC--ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPS--SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
..+.||+||.+.||++...+ +.+|+|++... +.+....|..|+..|.++ .|.+|+.|++|-..++.++|||||=+.
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~ 444 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI 444 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc
Confidence 35789999999999999854 47888876543 455667899999999999 599999999999999999999998654
Q ss_pred CCHHHHhccCCCCCCCH------HH---HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 506 GNLQALLLGEEADILSW------EG---RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~------~~---~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.++|.+.......| .+ .+..+|+...||.||||.|+|+-. |.+||+|||+|..+..+. ........
T Consensus 445 -DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT-TsI~kdsQ 521 (677)
T KOG0596|consen 445 -DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT-TSIVKDSQ 521 (677)
T ss_pred -cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccc-cceeeccc
Confidence 9999998875544433 22 344556666799999999999865 589999999999886543 34556678
Q ss_pred cCCCccccccccccC-----------CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 577 AGTPGYLDPEYYISN-----------RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-----------~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..... .|.+ +..+.||.
T Consensus 522 vGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~aK-------l~aI~~P~ 589 (677)
T KOG0596|consen 522 VGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIAK-------LHAITDPN 589 (677)
T ss_pred cCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHHH-------HHhhcCCC
Confidence 899999999998532 267899999999999999999999964321 2222 23344443
Q ss_pred ccCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFD-INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..-+++ ....+.+++++..||+.||.+|||..++++
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 222221 112234899999999999999999999987
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.14 Aligned_cols=234 Identities=25% Similarity=0.405 Sum_probs=181.1
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|++|.||++... +..+++|++........+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999984 678999999876655667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..+.+.....++.++ ..+||||+|+||++++++.++|+|||.+........ .....+
T Consensus 85 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~ 159 (253)
T cd05122 85 KDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVG 159 (253)
T ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----ccceec
Confidence 99987652 234444444333332 239999999999999999999999999987643321 234567
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|+|||.+.+..++.++||||||+++++|++|+.|+...... +....... .......++ . .....+
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~-----~--~~~~~~ 227 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----KALFKIAT-NGPPGLRNP-----E--KWSDEF 227 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHh-cCCCCcCcc-----c--ccCHHH
Confidence 88999999998888999999999999999999999998654321 11111111 111111110 0 012467
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+++.+|++.+|++|||+.|+++
T Consensus 228 ~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 228 KDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=260.80 Aligned_cols=247 Identities=17% Similarity=0.215 Sum_probs=172.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. ++..||+|.+..... .....+.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ 83 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC
Confidence 456899999999999998 467999999865422 2235678899999999999999999999999999999999974
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|.+++..... .+++..... .+|....+||||||+||+++.++.+||+|||+++...... .....
T Consensus 84 -~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 158 (284)
T cd07839 84 -DLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSA 158 (284)
T ss_pred -CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC---CCcCC
Confidence 78777754321 234443333 3333344999999999999999999999999998653221 11223
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC------cccccCC----
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD------IESIVDP---- 644 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~i~d~---- 644 (723)
..++..|+|||.+.+. .++.++|||||||+++||+||+.|+..........+.......... +....+.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 4568899999998765 4789999999999999999999986543321111111111111000 0000000
Q ss_pred cccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHED-----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ........+.+++.+|++.+|.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00112346679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=254.64 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=177.0
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC------hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.||+|++|.||+|.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46899999999999987 56799999987532 12346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCC-c
Q 004935 503 MANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSG-T 570 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~-~ 570 (723)
+++++|.+++.... .+++... +..+|+...+|+||||+||+++.++ .+||+|||++......... .
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (268)
T cd06630 85 MAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162 (268)
T ss_pred cCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC
Confidence 99999999986532 2233322 3333333349999999999998775 5999999999876433111 1
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......++..|+|||.+.+..++.++||||+|++++||++|+.||........... ........ .....
T Consensus 163 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~---------~~~~~ 232 (268)
T cd06630 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASAT---------TAPSI 232 (268)
T ss_pred ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccC---------CCCCC
Confidence 112234578899999999888899999999999999999999999864432211111 11111000 01112
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+......+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2223346779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=268.19 Aligned_cols=241 Identities=20% Similarity=0.284 Sum_probs=171.4
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++... ++.+|+|++.... ......|..|+.++..++|++|+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 4578999999999999984 4589999986422 2223458899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC-----CCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGEEAD-----ILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~~~~-----~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|+|.+++...... ...|..+ +..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--~~~~~~ 162 (332)
T cd05623 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSV 162 (332)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC--cceecc
Confidence 99999999753211 1223333 333444444999999999999999999999999987653221 122234
Q ss_pred ccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+............. . +....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~-~-p~~~~-- 234 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKERFQ-F-PAQVT-- 234 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----HHHHHHHhCCCcccc-C-CCccc--
Confidence 56999999999986 34688999999999999999999999975432 222222221111000 0 11001
Q ss_pred CHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQT--STKRPTMNQVVME 682 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~--p~~RPsm~evl~~ 682 (723)
.....+.+++.+|+..+ +..|++++|+++.
T Consensus 235 --~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 235 --DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 12234567777776543 4447888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=274.05 Aligned_cols=233 Identities=27% Similarity=0.470 Sum_probs=183.5
Q ss_pred hhhhccccCcEEEEEEEECCc--eEEEEEecC----CChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc--eEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDGT--EVAVKMLSP----SSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN--RGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E 501 (723)
|..+||+|.|-+||||.+... .||=-.++. .......+|..|+.+|+.|+|+||++++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 467899999999999999544 444222221 234455789999999999999999999999877665 668999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHHHHHHHHHhccc------cccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCc
Q 004935 502 FMANGNLQALLLGEEA----DILSWEGRLRIAIEAAK------VHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~~~l~i~~~~a~------vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 570 (723)
.|..|+|+.|+.+... -+.+|.+++.-.+.+.| ||||||-+||+|+.+ |.+||+|.|+|..+...
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---- 199 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----
Confidence 9999999999987532 24688888777777777 999999999999865 89999999999986422
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
....+.|||.|||||.+. ..|.+.+||||||+.++||.|+..||..-.....+-+.|..-..+..+.++-||
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP------ 271 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP------ 271 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH------
Confidence 223478999999999887 889999999999999999999999997554433343434333344444444444
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+++.+|+.. .++|||+.|+++
T Consensus 272 ------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 356999999999 999999999986
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=258.26 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=175.7
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|... ++.+++|.++.... .....+.+|++++++++||||+++++++... ...++|+||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 44678999999999999984 66899999875432 2234678899999999999999999998777 889999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++ +|.+++..... .+++...+.++.+ ...+||||||+||+++.++.+||+|||+++...... ..
T Consensus 88 ~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~ 162 (293)
T cd07843 88 VEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL---KP 162 (293)
T ss_pred cCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc---cc
Confidence 985 99988865432 3455444444433 333999999999999999999999999998764321 11
Q ss_pred eecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC----------------
Q 004935 573 TTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---------------- 635 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 635 (723)
.....++..|+|||.+.+.. ++.++|+||||++++||++|+.||...................
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 22345678999999987644 6899999999999999999999987543221111111100000
Q ss_pred CCcccccCCcccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 GDIESIVDPRLHEDFDIN-SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..........+...+... ....+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 2345779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=259.33 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=172.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|++|.||+|.. +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 356899999999999998 467999999875432 2234577899999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCC----------HHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILS----------WEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~----------~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+. ....+..+|+...+||||||+||+++.++.+||+|||+++...... ......
T Consensus 88 ~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 163 (291)
T cd07844 88 DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS---KTYSNE 163 (291)
T ss_pred CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---cccccc
Confidence 99998865432 222 2233444444445999999999999999999999999987542211 111223
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccc------c----
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESI------V---- 642 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i------~---- 642 (723)
.++..|+|||.+.+ ..++.++||||||++++||++|+.||..................... ...+ .
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 46788999998875 45889999999999999999999999654321111111111110000 0000 0
Q ss_pred ----CCcccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 ----DPRLHEDF-DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 ----d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.... .......+.+++.+|++.+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0111246679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=266.90 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=170.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 498 (723)
...+.||+|+||.||+|.. .++.||||++.... ....+.+.+|++++++++|+||+++++++... ...++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence 3457899999999999987 45689999987542 23345678999999999999999999987543 34689
Q ss_pred EEEeCCCCCHHHHhccCCC---CC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 499 IYEFMANGNLQALLLGEEA---DI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~---~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++|++ +++|.+++....- .. .+....+..+|+...+||||||+|||+++++.+||+|||+++.....
T Consensus 98 ~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 171 (343)
T cd07878 98 VTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----- 171 (343)
T ss_pred EeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-----
Confidence 99988 7799888754311 11 12223344444444599999999999999999999999999865321
Q ss_pred eeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-----------cc
Q 004935 572 VTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-----------IE 639 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~ 639 (723)
.....+++.|+|||.+.+ ..++.++|||||||+++||++|+.||........+..+... ..... ..
T Consensus 172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV-VGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-hCCCCHHHHHhcchhhHH
Confidence 223468999999999876 56899999999999999999999999654322222111111 00000 00
Q ss_pred cccC--CcccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVD--PRLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... +..... ........+.+++.+|++.+|.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000 00001124679999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=258.83 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=176.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~ 503 (723)
+.+.||+|++|.||+|... +..+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3567999999999999984 5799999998663 33346788999999999999999999999888 8899999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++ +|.+++.... ..+++...+.++. +...+|+||||+||++++++.+||+|||++........ ...
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 158 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADY 158 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--ccc
Confidence 85 8888876542 2344444444333 33339999999999999999999999999987643321 112
Q ss_pred ecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC--CCcccccC-------
Q 004935 574 TTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK--GDIESIVD------- 643 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~i~d------- 643 (723)
....++..|+|||.+.+ ..++.++||||||++++||+||+.||........+.......... .......+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 23456788999998765 457899999999999999999999987554322222111111000 00000000
Q ss_pred -------CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 -------PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 -------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.......+...+.+++.+|++.+|.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=258.62 Aligned_cols=232 Identities=20% Similarity=0.299 Sum_probs=177.0
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
..||+|+||.||++.. ++..||||.+..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999988 56799999987655556677999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 510 ALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 510 ~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
+++.... +.+... +..+|+...+||||+|+||++++++.++|+|||++....... .......++
T Consensus 106 ~~~~~~~---~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~ 179 (292)
T cd06657 106 DIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGT 179 (292)
T ss_pred HHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---ccccccccC
Confidence 9875432 233332 333344444999999999999999999999999987653221 122335678
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
..|+|||.+.+..++.++||||||++++||++|+.||........ ........ .+.+... ......+.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~~~~~---------~~~~~~~--~~~~~~l~ 247 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNL---------PPKLKNL--HKVSPSLK 247 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhC---------CcccCCc--ccCCHHHH
Confidence 899999999888899999999999999999999999865322111 11111111 1111100 01223567
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+++.+|++.+|.+||++.++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 8999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.89 Aligned_cols=241 Identities=19% Similarity=0.275 Sum_probs=171.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+++. .++.||+|++.... ......+.+|+.++..++|+||+.+++++...+..++||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999998 45689999986532 2234558899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC-----CCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGEEAD-----ILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~~~~-----~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|+|.+++...... ...|.. .+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 162 (331)
T cd05624 85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSV 162 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC--ceeecc
Confidence 99999999753211 112222 2333444444999999999999999999999999998654322 112233
Q ss_pred ccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..|++.|+|||.+.+ +.++.++|||||||+||||++|+.||..... .+............. +.+.+ .
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~-~p~~~-~-- 234 (331)
T cd05624 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHEERFQ-FPSHI-T-- 234 (331)
T ss_pred ccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCCCccc-CCCcc-c--
Confidence 569999999999875 4678999999999999999999999975432 111121111110000 01111 1
Q ss_pred CHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTK--RPTMNQVVME 682 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~ 682 (723)
+....+.+++.+|+...+.+ |++++++++.
T Consensus 235 --~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 --DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 12235678888888765543 4677777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.87 Aligned_cols=237 Identities=24% Similarity=0.381 Sum_probs=174.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCC------ceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~------~~~lV 499 (723)
.+.+.||+|++|.||+|.. .+..+++|++..... ..++|.+|+.+++++ .|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 3457899999999999998 456899999876543 346799999999999 7999999999996644 48999
Q ss_pred EEeCCCCCHHHHhccCC--CCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 500 YEFMANGNLQALLLGEE--ADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
|||+++++|.+++.... ...+.+.... ..+|+...+||||+|+||++++++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 167 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch
Confidence 99999999999886532 2334443333 33333334999999999999999999999999987653221
Q ss_pred CCceeeecccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
.......++..|+|||.+.. ..++.++|||||||+++||++|+.||........+.+ .. ....
T Consensus 168 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~~~---- 235 (275)
T cd06608 168 ---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----IP-RNPP---- 235 (275)
T ss_pred ---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----hh-ccCC----
Confidence 12233458889999998754 3467899999999999999999999965432211111 11 1111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+. ........+.+++.+|+..+|++|||++++++
T Consensus 236 -~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11113346779999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=252.43 Aligned_cols=234 Identities=20% Similarity=0.336 Sum_probs=186.0
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.++||+|+||.||+|.+ .|..||||.+...+ +.+++.+|+.+|++...+++|+++|.+.....+++|||||-.|+.
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 46899999999999988 57799999987553 457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCC---------CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 509 QALLLGEEADI---------LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 509 ~~~l~~~~~~~---------l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
.+.++.+.... .+-.+.++++|...+||||||+.||||+-+|.+||+|||.+-.+... ......+.||
T Consensus 116 SDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---MAKRNTVIGT 192 (502)
T KOG0574|consen 116 SDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---MAKRNTVIGT 192 (502)
T ss_pred HHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh---HHhhCccccC
Confidence 99987653221 12334567777777799999999999999999999999999776422 2233467899
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
+.|||||++..-.|..++||||+|+...||.-|++|+...+....+ +++.... .|.++ .+..-...+-
T Consensus 193 PFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----FMIPT~P-----PPTF~--KPE~WS~~F~ 260 (502)
T KOG0574|consen 193 PFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----FMIPTKP-----PPTFK--KPEEWSSEFN 260 (502)
T ss_pred cccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----EeccCCC-----CCCCC--ChHhhhhHHH
Confidence 9999999999999999999999999999999999999765432111 1111110 01111 1222344678
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+++.+|+-..|++|-|+.++++
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhh
Confidence 9999999999999999988876
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=253.00 Aligned_cols=226 Identities=20% Similarity=0.279 Sum_probs=173.2
Q ss_pred ccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||.|++|.||++... ++.|++|.+.... ....+.+.+|++++++++|+||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999996 6799999987543 23446799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.+... +... ..+..+|+...+|+||+|+||+++.++.++|+|||+++...... ......+
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCG 154 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccC
Confidence 999976422 2322 23334444444999999999999999999999999998764321 1223467
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|++||.+.+..++.++|+||||+++|||++|+.|+..... ...+.......... ....+......+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 223 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNG---------KLEFPNYIDKAA 223 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhccCC---------CCCCCcccCHHH
Confidence 8899999999888899999999999999999999999976542 11222222221000 001111113467
Q ss_pred HHHHHhccCCCCCCCCCH
Q 004935 659 VEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm 676 (723)
.+++.+|++.+|++||++
T Consensus 224 ~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 224 KDLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHHHHccCChhhCcCC
Confidence 899999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=272.56 Aligned_cols=228 Identities=23% Similarity=0.291 Sum_probs=165.2
Q ss_pred ccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc---cCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 434 LGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI---HHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 434 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
||+|+||.||+|+. .++.||||++.... ......+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999988 46799999986432 12234456677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++..... ... +....+..+|+...+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---CCccCcc
Confidence 999988865422 111 22233444444445999999999999999999999999987542221 1223456
Q ss_pred CCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
||..|+|||.+.+. .++.++|||||||+++||++|+.||..... .+..... ..+.. .+... ....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~~i-~~~~~------~~~~~---~~~~ 223 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYRNI-AFGKV------RFPKN---VLSD 223 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHHHH-HcCCC------CCCCc---cCCH
Confidence 89999999998765 489999999999999999999999965432 1211211 11111 11110 0122
Q ss_pred HHHHHHHhccCCCCCCCCCHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~e 678 (723)
.+.+++.+|++.+|.+||++.+
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCC
Confidence 5678999999999999996443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=259.47 Aligned_cols=251 Identities=19% Similarity=0.208 Sum_probs=177.9
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.+|.|+++.||++..+++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 455677778888888888899999998754 344567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC----ceeee
Q 004935 509 QALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG----THVTT 574 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~----~~~~~ 574 (723)
.+++.......+... ..+..+|+...+||||||+||+++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 999876432223332 2334444444599999999999999999999999988765322111 01112
Q ss_pred cccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc----C-------CCccc-
Q 004935 575 TIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG----K-------GDIES- 640 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~----~-------~~~~~- 640 (723)
...++..|+|||.+.. ..++.++|||||||+++||++|+.||..........+....... . .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence 3456778999999876 35889999999999999999999999754332222221111000 0 00000
Q ss_pred ---ccCCccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 ---IVDPRLH----EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 ---i~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..++... ..........+.+++.+||+.+|++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0001000 0011122346789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=256.86 Aligned_cols=247 Identities=20% Similarity=0.273 Sum_probs=171.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||+|++..... .....+.+|++++++++|+||+++.+++...+..++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 357899999999999987 467999999875432 223467899999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+.+.. .+..+|+...+||||||+||+++.++.+||+|||+++....... .....
T Consensus 88 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 163 (291)
T cd07870 88 DLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---TYSSE 163 (291)
T ss_pred CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC---CCCCc
Confidence 77766644321 122222 23333444449999999999999999999999999876432211 12233
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-------------CCccccc
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-------------GDIESIV 642 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~i~ 642 (723)
.++..|+|||.+.+. .++.++|||||||+++||++|+.||................... .......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 468899999998754 57889999999999999999999997543221111111110000 0000000
Q ss_pred CCcccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLHEDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
........ .......+.+++.+|++.+|++|||++|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0011346679999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=257.90 Aligned_cols=228 Identities=26% Similarity=0.354 Sum_probs=174.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. .++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 457899999999999998 46799999986532 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+.. ...+..+|+...+||||+|+||+++.++.+||+|||+++..... ..
T Consensus 85 ~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------~~ 156 (290)
T cd05580 85 GGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TY 156 (290)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------CC
Confidence 999999987642 2222 23334444444499999999999999999999999999875322 23
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+++.|+|||.+.+...+.++||||||++++||++|+.||...... +...... .+. ..+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~------~~~~~~~---- 221 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKIL-EGK------VRFPSFF---- 221 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-cCC------ccCCccC----
Confidence 346889999999998888999999999999999999999998654321 1111111 111 1111111
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRP-----TMNQVV 680 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-----sm~evl 680 (723)
...+.+++.+|++.+|.+|| +++|++
T Consensus 222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 23667999999999999998 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=248.05 Aligned_cols=236 Identities=23% Similarity=0.375 Sum_probs=182.1
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~ 504 (723)
.+.||+|++|.||+|... +..|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999985 67999999876542 4567899999999999999999999999888 88999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++.....++.++ ..+|+||+|+||+++.++.++|+|||.+......... ....
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~ 161 (260)
T cd06606 85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTG 161 (260)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-cccc
Confidence 999999987653 45555444444333 3399999999999999999999999999876433210 1123
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.....+.++||||||+++++|++|+.|+..... .............. .......
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~ 229 (260)
T cd06606 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSSGEP---------PEIPEHL 229 (260)
T ss_pred CCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccccCCC---------cCCCccc
Confidence 45688899999999888899999999999999999999999976541 11111111110111 1111122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++||++.+++.
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 346789999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=256.58 Aligned_cols=235 Identities=22% Similarity=0.307 Sum_probs=170.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHH-HHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVEL-LMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||++.. +++.||+|++.... .....++..|+.. ++..+|+||+++++++...+..++++|||+
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 356899999999999998 46799999987653 2334566667765 566689999999999999999999999997
Q ss_pred CCHHHHhccC--CCCCCCHHHHHHHH----------Hhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 506 GNLQALLLGE--EADILSWEGRLRIA----------IEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 506 gsL~~~l~~~--~~~~l~~~~~l~i~----------~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|+|.+++... ....+++...+.++ |+. ..+||||||+||+++.++.+||+|||+++..... ..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----~~ 159 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VA 159 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc----cc
Confidence 6888877542 22334554443333 333 3399999999999999999999999999865321 11
Q ss_pred eecccCCCcccccccccc----CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 573 TTTIAGTPGYLDPEYYIS----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.....++..|+|||.+.+ ..++.++|+|||||+++||++|+.||...... . +........ . .+.+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-~~~~~~~~~-~-----~~~~~~ 230 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F-QQLKQVVEE-P-----SPQLPA 230 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H-HHHHHHHhc-C-----CCCCCc
Confidence 223457889999998865 44688999999999999999999998643221 1 111111111 1 111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. .....+.+++.+|++.+|.+||+++++++
T Consensus 231 ~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 E---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11235789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=261.18 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=173.7
Q ss_pred hhhhccccCcEEEEEEEE----CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL----DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 456799999999999998 35699999998633 33346678999999999999999999999888 7899999
Q ss_pred EeCCCCCHHHHhccCC---CCCCCHH----------HHHHHHHhccccccCCCCCCEEEcC----CCcEEEEeccCcccc
Q 004935 501 EFMANGNLQALLLGEE---ADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSG----KFQAKIADFGLSRTF 563 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~---~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~----~~~~kl~DfGla~~~ 563 (723)
||+++ +|.+++.... ...+... ..+..+|....+||||||+||+++. ++.+||+|||+++..
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 99986 6666654321 1122222 2333344444499999999999999 899999999999876
Q ss_pred CCCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccc---------cHHHHHHHHh
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERI---------HITQWVSFML 633 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~---------~~~~~~~~~~ 633 (723)
..............++..|+|||.+.+. .++.++|||||||+++||++|+.||....... .+...+..+-
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 4332211222334678899999987764 57899999999999999999999997543321 1111111110
Q ss_pred cCC-----------CcccccCCcccCCCC---------H--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 634 GKG-----------DIESIVDPRLHEDFD---------I--NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 634 ~~~-----------~~~~i~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... ......+........ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 000000000000000 0 22346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=254.46 Aligned_cols=236 Identities=22% Similarity=0.336 Sum_probs=177.7
Q ss_pred ccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||.||++... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 67999999876543 3456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-----ceee
Q 004935 509 QALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-----THVT 573 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-----~~~~ 573 (723)
.+++.... .+++... +..+|+...+||||+|+||++++++.++|+|||++......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99987643 2333333 33334444499999999999999999999999998764322110 1122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....++..|+|||.......+.++||||||++++||++|+.||...... +....... +... ..... .
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~------~~~~~--~ 225 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNILN-GKIE------WPEDV--E 225 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhc-CCcC------CCccc--c
Confidence 3345788999999998888999999999999999999999998654321 22221111 1110 00000 0
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
....+.+++.+|++.+|.+|||++++.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1346789999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=253.81 Aligned_cols=230 Identities=22% Similarity=0.276 Sum_probs=166.1
Q ss_pred hccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHh---ccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMR---IHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~---l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+||+|+||.||++.. +++.+|+|.+..... .....+.+|..+++. .+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999988 467999998865421 222334555544443 479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+.+.....++ |....+||||||+|||+++++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 153 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----Ccc
Confidence 999999886542 24544443333 3333499999999999999999999999998754321 112
Q ss_pred cccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...++..|+|||.+.. ..++.++|||||||+++||++|+.||....... . ......... ....+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~-~~~~~~~~~------~~~~~~~~---- 221 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K-HEIDRMTLT------VNVELPDS---- 221 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-H-HHHHHHhhc------CCcCCccc----
Confidence 3468999999998864 568999999999999999999999997543221 1 111111110 11112112
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
....+.+++.+|+..+|++|| +++++++
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 234677999999999999999 5877766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=262.69 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=172.8
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLIY 500 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV~ 500 (723)
.+.||+|+||.||+|.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++... ...++|+
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 57899999999999997 5679999998643 233446778899999999999999999988543 3568999
Q ss_pred EeCCCCCHHHHhccCC--CCC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 501 EFMANGNLQALLLGEE--ADI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~--~~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
||+.+ +|.+.+...- ... .+....+..+|....+||||||+||+++.++.+||+|||+++...... ...
T Consensus 101 e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~ 175 (353)
T cd07850 101 ELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMT 175 (353)
T ss_pred eccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC----CCC
Confidence 99965 8888775431 111 122233444444445999999999999999999999999998653221 122
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH------------------HhcC-
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF------------------MLGK- 635 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~------------------~~~~- 635 (723)
...++..|+|||.+.+..++.++|||||||++++|++|+.||............... ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (353)
T cd07850 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR 255 (353)
T ss_pred CCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcC
Confidence 345788999999999999999999999999999999999998654321111111100 0000
Q ss_pred CC-----cccccCCcc----cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 GD-----IESIVDPRL----HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 ~~-----~~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ..+.....+ ...........+.+++.+|++.+|++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 256 PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000000 00001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=259.66 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=175.2
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC--CceEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG--TNRGLIY 500 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~lV~ 500 (723)
+.+.+.||+|+||.||+|.. .++.+|+|++... .......+.+|+.+++++ +|+||++++++|... ...++|+
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 44568999999999999988 4668999988542 233445678899999999 999999999998653 3679999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG- 569 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 569 (723)
||++ ++|..++... .+.|.....+ +|+...+||||||+||+++.++.+||+|||+++........
T Consensus 89 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 89 EYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred cccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 9998 5999888654 3444444433 33333499999999999999999999999999876433211
Q ss_pred -ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc----------CCC
Q 004935 570 -THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG----------KGD 637 (723)
Q Consensus 570 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~ 637 (723)
........++..|+|||.+.+ ..++.++||||||++++||+||+.||.................. ...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 112233457889999998765 45789999999999999999999998654322111111110000 000
Q ss_pred cccccC----Cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 638 IESIVD----PRLH--EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 638 ~~~i~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...+++ .... ..........+.+++.+|++.+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 0000 00001123467899999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.96 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=172.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++......++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 356899999999999997 466899999865432 234678899999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCC------H----HHHHHHHHhccccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCceeee
Q 004935 506 GNLQALLLGEEADILS------W----EGRLRIAIEAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~------~----~~~l~i~~~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
++|.+++.......+. + ...+..+|+...+||||+|+||+++. ++.+||+|||++....... ....
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~---~~~~ 161 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFT 161 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc---cccc
Confidence 5788777544322222 2 22333344444499999999999985 5679999999997653221 1112
Q ss_pred cccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc-----------
Q 004935 575 TIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV----------- 642 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~----------- 642 (723)
...+++.|+|||.+.+. .++.++|||||||+++||+||+.||........+.+... ..... .....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR-ILGTP-NEETWPGVTSLPDYKS 239 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCC-Chhhccccccchhhhh
Confidence 33567899999988664 578999999999999999999999975433222222111 11100 00000
Q ss_pred -CCcccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 -DPRLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 -d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
-+..... ........+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00112335789999999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=253.80 Aligned_cols=244 Identities=22% Similarity=0.259 Sum_probs=172.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecC--CceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEG--TNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|.. ++..||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 456799999999999987 56799999987542 222234567999999985 99999999999887 8899999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+ |+|.+.+.... ..++|.....++.+++ .+||||||+||+++. +.+||+|||+++....... .
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~----~ 155 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP----Y 155 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC----c
Confidence 7 58887776532 2455555554444433 399999999999999 9999999999987532211 1
Q ss_pred ecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----------CCcccc
Q 004935 574 TTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----------GDIESI 641 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~i 641 (723)
....++..|+|||.+.. ..++.++|||||||+++||++|+.||........ ..+....... ......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhcccccccc
Confidence 22457889999997654 5578899999999999999999999975433211 1111111111 000111
Q ss_pred cCCcccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+...+. ........+.+++.+|++.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 01110000 01123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=253.14 Aligned_cols=247 Identities=22% Similarity=0.285 Sum_probs=178.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh--hhHHHHHHHHHHHHhc---cCCceeeEEEEEecCCc-----eE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA--QGYKQFQAEVELLMRI---HHKNLTTLVGYCDEGTN-----RG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-----~~ 497 (723)
+.+.||+|+||.||+|... +..||+|++..... .....+.+|+.+++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 3568999999999999984 67999999974322 2234567788877766 59999999999988776 89
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
++|||+.+ +|.+++.......+++.....++.+++. +|+||+|+||++++++.+||+|||++.......
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc
Confidence 99999985 8988887654444666665555554443 999999999999999999999999997763321
Q ss_pred CCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc------
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI------ 641 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i------ 641 (723)
. .....++..|+|||.+.+..++.++|||||||+++||++|++||........+..+.............
T Consensus 162 ~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 162 A----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 1 122346888999999999899999999999999999999999987654433333332222111110000
Q ss_pred ---cCCcccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 ---VDPRLHED---FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ---~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
........ ...+....+.+++.+|++.+|++||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01122356679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=255.31 Aligned_cols=234 Identities=24% Similarity=0.326 Sum_probs=173.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
...+.||+|+||.||+|.. ++..+++|.+... .....+++.+|++++++++|+|++++++++......++|+||+
T Consensus 18 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 97 (308)
T cd06634 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (308)
T ss_pred HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEcc
Confidence 3356899999999999998 4568999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
. |++.+++..... .+++.... ..+|+...+||||||+||+++.++.+||+|||++......
T Consensus 98 ~-~~l~~~~~~~~~-~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------- 168 (308)
T cd06634 98 L-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (308)
T ss_pred C-CCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-------
Confidence 7 688877654321 23433333 3334444499999999999999999999999998765321
Q ss_pred ecccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 574 TTIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
....++..|+|||.+. ...++.++|||||||+++||++|+.|+........ ..... .+.. +....
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~-~~~~-----~~~~~-- 236 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIA-QNES-----PALQS-- 236 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH----HHHHh-hcCC-----CCcCc--
Confidence 2345788999999974 35678899999999999999999999865432111 11111 1111 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
......+.+++.+||+.+|.+||++++++..--
T Consensus 237 -~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 237 -GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 112345779999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=249.22 Aligned_cols=238 Identities=22% Similarity=0.346 Sum_probs=172.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC-----ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-----SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. ++..||+|.+... .....+.|.+|++++++++|+||+++++++... ...++++
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 467899999999999987 4669999987532 223456789999999999999999999998664 4578999
Q ss_pred EeCCCCCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 501 EFMANGNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
||+++++|.+++..... ....|. ..+..+|+...+|+||||+||+++.++.++|+|||+++...........
T Consensus 86 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (264)
T cd06653 86 EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165 (264)
T ss_pred EeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcc
Confidence 99999999999865422 111222 2233344444499999999999999999999999999865321111111
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....++..|+|||.+.+..++.++|||||||+++||++|+.||...... .. +....... . .+.+ +.
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-~~~~~~~~-~----~~~~----p~ 232 (264)
T cd06653 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AA-IFKIATQP-T----KPML----PD 232 (264)
T ss_pred ccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HH-HHHHHcCC-C----CCCC----Cc
Confidence 22345888999999999888999999999999999999999999654221 11 11111111 0 1111 12
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++ .|.+||+..+++.
T Consensus 233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 233 GVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 223467899999999 5799999997764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=252.53 Aligned_cols=230 Identities=22% Similarity=0.294 Sum_probs=176.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||.|+||.||++... +..||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 4578999999999999984 6799999987542 2446789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++... ..+... ..+..+|+...+|+||+|+||++++++.++|+|||++....... ...
T Consensus 84 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~ 157 (258)
T cd05578 84 GGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTT 157 (258)
T ss_pred CCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----ccc
Confidence 99999998754 122322 23334444444999999999999999999999999988754321 223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ............ . +.. +...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--~----~~~----~~~~ 225 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA--D----VLY----PATW 225 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc--c----ccC----cccC
Confidence 456788999999998888999999999999999999999999765432 112222111110 0 111 1112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
...+.+++.+|++.+|.+||+++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCcc
Confidence 24678999999999999999994
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=253.11 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=176.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||.|++|.||+|+. ++..||||.+..... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 357899999999999998 467899999876543 2345678899999999999999999999999999999999985
Q ss_pred CHHHHhccCC-CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEE-ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~-~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|.+++.... ...+.+.....++.++ ..+||||||+||++++++.++|+|||+++...... .....
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---~~~~~ 159 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSN 159 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---ccccc
Confidence 8888876542 2335555544444333 33999999999999999999999999997653221 11123
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cccccC-CcccCC--
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESIVD-PRLHED-- 649 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i~d-~~l~~~-- 649 (723)
..++..|++||.+.+. .++.++|||||||+++||++|+.||..........+.......... ...+.+ +.+...
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 4567899999988654 5789999999999999999999998755432222221111100000 000000 000000
Q ss_pred ---------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 ---------FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ---------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
........+.+++.+|++.+|.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00112345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-28 Score=246.49 Aligned_cols=233 Identities=24% Similarity=0.415 Sum_probs=179.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||++.. .+..|++|.+..... .....+.+|++++++++|+|++++++++...+..++++||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 357899999999999987 456899999977653 4557899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++... ..+++.....++. +...+||||||+||+++.++.++|+|||++........ ....
T Consensus 84 ~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 158 (254)
T cd06627 84 GSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---DDAS 158 (254)
T ss_pred CcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---cccc
Confidence 9999998754 2344444433333 33339999999999999999999999999987643322 1233
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..++..|+|||...+..++.++||||+|++++||++|+.|+...... ..... .... .. +.+.. ...
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~-~~~~-~~-----~~~~~----~~~ 224 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFR-IVQD-DH-----PPLPE----GIS 224 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH-Hhcc-CC-----CCCCC----CCC
Confidence 46788999999998888899999999999999999999998654321 11111 1111 10 11111 123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|+..+|++||++.+++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 36779999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=249.39 Aligned_cols=234 Identities=21% Similarity=0.252 Sum_probs=169.9
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHH-hccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLM-RIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.. .++.||+|.+..... .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999988 567999999875432 22234555655544 45899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCC--------HHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEADILS--------WEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~--------~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
++|.+++......... ....+..+|+...+||||+|+||++++++.+||+|||+++.... .....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~~~ 154 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKFV 154 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------cccCC
Confidence 9999998754322111 22233444444449999999999999999999999999876422 22345
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
++..|+|||.+.+..++.++||||||++++||++|..||...... +...... .+... ..+... ......
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~--~~~~~~----~~~~~~ 223 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNIL-SRRIN--WPEEVK----EFCSPE 223 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-hcccC--CCCccc----ccCCHH
Confidence 788999999998888999999999999999999999999654321 1111111 11110 000111 112346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
+.+++.+|++.+|++||++.++.+.|
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHH
Confidence 78999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=254.69 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=177.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||+|.. .++.|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 457899999999999998 456899999875432 22334567999999999 999999999999999999999999 8
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+.+...+.++.+++ .+|+||+|+||++++++.++|+|||+++...... ....
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----~~~~ 157 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTD 157 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----CcCC
Confidence 8999988765544566666655555544 3999999999999999999999999998653221 1123
Q ss_pred ccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHH------------HHHHHhcCCCccccc
Q 004935 576 IAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQ------------WVSFMLGKGDIESIV 642 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~i~ 642 (723)
..++..|+|||.+.. ..++.++||||||++++||++|+.||........... |.............+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 457889999998754 4579999999999999999999999865432211111 111100000010000
Q ss_pred CCccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLH---EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ..........+.+++.+|++.+|++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 0000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=262.68 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=173.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 501 (723)
+.+.||+|+||.||+|.. +++.||+|.++... ......+.+|+.++++++|+||+++++++... ...++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 357899999999999987 56799999987533 23446688999999999999999999987554 35789999
Q ss_pred eCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++ +|.+++... .+.+. ..+..+|+...+||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (336)
T cd07849 89 LMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164 (336)
T ss_pred hccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccC
Confidence 9975 888777543 23332 334444555559999999999999999999999999987543222122
Q ss_pred eeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccccCCc--
Q 004935 572 VTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIVDPR-- 645 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~d~~-- 645 (723)
......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+...+.... ...+.+..
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (336)
T cd07849 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLNCIISLRAR 243 (336)
T ss_pred CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhhchhhh
Confidence 2233567899999998754 5689999999999999999999999965432111 111111111100 00000000
Q ss_pred -------ccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 646 -------LHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 646 -------l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...... ......+.+++.+|++.+|++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 1123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=253.24 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=179.0
Q ss_pred hhhhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.||+|++|.||+++. ++..||||.+.... ....+.+..|++++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 457899999999999875 34689999987532 22345788999999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++.... .+.+.. .+..+|+...+||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (288)
T cd05583 84 LDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE- 160 (288)
T ss_pred EecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc-
Confidence 99999999999886542 223222 23333443449999999999999999999999999887543221
Q ss_pred ceeeecccCCCccccccccccCC--CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 570 THVTTTIAGTPGYLDPEYYISNR--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
.......++..|+|||.+.+.. .+.++||||||++++||++|+.||.............+..... .+...
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~ 232 (288)
T cd05583 161 -ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------KPPFP 232 (288)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------CCCCC
Confidence 1122345788999999987665 7889999999999999999999986433222222222222211 11111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
... ...+.+++.+|++.+|++|||+++|.+.|+..
T Consensus 233 ~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 233 KTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111 23567899999999999999999998877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=249.80 Aligned_cols=230 Identities=21% Similarity=0.281 Sum_probs=167.5
Q ss_pred hccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHH---HHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVEL---LMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.||+|+||.||++.. .++.||+|.+..... .....+..|..+ ++...|++|+.+++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 467999999875432 222234445444 444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+.+..+..++.+ ...+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PH 153 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----Cc
Confidence 999999886532 3555554444433 333999999999999999999999999987653221 12
Q ss_pred cccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...|+..|+|||.+.++ .++.++|||||||+++||++|+.||......... . ....... .++.+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~-~~~~~~~------~~~~~~~~---- 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-IDRMTLT------MAVELPDS---- 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-H-HHHHhhc------cCCCCCCc----
Confidence 34688999999998754 6899999999999999999999999754322111 1 1111100 11112111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
....+.+++.+|+..+|.+|| ++.++++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 134678999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=253.47 Aligned_cols=248 Identities=18% Similarity=0.236 Sum_probs=172.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCc-----eEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTN-----RGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----~~lV 499 (723)
..+.||+|+||.||+|.. +++.||+|....... .....+.+|+.++++++ |+||+++++++..... .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 356899999999999998 467999998765432 23457889999999995 6999999999877665 7999
Q ss_pred EEeCCCCCHHHHhccCC---CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC-CCcEEEEeccCccccCC
Q 004935 500 YEFMANGNLQALLLGEE---ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG-KFQAKIADFGLSRTFPV 565 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~ 565 (723)
|||+++ +|.+++.... ...+++...+.++.+++ .+||||||+||+++. ++.+||+|||+++....
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 999996 8888876432 22345555444444333 399999999999998 88999999999886532
Q ss_pred CCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccccc
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESIV 642 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i~ 642 (723)
... ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||..................... .....
T Consensus 164 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 164 PVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred Ccc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 211 1122346788999998865 45799999999999999999999998754332222221111100000 00000
Q ss_pred ---C----CcccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 ---D----PRLHE----DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 ---d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+ +.... .........+.+++.+|++.+|++||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=251.88 Aligned_cols=230 Identities=24% Similarity=0.347 Sum_probs=171.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|+. .+..|++|++.... ....+.+.+|++++++++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 35699999999999987 56699999986532 2334578899999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|++.+++.... ..+.+...+. .+|+...+||||||+||++++++.+||+|||++..... ...
T Consensus 105 ~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------~~~ 176 (313)
T cd06633 105 GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANS 176 (313)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-------CCC
Confidence 57777765432 2244444433 33444449999999999999999999999999865321 123
Q ss_pred ccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 576 IAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 576 ~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
..++..|+|||.+. ...++.++|||||||+++||++|+.|+........ +...... .. +.... .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~-~~-----~~~~~---~ 243 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQN-DS-----PTLQS---N 243 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhc-CC-----CCCCc---c
Confidence 46788999999984 45688899999999999999999999865432111 1111111 11 11110 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+.+++.+|++.+|.+||++.+++..
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112357789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.95 Aligned_cols=235 Identities=23% Similarity=0.392 Sum_probs=182.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||.|+||.||++... +..+++|++..... ...+.+.+|++++++++|+|++++++.+..+...++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3467999999999999985 67999999876533 4567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC--CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEE--ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~--~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|.+++.... ...+++...+.++.+++ .+|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 160 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---DLA 160 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc---cee
Confidence 99999987642 34455555444444333 3999999999999999999999999998754322 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....+++.|+|||.+.+..++.++||||+|+++++|++|+.|+.... ..+........ .. +.+.. .
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~-~~-----~~~~~----~ 226 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKG-QY-----PPIPS----Q 226 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcC-CC-----CCCCC----C
Confidence 33467889999999988889999999999999999999999986543 22222222211 11 11111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|+..+|++|||+.++++
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2236789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=251.99 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=173.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----------
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT---------- 494 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---------- 494 (723)
.+.+.||+|+||.||+|.. +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 4467899999999999998 46699999987543 223356788999999999999999999987654
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccC
Q 004935 495 NRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFP 564 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~ 564 (723)
..++|+||+++ ++.+.+... ...+++.....++ |+...+||||||+||++++++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 167 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccccc
Confidence 78999999986 676666543 2234444443333 33333999999999999999999999999998764
Q ss_pred CCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---ccc
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IES 640 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 640 (723)
.... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+..... ...... ...
T Consensus 168 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (302)
T cd07864 168 SEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR-LCGSPCPAVWPD 244 (302)
T ss_pred CCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCChhhccc
Confidence 3221 11122345778999998865 4578999999999999999999999975443222222211 111100 000
Q ss_pred cc--------CC------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IV--------DP------RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~--------d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+. ++ .+..... .....+.+++.+|++.+|++||++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00 0000000 12346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=253.55 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=173.0
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+.+.||+|+||.||+|... ++.||||+++... .....++..|+.++.+.. |+||++++++|......+++|||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 34678999999999999996 7799999997543 234456777888777775 9999999999999999999999986
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhc-----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEA-----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~-----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+ +|.+++.... ..+++.....++.++ ..+||||+|+||++++++.+||+|||++..+.... ..
T Consensus 98 ~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~----~~ 171 (296)
T cd06618 98 T-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----AK 171 (296)
T ss_pred c-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC----cc
Confidence 4 7776665422 245555444443332 33999999999999999999999999987653221 11
Q ss_pred ecccCCCccccccccccCC----CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 574 TTIAGTPGYLDPEYYISNR----LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~----~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
....++..|+|||.+.+.. ++.++||||||++++||++|+.||...... .+......... . +.+...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~-~-----~~~~~~ 242 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEE-P-----PSLPPN 242 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCC-C-----CCCCCC
Confidence 2335778999999987654 788999999999999999999998643221 11122222111 1 111100
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
......+.+++.+|++.+|.+||++.++++.
T Consensus 243 --~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 --EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0123467899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=250.62 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=177.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|++|.||++.. ++..+++|.+..... .....+..|++++++++|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 46799999999999998 466899999876532 2456788999999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++...+.+ +|+...+|+||||+||++++++.+||+|||.+....... ......
T Consensus 83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~ 158 (283)
T cd05118 83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPYTHY 158 (283)
T ss_pred CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---ccccCc
Confidence 8888876643 23444444333 333334999999999999999999999999998764332 112234
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccccC---------
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIVD--------- 643 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~d--------- 643 (723)
.++..|+|||.+.+. .++.++||||||+++++|+||+.||........+..... .+.... .....+
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR-TLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCchHhcccchhhhhhhhhhh
Confidence 577889999998876 789999999999999999999999865443221111111 111100 000000
Q ss_pred Cccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLH----EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+... .....+....+.+++.+|++.+|.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=259.22 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=173.6
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhh--------------HHHHHHHHHHHHhccCCceeeEEEEEecCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG--------------YKQFQAEVELLMRIHHKNLTTLVGYCDEGT 494 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 494 (723)
.+.||.|+||.||+|.. .++.||||.++...... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 46799999999999987 46799999986543211 125789999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 495 NRGLIYEFMANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
..++||||++ |+|.+++..... ....|.. .+..+|+...+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccc
Confidence 9999999997 689988865321 1122222 333444444499999999999999999999999999765411
Q ss_pred CC-----------CceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc
Q 004935 567 GS-----------GTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 567 ~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
.. .........++..|+|||.+.+. .++.++|||||||+++||++|+.||........+. .+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-~i~~~~~ 251 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG-RIFELLG 251 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhC
Confidence 10 01111223467889999998764 46899999999999999999999997554322221 1211111
Q ss_pred CCCcc---ccc------------CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 635 KGDIE---SIV------------DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 635 ~~~~~---~i~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ... .+.+.. ........+.+++.+|++.+|++||+++|++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11000 000 000000 00112346789999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=246.14 Aligned_cols=233 Identities=23% Similarity=0.374 Sum_probs=178.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|++|.||++.. ++..+++|.+.... ......+.+|++++++++|+||+++++++......++|+||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 356899999999999987 45689999987542 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccC--CCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGE--EADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~--~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|.+++... ....+.+.....++. +...+||||+|+||++++++.+||+|||+++..... ..
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----~~ 158 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MA 158 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-----Cc
Confidence 9999998652 123344444333333 333399999999999999999999999999876432 12
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....++..|+|||.+.+..++.++|+||||++++||++|+.||...... +. ......+.... ....
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~---------~~~~ 224 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DL-RYKVQRGKYPP---------IPPI 224 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH-HHHHhcCCCCC---------Cchh
Confidence 2345788999999999888999999999999999999999999754321 11 11111111111 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|.+||++.++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=260.07 Aligned_cols=231 Identities=23% Similarity=0.395 Sum_probs=182.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|.|+.|..|+. .+.+||||.+.+.. ......+.+|+++|+.++|||||+++.+......+++||||..+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 357899999999999988 67899999998753 33344589999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC--------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD--------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~--------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+.+++..+... .-+....++.+|+...||||||++||||+.++++||+|||++..+.. .......+
T Consensus 140 ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~----~~~lqt~c 215 (596)
T KOG0586|consen 140 GELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY----GLMLQTFC 215 (596)
T ss_pred chhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc----cccccccC
Confidence 9999999765221 12233445566666669999999999999999999999999988742 34456788
Q ss_pred CCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH--H
Q 004935 578 GTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN--S 654 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~--~ 654 (723)
|++.|.|||.+.+..+ .+++|+||+|++||-|+.|..||++..-.. .-++.+.+.+... -
T Consensus 216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRVLRGKYRIPFYM 278 (596)
T ss_pred CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchheeeeeccccee
Confidence 9999999999998886 579999999999999999999998653211 1111111111110 0
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+-+++.+.+..+|.+|++++++.+
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhh
Confidence 113448889999999999999999876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=245.07 Aligned_cols=222 Identities=19% Similarity=0.239 Sum_probs=164.4
Q ss_pred ccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCCHHH
Q 004935 434 LGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQA 510 (723)
Q Consensus 434 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 510 (723)
||+|+||.||++.. ++..+|+|.+....... .|+.....+ +|+|++++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999987 45689999986542211 123222222 79999999999999999999999999999999
Q ss_pred HhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCceeeecccCC
Q 004935 511 LLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 511 ~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
++.... .+++.....++.+++ .+||||||+||+++.++ .++|+|||+++..... ....++
T Consensus 99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~~~~ 169 (267)
T PHA03390 99 LLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SCYDGT 169 (267)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------ccCCCC
Confidence 987653 455555555444443 39999999999999998 9999999998765321 224578
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc-cHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI-HITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
..|+|||.+.+..++.++|||||||+++||++|+.||....... ....+.... . ... ... ......+
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~------~~~----~~~~~~~ 237 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-KKL------PFI----KNVSKNA 237 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-ccC------Ccc----cccCHHH
Confidence 89999999998889999999999999999999999997543322 122222211 1 000 000 1223367
Q ss_pred HHHHHhccCCCCCCCCC-HHHHHH
Q 004935 659 VEIAMACVSQTSTKRPT-MNQVVM 681 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPs-m~evl~ 681 (723)
.+++.+|++.+|.+||+ ++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 89999999999999995 688764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=252.07 Aligned_cols=246 Identities=24% Similarity=0.277 Sum_probs=171.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|.. ++..||+|.++.... .....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 356899999999999998 467999999875432 1233567899999999999999999998654 4679999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++ +|.+++.... ..+.+.....++ |+...+||||||+||++++++.+||+|||++........ ..
T Consensus 91 ~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~---~~ 165 (309)
T cd07845 91 EQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PM 165 (309)
T ss_pred CC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC---CC
Confidence 75 8888876532 234444444333 333349999999999999999999999999987643211 11
Q ss_pred ecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cc-cccC------
Q 004935 574 TTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IE-SIVD------ 643 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-~i~d------ 643 (723)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........+.... ....... .. ...+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII-QLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HhcCCCChhhchhhhccccccc
Confidence 22345778999999865 457899999999999999999999997554322221111 1111100 00 0000
Q ss_pred CcccCC--CC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHED--FD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~--~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+... .. ......+.+++.+|++.||++|||++|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00 012345678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=249.04 Aligned_cols=232 Identities=23% Similarity=0.298 Sum_probs=170.4
Q ss_pred hhhhccccCcEEEEEEEE-----CCceEEEEEecCCCh----hhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSA----QGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.||+|+||.||++.. ++..||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 356899999999999986 467899999875422 2346688999999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 500 YEFMANGNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+||+++++|.+++...... .. +....+..+|+...+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 161 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--E 161 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc--c
Confidence 9999999999998754221 11 222333344444449999999999999999999999999986533211 1
Q ss_pred eeecccCCCccccccccccC--CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 572 VTTTIAGTPGYLDPEYYISN--RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
......++..|+|||.+... .++.++||||||++++||++|+.|+...........+........ +....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~- 233 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------PPYPQ- 233 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-------CCCCc-
Confidence 12234588899999998753 468899999999999999999999864433223333333222211 11111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRP 674 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RP 674 (723)
.....+.+++.+|++.+|++||
T Consensus 234 ---~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 234 ---EMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred ---cCCHHHHHHHHHHhcCCHHHhc
Confidence 1223567999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.54 Aligned_cols=249 Identities=16% Similarity=0.201 Sum_probs=162.6
Q ss_pred HHhhhhccccCcEEEEEEEECC-----ceEEEEEecCCChhh-----------HHHHHHHHHHHHhccCCceeeEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSSAQG-----------YKQFQAEVELLMRIHHKNLTTLVGYCD 491 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~-----------~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 491 (723)
+.+.+.||+|+||.||+|...+ ..+|+|+........ ......+...+..+.|+|++.+++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 3456789999999999999743 366777643322111 011223344556678999999999775
Q ss_pred cCC----ceEEEEEeCCCCCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccC
Q 004935 492 EGT----NRGLIYEFMANGNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGL 559 (723)
Q Consensus 492 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGl 559 (723)
... ..++++|++.. ++.+.+..... ... +....+..+|+...+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGl 172 (294)
T PHA02882 94 FKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI 172 (294)
T ss_pred EecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCC
Confidence 543 33567776644 56555543211 111 222333444444449999999999999999999999999
Q ss_pred ccccCCCCCCc----eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC
Q 004935 560 SRTFPVEGSGT----HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 560 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
++.+....... .......||+.|+|||...+..++.++|||||||+++||++|+.||.................
T Consensus 173 a~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~-- 250 (294)
T PHA02882 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF-- 250 (294)
T ss_pred ceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH--
Confidence 98764322111 112234699999999999999999999999999999999999999976633222221111100
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
+..+..+.+.. ......+.+++..|+..+|++||+++++++.|+
T Consensus 251 --~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 251 --IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred --HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000011100 112346789999999999999999999998763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=234.19 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=172.3
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCC-ChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
...||.|..|.|++.... +..+|||.+... +....++++..++++.+-+ .|.||+.+|||..+....+-||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 356999999999999984 579999999765 4556678888998887775 89999999999999998899998853
Q ss_pred CHHHHhccCCCCC---------CCHHHHHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADI---------LSWEGRLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~---------l~~~~~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
-++.++......+ ......|.++-+. ..+|||+||+|||+|+.|++|++|||++-.+.. ....+..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd----SkAhtrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD----SKAHTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec----ccccccc
Confidence 3444444322211 1112222222221 129999999999999999999999999987643 2334556
Q ss_pred cCCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 577 AGTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 577 ~gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
+|-+.|||||.+.- ..|+.++|||||||.|+||.||+.||..-..+......+. .+. .|.|.+...
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl---n~e------PP~L~~~~g-- 320 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL---NEE------PPLLPGHMG-- 320 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH---hcC------CCCCCcccC--
Confidence 78999999999864 4689999999999999999999999987543322222222 211 133432211
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
-...+.++...|++.|+.+||...++++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2346789999999999999999888765
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=257.41 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=178.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC-----ceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT-----NRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~ 500 (723)
+.+.||.|++|.||+|... +..||||++.... ....+.+.+|+++++.++|+||+++++++.... ..+++|
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 4578999999999999984 5799999987653 344578999999999999999999999987765 789999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++ +|.+++.... .+++...+. .+|+...+||||||+|||++.++.++|+|||++..........
T Consensus 84 e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 84 ELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred cchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99984 8888886543 344444333 3333334999999999999999999999999998764432111
Q ss_pred eeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-----------c
Q 004935 571 HVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-----------I 638 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~ 638 (723)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.||........... +........ .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL-IVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHhcCCCChhHhhhccccch
Confidence 122334578899999999887 789999999999999999999999975543211111 111111000 0
Q ss_pred ccccCC-cccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 639 ESIVDP-RLHED-----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 639 ~~i~d~-~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...+.. ..... ........+.+++.+||+.+|.+||++++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 00000 001123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=250.73 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=170.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--------ce
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--------NR 496 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------~~ 496 (723)
...+.||+|+||.||+|.. +++.||||.+.... ......+.+|++++++++||||++++++|.... ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 3457899999999999998 46799999886432 222345678999999999999999999986654 34
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 497 GLIYEFMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++||||+.+ +|.+.+.... ..+++.....+ +|+...+|+||||+||+++.++.+||+|||++......
T Consensus 95 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 172 (310)
T cd07865 95 YLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172 (310)
T ss_pred EEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence 999999975 7887776542 12444443333 33333499999999999999999999999999866432
Q ss_pred CCCc-eeeecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---CCcccc
Q 004935 567 GSGT-HVTTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---GDIESI 641 (723)
Q Consensus 567 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i 641 (723)
.... .......++..|+|||.+.+.. ++.++||||||++++||++|+.|+....... ....+...... ......
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 251 (310)
T cd07865 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLISQLCGSITPEVWPGV 251 (310)
T ss_pred cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhcccc
Confidence 2111 1122345778899999886654 7889999999999999999999986543221 11111111110 000000
Q ss_pred -----cCC-cccCCC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 -----VDP-RLHEDF---------DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 -----~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+. .+.... .......+.+++.+|++.+|.+|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000 0001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=248.52 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=177.0
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|++|.||+|+.. ++.+++|++.... ....+.+..|++++++++|+|++++++++......++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 467999999999999984 6799999998653 3334678899999999999999999999999999999999998 5
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++.....++.+ ...+||||+|+||++++++.+||+|||+++....... .....
T Consensus 83 ~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~ 158 (282)
T cd07829 83 DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYTHE 158 (282)
T ss_pred CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc---ccCcc
Confidence 8999987642 23444444444333 3339999999999999999999999999987543221 12233
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC------cccc--cC---C
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD------IESI--VD---P 644 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~i--~d---~ 644 (723)
.++..|+|||.+.+. .++.++|||||||+++||++|+.||........+..... ...... ...+ .+ +
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH-HhCCCcHHHHHhhccccccccccc
Confidence 456789999998776 789999999999999999999999865432211111111 110000 0000 00 0
Q ss_pred cccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ........+.+++.+|++.+|++||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 00011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=250.11 Aligned_cols=231 Identities=23% Similarity=0.318 Sum_probs=178.0
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
++||+||||.||-... +|+.+|.|.+.+.. .++..-.+.|-++|.+++.+.||.+--.+...+.++||+..|.+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 6899999999997765 67789999886543 234455789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.-++.......++-.+.+-+|.+++. |.||+||+|||||+.|+++|+|.|+|..++.. ......
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g----~~~~~r 346 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG----KPIRGR 346 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC----Cccccc
Confidence 9999998876666666665554444332 88999999999999999999999999987532 233445
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||.||||||++..+.|+...|-||+||+||||+.|+.||....+...-.+ +..+.... ...+...+. .
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-vdrr~~~~------~~ey~~kFS----~ 415 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-VDRRTLED------PEEYSDKFS----E 415 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-HHHHHhcc------hhhcccccC----H
Confidence 899999999999999999999999999999999999999976554332222 11111111 011222232 2
Q ss_pred HHHHHHHhccCCCCCCCCCHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
..-++....++.||++|-.-+
T Consensus 416 eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHHccCHHHhccCC
Confidence 445667777889999886543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=238.10 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=178.8
Q ss_pred ccCHHHHHHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhc-cCCceeeEEEEEec
Q 004935 417 RFSYSNVLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRI-HHKNLTTLVGYCDE 492 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 492 (723)
.|+-++++.. ..||.|+||+|+|-.+ .|+.+|||+++.... ...++|+.|.+...+- +.||||+++|.+..
T Consensus 60 ~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 4555555443 4699999999999887 477999999987654 5678899999876665 79999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhcc---CC-----CC-----CCCHHHHHHHHHhccc-cccCCCCCCEEEcCCCcEEEEecc
Q 004935 493 GTNRGLIYEFMANGNLQALLLG---EE-----AD-----ILSWEGRLRIAIEAAK-VHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 493 ~~~~~lV~Ey~~~gsL~~~l~~---~~-----~~-----~l~~~~~l~i~~~~a~-vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
.+..++-||.|+- ||..+-.. -. .. .......|..+-.-.+ ||||+||+|||||..|.+||+|||
T Consensus 135 EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 135 EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999975 66544221 10 01 1112233333333333 999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG 636 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 636 (723)
++-.+.. +...+.-+|-..|||||.+.. ..|+.++||||+|++|+|+.||+-|+..... +.+.+......
T Consensus 214 IcGqLv~----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~g- 285 (361)
T KOG1006|consen 214 ICGQLVD----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIG- 285 (361)
T ss_pred chHhHHH----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcC-
Confidence 9977632 233455678889999999864 3489999999999999999999999876543 22222222211
Q ss_pred CcccccCCcccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 637 DIESIVDPRLHED-FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 637 ~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.- |.+... ...+....+.+++.-|+.++-++||...++.+.
T Consensus 286 dp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 222222 223455678899999999999999999888764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=262.94 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=183.4
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E 501 (723)
.+.||+|+||.||+|+. .|+.||||.++... ....+...+|+++|++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 46899999999999997 58899999998754 334566789999999999999999998765443 5689999
Q ss_pred eCCCCCHHHHhccCCC-------CCCCHH----HHHHHHHhccccccCCCCCCEEEc--CCC--cEEEEeccCccccCCC
Q 004935 502 FMANGNLQALLLGEEA-------DILSWE----GRLRIAIEAAKVHRDVKSTNILLS--GKF--QAKIADFGLSRTFPVE 566 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~-------~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~--~~~--~~kl~DfGla~~~~~~ 566 (723)
||.+|||...|...+. ..+... ..++.+++-..|||||||.||++- .++ .-||+|||.|+.+...
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 9999999999987532 223333 334444455559999999999984 334 3699999999987533
Q ss_pred CCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHH--HHHHHhcCCCcccccC
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQ--WVSFMLGKGDIESIVD 643 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~i~d 643 (723)
.......||..|++||.+.. ..|+.-+|.|||||++||+.||..||..........+ |......+..+...++
T Consensus 178 ----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 178 ----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred ----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 25567899999999999984 7899999999999999999999999976654433222 2222222222222222
Q ss_pred CcccCCC------------CHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhhhHh
Q 004935 644 PRLHEDF------------DINSVWKTVEIAMACVSQTSTKRP--TMNQVVMELNESLAIET 691 (723)
Q Consensus 644 ~~l~~~~------------~~~~~~~l~~l~~~Cl~~~p~~RP--sm~evl~~L~~~~~~~~ 691 (723)
+...+.. ...-...+-+.....+..+|.+|- ...+.-..+.+++...-
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 2222111 111233344566666677888887 77777777777775553
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.76 Aligned_cols=248 Identities=18% Similarity=0.292 Sum_probs=173.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.. ++..||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 356899999999999987 46799999987542 2345678889999999999999999988753 356789999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-c
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-T 570 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 570 (723)
|+. |+|.+++..... +++..... .+|+...+||||||+||++++++.+||+|||+++........ .
T Consensus 89 ~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (334)
T cd07855 89 LME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165 (334)
T ss_pred hhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCC
Confidence 996 689988865432 44433333 334444499999999999999999999999999765332211 1
Q ss_pred eeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----------CCc
Q 004935 571 HVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----------GDI 638 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 638 (723)
.......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+ ..+...... ..+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhhhhhchhhH
Confidence 11233468889999998765 46899999999999999999999999654321111 111111110 000
Q ss_pred ccccCC-cccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 639 ESIVDP-RLHEDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 639 ~~i~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+. ...... .......+.+++.+|++.+|.+||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000 000000 1122456889999999999999999998887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=269.11 Aligned_cols=250 Identities=18% Similarity=0.209 Sum_probs=164.5
Q ss_pred HHhhhhccccCcEEEEEEEECC---ceEEEE------------------EecCCChhhHHHHHHHHHHHHhccCCceeeE
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG---TEVAVK------------------MLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~---~~vavK------------------~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 486 (723)
+.+.+.||+|+||.||++.... ..+++| .+. ........+.+|+++|++++|+||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 4456789999999999987531 112222 111 112234568899999999999999999
Q ss_pred EEEEecCCceEEEEEeCCCCCHHHHhccCCC---C------CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEE
Q 004935 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEA---D------IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 487 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---~------~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~k 553 (723)
++++...+..++|+|++.. +|.+++..... . .. +....+..+|+...|||||||+|||++.++.+|
T Consensus 229 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 229 EEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred eEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999864 67666543211 1 11 122334444444559999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~ 633 (723)
|+|||+++.+.... ........||..|+|||.+.+..++.++|||||||++|||++|+.++..........+......
T Consensus 308 L~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 308 LGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999998764321 1222345789999999999999999999999999999999998864332211111111111110
Q ss_pred cCCC-cccccCC-----------ccc---CCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 634 GKGD-IESIVDP-----------RLH---EDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 634 ~~~~-~~~i~d~-----------~l~---~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.-+. ..+..++ .+. .... ......+.+++.+|++.||.+|||+.|+++
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0000000 000 0000 001124567789999999999999999987
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=253.96 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=171.0
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLIY 500 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV~ 500 (723)
.+.||+|+||.||+|.. ++..||||++.... ......+.+|++++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999987 46799999986532 223456889999999999999999999986543 458999
Q ss_pred EeCCCCCHHHHhccCCC--C----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 501 EFMANGNLQALLLGEEA--D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~--~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
||+.. +|..+....-. . ..+....+..+|+...+||||||+||+++.++.+||+|||+++..... ..
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~------~~ 172 (342)
T cd07879 100 PYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE------MT 172 (342)
T ss_pred ccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC------CC
Confidence 99975 77776532200 0 112223344444445599999999999999999999999998764221 12
Q ss_pred cccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH----------hcCCCcccccC
Q 004935 575 TIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM----------LGKGDIESIVD 643 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~i~d 643 (723)
...++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+....... ...........
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (342)
T cd07879 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252 (342)
T ss_pred CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHh
Confidence 3456788999999876 468999999999999999999999997543211111111100 00000000000
Q ss_pred --Cccc-CCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhhh
Q 004935 644 --PRLH-EDF---DINSVWKTVEIAMACVSQTSTKRPTMNQVVME--LNESLA 688 (723)
Q Consensus 644 --~~l~-~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~--L~~~~~ 688 (723)
+... ... .......+.+++.+|++.+|.+||++++++.. ++....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 000 00122357799999999999999999999853 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=248.22 Aligned_cols=235 Identities=23% Similarity=0.343 Sum_probs=177.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|++|.||+|.. ++..|++|++... .....+.+..|++++++++ |+||+++++++...+..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 456899999999999998 5679999998753 2234467899999999998 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC----
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG---- 569 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~---- 569 (723)
++++|.+++.... .+.+.....++.++ ..+|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (280)
T cd05581 85 PNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162 (280)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCC
Confidence 9999999997643 34444444433333 3399999999999999999999999999876432210
Q ss_pred -------------ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC
Q 004935 570 -------------THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG 636 (723)
Q Consensus 570 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 636 (723)
........++..|+|||......++.++||||||++++|+++|+.|+........ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~- 237 (280)
T cd05581 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----FQKILKL- 237 (280)
T ss_pred CCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhc-
Confidence 0112234578899999999888899999999999999999999999875542111 1111110
Q ss_pred CcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 004935 637 DIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTM----NQVVM 681 (723)
Q Consensus 637 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm----~evl~ 681 (723)
. ..+.. .....+.+++.+|++.+|++||++ +++++
T Consensus 238 --~----~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 238 --E----YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --C----CCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 01111 113357899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=249.73 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=171.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~~ 505 (723)
.+.||.|+||.||++.. +++.||+|++... .....+.+..|++++++++||||+++++++.. ....++++||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 57899999999999987 4668999987643 22334678899999999999999999998865 56788999998 4
Q ss_pred CCHHHHhccCCCC---CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 506 GNLQALLLGEEAD---IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 506 gsL~~~l~~~~~~---~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
++|.+++...... .. +....+..+|+...+||||+|+||++++++.+||+|||++...... .....+
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~------~~~~~~ 167 (328)
T cd07856 94 TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ------MTGYVS 167 (328)
T ss_pred cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC------cCCCcc
Confidence 6898888643211 11 2223344455555599999999999999999999999998754221 122356
Q ss_pred CCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH-----------HHhcCCCcccccCCcc
Q 004935 579 TPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS-----------FMLGKGDIESIVDPRL 646 (723)
Q Consensus 579 t~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~i~d~~l 646 (723)
+..|+|||.+.+ ..++.++|||||||+++||+||+.||...........+.. .........-+..-..
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPK 247 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccc
Confidence 788999998766 5689999999999999999999999865432111111111 0000000000000000
Q ss_pred cCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 647 HEDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 647 ~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...... .....+.+++.+|++.+|++||++.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 248 REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011111 123467899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=250.69 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=169.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEecCC--------ceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--------NRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------~~~ 497 (723)
+.+.||+|+||.||+|.. +++.+|+|++...... ....+.+|++++++++|+||+++++++.... ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 357899999999999998 4678999998654321 2346788999999999999999999875433 468
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+|+||+.. +|...+.... ..+++.... ..+|....+||||||+||++++++.+||+|||+++......
T Consensus 92 lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 169 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169 (311)
T ss_pred EEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCC
Confidence 99999976 6766665432 223443333 33344444999999999999999999999999998653322
Q ss_pred CCc--------eeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--
Q 004935 568 SGT--------HVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG-- 636 (723)
Q Consensus 568 ~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 636 (723)
... .......+++.|+|||.+.+. .++.++|||||||+++||++|++||....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (311)
T cd07866 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE 249 (311)
T ss_pred cccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 110 111234567889999987654 588999999999999999999999875443222222111110000
Q ss_pred ------Cccccc----C----CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 ------DIESIV----D----PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 ------~~~~i~----d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.... . +.+.... ......+.+++.+|++.+|.+|||+.|++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 250 TWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0 0000000 011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=254.15 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=171.6
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 501 (723)
.+.||+|+||.||+|.. ++..||||.+... .....+.+.+|+.++++++|+||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 46899999999999997 4679999998753 233345778999999999999999999987644 35799999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+. ++|.+++.... .+..... +..+|....+||||||+||+++.++.+||+|||+++...... .
T Consensus 90 ~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~ 163 (337)
T cd07858 90 LMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---D 163 (337)
T ss_pred CCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc---c
Confidence 997 68988886542 2333332 333344444999999999999999999999999998753321 1
Q ss_pred eeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC---Cccccc-----
Q 004935 572 VTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG---DIESIV----- 642 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~i~----- 642 (723)
......++..|+|||.+.. ..++.++|||||||+++||++|+.||........ ........... ....+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcCchhhh
Confidence 2223457889999998765 4689999999999999999999999865422111 11111111000 000000
Q ss_pred ----------CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 643 ----------DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 643 ----------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
++.+.. ........+.+++.+|++.+|++|||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 243 RYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 011223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=243.59 Aligned_cols=235 Identities=26% Similarity=0.346 Sum_probs=172.8
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCC-----ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS-----SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||++... +..+++|+++.. ......++..|+.++++++||||+++++++.+....++|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 34578999999999999884 335666665432 12234467789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccC--CCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 502 FMANGNLQALLLGE--EADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 502 y~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|+++++|.+++... ....+++...+.++.+ ...+|+||||+||++++ +.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-- 159 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-- 159 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc--
Confidence 99999999988642 2334555544443333 33399999999999986 469999999987653221
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.......++..|+|||.+.+..++.++|+||||+++++|++|..|+.... ......... .+. .+.+
T Consensus 160 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~~-~~~-----~~~~--- 225 (260)
T cd08222 160 -DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIV-EGP-----TPSL--- 225 (260)
T ss_pred -ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHH-cCC-----CCCC---
Confidence 12234557889999999988888999999999999999999999986432 122222211 111 1111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+......+.+++.+|+..+|++||++.|+++
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 -PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1223346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=255.24 Aligned_cols=251 Identities=21% Similarity=0.256 Sum_probs=170.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC--------------
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-------------- 493 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------------- 493 (723)
+.+.||.|+||.||+|.. .++.||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 357899999999999988 4669999998776656667889999999999999999999776543
Q ss_pred CceEEEEEeCCCCCHHHHhccCC---CCCCCH----HHHHHHHHhccccccCCCCCCEEEc-CCCcEEEEeccCccccCC
Q 004935 494 TNRGLIYEFMANGNLQALLLGEE---ADILSW----EGRLRIAIEAAKVHRDVKSTNILLS-GKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~ 565 (723)
...++|+||++ ++|.+++.... .....| ...+..+|+...+||||||+||+++ ++..+||+|||+++.+..
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 35789999998 58988875431 111122 2233444444449999999999998 456789999999976532
Q ss_pred CCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----CC--
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----GD-- 637 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~-- 637 (723)
............++..|+|||.+.. ..++.++|||||||+++||++|+.||................... ..
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07854 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247 (342)
T ss_pred ccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 2111111223357889999998654 457889999999999999999999997553321111111100000 00
Q ss_pred --ccc-ccCCcccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 638 --IES-IVDPRLHEDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 638 --~~~-i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... .......... .......+.+++.+|++.+|.+|||+.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000000000 0012245779999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=281.51 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=180.6
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
..||.|.||.||-|.. +|.-.|+|-+.... ....+...+|..++..++|||+|+.+|.-...+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 5899999999999987 56688999876543 3445678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCC--C------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc-eeeecccC
Q 004935 508 LQALLLGEEA--D------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT-HVTTTIAG 578 (723)
Q Consensus 508 L~~~l~~~~~--~------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~g 578 (723)
|.+++..... + ..+....+..+|+...|||||||.||+|+.+|.+|++|||.|..+....+.. .......|
T Consensus 1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~G 1400 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMG 1400 (1509)
T ss_pred HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcC
Confidence 9999875421 1 1233445667777777999999999999999999999999998875432111 11234679
Q ss_pred CCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 579 TPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 579 t~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
|+.|||||.+.+.. ...+.||||+|||++||+||++||......- +++ .....|.. |.+.+. -.
T Consensus 1401 T~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIM-y~V~~gh~-----Pq~P~~----ls 1467 (1509)
T KOG4645|consen 1401 TPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIM-YHVAAGHK-----PQIPER----LS 1467 (1509)
T ss_pred CchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHH-hHHhccCC-----CCCchh----hh
Confidence 99999999997643 5678999999999999999999997654321 111 12222222 223222 23
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..-.+++.+|++.||++|.++.|+++
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 34569999999999999977665543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=238.44 Aligned_cols=225 Identities=27% Similarity=0.358 Sum_probs=172.8
Q ss_pred ccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
||+|+||.||++... ++.+++|.+..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999984 67999999876532 2456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... .+++... +..+|+...+|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCG 155 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcC
Confidence 99987542 2333332 333344334999999999999999999999999998753321 12234567
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
+..|++||...+...+.++|+||||++++|+++|+.||..... .+....... .. ..+.... ...+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-~~------~~~~~~~----~~~l 220 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK-DP------LRFPEFL----SPEA 220 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc-CC------CCCCCCC----CHHH
Confidence 8899999999888899999999999999999999999965432 121222211 11 1111111 2367
Q ss_pred HHHHHhccCCCCCCCCCHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~e 678 (723)
.+++.+|+..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 79999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=253.56 Aligned_cols=237 Identities=22% Similarity=0.354 Sum_probs=181.4
Q ss_pred hhhhccccCcEEEEEEEECCc--eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+..-||.|+||.||+|..... -.|-|++...+.....+|+-|++||....||+||+|++.|...+.++++.|||.||-
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 345689999999999988644 567788887777888999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC-----C----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 508 LQALLLGEEA-----D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 508 L~~~l~~~~~-----~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
....+..-.. + .......|..+|+.-.||||||+.|||++-+|.++|+|||.+..... .......+.|
T Consensus 116 VDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---t~qkRDsFIG 192 (1187)
T KOG0579|consen 116 VDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---TRQKRDSFIG 192 (1187)
T ss_pred HhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh---HHhhhccccC
Confidence 9877653211 1 12234456666666669999999999999999999999999865421 1233456889
Q ss_pred CCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 579 TPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 579 t~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
|+.|||||+.. ..+|+.++|||||||.|.||.-+.+|....+...-+.. +.+.. .|.|.....
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-----iaKSe-----PPTLlqPS~-- 260 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSE-----PPTLLQPSH-- 260 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-----HhhcC-----CCcccCcch--
Confidence 99999999865 45799999999999999999999998754432211111 11111 123322111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
=...+-++..+|+..+|..||++.++++
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1235679999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=249.46 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=171.8
Q ss_pred HHHHHHHHh--hhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--
Q 004935 422 NVLRITNNF--ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-- 493 (723)
Q Consensus 422 ~l~~~t~~f--~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-- 493 (723)
++...+.+| .+.||+|+||.||+|.. ++..||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 333444444 46799999999999987 46799999987532 23346788999999999999999999988543
Q ss_pred ----CceEEEEEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccC
Q 004935 494 ----TNRGLIYEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGL 559 (723)
Q Consensus 494 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGl 559 (723)
...+++++++ +++|.+++... .+++.... ..+|+...+||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3456777776 78998887643 24444333 334444449999999999999999999999999
Q ss_pred ccccCCCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC-C
Q 004935 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG-D 637 (723)
Q Consensus 560 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 637 (723)
++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+...+....... .
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 167 ARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 876421 1223457889999998866 5688999999999999999999999865432222211111110000 0
Q ss_pred c-c---------------cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 638 I-E---------------SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 638 ~-~---------------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+ . ........ .........+.+++.+|++.+|.+||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0 00000000 0000123357799999999999999999988864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=246.38 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=169.1
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLIY 500 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV~ 500 (723)
.+.||+|+||.||+|.. ++..||||++... .....+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 46899999999999987 4679999998643 2233456889999999999999999999986554 358999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+ +++|.+++... .+.+..... .+|+...+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---- 171 (343)
T cd07880 100 PFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---- 171 (343)
T ss_pred ecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC----
Confidence 999 67998887643 234433333 333334499999999999999999999999999865321
Q ss_pred eeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH----------hcCCCcc
Q 004935 571 HVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM----------LGKGDIE 639 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~ 639 (723)
.....+++.|+|||.+.+ ..++.++|||||||++++|++|+.||..........+..... +......
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred --ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 123457889999999876 458899999999999999999999997543211111111100 0000000
Q ss_pred cccC--CcccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVD--PRLHE----DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... +.... .........+.+++.+|++.+|++|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000 000112235779999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=246.60 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=169.2
Q ss_pred hhhhccccCcEEEEEEEEC----CceEEEEEecCCC--hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC----CceEE
Q 004935 430 FERVLGNGGFGTVYHGYLD----GTEVAVKMLSPSS--AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG----TNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~~l 498 (723)
+.+.||+|+||.||++... +..||+|.+.... ....+.+.+|+++++++ +|+||+++++++... ...++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 4578999999999999984 4589999987532 22356788999999999 599999999976432 45678
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
++||+. ++|.+++.... .+.+.. .+..+|....+||||||+||++++++.+||+|||+++.+.....
T Consensus 84 ~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 84 YEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 888886 58988886432 233333 33344444449999999999999999999999999986543221
Q ss_pred C-ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccccC
Q 004935 569 G-THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIVD 643 (723)
Q Consensus 569 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~d 643 (723)
. ........++..|+|||.+.+ ..++.++|||||||++++|++|+.||........+.+ +........ ...+.+
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ-ILQVLGTPDEETLSRIGS 239 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHH-HHHHhCCCCHHHHHhhhh
Confidence 1 111223468899999998765 4689999999999999999999999865432111111 111100000 000000
Q ss_pred ---------------CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 ---------------PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ---------------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+. .........+.+++.+|++.+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=234.55 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=181.9
Q ss_pred hhhccccCcEEEEEEEEC-------CceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 501 (723)
..++-+|.||.||+|.+. .+.|.+|.++.... -....|+.|.-.+..+.|||+.++.+.+.+ .+..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 457899999999999762 23688888766543 345678999999999999999999999855 567889999
Q ss_pred eCCCCCHHHHhccC------CCCCCCHHHH------HHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 502 FMANGNLQALLLGE------EADILSWEGR------LRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 502 y~~~gsL~~~l~~~------~~~~l~~~~~------l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
++.-|+|+.+|... ..+.+.-.+. +..+++..+ ||.||.++|+++|+..++||+|-.+++.+-+
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP 448 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence 99999999999732 2223333332 222322222 9999999999999999999999999998754
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.+.. -..........||+||.+....|+.++|||||||+||||+| |+.|+...+. ..+...+.+| .
T Consensus 449 ~DYh-cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----fEm~~ylkdG-------y 515 (563)
T KOG1024|consen 449 GDYH-CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----FEMEHYLKDG-------Y 515 (563)
T ss_pred cccc-ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----HHHHHHHhcc-------c
Confidence 3321 11122345679999999999999999999999999999998 8888865432 1233444443 2
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
++. .+.+++.++..++.-||+..|++||+++|++.-|.|.
T Consensus 516 Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 516 RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 232 2345777899999999999999999999999988764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=264.89 Aligned_cols=245 Identities=29% Similarity=0.398 Sum_probs=172.8
Q ss_pred HHHHHHhh--hhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----
Q 004935 424 LRITNNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG----- 493 (723)
Q Consensus 424 ~~~t~~f~--~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----- 493 (723)
.+.-.+|+ ++||+||||.|||++. +|+.+|||++.... ........+|+..|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34455665 4799999999999986 89999999997653 34456788999999999999999987522110
Q ss_pred --------------------------------------------------------------------------------
Q 004935 494 -------------------------------------------------------------------------------- 493 (723)
Q Consensus 494 -------------------------------------------------------------------------------- 493 (723)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEeCCCCCHHHHhccCCCC---CCC------HHHHHHHHH
Q 004935 494 ----------------------------------TNRGLIYEFMANGNLQALLLGEEAD---ILS------WEGRLRIAI 530 (723)
Q Consensus 494 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~---~l~------~~~~l~i~~ 530 (723)
..+|+=||||+.-+|+++++.+... ..- ....+.++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0123456777776666666544221 111 223466677
Q ss_pred hccccccCCCCCCEEEcCCCcEEEEeccCccccC---------------CCCCCceeeecccCCCccccccccccC---C
Q 004935 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFP---------------VEGSGTHVTTTIAGTPGYLDPEYYISN---R 592 (723)
Q Consensus 531 ~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~---------------~~~~~~~~~~~~~gt~~y~aPE~~~~~---~ 592 (723)
+.+.|||||||.||+||++..+||+|||+|.... ..+......+...||.-|+|||.+.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 7777999999999999999999999999998721 011112234567899999999998754 4
Q ss_pred CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCC
Q 004935 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTK 672 (723)
Q Consensus 593 ~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~ 672 (723)
|+.|+|+||+||||+||+. ||...-++... -..++.+.+..- .++..++...-.+++.++++.||++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999999986 35433222221 122334433322 2233344445679999999999999
Q ss_pred CCCHHHHHH
Q 004935 673 RPTMNQVVM 681 (723)
Q Consensus 673 RPsm~evl~ 681 (723)
|||+.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=251.71 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=169.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc------eEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN------RGLIY 500 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~lV~ 500 (723)
.+.||+|++|.||+|.. ++..||+|++... .....+.+.+|+.++++++|+|++++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 56899999999999998 4568999998653 22334667889999999999999999988765554 89999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+ +++|.+++... .+.+... +..+|+...+||||||+||++++++.+||+|||++......
T Consensus 100 e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (343)
T cd07851 100 HLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---- 171 (343)
T ss_pred ecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc----
Confidence 998 56999988653 2344333 33334444499999999999999999999999999865321
Q ss_pred eeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC----------CCcc
Q 004935 571 HVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK----------GDIE 639 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~ 639 (723)
.....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+.......... ....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 223457888999998865 367899999999999999999999986543211111111110000 0000
Q ss_pred cccC-------CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVD-------PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+. +.+... .......+.+++.+|++.+|++|||+.+|++
T Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 250 NYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 000000 0012346889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=230.50 Aligned_cols=227 Identities=26% Similarity=0.390 Sum_probs=174.3
Q ss_pred CcEEEEEEEEC--CceEEEEEecCCChhh-HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhcc
Q 004935 438 GFGTVYHGYLD--GTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG 514 (723)
Q Consensus 438 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 514 (723)
+||.||+|... +..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999985 5799999998765444 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccc
Q 004935 515 EEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584 (723)
Q Consensus 515 ~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~a 584 (723)
... +++.....++.+ ...+|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMA 154 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCCC
Confidence 432 444444333333 333999999999999999999999999998764321 2234567889999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHh
Q 004935 585 PEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMA 664 (723)
Q Consensus 585 PE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~ 664 (723)
||......++.++||||||++++||++|..|+........+.+... .+.... .. ........+.+++.+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~----~~---~~~~~~~~~~~~i~~ 223 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF----PP---PEWKISPEAKDLIRK 223 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC----cc---ccccCCHHHHHHHHH
Confidence 9999888899999999999999999999999865322222222111 111100 00 000022467899999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 004935 665 CVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 665 Cl~~~p~~RPsm~evl~ 681 (723)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=252.50 Aligned_cols=228 Identities=22% Similarity=0.323 Sum_probs=180.4
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+...+|.|+|+.|-++.. +++..+||++.... .+-.+|+.++.+. .|+||+++.+.|.++.+.++|||.+.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 34556799999999998887 46689999997662 2346778777666 79999999999999999999999999
Q ss_pred CCCHHHHhccCCC---CCCCHHHHHHHHHhccc----cccCCCCCCEEE-cCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA---DILSWEGRLRIAIEAAK----VHRDVKSTNILL-SGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~---~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl-~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|-+.+.+..... ..-.|...+..++++.| |||||||+|||+ ++.++++|+|||.++....+ ....
T Consensus 400 g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp 473 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTP 473 (612)
T ss_pred ccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh------hccc
Confidence 9988777665422 23458888777777766 999999999999 58899999999999876433 2334
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
+-|..|.|||.+....|++++|+||||++||||++|+.|+.....+.. +...+..+... .....
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e----i~~~i~~~~~s------------~~vS~ 537 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE----IHTRIQMPKFS------------ECVSD 537 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH----HHHhhcCCccc------------cccCH
Confidence 678899999999999999999999999999999999999986654411 22233332222 22233
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+|+.+||+.+|.+||+|.++..
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhcc
Confidence 5569999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=264.18 Aligned_cols=132 Identities=27% Similarity=0.348 Sum_probs=107.5
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... ++.||||+++... ......+..|+.+++.++|+||+++++++......++||||++
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 3578999999999999985 7799999987542 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 505 NGNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
+++|.+++..... ..+.+. ..+..+|....|||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999865321 112222 23344444444999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=230.66 Aligned_cols=211 Identities=19% Similarity=0.148 Sum_probs=157.0
Q ss_pred cCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhcc
Q 004935 437 GGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG 514 (723)
Q Consensus 437 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 514 (723)
|.+|.||++.. +++.+|+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999998 56799999987543 234555666666899999999999999999999999999999998865
Q ss_pred CCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccc
Q 004935 515 EEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584 (723)
Q Consensus 515 ~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~a 584 (723)
... +++... +..+|+...+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~y~a 150 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENMYCA 150 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCccccC
Confidence 422 333332 33334444499999999999999999999999988665321 122345678999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHh
Q 004935 585 PEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMA 664 (723)
Q Consensus 585 PE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~ 664 (723)
||.+.+..++.++||||+|++++||++|+.|+....... .......+... ....+.+++.+
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~~~~~----~~~~~~~li~~ 211 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLNIPEW----VSEEARSLLQQ 211 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccCCccc----CCHHHHHHHHH
Confidence 999988889999999999999999999998765321100 00000011111 22357789999
Q ss_pred ccCCCCCCCCCHHHH
Q 004935 665 CVSQTSTKRPTMNQV 679 (723)
Q Consensus 665 Cl~~~p~~RPsm~ev 679 (723)
|++.+|++||++.+.
T Consensus 212 ~l~~dp~~R~~~~~~ 226 (237)
T cd05576 212 LLQFNPTERLGAGVA 226 (237)
T ss_pred HccCCHHHhcCCCcc
Confidence 999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=206.44 Aligned_cols=246 Identities=18% Similarity=0.286 Sum_probs=174.7
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
++||+|.+|+||+|+.. .+.||+|+.+... ........+|+-+|+.++|+|||++++....+...-+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 57999999999999874 5589999987543 22345678999999999999999999999999999999999976 7
Q ss_pred HHHHhccCCCC---------CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 508 LQALLLGEEAD---------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 508 L~~~l~~~~~~---------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
|..+....... .++..+.+.+++.....|||+||+|.|++.+|+.|++|||+++.+... ...-+....
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---vrcysaevv 163 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---VRCYSAEVV 163 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc---eEeeeceee
Confidence 77776544322 234444455555555599999999999999999999999999987532 234455667
Q ss_pred CCccccccccccCC-CCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh--cCCC---cccccCCcccCCCC
Q 004935 579 TPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML--GKGD---IESIVDPRLHEDFD 651 (723)
Q Consensus 579 t~~y~aPE~~~~~~-~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~--~~~~---~~~i~d~~l~~~~~ 651 (723)
|..|++|..+.+.+ |++..|+||-|||+.|+.. |++.|.+....+.+..+.+..- .+.. +..+-|-...+.++
T Consensus 164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp 243 (292)
T KOG0662|consen 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP 243 (292)
T ss_pred eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence 99999999998765 8999999999999999986 5555555444444444433321 1111 22222222222221
Q ss_pred HH-----HH----HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 IN-----SV----WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~-----~~----~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. .+ ..-.++..+.+.-+|.+|.+++++++
T Consensus 244 attswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 244 ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 11 11245666666668999999887765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=244.77 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=182.4
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+++||.|.||+||-|++ .|+.||||++.+.. .+...++.+|+.+|++++||.||.+...|+..+..+.|||-+.+-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57999999999999988 68899999997653 344578999999999999999999999999999999999999776
Q ss_pred CHHHHhccCCCC---------CCCHHHHHHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEAD---------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~---------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
-|+..|...... +.++...++.+|...++|+||||+||||... -++||+|||.|+.++.. ....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRr 724 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRR 724 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh----hhhh
Confidence 666666544322 1223344555555556999999999999754 47999999999998643 3345
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
.+.||+.|+|||.+..+.|...-|+||.|||+|--++|.-||....+..+..+-+.++.......++
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~ei------------- 791 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEI------------- 791 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhc-------------
Confidence 6789999999999999999999999999999999999999998766544444444445444332222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
....++++...++..-.+|-|....+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 22456888888888888888877654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=253.93 Aligned_cols=233 Identities=28% Similarity=0.384 Sum_probs=176.2
Q ss_pred hhhccccCcEE-EEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGT-VYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+++|.|+-|+ ||+|..+++.||||++-... ....++|++.|+.- .|||||++++.-.+....|+..|.|.. +|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 46899998875 89999999999999986433 23568999999888 699999999888888899999999987 99
Q ss_pred HHHhccC--CCC----CCCHHHHHHHHHhccc------cccCCCCCCEEEcC---C--CcEEEEeccCccccCCCCCCce
Q 004935 509 QALLLGE--EAD----ILSWEGRLRIAIEAAK------VHRDVKSTNILLSG---K--FQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 509 ~~~l~~~--~~~----~l~~~~~l~i~~~~a~------vH~Dlk~~NILl~~---~--~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++++... +.. .-.|...-+++-++|| |||||||+||||+. + .+++|+|||+++.+....+.-.
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 9999873 111 2223333334444444 99999999999976 3 5799999999999876554444
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcC-CCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITS-KSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......||-||+|||.+...+-+.++||||+|||+|..++| ++||...-++ -+........+.. +...
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~~~~~L~~-----L~~~- 738 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILTGNYTLVH-----LEPL- 738 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhcCccceee-----eccC-
Confidence 45667899999999999999999999999999999999997 8899754322 1111111111111 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.++ ...+++.++++.+|..||++.+|+.
T Consensus 739 -~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 739 -PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 5679999999999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=250.10 Aligned_cols=236 Identities=25% Similarity=0.440 Sum_probs=183.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEe-----cCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCD-----EGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-----~~~~~~lV~E 501 (723)
|.+.||.|.+|.||+++. +++.+|+|++...... ..+...|.++|+.. .|||++.++|++. .+++++||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 467899999999998876 6779999999876543 35678899999888 7999999999984 3577899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
||.+||..+++++-....+.|.....|+.+++. +|||||-.||||+.++.+||+|||.+..+.. +..
T Consensus 102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds---T~g 178 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS---TVG 178 (953)
T ss_pred ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec---ccc
Confidence 999999999998766666777665555544432 9999999999999999999999999987632 233
Q ss_pred eeecccCCCccccccccccC-----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 572 VTTTIAGTPGYLDPEYYISN-----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
......||+.|||||++... .|+..+|+||+|++..||--|.+|+..+.....+ +.+.. .|..
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----F~IpR-------NPPP 246 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR-------NPPP 246 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----ccCCC-------CCCc
Confidence 44567899999999998653 4778999999999999999999998766432111 11111 1222
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.-..+..=..++.+++..|+..|-.+||++.++++
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 22222333457889999999999999999988775
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=234.60 Aligned_cols=256 Identities=18% Similarity=0.271 Sum_probs=187.7
Q ss_pred ccCHHHHHHHHHHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhcc-CC-----ceeeEEE
Q 004935 417 RFSYSNVLRITNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HK-----NLTTLVG 488 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g 488 (723)
.+...+.+...+.....+|+|.||.|-+..+. +..||||+++.-... .+..+-|+++|+++. +. .+|.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 44455555666666789999999999999884 458999999754433 234578999999993 22 4788889
Q ss_pred EEecCCceEEEEEeCCCCCHHHHhccCCCCCCC----------HHHHHHHHHhccccccCCCCCCEEEcC----------
Q 004935 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILS----------WEGRLRIAIEAAKVHRDVKSTNILLSG---------- 548 (723)
Q Consensus 489 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~----------~~~~l~i~~~~a~vH~Dlk~~NILl~~---------- 548 (723)
|++-.++.++|+|.| +-|+.+++..+....+. +...+..+++...+|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 34999999886554443 444555555556699999999999832
Q ss_pred ----------CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcccc
Q 004935 549 ----------KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIER 618 (723)
Q Consensus 549 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~ 618 (723)
+..+||+|||.|+.-. .....+..|..|+|||.+.+-.++.++||||+||||.|+.||...|+.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDH------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceec------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2458999999998742 222556789999999999999999999999999999999999999886
Q ss_pred CcccccHHHHHHHHhcCC-----------------Cc-----------ccccCCc--c--cCCCCHHHHHHHHHHHHhcc
Q 004935 619 THERIHITQWVSFMLGKG-----------------DI-----------ESIVDPR--L--HEDFDINSVWKTVEIAMACV 666 (723)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~-----------------~~-----------~~i~d~~--l--~~~~~~~~~~~l~~l~~~Cl 666 (723)
..+..++ ..+...+++- ++ ..+.++. + .......+...+++|+.+++
T Consensus 312 Hen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 312 HENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 6544444 2222222211 00 1111111 0 01123356778999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 004935 667 SQTSTKRPTMNQVVM 681 (723)
Q Consensus 667 ~~~p~~RPsm~evl~ 681 (723)
..||.+|+|+.|+++
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=225.52 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=173.8
Q ss_pred HhhhhccccCcEEEEEEEEC------CceEEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD------GTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV 499 (723)
+....||+|.||.||+|.-. ...+|+|+++..... ......+|+.+++.++|+|++.|...+.+ +...+|+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 34578999999999999652 227899999765321 12456899999999999999999998866 7778999
Q ss_pred EEeCCCCCHHHHhccCC---CCCCC----------HHHHHHHHHhccccccCCCCCCEEEcCC----CcEEEEeccCccc
Q 004935 500 YEFMANGNLQALLLGEE---ADILS----------WEGRLRIAIEAAKVHRDVKSTNILLSGK----FQAKIADFGLSRT 562 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~---~~~l~----------~~~~l~i~~~~a~vH~Dlk~~NILl~~~----~~~kl~DfGla~~ 562 (723)
+||.+. +|.+.++-+. ...+. ....+..+|+--.+||||||.|||+..+ |.+||+|+|+++.
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 999987 8888776432 12221 2222333344444999999999999888 8999999999998
Q ss_pred cCCCCCCceeeecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccc------cHHHH--HHHHh
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERI------HITQW--VSFML 633 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~------~~~~~--~~~~~ 633 (723)
+...-........+..|..|+|||.+.+.+ ||.+.|||+.|||+.||+|-++.|.+..+.. +..+. +-..+
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 755433333344567899999999998865 8999999999999999999888776443211 11111 11122
Q ss_pred cCCCcccccC----Ccc-------c-CCCCHH-----------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 634 GKGDIESIVD----PRL-------H-EDFDIN-----------SVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 634 ~~~~~~~i~d----~~l-------~-~~~~~~-----------~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+.....++-| |.. + ...+.. .....+++..+++..||.+|.|++++++.
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 2111111100 000 0 000000 01226789999999999999999988763
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=225.20 Aligned_cols=228 Identities=24% Similarity=0.296 Sum_probs=172.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+|.++||+|.||+|-..+- .++.+|+|++++.. ......-+.|-++|+.-+||.+..|--.+...+.++.||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 3568999999999988876 57799999998763 233345578999999999999999988889999999999999
Q ss_pred CCCCHHHHhccCC----CCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEE----ADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~----~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
.+|.|.-+|.... ...--+-..+..|+++.| |.||||.+|.|||.+|++||+|||+++.--.. ......
T Consensus 251 nGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~---g~t~kT 327 (516)
T KOG0690|consen 251 NGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY---GDTTKT 327 (516)
T ss_pred cCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc---cceecc
Confidence 9999998887541 122222333444555544 99999999999999999999999999864322 334567
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.+||+.|+|||.+....|..++|.|.+|||+|||++|+.||........ .+.+ -.+ |-++.....
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeLI----l~e------d~kFPr~ls---- 392 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-FELI----LME------DLKFPRTLS---- 392 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-HHHH----Hhh------hccCCccCC----
Confidence 8999999999999999999999999999999999999999975533211 1111 111 111111111
Q ss_pred HHHHHHHHhccCCCCCCCC
Q 004935 656 WKTVEIAMACVSQTSTKRP 674 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RP 674 (723)
.....+....+..||.+|-
T Consensus 393 ~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHHHHHhhcChHhhc
Confidence 1344667778889999995
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=231.98 Aligned_cols=228 Identities=23% Similarity=0.316 Sum_probs=172.4
Q ss_pred HhhhhccccCcEEEEEEEECCc--eEEEEEecCCCh---hhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSA---QGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+|..+||+|+||.|..|...|. .+|||++++... .+.+--+.|-++|+.. +-|.++.+..++...+.++.||||
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEy 431 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEY 431 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEE
Confidence 6788999999999999988655 799999987532 2223345677777766 678999999999999999999999
Q ss_pred CCCCCHHHHhccC----CCCCCCHHHHH----HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 503 MANGNLQALLLGE----EADILSWEGRL----RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~----~~~~l~~~~~l----~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+.+|+|--++.+- +..+.-++..+ -+++...+|.||||..|||||.+|++||+|||+++.--.. ...+.
T Consensus 432 vnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~---~~TTk 508 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD---GVTTK 508 (683)
T ss_pred ecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC---Cccee
Confidence 9999998777642 22223333333 3333444499999999999999999999999999864322 23455
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..+||+.|+|||.+..++|..++|.|||||+|+||+.|++||++..+...+..+..... .++..-
T Consensus 509 TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------------syPKsl 573 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------------SYPKSL 573 (683)
T ss_pred eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------------cCcccc
Confidence 68999999999999999999999999999999999999999998776543333222111 111222
Q ss_pred HHHHHHHHHhccCCCCCCCC
Q 004935 655 VWKTVEIAMACVSQTSTKRP 674 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP 674 (723)
..+.+.+...-+...|.+|-
T Consensus 574 SkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 574 SKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cHHHHHHHHHHhhcCCcccc
Confidence 23556778888888998884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=258.58 Aligned_cols=189 Identities=24% Similarity=0.358 Sum_probs=157.3
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.++||+|+||.|..+++. ++.+|.|++++- .......|..|-.+|..-..+=|+.+.-.|.+..++|||||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 34589999999999999984 568999999863 2234467899999999889999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH--------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEADILSWEG--------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~--------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+||+|-.++.+...-.=.|++ .+..+|....|||||||+|||||..|++||+|||.+-.+..++ ...+..
T Consensus 158 pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG--~V~s~~ 235 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG--TVRSSV 235 (1317)
T ss_pred cCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC--cEEecc
Confidence 999999999876533334543 2444455555999999999999999999999999998775443 455667
Q ss_pred ccCCCccccccccc----c-CCCCChhhHHHHHHHHHHHHcCCCccccC
Q 004935 576 IAGTPGYLDPEYYI----S-NRLTEKSDVYNFGVVLLEIITSKSVIERT 619 (723)
Q Consensus 576 ~~gt~~y~aPE~~~----~-~~~~~~~DV~SfGvvL~elltg~~p~~~~ 619 (723)
..|||-|++||.+. + +.|...+|.||+||++|||+.|..||...
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 78999999999985 2 57999999999999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=234.39 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=176.6
Q ss_pred HHHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-------hhHHHHHHHHHHHHhccCCceeeEEEEEec-
Q 004935 423 VLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-------QGYKQFQAEVELLMRIHHKNLTTLVGYCDE- 492 (723)
Q Consensus 423 l~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~- 492 (723)
.+...+-...+||+|||+.||+|.+ ..+.||||+-..... .-.+...+|.++.+.|.||.||++++|+.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3444445567899999999999987 566899998654321 113457889999999999999999999855
Q ss_pred CCceEEEEEeCCCCCHHHHhccCC----CCCCCHHHHHHHHHhcc------ccccCCCCCCEEEcC---CCcEEEEeccC
Q 004935 493 GTNRGLIYEFMANGNLQALLLGEE----ADILSWEGRLRIAIEAA------KVHRDVKSTNILLSG---KFQAKIADFGL 559 (723)
Q Consensus 493 ~~~~~lV~Ey~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~~a------~vH~Dlk~~NILl~~---~~~~kl~DfGl 559 (723)
.+..+-|+|||++.+|.-+|..+. .++-++.-++.-|+.+. +||-||||.||||-+ .|.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 456789999999999999997652 12222222222222222 299999999999954 57899999999
Q ss_pred ccccCCCCCC----ceeeecccCCCccccccccccC----CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH
Q 004935 560 SRTFPVEGSG----THVTTTIAGTPGYLDPEYYISN----RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 560 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~ 631 (723)
++.+..+... ...+...+||..|++||++.-+ +.+.|+||||.|||+|..+.|+.||.......++.+.-..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9998654332 2344567899999999998643 5789999999999999999999999766544444432221
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
.- . .+ ..+. ..+........++.+|++..-++|....++.
T Consensus 700 lk-A---tE---VqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 700 LK-A---TE---VQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hc-c---ee---ccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 1 01 1111 1111223556899999999989988766554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=242.68 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=155.7
Q ss_pred hhhhccccCcEEEEEEEE------------------CCceEEEEEecCCChhhHHHH--------------HHHHHHHHh
Q 004935 430 FERVLGNGGFGTVYHGYL------------------DGTEVAVKMLSPSSAQGYKQF--------------QAEVELLMR 477 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~f--------------~~Ei~~l~~ 477 (723)
+.++||+|+||.||+|.+ .++.||||++........++| ..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999964 234799999875543333333 447777888
Q ss_pred ccCCce-----eeEEEEEec--------CCceEEEEEeCCCCCHHHHhccCCC----------------------CCCCH
Q 004935 478 IHHKNL-----TTLVGYCDE--------GTNRGLIYEFMANGNLQALLLGEEA----------------------DILSW 522 (723)
Q Consensus 478 l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~ 522 (723)
++|.++ +++++||.. .+..+|||||+++|+|.++++.... ..+.|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 877655 678888753 3568999999999999999874311 11223
Q ss_pred HHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCC
Q 004935 523 EGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592 (723)
Q Consensus 523 ~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 592 (723)
.... ..+|....+||||||+|||++.++.+||+|||+++....... .......+++.|+|||.+....
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeChhhhcCCC
Confidence 3333 333333349999999999999999999999999976532211 1111233578999999875432
Q ss_pred ----------------------CCChhhHHHHHHHHHHHHcCCC-ccccCcc--------cccHHHHHHHHhcCCCcccc
Q 004935 593 ----------------------LTEKSDVYNFGVVLLEIITSKS-VIERTHE--------RIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 593 ----------------------~~~~~DV~SfGvvL~elltg~~-p~~~~~~--------~~~~~~~~~~~~~~~~~~~i 641 (723)
...+.||||+||+++||++|.. |+..... ...+..|... ....
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~~---- 460 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQK---- 460 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cccC----
Confidence 1235799999999999999875 5542210 0111112111 0100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTS---TKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPsm~evl~ 681 (723)
.+-.. .........+++.+++..+| .+|+|++|+++
T Consensus 461 ~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 01000 11122356788888998765 78999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=219.84 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=183.5
Q ss_pred CHHHHHHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCc
Q 004935 419 SYSNVLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTN 495 (723)
Q Consensus 419 ~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 495 (723)
++.++-+.| .+.||+|+++.|-.+.. ++..+|||++.+.......+..+|++++... .|+||+.|+.|+++++.
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 456676666 47899999999987654 7889999999988777778899999999888 69999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCC----CC----CCCHHHHHHHHHhccccccCCCCCCEEEcCCC---cEEEEeccCccccC
Q 004935 496 RGLIYEFMANGNLQALLLGEE----AD----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKF---QAKIADFGLSRTFP 564 (723)
Q Consensus 496 ~~lV~Ey~~~gsL~~~l~~~~----~~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~---~~kl~DfGla~~~~ 564 (723)
.|||||-|.+|+|-.++.++. .+ +.+....++++|...+.||||||+|||-.... -+||+||.+..-..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 999999999999999887652 11 23455567777777779999999999986543 37999998875432
Q ss_pred CCCCC----ceeeecccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcc------cccHHHHH
Q 004935 565 VEGSG----THVTTTIAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHE------RIHITQWV 629 (723)
Q Consensus 565 ~~~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~------~~~~~~~~ 629 (723)
....- +.......|+..|||||+.. ...|+.++|.||+|||||-|+.|-+||.+.-. +.......
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 22111 11223457889999999853 23588999999999999999999999976522 11112211
Q ss_pred H----HHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 630 S----FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 630 ~----~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+ ..+.+|. .+.-|+.+. ......-+++...+..++.+|-++.+++.
T Consensus 311 Q~~LFesIQEGk-YeFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 311 QNKLFESIQEGK-YEFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHhccC-CcCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 1222221 111111111 11223346777777789999988888876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=249.69 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=147.1
Q ss_pred hhhhccccCcEEEEEEEEC------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEE------EecCCceE
Q 004935 430 FERVLGNGGFGTVYHGYLD------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY------CDEGTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~~~~~~~ 497 (723)
+.+.||+|+||.||+|.+. +..||||++...... +.+..| .+.+..+.++..++.. +......+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 3578999999999999983 568999997643321 111111 1112222222221111 34567889
Q ss_pred EEEEeCCCCCHHHHhccCCCC------------------------CCCH----HHHHHHHHhccccccCCCCCCEEEcC-
Q 004935 498 LIYEFMANGNLQALLLGEEAD------------------------ILSW----EGRLRIAIEAAKVHRDVKSTNILLSG- 548 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~------------------------~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~- 548 (723)
+|+||+++++|.+++...... +..+ ...+..+|+...+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 999999999999988653210 0012 22344444444599999999999996
Q ss_pred CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccC----------------------CCCChhhHHHHHHHH
Q 004935 549 KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN----------------------RLTEKSDVYNFGVVL 606 (723)
Q Consensus 549 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DV~SfGvvL 606 (723)
++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|||||||+|
T Consensus 292 ~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 5799999999998653221 1223446789999999965322 234567999999999
Q ss_pred HHHHcCCCccccCcccccHHHHHHHHhcCCC----cccccCCc----ccCCCC--HHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 607 LEIITSKSVIERTHERIHITQWVSFMLGKGD----IESIVDPR----LHEDFD--INSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 607 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~i~d~~----l~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
|||+++..+.+.. +.+..+.....+. ....+.+. +...+. ........+++.+|++.||++|||+
T Consensus 370 ~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 370 LQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 9999977654321 1111111110000 00001111 000000 0011234589999999999999999
Q ss_pred HHHHH
Q 004935 677 NQVVM 681 (723)
Q Consensus 677 ~evl~ 681 (723)
+|+++
T Consensus 445 ~e~L~ 449 (566)
T PLN03225 445 KAALA 449 (566)
T ss_pred HHHhC
Confidence 99987
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=214.26 Aligned_cols=234 Identities=20% Similarity=0.270 Sum_probs=171.9
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEec----CCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE----GTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~Ey~~ 504 (723)
++||-|-.|.|-.... .++..|+|++... ....+|+++.-.. .|||||.+++.+.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 6899999999998877 5668999998643 2346788876555 79999999998854 456789999999
Q ss_pred CCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|.|...+..+....+.-. ..++.+|..-+.||||||+|+|... +-.+||+|||+|+.-.. ..
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~----~~ 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE----PG 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC----Cc
Confidence 9999999987655444332 2333444444499999999999964 45789999999987432 22
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....+.|+.|.|||++...+|+..+|+||+||++|-|++|-+||...... .+..-++..+..+.. +.-+|.+
T Consensus 219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aispgMk~rI~~gqy-~FP~pEW----- 291 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKRRIRTGQY-EFPEPEW----- 291 (400)
T ss_pred cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCChhHHhHhhccCc-cCCChhH-----
Confidence 334567899999999999999999999999999999999999999866542 222223333333221 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.....-+++...+..+|++|.|+.+++.
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122344567888889999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=199.77 Aligned_cols=184 Identities=26% Similarity=0.330 Sum_probs=144.9
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCC-ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
..||+|++|.|-+-++ +|...|+|++... ..+..++.+.|+.+..+- .+|.+|.++|........++.||.|+- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4699999998876665 7889999999765 345667888999876554 799999999999999999999999975 7
Q ss_pred HHHHhcc----CC--------CCCCCHHHHHHHHHhccc-cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 508 LQALLLG----EE--------ADILSWEGRLRIAIEAAK-VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 508 L~~~l~~----~~--------~~~l~~~~~l~i~~~~a~-vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|..+-.+ .. .-+.+..+.+.++++... ||||+||+|||++.+|++|+||||++-.+.. +...+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d----SiAkt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD----SIAKT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh----hhHHH
Confidence 7655332 11 112345555666665555 9999999999999999999999999987642 22233
Q ss_pred cccCCCcccccccccc----CCCCChhhHHHHHHHHHHHHcCCCccccCc
Q 004935 575 TIAGTPGYLDPEYYIS----NRLTEKSDVYNFGVVLLEIITSKSVIERTH 620 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~----~~~~~~~DV~SfGvvL~elltg~~p~~~~~ 620 (723)
...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.|++...
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 4567889999999853 368999999999999999999999997654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=202.91 Aligned_cols=199 Identities=33% Similarity=0.573 Sum_probs=163.9
Q ss_pred ccccCcEEEEEEEEC--CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHH
Q 004935 434 LGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQA 510 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 510 (723)
||+|++|.||++... +..+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999996 779999999866543 34679999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 511 LLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 511 ~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
++.... ..+++..+. ..+++...+|+||+|.||+++. +..++|+|||.+........ ......+.
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~ 156 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGT 156 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCC
Confidence 987542 123333333 3333334499999999999999 89999999999987543211 12334577
Q ss_pred CccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 580 PGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 580 ~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
..|++||..... ..+.+.|+|++|+++++| ..+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~~ 190 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PEL 190 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HHH
Confidence 899999998877 888999999999999999 356
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.+++.+|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-25 Score=214.62 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=171.6
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCC-hh-hHHHHHHHHHHHHhccCCceeeEEEEEecC--------CceEEE
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEG--------TNRGLI 499 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~~~lV 499 (723)
.+||+|.||.||+|+. .++.||+|+.-... .. -.....+|+++|..++|+|++.++..|... ...+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 5799999999999987 45578888754322 11 124568999999999999999999988442 347899
Q ss_pred EEeCCCCCHHHHhccCCCC-CC--------CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-
Q 004935 500 YEFMANGNLQALLLGEEAD-IL--------SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG- 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~-~l--------~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 569 (723)
+++|+. +|..+|...... .+ .....+..+|..-.+|||+|+.|+|++.++.+||+|||+++.+......
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~ 181 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVV 181 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccC
Confidence 999987 888888765221 11 1223345555555699999999999999999999999999876433221
Q ss_pred ceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---CCcccccC--
Q 004935 570 THVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---GDIESIVD-- 643 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i~d-- 643 (723)
...-+....|+.|++||.+.+. .++++.|||.-|||+.||+||.+.+++..+... ...++...+. +....+..
T Consensus 182 kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is~LcGs~tkevWP~~d~lp 260 (376)
T KOG0669|consen 182 KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLISQLCGSITKEVWPNVDNLP 260 (376)
T ss_pred CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHHHHhccCCcccCCCcccch
Confidence 1122345569999999999876 589999999999999999999988876654332 2223332221 11111100
Q ss_pred -------CcccC-CC--CHHHHH------HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 -------PRLHE-DF--DINSVW------KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 -------~~l~~-~~--~~~~~~------~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+.. .+ -.+.+. ..++++...+..||.+|+++.+++.
T Consensus 261 L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 261 LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00110 00 011122 5678999999999999999888764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=224.85 Aligned_cols=189 Identities=23% Similarity=0.379 Sum_probs=147.6
Q ss_pred hhccccCcEEEEEEEECC--ceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||-|+||.|..++.-+ ..+|.|.+++.+. ........|-+||.....+=||+|+-.|.+++.+|+||+|+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 469999999999998743 3789998876542 23345678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCC--------CCCCc
Q 004935 507 NLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPV--------EGSGT 570 (723)
Q Consensus 507 sL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~--------~~~~~ 570 (723)
++-.+|.+... .+-.+.. .+...|.+..|||||||+|||||.+|++||.|||||.-+.- .+...
T Consensus 715 DmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~ 794 (1034)
T KOG0608|consen 715 DMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHH 794 (1034)
T ss_pred cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCcc
Confidence 99988876421 1111222 23334445559999999999999999999999999874410 00000
Q ss_pred e-------------------------------eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccC
Q 004935 571 H-------------------------------VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERT 619 (723)
Q Consensus 571 ~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~ 619 (723)
. ......||+.|+|||++....++..+|.||.||||+||+.|+.||...
T Consensus 795 RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 795 RQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred ccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCC
Confidence 0 001236999999999999999999999999999999999999999754
Q ss_pred c
Q 004935 620 H 620 (723)
Q Consensus 620 ~ 620 (723)
.
T Consensus 875 t 875 (1034)
T KOG0608|consen 875 T 875 (1034)
T ss_pred C
Confidence 3
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-24 Score=222.13 Aligned_cols=226 Identities=20% Similarity=0.312 Sum_probs=177.7
Q ss_pred hccccCcEEEEEEEECCce--EEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLDGTE--VAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~--vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||-|+||.|=..+.++.. .|+|++++.. ....+....|-.+|...+.|.||+|+-.+.+....|++||-|-+|.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 6999999999999887664 7888887653 2334557789999999999999999999999999999999999999
Q ss_pred HHHHhccCCC---C-----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCC
Q 004935 508 LQALLLGEEA---D-----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579 (723)
Q Consensus 508 L~~~l~~~~~---~-----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 579 (723)
|...|+.+.. . +-.....+.++|....|.|||||+|.+||.+|-+||.|||.|+.+... ..+..++||
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g----~KTwTFcGT 582 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG----RKTWTFCGT 582 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC----CceeeecCC
Confidence 9999987521 1 122344566667777799999999999999999999999999987533 345678999
Q ss_pred CccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHH
Q 004935 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTV 659 (723)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 659 (723)
+.|.|||.+.....+.++|.||+||+++||++|++||...+.......+++ | +..+--|+ .......
T Consensus 583 pEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-----G-id~i~~Pr-------~I~k~a~ 649 (732)
T KOG0614|consen 583 PEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-----G-IDKIEFPR-------RITKTAT 649 (732)
T ss_pred cccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh-----h-hhhhhccc-------ccchhHH
Confidence 999999999999999999999999999999999999987654322211111 1 11111121 2233556
Q ss_pred HHHHhccCCCCCCCCC
Q 004935 660 EIAMACVSQTSTKRPT 675 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPs 675 (723)
+++.+.+..+|.+|-.
T Consensus 650 ~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHhcCcHhhhc
Confidence 8899999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-24 Score=221.78 Aligned_cols=261 Identities=23% Similarity=0.264 Sum_probs=191.8
Q ss_pred cccccCHHHHHHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc------CCceee
Q 004935 414 KNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH------HKNLTT 485 (723)
Q Consensus 414 ~~~~~~~~~l~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~ 485 (723)
...++.+.|++.-.|......|+|-|++|.+|.. .+..||||++..... -.+.=++|+++|++|. --|.+.
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 4456788888888888888899999999999998 466999999986643 2344578999999994 347888
Q ss_pred EEEEEecCCceEEEEEeCCCCCHHHHhccCCC-------CCCCHHHHHHHHHhccc----cccCCCCCCEEEcCC-CcEE
Q 004935 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-------DILSWEGRLRIAIEAAK----VHRDVKSTNILLSGK-FQAK 553 (723)
Q Consensus 486 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~-~~~k 553 (723)
|+-.|...+++|||+|-+.- +|.++|.+-.. .+-.+.++|.+|+.... +|.||||.|||+++. ..+|
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 99899999999999998754 89999876422 12356677777777665 999999999999976 4679
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH---
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS--- 630 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~--- 630 (723)
|||||.|...... ..+....+..|.|||.+.|-.|+...|+||.||.||||.||+-.|.+......+.-.+.
T Consensus 578 LCDfGSA~~~~en-----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 578 LCDFGSASFASEN-----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eccCccccccccc-----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999999765322 22334456689999999999999999999999999999999998876544322211111
Q ss_pred ----HHhcCCCc-ccccCCcc--------------------------------cC-----CCCHHHHHHHHHHHHhccCC
Q 004935 631 ----FMLGKGDI-ESIVDPRL--------------------------------HE-----DFDINSVWKTVEIAMACVSQ 668 (723)
Q Consensus 631 ----~~~~~~~~-~~i~d~~l--------------------------------~~-----~~~~~~~~~l~~l~~~Cl~~ 668 (723)
.++..+.. ..-+|..+ .+ ......+..+.+|...|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 11221110 00111110 00 11223466778999999999
Q ss_pred CCCCCCCHHHHHH
Q 004935 669 TSTKRPTMNQVVM 681 (723)
Q Consensus 669 ~p~~RPsm~evl~ 681 (723)
||++|.|..++++
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-23 Score=192.95 Aligned_cols=246 Identities=18% Similarity=0.345 Sum_probs=178.7
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecC--CceEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEG--TNRGLIYEF 502 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~Ey 502 (723)
+.+.+.+|+|.++.||.|.. ++..++||++++.. .+.+.+|+++|..++ ||||++|++...+. ....||+||
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 44568999999999999985 67799999998543 467899999999996 99999999988654 456899999
Q ss_pred CCCCCHHHHhccCC-CC----CCCHHHHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCceeeecc
Q 004935 503 MANGNLQALLLGEE-AD----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 503 ~~~gsL~~~l~~~~-~~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+.+-+...+-..-. .+ .......+..+|.....|||+||.|+++|.. -..+|+|+|+|.+..+... -...
T Consensus 117 v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e----YnVR 192 (338)
T KOG0668|consen 117 VNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVR 192 (338)
T ss_pred hccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce----eeee
Confidence 99988776543321 11 2345667888888888999999999999965 5689999999998754322 1223
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCccc-ccHHHHHHHHhcCCCc-------ccccCCccc
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHER-IHITQWVSFMLGKGDI-------ESIVDPRLH 647 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~-------~~i~d~~l~ 647 (723)
..+..|--||.+.. ..|+.+-|+|||||+|.+|+..+.||....+. +.+...++ .++..++ .-.+||++.
T Consensus 193 VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~KY~i~Ldp~~~ 271 (338)
T KOG0668|consen 193 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLNKYQIDLDPQFE 271 (338)
T ss_pred eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHHHHccCCChhHh
Confidence 45667889999875 45888999999999999999999999755443 22333222 2222111 111333332
Q ss_pred C---CCC------------H-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 E---DFD------------I-NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ~---~~~------------~-~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ... . -.....++++.+.+..|-++|+|++|+..
T Consensus 272 ~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 272 DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 000 0 01246788999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=197.97 Aligned_cols=186 Identities=32% Similarity=0.475 Sum_probs=152.1
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||.|++|.||++... +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 3567999999999999995 479999999876554 5678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++...... +++... +..+++...+|+||+++||+++.++.++|+|||.+........ ......
T Consensus 83 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--ALLKTV 159 (225)
T ss_pred CHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--ccccce
Confidence 999998764321 333333 3333444449999999999999999999999999987643321 012334
Q ss_pred cCCCcccccccc-ccCCCCChhhHHHHHHHHHHHHcCCCcccc
Q 004935 577 AGTPGYLDPEYY-ISNRLTEKSDVYNFGVVLLEIITSKSVIER 618 (723)
Q Consensus 577 ~gt~~y~aPE~~-~~~~~~~~~DV~SfGvvL~elltg~~p~~~ 618 (723)
.++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=201.09 Aligned_cols=231 Identities=19% Similarity=0.284 Sum_probs=169.5
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.++||+|+|++|..+.+. .+.+|+|++++.- ..+..=.+.|-.+.... +||.+|.|..++.....++.|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 468999999999999884 5589999987642 22223345666666555 79999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA----DI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|+|--++..... .+ -...-.+.++++-..|.||||..|+|||..|++||.|||+++.--.. ...++..
T Consensus 335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~---gd~tstf 411 (593)
T KOG0695|consen 335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP---GDTTSTF 411 (593)
T ss_pred CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC---Ccccccc
Confidence 9999766654311 11 12233455666666699999999999999999999999999864322 2345678
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccC---cccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERT---HERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+-. +.+.+...++-+.+-+..+. -|+-
T Consensus 412 cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---iprs------- 481 (593)
T KOG0695|consen 412 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IPRS------- 481 (593)
T ss_pred cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---ccce-------
Confidence 9999999999999999999999999999999999999999732 22233334443333332211 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCC
Q 004935 654 SVWKTVEIAMACVSQTSTKRP 674 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP 674 (723)
-..+...+.+.-+.+||.+|.
T Consensus 482 lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhc
Confidence 112345677788889998884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=203.03 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=175.9
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 501 (723)
++-||-|.||.||...+ +++.||+|++..- +....+++.+|+++|..++|.|++..++..... .+.+.+.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46899999999999988 6789999998643 334567899999999999999999988876433 35667888
Q ss_pred eCCCCCHHHHhccCCC--------CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEA--------DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~--------~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
.|.. +|.+.+-.... -..++.+.+++++.....||||||.|.|++.+...||+|||+++....+.. ...
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~hM 214 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LNM 214 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hhh
Confidence 8865 67766644311 123566778888888889999999999999999999999999998654332 223
Q ss_pred ecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----------CCcccc
Q 004935 574 TTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----------GDIESI 641 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~i 641 (723)
+....|..|+|||.+.+.+ |+.+.||||.|||+.||+-++-.|+....... .+.+...++. |....+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-L~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-LQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-HHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 4445688999999998764 89999999999999999998877764432111 1111111111 111111
Q ss_pred cCCcccCC---------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 642 VDPRLHED---------FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 642 ~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
+....+.. .....-...+.+.+.++..+|.+|.+..+++..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111100 0111122345777888999999999998888765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-23 Score=202.60 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=174.1
Q ss_pred hccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEEEEe
Q 004935 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLIYEF 502 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV~Ey 502 (723)
.+|.|.- .|..+.+ .+++||+|++... .....++..+|...+..+.|+|+++++.++.-. .+.++|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4667766 5666655 5779999987543 234457789999999999999999999998543 457899999
Q ss_pred CCCCCHHHHhccCCC------CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 503 MANGNLQALLLGEEA------DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~------~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
|.. +|...+.-... -.++....++..+....+||||||+||++..+..+||.|||+|+.... ....+..
T Consensus 103 m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~----~~~mtpy 177 (369)
T KOG0665|consen 103 MDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT----DFMMTPY 177 (369)
T ss_pred hhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc----ccccCch
Confidence 975 88877653211 123445566677777779999999999999999999999999986432 2345667
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc------------------
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI------------------ 638 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 638 (723)
..+..|+|||.+.+..+.+.+||||.||++.||++|+-.|.+. +++.+|.+....-|..
T Consensus 178 VvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~ 254 (369)
T KOG0665|consen 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN 254 (369)
T ss_pred hheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence 7889999999999988999999999999999999999888633 3455554432211110
Q ss_pred ---------cccc-CCcccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 639 ---------ESIV-DPRLHED--FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 639 ---------~~i~-d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+ |.-+... .+.-....+.+++.+++-.+|++|.++++++.
T Consensus 255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 0000000 01112345679999999999999999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-22 Score=217.47 Aligned_cols=238 Identities=22% Similarity=0.347 Sum_probs=180.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
...+|.|.+|.|||++. .++..|||+++.......+-.+.|+-+++.-+|+||+.++|-+...+..++.|||+.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 46799999999999998 5779999999887777777889999999999999999999999999999999999999999
Q ss_pred HHHhccCC---CCC-----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 509 QALLLGEE---ADI-----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 509 ~~~l~~~~---~~~-----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
++.-+... ... -.-.+.++..|.+.++|||||-.|||+++.+.+|++|||.+..+... ......+.||+
T Consensus 100 Qdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat---i~KrksfiGtp 176 (829)
T KOG0576|consen 100 QDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT---IAKRKSFIGTP 176 (829)
T ss_pred cceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh---hhhhhcccCCc
Confidence 98755421 000 11223467778888899999999999999999999999998765422 22345678999
Q ss_pred ccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 581 GYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 581 ~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
.|||||... .+.|.+++|||+.|+...|+---++|...... .+ +..+..+... -.|++..+... ...
T Consensus 177 ywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr-~l~LmTkS~~---qpp~lkDk~kw--s~~ 246 (829)
T KOG0576|consen 177 YWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MR-ALFLMTKSGF---QPPTLKDKTKW--SEF 246 (829)
T ss_pred cccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HH-HHHHhhccCC---CCCcccCCccc--hHH
Confidence 999999874 45699999999999999998776666433221 11 1122221111 11333322221 124
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+-++++.|+..+|.+||+++..++
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 568999999999999999987664
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-20 Score=191.32 Aligned_cols=119 Identities=24% Similarity=0.356 Sum_probs=87.8
Q ss_pred HHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-----C---CceeeEEEEEe----
Q 004935 426 ITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-----H---KNLTTLVGYCD---- 491 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~---- 491 (723)
.+|-..++||-|.|++||.+.+ ..+.||+|+.+..... .+..+.||++|++++ | ..||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3344568999999999999998 4568999998754322 245689999999993 2 37999999984
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHH------HHhccc-----cccCCCCCCEEE
Q 004935 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI------AIEAAK-----VHRDVKSTNILL 546 (723)
Q Consensus 492 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i------~~~~a~-----vH~Dlk~~NILl 546 (723)
++.+.+||+|++-. +|-.++.....+-+.....-+| .+++.| ||.||||+||||
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 46789999999954 8888887765444444333333 333333 999999999999
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=188.79 Aligned_cols=237 Identities=19% Similarity=0.328 Sum_probs=181.6
Q ss_pred HhhhhccccCcEEEEEEEECCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
++..+|.+...|..|+|++.|..+++|++.... ....++|..|.-.|+-+.||||++++|.|....+..++..||+.|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345578899999999999999999999987543 334468999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----cc--------cCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----VH--------RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----vH--------~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|...|++...-+.+-.+.+++++++|+ .| --|.+..+++|++.+++|+- +-+++ +....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kf-------sfqe~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-------SFQEV 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cccee-------eeecc
Confidence 9999999887666666777777777776 33 35888999999999998852 11111 11223
Q ss_pred cccCCCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 575 TIAGTPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
...-.+.||+||.+...+ --.++|+|||.++||||.|+..||.......- -++..+ ..++...+
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---gmkial----------eglrv~ip 411 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---GMKIAL----------EGLRVHIP 411 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---hhhhhh----------ccccccCC
Confidence 345678999999998654 34689999999999999999999975432110 011111 12222233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
+.....+.+++.-|...||.+||.+..|+-.|+.+
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33344678999999999999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=179.60 Aligned_cols=164 Identities=21% Similarity=0.234 Sum_probs=119.7
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCc
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~ 581 (723)
|+|.+++... ...+++.....++.+++. +|..-||+|||++.++.+|+ ||+++..... ...|++.
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPE--------QSRVDPY 69 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeeccc--------cCCCccc
Confidence 7899998754 235788888887777766 78877999999999999999 9998865321 1257899
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH--HHHH
Q 004935 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV--WKTV 659 (723)
Q Consensus 582 y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~--~~l~ 659 (723)
|+|||.+.+..++.++|||||||++|||+||+.||............+....... ++.-. ....... ..+.
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~ 142 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRDR-SNLESVSAARSFA 142 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------Ccccc-ccHHHHHhhhhHH
Confidence 9999999999999999999999999999999999865433222222111111110 00000 0011111 2588
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 660 EIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
+++.+|++.+|.+||++.|+++.+....
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=202.94 Aligned_cols=181 Identities=20% Similarity=0.309 Sum_probs=142.4
Q ss_pred hhccccCcEEEEEEEECC--ceEEEEEecCCChh--------hHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEE
Q 004935 432 RVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQ--------GYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~--------~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 498 (723)
+.+|+|+||.|+.+.++. ..|+||++.+...- ..-..-.|+++|..++ |+||++++.+|++.+..+|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 579999999999999954 48999998764310 1112567999999997 9999999999999999999
Q ss_pred EEEeC-CCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 499 IYEFM-ANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 499 V~Ey~-~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
++|-. ++-+|.+++..+.. +..-..+ .++.+|+...||||||-+||.++.+|-+||+|||.+....
T Consensus 647 ~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k----- 721 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----- 721 (772)
T ss_pred EecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc-----
Confidence 99965 46688898875422 1111222 2333444444999999999999999999999999987753
Q ss_pred ceeeecccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccc
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIE 617 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~ 617 (723)
...-....||.+|.|||.+.+.+| ....|||++||+||.++....||.
T Consensus 722 sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 223345789999999999999887 466899999999999999888875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=181.74 Aligned_cols=243 Identities=19% Similarity=0.297 Sum_probs=168.7
Q ss_pred HHhhhhccccCcEEEEEEEECC--ceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEE-EecCCceEEEEEeC
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGY-CDEGTNRGLIYEFM 503 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~Ey~ 503 (723)
+++.+.||+|.||.+-.+.+.+ +.+++|-+...- ...++|.+|..---.| .|.||+.-++. +...+....++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 5567899999999999999854 489999876442 2357888888765555 69999987764 56667778999999
Q ss_pred CCCCHHHHhccCC---CCCCCHHHHHHHHHhccc----cccCCCCCCEEEc--CCCcEEEEeccCccccCCCCCCceeee
Q 004935 504 ANGNLQALLLGEE---ADILSWEGRLRIAIEAAK----VHRDVKSTNILLS--GKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 504 ~~gsL~~~l~~~~---~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|.|+|.+-+.... ........++..|++..| ||||||.+|||+- +..++||+|||+++... ....
T Consensus 105 P~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g------~tV~ 178 (378)
T KOG1345|consen 105 PRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG------TTVK 178 (378)
T ss_pred ccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC------ceeh
Confidence 9999998876531 122234455555666555 9999999999983 33589999999987642 1223
Q ss_pred cccCCCccccccccccC-----CCCChhhHHHHHHHHHHHHcCCCccccCc-ccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 575 TIAGTPGYLDPEYYISN-----RLTEKSDVYNFGVVLLEIITSKSVIERTH-ERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~-----~~~~~~DV~SfGvvL~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
....+..|.+||..... ...+.+|||.|||+++.++||+.|++... ......+|.+...+.. . .-|+.-.
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~--~~P~~F~ 254 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--P--ALPKKFN 254 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--c--cCchhhc
Confidence 34566789999986532 35778999999999999999999998543 2233445544332221 1 1122222
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
.+. .+++++-.+-+..++++|=-..++.++-+.
T Consensus 255 ~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 255 PFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccC----HHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 222 356677788889999998666666655443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=194.32 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=174.7
Q ss_pred hhhccccCcEEEEEEEE-----CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.++||+|.|++||++.+ .++.||+|.+...+.. .+...|++.|..+ .+.||+++.+++...+...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 47899999999999987 2348999998765433 4689999999999 59999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCC-----CHHHHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCC------------
Q 004935 505 NGNLQALLLGEEADIL-----SWEGRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVE------------ 566 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l-----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~------------ 566 (723)
.-...++...-.-..+ .....+...+....|||||||+|+|.+.. +.-.|.|||+|......
T Consensus 119 H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~ 198 (418)
T KOG1167|consen 119 HDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGR 198 (418)
T ss_pred ccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcc
Confidence 9988888766432211 22233444445555999999999999865 56789999999721000
Q ss_pred ------CC-----------------------CceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 567 ------GS-----------------------GTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 567 ------~~-----------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
+. ........+||+||+|||++.. ...++++||||-|||++.+++++.||
T Consensus 199 ~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 199 HATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred cCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccc
Confidence 00 0001123469999999999864 56899999999999999999999999
Q ss_pred ccCcccc-cHHHHHHH---------HhcCCC--ccc------c---------cC-CcccC---------CCCHHHHHHHH
Q 004935 617 ERTHERI-HITQWVSF---------MLGKGD--IES------I---------VD-PRLHE---------DFDINSVWKTV 659 (723)
Q Consensus 617 ~~~~~~~-~~~~~~~~---------~~~~~~--~~~------i---------~d-~~l~~---------~~~~~~~~~l~ 659 (723)
....++. .+.+.+.. ....|. +.+ + ++ ..+.. .........++
T Consensus 279 f~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~ 358 (418)
T KOG1167|consen 279 FKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLL 358 (418)
T ss_pred ccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHH
Confidence 7554332 22222211 111222 111 0 00 00000 00011233678
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 004935 660 EIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 660 ~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
++..+|+..+|.+|.|++++++
T Consensus 359 dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 359 DLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred HHHHHHccCChhhcccHHHHhc
Confidence 9999999999999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=224.14 Aligned_cols=188 Identities=17% Similarity=0.185 Sum_probs=120.3
Q ss_pred HhccC-CceeeEEEEE-------ecCCceEEEEEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhcccccc
Q 004935 476 MRIHH-KNLTTLVGYC-------DEGTNRGLIYEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHR 537 (723)
Q Consensus 476 ~~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~ 537 (723)
+.++| +||..++++| ......++++||+ .++|.+++.... ..+++. ..+..+|+...+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 34556 6888888887 2234567788987 559999997532 223333 33444444444999
Q ss_pred CCCCCCEEEcCC-------------------CcEEEEeccCccccCCCCCC-------------ceeeecccCCCccccc
Q 004935 538 DVKSTNILLSGK-------------------FQAKIADFGLSRTFPVEGSG-------------THVTTTIAGTPGYLDP 585 (723)
Q Consensus 538 Dlk~~NILl~~~-------------------~~~kl~DfGla~~~~~~~~~-------------~~~~~~~~gt~~y~aP 585 (723)
||||+||||+.. +.+|++|||+++........ ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 44566666666532110000 0001123578889999
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhc
Q 004935 586 EYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMAC 665 (723)
Q Consensus 586 E~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C 665 (723)
|++.+..++.++|||||||+||||++|..|+..... .+..... . ...+... .......+++.+|
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~-~--------~~~~~~~-----~~~~~~~~~~~~~ 248 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH-R--------VLPPQIL-----LNWPKEASFCLWL 248 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH-h--------hcChhhh-----hcCHHHHHHHHHh
Confidence 999999999999999999999999999887643211 1111111 0 1111111 1122456788899
Q ss_pred cCCCCCCCCCHHHHHH
Q 004935 666 VSQTSTKRPTMNQVVM 681 (723)
Q Consensus 666 l~~~p~~RPsm~evl~ 681 (723)
|+.+|.+||+|.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=184.48 Aligned_cols=174 Identities=21% Similarity=0.226 Sum_probs=122.4
Q ss_pred HhhhhccccCcEEEEEEEE---CCceEEEEEecCC-----ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL---DGTEVAVKMLSPS-----SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||+||+|.+ ++..||||++... .....+.|.+|+++|++++|+|+++.+.. .+..++||
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVm 97 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVR 97 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEE
Confidence 3467899999999999987 3457899987533 12234669999999999999999853322 24579999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHH----HHHHHHhccccccCC-CCCCEEEcCCCcEEEEeccCccccCCCCCCcee---
Q 004935 501 EFMANGNLQALLLGEEADILSWEG----RLRIAIEAAKVHRDV-KSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV--- 572 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~----~l~i~~~~a~vH~Dl-k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~--- 572 (723)
||+++++|... ... ....|.. .+..+|+...+|||| ||+|||++.++.+||+|||+++.+...+.....
T Consensus 98 E~~~G~~L~~~-~~~--~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 98 GWTEGVPLHLA-RPH--GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred EccCCCCHHHh-Ccc--chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhh
Confidence 99999999743 211 1123443 344455555599999 999999999999999999999987544321111
Q ss_pred --eecccCCCccccccccccCC------CCChhhHHHHHHHHHHHHcCCCcc
Q 004935 573 --TTTIAGTPGYLDPEYYISNR------LTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 573 --~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
.....+++.|+|||.+.-.+ .+..+|-| +-||..-+
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW--------~~TGDlg~ 218 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW--------LATGKKVY 218 (365)
T ss_pred hhhhhhhccCccCCcccCChhhhccccccccccCcE--------EeCCCEEE
Confidence 13456888899999986432 23346666 44666543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-18 Score=168.64 Aligned_cols=170 Identities=14% Similarity=0.098 Sum_probs=124.0
Q ss_pred HHHHHhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHH---H------HHHHHHHHHhccCCceeeEEEEEecC--
Q 004935 425 RITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYK---Q------FQAEVELLMRIHHKNLTTLVGYCDEG-- 493 (723)
Q Consensus 425 ~~t~~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~---~------f~~Ei~~l~~l~H~nIv~l~g~~~~~-- 493 (723)
+-.+...+++|.|+||.||....+++.+|||.+.+......+ . |.+|++.+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 333444689999999999998777779999999865432222 2 68999999999999999998885432
Q ss_pred ------CceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 494 ------TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 494 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+..+|+|||+++.+|.++..........+...+..+|+...+|||+||+||+++.++ ++|+|||.......+.
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~ 188 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK 188 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh
Confidence 357899999999999887532222122444555666666669999999999999988 9999999887542111
Q ss_pred CCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHH
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEII 610 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ell 610 (723)
. . ..+.....+..++|+||||+.+.-..
T Consensus 189 a---~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 189 A---K------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred h---H------------HHHHHHhHhcccccccceeEeehHHH
Confidence 1 0 01233344667999999999987653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-16 Score=168.14 Aligned_cols=252 Identities=17% Similarity=0.202 Sum_probs=176.0
Q ss_pred HHhhhhccccCcEEEEEEEECC---ceEEEEEecCCChhhHHHHHHHHHHHHhccC----CceeeEEEEE-ecCCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG---TEVAVKMLSPSSAQGYKQFQAEVELLMRIHH----KNLTTLVGYC-DEGTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~lV 499 (723)
+.+.+.||+|+||.||.+.... ..+|+|............+..|+.++..+.+ +++..+++.. ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 3446789999999999999854 3688888776543332368889999998863 6888888888 477788999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCC-----CcEEEEeccCcc--c
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGK-----FQAKIADFGLSR--T 562 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~-----~~~kl~DfGla~--~ 562 (723)
|+.+ +-+|.++........++....+. .+|+...+||||||.|+++... ..+.|.|||+++ .
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 8876 56999987654444444444444 4444455999999999999865 468999999998 3
Q ss_pred cCCCCCC--ce--e-eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC
Q 004935 563 FPVEGSG--TH--V-TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 563 ~~~~~~~--~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
....... .. . .....||..|.++....+...+.+.|+||++.++.|++.|..||..........+ +........
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~-~~~~~~~~~ 257 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK-FEKDPRKLL 257 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-HHHHhhhhc
Confidence 2222111 01 1 2345699999999999999999999999999999999999999965543322222 111111111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.. . ..... ...+.++...+-..+..++|....+...|+++....
T Consensus 258 ~~----~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 258 TD----R--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cc----c--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11 0 11112 223445555555589999999999999998888665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-16 Score=164.70 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=177.5
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChh---hHHHHHHHHHHHHhccCC-ceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQ---GYKQFQAEVELLMRIHHK-NLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++..++......+++++++.++
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 467899999999999988 88899998765432 367899999999999988 7999999997777789999999999
Q ss_pred CHHHHhccCCC-CCC------CH----HHHHHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCc---e
Q 004935 507 NLQALLLGEEA-DIL------SW----EGRLRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGT---H 571 (723)
Q Consensus 507 sL~~~l~~~~~-~~l------~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~---~ 571 (723)
++.+++..... ..+ .+ ...+..+|....+|||+||+||+++... .++++|||.++......... .
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (384)
T COG0515 84 SLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163 (384)
T ss_pred cHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccc
Confidence 99977765421 011 11 2223344555559999999999999988 79999999998654333211 1
Q ss_pred eeecccCCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCccc---ccHHHHHHHHhcCCCcccccCCc
Q 004935 572 VTTTIAGTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHER---IHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
......++..|++||.+.+ .......|+||+|++++++++|..|+...... ......+...... ... ..
T Consensus 164 ~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~ 238 (384)
T COG0515 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLA----SP 238 (384)
T ss_pred cccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccc----cc
Confidence 3456789999999999987 57899999999999999999999996544321 1111211111111 000 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
............+.+++..|+..+|..|.++.+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111001223467799999999999999999887765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.3e-17 Score=174.36 Aligned_cols=208 Identities=21% Similarity=0.317 Sum_probs=148.8
Q ss_pred HHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc-----------cccCCCCCC
Q 004935 475 LMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-----------VHRDVKSTN 543 (723)
Q Consensus 475 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~-----------vH~Dlk~~N 543 (723)
|+.+.|.|+.+++|.|.++...+.|.+|+..|+|++.+.... ..++|.-......+++. .|+.++++|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 457899999999999999999999999999999999998742 23444433333333222 899999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccC---C----CCChhhHHHHHHHHHHHHcCCCcc
Q 004935 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN---R----LTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
+++|..+.+||+|||+......... ........-..-|.|||.+... . .+.++||||||++++|+++.+.||
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999887642111 1111222345679999998763 1 477899999999999999999999
Q ss_pred ccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 617 ERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
..........+.+..... .......|.+.... +....+..++..||..+|.+||++++|-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875443332333333222 11222233332111 233368899999999999999999999988876654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=145.13 Aligned_cols=187 Identities=14% Similarity=0.097 Sum_probs=133.5
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChh----hHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQ----GYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~----~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...|++|+||+||.+..++.+++.+.+.....- ....|.+|+++|+++. |++++.++++ +..+++|||+++
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 457999999999988888889998888765431 1235889999999995 5889999886 446899999999
Q ss_pred CCHHHHhccCCCC-CCCHHHHHHHHHhccccccCC-CCCCEEEcCCCcEEEEeccCccccCCCCCCce--e--------e
Q 004935 506 GNLQALLLGEEAD-ILSWEGRLRIAIEAAKVHRDV-KSTNILLSGKFQAKIADFGLSRTFPVEGSGTH--V--------T 573 (723)
Q Consensus 506 gsL~~~l~~~~~~-~l~~~~~l~i~~~~a~vH~Dl-k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~--------~ 573 (723)
.+|.+.+...... ..+....+..+|+...+|||| ||+|||++.++.++|+|||++........... . .
T Consensus 83 ~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk 162 (218)
T PRK12274 83 AAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLK 162 (218)
T ss_pred ccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHH
Confidence 9998665322110 112233455566666699999 79999999999999999999986543221000 0 0
Q ss_pred ecccCCCccccccccccC-CCC-ChhhHHHHHHHHHHHHcCCCccccCcc
Q 004935 574 TTIAGTPGYLDPEYYISN-RLT-EKSDVYNFGVVLLEIITSKSVIERTHE 621 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~-~~~-~~~DV~SfGvvL~elltg~~p~~~~~~ 621 (723)
.....++.|++|+....- ..+ ...+.++-|.-+|.++|++.+.....+
T Consensus 163 ~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 163 HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 112367777888764322 333 567888999999999999988765544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-16 Score=178.91 Aligned_cols=232 Identities=19% Similarity=0.260 Sum_probs=160.0
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCC-h---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS-A---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||.+.|=+|.+|+.+.+.|+||++-+.. . ...++...|++ ...++|||.+++.-+-......+||=+|+.+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 35789999999999999988889999987654 2 23344455555 5566999999987766666666777777765
Q ss_pred CCHHHHhccCCC--------CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc--cCCCCCCc--eee
Q 004935 506 GNLQALLLGEEA--------DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT--FPVEGSGT--HVT 573 (723)
Q Consensus 506 gsL~~~l~~~~~--------~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~--~~~~~~~~--~~~ 573 (723)
+|.|.+..+.- -+++....+.-+|....+|||||.+|||++.-.=+.|+||..-+. ++.++... ..-
T Consensus 106 -nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF 184 (1431)
T KOG1240|consen 106 -NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF 184 (1431)
T ss_pred -hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence 88888876521 123444556666667779999999999999988899999987653 22222111 111
Q ss_pred ecccCCCccccccccccC-----------CCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCC-----
Q 004935 574 TTIAGTPGYLDPEYYISN-----------RLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKG----- 636 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~----- 636 (723)
.....-..|+|||.+... ..+++=||||.||++.||++ |+++|.- .+.....-+..
T Consensus 185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccCccCHHH
Confidence 112233479999987541 26778899999999999998 5777742 22221111100
Q ss_pred CcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 637 DIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 637 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
-+.++-|+ .+.++++.|++.||++|-++++.++.
T Consensus 258 ~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 01122222 35689999999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-16 Score=180.18 Aligned_cols=242 Identities=20% Similarity=0.217 Sum_probs=166.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEec----C-CChh-hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLS----P-SSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~----~-~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+++|.|.+|.|+.... .....+.|... . .... ....+..|..+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 56899999997776654 22223333222 1 1111 122366788888889999998877776666555556999
Q ss_pred CCCCCHHHHhccC-C---CCC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC-Cceee
Q 004935 503 MANGNLQALLLGE-E---ADI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-GTHVT 573 (723)
Q Consensus 503 ~~~gsL~~~l~~~-~---~~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~ 573 (723)
++. +|..++... . .++ .+....++..+.....|||+|++|+++..++.+||+|||.+..+..... .....
T Consensus 403 ~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~ 481 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHES 481 (601)
T ss_pred ccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhh
Confidence 999 999988764 1 111 2334455777778889999999999999999999999999987654333 12556
Q ss_pred ecccCCCccccccccccCCCCC-hhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC--
Q 004935 574 TTIAGTPGYLDPEYYISNRLTE-KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF-- 650 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~-~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~-- 650 (723)
....|+..|+|||.+.+..|.. ..||||.|+++..|.+|+.||......+... .......+... ..+..
T Consensus 482 ~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~-----~~~~~~~ 553 (601)
T KOG0590|consen 482 SGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNI-----FEGPNRL 553 (601)
T ss_pred cCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccccccc-----ccChHHH
Confidence 6788999999999999999875 5899999999999999999997543322110 00100100000 00110
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...-......++.++++.+|.+|.||++|++
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0112334568888999999999999999876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.5e-15 Score=141.47 Aligned_cols=191 Identities=20% Similarity=0.311 Sum_probs=150.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
...+.||.|+||.+|.|.. .|..||||+-+.... ..++.-|.++...++ ...|..+..|..+...-.|||+.+ +
T Consensus 18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred EEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 3467899999999999987 688999999765443 246788999999996 467888888889999999999988 5
Q ss_pred CCHHHHhccCCCC-----C----CCHHHHHHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCCCcee-
Q 004935 506 GNLQALLLGEEAD-----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHV- 572 (723)
Q Consensus 506 gsL~~~l~~~~~~-----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~- 572 (723)
-||++++.-.+.. + -+...|+...|....|||||||+|+|..-+ ..+.++|||+|+.+.......+.
T Consensus 95 PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIp 174 (341)
T KOG1163|consen 95 PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIP 174 (341)
T ss_pred ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCc
Confidence 6999988654321 1 134456666666667999999999999744 46889999999987433322222
Q ss_pred ---eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc
Q 004935 573 ---TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER 622 (723)
Q Consensus 573 ---~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~ 622 (723)
.....||..|.+-....+...+.+.|+=|+|.+|....-|..||++....
T Consensus 175 yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 175 YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 23467999999888888888899999999999999999999999977543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=143.89 Aligned_cols=253 Identities=16% Similarity=0.245 Sum_probs=177.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
..++||+|+||..+.|+. ++.+||||.-...+. ..++..|.+..+.| ..++|...+-|-.++-+-.||+|.+ +-
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 467899999999999986 889999998654332 24678888888888 5789999888888888889999988 56
Q ss_pred CHHHHhccCCCC---------CCCHHHHHHHHHhccccccCCCCCCEEEcCC-----CcEEEEeccCccccCCCCCCce-
Q 004935 507 NLQALLLGEEAD---------ILSWEGRLRIAIEAAKVHRDVKSTNILLSGK-----FQAKIADFGLSRTFPVEGSGTH- 571 (723)
Q Consensus 507 sL~~~l~~~~~~---------~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-----~~~kl~DfGla~~~~~~~~~~~- 571 (723)
||+|+..-+... +.+...|+..+|+.-.|.|||||+|+||..- ..+.|+|||+|+.+.......+
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI 188 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI 188 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence 999887644221 1233344444444444889999999999743 3589999999998754433322
Q ss_pred ---eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 572 ---VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 572 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......||..||+-....+...+.+.|.=|+|-++...+-|..||++......-..+- .+++.....-+ ..|.+
T Consensus 189 PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe--KIGe~Kr~T~i-~~Lc~ 265 (449)
T KOG1165|consen 189 PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE--KIGETKRSTPI-EVLCE 265 (449)
T ss_pred ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH--HhccccccCCH-HHHHh
Confidence 2345679999999999999999999999999999999999999999775543322222 22221111000 01222
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.+ +++...-++.+.. .+-.+-|...-+...+.+++.....
T Consensus 266 g~-P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 266 GF-PEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred cC-HHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCC
Confidence 22 3344455555543 3556778888777777777755443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.8e-15 Score=143.25 Aligned_cols=130 Identities=21% Similarity=0.217 Sum_probs=87.3
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCChh--h-------HHH-----------------HHHHHHHHHhccCCce
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQ--G-------YKQ-----------------FQAEVELLMRIHHKNL 483 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~nI 483 (723)
...||+|+||.||+|.. +|+.||||+++..... . ..+ ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998 5789999999754211 0 112 2359999999988776
Q ss_pred eeEEEEEecCCceEEEEEeCCCCCHHHHhccCCC----CCCCHH----HHHHHH-HhccccccCCCCCCEEEcCCCcEEE
Q 004935 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA----DILSWE----GRLRIA-IEAAKVHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 484 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~----~~l~~~----~~l~i~-~~~a~vH~Dlk~~NILl~~~~~~kl 554 (723)
.....+.. ...++||||++++++......... ....+. ..+..+ +....+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 43322221 233899999999877654322111 111222 223333 233449999999999998 478999
Q ss_pred EeccCcccc
Q 004935 555 ADFGLSRTF 563 (723)
Q Consensus 555 ~DfGla~~~ 563 (723)
+|||+|...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.7e-14 Score=144.95 Aligned_cols=217 Identities=21% Similarity=0.257 Sum_probs=129.4
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccC-----------CceeeEEEE-----
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHH-----------KNLTTLVGY----- 489 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H-----------~nIv~l~g~----- 489 (723)
.+.||.|+++.||.+.+. ++++|||++.... ....+++.+|.-....+.+ +-++++--.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 467999999999999995 5799999975432 3356777777766655432 222222111
Q ss_pred ---EecCC--------ceEEEEEeCCCCCHHHHhcc---CCC--CCCCHHHHHHHHH----------hccccccCCCCCC
Q 004935 490 ---CDEGT--------NRGLIYEFMANGNLQALLLG---EEA--DILSWEGRLRIAI----------EAAKVHRDVKSTN 543 (723)
Q Consensus 490 ---~~~~~--------~~~lV~Ey~~~gsL~~~l~~---~~~--~~l~~~~~l~i~~----------~~a~vH~Dlk~~N 543 (723)
..... +.+++|+-+ .++|.+++.. ... ..+....++.+.+ ....||+||||+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~n 175 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPEN 175 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceee
Confidence 11111 235677777 4588887542 111 1223333444333 3334999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccccccccc--------CCCCChhhHHHHHHHHHHHHcCCCc
Q 004935 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS--------NRLTEKSDVYNFGVVLLEIITSKSV 615 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~SfGvvL~elltg~~p 615 (723)
++++.+|.++|+||+...... ..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+.|
T Consensus 176 fll~~~G~v~Lg~F~~~~r~g-----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 176 FLLDQDGGVFLGDFSSLVRAG-----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp EEE-TTS-EEE--GGGEEETT-----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred EEEcCCCCEEEcChHHHeecC-----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999998876532 12221 445678999997643 2478999999999999999999999
Q ss_pred cccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 004935 616 IERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKR 673 (723)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 673 (723)
|......... . ..+. ... +.+..+..++...++.+|.+|
T Consensus 250 f~~~~~~~~~-~----------------~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADP-E----------------WDFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTS-G----------------GGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccc-c----------------ccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9755332110 0 0111 122 455577899999999999887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.2e-14 Score=137.80 Aligned_cols=129 Identities=16% Similarity=0.196 Sum_probs=94.0
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc-----cCCceeeEEEEEecCC---ceE-EEEE
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-----HHKNLTTLVGYCDEGT---NRG-LIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~~-lV~E 501 (723)
.+.||+|+||.||. .......+||+.........+++.+|+++++++ .||||++++|++.++. ..+ +|+|
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred cceecCCCceEEEE-CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 46899999999996 222334479988765545567899999999999 5799999999998764 323 7899
Q ss_pred e--CCCCCHHHHhccCCC-CCCCHH-H---HH-HHHHhccccccCCCCCCEEEcC----CCcEEEEeccCc
Q 004935 502 F--MANGNLQALLLGEEA-DILSWE-G---RL-RIAIEAAKVHRDVKSTNILLSG----KFQAKIADFGLS 560 (723)
Q Consensus 502 y--~~~gsL~~~l~~~~~-~~l~~~-~---~l-~i~~~~a~vH~Dlk~~NILl~~----~~~~kl~DfGla 560 (723)
| +++|+|.+++..... ....+. + .+ ..+++...+||||||+|||++. +.+++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 668999999965321 111111 2 22 4556666699999999999974 347999995444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=135.88 Aligned_cols=131 Identities=22% Similarity=0.244 Sum_probs=90.9
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCChh--------------------------hHHHHHHHHHHHHhccCCce
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQ--------------------------GYKQFQAEVELLMRIHHKNL 483 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~--------------------------~~~~f~~Ei~~l~~l~H~nI 483 (723)
.+.||+|++|.||+|.. +|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999998 4889999998764211 01124688999999999987
Q ss_pred eeEEEEEecCCceEEEEEeCCCCCHHHH-hccCCC---CCCC----HHHHHHHHHh-ccccccCCCCCCEEEcCCCcEEE
Q 004935 484 TTLVGYCDEGTNRGLIYEFMANGNLQAL-LLGEEA---DILS----WEGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 484 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~---~~l~----~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl 554 (723)
.....+... ..+|||||++++++... +..... .... ....+..+|. ...+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 544433322 34899999998865432 332211 1111 2223334444 4559999999999999 789999
Q ss_pred EeccCccccC
Q 004935 555 ADFGLSRTFP 564 (723)
Q Consensus 555 ~DfGla~~~~ 564 (723)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.8e-14 Score=138.66 Aligned_cols=130 Identities=18% Similarity=0.298 Sum_probs=101.8
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChh--------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQ--------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.||+|++|.||+|...+..|++|+....... ....+.+|++++..++|+++.....++...+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46899999999999999899999987643211 1246889999999999999887777777778889999999
Q ss_pred CCCCHHHHhccCCCCCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 504 ANGNLQALLLGEEADILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
++++|.+++.........+ ...+..+|+...+|||++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986543211122 2233444455559999999999999 78899999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.1e-14 Score=137.90 Aligned_cols=129 Identities=21% Similarity=0.307 Sum_probs=100.0
Q ss_pred hccccCcEEEEEEEECCceEEEEEecCCCh--------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPSSA--------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.||+|+||.||+|.+.+..|++|....... ....++.+|++++.+++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999999999999654321 123567899999999998876655555666677799999999
Q ss_pred CCCHHHHhccCCC-CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 505 NGNLQALLLGEEA-DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 505 ~gsL~~~l~~~~~-~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
+++|.+++..... ........+..+|+...+|||++|.||+++ ++.+++.|||+++.
T Consensus 81 g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998765321 122333445555555669999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.3e-15 Score=158.74 Aligned_cols=177 Identities=27% Similarity=0.305 Sum_probs=136.9
Q ss_pred hccccCcEEEEEEE-----ECCceEEEEEecCCChh--hHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGY-----LDGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~-----~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+|+|.||.|+... ..+.-+|.|.+.+.+.. .......|..++..++ |+.+|++.-.+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998543 34567888887654321 1114567888888887 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCC----CCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEAD----ILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~~----~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.|...+...... .-..... +...++.+.+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------IA 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-------hc
Confidence 99998888765321 1111222 333333444999999999999999999999999998753221 12
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcccc
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIER 618 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~ 618 (723)
+||..|||||.+. ......|.||||++.+||+||..||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999987 577889999999999999999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-13 Score=156.28 Aligned_cols=131 Identities=20% Similarity=0.318 Sum_probs=103.1
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCC--------hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.||+|+||.||+|.+.+..+++|+..... ....+++.+|++++++++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 5789999999999999987776666543211 11235688999999999999999888888887888999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
+++++|.+++........++...+..+|+...+||||||+|||+ +++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999885322222334455566666666999999999999 577999999999976
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.8e-14 Score=150.82 Aligned_cols=165 Identities=25% Similarity=0.364 Sum_probs=117.9
Q ss_pred ceEEEEEeCCCCCHHHHhccC-CCCCCCHHHHHHHHHhccc-------cccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 495 NRGLIYEFMANGNLQALLLGE-EADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~~a~-------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
.+++.|+++...+|++++.++ .....+|...+.+..+.+. +|||+||.||+...+.++||.|||+.......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 577899999999999999754 3445566666666666663 89999999999999999999999998776443
Q ss_pred CC---CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 567 GS---GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 567 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
.. .....+...||..||+||.+.+..|+.|+||||+|+||+|+++ -...++.... ..-++++. +
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------~~d~r~g~----i 477 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------LTDIRDGI----I 477 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh--------hhhhhcCC----C
Confidence 31 1223455679999999999999999999999999999999988 2222221100 00111221 2
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
+|....+.+ .-..+..+++...|.+||+.
T Consensus 478 p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 478 PPEFLQDYP-----EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred ChHHhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence 222222222 22478889999999999943
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.2e-13 Score=154.14 Aligned_cols=235 Identities=18% Similarity=0.254 Sum_probs=155.7
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||+||+|.. +++.||+|+-++.+.. +|.--.+++.+|+ -+-|..+...+.-.+..+||+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 57899999999999988 5679999998876542 2222233444444 122333333344567778999999999
Q ss_pred CHHHHhccCCC--C--C----CCHHHHHHHHHhccccccCCCCCCEEEcC-------CCcEEEEeccCccccCCCCCCce
Q 004935 507 NLQALLLGEEA--D--I----LSWEGRLRIAIEAAKVHRDVKSTNILLSG-------KFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 507 sL~~~l~~~~~--~--~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~-------~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|.+++..... . + .+....+..+|...+|||||||+|.||.. ...++|+|||.+..+..-..+ .
T Consensus 780 tlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~ 858 (974)
T KOG1166|consen 780 TLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG-T 858 (974)
T ss_pred cHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC-c
Confidence 99999985421 1 1 12334455556666699999999999942 356899999999877544432 3
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.-....+|-++-.+|...|..++...|-|.+.-+++-|+.|+..- ...|. ...++..+....
T Consensus 859 ~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~g~-~~~~~~~~~Ry~- 920 (974)
T KOG1166|consen 859 KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKNGS-SWMVKTNFPRYW- 920 (974)
T ss_pred EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcCCc-ceeccccchhhh-
Confidence 345567888999999999999999999999999999999998421 11111 111222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
...+|. ++....|..+-..=|...++...|++.++.
T Consensus 921 ~~~~W~--~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 921 KRDMWN--KFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hHHHHH--HHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 122222 444444444445557888888888887743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=130.04 Aligned_cols=132 Identities=17% Similarity=0.212 Sum_probs=95.0
Q ss_pred HHhhhhccccCcEEEEEEEE-CCceEEEEEecCCCh----------------------hhHHHHHHHHHHHHhccCCc--
Q 004935 428 NNFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA----------------------QGYKQFQAEVELLMRIHHKN-- 482 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l~~l~H~n-- 482 (723)
+...+.||+|+||.||++.. +++.||||++..... .....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 44567899999999999988 578999998764321 01123678899999998874
Q ss_pred eeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCC--CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCc
Q 004935 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA--DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLS 560 (723)
Q Consensus 483 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla 560 (723)
+...++. ...++||||+++++|......... -...+...+..+++...+||||||+||+++++++++|+|||++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~ 172 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQM 172 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcc
Confidence 4445442 345899999999999876531110 0112333344455555599999999999999999999999999
Q ss_pred ccc
Q 004935 561 RTF 563 (723)
Q Consensus 561 ~~~ 563 (723)
...
T Consensus 173 ~~~ 175 (198)
T cd05144 173 VST 175 (198)
T ss_pred ccC
Confidence 765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.2e-13 Score=150.11 Aligned_cols=204 Identities=20% Similarity=0.231 Sum_probs=137.3
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.|..|++|.||..++. .+..|+|+-+ +.. +.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee---------------------chh
Confidence 467899999999999875 5577775432 111 0100 22222333333 344
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC------------ceeeecc
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG------------THVTTTI 576 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~------------~~~~~~~ 576 (723)
...+.............+...+.++++|||+||+|.++..-|++|+.|||+++........ ......+
T Consensus 139 ~tllk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqv 218 (1205)
T KOG0606|consen 139 ATLLKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQV 218 (1205)
T ss_pred hhhcccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccc
Confidence 4444443334444456778888889999999999999999999999999999864211110 1112446
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
+||+.|+|||++....|...+|.|++|+|+||.+-|+.||.+......+.+.+. ... .+.+ .+.....
T Consensus 219 cgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis----d~i-------~wpE-~dea~p~ 286 (1205)
T KOG0606|consen 219 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----DDI-------EWPE-EDEALPP 286 (1205)
T ss_pred cCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh----hhc-------cccc-cCcCCCH
Confidence 899999999999999999999999999999999999999987644333332222 211 0111 1222333
Q ss_pred HHHHHHHhccCCCCCCCCC
Q 004935 657 KTVEIAMACVSQTSTKRPT 675 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPs 675 (723)
.+.+++.+.++.+|.+|--
T Consensus 287 Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 287 EAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred HHHHHHHHHHHhChHhhcc
Confidence 5678888999999999953
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.1e-12 Score=126.25 Aligned_cols=130 Identities=22% Similarity=0.283 Sum_probs=91.7
Q ss_pred HhhhhccccCcEEEEEEE-E--CCceEEEEEecCCChh------------------------hHHHHHHHHHHHHhccCC
Q 004935 429 NFERVLGNGGFGTVYHGY-L--DGTEVAVKMLSPSSAQ------------------------GYKQFQAEVELLMRIHHK 481 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~H~ 481 (723)
.+.+.||+|++|.||+|. . +++.||||+++..... ....+..|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 345789999999999998 3 6789999998753210 112367899999999763
Q ss_pred c--eeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCC-C---CCCH----HHHHHHHHhcc-ccccCCCCCCEEEcCCC
Q 004935 482 N--LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA-D---ILSW----EGRLRIAIEAA-KVHRDVKSTNILLSGKF 550 (723)
Q Consensus 482 n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~---~l~~----~~~l~i~~~~a-~vH~Dlk~~NILl~~~~ 550 (723)
. +.+.+++ ...++||||+++++|......... . ...+ ...+..+|+.. .+||||||+||+++ ++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~ 185 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG 185 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC
Confidence 3 4455543 235899999999888765422211 1 1122 23344455556 69999999999999 88
Q ss_pred cEEEEeccCcccc
Q 004935 551 QAKIADFGLSRTF 563 (723)
Q Consensus 551 ~~kl~DfGla~~~ 563 (723)
+++|+|||.+...
T Consensus 186 ~i~LiDFg~a~~~ 198 (237)
T smart00090 186 KVVIIDVSQSVEL 198 (237)
T ss_pred CEEEEEChhhhcc
Confidence 9999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.9e-11 Score=114.38 Aligned_cols=128 Identities=16% Similarity=0.143 Sum_probs=99.6
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccC--CceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH--KNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+.||+|.++.||++..++..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 5689999999999999889999999876543 4678999999999977 58999999988888899999999998776
Q ss_pred HHhccC--CCCCCCHHHHHHHHHhc---cccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 510 ALLLGE--EADILSWEGRLRIAIEA---AKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 510 ~~l~~~--~~~~l~~~~~l~i~~~~---a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
.+ ... ..........+...+.. ..+|+|++|+||++++.+.+++.|||.++.
T Consensus 82 ~~-~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 000 00011222334444443 248999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-11 Score=124.03 Aligned_cols=131 Identities=20% Similarity=0.193 Sum_probs=98.5
Q ss_pred hhcc-ccCcEEEEEEEECCceEEEEEecCCC-------------hhhHHHHHHHHHHHHhccCCce--eeEEEEEecCC-
Q 004935 432 RVLG-NGGFGTVYHGYLDGTEVAVKMLSPSS-------------AQGYKQFQAEVELLMRIHHKNL--TTLVGYCDEGT- 494 (723)
Q Consensus 432 ~~lG-~G~~g~Vy~~~~~~~~vavK~~~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~- 494 (723)
..|| .||.|+||+....+..++||++.... ......+.+|++++.+++|+++ +..++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4788 89999999999999999999885321 1123567899999999998885 67777654332
Q ss_pred ---ceEEEEEeCCC-CCHHHHhccCCCC---CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 495 ---NRGLIYEFMAN-GNLQALLLGEEAD---ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 495 ---~~~lV~Ey~~~-gsL~~~l~~~~~~---~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
..++|+||+++ .+|.+++...... ..+....+..+|+...+||||||.|||++.++.++|+|||.+..
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 23599999997 6999887653211 12233445556666669999999999999988999999998875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-11 Score=124.55 Aligned_cols=194 Identities=20% Similarity=0.210 Sum_probs=122.6
Q ss_pred cCCceeeEEEEEec---------------------------CCceEEEEEeCCCCCHHHHhccCCCC-------CCCHHH
Q 004935 479 HHKNLTTLVGYCDE---------------------------GTNRGLIYEFMANGNLQALLLGEEAD-------ILSWEG 524 (723)
Q Consensus 479 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~-------~l~~~~ 524 (723)
+|||||.+.++|.+ ...+++||.-.+. +|++++..+... ..+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 68888888776532 2346788877765 888888754221 122333
Q ss_pred HHHHHHhccccccCCCCCCEEEc--CCC--cEEEEeccCccccCCCCCC---ceeeecccCCCccccccccccCC-----
Q 004935 525 RLRIAIEAAKVHRDVKSTNILLS--GKF--QAKIADFGLSRTFPVEGSG---THVTTTIAGTPGYLDPEYYISNR----- 592 (723)
Q Consensus 525 ~l~i~~~~a~vH~Dlk~~NILl~--~~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----- 592 (723)
.+..+++....|||+|++|||+. +|. ...|+|||.+-.-...+-. ........|...-||||......
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 34444555558999999999983 443 5789999987532110000 00112234666789999875322
Q ss_pred -CCChhhHHHHHHHHHHHHcCCCccccCcccc-cHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCC
Q 004935 593 -LTEKSDVYNFGVVLLEIITSKSVIERTHERI-HITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTS 670 (723)
Q Consensus 593 -~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p 670 (723)
--.|+|.|+.|.+.||+++...||....+.. +... ..+.. -|.+... +...+.+++...++.+|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~q-----LPalp~~----vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQ-----LPALPSR----VPPVARQLVFDLLKRDP 498 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhh-----CCCCccc----CChHHHHHHHHHhcCCc
Confidence 2469999999999999999999997643311 1111 11111 1333322 33356789999999999
Q ss_pred CCCCCHHHHHHHHHHhh
Q 004935 671 TKRPTMNQVVMELNESL 687 (723)
Q Consensus 671 ~~RPsm~evl~~L~~~~ 687 (723)
++||+..-+...|+-.+
T Consensus 499 skRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 499 SKRVSPNIAANVLNLSL 515 (598)
T ss_pred cccCCccHHHhHHHHHH
Confidence 99999877776665443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.6e-11 Score=116.25 Aligned_cols=128 Identities=23% Similarity=0.249 Sum_probs=85.1
Q ss_pred hhhccccCcEEEEEEEEC-CceEEEEEecCCChh--hHHH----------------------HHHHHHHHHhccCCc--e
Q 004935 431 ERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQ--GYKQ----------------------FQAEVELLMRIHHKN--L 483 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~n--I 483 (723)
.+.||+|+||.||+|... ++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999985 779999998754211 1111 135666777775443 4
Q ss_pred eeEEEEEecCCceEEEEEeCCCCC-----HHHHhccCC--CCCCCHHHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEE
Q 004935 484 TTLVGYCDEGTNRGLIYEFMANGN-----LQALLLGEE--ADILSWEGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 484 v~l~g~~~~~~~~~lV~Ey~~~gs-----L~~~l~~~~--~~~l~~~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
.+.+++ ...++||||++++. |.+...... .-...+...+..++. ...+||||||+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 444443 24689999999953 433322100 001223344445555 5559999999999999 8899999
Q ss_pred eccCcccc
Q 004935 556 DFGLSRTF 563 (723)
Q Consensus 556 DfGla~~~ 563 (723)
|||.+...
T Consensus 157 Dfg~a~~~ 164 (187)
T cd05119 157 DVPQAVEI 164 (187)
T ss_pred ECcccccc
Confidence 99999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.8e-10 Score=121.37 Aligned_cols=132 Identities=22% Similarity=0.265 Sum_probs=88.7
Q ss_pred hhccccCcEEEEEEEE-CCceEEEEEecCCChhhH----------------------------------------HHHHH
Q 004935 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGY----------------------------------------KQFQA 470 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~----------------------------------------~~f~~ 470 (723)
+.||.|++|.||+|++ +|+.||||+.++...... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4799999999999998 678999999876531110 12555
Q ss_pred HHHHHHhcc----CCceeeEEEEE-ecCCceEEEEEeCCCCCHHHHhccCCC--CCCCHHHH-----HHHHHhccccccC
Q 004935 471 EVELLMRIH----HKNLTTLVGYC-DEGTNRGLIYEFMANGNLQALLLGEEA--DILSWEGR-----LRIAIEAAKVHRD 538 (723)
Q Consensus 471 Ei~~l~~l~----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~-----l~i~~~~a~vH~D 538 (723)
|++.+.+++ |.+-+.+-..+ ...+..+|||||+++++|.+....... ........ +..++....+|+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D 282 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHAD 282 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 666666662 22223322222 234567999999999999887643211 11111111 2233344449999
Q ss_pred CCCCCEEEcCCCcEEEEeccCcccc
Q 004935 539 VKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 539 lk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
+||.||+++.++++++.|||++..+
T Consensus 283 ~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 283 LHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-12 Score=144.19 Aligned_cols=241 Identities=18% Similarity=0.294 Sum_probs=168.6
Q ss_pred hhhhccccCcEEEEEEEEC---CceEEEEEecCCC--hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD---GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+|+.|-..... ...+|+|.+.... .....+...|..+-.++. |+|++.+++.....+..+++.+|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 3456999999999877663 2356777665443 223344556777777776 999999999999999999999999
Q ss_pred CCCCHHHHh-ccCC-----CC----CCCHHHHHHHHH-hccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCce
Q 004935 504 ANGNLQALL-LGEE-----AD----ILSWEGRLRIAI-EAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 504 ~~gsL~~~l-~~~~-----~~----~l~~~~~l~i~~-~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 571 (723)
.+|++.+.+ .... .. ..+....+...| ..+..|||+||+|.+++..+ ..+++|||+|..+........
T Consensus 104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~ 183 (601)
T KOG0590|consen 104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER 183 (601)
T ss_pred cccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcce
Confidence 999998887 3321 11 112233455566 66779999999999999999 999999999998766233344
Q ss_pred eeecccC-CCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccc-cHHHHHHHHhcCCCcccccCCcccC
Q 004935 572 VTTTIAG-TPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERI-HITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 572 ~~~~~~g-t~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++...... ....|.... +... .....
T Consensus 184 ~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~----~~~~~ 256 (601)
T KOG0590|consen 184 SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFT----QLPWN 256 (601)
T ss_pred eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---cccc----cCccc
Confidence 4455667 9999999999885 45678999999999999999999987654322 112222111 0000 00001
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. .....++..+++..+|+.|.+.+++..
T Consensus 257 ~~----~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 257 SI----SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cC----ChhhhhcccccccCCchhccccccccc
Confidence 11 113457778888899999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.7e-10 Score=107.77 Aligned_cols=127 Identities=15% Similarity=0.117 Sum_probs=90.0
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceee-EEEEEecCCceEEEEEeCCCCCHHH
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT-LVGYCDEGTNRGLIYEFMANGNLQA 510 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gsL~~ 510 (723)
+.|+.|.++.||++...++.+++|+...... ....+..|+++++.+.+.++++ ++.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 4578899999999999999999999865432 2245788999999997666554 44433 334689999999988865
Q ss_pred HhccCCCCCCCHHHHHHHHHhccc-----cccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 511 LLLGEEADILSWEGRLRIAIEAAK-----VHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 511 ~l~~~~~~~l~~~~~l~i~~~~a~-----vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
.............+.+..+|.... +|||++|.||+++ ++.+++.|||.+..
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 311000111123344555555543 9999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.4e-08 Score=110.50 Aligned_cols=132 Identities=18% Similarity=0.209 Sum_probs=86.7
Q ss_pred hhccccCcEEEEEEEE-C-CceEEEEEecCCChhh----------------------------------H------HHHH
Q 004935 432 RVLGNGGFGTVYHGYL-D-GTEVAVKMLSPSSAQG----------------------------------Y------KQFQ 469 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-~-~~~vavK~~~~~~~~~----------------------------------~------~~f~ 469 (723)
+.||.|++|.||+|++ + |+.||||+.++.-... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 4799999999999998 3 7899999997652110 0 1245
Q ss_pred HHHHHHHhcc----CCceeeEEEEEec-CCceEEEEEeCCCCCHHHHh--ccCCCCCCCHHHH-----HHHHHhcccccc
Q 004935 470 AEVELLMRIH----HKNLTTLVGYCDE-GTNRGLIYEFMANGNLQALL--LGEEADILSWEGR-----LRIAIEAAKVHR 537 (723)
Q Consensus 470 ~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l--~~~~~~~l~~~~~-----l~i~~~~a~vH~ 537 (723)
+|+..+.+++ +.+.+.+-..+.+ .+..+|||||++++.+.+.- .....+.-....+ +..++....+|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~GffHa 284 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDGFFHA 284 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 5555555553 4333433333322 45678999999999998752 2221111111111 122233444999
Q ss_pred CCCCCCEEEcCCC----cEEEEeccCcccc
Q 004935 538 DVKSTNILLSGKF----QAKIADFGLSRTF 563 (723)
Q Consensus 538 Dlk~~NILl~~~~----~~kl~DfGla~~~ 563 (723)
|+||.||+++.++ ++++.|||++..+
T Consensus 285 DpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 285 DMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 9999999999888 9999999998765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.7e-09 Score=123.32 Aligned_cols=95 Identities=32% Similarity=0.442 Sum_probs=80.5
Q ss_pred eecCccCCCC-----CCC---CC-----ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcE
Q 004935 260 LWQGLNCSYP-----EYD---PP-----RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTE 326 (723)
Q Consensus 260 ~w~g~~c~~~-----~~~---~~-----~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~ 326 (723)
+|.|..|... +-. .+ .++.|+|++|+|+|.+|+.|++|++|+.|+|++|+|+|.+|..+++|++|+.
T Consensus 391 ~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ 470 (623)
T PLN03150 391 GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470 (623)
T ss_pred CCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 7999988522 211 12 2789999999999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCchhhcccCc---cccccCCCC
Q 004935 327 LNLKGTIPNGLIEKQKNGL---LSLSVEGNP 354 (723)
Q Consensus 327 l~l~~n~~~g~~p~~~~~~---~~l~~~~n~ 354 (723)
|+|++|.++|.+|..+..+ ..|.+.+|.
T Consensus 471 LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred EECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 9999999999999877644 445566664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-09 Score=131.07 Aligned_cols=173 Identities=21% Similarity=0.257 Sum_probs=89.0
Q ss_pred eecccccccCCcceEEEEEEcCccccCCcccc----------eeeeEEEEeeeeecc-----------------------
Q 004935 171 FSEFENVQANNQTREIIIYINGIDWFGPFSPL----------HFAANTIYSTWPILT----------------------- 217 (723)
Q Consensus 171 F~e~~~~~~~~~~R~f~i~ln~~~~~~~~~p~----------~l~~~~~~~~~p~~~----------------------- 217 (723)
+|.|.++.|....|+-.+.+.++.+.+.+++. .+..|.+.+.+|...
T Consensus 57 ~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~ 136 (968)
T PLN00113 57 VCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136 (968)
T ss_pred CCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc
Confidence 47788888865567777777776554433221 233333333333221
Q ss_pred ---cceEEEEEEc-CCCCCcchhhhhhhhhhhhccccccccCCCceeecCc---------cCCC----C--CCCCCceEE
Q 004935 218 ---AEKIEFSINT-TESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGL---------NCSY----P--EYDPPRITS 278 (723)
Q Consensus 218 ---~~~~~lsl~~-~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~---------~c~~----~--~~~~~~l~~ 278 (723)
.....+.+.. ...+.+|..+..+..++.+++..+...+..+...... .|.. + -...++|+.
T Consensus 137 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 216 (968)
T PLN00113 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW 216 (968)
T ss_pred cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccE
Confidence 1112233333 2234566666666666666665444333222110000 0000 0 011245666
Q ss_pred EEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc
Q 004935 279 LNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 279 l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~ 343 (723)
|+|++|+++|.+|..|++|++|++|+|++|+++|.+|..++++++|+.|+|++|.+.+.+|..+.
T Consensus 217 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 281 (968)
T PLN00113 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281 (968)
T ss_pred EECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh
Confidence 66666666666666666666666666666666666666666666666666666666666655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.1e-07 Score=89.48 Aligned_cols=126 Identities=21% Similarity=0.265 Sum_probs=95.8
Q ss_pred hccccCcEEEEEEEECCceEEEEEecCCC---h-----hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPSS---A-----QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~---~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+++|+-+.+|.+.+-|.++++|.-.+.. + -...+-.+|++++.+++--.|..-+=|..+.+...++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998888788888754432 1 123456789999999976666655566677888899999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHH----HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 505 NGNLQALLLGEEADILSWEGRL----RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l----~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
+-.|.+.+.... ......+ .-+|....||+||.++||++..+. +.++|||++..
T Consensus 83 G~~lkd~l~~~~---~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEAR---PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhcc---hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999987652 3333333 334444559999999999998775 99999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.1e-08 Score=106.58 Aligned_cols=237 Identities=20% Similarity=0.206 Sum_probs=156.1
Q ss_pred Hhhhhccc--cCcEEEEEEEE----CCceEEEEEecC--CChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGN--GGFGTVYHGYL----DGTEVAVKMLSP--SSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~--G~~g~Vy~~~~----~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+...+|. |.+|.||.+.. ++..+|+|.-+. ......+.=.+|+...+++ .|+|.++.......++..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 44567899 99999999877 345788887432 2222233345677777777 599999988888889999999
Q ss_pred EEeCCCCCHHHHhccCC---CCC------CCHHHHHHHHHhccc----cccCCCCCCEEEcCC-CcEEEEeccCccccCC
Q 004935 500 YEFMANGNLQALLLGEE---ADI------LSWEGRLRIAIEAAK----VHRDVKSTNILLSGK-FQAKIADFGLSRTFPV 565 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~---~~~------l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~ 565 (723)
.|++. .+|..+.+... ... ..|..+..-++...+ +|-|+||.||++..+ ..+++.|||+...+..
T Consensus 197 tE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD 275 (524)
T ss_pred ecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccC
Confidence 99886 57777765431 122 233332222333333 899999999999999 8899999999988754
Q ss_pred CCCC--ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 566 EGSG--THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 566 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
..-. ..+.....+...|++||.. .+.++..+|+|++|.+.+|..++......... ..|.. +....
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~-------~r~~~- 342 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQ-------LRQGY- 342 (524)
T ss_pred CccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC----CCccc-------ccccc-
Confidence 4311 1222333678899999976 45688999999999999999998765432210 01110 00000
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+..++.......+...+..+++.+|-.|++.+.+..
T Consensus 343 --ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 --IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111223445788899999999988766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3e-08 Score=99.96 Aligned_cols=192 Identities=19% Similarity=0.325 Sum_probs=121.3
Q ss_pred HHHHhccCCceeeEEEEEecCC-----ceEEEEEeCCCCCHHHHhccCCC--C------CCCHHHHHHHHHhccc-----
Q 004935 473 ELLMRIHHKNLTTLVGYCDEGT-----NRGLIYEFMANGNLQALLLGEEA--D------ILSWEGRLRIAIEAAK----- 534 (723)
Q Consensus 473 ~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~--~------~l~~~~~l~i~~~~a~----- 534 (723)
.-|-.+.|-|||+++.|..+.. ...++.|||..|++.++|++... . .-.|..++.-++...+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445567999999999885543 46789999999999999986421 1 1245566666666665
Q ss_pred -cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcC
Q 004935 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITS 612 (723)
Q Consensus 535 -vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg 612 (723)
+|+++..+-|++..++-+|+.--.-....+.-... ........+-++|.+||+-.....+..+|||+||+-.+||-.+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999988887532111111000000 0111223467799999998888889999999999999999877
Q ss_pred CCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 613 KSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 613 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.---...........-.... +...-++.- ...+..|++..|..||+|++.+-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~-----i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANV-----IIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhhh-----eeeccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 63211111100000000000 000001111 25667899999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.6e-07 Score=100.14 Aligned_cols=159 Identities=16% Similarity=0.199 Sum_probs=112.8
Q ss_pred CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCC-----CCCH
Q 004935 448 DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD-----ILSW 522 (723)
Q Consensus 448 ~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----~l~~ 522 (723)
++.+|.|...+...........+.++.|+.+|||||++++......+..|||+|-+. .|..++...... ..+.
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHHHHHH
Confidence 566888888776554334556788999999999999999999999999999999874 455555543221 2344
Q ss_pred HHHHHHHHhccc-cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHH
Q 004935 523 EGRLRIAIEAAK-VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYN 601 (723)
Q Consensus 523 ~~~l~i~~~~a~-vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S 601 (723)
...|.++++-+. +|++|..+.|+++..|+.||++|.++........ ......---.|..|+.+.... -..|.|-
T Consensus 114 l~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 114 LAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cchhhhh
Confidence 556666665555 9999999999999999999999998865422111 011111122455665443222 3569999
Q ss_pred HHHHHHHHHcCC
Q 004935 602 FGVVLLEIITSK 613 (723)
Q Consensus 602 fGvvL~elltg~ 613 (723)
|||+++|++.|.
T Consensus 189 Lg~li~el~ng~ 200 (690)
T KOG1243|consen 189 LGCLIEELFNGS 200 (690)
T ss_pred HHHHHHHHhCcc
Confidence 999999999993
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.7e-08 Score=76.51 Aligned_cols=61 Identities=39% Similarity=0.502 Sum_probs=54.6
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIP 334 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~ 334 (723)
|+|+.|+|++|+|+.--+..|..+++|++|+|++|+++.--|..+..+++|+.|+|++|.+
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999954446799999999999999999977778999999999999999964
|
... |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.7e-07 Score=90.19 Aligned_cols=80 Identities=14% Similarity=0.223 Sum_probs=61.9
Q ss_pred hhccccCcEEEEEEEECC-ceEEEEEecCCCh-hhHHHHHHHHHHHHhccCC--ceeeEEEEEecCC---ceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHK--NLTTLVGYCDEGT---NRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~---~~~lV~Ey~~ 504 (723)
+.|+.|..+.||++...+ ..+++|+...... .....+..|+++++.+++. ++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 458899999999998876 7999999765432 2345789999999999764 4577888876643 5689999999
Q ss_pred CCCHHHH
Q 004935 505 NGNLQAL 511 (723)
Q Consensus 505 ~gsL~~~ 511 (723)
+.++.+.
T Consensus 84 G~~l~~~ 90 (223)
T cd05154 84 GRVLRDR 90 (223)
T ss_pred CEecCCC
Confidence 8877553
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.2e-07 Score=83.56 Aligned_cols=131 Identities=20% Similarity=0.263 Sum_probs=92.4
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCC--------hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
..|-+|+-+.|+++.+.|+...||.-.... .-..++..+|++.|.+++--.|.--.-++.+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 467899999999999999998888643221 113456789999999987666655445566666778999999
Q ss_pred CC-CCHHHHhccCCC----CC--CCHHHHHHHHHhccc----cccCCCCCCEEEcCCC---cEEEEeccCccc
Q 004935 504 AN-GNLQALLLGEEA----DI--LSWEGRLRIAIEAAK----VHRDVKSTNILLSGKF---QAKIADFGLSRT 562 (723)
Q Consensus 504 ~~-gsL~~~l~~~~~----~~--l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~~---~~kl~DfGla~~ 562 (723)
++ .++.+++..... +. ....+++--.++..| ||+||..+||+|..++ .+.+.|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 87 467777765311 11 234444433444333 9999999999997654 458999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.42 E-value=1e-06 Score=85.80 Aligned_cols=127 Identities=19% Similarity=0.202 Sum_probs=81.9
Q ss_pred hhccccCcEEEEEEEEC--------CceEEEEEecCCCh----------------------hhHHHHH----HHHHHHHh
Q 004935 432 RVLGNGGFGTVYHGYLD--------GTEVAVKMLSPSSA----------------------QGYKQFQ----AEVELLMR 477 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~~~----------------------~~~~~f~----~Ei~~l~~ 477 (723)
..||.|.-+.||.|... +..+|||+.+.... ...+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999864 26999999753210 0012233 89999999
Q ss_pred ccC--CceeeEEEEEecCCceEEEEEeCCCCCHHH-HhccCCC---CC----CCHHHHHHHH-HhccccccCCCCCCEEE
Q 004935 478 IHH--KNLTTLVGYCDEGTNRGLIYEFMANGNLQA-LLLGEEA---DI----LSWEGRLRIA-IEAAKVHRDVKSTNILL 546 (723)
Q Consensus 478 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~---~~----l~~~~~l~i~-~~~a~vH~Dlk~~NILl 546 (723)
+.. -++...+++ ...++||||+.+..+.. .+..... .. .+....+..+ ++...|||||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 455666654 56789999998753321 2221100 00 0111222222 34445999999999999
Q ss_pred cCCCcEEEEeccCcccc
Q 004935 547 SGKFQAKIADFGLSRTF 563 (723)
Q Consensus 547 ~~~~~~kl~DfGla~~~ 563 (723)
++ +.+.|+|||.+...
T Consensus 159 ~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 159 HD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EC-CcEEEEECCCceeC
Confidence 74 67999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4e-07 Score=104.74 Aligned_cols=188 Identities=18% Similarity=0.231 Sum_probs=118.7
Q ss_pred ccCCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCC----CCCCHHHH----HHHHHhccccccCCCCCCEEEcCC
Q 004935 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA----DILSWEGR----LRIAIEAAKVHRDVKSTNILLSGK 549 (723)
Q Consensus 478 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~----~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~ 549 (723)
.+||-++....-+.-.....|+++|..+++|...|+.... ..-..... ...++...++|+|++|.|++...+
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 3455555444334456778899999999999999876421 11111111 222222224999999999999999
Q ss_pred CcEEEEeccCccccCCC---------------------CC-------CceeeecccCCCccccccccccCCCCChhhHHH
Q 004935 550 FQAKIADFGLSRTFPVE---------------------GS-------GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYN 601 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~---------------------~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S 601 (723)
+..+++|||........ .. .........+|+.|.+||...+......+|.|+
T Consensus 941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~ 1020 (1205)
T KOG0606|consen 941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWS 1020 (1205)
T ss_pred CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhh
Confidence 99999999843321100 00 001123456899999999999999999999999
Q ss_pred HHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 004935 602 FGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 602 fGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
+|++++|.++|.+||.......- ++... .+.+ .+ .....+......+++..-+..+|.+|-.|.
T Consensus 1021 ~g~~l~e~l~g~pp~na~tpq~~----f~ni~-~~~~------~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQQI----FENIL-NRDI------PW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhcCCCCCCCcchhhh----hhccc-cCCC------CC-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999976543211 11111 1111 00 001111222345667777778888887665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.4e-05 Score=80.95 Aligned_cols=261 Identities=15% Similarity=0.151 Sum_probs=142.7
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEE------ecCC-ceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYC------DEGT-NRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~------~~~~-~~~lV~Ey 502 (723)
.+-||+|+-+.+|-----+..| -|++..-...... +.+..|.+. .||-+..-+.|- .+.. ...++|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 4679999999999543222333 4776654332211 223333333 455433212221 1112 24566666
Q ss_pred CCCC-CHHHHhcc----CCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 503 MANG-NLQALLLG----EEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 503 ~~~g-sL~~~l~~----~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+++. -...+... +......|.-.++.+-. ..++-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec----
Confidence 6543 22233221 12334566655444333 33356899999999999999999986543332
Q ss_pred CCceeeecccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcC-CCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITS-KSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
.+........|...|.+||... +-.-+...|-|.+|+++++++.| ++||.+......-..-....+..+.....
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 1123334456888999999865 33457789999999999999987 89997543211000000000111111100
Q ss_pred cCC--ccc---CCCCHH-HHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHhhhhHhhhhhccCc
Q 004935 642 VDP--RLH---EDFDIN-SVWKTVEIAMACVSQ--TSTKRPTMNQVVMELNESLAIETARLKAAGK 699 (723)
Q Consensus 642 ~d~--~l~---~~~~~~-~~~~l~~l~~~Cl~~--~p~~RPsm~evl~~L~~~~~~~~~~~~~~~~ 699 (723)
-|. .+. ...+.+ -...+..+..+|+.. .+.-|||.+.++..|.++.+.-.....++.|
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 010 000 011111 122445667788765 4678999999999998877666555444444
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.13 E-value=1e-05 Score=78.57 Aligned_cols=118 Identities=24% Similarity=0.259 Sum_probs=70.2
Q ss_pred EEEEEEE-CCceEEEEEecCCCh--------------------------hhHHHHHHHHHHHHhccCC--ceeeEEEEEe
Q 004935 441 TVYHGYL-DGTEVAVKMLSPSSA--------------------------QGYKQFQAEVELLMRIHHK--NLTTLVGYCD 491 (723)
Q Consensus 441 ~Vy~~~~-~~~~vavK~~~~~~~--------------------------~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 491 (723)
.||.|.. ++..+|||+.+.... .......+|.+.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899987 567999999754210 0123467899999999766 45556544
Q ss_pred cCCceEEEEEeCC--CCCHHHHhccC--CCCCC----CHHHHHHH-HHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 492 EGTNRGLIYEFMA--NGNLQALLLGE--EADIL----SWEGRLRI-AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 492 ~~~~~~lV~Ey~~--~gsL~~~l~~~--~~~~l----~~~~~l~i-~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
....+||||++ +..+..+.... ..... .+...+.. .+....+||||.+.||+++++ .+.|+|||.+..
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 24579999999 54554433222 11111 11221222 234555999999999999988 999999998865
Q ss_pred c
Q 004935 563 F 563 (723)
Q Consensus 563 ~ 563 (723)
.
T Consensus 156 ~ 156 (188)
T PF01163_consen 156 S 156 (188)
T ss_dssp T
T ss_pred c
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.5e-06 Score=92.39 Aligned_cols=229 Identities=20% Similarity=0.217 Sum_probs=144.6
Q ss_pred hhhccccCcEEEEEEEE---CCceEEEEEecCCChhhHHH--HHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYL---DGTEVAVKMLSPSSAQGYKQ--FQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~--f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
...||.|.|+.|++... ++..+++|.+.........+ -..|+.+...+ .|.+++....-+....+.++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999998765 35588999877654332222 24566666655 58888887766666777778899999
Q ss_pred CCCHHHHhccC----CCCCCCHHHHHHHHHhccc----cccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCceeeec
Q 004935 505 NGNLQALLLGE----EADILSWEGRLRIAIEAAK----VHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 505 ~gsL~~~l~~~----~~~~l~~~~~l~i~~~~a~----vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++++.....-. ....+....++-.++.+++ +|+|+||+||++..+ +..+++|||.+..+... ...
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~------~~~ 423 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS------SGV 423 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee------ccc
Confidence 99887655211 2222333333333333333 999999999999886 78899999998643211 111
Q ss_pred ccCCCccc--cccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 576 IAGTPGYL--DPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 576 ~~gt~~y~--aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....-++. +++......+-.+.|++|||.-+.|..++...-.... +|.. +..+.. +.+.+.
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~~--i~~~~~-----p~~~~~---- 486 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSLT--IRSGDT-----PNLPGL---- 486 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCcccc------ccee--eecccc-----cCCCch----
Confidence 22223333 5555566778899999999999999999875433211 1111 111111 111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMEL 683 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L 683 (723)
...+..++......++..||.+.+.....
T Consensus 487 -~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 487 -KLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred -HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 13455677778888999999877765543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.9e-05 Score=78.99 Aligned_cols=130 Identities=17% Similarity=0.089 Sum_probs=86.0
Q ss_pred hccccCcEEEEEEEECCceEEEEEecCCChh-hHH----------HHHHHHHHHHhccCCce--eeEEEEEec-----CC
Q 004935 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQ-GYK----------QFQAEVELLMRIHHKNL--TTLVGYCDE-----GT 494 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~----------~f~~Ei~~l~~l~H~nI--v~l~g~~~~-----~~ 494 (723)
.+-.-....|++..++|+.+.||+....... ..+ .+.+|...+.++...+| +..+++... ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3444444557788889999999987544311 112 37899999988854433 445566543 23
Q ss_pred ceEEEEEeCCCC-CHHHHhccCCCCCC----------CHHHHHHHHHhccccccCCCCCCEEEcC-------CCcEEEEe
Q 004935 495 NRGLIYEFMANG-NLQALLLGEEADIL----------SWEGRLRIAIEAAKVHRDVKSTNILLSG-------KFQAKIAD 556 (723)
Q Consensus 495 ~~~lV~Ey~~~g-sL~~~l~~~~~~~l----------~~~~~l~i~~~~a~vH~Dlk~~NILl~~-------~~~~kl~D 556 (723)
..+||+|++++- +|.+++........ ...+.+.-+|+...+|+|++++|||++. +..+.++|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 467999999986 89988753111111 1222333445555599999999999985 46899999
Q ss_pred ccCccc
Q 004935 557 FGLSRT 562 (723)
Q Consensus 557 fGla~~ 562 (723)
|+.++.
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00019 Score=80.27 Aligned_cols=131 Identities=20% Similarity=0.254 Sum_probs=86.0
Q ss_pred hhccccCcEEEEEEEEC-CceEEEEEecCCChhh----------------------------------------HHHHHH
Q 004935 432 RVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQG----------------------------------------YKQFQA 470 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~----------------------------------------~~~f~~ 470 (723)
+-|+.++-|.||+|++. |+.||||+.++.-... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999995 8899999987642211 012445
Q ss_pred HHHHHHhcc-----CCceeeEEEEE-ecCCceEEEEEeCCCCCHHHHh--ccCCCCCCCHHHH-----HHHHHhcccccc
Q 004935 471 EVELLMRIH-----HKNLTTLVGYC-DEGTNRGLIYEFMANGNLQALL--LGEEADILSWEGR-----LRIAIEAAKVHR 537 (723)
Q Consensus 471 Ei~~l~~l~-----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l--~~~~~~~l~~~~~-----l~i~~~~a~vH~ 537 (723)
|..-+.+++ .+++ .+=..| +-.+...|+|||++|-.+.+.. .....+.-..... ++.+......|.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHa 289 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHA 289 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcccc
Confidence 555555552 2332 222223 3356778999999998888774 3322221111111 222333344999
Q ss_pred CCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 538 DVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 538 Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
|..|.||+++.+++..+.|||+...+
T Consensus 290 DpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 290 DPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred CCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999998654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.1e-05 Score=80.60 Aligned_cols=129 Identities=22% Similarity=0.275 Sum_probs=90.2
Q ss_pred HhhhhccccCcEEEEEEEEC-CceEEEEEecCCCh----------------------hhHHHHHHHHHHHHhccCC--ce
Q 004935 429 NFERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSA----------------------QGYKQFQAEVELLMRIHHK--NL 483 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l~~l~H~--nI 483 (723)
.+.+.||.|.-+.||.|... |.++|||.-+.... -.....++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34678999999999999984 78999997543211 0123467899999998654 55
Q ss_pred eeEEEEEecCCceEEEEEeCCCCCHHHHhc--cCCCCCC-CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCc
Q 004935 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLL--GEEADIL-SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLS 560 (723)
Q Consensus 484 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~--~~~~~~l-~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla 560 (723)
.+-+++ +..++||||+++--|...-- .....++ .....+..+.....||+|+..-||++++++.+.++||=-+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccc
Confidence 555543 55689999999866655431 1111111 2334455556666699999999999999999999999654
Q ss_pred c
Q 004935 561 R 561 (723)
Q Consensus 561 ~ 561 (723)
.
T Consensus 250 v 250 (304)
T COG0478 250 V 250 (304)
T ss_pred c
Confidence 4
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.8e-06 Score=79.02 Aligned_cols=108 Identities=20% Similarity=0.190 Sum_probs=56.5
Q ss_pred EEEEecCCCCCCCccCCCCCCCceEecCCC---CCCccccC------ccccccCCCCCCchhhhhhceeccCCCCceEEe
Q 004935 85 FRRWDIGSRSSETFRYPDDIYDRIWLPNSL---PNSEPINT------TSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLS 155 (723)
Q Consensus 85 ~~r~~~g~~~~~~~rypdD~~dR~W~~~~~---~~~~~~~t------~~~i~~~~~~~~P~~v~~tA~~~~~~~~~~~~~ 155 (723)
+.|.|+|+. .| +|...+.|.++.. ..|.-... .........-..++.++||+..... .+.+.
T Consensus 2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~---~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS---SFSYD 72 (174)
T ss_dssp EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS---SEEEE
T ss_pred EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC---ceEEE
Confidence 579999986 23 7889999999765 22311110 0011112222336799999987322 33333
Q ss_pred eCCCCCccceEEEeeeecccccc----cCCcceEEEEEEcCccccCCcccc
Q 004935 156 WEPNDPKFLYYAYLYFSEFENVQ----ANNQTREIIIYINGIDWFGPFSPL 202 (723)
Q Consensus 156 w~~~~~~~~y~~~lhF~e~~~~~----~~~~~R~f~i~ln~~~~~~~~~p~ 202 (723)
. |..+...|-|.|||||+..-. .....|+|+|++||+.....|++.
T Consensus 73 i-p~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~ 122 (174)
T PF11721_consen 73 I-PVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIY 122 (174)
T ss_dssp E-E--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HH
T ss_pred E-ecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHH
Confidence 3 445556699999999998654 223679999999998876555543
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.4e-06 Score=91.69 Aligned_cols=115 Identities=18% Similarity=0.193 Sum_probs=60.0
Q ss_pred EEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCC------ce-----------eecCccCCCCCCCCCceEEEEcCC
Q 004935 221 IEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQD------AY-----------LWQGLNCSYPEYDPPRITSLNLSS 283 (723)
Q Consensus 221 ~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~------~~-----------~w~g~~c~~~~~~~~~l~~l~ls~ 283 (723)
.=+.|+.+.--.+|.+++++..++-+++..+....-. +| .=.|+.-. -.....|+.||||+
T Consensus 35 ~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~d--iF~l~dLt~lDLSh 112 (1255)
T KOG0444|consen 35 TWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTD--IFRLKDLTILDLSH 112 (1255)
T ss_pred eEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCch--hcccccceeeecch
Confidence 3377777777789999999988887776555332111 10 01111110 01122455555555
Q ss_pred CcccccCcccccCCCCCCeeeCcCCcCcCCCCccC-CCCCCCcEEEccCCCCCCchh
Q 004935 284 SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFL-SQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 284 n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l-~~l~~L~~l~l~~n~~~g~~p 339 (723)
|+|. ..|..+-+-.++-+|+||+|++. +||..+ -+|+.|-+||||+|.+....|
T Consensus 113 NqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPP 167 (1255)
T KOG0444|consen 113 NQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPP 167 (1255)
T ss_pred hhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCH
Confidence 5555 45555555555555555555554 455433 345555555555555554333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.5e-06 Score=80.03 Aligned_cols=59 Identities=36% Similarity=0.528 Sum_probs=36.3
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
.++.|-||+|+|+ .+||.|+.|.+|++|+|+||++. .+|.+++.|++|+.|+++-|.+.
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~ 92 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN 92 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh
Confidence 4555666666666 56666666666666666666665 56666666666666666655543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.8e-06 Score=79.46 Aligned_cols=61 Identities=30% Similarity=0.422 Sum_probs=57.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
.+|+.|++++|++. .+|.+++.|++|+.|+++-|+|. .+|..+|.++.|+.|||+.|+++.
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e 116 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE 116 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc
Confidence 47889999999998 89999999999999999999998 799999999999999999988764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.1e-06 Score=93.11 Aligned_cols=148 Identities=19% Similarity=0.256 Sum_probs=95.8
Q ss_pred HHHHHHHhccc-cccCCCCCCEEEcCCCcEEEEeccCccccCCC------CCCceeeecccCCCccccccccccCCCCCh
Q 004935 524 GRLRIAIEAAK-VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE------GSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596 (723)
Q Consensus 524 ~~l~i~~~~a~-vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 596 (723)
..+.+.|+.|. ||++|.|++|.+++.+.+||+.|+.+...... ...............|.|||++.....+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 45667777777 99999999999999999999999988654321 111111222345668999999999889999
Q ss_pred hhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 597 SDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 597 ~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
+|+||+|++++-+..|..+.-.................. ... .+..+.+.++.+-+.+.+..++.-||++
T Consensus 190 sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~---------~~~-~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA---------GAF-GYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc---------ccc-cccccCcHHHHHHHHHHhcCCcccCcch
Confidence 999999999999995444433222211111111111100 000 0112233456677778889999999977
Q ss_pred HHHHH
Q 004935 677 NQVVM 681 (723)
Q Consensus 677 ~evl~ 681 (723)
.++..
T Consensus 260 ~~l~~ 264 (700)
T KOG2137|consen 260 DLLLS 264 (700)
T ss_pred hhhhc
Confidence 76543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.9e-06 Score=58.40 Aligned_cols=36 Identities=36% Similarity=0.662 Sum_probs=23.1
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCc
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT 311 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~ 311 (723)
+|+.|+|++|+++ .||+.|++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4666777777776 56666667777777777776665
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.85 E-value=6.6e-05 Score=75.63 Aligned_cols=126 Identities=20% Similarity=0.340 Sum_probs=82.8
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCce--eeEEEEEecCCceEEEEEeCCCCC-H
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL--TTLVGYCDEGTNRGLIYEFMANGN-L 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gs-L 508 (723)
..||+|..+.||+. .+..+++|....... .....+|.++++.+..-.+ .+.++++...+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 355778898876432 3456889999999865444 667788777777889999999963 2
Q ss_pred HHHh---------------------ccCCCCCCC---------------------HHHHHHHHHh-c----cccccCCCC
Q 004935 509 QALL---------------------LGEEADILS---------------------WEGRLRIAIE-A----AKVHRDVKS 541 (723)
Q Consensus 509 ~~~l---------------------~~~~~~~l~---------------------~~~~l~i~~~-~----a~vH~Dlk~ 541 (723)
...+ +.-...... +...+...++ . ..+|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 110000000 1111111111 0 018999999
Q ss_pred CCEEEcCCCcEEEEeccCccc
Q 004935 542 TNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 542 ~NILl~~~~~~kl~DfGla~~ 562 (723)
.||++++++ +.|.||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.82 E-value=3.3e-06 Score=87.55 Aligned_cols=118 Identities=27% Similarity=0.323 Sum_probs=76.2
Q ss_pred EEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCccccc-CCCCCC
Q 004935 223 FSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYIS-TLTSIQ 301 (723)
Q Consensus 223 lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~-~l~~L~ 301 (723)
+....+.-.++||.++.||.+..+.+-.+-...- | +-..|+ .|..|.++.|++. .+|.+++ +|++|.
T Consensus 188 ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~l-P---ef~gcs-------~L~Elh~g~N~i~-~lpae~~~~L~~l~ 255 (565)
T KOG0472|consen 188 LDCNSNLLETLPPELGGLESLELLYLRRNKIRFL-P---EFPGCS-------LLKELHVGENQIE-MLPAEHLKHLNSLL 255 (565)
T ss_pred cccchhhhhcCChhhcchhhhHHHHhhhcccccC-C---CCCccH-------HHHHHHhcccHHH-hhHHHHhcccccce
Confidence 4445555677888888888777665533311110 1 222343 5667777777776 6777765 788888
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC--ccccccCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG--LLSLSVEGNP 354 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~--~~~l~~~~n~ 354 (723)
+|||..|+|. ++|+.++.|.+|..||||+|.+++. |.++++ +..+.+.|||
T Consensus 256 vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 256 VLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLGNLHLKFLALEGNP 308 (565)
T ss_pred eeeccccccc-cCchHHHHhhhhhhhcccCCccccC-CcccccceeeehhhcCCc
Confidence 8888888887 7788888888888888888877764 334443 3445566665
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.71 E-value=2.6e-05 Score=56.22 Aligned_cols=38 Identities=42% Similarity=0.555 Sum_probs=33.4
Q ss_pred CCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 298 TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 298 ~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|++|+|++|+++ .||..+++|++|+.|+|++|.++.
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 57999999999999 799889999999999999999874
|
... |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.69 E-value=1.8e-05 Score=82.19 Aligned_cols=46 Identities=28% Similarity=0.545 Sum_probs=28.9
Q ss_pred cCccc-ccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 289 DIAPY-ISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 289 ~ip~~-~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
.+|++ +.+|.+|..|||.+|.+. .||..+++|++|++|.|.||.|.
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 44544 666666666666666665 56666666666666666666665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=7.3e-05 Score=87.23 Aligned_cols=65 Identities=20% Similarity=0.252 Sum_probs=45.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~ 343 (723)
++|+.|+|++|+|++ ||..+ .+|+.|+|++|+|+ .||..++++++|+.|+|++|.++|.+|..+.
T Consensus 402 s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 402 SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence 356666666666663 56432 35667777777777 6788888888888888888888887776553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00025 Score=72.38 Aligned_cols=71 Identities=15% Similarity=0.137 Sum_probs=53.7
Q ss_pred CcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCCCHHHH
Q 004935 438 GFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANGNLQAL 511 (723)
Q Consensus 438 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 511 (723)
.-..||+...++..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||++++.++...
T Consensus 11 ~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 11 SGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 337899998877788899886543 345678999998884 44455778877776778999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00037 Score=65.53 Aligned_cols=125 Identities=22% Similarity=0.322 Sum_probs=82.9
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHHH
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQA 510 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 510 (723)
.+.|++|.+|.||.|.+.+..+|+|+-+..+. ...+..|+++|..+.-.++.+=+-++.. -.+.|||..+-.|.+
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~ 101 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence 56899999999999999999999999876654 3679999999999987766543322222 234499999988887
Q ss_pred HhccCCC-CCCCHHHHHHHHHhc-cccccCCC-CC-CEEEcCCCcEEEEeccCccc
Q 004935 511 LLLGEEA-DILSWEGRLRIAIEA-AKVHRDVK-ST-NILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 511 ~l~~~~~-~~l~~~~~l~i~~~~-a~vH~Dlk-~~-NILl~~~~~~kl~DfGla~~ 562 (723)
.-..... ..+..... ...++. ..-|+.|. |. ||++. +..+.|+||..|..
T Consensus 102 ~~~~~~rk~l~~vlE~-a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGGDRKHLLRVLEK-AYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred hhhcccHHHHHHHHHH-HHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 7553211 11111111 112222 22466654 33 45554 44899999998874
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.54 E-value=1.6e-05 Score=86.68 Aligned_cols=97 Identities=24% Similarity=0.239 Sum_probs=70.9
Q ss_pred cCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCccc-ccCCCCCCeeeC
Q 004935 227 TTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPY-ISTLTSIQILDL 305 (723)
Q Consensus 227 ~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~-~~~l~~L~~L~l 305 (723)
..-++.+|+.|-.|+.+.++++..+.... |-..-....++..||||+|++. +||.+ +.+|+.|-.|||
T Consensus 89 ~LKnsGiP~diF~l~dLt~lDLShNqL~E----------vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 89 NLKNSGIPTDIFRLKDLTILDLSHNQLRE----------VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred ccccCCCCchhcccccceeeecchhhhhh----------cchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcc
Confidence 34567799999999999988876553222 1100112346778888888887 78866 678888888888
Q ss_pred cCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 306 SNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 306 s~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
|+|+|. .+|+.+..|..|+.|.|++|-+.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 888887 77888888888888888887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0018 Score=70.14 Aligned_cols=157 Identities=19% Similarity=0.314 Sum_probs=106.1
Q ss_pred CcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe----cCCceEEEEEeCCC-CCHHH
Q 004935 438 GFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD----EGTNRGLIYEFMAN-GNLQA 510 (723)
Q Consensus 438 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~ 510 (723)
.-.+.||+.. +|..+++|+++....+....-..-++.++++.|.|+|++...+. .+...++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899987 78899999995543333333456688999999999999998875 34467899999985 57766
Q ss_pred HhccCC-------------C----CCCCHH--HHHHHHHhccc----cccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 511 LLLGEE-------------A----DILSWE--GRLRIAIEAAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 511 ~l~~~~-------------~----~~l~~~--~~l~i~~~~a~----vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+-.... . +..=|. -++..++...| .-+-|.+++||++.+.+++|+.+|....+..+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 543210 0 011132 23333333322 447899999999999999999999876653322
Q ss_pred CCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCC
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~ 614 (723)
. |-+ .--.+-|.=.||.+++.|-||..
T Consensus 448 ~-----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 T-----------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C-----------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 0 111 11246788999999999999964
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0004 Score=77.42 Aligned_cols=131 Identities=20% Similarity=0.229 Sum_probs=84.5
Q ss_pred hhccccCcEEEEEEEE-CCceEEEEEecCCChhh-------------------------------------HHHHHHHHH
Q 004935 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQG-------------------------------------YKQFQAEVE 473 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-------------------------------------~~~f~~Ei~ 473 (723)
+-||..+.|.||+|++ +|..||||+-++.-... .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999 56689999976542111 012555555
Q ss_pred HHHhc----cCCc------eeeEEEEEecCCceEEEEEeCCCCCHHHH--hccCCCCCCCHHHHH-----HHHHhccccc
Q 004935 474 LLMRI----HHKN------LTTLVGYCDEGTNRGLIYEFMANGNLQAL--LLGEEADILSWEGRL-----RIAIEAAKVH 536 (723)
Q Consensus 474 ~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~--l~~~~~~~l~~~~~l-----~i~~~~a~vH 536 (723)
-..++ +|-+ |.+++- .-...+.|+||||+|..+.+. +.+..-........+ ..+.....+|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffH 324 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFH 324 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCcc
Confidence 44333 4555 222222 224567899999999877655 333322222222222 2222333499
Q ss_pred cCCCCCCEEEcC----CCcEEEEeccCccccC
Q 004935 537 RDVKSTNILLSG----KFQAKIADFGLSRTFP 564 (723)
Q Consensus 537 ~Dlk~~NILl~~----~~~~kl~DfGla~~~~ 564 (723)
+|=.|-||+++. ++++.+-|||+...+.
T Consensus 325 aDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 325 ADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999993 6789999999988763
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0015 Score=63.99 Aligned_cols=128 Identities=16% Similarity=0.111 Sum_probs=87.3
Q ss_pred ccccCcEEEEEEEECCceEEEEEecCCC------hhhHHHHHHHHHHHHhccCC--ceeeEEEEEe-cC----CceEEEE
Q 004935 434 LGNGGFGTVYHGYLDGTEVAVKMLSPSS------AQGYKQFQAEVELLMRIHHK--NLTTLVGYCD-EG----TNRGLIY 500 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~-~~----~~~~lV~ 500 (723)
-|+||.+-|++-.++|..+-+|+-...- +-+...|.+|...|.++... .+.+.+ ++. .. ..-.||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 3679999999999988889999865221 33557899999999999533 344444 332 11 2356899
Q ss_pred EeCCC-CCHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCc--EEEEeccCccc
Q 004935 501 EFMAN-GNLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQ--AKIADFGLSRT 562 (723)
Q Consensus 501 Ey~~~-gsL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~--~kl~DfGla~~ 562 (723)
|-+++ -+|.+++........+- .+.+.-+|+....|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97763 58888886542222222 22333344444499999999999986666 99999987764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=8.7e-05 Score=80.67 Aligned_cols=124 Identities=21% Similarity=0.189 Sum_probs=85.7
Q ss_pred ceEEEEEEcCCCCCcchhhhh-hhhhhhhccccccccCCCceeecCccCC-------------CCC--CCCCceEEEEcC
Q 004935 219 EKIEFSINTTESSTLPPILNA-YEIYRAKEFLQFLTNQQDAYLWQGLNCS-------------YPE--YDPPRITSLNLS 282 (723)
Q Consensus 219 ~~~~lsl~~~~~s~lPp~ina-le~~~~~~~~~~~~~~~~~~~w~g~~c~-------------~~~--~~~~~l~~l~ls 282 (723)
+.+.+.|..+--++||+-.-. +..++.+++..+..---....++|+..- .++ ....++..|+|+
T Consensus 198 sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~ 277 (873)
T KOG4194|consen 198 SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLE 277 (873)
T ss_pred hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecc
Confidence 566788888888899876544 5555555543332111111112221111 000 022478899999
Q ss_pred CCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc
Q 004935 283 SSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK 342 (723)
Q Consensus 283 ~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~ 342 (723)
.|+++-.--.++-+|++|+.|+||+|.+...-++.+.-.++|+.|+|++|.++..-+.++
T Consensus 278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf 337 (873)
T KOG4194|consen 278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF 337 (873)
T ss_pred cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH
Confidence 999997777889999999999999999998889999999999999999999887666554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00067 Score=67.36 Aligned_cols=98 Identities=20% Similarity=0.188 Sum_probs=67.9
Q ss_pred HHHHHHHHHHHhccCC--ceeeEEEEEecCC----ceEEEEEeCCCC-CHHHHhccCC----CCCC----CHHHHHHHHH
Q 004935 466 KQFQAEVELLMRIHHK--NLTTLVGYCDEGT----NRGLIYEFMANG-NLQALLLGEE----ADIL----SWEGRLRIAI 530 (723)
Q Consensus 466 ~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~----~~~l----~~~~~l~i~~ 530 (723)
....+|...+.++... ...+.+++..... ..++|+|++++. +|.+++.... ...- .....+.-+|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4678888888888543 3456666665432 347999999984 7999887621 1111 1222344445
Q ss_pred hccccccCCCCCCEEEcCCC---cEEEEeccCcccc
Q 004935 531 EAAKVHRDVKSTNILLSGKF---QAKIADFGLSRTF 563 (723)
Q Consensus 531 ~~a~vH~Dlk~~NILl~~~~---~~kl~DfGla~~~ 563 (723)
+...+|+|+++.|||++.+. .+.++||+.++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 55559999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0008 Score=66.19 Aligned_cols=130 Identities=15% Similarity=0.093 Sum_probs=79.9
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHH---------HHHHHHHHhccC---CceeeEEEEEe-----cCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQF---------QAEVELLMRIHH---KNLTTLVGYCD-----EGT 494 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f---------~~Ei~~l~~l~H---~nIv~l~g~~~-----~~~ 494 (723)
+++-......|.+-..+++.+.+|..+.......+.| .+++..+.+++. ...+.++.... -..
T Consensus 37 kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred EeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 4455555666777777899999999876554333322 234444444432 22333232222 223
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 495 NRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
..+|+|||++|-.|.+...-.+...-...+.+.-+|+....|+|..|.|++++++ .+++.||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 4568999999988876542211100123345666777777999999999999965 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00011 Score=70.14 Aligned_cols=78 Identities=35% Similarity=0.484 Sum_probs=32.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccC-CCCCCCcEEEccCCCCCCchh---h-cccCcccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFL-SQLPFLTELNLKGTIPNGLIE---K-QKNGLLSL 348 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l-~~l~~L~~l~l~~n~~~g~~p---~-~~~~~~~l 348 (723)
.+|+.|+||+|+++ .|+ .+..|++|+.|+|++|+++ .|+..+ ..+++|+.|+|++|.+...-- . .+..+..+
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 47889999999998 454 5778899999999999998 465444 468999999999998865321 1 12244456
Q ss_pred ccCCCC
Q 004935 349 SVEGNP 354 (723)
Q Consensus 349 ~~~~n~ 354 (723)
+..|||
T Consensus 119 ~L~~NP 124 (175)
T PF14580_consen 119 SLEGNP 124 (175)
T ss_dssp E-TT-G
T ss_pred eccCCc
Confidence 666775
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00076 Score=69.41 Aligned_cols=124 Identities=19% Similarity=0.166 Sum_probs=76.6
Q ss_pred ccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCcee-eEEEEEecCCceEEEEEeCCCCCHHHH-
Q 004935 434 LGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT-TLVGYCDEGTNRGLIYEFMANGNLQAL- 511 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~~~- 511 (723)
+..|-...+|+...++..+++|+.......-.-+..+|.++++.+....++ ++++.+. .++|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 456777889998877888999986544322112457899999988654443 3444432 3689999998765421
Q ss_pred ----------------hccCC--CCCCCHHHH--------------------HHHHHhc--------cccccCCCCCCEE
Q 004935 512 ----------------LLGEE--ADILSWEGR--------------------LRIAIEA--------AKVHRDVKSTNIL 545 (723)
Q Consensus 512 ----------------l~~~~--~~~l~~~~~--------------------l~i~~~~--------a~vH~Dlk~~NIL 545 (723)
++... ...+....+ +...... +-+|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 11111 111111111 1111111 1299999999999
Q ss_pred EcCCCcEEEEeccCccc
Q 004935 546 LSGKFQAKIADFGLSRT 562 (723)
Q Consensus 546 l~~~~~~kl~DfGla~~ 562 (723)
+++++ +.|.||..+..
T Consensus 160 ~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 160 VTPQG-LKLIDWEYASD 175 (256)
T ss_pred EeCCC-CEEEeccccCc
Confidence 99876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0006 Score=79.78 Aligned_cols=53 Identities=25% Similarity=0.293 Sum_probs=23.1
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+|+.|+|++|+|++ ||+.. ++|+.|++++|+|++ ||... .+|+.|+|++|.++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt 395 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLT 395 (788)
T ss_pred ccceEecCCCccCC-CCCCC---cccceehhhcccccc-Ccccc---cccceEEecCCccc
Confidence 45556666665553 44322 223334444444442 33321 23444444444444
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0014 Score=65.86 Aligned_cols=77 Identities=17% Similarity=0.287 Sum_probs=57.9
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCC--ceeeEEEEEec---CCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK--NLTTLVGYCDE---GTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~---~~~~~lV~Ey~~~g 506 (723)
+.|+.|..+.||+...+++.+++|..... .....+..|..+++.+... .+..++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 45888999999999998899999997655 4456788999999888543 34566665533 33468999999998
Q ss_pred CHHH
Q 004935 507 NLQA 510 (723)
Q Consensus 507 sL~~ 510 (723)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 8877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0021 Score=62.56 Aligned_cols=122 Identities=26% Similarity=0.352 Sum_probs=85.6
Q ss_pred HhhhhccccCc-EEEEEEEECCceEEEEEecC---CCh------------------hhHHHHHHHHHHHHhcc---CCce
Q 004935 429 NFERVLGNGGF-GTVYHGYLDGTEVAVKMLSP---SSA------------------QGYKQFQAEVELLMRIH---HKNL 483 (723)
Q Consensus 429 ~f~~~lG~G~~-g~Vy~~~~~~~~vavK~~~~---~~~------------------~~~~~f~~Ei~~l~~l~---H~nI 483 (723)
.|.+.||.|.- |.||++..+|..+|+|++.. ... .-...|..|++..++++ +.++
T Consensus 40 ~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~ 119 (207)
T PF13095_consen 40 EFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGL 119 (207)
T ss_pred eeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCc
Confidence 45678999999 99999999999999999321 100 11235889999988884 4566
Q ss_pred --eeEEEEEecC------------------CceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 004935 484 --TTLVGYCDEG------------------TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTN 543 (723)
Q Consensus 484 --v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~vH~Dlk~~N 543 (723)
|+.+||..-. ....+|.||++... .......-...+.+.+++....+-+|+++.|
T Consensus 120 ~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~n 194 (207)
T PF13095_consen 120 WAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----PLQIRDIPQMLRDLKILHKLGIVPRDVKPRN 194 (207)
T ss_pred eEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----ccchhHHHHHHHHHHHHHHCCeeeccCcccc
Confidence 8999997222 12368899887654 0011122234455667777777999999999
Q ss_pred EEEcCCCcEEEEeccCc
Q 004935 544 ILLSGKFQAKIADFGLS 560 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla 560 (723)
.. .-||+|||.+
T Consensus 195 y~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 195 YR-----GGKLVDFSSS 206 (207)
T ss_pred cc-----CCEEEecccC
Confidence 86 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0043 Score=60.79 Aligned_cols=123 Identities=18% Similarity=0.351 Sum_probs=85.3
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCC----------------hhhHHHHHHHHHHHHhcc------CCceeeEEEE
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSS----------------AQGYKQFQAEVELLMRIH------HKNLTTLVGY 489 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~ 489 (723)
..||+|+.-.||.-- ++....||+..... ....+++.+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 579999999888532 34467788887655 223567778887766665 8899999999
Q ss_pred EecCCceEEEEEeCCC------CCHHHHhccCCCCCCCHHHH----HHHHHhccccccCCCCCCEEEcCCC----cEEEE
Q 004935 490 CDEGTNRGLIYEFMAN------GNLQALLLGEEADILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKF----QAKIA 555 (723)
Q Consensus 490 ~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~----~~kl~ 555 (723)
..+.....+|+|.+.+ -+|.+++....-.. ...+. .+.+++...+.+|++|.||++.... .+.|+
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlI 164 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLI 164 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEE
Confidence 9999999999998753 25778875442221 22222 2334455558999999999996432 46666
Q ss_pred e
Q 004935 556 D 556 (723)
Q Consensus 556 D 556 (723)
|
T Consensus 165 D 165 (199)
T PF10707_consen 165 D 165 (199)
T ss_pred e
Confidence 5
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.08 E-value=7.3e-05 Score=85.47 Aligned_cols=79 Identities=27% Similarity=0.380 Sum_probs=50.6
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC-chhhcc--cCccccccC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG-LIEKQK--NGLLSLSVE 351 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g-~~p~~~--~~~~~l~~~ 351 (723)
.|+.|+||+|.|+ .||.++.++..|++|...+|+|. ..| .+.++++|+.+|||.|.++- .+|... -++..|.++
T Consensus 408 ~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlS 484 (1081)
T KOG0618|consen 408 ELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLS 484 (1081)
T ss_pred HhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeecc
Confidence 4455555555555 55555555555555555555555 466 67788999999999888874 334332 356778888
Q ss_pred CCCCC
Q 004935 352 GNPDL 356 (723)
Q Consensus 352 ~n~~l 356 (723)
||+.+
T Consensus 485 GN~~l 489 (1081)
T KOG0618|consen 485 GNTRL 489 (1081)
T ss_pred CCccc
Confidence 88743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00028 Score=54.97 Aligned_cols=56 Identities=34% Similarity=0.421 Sum_probs=44.0
Q ss_pred CCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCcc---ccccCCC
Q 004935 298 TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLL---SLSVEGN 353 (723)
Q Consensus 298 ~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~---~l~~~~n 353 (723)
++|+.|+|++|+|+.--+..+..+++|+.|+|++|.++...|..+.++. .+.+.+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 5799999999999965557889999999999999999877666655443 3444554
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00018 Score=72.21 Aligned_cols=76 Identities=26% Similarity=0.363 Sum_probs=57.0
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh--hcccCccccccCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE--KQKNGLLSLSVEG 352 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p--~~~~~~~~l~~~~ 352 (723)
.|+.||||+|.++ .|..++.-++.++.|+||+|.+. .+- .+..|++|+.||||+|.++...- ..+++...+.+.+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhh
Confidence 5788899999988 78888999999999999999987 333 37888999999999998875322 2244455555444
Q ss_pred C
Q 004935 353 N 353 (723)
Q Consensus 353 n 353 (723)
|
T Consensus 362 N 362 (490)
T KOG1259|consen 362 N 362 (490)
T ss_pred h
Confidence 4
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0032 Score=63.81 Aligned_cols=71 Identities=18% Similarity=0.243 Sum_probs=47.6
Q ss_pred hccccCcEEEEEEEEC---CceEEEEEecCCChhhHHHHHHHHHHHHhccCCcee-eEEEEEecCCceEEEEEeCCCCCH
Q 004935 433 VLGNGGFGTVYHGYLD---GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT-TLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.|..|-...+|+.... ++.+++|+....... ..+..+|+.+++.+...+++ ++++.+. ..++|||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 4667778899998875 468999987654321 12335789899888544444 4444332 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.011 Score=64.16 Aligned_cols=74 Identities=18% Similarity=0.149 Sum_probs=53.0
Q ss_pred hhccccCcEEEEEEEECCc--eEEEEEecCCC-------hhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEEE
Q 004935 432 RVLGNGGFGTVYHGYLDGT--EVAVKMLSPSS-------AQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~-------~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 499 (723)
+.||.|.+..||+....++ .|+||.-.+.. .-...++..|.+.|..+. ...+.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 4689999999999999654 89999854221 123456788888888763 24566677663 3557899
Q ss_pred EEeCCCCC
Q 004935 500 YEFMANGN 507 (723)
Q Consensus 500 ~Ey~~~gs 507 (723)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0073 Score=60.26 Aligned_cols=126 Identities=24% Similarity=0.271 Sum_probs=77.0
Q ss_pred hccccCcEEEEEEEE-CCceEEEEEecCCChhh-------------------HHH-----HHHHHHHHHhcc--CCceee
Q 004935 433 VLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQG-------------------YKQ-----FQAEVELLMRIH--HKNLTT 485 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-------------------~~~-----f~~Ei~~l~~l~--H~nIv~ 485 (723)
.|..|.-+.||+|.- ++..+|||++....... .++ ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577888899999987 57799999987543211 111 246777777763 333444
Q ss_pred EEEEEecCCceEEEEEeCCCCC-HHHHhccCCCCCCCHH-------HHHHHHHhccc-cccCCCCCCEEEcCCCcEEEEe
Q 004935 486 LVGYCDEGTNRGLIYEFMANGN-LQALLLGEEADILSWE-------GRLRIAIEAAK-VHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 486 l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~l~~~-------~~l~i~~~~a~-vH~Dlk~~NILl~~~~~~kl~D 556 (723)
-+++. +-.|||||+.... -.-.|..-....-.+. +.+..+...|. ||+||+.=|||+. ++.+.|+|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID 209 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIID 209 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEE
Confidence 44432 3468999997541 1111111110000122 22333334333 9999999999999 88999999
Q ss_pred ccCcccc
Q 004935 557 FGLSRTF 563 (723)
Q Consensus 557 fGla~~~ 563 (723)
+|-|...
T Consensus 210 ~~QaV~~ 216 (268)
T COG1718 210 VSQAVTI 216 (268)
T ss_pred Ccccccc
Confidence 9988764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0015 Score=76.73 Aligned_cols=56 Identities=20% Similarity=0.343 Sum_probs=25.4
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
.|+.|+|++|+|+ .||..+. ++|+.|+|++|+|++ +|..+. ++|+.|+|++|.+++
T Consensus 263 ~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 263 ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred CCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc
Confidence 3445555555554 3444332 245555555555542 343322 244455555555443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=9.5e-05 Score=82.27 Aligned_cols=82 Identities=33% Similarity=0.434 Sum_probs=61.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCcc----------------------CCCCCCCcEEEccC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF----------------------LSQLPFLTELNLKG 331 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~----------------------l~~l~~L~~l~l~~ 331 (723)
+.++.||||+|+++..= .+..|++|++|||++|.|+ .+|.. +.+|.+|+.|||+.
T Consensus 187 ~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL~gie~LksL~~LDlsy 263 (1096)
T KOG1859|consen 187 PALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTLRGIENLKSLYGLDLSY 263 (1096)
T ss_pred HHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhhhhHHhhhhhhccchhH
Confidence 67899999999998533 8899999999999999988 55542 34567777888888
Q ss_pred CCCCCchhhc----ccCccccccCCCCCCCC
Q 004935 332 TIPNGLIEKQ----KNGLLSLSVEGNPDLCP 358 (723)
Q Consensus 332 n~~~g~~p~~----~~~~~~l~~~~n~~lc~ 358 (723)
|.+.+.-... +..+..|.+.|||--|-
T Consensus 264 Nll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 264 NLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 8877643222 22455678899997774
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.00038 Score=72.59 Aligned_cols=86 Identities=23% Similarity=0.211 Sum_probs=72.0
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Cccccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLS 349 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~ 349 (723)
.++|+.|+|++|.+++.=+.+|..+.+|+.|.|..|+|.-.--..+-.|..|+.|+|.+|+++-.-|-.+. .+..+.
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 37899999999999999899999999999999999999744444577899999999999999987776654 344566
Q ss_pred cCCCCCCCC
Q 004935 350 VEGNPDLCP 358 (723)
Q Consensus 350 ~~~n~~lc~ 358 (723)
+-+||..|.
T Consensus 353 l~~Np~~Cn 361 (498)
T KOG4237|consen 353 LLSNPFNCN 361 (498)
T ss_pred hccCcccCc
Confidence 778988884
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0025 Score=79.66 Aligned_cols=98 Identities=17% Similarity=0.228 Sum_probs=44.9
Q ss_pred EEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCe
Q 004935 223 FSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQI 302 (723)
Q Consensus 223 lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~ 302 (723)
+.+.......+|..+. .+.+..+.+..+. ...-|.|+.+ .++|+.|+|+++...+.|| .++.+++|+.
T Consensus 594 L~~~~~~l~~lP~~f~-~~~L~~L~L~~s~----l~~L~~~~~~------l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~ 661 (1153)
T PLN03210 594 LRWDKYPLRCMPSNFR-PENLVKLQMQGSK----LEKLWDGVHS------LTGLRNIDLRGSKNLKEIP-DLSMATNLET 661 (1153)
T ss_pred EEecCCCCCCCCCcCC-ccCCcEEECcCcc----cccccccccc------CCCCCEEECCCCCCcCcCC-ccccCCcccE
Confidence 4444444455665542 3444444433221 1123554432 1345555555444334444 2445555555
Q ss_pred eeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 303 LDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 303 L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|+|++|...+.+|..+++|++|+.|+|+++
T Consensus 662 L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 662 LKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred EEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 555554444455555555555555555543
|
syringae 6; Provisional |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.001 Score=63.67 Aligned_cols=77 Identities=32% Similarity=0.450 Sum_probs=24.9
Q ss_pred CceEEEEcCCCcccccCccccc-CCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh---hcccCccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYIS-TLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE---KQKNGLLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p---~~~~~~~~l~ 349 (723)
.+++.|+|++|+++ .| +.++ .|++|+.||||+|+++ .|+ .+..|+.|+.|+|++|.++..-+ ..+-++..+.
T Consensus 19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 46899999999998 45 4676 6899999999999999 454 47889999999999999986532 2344566677
Q ss_pred cCCCC
Q 004935 350 VEGNP 354 (723)
Q Consensus 350 ~~~n~ 354 (723)
..+|.
T Consensus 95 L~~N~ 99 (175)
T PF14580_consen 95 LSNNK 99 (175)
T ss_dssp -TTS-
T ss_pred CcCCc
Confidence 76663
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0018 Score=80.94 Aligned_cols=80 Identities=20% Similarity=0.245 Sum_probs=62.1
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccccccCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEG 352 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~ 352 (723)
+++|+.|+|++|...+.||.++++|++|+.|+|++|+.-+.+|..+ ++++|+.|+|+++..-..+|....++..|.+.+
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~ 855 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSR 855 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCC
Confidence 4689999999999999999999999999999999987777899876 788888888888655444554333444444433
Q ss_pred C
Q 004935 353 N 353 (723)
Q Consensus 353 n 353 (723)
|
T Consensus 856 n 856 (1153)
T PLN03210 856 T 856 (1153)
T ss_pred C
Confidence 3
|
syringae 6; Provisional |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.004 Score=65.48 Aligned_cols=128 Identities=17% Similarity=0.208 Sum_probs=81.0
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCc--eeeEEEE------EecCCceEEEEEeC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN--LTTLVGY------CDEGTNRGLIYEFM 503 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~Ey~ 503 (723)
+.|..|....+|+...+++.+++|+.... ...+...|++++..+++.. +.+.+.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 35667777899998887788999988652 2356777888888885443 3444432 12234568999999
Q ss_pred CCCCHHH----H----------hccC----C-----CCCCCHHHHHHH--------------------HHh-------cc
Q 004935 504 ANGNLQA----L----------LLGE----E-----ADILSWEGRLRI--------------------AIE-------AA 533 (723)
Q Consensus 504 ~~gsL~~----~----------l~~~----~-----~~~l~~~~~l~i--------------------~~~-------~a 533 (723)
+|..+.. . ++.. . .....|...... +.+ ..
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876532 0 1100 0 012233322111 011 11
Q ss_pred ccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 534 KVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 534 ~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
.+|+|+.|.||+++++..+.|.||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 29999999999999987778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0019 Score=75.87 Aligned_cols=74 Identities=22% Similarity=0.460 Sum_probs=51.7
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc-CccccccC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN-GLLSLSVE 351 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~-~~~~l~~~ 351 (723)
+++|+.|++++|+|++ ||..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|.++. +|..+. .+..+.+.
T Consensus 324 ~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~~sL~~LdLs 396 (754)
T PRK15370 324 PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLPAALQIMQAS 396 (754)
T ss_pred cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHHHHHHHHhhc
Confidence 3578888888888885 777664 68888888888887 5776653 578888888888875 343332 33344444
Q ss_pred CC
Q 004935 352 GN 353 (723)
Q Consensus 352 ~n 353 (723)
+|
T Consensus 397 ~N 398 (754)
T PRK15370 397 RN 398 (754)
T ss_pred cC
Confidence 44
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.00083 Score=73.33 Aligned_cols=127 Identities=19% Similarity=0.259 Sum_probs=80.9
Q ss_pred EEEEEcCCCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCccc---ccCC
Q 004935 222 EFSINTTESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPY---ISTL 297 (723)
Q Consensus 222 ~lsl~~~~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~---~~~l 297 (723)
.+.|..+.-..+ +..+..+..++.+.+..+..+.-.-..+.|+ .+|..|||++|.|++.|-+. |..|
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~l---------ssL~~LdLr~N~ls~~IEDaa~~f~gl 391 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGL---------SSLHKLDLRSNELSWCIEDAAVAFNGL 391 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHh---------hhhhhhcCcCCeEEEEEecchhhhccc
Confidence 355555333333 3344445555555554443332222233333 47889999999999988653 7789
Q ss_pred CCCCeeeCcCCcCcCCCCc-cCCCCCCCcEEEccCCCCCCchhhccc--CccccccCCCCCCCC
Q 004935 298 TSIQILDLSNNNLTGPVPD-FLSQLPFLTELNLKGTIPNGLIEKQKN--GLLSLSVEGNPDLCP 358 (723)
Q Consensus 298 ~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~~p~~~~--~~~~l~~~~n~~lc~ 358 (723)
++|+.|+|.+|+|. .||. .+..|++|+.|||.+|-+...-|..+. .+..|-+.....+|.
T Consensus 392 ~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 392 PSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred hhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 99999999999998 6664 788899999999999887776665543 333444444444553
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.01 Score=62.52 Aligned_cols=75 Identities=13% Similarity=0.065 Sum_probs=57.8
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccC---CceeeEEEEEec---CCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH---KNLTTLVGYCDE---GTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~---~~~~~lV~Ey~~~ 505 (723)
+.||.|..+.||+....+..+.+|..+... ....|..|.+.|+.+.. -.+.+++++|.. .+..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 479999999999998766677788854321 22578999999999853 367888888854 3668999999998
Q ss_pred CCH
Q 004935 506 GNL 508 (723)
Q Consensus 506 gsL 508 (723)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.013 Score=59.52 Aligned_cols=72 Identities=17% Similarity=0.282 Sum_probs=45.9
Q ss_pred hccccCcE-EEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCC---ceeeEEEEEecC---CceEEEEEeCCC
Q 004935 433 VLGNGGFG-TVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK---NLTTLVGYCDEG---TNRGLIYEFMAN 505 (723)
Q Consensus 433 ~lG~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~~~ 505 (723)
.|+.|+.. .||+. +..+++|..+... ...++.+|.++|..+... .+...++.+... ...+++|+++++
T Consensus 4 ~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 4 PVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 46666666 58875 3467778755422 235789999999888532 334444444332 234789999998
Q ss_pred CCHH
Q 004935 506 GNLQ 509 (723)
Q Consensus 506 gsL~ 509 (723)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.00096 Score=73.97 Aligned_cols=170 Identities=19% Similarity=0.174 Sum_probs=111.6
Q ss_pred hccccCcEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCCc-eeeEEEEEecCCceEEEEEeCCCC-CHH
Q 004935 433 VLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN-LTTLVGYCDEGTNRGLIYEFMANG-NLQ 509 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~g-sL~ 509 (723)
-.++|+++++||.+...+ ...++.+... ....-++++|.+++||| .+..++-+.......++++++..| +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 357899999999887544 2334443322 34567899999999999 666666677777888999999877 221
Q ss_pred HHhccCCC--CCCCHHHH-------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 510 ALLLGEEA--DILSWEGR-------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 510 ~~l~~~~~--~~l~~~~~-------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
......+. .......- +...+..-.+|+| ||+..+ ...|..||+....+.... ......+++
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~ 394 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTP 394 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCC
Confidence 11110000 00000000 1111111237777 777766 578999999987764332 234567899
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
.|+|||....+.+..+.|+|+.|+--.++--|-+|-
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 999999999999999999999998766666666554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 723 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-51 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 433 bits (1117), Expect = e-148
Identities = 118/300 (39%), Positives = 176/300 (58%), Gaps = 18/300 (6%)
Query: 408 NGSFELKNQRFSYSNVLRITNNF--ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQG 464
+ ++ R ++ TNNF + ++G+G FG VY G L DG +VA+K +P S+QG
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78
Query: 465 YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSW 522
++F+ E+E L H +L +L+G+CDE LIY++M NGNL+ L G + +SW
Sbjct: 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 523 EGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572
E RL I I AA+ +HRDVKS NILL F KI DFG+S+ TH+
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ-THL 197
Query: 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIE--RTHERIHITQWVS 630
+T + GT GY+DPEY+I RLTEKSDVY+FGVVL E++ ++S I E +++ +W
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 631 FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690
G +E IVDP L + S+ K + A+ C++ +S RP+M V+ +L +L ++
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-118
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 27/298 (9%)
Query: 412 ELKNQRFSYSNVLRITNNFER--------VLGNGGFGTVYHGYLDGTEVAVKMLS----P 459
+ + FS+ + +TNNF+ +G GGFG VY GY++ T VAVK L+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 460 SSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-EEAD 518
++ + +QF E++++ + H+NL L+G+ +G + L+Y +M NG+L L +
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 519 ILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568
LSW R +IA AA +HRD+KS NILL F AKI+DFGL+R + +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFA 187
Query: 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
T +T+ I GT Y+ PE + +T KSD+Y+FGVVLLEIIT ++ E +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 629 VSFMLG-KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
+ + IE +D ++ D D SV +A C+ + KRP + +V L E
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-114
Identities = 105/288 (36%), Positives = 164/288 (56%), Gaps = 25/288 (8%)
Query: 416 QRFSYSNVLRITNNF--ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYK-QFQAE 471
+RFS + ++NF + +LG GGFG VY G L DGT VAVK L QG + QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 472 VELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLRIA 529
VE++ H+NL L G+C T R L+Y +MANG++ + L L W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 530 IEAAK-------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576
+ +A+ +HRDVK+ NILL +F+A + DFGL++ + THVTT +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVTTAV 195
Query: 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH----ERIHITQWVSFM 632
GT G++ PEY + + +EK+DV+ +GV+LLE+IT + + + + + WV +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680
L + +E++VD L ++ V + +++A+ C + +RP M++VV
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 5e-72
Identities = 69/307 (22%), Positives = 112/307 (36%), Gaps = 44/307 (14%)
Query: 418 FSYSNVLRITNNFE--RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELL 475
N+ + + V G FG V+ L VAVK+ Q + Q + EV L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSL 72
Query: 476 MRIHHKNLTTLVGYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIE 531
+ H+N+ +G GT+ LI F G+L L ++SW IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAET 129
Query: 532 AAK--------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571
A+ HRD+KS N+LL A IADFGL+ F G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE-AGKSAG 188
Query: 572 VTTTIAGTPGYLDPEY-----YISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE--RIH 624
T GT Y+ PE + D+Y G+VL E+ + + + + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 625 ITQWVSFMLGKGDIESIV-----DPRLHEDFDINSVWKTV-EIAMACVSQTSTKRPTMNQ 678
+ + D++ +V P L + + ++ + E C + R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 679 VVMELNE 685
V + +
Sbjct: 309 VGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-57
Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLV 487
+ +G G FGTV+ G++VAVK+L A+ +F EV ++ R+ H N+ +
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEAAK------------ 534
G + N ++ E+++ G+L LL A + L RL +A + AK
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHR++KS N+L+ K+ K+ DFGLSR ++ S + + AGTP ++ PE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
EKSDVY+FGV+L E+ T ++ ++ Q V +G RL ++N
Sbjct: 218 EKSDVYSFGVILWELATL----QQPWGNLNPAQ-VVAAVGFKCK------RLEIPRNLNP 266
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
I C + KRP+ ++ L
Sbjct: 267 QVA--AIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 67/328 (20%), Positives = 115/328 (35%), Gaps = 54/328 (16%)
Query: 418 FSYSNVLRITNNFE--RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELL 475
+ S +N + ++G G +G VY G LD VAVK+ S ++ Q + + + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYRV 61
Query: 476 MRIHHKNLTTLVGYCDEGTNRG-----LIYEFMANGNLQALLLGEEADILSWEGRLRIAI 530
+ H N+ + + T G L+ E+ NG+L L W R+A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAH 118
Query: 531 EAAK-------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFP-----VE 566
+ HRD+ S N+L+ I+DFGLS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 567 GSGTHVTTTIAGTPGYLDPEY-------YISNRLTEKSDVYNFGVVLLEIITSKSVIERT 619
G + + GT Y+ PE ++ D+Y G++ EI + +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 620 HE----RIHITQWVSFMLGKGDIESIVD-----PRLHEDFDINSV--WKTVEIAMACVSQ 668
++ V D++ +V P+ E + NS+ E C Q
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 669 TSTKRPTMNQVVMELNESLAIETARLKA 696
+ R T + L + R K+
Sbjct: 299 DAEARLTAQXAEERM-AELMMIWERNKS 325
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 52/284 (18%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS----SAQGYKQFQAEVELLMRIHHKNLTT 485
E ++G GGFG VY + G EVAVK +Q + + E +L + H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------- 534
L G C + N L+ EF G L +L G+ + + + A++ A+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 535 --VHRDVKSTNILLSGKFQ--------AKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
+HRD+KS+NIL+ K + KI DFGL+R T + AG ++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT--KMSAAGAYAWMA 182
Query: 585 PEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG---DIESI 641
PE ++ ++ SDV+++GV+L E++T + I + I S
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAVAYGVAMNKLALPIPST 238
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ C + RP+ ++ +L
Sbjct: 239 CPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-53
Identities = 48/279 (17%), Positives = 103/279 (36%), Gaps = 46/279 (16%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTL 486
NF L G ++ G G ++ VK+L S + + F E L H N+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 487 VGYCDE--GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
+G C + LI +M G+L +L ++ ++ A++ A+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE---YYI 589
+ S ++++ A+I+ + +F + P ++ PE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF--------QSPGRMYAPAWVAPEALQKKP 184
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG---DIESIVDPRL 646
+ +D+++F V+L E++T E + + + +G I + P +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTR----EVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ C+++ KRP + +V L +
Sbjct: 241 ------------SKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
E V+G G FG V +VA+K + S + K F E+ L R++H N+ L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGRLRIAIEAAK-------------V 535
C L+ E+ G+L +L G E + + ++ ++ +
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 536 HRDVKSTNILLSGKFQ-AKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
HRD+K N+LL KI DFG + T G+ ++ PE + + +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI------QTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQW-VSFMLGKGDIESIVDPRLHEDFDIN 653
EK DV+++G++L E+IT + + I + + + + G R ++
Sbjct: 182 EKCDVFSWGIILWEVITR----RKPFDEIGGPAFRIMWAVHNGT-------RPPLIKNLP 230
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
+ + C S+ ++RP+M ++V +
Sbjct: 231 KPIE--SLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 53/303 (17%)
Query: 415 NQRFSYSNVLRITNN---FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG----- 464
F S + + +N +E+ +G GGFG V+ G L D + VA+K L ++G
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 465 --YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSW 522
+++FQ EV ++ ++H N+ L G ++ EF+ G+L LL + + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKW 121
Query: 523 EGRLRIAIEAAK------------VHRDVKSTNILLS-----GKFQAKIADFGLSRTFPV 565
+LR+ ++ A VHRD++S NI L AK+ADFGLS+
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-- 179
Query: 566 EGSGTHVTTTIAGTPGYLDPE--YYISNRLTEKSDVYNFGVVLLEIITSKSV-IERTHER 622
H + + G ++ PE TEK+D Y+F ++L I+T + E ++ +
Sbjct: 180 ----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 623 IHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682
I + + I PRL + C S KRP + +V E
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKE 283
Query: 683 LNE 685
L+E
Sbjct: 284 LSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 6e-52
Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLV 487
+ +G+G FGTVY G G +VAVKML+ + + Q + F+ EV +L + H N+ +
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
GY ++ ++ +L L E + + IA + A+ +HR
Sbjct: 87 GYSTAP-QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE---YYISNRLT 594
D+KS NI L KI DFGL+ SG+H ++G+ ++ PE SN +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
+SDVY FG+VL E++T + + I+ + M+G+G + + +
Sbjct: 204 FQSDVYAFGIVLYELMTG----QLPYSNINNRDQIIEMVGRGSLSPDLSKVRS---NCPK 256
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
K + C+ + +RP+ +++ E+ E
Sbjct: 257 RMK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 56/279 (20%), Positives = 104/279 (37%), Gaps = 39/279 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLV 487
++G G FG VYHG G EVA++++ + K F+ EV + H+N+ +
Sbjct: 37 IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G C + +I L +++ + +L +IA E K +H+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154
Query: 538 DVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-- 593
D+KS N+ + I DFGL G G +L PE
Sbjct: 155 DLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 594 -------TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646
++ SDV+ G + E+ E + + + +G G ++ +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAR----EWPFKTQPAEA-IIWQMGTGMKPNLSQIGM 268
Query: 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ +I + C + +RPT +++ L +
Sbjct: 269 GKEI--------SDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 67/303 (22%), Positives = 108/303 (35%), Gaps = 43/303 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDGT--EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
VLG G FG T + +K L + + F EV+++ + H N+ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G + I E++ G L+ ++ ++ W R+ A + A +HR
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH-----------VTTTIAGTPGYLDPE 586
D+ S N L+ +ADFGL+R E + T+ G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG---DIESIVD 643
EK DV++FG+VL EII + R T +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR---TMDFGLNVRGFLDRYCPPNCP 249
Query: 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEYES 703
P I + C KRP+ ++ L E+L + A G + E
Sbjct: 250 PSFF------------PITVRCCDLDPEKRPSFVKLEHWL-ETLRMHLAGHLPLGPQLEQ 296
Query: 704 KDS 706
D
Sbjct: 297 LDR 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 44/294 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVE--LLMRIHHKNLTTLV 487
+ +G G +G V+ G G +VAVK+ + E E + + H+N+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 488 GYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
+GT LI ++ NG+L L L + L++A +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTF-PVEGSGTHVTTTIAGTPGYLD 584
HRD+KS NIL+ IAD GL+ F T GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 585 PE------YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-RIHITQWVSFMLGKGD 637
PE + +D+Y+FG++L E+ E ++ V D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 638 IESIVD-----PRLHEDFDINSVWKTV-EIAMACVSQTSTKRPTMNQVVMELNE 685
+ IV P + + + + ++ C + R T +V L +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 44/294 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVEL--LMRIHHKNLTTLV 487
+G G +G V+ G G VAVK+ S + K + E EL + + H+N+ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 488 GYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
+ LI + G+L L L LRI + A
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT-TTIAGTPGYLD 584
HRD+KS NIL+ Q IAD GL+ + V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 585 PE------YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-RIHITQWVSFMLGKGD 637
PE ++ D++ FG+VL E+ + + V D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 638 IESIVD-----PRLHEDFDINSVWKTV-EIAMACVSQTSTKRPTMNQVVMELNE 685
+ +V P + + + ++ ++ C Q + R T ++ L +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 58/297 (19%), Positives = 107/297 (36%), Gaps = 50/297 (16%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVE--LLMRIHHKNLTTLV 487
+ +G G FG V+ G G EVAVK+ S + + + E E + + H+N+ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 488 GYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
++ L+ ++ +G+L L ++ EG +++A+ A
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEI 159
Query: 535 ---------VHRDVKSTNILLSGKFQAKIADFGLSRTF-PVEGSGTHVTTTIAGTPGYLD 584
HRD+KS NIL+ IAD GL+ + GT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 585 PE------YYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-RIHITQWVSFMLGKGD 637
PE +++D+Y G+V EI S+ + ++ V +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 638 IESIV---------DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
+ +V R + + K + C R T ++ L++
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-36
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+ +G G FG V G G +VAVK + + + F AE ++ ++ H NL L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 490 CDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
E +G +Y E+MA G+L L +L + L+ +++ + VH
Sbjct: 255 IVE--EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+ + N+L+S AK++DFGL++ + + T PE + + K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTA----PEALREKKFSTK 366
Query: 597 SDVYNFGVVLLEIIT 611
SDV++FG++L EI +
Sbjct: 367 SDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 37/202 (18%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+ +G G FG V G G +VAVK + + + F AE ++ ++ H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 490 CDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
E +G +Y E+MA G+L L +L + L+ +++ + VH
Sbjct: 83 IVE--EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG-------TPGYLDPEYYI 589
RD+ + N+L+S AK++DFGL++ ++T T PE
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTA----PEALR 187
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ + KSDV++FG++L EI +
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
F + LG G FG+V D VAVK L S+ + + F+ E+E+L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 484 TTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
G C R LI E++ G+L+ L + + L+ + K
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 132
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEY 587
+HRD+ + NIL+ + + KI DFGL++ P + V I PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA----PES 188
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
++ + SDV++FGVVL E+ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
F + LG G FG+V D VAVK L S+ + + F+ E+E+L + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 484 TTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
G C R LI E++ G+L+ L + + L+ + K
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 163
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEY 587
+HRD+ + NIL+ + + KI DFGL++ P + V I PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA----PES 219
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
++ + SDV++FGVVL E+ T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 430 FERVLGNGGFGTVYHGYLD------GTEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
R LG G FG V D G +VAVK L P S + E+E+L ++H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 483 LTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ G C E G LI EF+ +G+L+ L + ++ + +L+ A++ K
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLG 143
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPE 586
VHRD+ + N+L+ + Q KI DFGL++ + V + PE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA----PE 199
Query: 587 YYISNRLTEKSDVYNFGVVLLEIIT 611
+ ++ SDV++FGV L E++T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-33
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 27/201 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKNLTTL 486
+G G FG V+ G L T VAVK +F E +L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
+G C + ++ E + G+ L E A L + L++ +AA +H
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEYYIS 590
RD+ + N L++ K KI+DFG+SR E G + + T PE
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTA----PEALNY 289
Query: 591 NRLTEKSDVYNFGVVLLEIIT 611
R + +SDV++FG++L E +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP--SSAQGYKQFQAEVELLMRIHHKN 482
R+LG G FG+V L +VAVKML ++ ++F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 483 LTTLVGYCDEGTNRG------LIYEFMANGNLQALL----LGEEADILSWEGRLRIAIEA 532
+ LVG +G +I FM +G+L A L +GE L + +R ++
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-G 581
A +HRD+ + N +L+ +ADFGLSR + + + P
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASKLPVK 204
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+L E N T SDV+ FGV + EI+T
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL 483
+ LG G FG+V D VAVK L S + FQ E+++L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 484 TTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
G + L+ E++ +G L+ L A L L + + K
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGS 145
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEY 587
VHRD+ + NIL+ + KIADFGL++ P++ V I PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PES 201
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
N + +SDV++FGVVL E+ T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
+R LG G FG V+ VAVK L + K FQ E ELL + H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--------------LRI 528
+ G C +G +++E+M +G+L L D + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT--- 575
A + A VHRD+ + N L+ KI DFG+SR V + +
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTM 196
Query: 576 --IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
I P PE + + T +SDV++FGV+L EI T
Sbjct: 197 LPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 61/195 (31%), Positives = 88/195 (45%), Gaps = 17/195 (8%)
Query: 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
+ LG G +G VY G VAVK L + + ++F E ++ I H NL L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G C +I EFM GNL L +S L +A + + +HR
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEK 596
++ + N L+ K+ADFGLSR + T+ A P + PE N+ + K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 597 SDVYNFGVVLLEIIT 611
SDV+ FGV+L EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP--SSAQGYKQFQAEVELLMRIHHKN 482
++LG G FG+V G L +VAVK + SS + ++F +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 483 LTTLVGYCDEGTNRG-----LIYEFMANGNLQALL----LGEEADILSWEGRLRIAIEAA 533
+ L+G C E +++G +I FM G+L L L + + L+ ++ A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 534 K----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GY 582
+HRD+ + N +L +ADFGLS+ + + IA P +
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPVKW 215
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ E T KSDV+ FGV + EI T
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 41/217 (18%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
+ LG G FG V+ VAVK L +S + FQ E ELL + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-------------LRIA 529
+ G C EG +++E+M +G+L L D G L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 530 IEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579
+ A VHRD+ + N L+ KI DFG+SR + + G
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTD----YYRVGG 218
Query: 580 PGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
L PE + + T +SDV++FGVVL EI T
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 63/198 (31%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
+ LG G +G VY G VAVK L + + ++F E ++ I H NL L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 488 GYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
G C T Y EFM GNL L +S L +A + +
Sbjct: 76 GVC---TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRL 593
+HRD+ + N L+ K+ADFGLSR + T+ A P + PE N+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 594 TEKSDVYNFGVVLLEIIT 611
+ KSDV+ FGV+L EI T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 30/205 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
R LG G FG V D VAVK L + Q ++ E+++L ++H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 483 LTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ G C++ L+ E++ G+L+ L + L A + +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPE 586
+HRD+ + N+LL KI DFGL++ P V + PE
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA----PE 207
Query: 587 YYISNRLTEKSDVYNFGVVLLEIIT 611
+ SDV++FGV L E++T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
R LG G FG VY G G T VA+K ++ +S + +F E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--------LRIAIEAA 533
++ L+G +G +I E M G+L++ L + + +++A E A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 534 K----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GY 582
VHRD+ + N +++ F KI DFG++R + + + P +
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 206
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ PE T SDV++FGVVL EI T
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-32
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
E LG G FG V+ G +G T VA+K L P + + F E +++ ++ H+ L L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
E ++ E+M+ G+L L GE L + +A + A VHRD
Sbjct: 247 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKS 597
+++ NIL+ K+ADFGL+R + + A P + PE + R T KS
Sbjct: 306 LRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 598 DVYNFGVVLLEIIT 611
DV++FG++L E+ T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 425 RITNNFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP-SSAQGYKQFQAEVELLMRI 478
R+ + +RV+G G FG VYHG + A+K LS + Q + F E L+ +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 479 HHKNLTTLVGYCDEGTNRGLI-YEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--- 534
+H N+ L+G + +M +G+L + + + + + + ++ A+
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGME 138
Query: 535 -------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL---- 583
VHRD+ + N +L F K+ADFGL+R + + L
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--IL--DREYYSVQQHRHARLPVKW 194
Query: 584 -DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
E + R T KSDV++FGV+L E++T
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
R LG+G FG VY G + G +VAVK L S Q F E ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK-- 534
N+ +G + R ++ E MA G+L++ L + L+ L +A + A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 535 --------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG-Y 582
+HRD+ + N LL+ AKI DFG++R + + + A P +
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ PE ++ T K+D ++FGV+L EI +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 27/199 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+ LG+G FG V G G +VAVKM+ S +F E + +M++ H L G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
C + ++ E+++NG L L L L + + + +HRD
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQFIHRD 129
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEYYISNR 592
+ + N L+ K++DFG++R +++ + PE + +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSA----PEVFHYFK 181
Query: 593 LTEKSDVYNFGVVLLEIIT 611
+ KSDV+ FG+++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKNL 483
E+++G+G G V +G L VA+K L + + + F +E ++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L G G ++ E+M NG+L L + + + +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEYYI 589
VHRD+ + N+L+ K++DFGLSR + + TT I T PE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIA 227
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ SDV++FGVV+ E++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
E LG G FG V+ G +G T VA+K L P + + F E +++ ++ H+ L L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
E ++ E+M+ G+L L GE L + +A + A VHRD
Sbjct: 330 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISNRLTEKS 597
+++ NIL+ K+ADFGL+R + + A P + PE + R T KS
Sbjct: 389 LRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 598 DVYNFGVVLLEIIT 611
DV++FG++L E+ T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 25/198 (12%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
F + +G+G FG V+ GY +VA+K + + + F E E++M++ H L L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
C E L+ EFM +G L L + + E L + ++ + +HRD
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT-----IAGTPGYLDPEYYISNRL 593
+ + N L+ K++DFG++R + ++T + PE + +R
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWAS----PEVFSFSRY 182
Query: 594 TEKSDVYNFGVVLLEIIT 611
+ KSDV++FGV++ E+ +
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG G FG V+ GY +G T+VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 489 YCDEGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
T + I E+M NG+L L L+ L +A + A+ +H
Sbjct: 76 VV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG-------TPGYLDPEYYI 589
RD+++ NIL+S KIADFGL+R +E + T G T PE
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDN---EYTAREGAKFPIKWTA----PEAIN 183
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
T KSDV++FG++L EI+T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 29/200 (14%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
F + LG G FG V +G G +VA+KM+ S +F E +++M + H+ L L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
C + +I E+MANG L L + L + + + +HRD
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG-------TPGYLDPEYYISN 591
+ + N L++ + K++DFGLSR V T+ G +P PE + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDD---EYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
+ + KSD++ FGV++ EI +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
+VLG+G FGTVY G VA+K L +S + K+ E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C T + LI + M G L + E D + + L ++ AK
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISN 591
VHRD+ + N+L+ KI DFGL++ + P ++ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
T +SDV+++GV + E++T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 27/199 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
E+ LG G FG V+ + T+VAVK + P S + F AE ++ + H L L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
+ +I EFMA G+L L +E + + + A+ +HRD
Sbjct: 251 VVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEYYISNR 592
+++ NIL+S KIADFGL+R T T PE
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTA----PEAINFGS 361
Query: 593 LTEKSDVYNFGVVLLEIIT 611
T KSDV++FG++L+EI+T
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 56/204 (27%), Positives = 80/204 (39%), Gaps = 28/204 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP---SSAQGYKQFQAEVELLMRIHHK 481
LG+G FG V G D VAVK L P S + F EV + + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
NL L G + ++ E G+L L + L R A++ A+
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVAEGMGYLES 139
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEY 587
+HRD+ + N+LL+ + KI DFGL R P + A PE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
+ + SD + FGV L E+ T
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
F LG FG VY G+L G VA+K L + ++F+ E L R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------------LGEEADILSWEGRLR 527
N+ L+G + +I+ + ++G+L L L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 528 IAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT-- 575
+ + A VH+D+ + N+L+ K KI+D GL R V + +
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKLLGNS 190
Query: 576 ---IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
I PE + + + SD++++GVVL E+ +
Sbjct: 191 LLPIRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 51/227 (22%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
+ LG G FG V T VAVKML +S + +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL----------------------LGEEADI 519
++ L G C + LI E+ G+L+ L +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 520 LSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569
L+ + A + ++ VHRD+ + NIL++ + KI+DFGLSR V
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEED 204
Query: 570 THVTTTIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
++V + G + E + T +SDV++FGV+L EI+T
Sbjct: 205 SYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKNL 483
++V+G G FG V G L VA+K L + + + F E ++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L G + ++ E+M NG+L + L +A + + + A
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEYYI 589
VHRD+ + NIL++ K++DFGL R + + T I T PE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEAIA 223
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ T SDV+++G+VL E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 425 RITNNFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP-SSAQGYKQFQAEVELLMRI 478
+ +F V+G G FG VYHG L AVK L+ + QF E ++
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 479 HHKNLTTLVGYC-DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--- 534
H N+ +L+G C + ++ +M +G+L+ + E + + + + ++ AK
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMK 142
Query: 535 -------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPE 586
VHRD+ + N +L KF K+ADFGL+R + + T A P ++ E
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 587 YYISNRLTEKSDVYNFGVVLLEIIT 611
+ + T KSDV++FGV+L E++T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
R LG+G FG VY G + G +VAVK L S Q F E ++ + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK-- 534
N+ +G + R ++ E MA G+L++ L + L+ L +A + A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 535 --------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG-Y 582
+HRD+ + N LL+ AKI DFG++R + +G + A P +
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ PE ++ T K+D ++FGV+L EI +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 429 NFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
+F V+G G FG VYHG L AVK L+ + QF E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 483 LTTLVGYC-DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
+ +L+G C + ++ +M +G+L+ + E + + + + ++ AK
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLAS 210
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYIS 590
VHRD+ + N +L KF K+ADFGL+R + + T A P ++ E +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 591 NRLTEKSDVYNFGVVLLEIIT 611
+ T KSDV++FGV+L E++T
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 27/201 (13%)
Query: 431 ERVLGNGGFGTVYHGYLDG----TEVAVKMLSP--SSAQGYKQFQAEVELLMRIHHKNLT 484
++ LG+G FGTV GY VAVK+L + + AE ++ ++ + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
++G C+ + L+ E G L L + + + + + + +
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEYYIS 590
VHRD+ + N+LL + AKI+DFGLS+ + + T + PE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECINY 194
Query: 591 NRLTEKSDVYNFGVVLLEIIT 611
+ + KSDV++FGV++ E +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFS 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 46/222 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDG---------TEVAVKMLSP-SSAQGYKQFQAEVELLMRI- 478
+ LG G FG V G VAVKML ++ + +E+E++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------------LGEEADILSWEG 524
HKN+ L+G C + +I E+ + GNL+ L + ++++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
+ + A+ +HRD+ + N+L++ KIADFGL+R + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK-- 214
Query: 575 TIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
T G L PE T +SDV++FGV++ EI T
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRI-HH 480
+ LG G FG V G VAVKML ++ ++ +E+++L+ I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 481 KNLTTLVGYC-DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-------------- 525
N+ L+G C G +I EF GNL L + + + ++
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 526 LRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575
+ + + AK +HRD+ + NILLS K KI DFGL+R + +V
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKG 208
Query: 576 IAGTP-GYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
A P ++ PE T +SDV++FGV+L EI +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 28/202 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNL 483
R+LG G FG VY G VAVK K+ F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L+G +E +I E G L L + + + +++ K
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLT-LVLYSLQICKAMAYLESIN 133
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEYYI 589
VHRD+ NIL++ K+ DFGLSR +E + + I PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMS----PESIN 187
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
R T SDV+ F V + EI++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
++V+G G FG VY G L VA+K L + + F E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L G + +I E+M NG L L ++ + S + + A
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANM 166
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT----TIAGTPGYLDPEYY 588
VHRD+ + NIL++ K++DFGLSR + T+ T+ I T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAI 222
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
+ T SDV++FG+V+ E++T
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 32/204 (15%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKNL 483
R +G G FG V+ G VA+K +S ++F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L+G E +I E G L++ L + L + A + +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR 136
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEY 587
VHRD+ + N+L+S K+ DFGLSR + G PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWMA----PES 188
Query: 588 YISNRLTEKSDVYNFGVVLLEIIT 611
R T SDV+ FGV + EI+
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILM 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 66/227 (29%), Positives = 91/227 (40%), Gaps = 51/227 (22%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHK 481
+ R +G G FG V+ G T VAVKML +SA FQ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR---------------- 525
N+ L+G C G L++E+MA G+L L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 526 ------LRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569
L IA + A VHRD+ + N L+ KIADFGLSR + +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSAD 228
Query: 570 THVTTTIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+ A + PE NR T +SDV+ +GVVL EI +
Sbjct: 229 YYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 431 ERVLGNGGFGTVYHGYLDG----TEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTT 485
+ LG G FG+V G +VA+K+L + + + E +++ ++ + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------V 535
L+G C L+ E G L L+G+ + + + + + V
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEYYI 589
HRD+ + N+LL + AKI+DFGLS+ + ++ T AG PE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ + +SDV+++GV + E ++
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS 208
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPS-SAQGYKQFQAEVELLMRI-HH 480
F + LG G FG V G +VAVKML + A + +E++++ + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALL------------LGEEADILSWEGRLRI 528
+N+ L+G C G +I E+ G+L L S L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
+ + A+ +HRDV + N+LL+ AKI DFGL+R + ++
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSNYI----VK 223
Query: 579 TPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
L PE T +SDV+++G++L EI +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKML-SPSSAQGYKQFQAEVELLMRIHHKN 482
+VLG+G FGTV+ G V +K++ S Q ++ + + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C + + L+ +++ G+L + L + L ++ AK
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISN 591
VHR++ + N+LL Q ++ADFG++ + + + A TP ++ E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADL--LPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
+ T +SDV+++GV + E++T
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 48/222 (21%), Positives = 80/222 (36%), Gaps = 60/222 (27%)
Query: 430 FERVLGNGGFGTVYHGYLDG---------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHH 480
F LG G F ++ G TEV +K+L + + F ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
K+L G C G L+ EF+ G+L L + ++ +L +A + A
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLE 130
Query: 535 ----VHRDVKSTNILLSGKFQ--------AKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
+H +V + NILL + K++D G+S T
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------------------- 171
Query: 583 LDPEYY-----------ISN--RLTEKSDVYNFGVVLLEIIT 611
L + I N L +D ++FG L EI +
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 76/233 (32%)
Query: 430 FERVLGNGGFGTVYHGYLDG----TEVAVKMLSP-SSAQGYKQFQAEVELLMRI-HHKNL 483
F+ V+G G FG V + + A+K + +S ++ F E+E+L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 484 TTLVGYCDEGTNRG---LIYEFMANGNLQALL--------------LGEEADILSWEGRL 526
L+G C +RG L E+ +GNL L A LS + L
Sbjct: 89 INLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 527 RIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576
A + A+ +HRD+ + NIL+ + AKIADFGLSR
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------------- 190
Query: 577 AGTPGYLDPEYYIS------------------NRLTEKSDVYNFGVVLLEIIT 611
E Y+ + T SDV+++GV+L EI++
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPS-SAQGYKQFQAEVELLMRI-HH 480
F + LG G FG V G VAVKML PS + +E+++L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALL----------------LGEEADILSWEG 524
N+ L+G C G +I E+ G+L L + ++ L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
L + + AK +HRD+ + NILL+ KI DFGL+R ++ +V
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYV-- 202
Query: 575 TIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
L PE + T +SDV+++G+ L E+ +
Sbjct: 203 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 46/222 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDG---------TEVAVKMLSP-SSAQGYKQFQAEVELLMRI- 478
+ LG G FG V G VAVKML ++ + +E+E++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLL--------------GEEADILSWEG 524
HKN+ L+G C + +I E+ + GNL+ L + ++++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
+ + A+ +HRD+ + N+L++ KIADFGL+R + +
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK-- 260
Query: 575 TIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
T G L PE T +SDV++FGV++ EI T
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 46/222 (20%)
Query: 430 FERVLGNGGFGTVYHGYLDG---------TEVAVKMLSP-SSAQGYKQFQAEVELLMRI- 478
+ LG G FG V G T+VAVKML ++ + +E+E++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR------------- 525
HKN+ L+G C + +I E+ + GNL+ L L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 526 -LRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
+ A + A+ +HRD+ + N+L++ KIADFGL+R + +
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK-- 248
Query: 575 TIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
T G L PE T +SDV++FGV+L EI T
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 27/204 (13%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVK--MLSPSSAQGYKQFQAEVELLMRIHHKNLTT 485
F+ +G G F TVY G EVA + ++F+ E E+L + H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 486 LVGYC-DEGTNRGLIY---EFMANGNLQALL-----LGEEADILSWEGRLRIAIE----- 531
+ I E M +G L+ L + + + SW ++ ++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV-LRSWCRQILKGLQFLHTR 148
Query: 532 -AAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+K NI ++G KI D GL+ + GTP ++ PE Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFMAPEMY- 202
Query: 590 SNRLTEKSDVYNFGVVLLEIITSK 613
+ E DVY FG+ +LE+ TS+
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSE 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSP-SSAQGYKQFQAEVELLMRIHHKN 482
+VLG+G FGTVY G VA+K L +S + K+ E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+G C T + LI + M G L + E D + + L ++ AK
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP-GYLDPEYYISN 591
VHRD+ + N+L+ KI DFGL++ + P ++ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
T +SDV+++GV + E++T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 51/227 (22%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPS-SAQGYKQFQAEVELLMRI-HH 480
F +VLG+G FG V + G +VAVKML + + +E++++ ++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALL---------------------LGEEADI 519
+N+ L+G C LI+E+ G+L L E+ ++
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 520 LSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569
L++E L A + AK VHRD+ + N+L++ KI DFGL+R +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMSDS 226
Query: 570 THVTTTIAGTPGYL-----DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
+V L PE T KSDV+++G++L EI +
Sbjct: 227 NYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 28/202 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNL 483
R +G G FG V+ G VA+K ++ ++ F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L+G E +I E G L++ L + L + A + +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR 511
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT----IAGTPGYLDPEYYI 589
VHRD+ + N+L+S K+ DFGLSR +E S + + I PE
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA----PESIN 565
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
R T SDV+ FGV + EI+
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 431 ERVLGNGGFGTVYHGYLDG----TEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTT 485
+ LG G FG+V G +VA+K+L + + + E +++ ++ + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------V 535
L+G C L+ E G L L+G+ + + + + + V
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------TPGYLDPEYYI 589
HR++ + N+LL + AKI+DFGLS+ + S + T AG PE
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA----PECIN 512
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ + +SDV+++GV + E ++
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKM--LSPSSAQGYKQFQAEVELLMRIHHK 481
++E +G G +G DG + K + + +EV LL + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 482 NLTTLVGYCD---EGTNRGL--IYEFMANGNLQALL--------LGEEADILSWEGRLRI 528
N+ V Y D + TN L + E+ G+L +++ +E +L +L +
Sbjct: 66 NI---VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 529 AIE---------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579
A++ +HRD+K N+ L GK K+ DFGL+R T T GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGT 179
Query: 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P Y+ PE EKSD+++ G +L E+
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKM--LSPSSAQGYKQFQAEVELLMRIHHK 481
+ + +G G FG DG + +K +S S++ ++ + EV +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL------LGEEADILSWEGRLRIAI----E 531
N+ +E + ++ ++ G+L + L +E IL W ++ +A+ +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+KS NI L+ ++ DFG++R S + GTP YL PE +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENK 200
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
KSD++ G VL E+ T K
Sbjct: 201 PYNNKSDIWALGCVLYELCTLK 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 39/200 (19%), Positives = 73/200 (36%), Gaps = 32/200 (16%)
Query: 431 ERVLGNGGFGTVYHGY---LDGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTL 486
+ + +GG G +Y ++G V +K L S + AE + L + H ++ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 487 --VGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
+ + Y E++ +L+ + L + +E
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHS 200
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
V+ D+K NI+L+ + Q K+ D G + GTPG+ PE +
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NS-FGYLYGTPGFQAPE-IVRT 251
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
T +D+Y G L +
Sbjct: 252 GPTVATDIYTVGRTLAALTL 271
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 429 NFERVLGNGGFGTVYH-GYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTL 486
+ VLG+G GT+ + G D +VAVK + P + EV+LL H N+
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRY 83
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR--LRIAIEAAK-------VHR 537
+ + + E A LQ + ++ L E L+ VHR
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 538 DVKSTNILLS-----GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN- 591
D+K NIL+S GK +A I+DFGL + V + + GT G++ PE +
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 592 --RLTEKSDVYNFGVVLLEIIT 611
T D+++ G V +I+
Sbjct: 203 KENPTYTVDIFSAGCVFYYVIS 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVK---MLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ +G G F VY LDG VA+K + A+ E++LL +++H N+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV--- 94
Query: 487 VGYCDEGTNRGLIY---EFMANGNLQALL--------LGEEADILSWEGRLRIAI----E 531
+ Y + E G+L ++ L E + + +L A+
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 532 AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K N+ ++ K+ D GL R F S T ++ GTP Y+ PE N
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 592 RLTEKSDVYNFGVVLLEIITSK 613
KSD+++ G +L E+ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQ 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 31/202 (15%)
Query: 431 ERVLGNGGFGTVYHGYLD---GTEVAVKMLSPSSA--QGYKQ-FQAEVELLMRIHHKNLT 484
R++G GG G VY D VA+K++S + + ++ Q E R+ ++
Sbjct: 39 RRLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV- 96
Query: 485 TLVGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
V D G G +Y + +L A+L + L+ + I +
Sbjct: 97 --VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT--IAGTPGYLDPEYYI 589
HRDVK NIL+S A + DFG++ + +T GT Y+ PE +
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASA----TTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 590 SNRLTEKSDVYNFGVVLLEIIT 611
+ T ++D+Y VL E +T
Sbjct: 209 ESHATYRADIYALTCVLYECLT 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 55/231 (23%)
Query: 424 LRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH 479
LR ++FE VLG G FG V LD A+K + + + +EV LL ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 480 HKNLTTLVG-YCDEG---------TNRGLIY---EFMANGNLQALL-----LGEEADILS 521
H+ + + + + ++ E+ NG L L+ + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 522 WEGRLRIAIEA-------AKVHRDVKSTNILLSGKFQAKIADFGLSRTF----------- 563
R +EA +HRD+K NI + KI DFGL++
Sbjct: 121 L---FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 564 PVEGSGTHVTTTIAGTPGYLDPE------YYISNRLTEKSDVYNFGVVLLE 608
+ T+ GT Y+ E +Y EK D+Y+ G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFE 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 53/215 (24%), Positives = 79/215 (36%), Gaps = 33/215 (15%)
Query: 430 FERVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
F + LG GGF V G DG A+K + Q ++ Q E ++ +H N+ LV
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 488 GYCDEGTNRG----LIYEFMANGNLQALLLG--------EEADILSWEGRLRIAIEAAK- 534
YC L+ F G L + E IL L +
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL---LLGICRGLEA 149
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGY 582
HRD+K TNILL + Q + D G + G+ T+ T Y
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 583 LDPE---YYISNRLTEKSDVYNFGVVLLEIITSKS 614
PE + E++DV++ G VL ++ +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTT 485
LG GG TVY + +VA+K + + K+F+ EV ++ H+N+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-- 73
Query: 486 LVGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRI------AIEAAK-- 534
V D Y E++ L + LS + + I+ A
Sbjct: 74 -VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM 130
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT--IAGTPGYLDPEYYIS 590
VHRD+K NIL+ KI DFG+++ S T +T T + GT Y PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 591 NRLTEKSDVYNFGVVLLEIIT 611
E +D+Y+ G+VL E++
Sbjct: 187 EATDECTDIYSIGIVLYEMLV 207
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/285 (19%), Positives = 104/285 (36%), Gaps = 57/285 (20%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH 480
R +F+ ++G+GGFG V+ +DG +K + ++ ++ + EV+ L ++ H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63
Query: 481 KN-------------LTTLVGYCDEGTNRGLIY---EFMANGNLQALL------LGEEAD 518
N + ++ EF G L+ + ++
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 519 ILSWEGRLRIAIEA----AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
L ++ ++ ++RD+K +NI L Q KI DFGL + T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGKRT 179
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634
GT Y+ PE S ++ D+Y G++L E++ T + L
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT-------DLR 232
Query: 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
G I I D + + +S+ RP +++
Sbjct: 233 DGIISDIFDKKEK------------TLLQKLLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 56/292 (19%), Positives = 102/292 (34%), Gaps = 53/292 (18%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQAEVELLMRIH 479
R +FE + LG GGFG V+ +D A+K + P+ ++ EV+ L ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 480 HKNLTTLVGYCDEGTN---------RGLIY---EFMANGNLQALL-------LGEEADIL 520
H + E + +Y + NL+ + E + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 521 SWEGRLRIAIEAA----KVHRDVKSTNILLSGKFQAKIADFGLSR---------TFPVEG 567
++ A+E +HRD+K +NI + K+ DFGL T
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQ 627
T GT Y+ PE N + K D+++ G++L E++ ER+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---FSTQMERVRT-- 236
Query: 628 WVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + + + F + +S + +RP +
Sbjct: 237 ----------LTDVRNLKFPPLFTQKYP-CEYVMVQDMLSPSPMERPEAINI 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 53/234 (22%), Positives = 82/234 (35%), Gaps = 46/234 (19%)
Query: 419 SYSNVLRITNNFERVLGNGGFGTVYH-GYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMR 477
++ L+ E++LG G GTV G G VAVK + E++LL
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTE 64
Query: 478 I-HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-- 534
H N+ + E N NLQ L+ E ++ +L+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLL 121
Query: 535 ---------------VHRDVKSTNILLSGK-------------FQAKIADFGLSRTF-PV 565
+HRD+K NIL+S + I+DFGL +
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 566 EGSGTHVTTTIAGTPGYLDPE-------YYISNRLTEKSDVYNFGVVLLEIITS 612
+ S +GT G+ PE RLT D+++ G V I++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTT 485
+LG GG V+ D +VAVK+L A+ Y +F+ E + ++H +
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 486 L--VGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ G E L Y E++ L+ ++ E ++ + + + +A +
Sbjct: 77 VYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH 133
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT--IAGTPGYLDPEYY 588
+HRDVK NI++S K+ DFG++R + SG VT T + GT YL PE
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARA--IADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
+ + +SDVY+ G VL E++T
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 46/242 (19%), Positives = 79/242 (32%), Gaps = 53/242 (21%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEVAVKMLS-----------------PSSAQGYKQF 468
N++ R L G F + D A+K S Y F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 469 QAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRI 528
+ E++++ I ++ T G +IYE+M N ++ ++ + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 529 AIEAAK------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570
HRDVK +NIL+ + K++DFG S
Sbjct: 151 Q-VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-----D 204
Query: 571 HVTTTIAGTPGYLDPEYYISNRLT---EKSDVYNFGVVLLEIIT------SKSVIERTHE 621
GT ++ PE + SN + K D+++ G+ L + K +
Sbjct: 205 KKIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 622 RI 623
I
Sbjct: 264 NI 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/239 (26%), Positives = 96/239 (40%), Gaps = 52/239 (21%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHH 480
+FE R LG G FG VY +A+K+L + + Q + EVE+ + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
N+ L GY + T LI E+ G + L + A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFD-EQRTATYITELA 119
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+HRD+K N+LL + KIADFG S P + T + GT YL
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYL 174
Query: 584 DPEYYISNRL-TEKSDVYNFGVVLLEIIT------SKSVIERTHERI-----HITQWVS 630
PE I R+ EK D+++ GV+ E + + + E T++RI +V+
Sbjct: 175 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEFTFPDFVT 231
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 23/231 (9%)
Query: 401 RRMQVAKNGSFELKNQRFSYSNVL-RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVK 455
RR+ S L++ + S +F+ LG+G +G V+ DG AVK
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 456 --MLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL 512
M + + AEV ++ H L +EG L E +LQ
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC 147
Query: 513 LGE-----EADILSWEGRLRIAIEA----AKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
EA + + +A+ VH DVK NI L + + K+ DFGL
Sbjct: 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
Query: 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
G P Y+ PE + +DV++ G+ +LE+ +
Sbjct: 208 ----GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/216 (25%), Positives = 81/216 (37%), Gaps = 42/216 (19%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTT 485
+LG G V+ G G A+K+ + S E E+L +++HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 486 LVGYCDEGTNRG--LIYEFMANGNL--------QALLLGE-EADILSWEGRLRIAIEAAK 534
L +E T R LI EF G+L A L E E I+ LR +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV-----LRDVVGGMN 126
Query: 535 -------VHRDVKSTNILLS----GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
VHR++K NI+ G+ K+ DFG +R ++ GT YL
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLYGTEEYL 182
Query: 584 DPEYYISNRL--------TEKSDVYNFGVVLLEIIT 611
P+ Y L D+++ GV T
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 19/230 (8%), Positives = 51/230 (22%), Gaps = 55/230 (23%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLT 484
L G V+ + A+K+ + S ++ R+ ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 485 TLVGYC------DEGTNRG--------------------LIYEFMANGNLQALL-----L 513
D + L+ + +L+ L +
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 514 GEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTF 563
+ + + VH N+ + + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRL--TEKSDVYNFGVVLLEIIT 611
+ Y E+ ++ T + + G+ + +
Sbjct: 245 G------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 49/198 (24%), Positives = 83/198 (41%), Gaps = 19/198 (9%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
VLG G +G VY G + +A+K + ++ + E+ L + HKN+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI-----------EAAKVHRD 538
E + E + G+L ALL + + E + + VHRD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 539 VKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL--TE 595
+K N+L++ KI+DFG S+ T T GT Y+ PE +
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE---TFTGTLQYMAPEIIDKGPRGYGK 204
Query: 596 KSDVYNFGVVLLEIITSK 613
+D+++ G ++E+ T K
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 31/230 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHH 480
+F+ +LG G F VY G EVA+KM+ + + Q EV++ ++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA--IEAAK---- 534
++ L Y ++ L+ E NG + L E R + I
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+ +N+LL+ KIADFGL+ + + T+ GTP Y+ PE +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPE-IATR 186
Query: 592 RL-TEKSDVYNFGVVLLEIITSK-----SVIERTHERI-----HITQWVS 630
+SDV++ G + ++ + ++ T ++ + ++S
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 54/217 (24%), Positives = 79/217 (36%), Gaps = 44/217 (20%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTT 485
+LG G V+ G G A+K+ + S E E+L +++HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 486 LVGYCDEGTNRG--LIYEFMANGNL--------QALLLGEEADILSWEGR--LRIAIEAA 533
L +E T R LI EF G+L A L E E LR +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES------EFLIVLRDVVGGM 125
Query: 534 K-------VHRDVKSTNILLS----GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
VHR++K NI+ G+ K+ DFG +R ++ GT Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLYGTEEY 181
Query: 583 LDPEYYISNRL--------TEKSDVYNFGVVLLEIIT 611
L P+ Y L D+++ GV T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 50/238 (21%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHH 480
++F+ R LG G FG VY + +A+K+L S + Q + E+E+ + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
N+ + Y + L+ EF G L L GR +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL--------YKELQKHGRFD-EQRSATFMEELA 124
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+HRD+K N+L+ K + KIADFG S P + T+ GT YL
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-----SLRRRTMCGTLDYL 179
Query: 584 DPEYYISNRL-TEKSDVYNFGVVLLEIITSK-----SVIERTHERI-----HITQWVS 630
PE I + EK D++ GV+ E + TH RI ++S
Sbjct: 180 PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 2e-22
Identities = 29/233 (12%), Positives = 58/233 (24%), Gaps = 57/233 (24%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS----------------------------PSS 461
VLG G V +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 462 AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFMANGNLQALL-----LG 514
A+ + +F +L+ K + + + +R +Y M NLQ
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 202
Query: 515 EEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFP 564
L RL++ ++ + VH ++ +I+L + + F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 565 VEGSGTHV-TTTIAGTPGYLDPE-----YYISNRLTEKSDVYNFGVVLLEIIT 611
+G+ P + +T D + G+ + I
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 33/208 (15%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ LG GGFG V G +VA+K S + +++ E++++ +++H N+ +
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 487 VGYCDEGTNRG------LIYEFMANGNLQALLLG-------EEADILSWEGRLRIAIEAA 533
D L E+ G+L+ L +E I + L A
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL---LSDISSAL 134
Query: 534 K-------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+ +HRD+K NI+L Q KI D G ++ + T GT YL
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD----QGELCTEFVGTLQYL 190
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIIT 611
PE + T D ++FG + E IT
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 62/266 (23%)
Query: 403 MQVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKM-- 456
M + S +N F ++L + + +G G +G V A+K+
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 457 ---LSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLL 513
+ + + ++ + EV L+ ++HH N+ L ++ L+ E G+L L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 514 GEEADILSWEGRLRIAI-------------------------------EAAKV------- 535
D + + +
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 536 ----------HRDVKSTNILLSGKFQA--KIADFGLSRTF-PVEGSGTHVTTTIAGTPGY 582
HRD+K N L S K+ DFGLS+ F + + TT AGTP +
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 583 LDPE--YYISNRLTEKSDVYNFGVVL 606
+ PE + K D ++ GV+L
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 46/232 (19%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHHKNLTTL 486
R LG GGF + A K++ S + E+ + + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------------ 534
G+ ++ ++ E +L ++ L EA
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSL--------LELHKRRKALT-EPEARYYLRQIVLGCQYL 131
Query: 535 -----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+K N+ L+ + KI DFGL+ +G + GTP Y+ PE +
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VL 187
Query: 590 SNRL-TEKSDVYNFGVVLLEIITSK-----SVIERTHERI-----HITQWVS 630
S + + + DV++ G ++ ++ K S ++ T+ RI I + ++
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 239
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 46/232 (19%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHHKNLTTL 486
R LG GGF + A K++ S + E+ + + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------------ 534
G+ ++ ++ E +L ++ L EA
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL--------LELHKRRKALT-EPEARYYLRQIVLGCQYL 157
Query: 535 -----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
+HRD+K N+ L+ + KI DFGL+ +G + GTP Y+ PE +
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VL 213
Query: 590 SNRL-TEKSDVYNFGVVLLEIITSK-----SVIERTHERI-----HITQWVS 630
S + + + DV++ G ++ ++ K S ++ T+ RI I + ++
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 42/203 (20%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
F VLG+G F V+ L G A+K + S A + E+ +L +I H+N+ TL
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 487 VGYCDEGTNRGLIYEFMANGNL-------------QALLLGEEADILSWEGRLRIAIEAA 533
+ T+ L+ + ++ G L A + ++ + + A
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVI------QQVLSAV 119
Query: 534 K-------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
K VHRD+K N+L + I DFGLS+ + +T GTPGY+
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-----NGIMSTACGTPGYV 174
Query: 584 DPEYYISNRLTEKSDVYNFGVVL 606
PE ++ D ++ GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 1e-21
Identities = 31/238 (13%), Positives = 60/238 (25%), Gaps = 66/238 (27%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS----------------------------PSS 461
VLG G V +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 462 AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--NRGLIYEFMANGNLQALL-----LG 514
A+ + +F +L+ K + + + +R +Y M NLQ
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 197
Query: 515 EEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFP 564
L RL++ ++ + VH ++ +I+L + + F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 565 VEGSGTHVTTTIAGTPGYLDPEY-----------YISNRLTEKSDVYNFGVVLLEIIT 611
+ + G+ PE +T D + G+V+ I
Sbjct: 257 ------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 23/194 (11%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ LG+G FG V+ G K ++ + E+ ++ ++HH L L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIEAAK------- 534
++ LI EF++ G L + E EA+++++ +R A E K
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACEGLKHMHEHSI 170
Query: 535 VHRDVKSTNILLSGKFQA--KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
VH D+K NI+ K + KI DFGL+ + + T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVDREP 226
Query: 593 LTEKSDVYNFGVVL 606
+ +D++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 30/197 (15%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
E +G G +G V A K + + +F+ E+E++ + H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 487 VGYCDEGTNRGLIYEFMANGNL-----QALLLGEE--ADILSWEGRLRIAIEAAK----- 534
++ T+ L+ E G L + E A I+ + + A
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM------KDVLSAVAYCHKL 125
Query: 535 --VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
HRD+K N L K+ DFGL+ F + T GTP Y+ P+ +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ-VL 180
Query: 590 SNRLTEKSDVYNFGVVL 606
+ D ++ GV++
Sbjct: 181 EGLYGPECDEWSAGVMM 197
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 46/249 (18%), Positives = 84/249 (33%), Gaps = 47/249 (18%)
Query: 399 LRRRMQVAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGY-LDGTEVAVKM- 456
+ + +N F +V + + +G+GG V+ A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 457 -LSPSSAQGYKQFQAEVELLMRIHHKNLT--TLVGYCDEGTNRGLIYEFM--ANGNLQAL 511
L + Q ++ E+ L ++ + L Y IY M N +L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDL--- 114
Query: 512 LLGEEADILSWEGRLRIA---------IEAAK-------VHRDVKSTNILLSGKFQAKIA 555
L + + +EA VH D+K N L+ K+
Sbjct: 115 -----NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 168
Query: 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE-----------YYISNRLTEKSDVYNFGV 604
DFG++ + + V + GT Y+ PE ++++ KSDV++ G
Sbjct: 169 DFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 605 VLLEIITSK 613
+L + K
Sbjct: 228 ILYYMTYGK 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 29/198 (14%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKML--SPSSAQGYKQFQAEVELLMRIHHKNLT 484
+ + LG G F V G E A K++ SA+ +++ + E + ++ H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 485 TLVGYCDEGTNRGLIYEFMANGNL------QALLLGEEADILSWEGRLRIAIEAAK---- 534
L E + L+++ + G L + +A ++ +E+
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILESIAYCHS 123
Query: 535 ---VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
VHR++K N+LL+ K + K+ADFGL+ + + AGTPGYL PE
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV----NDSEAWHGFAGTPGYLSPEVL 179
Query: 589 ISNRLTEKSDVYNFGVVL 606
+ ++ D++ GV+L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 34/228 (14%)
Query: 402 RMQVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKML 457
R + G + F S ++ ++ + LG+G +G V + E A+K++
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 458 SPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE 515
+ S + EV +L + H N+ L + ++ N L+ E G L ++
Sbjct: 71 RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 516 E-------ADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGK---FQAKIADFG 558
A I+ + + VHRD+K N+LL K KI DFG
Sbjct: 131 MKFNEVDAAVII------KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
LS F GT Y+ PE + + EK DV++ GV+L
Sbjct: 185 LSAVF----ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLS---PSSA 462
F + ++ ++ RVLG G FG V + G E AVK++S
Sbjct: 8 HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67
Query: 463 QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE------ 516
+ EV+LL ++ H N+ L + ++ L+ E G L ++ +
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 517 -ADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPV 565
A I+ R + VHRD+K N+LL K +I DFGLS F
Sbjct: 128 AARII------RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 179
Query: 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
+ GT Y+ PE + EK DV++ GV+L
Sbjct: 180 --EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 6e-21
Identities = 31/215 (14%), Positives = 60/215 (27%), Gaps = 32/215 (14%)
Query: 430 FERVLGNGGFGTVYHGY-------LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN 482
+LG G F VY + + +K+ P++ + +E L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALL---LGEEADILSWEGRLRIAIEAAK----- 534
L+ E + G L + ++ + A+
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 535 -----VHRDVKSTNILLSGKFQA-----------KIADFGLSRTFPVEGSGTHVTTTIAG 578
+H D+K N +L F + D G S + GT + T
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT-IFTAKCE 247
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
T G+ E + + D + + ++
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 44/205 (21%), Positives = 76/205 (37%), Gaps = 37/205 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKM-----LSPSSAQGYKQFQAEVELLMRIHHKN 482
V+G G F V G + AVK+ + S + + E + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNL---------QALLLGEE--ADILSWEGRLRIAIE 531
+ L+ +++EFM +L + E + + R +E
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM------RQILE 141
Query: 532 AAK-------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
A + +HRDVK +LL+ K + K+ FG++ G V GTP
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTPH 198
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVL 606
++ PE + DV+ GV+L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 49/219 (22%), Positives = 77/219 (35%), Gaps = 35/219 (15%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLV 487
RVL GGF VY G E A+K L + + + EV + ++ H N+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 488 GYCDEGTNRG-------LIYEFMANGNLQALLLG-------EEADILSWEGRLRIAIEA- 532
G L+ + G L L +L + A++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 533 -----AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA---------G 578
+HRD+K N+LLS + K+ DFG + T + A
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 579 TPGYLDPE---YYISNRLTEKSDVYNFGVVLLEIITSKS 614
TP Y PE Y + + EK D++ G +L + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 40/208 (19%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ---------FQAEVELLMRI 478
+ +LG G V E AVK++ + + EV++L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 479 -HHKNLTTLVGYCDEGTNRGLIYEFMANGNL-----QALLLGE-EADILSWEGRLRIAIE 531
H N+ L + T L+++ M G L + + L E E + +R +E
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLE 135
Query: 532 AAK-------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
VHRD+K NILL K+ DFG S + GTP YL
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSYLA 191
Query: 585 PE------YYISNRLTEKSDVYNFGVVL 606
PE ++ D+++ GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 402 RMQVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKML 457
M G + F + + ++N++ LG G F V G E A K++
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 458 --SPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL-----QA 510
SA+ +++ + E + ++ H N+ L E + L+++ + G L
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 511 LLLGEE--ADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGKFQA---KIADFG 558
E + + + +E+ VHR++K N+LL+ K + K+ADFG
Sbjct: 123 EFYSEADASHCI------QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
L+ + AGTPGYL PE + ++ D++ GV+L
Sbjct: 177 LAIEVN----DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 41/234 (17%), Positives = 75/234 (32%), Gaps = 58/234 (24%)
Query: 421 SNVLRITNN---FERVLGNGGFGTVYHGY-LDGTEVAVKM-----LSPSSAQGYKQFQAE 471
+ + + + +G+GG V+ A+K + Y+ E
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN---E 57
Query: 472 VELLMRIHHKNLT--TLVGYCDEGTNRGLIYEFM--ANGNLQALLLGEEADILSWEGRLR 527
+ L ++ + L Y IY M N +L L + +
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDL--------NSWLKKKKSID 106
Query: 528 IAIEAAK-----------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570
E VH D+K N L+ K+ DFG++ + +
Sbjct: 107 PW-ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ-PDTTS 163
Query: 571 HVTTTIAGTPGYLDPE-----------YYISNRLTEKSDVYNFGVVLLEIITSK 613
V + GT Y+ PE ++++ KSDV++ G +L + K
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 39/207 (18%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--------SAQGYKQFQAEVELLMRI 478
+ LG+G G V + +VA++++S A + E+E+L ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNL-----QALLLGE-EADILSWEGRLRIAIEA 532
+H + + + D + ++ E M G L L E + + A
Sbjct: 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLLA 251
Query: 533 AK-------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
+ +HRD+K N+LLS + KI DFG S+ T + T+ GTP Y
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 307
Query: 583 LDPE---YYISNRLTEKSDVYNFGVVL 606
L PE + D ++ GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 45/254 (17%), Positives = 83/254 (32%), Gaps = 56/254 (22%)
Query: 400 RRRMQVAKNGSFELKNQRFSYSNVLRITNN---FERVLGNGGFGTVYHGY-LDGTEVAVK 455
R+ M G+ + S + + + + +G+GG V+ A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 456 M-----LSPSSAQGYKQFQAEVELLMRIHHKNLT--TLVGYCDEGTNRGLIYEFM--ANG 506
+ Y+ E+ L ++ + L Y IY M N
Sbjct: 87 YVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNI 140
Query: 507 NLQALLLGEEADILSWEGRLRIA---------IEAAK-------VHRDVKSTNILLSGKF 550
+L L + + +EA VH D+K N L+
Sbjct: 141 DL--------NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG 191
Query: 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE-----------YYISNRLTEKSDV 599
K+ DFG++ + + V + G Y+ PE ++++ KSDV
Sbjct: 192 MLKLIDFGIANQMQ-PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 600 YNFGVVLLEIITSK 613
++ G +L + K
Sbjct: 251 WSLGCILYYMTYGK 264
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 57/199 (28%), Positives = 82/199 (41%), Gaps = 32/199 (16%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG--YKQFQAEVELLMRIHHKNLT 484
N +LG G FG V + E AVK+++ +SA+ EVELL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 485 TLVGYCDEGTNRGLIYEFMANGNL-----QALLLGEE--ADILSWEGRLRIAIEAAK--- 534
L ++ ++ ++ E G L + E A I+ +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII------KQVFSGITYMH 138
Query: 535 ----VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
VHRD+K NILL K KI DFGLS F GT Y+ PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTKMKDRIGTAYYIAPE- 193
Query: 588 YISNRLTEKSDVYNFGVVL 606
+ EK DV++ GV+L
Sbjct: 194 VLRGTYDEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 33/201 (16%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTT 485
F+R LG+G FG V+ G E +K ++ +Q +Q +AE+E+L + H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 486 LVGYCDEGTNRGLIYEFMANGNL------QALLLG----EEADILSWEGRLRIAIEAAK- 534
+ ++ N ++ E G L L ++ + A
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----MKQMMNALAY 139
Query: 535 ------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
VH+D+K NIL KI DFGL+ F +T AGT Y+ P
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF----KSDEHSTNAAGTALYMAP 195
Query: 586 EYYISNRLTEKSDVYNFGVVL 606
E +T K D+++ GVV+
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVM 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 23/194 (11%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ LG G FG V+ G A K + + + E++ + + H L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIEAAK------- 534
++ +IYEFM+ G L + E E + + + +R +
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVCKGLCHMHENNY 276
Query: 535 VHRDVKSTNILLSGKFQA--KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
VH D+K NI+ + K K+ DFGL+ GT + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 593 LTEKSDVYNFGVVL 606
+ +D+++ GV+
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 19/215 (8%)
Query: 412 ELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQ 469
+LK + Y + + R +G G FG V+ G + AVK + +
Sbjct: 45 KLKPVDYEYREEVHWMTHQPR-VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----V 98
Query: 470 AEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL--LG--EEADILSWEGR 525
E+ + + L G EG + E + G+L L+ +G E L + G+
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ 158
Query: 526 LRIAIE----AAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTT--TIAG 578
+E +H DVK+ N+LLS +A + DFG + +G G + T I G
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
T ++ PE + K D+++ ++L ++
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 39/207 (18%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--------SAQGYKQFQAEVELLMRI 478
+ LG+G G V + +VA+K++S A + E+E+L ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNL-----QALLLGE-EADILSWEGRLRIAIEA 532
+H + + + D + ++ E M G L L E + + A
Sbjct: 73 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLLA 126
Query: 533 AK-------VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
+ +HRD+K N+LLS + KI DFG S+ T + T+ GTP Y
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 182
Query: 583 LDPE---YYISNRLTEKSDVYNFGVVL 606
L PE + D ++ GV+L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-20
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 28/197 (14%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKML--SPSSAQGYKQFQAEVELLMRIHHKNLTT 485
LG G F V L G E A ++ SA+ +++ + E + + H N+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 486 LVGYCDEGTNRGLIYEFMANGNL------QALLLGEEADILSWEGRLRIAIEAAK----- 534
L E + LI++ + G L + +A ++ +EA
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEAVLHCHQM 129
Query: 535 --VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
VHR++K N+LL+ K + K+ADFGL+ E AGTPGYL PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLR 186
Query: 590 SNRLTEKSDVYNFGVVL 606
+ + D++ GV+L
Sbjct: 187 KDPYGKPVDLWACGVIL 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 39/207 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG--------YKQFQAEVELLMRIH 479
+ V+G G V G E AVK++ ++ + + + E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 480 -HKNLTTLVGYCDEGTNRGLIYEFMANGNL-----QALLLGE-EADILSWEGRLRIAIEA 532
H ++ TL+ + + L+++ M G L + + L E E + +R +EA
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA 212
Query: 533 AK-------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
VHRD+K NILL Q +++DFG S + GTPGYL P
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL----EPGEKLRELCGTPGYLAP 268
Query: 586 E------YYISNRLTEKSDVYNFGVVL 606
E ++ D++ GV+L
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 45/231 (19%)
Query: 410 SFELKNQRFSYSNVLRITNN--FERVLGNGGFGTVYHGY--LDGTEVAVKMLS------- 458
+ + +I + R LG+G +G V +E A+K++
Sbjct: 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 459 ------PSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL 512
+ + +++ E+ LL + H N+ L ++ L+ EF G L +
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 513 LGEE-------ADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGK---FQAKIA 555
+ A+I+ + + VHRD+K NILL K KI
Sbjct: 138 INRHKFDECDAANIM------KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
DFGLS F S + GT Y+ PE + + EK DV++ GV++
Sbjct: 192 DFGLSSFF----SKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 45/215 (20%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 418 FSYSNVLRITNNFE--------RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ 467
F + V +LG G FG V+ G ++A K++ + ++
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 468 FQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL------QALLLGE-EADIL 520
+ E+ ++ ++ H NL L + + L+ E++ G L ++ L E + +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 521 SWEGRLRIAIEAAK-------VHRDVKSTNILLSGKFQA--KIADFGLSRTFPVEGSGTH 571
++ E + +H D+K NIL + KI DFGL+R +
Sbjct: 193 -----MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----KPRE 243
Query: 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
GTP +L PE + ++ +D+++ GV+
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 33/228 (14%)
Query: 404 QVAKNGSFELKNQRFSYSNVLRITNNFE---RVLGNGGFGTVYHGY--LDGTEVAVKML- 457
+ +L + + ++ N + + LG G F V G E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 458 -SPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE 515
+ E+ +L + L + + LI E+ A G + +L L E
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 516 EADILSWEGRLRIAIEAAK--------------VHRDVKSTNILLSGKFQA---KIADFG 558
A+++S E I K VH D+K NILLS + KI DFG
Sbjct: 124 LAEMVS-E---NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
+SR I GTP YL PE + +T +D++N G++
Sbjct: 180 MSRKI----GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 30/201 (14%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVK------MLSPSSAQGYKQFQAEVELLMRIHH 480
LG+G F V G E A K + S ++ + EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEAAK-- 534
N+ TL + T+ LI E ++ G L L + E + + L+ ++
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF---LKQILDGVHYL 124
Query: 535 -----VHRDVKSTNILLSGKFQA----KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
H D+K NI+L K K+ DFG++ + I GTP ++ P
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGTPEFVAP 180
Query: 586 EYYISNRLTEKSDVYNFGVVL 606
E L ++D+++ GV+
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 30/201 (14%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLS------PSSAQGYKQFQAEVELLMRIHH 480
+ LG+G F V G E A K + ++ + EV +L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEAAK-- 534
N+ TL + T+ LI E ++ G L L + E + S+ ++ ++
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILDGVNYL 131
Query: 535 -----VHRDVKSTNILLSGK----FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
H D+K NI+L K K+ DFGL+ I GTP ++ P
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----EDGVEFKNIFGTPEFVAP 187
Query: 586 EYYISNRLTEKSDVYNFGVVL 606
E L ++D+++ GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 36/204 (17%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLS----PSSAQGYKQFQAEVELLMRIHHKNL 483
+LG G +G V AVK+L G + E++LL R+ HKN+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 484 TTL--VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
L V Y +E ++ E+ +Q +L D + E R + +A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEY-CVCGMQEML-----DSVP-EKRFPVC-QAHGYFCQLID 120
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
VH+D+K N+LL+ KI+ G++ + T+ G+P +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQP 179
Query: 585 PEYYISNRLTE--KSDVYNFGVVL 606
PE K D+++ GV L
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTL 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 32/206 (15%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTLVGY 489
V+G+G V Y +VA+K ++ Q E++ + + HH N+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI-------------EAA 533
L+ + ++ G++ ++ A G L IA +
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 534 KVHRDVKSTNILLSGKFQAKIADFGLSR--TFPVEGSGTHVTTTIAGTPGYLDPE----- 586
++HRDVK+ NILL +IADFG+S + + V T GTP ++ PE
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201
Query: 587 -YYISNRLTEKSDVYNFGVVLLEIIT 611
Y K+D+++FG+ +E+ T
Sbjct: 202 RGY-----DFKADIWSFGITAIELAT 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 56/199 (28%), Positives = 83/199 (41%), Gaps = 32/199 (16%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG--YKQFQAEVELLMRIHHKNLT 484
N +LG G FG V + E AVK+++ +SA+ EVELL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEE-------ADILSWEGRLRIAIEAAK--- 534
L ++ ++ ++ E G L ++ + A I+ +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII------KQVFSGITYMH 138
Query: 535 ----VHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
VHRD+K NILL K KI DFGLS F GT Y+ PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTKMKDRIGTAYYIAPE- 193
Query: 588 YISNRLTEKSDVYNFGVVL 606
+ EK DV++ GV+L
Sbjct: 194 VLRGTYDEKCDVWSAGVIL 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 43/227 (18%)
Query: 403 MQVAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS 460
M+ K E Y + LG+G F V G E A K +
Sbjct: 2 METFKQQKVEDF-----Y--------DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR 48
Query: 461 SAQGYKQ------FQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG 514
++ ++ + EV +L ++ H N+ TL + T+ LI E ++ G L L
Sbjct: 49 QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 515 E----EADILSWEGRLRIAIEAAK-------VHRDVKSTNILLSGK----FQAKIADFGL 559
+ E + S+ ++ ++ H D+K NI+L K K+ DFGL
Sbjct: 109 KESLSEEEATSF---IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVL 606
+ I GTP ++ PE L ++D+++ GV+
Sbjct: 166 AHEI----EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 44/205 (21%), Positives = 74/205 (36%), Gaps = 46/205 (22%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMR-IHHKNLTT 485
+ +G G + E AVK++ S E+E+L+R H N+ T
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80
Query: 486 LVGYCDEGTNRGLIYEFMANGNL-------------QALLLGEEADILSWEGRLRIAIEA 532
L D+G ++ E M G L +A + +L +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA------SAVL------FTITKT 128
Query: 533 AK-------VHRDVKSTNILLSGKFQA----KIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
+ VHRD+K +NIL + +I DFG ++ E + T T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTAN 185
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVL 606
++ PE D+++ GV+L
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 43/204 (21%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTL 486
+ LG G +G V + VAVK++ A + + E+ + ++H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK------- 534
Y GN+Q L L GE D + + + +A +
Sbjct: 71 -------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQLMA 116
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
HRD+K N+LL + KI+DFGL+ T + + + GT Y+
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVA 175
Query: 585 PEYYISNRL--TEKSDVYNFGVVL 606
PE + R E DV++ G+VL
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVL 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 35/194 (18%), Positives = 73/194 (37%), Gaps = 24/194 (12%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
LG G FG V+ K + + E+ +L H+N+ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGE-----EADILSWEGRLRIAIEAAK------- 534
+ +I+EF++ ++ + E +I+S+ + EA +
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCEALQFLHSHNI 123
Query: 535 VHRDVKSTNILLSGKFQA--KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
H D++ NI+ + + KI +FG +R + P Y PE + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 593 LTEKSDVYNFGVVL 606
++ +D+++ G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 49/201 (24%), Positives = 77/201 (38%), Gaps = 30/201 (14%)
Query: 429 NFERVLGNGGFGTVYHGY--LDGTEVAVK------MLSPSSAQGYKQFQAEVELLMRIHH 480
+ LG+G F V G + A K S + + EV +L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEAAK-- 534
N+ TL + T+ LI E +A G L L + E + + L+ +
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF---LKQILNGVYYL 130
Query: 535 -----VHRDVKSTNILLSGKFQA----KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
H D+K NI+L + KI DFGL+ + I GTP ++ P
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTPEFVAP 186
Query: 586 EYYISNRLTEKSDVYNFGVVL 606
E L ++D+++ GV+
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 47/202 (23%), Positives = 71/202 (35%), Gaps = 44/202 (21%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLV 487
++ LG G F AVK++S Q E+ L H N+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLH 72
Query: 488 GYCDEGTNRGLIYEFMANGNL-------------QALLLGEEADILSWEGRLRIAIEAAK 534
+ + L+ E + G L +A + I+ R + A
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA------SYIM------RKLVSAVS 120
Query: 535 -------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
VHRD+K N+L + + KI DFG +R P + T T Y
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAA 177
Query: 585 PEYYISNRLTEKSDVYNFGVVL 606
PE N E D+++ GV+L
Sbjct: 178 PELLNQNGYDESCDLWSLGVIL 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 43/204 (21%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTL 486
+ LG G +G V + VAVK++ A + + E+ + ++H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK------- 534
Y GN+Q L L GE D + + + +A +
Sbjct: 71 -------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQLMA 116
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
HRD+K N+LL + KI+DFGL+ T + + + GT Y+
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVA 175
Query: 585 PEYYISNRL--TEKSDVYNFGVVL 606
PE + R E DV++ G+VL
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVL 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 37/200 (18%), Positives = 66/200 (33%), Gaps = 26/200 (13%)
Query: 435 GNGGFGTVYHGY--LDGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYC 490
G TV G V V+ ++ + Q E+ + +H N+
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAI-------------EAAKVHR 537
++ FMA G+ + L+ D ++ E IA VHR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIHHMGYVHR 152
Query: 538 DVKSTNILLSGKFQAKIADFG----LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
VK+++IL+S + ++ + + +L PE N
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 594 --TEKSDVYNFGVVLLEIIT 611
KSD+Y+ G+ E+
Sbjct: 213 GYDAKSDIYSVGITACELAN 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 31/200 (15%)
Query: 433 VLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNLTTLVGY 489
+G G FG V+ G VA+K++ A+ + Q E+ +L + +T G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 490 CDEGTNRGLIYEFMANGNLQALL----LGEE--ADILSWEGRLRIAIEA-------AKVH 536
+ T +I E++ G+ LL L E A IL R ++ K+H
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL------REILKGLDYLHSEKKIH 142
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT---TTIAGTPGYLDPEYYISNRL 593
RD+K+ N+LLS + K+ADFG++ G T T GTP ++ PE +
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 594 TEKSDVYNFGVVLLEIITSK 613
K+D+++ G+ +E+ +
Sbjct: 197 DSKADIWSLGITAIELARGE 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 65/226 (28%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS---------------PSSAQGYKQFQA---- 470
+G G +G V Y D T A+K+LS P +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 471 -------EVELLMRIHHKNLTTLVGYCDEGTNRGL--IYEFMANGNLQALLLGEEADILS 521
E+ +L ++ H N+ LV D+ L ++E + G + ++ +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM--------EVPT 130
Query: 522 WEGRLRIAIEAAK-----------------VHRDVKSTNILLSGKFQAKIADFGLSRTFP 564
L +A +HRD+K +N+L+ KIADFG+S F
Sbjct: 131 -LKPLSED-QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTE----KSDVYNFGVVL 606
+GS ++ T GTP ++ PE +S DV+ GV L
Sbjct: 188 -KGSDALLSNT-VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL 230
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 33/204 (16%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLV 487
E VLG G V + E AVK++ + EVE+L + H+N+ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 488 GYCDEGTNRGLIYEFMANGNL-----QALLLGE-EADILSWEGRLRIAIEAAK------- 534
+ +E L++E M G++ + E EA ++ ++ A
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDVASALDFLHNKGI 132
Query: 535 VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTT----TIAGTPGYLDPE- 586
HRD+K NIL Q KI DF L + G + ++T T G+ Y+ PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 587 ----YYISNRLTEKSDVYNFGVVL 606
++ ++ D+++ GV+L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 38/199 (19%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
+G G GTVY G EVA++ ++ + E+ ++ + N+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI-------------EAAKV 535
G ++ E++A G+L D+++ E + IA +
Sbjct: 88 VGDELWVVMEYLAGGSLT--------DVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 536 HRDVKSTNILLSGKFQAKIADFG----LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
HRD+KS NILL K+ DFG ++ +T+ GTP ++ PE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRK 191
Query: 592 RLTEKSDVYNFGVVLLEII 610
K D+++ G++ +E+I
Sbjct: 192 AYGPKVDIWSLGIMAIEMI 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTT 485
+ +G G F V L G EVA+K++ + + ++ EV ++ ++H N+
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------- 534
L + LI E+ A+G GE D L GR++ EA
Sbjct: 79 LFEVIETEKTLYLIMEY-ASG-------GEVFDYLVAHGRMKEK-EARSKFRQIVSAVQY 129
Query: 535 ------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
VHRD+K+ N+LL KIADFG S F G + G P Y PE
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAF-CGAPPYAAPE-L 184
Query: 589 ISNRLTE--KSDVYNFGVVL 606
+ + + DV++ GV+L
Sbjct: 185 FQGKKYDGPEVDVWSLGVIL 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 38/199 (19%)
Query: 434 LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD 491
+G G G V G +VAVKM+ Q + EV ++ H N+ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 492 EGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI-------------EAAKV 535
G ++ EF+ G L DI+S + RL IA +
Sbjct: 113 VGEELWVLMEFLQGGAL--------TDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 536 HRDVKSTNILLSGKFQAKIADFG----LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
HRD+KS +ILL+ + K++DFG +S+ P ++ GTP ++ PE +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-------KSLVGTPYWMAPEVISRS 216
Query: 592 RLTEKSDVYNFGVVLLEII 610
+ D+++ G++++E++
Sbjct: 217 LYATEVDIWSLGIMVIEMV 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 39/229 (17%), Positives = 75/229 (32%), Gaps = 48/229 (20%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVK--MLSPSSAQGYKQFQAEVELLMRI 478
R T F +G+G FG+V+ LDG A+K + + + EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 479 -HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG--------EEADILSWEGRLRIA 529
H ++ E + + E+ G+L + +EA++ ++
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 530 I----EAAKVHRDVKSTNILLS-------------------GKFQAKIADFGLSRTFPVE 566
+ + VH D+K +NI +S K KI D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS-- 185
Query: 567 GSGTHVTTTIAGTPGYLDPEYYISNRL--TEKSDVYNFGVVLLEIITSK 613
G +L E + K+D++ + ++ ++
Sbjct: 186 -----SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 31/196 (15%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
E LG G VY A+K+L + + K + E+ +L+R+ H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 488 GYCDEGTNRGLIYEFMANGNL-----QALLLGEE--ADILSWEGRLRIAIEAAK------ 534
+ T L+ E + G L + E AD + + +EA
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV------KQILEAVAYLHENG 168
Query: 535 -VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
VHRD+K N+L + KIADFGLS+ + T+ GTPGY PE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV----EHQVLMKTVCGTPGYCAPEILRG 224
Query: 591 NRLTEKSDVYNFGVVL 606
+ D+++ G++
Sbjct: 225 CAYGPEVDMWSVGIIT 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 33/199 (16%)
Query: 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTLVGY 489
LG G G V+ G +A K++ Q E+++L + + G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL------RIAIEAAK--------- 534
+ E M G+L +L GR+ +++I K
Sbjct: 100 FYSDGEISICMEHMDGGSL--------DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRDVK +NIL++ + + K+ DFG+S S + + GT Y+ PE
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS---MANSFVGTRSYMSPERLQGTH 206
Query: 593 LTEKSDVYNFGVVLLEIIT 611
+ +SD+++ G+ L+E+
Sbjct: 207 YSVQSDIWSMGLSLVEMAV 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 45/211 (21%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
LG+G FG VY G A K++ S + + + E+E+L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 490 CDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI-------------EAA 533
++ EF G + A++L + L I +
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIML-------ELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 534 KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGYLDPEY 587
+HRD+K+ N+L++ + ++ADFG+S T+ GTP ++ PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS---------AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 588 YISNRLTE-----KSDVYNFGVVLLEIITSK 613
+ + + K+D+++ G+ L+E+ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 42/205 (20%), Positives = 71/205 (34%), Gaps = 42/205 (20%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKML--------SPSSAQGYKQFQAEVELLMRIHH 480
LG+G FG V+ EV VK + + E+ +L R+ H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
N+ ++ + L+ E +G + + RL A+
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEP-LASYIFRQLV 140
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+HRD+K NI+++ F K+ DFG + G T GT Y
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTF-CGTIEYC 196
Query: 584 DPEYYISNRLTE--KSDVYNFGVVL 606
PE + + ++++ GV L
Sbjct: 197 APE-VLMGNPYRGPELEMWSLGVTL 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 36/207 (17%)
Query: 433 VLGNGGFGTVYHGYL--DGTEVAVK-MLSPSSAQGYKQFQAEVELLMR-IHHKNLTTLVG 488
LG G +G V G +AVK + + ++Q K+ ++++ MR + T G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL------RIAIEAAK-------- 534
+ + E M + +L ++ + +IA+ K
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRDVK +N+L++ Q K+ DFG+S AG Y+ PE I+
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISG----YLVDDVAKDIDAGCKPYMAPE-RINP 183
Query: 592 RLTE-----KSDVYNFGVVLLEIITSK 613
L + KSD+++ G+ ++E+ +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 48/205 (23%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTT 485
LG G FG V G L G +VAVK+L+ S + + E++ L H ++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK------ 534
L Y+ ++ +++ GE D + GR+ EA +
Sbjct: 76 L-------------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQIL 121
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
VHRD+K N+LL AKIADFGLS G + T+ G+P Y
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-CGSPNYA 177
Query: 584 DPEYYISNRLTE--KSDVYNFGVVL 606
PE IS RL + D+++ GV+L
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVIL 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 44/207 (21%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKML------SPSSAQGYKQFQAEVELLMRIH--- 479
+LG GGFGTV+ G+ D +VA+K++ S EV LL ++
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 480 -HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL---------RIA 529
H + L+ + + L+ E + D ++ +G L
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 530 IEAAK-------VHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
+ A + VHRD+K NIL+ + AK+ DFG T GT
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDF-DGTRV 203
Query: 582 YLDPEYYISNRLTE--KSDVYNFGVVL 606
Y PE +IS + V++ G++L
Sbjct: 204 YSPPE-WISRHQYHALPATVWSLGILL 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVG 488
++GNG +G VY G G A+K++ + ++ + E+ +L + HH+N+ T G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 489 -YCDEGTNRG-----LIYEFMANGNLQALLLGEEADILSWEGRLRIAI------------ 530
+ + L+ EF G++ L+ + + L E IA
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEW--IAYICREILRGLSHL 145
Query: 531 -EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV-TTTIAGTPGYLDPEYY 588
+ +HRD+K N+LL+ + K+ DFG+S T T GTP ++ PE
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVI 201
Query: 589 ISNRLTE-----KSDVYNFGVVLLEIITSK 613
+ + KSD+++ G+ +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 48/206 (23%), Positives = 78/206 (37%), Gaps = 42/206 (20%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKML------SPSSAQGYKQFQAEVELLMRIHHK 481
+LG+GGFG+VY G D VA+K + + EV LL ++
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 482 --NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL---------RIAI 530
+ L+ + + + LI E + D ++ G L +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPV-------QDLFDFITERGALQEELARSFFWQVL 159
Query: 531 EAAK-------VHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
EA + +HRD+K NIL+ + + K+ DFG T T GT Y
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF-DGTRVY 214
Query: 583 LDPEYYISNRLTE--KSDVYNFGVVL 606
PE +I + V++ G++L
Sbjct: 215 SPPE-WIRYHRYHGRSAAVWSLGILL 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 39/202 (19%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTL 486
+VLG G G V + + A+KML + + EVEL R ++ +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 487 VG-YCDEGTNRGLIY---EFMANGNL-------QALLLGE-EADILSWEGRLRIAIEAAK 534
V Y + R + E + G L E EA + ++ EA +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEAIQ 175
Query: 535 -------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
HRDVK N+L + K K+ DFG ++ + TT TP Y+
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----SHNSLTTPCYTPYYVA 231
Query: 585 PEYYISNRLTEKSDVYNFGVVL 606
PE + + D+++ GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 44/201 (21%), Positives = 79/201 (39%), Gaps = 40/201 (19%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLV 487
++VLG G G V + G + A+K+L S + + EV+ + ++ ++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 488 G-YCDEGTNRGLIY---EFMANGNL-------QALLLGE-EADILSWEGRLRIAIEAAK- 534
Y + + + E M G L E EA + +R A +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI-----MRDIGTAIQF 143
Query: 535 ------VHRDVKSTNILLSGKFQA---KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
HRDVK N+L + K + K+ DFG ++ + T TP Y+ P
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-----QNALQTPCYTPYYVAP 198
Query: 586 EYYISNRLTEKSDVYNFGVVL 606
E + + D+++ GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 39/230 (16%)
Query: 407 KNGSFELKNQRFSYSNVLRITNNFER--VLGNGGFGTVYHGYL--DGTEVAVK-MLSPSS 461
+ G + QR+ N+ E +G+G G V+ G +AVK M +
Sbjct: 9 QTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 462 AQGYKQFQAEVELLMR-IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEA--- 517
+ K+ +++++++ + G T+ + E M + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 518 DILSWEGRLRIAIEAAK-----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566
IL ++ + K +HRDVK +NILL + Q K+ DFG+S
Sbjct: 124 RILG-----KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--- 175
Query: 567 GSGTHVTTTIAGTPGYLDPE-----YYISNRLTEKSDVYNFGVVLLEIIT 611
AG Y+ PE ++DV++ G+ L+E+ T
Sbjct: 176 -VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 47/204 (23%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYK---QFQAEVELLMRIHHKNLTT 485
LG G FG V +VA+K +S + + + E+ L + H ++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLL----GEEADILSWEGRLRIAIEAAK------- 534
L Y+ + +++ GE D + + R+ E +
Sbjct: 74 L-------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTED-EGRRFFQQIIC 119
Query: 535 ----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
VHRD+K N+LL KIADFGLS G + T+ G+P Y
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTS-CGSPNYAA 175
Query: 585 PEYYISNRLTE--KSDVYNFGVVL 606
PE I+ +L + DV++ G+VL
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVL 198
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 35/205 (17%)
Query: 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMR-IHHKNLTTLVG 488
+G G +G+V G +AVK + + + KQ +++++MR + G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRL------RIAIEAAK-------- 534
+ + E M+ + + + + +I + K
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFY---KYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K +NILL K+ DFG+S + T AG Y+ PE I
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPE-RIDP 199
Query: 592 RLTE-----KSDVYNFGVVLLEIIT 611
+ +SDV++ G+ L E+ T
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELAT 224
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-16
Identities = 33/106 (31%), Positives = 47/106 (44%), Gaps = 10/106 (9%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN-----LK 330
+ LNL + I+G I + L + ILDLS+N L G +P +S L LTE++ L
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 331 GTIPNGLIEKQKNGLLSLSVEGNPDLC--PEASCTADESNGSRDNK 374
G IP Q NP LC P C ++G ++
Sbjct: 718 GPIPEM---GQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-11
Identities = 26/86 (30%), Positives = 39/86 (45%), Gaps = 7/86 (8%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
+ L L ++G G I P +S + + L LS N L+G +P L L L +L L
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 330 --KGTIPNGLIEKQKNGLLSLSVEGN 353
+G IP L L +L ++ N
Sbjct: 453 MLEGEIPQEL--MYVKTLETLILDFN 476
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 8e-11
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 274 PRITSLNLSSSGIAGDI-APYISTLTSIQILDLSNNNLTGPVPDFLSQLPF-LTEL---- 327
+ SL LSS+ +G++ + + +++LDLS N +G +P+ L+ L L L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 328 -NLKGTIPNGLIEKQKNGLLSLSVEGN 353
N G I L + KN L L ++ N
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNN 404
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 10/85 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----N 328
+ L++SS+ + I P++ +++Q LD+S N L+G +S L L
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 329 LKGTIPNGLIEKQKNGLLSLSVEGN 353
G IP ++ L LS+ N
Sbjct: 259 FVGPIPPLPLKS----LQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-10
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVP-DFLSQLPFLTEL----- 327
+T L+LS + G + P+ + + ++ L LS+NN +G +P D L ++ L L
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 328 NLKGTIPNGLIEKQKNGLLSLSVEGN 353
G +P L + LL+L + N
Sbjct: 354 EFSGELPESLTNLSAS-LLTLDLSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-10
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYIST-LTSIQILDLSNNNLTGPVPDFLSQLPFLTEL----- 327
+ L+L+ + G+I ++S ++ LDLS N+ G VP F L L
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 328 NLKGTIPNGLIEKQKNGLLSLSVEGN 353
N G +P + K + L L + N
Sbjct: 329 NFSGELPMDTLLKMRG-LKVLDLSFN 353
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-10
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 14/82 (17%)
Query: 261 WQGLNCSYPEYDPPRITSLNLSS---SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
+ G+ C ++TS++LSS + ++ + +LT ++ L LSN+++ G V F
Sbjct: 42 FDGVTC-----RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF 96
Query: 318 LSQLPFLTELNL-----KGTIP 334
LT L+L G +
Sbjct: 97 -KCSASLTSLDLSRNSLSGPVT 117
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-09
Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----NLKG 331
++LS++ + G+I +I L ++ IL LSNN+ +G +P L L L G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 332 TIPNGLIEKQKNGLLSLSVEGN 353
TIP + KQ + + + G
Sbjct: 553 TIPAAMF-KQSGKIAANFIAGK 573
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-09
Identities = 28/84 (33%), Positives = 39/84 (46%), Gaps = 7/84 (8%)
Query: 273 PPRITSLNLSSSGIAGDIAPYI--STLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL--- 327
+ +L+LSS+ +G I P + + ++Q L L NN TG +P LS L L
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 328 --NLKGTIPNGLIEKQKNGLLSLS 349
L GTIP+ L K L L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLW 450
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 20/69 (28%), Positives = 33/69 (47%), Gaps = 5/69 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL---- 329
N++S G +P S+ LD+S N L+G +P + +P+L LNL
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 330 -KGTIPNGL 337
G+IP+ +
Sbjct: 668 ISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 8/69 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----N 328
+ L +S + I+GD+ +S +++ LD+S+NN + +P FL L L
Sbjct: 178 GELKHLAISGNKISGDV-D-VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234
Query: 329 LKGTIPNGL 337
L G +
Sbjct: 235 LSGDFSRAI 243
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 14/77 (18%), Positives = 28/77 (36%), Gaps = 1/77 (1%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN-LKGT 332
+ L LS++ +G+I + S+ LDL+ N G +P + + N + G
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573
Query: 333 IPNGLIEKQKNGLLSLS 349
+ +
Sbjct: 574 RYVYIKNDGMKKECHGA 590
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 22/69 (31%), Positives = 35/69 (50%), Gaps = 5/69 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK--- 330
+ +L L + + G+I +S T++ + LSNN LTG +P ++ +L L L L
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 331 --GTIPNGL 337
G IP L
Sbjct: 526 FSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-09
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 5/69 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----N 328
++ L L + + G+I + + +++ L L N+LTG +P LS L +
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 329 LKGTIPNGL 337
L G IP +
Sbjct: 502 LTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-08
Identities = 25/87 (28%), Positives = 34/87 (39%), Gaps = 9/87 (10%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF--LSQLPFLTELNL-- 329
+ SL LS+S I G + S+ LDLS N+L+GPV L L LN+
Sbjct: 77 TGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSS 135
Query: 330 ---KGTIPNGLIEKQKNGLLSLSVEGN 353
K + L L + N
Sbjct: 136 NTLDFPGKVSGGLKLNS-LEVLDLSAN 161
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 25/70 (35%), Positives = 33/70 (47%), Gaps = 8/70 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLS-QLPFLTEL----- 327
+ LN+SS+ G I P L S+Q L L+ N TG +PDFLS LT L
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 328 NLKGTIPNGL 337
+ G +P
Sbjct: 305 HFYGAVPPFF 314
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 9/70 (12%)
Query: 274 PRITSLNLSSSGIAGDI-APYISTLTSIQILDLSNNNLTGPVPD---FLSQLPFLTELNL 329
+ LN+SS+ + L S+++LDLS N+++G L L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 330 -----KGTIP 334
G +
Sbjct: 186 SGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-07
Identities = 7/65 (10%), Positives = 21/65 (32%), Gaps = 5/65 (7%)
Query: 278 SLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL-----KGT 332
+ G + ++ L++ ++++ G + L++ G
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 333 IPNGL 337
IP +
Sbjct: 648 IPKEI 652
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN-----LK 330
++L+ + +A D+ + ++ LDL NN + G +P L+QL FL LN L
Sbjct: 223 TQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 331 GTIPNGLIEKQKNGLLSLSVEGNPDLC--PEASCT 363
G IP G ++ + N LC P +CT
Sbjct: 282 GEIPQGGNLQR---FDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 33/109 (30%)
Query: 261 WQGLNCSYPEYDPPRITSLNLSSSGIA---------------------------GDIAPY 293
W G+ C + R+ +L+LS + G I P
Sbjct: 38 WLGVLCD-TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 294 ISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK-----GTIPNGL 337
I+ LT + L +++ N++G +PDFLSQ+ L L+ GT+P +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 5/69 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL-----N 328
++ L ++ + ++G I ++S + ++ LD S N L+G +P +S LP L +
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 329 LKGTIPNGL 337
+ G IP+
Sbjct: 161 ISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 3e-08
Identities = 18/80 (22%), Positives = 33/80 (41%), Gaps = 12/80 (15%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL------NLK 330
+L+ S + ++G + P IS+L ++ + N ++G +PD L L
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 331 GTIPNGLIEKQKNGLLSLSV 350
G IP L+L+
Sbjct: 188 GKIPPTF------ANLNLAF 201
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 6/64 (9%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK----- 330
TS+ +S + + G I P + L ++ +DLS N L G +++L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 331 GTIP 334
+
Sbjct: 235 FDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 21/78 (26%), Positives = 33/78 (42%), Gaps = 12/78 (15%)
Query: 272 DPPRITSLNLSSS----GIAGDIAPYISTLTSIQILDLSNNNLTG--PVPDFLSQLPFLT 325
+P ++S ++ G + + + LDLS NL P+P L+ LP+L
Sbjct: 20 NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79
Query: 326 EL------NLKGTIPNGL 337
L NL G IP +
Sbjct: 80 FLYIGGINNLVGPIPPAI 97
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 42/207 (20%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG G +G+VY G VA+K + ++ E+ ++ + ++ G
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI-------------EA 532
+ T+ ++ E+ G++ + I L IA
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDI-------IRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 533 AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA------GTPGYLDPE 586
K+HRD+K+ NILL+ + AK+ADFG++ +T T+A GTP ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVA---------GQLTDTMAKRNTVIGTPFWMAPE 195
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSK 613
+D+++ G+ +E+ K
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 41/207 (19%), Positives = 71/207 (34%), Gaps = 41/207 (19%)
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------VHRDVKS 541
C + + ++M E L EA + +HRD+K
Sbjct: 142 LCRKEN----LKDWMNRRCSLEDR--EHGVCLHI---FIQIAEAVEFLHSKGLMHRDLKP 192
Query: 542 TNILLSGKFQAKIADFGLSRTFPVEGSGTHVT---------TTIAGTPGYLDPEYYISNR 592
+NI + K+ DFGL + V T GT Y+ PE N
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 593 LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652
+ K D+++ G++L E++ S S ER+ I I + + + F
Sbjct: 253 YSHKVDIFSLGLILFELLYSFST---QMERVRI------------ITDVRNLKFPLLFTQ 297
Query: 653 NSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + +S + T+RP +
Sbjct: 298 KYP-QEHMMVQDMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 5/63 (7%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQAEVELLMRIH 479
R +FE + +G GGFG V+ +D A+K + P+ ++ EV+ L ++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 480 HKN 482
H
Sbjct: 63 HPG 65
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 48/205 (23%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTT 485
LG G FG V G L G +VAVK+L+ S + + E++ L H ++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIEAAK------ 534
L Y+ ++ + +++ GE D + GRL E+ +
Sbjct: 81 L-------------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-ESRRLFQQIL 126
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
VHRD+K N+LL AKIADFGLS G + T+ G+P Y
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-CGSPNYA 182
Query: 584 DPEYYISNRLTE--KSDVYNFGVVL 606
PE IS RL + D+++ GV+L
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVIL 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 24/200 (12%), Positives = 48/200 (24%), Gaps = 57/200 (28%)
Query: 431 ERVLGNGGFGTVYHGYLD---GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLT 484
G + D +VA+ + P ++ + L RI +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 485 TLVGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
++ D R E++ G+LQ + S G +R A
Sbjct: 95 RVL---DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR 147
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+ + +S +A P +
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAY-----------------------PATMPDA----- 179
Query: 592 RLTEKSDVYNFGVVLLEIIT 611
+ D+ G L ++
Sbjct: 180 --NPQDDIRGIGASLYALLV 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 43/208 (20%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLS---PSSAQGYKQFQAEVELLMRIHHKNLTTL 486
R +G+G FG VY + VA+K +S S + ++ EV L ++ H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR---IAI------------- 530
G L+ E+ + + L+ IA
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD--------LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 531 EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT--TTIAGTPGYLDPEYY 588
+HRDVK+ NILLS K+ DFG + + + GTP ++ PE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPANSFVGTPYWMAPEVI 222
Query: 589 ISNRLTE---KSDVYNFGVVLLEIITSK 613
++ + K DV++ G+ +E+ K
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 50/199 (25%), Positives = 76/199 (38%), Gaps = 38/199 (19%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+ +G+G FG L VAVK + +A + Q E+ + H N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKE 83
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------------- 534
T+ +I E+ + G L + + GR EA
Sbjct: 84 VILTPTHLAIIMEYASGGEL--------YERICNAGRFSED-EARFFFQQLLSGVSYCHS 134
Query: 535 ---VHRDVKSTNILLSGKFQA--KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
HRD+K N LL G KI DFG S++ V S + GTP Y+ PE +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPK---STVGTPAYIAPE-VL 189
Query: 590 SNRLTE--KSDVYNFGVVL 606
+ + +DV++ GV L
Sbjct: 190 LRQEYDGKIADVWSCGVTL 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPS---SAQGYKQFQAEVELLMRIHH 480
+ F RVLG GGFG V+ + T A K L+ +GY+ E ++L ++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 481 KNLTTLVGYCDEGTNR-GLIYEFMANGNL--QALLLGEEADILSWEGRLR-------IAI 530
+ + +L Y E L+ M G++ + E+ E R +
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 531 E----AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
E ++RD+K N+LL +I+D GL+ + T AGTPG++ PE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPE 359
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSKS 614
+ D + GV L E+I ++
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 45/203 (22%), Positives = 76/203 (37%), Gaps = 28/203 (13%)
Query: 429 NFERVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGYKQFQ---AEVELLMRIHHKNL 483
F ++LG G F TV E A+K+L + E +++ R+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEE------ADILSWEGRLRIAIE- 531
L + + NG L + E A+I+S A+E
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------ALEY 145
Query: 532 ---AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K NILL+ +I DFG ++ E + GT Y+ PE
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSPELL 204
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
+ SD++ G ++ +++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 55/206 (26%), Positives = 82/206 (39%), Gaps = 25/206 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPS---SAQGYKQFQAEVELLMRIHH 480
N F RVLG GGFG V + T A K L +G E ++L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 481 KNLTTLVGYCDEGTNR-GLIYEFMANGNLQALLLGEEADILSWEGRLR-------IAIE- 531
+ + +L Y E + L+ M G+L+ + E R +E
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLED 301
Query: 532 ---AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
V+RD+K NILL +I+D GL+ V GT GY+ PE
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKS 614
+ R T D + G +L E+I +S
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 33/211 (15%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++FE +V+G G F V + T A+K+++ + F+ E ++L+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 481 KNLTTLVGYCDEGTNRGL--IYEFMANGNLQALLLGEEADILSWEGRLR-------IAIE 531
+ +T L + L + E+ G+L LL + + + R +AI+
Sbjct: 121 RWITQL--HFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIP-AEMARFYLAEIVMAID 176
Query: 532 A----AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
+ VHRD+K NILL ++ADFG +G+ + GTP YL PE
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR--SLVAVGTPDYLSPEI 234
Query: 588 YISNRLTEKSDVYN-------FGVVLLEIIT 611
+ + Y GV E+
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
+FE +V+G G FG V L + A+K+L+ + F+ E ++L+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 481 KNLTTLVGYC--DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR-------IAIE 531
K +TTL Y D+ N L+ ++ G+L LL E D L E R IAI+
Sbjct: 134 KWITTLH-YAFQDDN-NLYLVMDYYVGGDLLTLLSKFE-DRLP-EEMARFYLAEMVIAID 189
Query: 532 A----AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
+ VHRD+K NIL+ ++ADFG +G+ ++ GTP Y+ PE
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPE- 246
Query: 588 YISNRLTEKSDVYN-------FGVVLLEIIT 611
I + Y GV + E++
Sbjct: 247 -ILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 13/143 (9%)
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----- 534
+ L ++ ++ + + +++ + D L+ E + + + AK
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 535 -----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG-YLDPEYY 588
+HRD+ + NILLS K KI DFGL+R + +V A P ++ PE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPETI 267
Query: 589 ISNRLTEKSDVYNFGVVLLEIIT 611
T +SDV++FGV+L EI +
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKML-SPSSAQGYKQFQAEVELLMRI-HH 480
+ LG G FG V G VAVKML ++ ++ +E+++L+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 481 KNLTTLVGYC-DEGTNRGLIYEFMANGNLQALL 512
N+ L+G C G +I EF GNL L
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 31/166 (18%)
Query: 422 NVLRITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ---FQA--EV 472
+V +E++ LG G F TVY VA+K + K A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-----EEADILSW----- 522
+LL + H N+ L+ +N L+++FM +L+ ++ + I ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 523 EG-----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
+G + I +HRD+K N+LL K+ADFGL+++F
Sbjct: 123 QGLEYLHQHWI------LHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQFQ---AEVELLMRIHH 480
N+F R++G GGFG VY T A+K L + + E +L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 481 KNLTTLVG--YCDEGTNRGL--IYEFMANGNLQALLLGE----EADILSWEGRLRIAIE- 531
+ +V Y T L I + M G+L L EAD+ + + + +E
Sbjct: 249 GDCPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 532 ---AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
V+RD+K NILL +I+D GL+ F + GT GY+ PE
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVL 362
Query: 589 ISNRLTEKS-DVYNFGVVLLEIITSKS 614
+ S D ++ G +L +++ S
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 31/172 (18%)
Query: 426 ITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKML--------SPSSAQGYKQFQAEVE 473
+ +E++ +G G +G V+ G VA+K A E+
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIR 54
Query: 474 LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRI 528
+L ++ H NL L+ L++E+ + + L E + S +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 529 AIE---AAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-TH--VT 573
A+ HRDVK NIL++ K+ DFG +R T
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 37/207 (17%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQFQ---AEVELLMRIHH 480
+ F+ + LG G FG V + A+K+L KQ + E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR------------I 528
L L + +N ++ E++ G GE L GR +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-AG-------GEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 529 AIE----AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
E ++RD+K N+L+ + ++ DFG ++ T T+ GTP L
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWTLCGTPEALA 206
Query: 585 PEYYISNRLTEKSDVYNFGVVLLEIIT 611
PE +S + D + GV++ E+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 428 NNFERV--LGNGGFGTVYHGYLDGTE--VAVKMLS-------PSSAQGYKQFQAEVELLM 476
+ ++ LG G + TVY G T+ VA+K + P +A EV LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLK 55
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL-----LGEEADILSWEGRLRIAIE 531
+ H N+ TL + L++E++ + +L+ L + ++ + +L +
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 532 ---AAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPV 565
KV HRD+K N+L++ + + K+ADFGL+R +
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/177 (25%), Positives = 71/177 (40%), Gaps = 24/177 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
++E +V+G G FG V T A+K+LS F E +++ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR-------IAIEA- 532
+ L + ++ E+M G+L L+ + E R +A++A
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP----EKWARFYTAEVVLALDAI 184
Query: 533 ---AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
+HRDVK N+LL K+ADFG + G T GTP Y+ PE
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPE 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 37/156 (23%), Positives = 57/156 (36%), Gaps = 37/156 (23%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTL 486
+VLG G G V + + A+KML + + EVEL R ++ +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 487 VG-YCDEGTNRGLIY---EFMANGNL-------QALLLGEE--ADILSWEGRLRIAIEAA 533
V Y + R + E + G L E ++I ++ EA
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI------MKSIGEAI 130
Query: 534 K-------VHRDVKSTNILLSGKFQA---KIADFGL 559
+ HRDVK N+L + K K+ DFG
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 39/168 (23%)
Query: 425 RITNNFERV--LGNGGFGTVYHGY-LDGTEVAVKMLS--------PSSAQGYKQFQAEVE 473
+ ++++ +G G +G VY G VA+K + PS+A E+
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI------REIS 71
Query: 474 LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-----EEADILSW-----E 523
LL +HH N+ +L+ L++EFM +L+ +L +++ I +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 524 G-----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566
G + RI +HRD+K N+L++ K+ADFGL+R F +
Sbjct: 131 GVAHCHQHRI------LHRDLKPQNLLINSDGALKLADFGLARAFGIP 172
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 47/176 (26%)
Query: 425 RITNNFERV---LGNGGFGTVYHG----YLDGTEVAVKMLS----PSSAQGYKQFQAEVE 473
R+ + FE +G G +G VY D + A+K + SA E+
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIA 70
Query: 474 LLMRIHHKNLTTLVGYCDEGTNRG--LIYEFMANGNLQALLLGEEADILSWEGRLRIAIE 531
LL + H N+ +L +R L++++ + +L ++ + S + + +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII---KFHRASKANKKPVQLP 126
Query: 532 AAKV--------------------HRDVKSTNILLSGKFQA----KIADFGLSRTF 563
V HRD+K NIL+ G+ KIAD G +R F
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQFQ---AEVELLMRIHH 480
++FE R +G G FG V + T+ A+K ++ + + E++++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 481 KNLTTLVGYC--DEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIE--- 531
L L Y DE + ++ + + G+L+ L E + + L +A++
Sbjct: 75 PFLVNLW-YSFQDE-EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 532 -AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRD+K NILL I DF ++ TT+AGT Y+ PE + S
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAA----MLPRETQITTMAGTKPYMAPEMFSS 188
Query: 591 NRLTEKS---DVYNFGVVLLEIITSKS 614
+ S D ++ GV E++ +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 41/164 (25%)
Query: 428 NNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEVELL 475
NF++V +G G +G VY L G VA+K + PS+A E+ LL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLL 56
Query: 476 MRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL------LGEEADILSW-----EG 524
++H N+ L+ L++EF+ + +L+ + I S+ +G
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 525 -----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
R+ +HRD+K N+L++ + K+ADFGL+R F
Sbjct: 116 LAFCHSHRV------LHRDLKPQNLLINTEGAIKLADFGLARAF 153
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/85 (21%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+T L+LS + ++L+S+Q+L++S+NN L L L+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
T ++ + L L++ N
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 5/85 (5%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P +L+LS + + + + +Q+LDLS + L L+ L L G
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
++ G + L L
Sbjct: 87 PIQSLALGAFSGLSS-LQKLVAVET 110
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
++ L+ S + + +L ++ LD+S+ + + L L L +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 330 --KGTIPNGLIEKQKNGLLSLSVEGN 353
+ + + +N L L +
Sbjct: 456 SFQENFLPDIFTELRN-LTFLDLSQC 480
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ L ++ + + P I + L ++ LDLS L P + L L LN+
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
++ + + L L N
Sbjct: 505 NFFSLDTFPYKCLNS-LQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 15/56 (26%), Positives = 24/56 (42%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+++L L+ + I S L+S+Q L NL + L L ELN+
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 18/89 (20%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKG- 331
+ L + +A I L +++ L++++N + +P++ S L L L+L
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 332 ---TIPNGLIEKQKN---GLLSLSVEGNP 354
+I + LSL + NP
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 9/113 (7%)
Query: 248 FLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIA--GDIAPYISTLTSIQILDL 305
L+ + ++ + ++ E D P + L+LS +G++ G + TS++ LDL
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 306 SNNNLTGPVPDFLSQLPFLTELNL-----KGTIPNGLIEKQKNGLLSLSVEGN 353
S N + +FL L L L+ K + +N L+ L +
Sbjct: 381 SFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDISHT 431
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 9/85 (10%)
Query: 274 PRITSLNLSSSGIAG-DIAPYISTLTSIQILDLSNNNLTGPVPD---FLSQLPFL-TELN 328
+ LN++ + I + Y S LT+++ LDLS+N + L Q+P L L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 329 LKG----TIPNGLIEKQKNGLLSLS 349
L I G ++ + L+L
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLR 208
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 18/76 (23%), Positives = 25/76 (32%), Gaps = 2/76 (2%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
++S +L S I S Q L+L N L L LT + KG
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 334 PNGLIEKQKNGLLSLS 349
++ L LS
Sbjct: 340 AFSEVDLPSLEFLDLS 355
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 25/206 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQF---QAEVELLMRIHH 480
N FE ++LG G FG V T A+K+L + E +L H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 481 KNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEGRLRI 528
LT L Y + +R + E+ G L + + E+ A+I+S L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 529 AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
E V+RD+K N++L KI DFGL + +G+ T GTP YL PE
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLAPEVL 321
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKS 614
N D + GVV+ E++ +
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 40/163 (24%)
Query: 428 NNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEVELL 475
+E++ +G G +GTV+ VA+K + PSSA E+ LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 476 MRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-----EEADILSW-----EG- 524
+ HKN+ L L++EF + +L+ + + S+ +G
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 525 ----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
+ +HRD+K N+L++ + K+A+FGL+R F
Sbjct: 115 GFCHSRNV------LHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ LNL S+G L ++I+DL NNL + L LNL+
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNPDLC 357
++ + L L + NP C
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+T L+L S+ I ++ LDLS+N L+ QL L EL L
Sbjct: 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 332 ----TIPNGLIEKQKN-GLLSLSVEGNP--DLCPEA 360
+ + ++ N L L + N + P
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
+CS+ P+ P IT LNL+ + + A + + + LD+ N ++ P+
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 318 LSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
+LP L LNL+ + + N L L + N
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTN-LTELHLMSN 107
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG--PVPDFLSQLPFLTELNLKG 331
I + LS + + + S+Q L L L P L LT L+L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGN 353
I + ++E + L L ++ N
Sbjct: 490 NNIANINDDMLEGLEK-LEILDLQHN 514
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 12/59 (20%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 274 PRITSLNLSSSGIAGDIAPY-ISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ L+L + I ++ L +I + LS N + + +P L L L+
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 13/56 (23%), Positives = 22/56 (39%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+T L+LS + + + L ++ L NN+ L L + LNL
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 24/88 (27%), Positives = 30/88 (34%), Gaps = 13/88 (14%)
Query: 274 PRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
P + L L + L ++ ILDLSNNN+ D L L L L+L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL-- 511
Query: 332 TIPNGLIEKQKNGLLSLSVEGNPDLCPE 359
Q N L L NP
Sbjct: 512 ---------QHNNLARLWKHANPGGPIY 530
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 22/79 (27%), Positives = 35/79 (44%), Gaps = 2/79 (2%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTL--TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
I +L+LS+S ++ L T++ +LDLS NNL D + LP L L+
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 332 TIPNGLIEKQKNGLLSLSV 350
L +GL ++
Sbjct: 282 NNIQHLFSHSLHGLFNVRY 300
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
P + LNL + ++ + T++ L L +N++ + + L L+L
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
+ G + +N L L + N
Sbjct: 133 LSSTKLGTQVQLEN-LQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 13/92 (14%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT--------GPVPDFLSQLPFLT 325
+T L+LS++ IA + L ++ILDL +NNL G FL L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 326 ELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
LNL+ IP + + L + + N
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFE-LKIIDLGLN 570
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYIS----TLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+ L+LS+S + + + + IL+L+ N ++ D S L L L+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 330 -----KGTIPNGLIEKQKNGLLSLSVEGN 353
+ +N + + + N
Sbjct: 413 GLNEIGQELTGQEWRGLEN-IFEIYLSYN 440
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 13/92 (14%)
Query: 274 PRITSLNLSS--------SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLT 325
++ L+L G ++ L+ + IL+L +N + L L
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 326 ELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
++L T+P + Q + L SL+++ N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVS-LKSLNLQKN 594
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 16/89 (17%), Positives = 27/89 (30%), Gaps = 8/89 (8%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL----- 327
+ L LSS+ I + + L L+N L + + L T +
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 328 ---NLKGTIPNGLIEKQKNGLLSLSVEGN 353
L T + + L L + N
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 10/54 (18%), Positives = 24/54 (44%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
T ++S + + L ++ L++ +N++ G + + L L L+L
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 14/93 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNN---------NLTGPVPDFLSQLPFL 324
P++ L + I + + L +++ L+L + +L L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 325 TELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
LN++ I + + N L LS+ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLIN-LKYLSLSNS 363
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 40/168 (23%)
Query: 428 NNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS-------PSSAQGYKQFQAEVELLM 476
+ F+++ LGNG + TVY G G VA+K + PS+A E+ L+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI------REISLMK 58
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-- 534
+ H+N+ L L++EFM + +L+ + + + + L + + K
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYM--DSRTVGNTPRGLELNL--VKYF 113
Query: 535 ----------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566
+HRD+K N+L++ + Q K+ DFGL+R F +
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 40/184 (21%), Positives = 63/184 (34%), Gaps = 53/184 (28%)
Query: 425 RITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEV 472
+ +E + +G G +G V G VA+K A E+
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM------REI 75
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA 532
+LL ++ H+NL L+ C + L++EF+ + IL ++
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFV------------DHTILDDLELFPNGLDY 123
Query: 533 AKV--------------------HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-TH 571
V HRD+K NIL+S K+ DFG +RT G
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 572 --VT 573
T
Sbjct: 184 EVAT 187
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 37/180 (20%), Positives = 60/180 (33%), Gaps = 40/180 (22%)
Query: 421 SNVLRITNNF--ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLM 476
VL + NF + +G G FG + G VA+K+ S Q E
Sbjct: 2 MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYK 59
Query: 477 RIHH-KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR-------LR 527
++ + + + G ++ E LLG D+ R L
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLM 109
Query: 528 IAIEAAK----------VHRDVKSTNILLSGKFQAK-----IADFGLSRTFPVEGSGTHV 572
IAI+ ++RDVK N L+ I DF L++ + + H+
Sbjct: 110 IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 41/163 (25%)
Query: 428 NNFERV--LGNGGFGTVYHGYLDGTE--VAVKMLS--------PSSAQGYKQFQAEVELL 475
+ + +G G +G VY + A+K + PS+ E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTI------REISIL 54
Query: 476 MRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLG-----EEADILSW-----EG- 524
+ H N+ L L++E + + +L+ LL E S+ G
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 525 ----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
R+ +HRD+K N+L++ + + KIADFGL+R F
Sbjct: 114 AYCHDRRV------LHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY 465
S E+ + F + ++ + +G+G G V Y + VA+K LS
Sbjct: 50 SVEVGDSTF------TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------- 96
Query: 466 KQFQA---------EVELLMRIHHKNLTTLV------GYCDEGTNRGLIYEFMA---NGN 507
+ FQ E+ L+ ++HKN+ +L+ +E + L+ E M
Sbjct: 97 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 156
Query: 508 LQALLLGEEADILSWEG-RLRIAIEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPV 565
+Q L E L ++ + +A + HRD+K +NI++ KI DFGL+RT
Sbjct: 157 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 566 EGSGT-HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
T +V T Y PE + E D+++ G ++ E++ K
Sbjct: 217 SFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 30/208 (14%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQF---QAEVELLMRIHH 480
N+F+ ++LG G FG V T A+K+L + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 481 KNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEGRL-R 527
LT L Y + +R + E+ G L + + EE A+I+S L
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 528 IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG-SGTHVTTTIAGTPGYLDPE 586
+ V+RD+K N++L KI DFGL + EG S T GTP YL PE
Sbjct: 124 RDV----VYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPE 175
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSKS 614
N D + GVV+ E++ +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 58/250 (23%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLS-----PS 460
S E+ + F + ++ + +G+G G V Y + VA+K LS +
Sbjct: 13 SVEIGDSTF------TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 461 SAQG-YKQFQAEVELLMRIHHKNLTTLV------GYCDEGTNRGLIYEFMANGNLQALL- 512
A+ Y+ E+ L+ ++HKN+ L+ +E + ++ E M + NL ++
Sbjct: 67 HAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ 121
Query: 513 --LGEEADILSWEGRLRI----------AIEAAKV-HRDVKSTNILLSGKFQAKIADFGL 559
L E R+ + +A + HRD+K +NI++ KI DFGL
Sbjct: 122 MELDHE--------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 560 SRTFPVEGSGT-HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIER 618
+RT T +V T Y PE + E D+++ G ++ E+I +
Sbjct: 174 ARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 619 THERIHITQW 628
T HI QW
Sbjct: 229 TD---HIDQW 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 48/184 (26%), Positives = 69/184 (37%), Gaps = 42/184 (22%)
Query: 425 RITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS-PSSAQGYKQFQA----EVELL 475
T+ +E V +G G +GTVY G VA+K + P+ G EV LL
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 476 MRIH---HKNLTTL--VGYCDEGTNRGLIY---EFMANGNLQALL------LGEEADILS 521
R+ H N+ L V + E + +L+ L I
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 522 W-----EG-----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571
G I VHRD+K NIL++ K+ADFGL+R + + + T
Sbjct: 125 LMRQFLRGLDFLHANCI------VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 572 --VT 573
VT
Sbjct: 179 VVVT 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 48/188 (25%), Positives = 71/188 (37%), Gaps = 52/188 (27%)
Query: 425 RITNNFERV--LGNGGFGTVY---HGYLDGTEVAVKMLS--------PSSAQGYKQFQAE 471
R +E V +G G +G V+ G VA+K + P S E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------RE 61
Query: 472 VELLMRIH---HKNLTTL-----VGYCDEGTNRGLIYEFMANGNLQALL------LGEEA 517
V +L + H N+ L V D T L++E + + +L L
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 518 DILSW-----EG-----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567
I G R+ VHRD+K NIL++ Q K+ADFGL+R + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRV------VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 568 SGTH--VT 573
+ T VT
Sbjct: 175 ALTSVVVT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELN-- 328
R+T L+L G +G + I LT +++L L ++ P +S +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 329 ---LKGTIPNGLIEKQKNGLLSLSVEGNPDLCP 358
+ T + + + L+ + +P
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 7/83 (8%)
Query: 276 ITSLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG--- 331
I + + + + + + + + +L+ N L G +P F L LNL
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQI 365
Query: 332 -TIPNGLIEKQKNGLLSLSVEGN 353
IP + + +LS N
Sbjct: 366 TEIPANFCGFTEQ-VENLSFAHN 387
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 5/85 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
++ L + + G + P + + L+L+ N +T +F + L+
Sbjct: 330 KKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
IPN K + + ++ N
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDFSYNE 413
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 13/87 (14%), Positives = 32/87 (36%), Gaps = 11/87 (12%)
Query: 274 PRITSLNLS-------SSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTE 326
+++++ S + P ++ ++LSNN ++ + S L+
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 327 LNLKG----TIPNGLIEKQKNGLLSLS 349
+NL G IP ++ + +
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTY 488
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 2/69 (2%)
Query: 263 GLNCSYPEYDPPRITSLNLSSSGIAGDIAPYIS--TLTSIQILDLSNNNLTGPVPDFLSQ 320
G N S + + N + P +S + + L L +G VPD + Q
Sbjct: 44 GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 321 LPFLTELNL 329
L L L L
Sbjct: 104 LTELEVLAL 112
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 13/97 (13%)
Query: 274 PRITSLNLSS---SGIAGDIA--PYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328
P + ++LS S + D N P+ ++ P LT+L
Sbjct: 513 PYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 329 LKG----TIPNGLIEKQKNGLLSLSVEGNPDLCPEAS 361
+ + + + L ++ NP++ + S
Sbjct: 573 IGSNDIRKVNEKITPN----ISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 9/54 (16%), Positives = 19/54 (35%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+ N + L + +++ N +P FL LP + +N+
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 11/93 (11%), Positives = 31/93 (33%), Gaps = 11/93 (11%)
Query: 279 LNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK-----GTI 333
+ + + I+ S+ L + +N++ ++ L++K
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISID 603
Query: 334 PNGLIEKQKNGLLSLSVEGNPDLCPEASCTADE 366
+ + + G+ L + D+ C A +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIR---GCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 16/95 (16%), Positives = 27/95 (28%), Gaps = 14/95 (14%)
Query: 274 PRITSLNLSS-------SGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLT 325
++S+NL D + +DL N LT + LP+L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLV 516
Query: 326 ELNLKG----TIPNGLIEKQKNGLLSLSVEGNPDL 356
++L P + L + D
Sbjct: 517 GIDLSYNSFSKFPTQPLNSST--LKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 7/61 (11%), Positives = 17/61 (27%), Gaps = 1/61 (1%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336
T + S+ I ++ + LT ++ + N+ + T
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 337 L 337
Sbjct: 245 W 245
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 14/94 (14%), Positives = 31/94 (32%), Gaps = 17/94 (18%)
Query: 274 PRITSLNLSS---SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPF------- 323
++ +L+ + I +++ + +D S N + L
Sbjct: 377 EQVENLSFAHNKLKYIPNIFD--AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 324 LTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
++ +NL P L L S+++ GN
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSP-LSSINLMGN 467
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 48/174 (27%)
Query: 425 RITNNFERV--LGNGGFGTVYHG--YLDGTEVAVKMLS--------PSSAQGYKQFQAEV 472
+ +E++ +G G FG V+ G +VA+K + P +A E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REI 67
Query: 473 ELLMRIHHKNLTTLVGYC-----DEGTNRGLIY---EFMANGNLQALLLG-----EEADI 519
++L + H+N+ L+ C +G IY +F + +L LL ++I
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 126
Query: 520 LSW-----EG-----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563
G R +I +HRD+K+ N+L++ K+ADFGL+R F
Sbjct: 127 KRVMQMLLNGLYYIHRNKI------LHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 39/211 (18%)
Query: 429 NFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQGYKQF---QAEVELLM---RI-- 478
NF VLG G FG V GT+ AVK+L K +VE M R+
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLA 396
Query: 479 ---HHKNLTTLVGYCDEGTNRG-LIYEFMANGNL-----QALLLGEE------ADILSWE 523
LT L C + +R + E++ G+L Q E A+I
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 524 GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
L+ ++RD+K N++L + KIADFG+ + +G T T GTP Y+
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYI 509
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
PE + D + FGV+L E++ ++
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 65/268 (24%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 404 QVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSP 459
A G ++ Q F + + +G G +G V Y L+ VA+K +SP
Sbjct: 9 AAAAAGPEMVRGQVFD------VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62
Query: 460 SSAQGY-KQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG-----LIYEFMANGNLQALLL 513
Q Y ++ E+++L+R H+N+ + T ++ + M +L LL
Sbjct: 63 FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL- 120
Query: 514 GEEADILSWEGR-------LRI--AIEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTF 563
+ LS + LR I +A V HRD+K +N+LL+ KI DFGL+R
Sbjct: 121 --KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 564 PVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHER 622
+ T T T Y PE ++ T+ D+++ G +L E+++++ + H
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-- 236
Query: 623 IHITQWVSFM--LGK---GDIESIVDPR 645
++ Q + LG D+ I++ +
Sbjct: 237 -YLDQLNHILGILGSPSQEDLNCIINLK 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 8e-09
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 47/212 (22%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYKQFQ---AEVELLMR 477
+F+ R LG G FG V+ L +G A+K+L KQ + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--- 534
+ H + + G + +I +++ G GE +L R AK
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYI-EG-------GELFSLLRKSQRFPN--PVAKFYA 112
Query: 535 ---------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGT 579
++RD+K NILL KI DFG ++ P VT T+ GT
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYTLCGT 166
Query: 580 PGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT 611
P Y+ PE + + D ++FG+++ E++
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ +T L+LS + TL +Q+L++S+NNL +QL L+ L+
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGNP 354
T L K+ L ++ N
Sbjct: 531 NRIETSKGILQHFPKS-LAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 6/85 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ +L ++ + + + + T++ LDLS L L L LN+
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
+ + + + L +L N
Sbjct: 508 NLLFLDSSHYNQLYS-LSTLDCSFN 531
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 18/84 (21%), Positives = 28/84 (33%), Gaps = 5/84 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ L+LS I L + L L+ N + P S L L L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
++ + I + L L+V N
Sbjct: 116 LASLESFPIGQLIT-LKKLNVAHN 138
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 18/89 (20%), Positives = 39/89 (43%), Gaps = 8/89 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKG- 331
+ +L + +A + I L +++ L++++N + +P + S L L ++L
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 332 ---TIPNGLIE---KQKNGLLSLSVEGNP 354
TI ++ + LSL + NP
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNP 192
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 11/100 (11%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
C P+ P +++LS + + + S + +Q LDLS +
Sbjct: 16 YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 318 LSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
L L+ L L G + G + L +L
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTS-LENLVAVET 114
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 17/85 (20%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKG- 331
+ L+LS +G ++ L +Q LD ++ L L L L++
Sbjct: 376 NSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
+G+ + L +L + GN
Sbjct: 435 NTKIDFDGIFLGLTS-LNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 14/86 (16%), Positives = 24/86 (27%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPY-ISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
+ L+ S + +L + LD+S N L L L +
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 330 --KGTIPNGLIEKQKNGLLSLSVEGN 353
K + + N L L +
Sbjct: 459 SFKDNTLSNVFANTTN-LTFLDLSKC 483
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 274 PRITSLNLSSSGIAG-DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLT----ELN 328
+ LN++ + I + Y S LT++ +DLS N + + L L L+
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 329 LKG----TIPNGLIEKQKNGLLSLS 349
+ I + + K L+L
Sbjct: 188 MSLNPIDFIQDQAFQGIKLHELTLR 212
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 9e-09
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 428 NNFE--RVLGNGGFGTVY---HGYLDGTEV--AVKMLSPSSAQGYKQFQ--AEVELLMRI 478
+ FE +VLG G FG V+ A+K+L ++ + + + E ++L+ +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 479 HHKNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEGRL 526
+H + L Y + + LI +F+ G+L + ++ EE A++ L
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 527 -RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585
+ I ++RD+K NILL + K+ DFGLS+ + + GT Y+ P
Sbjct: 143 HSLGI----IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAP 195
Query: 586 EYYISNRLTEKSDVYNFGVVLLEIITSKS 614
E T+ +D ++FGV++ E++T
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQF---QAEVELLMRI-H 479
+F+ RV+G G + V L T+ A+K++ + Q E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 480 HKNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEGRLR 527
H L L C + +R + E++ G+L + L EE A+I L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 528 IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
E ++RD+K N+LL + K+ D+G+ + G T T GTP Y+ PE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEI 181
Query: 588 YISNRLTEKSDVYNFGVVLLEIITSKS 614
D + GV++ E++ +S
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 42/169 (24%)
Query: 425 RITNNFERV--LGNGGFGTVYHGY--LDGTEVAVKMLS--------PSSAQGYKQFQAEV 472
+ + R+ LG G +G VY + VA+K + P +A EV
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REV 84
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM---------ANGNLQALLLGEEADILSWE 523
LL + H+N+ L LI+E+ N ++ I S+
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDV------SMRVIKSFL 138
Query: 524 GRLRIAIE---AAKV-HRDVKSTNILLSGKFQA-----KIADFGLSRTF 563
+L + + + HRD+K N+LLS + KI DFGL+R F
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL--- 486
+ LG GG G V+ VA+K + + Q K E++++ R+ H N+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 487 -----------VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-------LRI 528
VG E + ++ E+M +L +L E L E LR
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQLLRG 132
Query: 529 --AIEAAKV-HRDVKSTNILL-SGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLD 584
I +A V HRD+K N+ + + KI DFGL+R S + T Y
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 585 PEYYIS-NRLTEKSDVYNFGVVLLEIITSK 613
P +S N T+ D++ G + E++T K
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 43/211 (20%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 419 SYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVEL 474
S+ ++++ R LG G + V+ + +V VK+L P + K+ E+++
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKI 83
Query: 475 LMRI-HHKNLTTL--VGYCDEGTNRGLIYEFMANGNLQALL--LGEEADILSWEGRLRIA 529
L + N+ TL + L++E + N + + L L + DI + + A
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-DIRFYMYEILKA 142
Query: 530 IE----AAKVHRDVKSTNILL-SGKFQAKIADFGLSRTFPVEGSGTH-VTTTIAGTPGYL 583
++ +HRDVK N+++ + ++ D+GL+ + V + +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 584 DPEYYISNRLTEKS-DVYNFGVVLLEIITSK 613
PE + ++ + S D+++ G +L +I K
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 65/228 (28%), Positives = 93/228 (40%), Gaps = 28/228 (12%)
Query: 407 KNGSFELKNQRFSYSNVLRITN-NFERVLGNGGFGTVYHGYLDGTE--VAVKMLSPSSAQ 463
K S E + SN L I N F RVLG G FG V + T AVK+L
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 464 GYKQF---QAEVELLMRI-HHKNLTTLVGYCDEGTNRG-LIYEFMANGNL-----QALLL 513
E +L +H LT L C + +R + EF+ G+L ++
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121
Query: 514 GEE------ADILSWEGRL-RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566
E A+I+S L I ++RD+K N+LL + K+ADFG+ +
Sbjct: 122 DEARARFYAAEIISALMFLHDKGI----IYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
G T T GTP Y+ PE D + GV+L E++ +
Sbjct: 178 GVTTA---TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 39/194 (20%), Positives = 69/194 (35%), Gaps = 44/194 (22%)
Query: 421 SNVLRITNNF--ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLM 476
+ ++ R +G G FG ++ G L+ +VA+K S Q + E
Sbjct: 3 GQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYK 60
Query: 477 RIHH-KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR-------LR 527
+ + + + EG + L+ + LLG D+L GR
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAM 110
Query: 528 IAIEAAK----------VHRDVKSTNILL---SGKFQAKI--ADFGLSRTFPVEGSGTHV 572
A + V+RD+K N L+ + K I DFG+ + + + H+
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
Query: 573 ----TTTIAGTPGY 582
++GT Y
Sbjct: 171 PYREKKNLSGTARY 184
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 428 NNFE--RVLGNGGFGTVY---HGYLDGTEV--AVKMLSPSS-AQGYKQF---QAEVELLM 476
FE RVLG GG+G V+ T A+K+L + + K +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 477 RIHHKNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEG 524
+ H + L+ Y + + LI E+++ G L + + E+ A+I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--- 132
Query: 525 RLRIAIE----AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
A+ ++RD+K NI+L+ + K+ DFGL + +G+ TH T GT
Sbjct: 133 ----ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---TFCGTI 185
Query: 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS 614
Y+ PE + + D ++ G ++ +++T
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 11/105 (10%)
Query: 260 LWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT-------G 312
+ ++CS +Y +++ LS + I +T + I + LSNN +T
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 313 PVPDFLSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
P LT ++L+ ++ + L ++ V N
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN 763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 15/80 (18%), Positives = 30/80 (37%), Gaps = 1/80 (1%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLK 330
+ R+T L+L+ G G + I LT +++L ++ T +L K
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 331 GTIPNGLIEKQKNGLLSLSV 350
I + + L++
Sbjct: 381 HRIRMHYKKMFLDYDQRLNL 400
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 11/91 (12%)
Query: 279 LNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----TIP 334
+ + I I+T S+ L + +N++ V + L P L L++ +I
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISID 843
Query: 335 NG-LIEKQKNGLLSLSVEGNPDLCPEASCTA 364
+ + G+ L + D+ C A
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDIR---GCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 14/53 (26%), Positives = 21/53 (39%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
N + + S L + ++L N +PDFL LP L LN+
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 9/85 (10%), Positives = 28/85 (32%), Gaps = 9/85 (10%)
Query: 274 PRITSLNLSS---SGIAGDIAPYIST--LTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328
+ S++ S +I+ + + + LS N + + + ++ +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 329 LKG----TIPNGLIEKQKNGLLSLS 349
L +IP ++ + +
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTY 728
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 14/94 (14%), Positives = 30/94 (31%), Gaps = 15/94 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGP---------VPDFLSQLPFL 324
+T + L + + ++ L +Q L+++ N + D P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 325 TEL-----NLKGTIPNGLIEKQKNGLLSLSVEGN 353
NL+ + ++K L L N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVK-LGLLDCVHN 583
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 14/85 (16%), Positives = 28/85 (32%), Gaps = 8/85 (9%)
Query: 274 PRITSLNLSSSGIAG-DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P+I + + + + + + + +LD +N + + F LT+L L
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAF-GTNVKLTDLKLDYN 605
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
IP + L N
Sbjct: 606 QIEEIPEDFCAFTDQ-VEGLGFSHN 629
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 12/93 (12%), Positives = 34/93 (36%), Gaps = 15/93 (16%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDL------SNNNLTGPVPDFLSQLPFLTEL 327
P ++++++S + + + ++ + N + P ++ P L +L
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 328 NLKG----TIPNGLIEKQKNGLLSLSVEGNPDL 356
+ + L + L L + NP++
Sbjct: 812 QIGSNDIRKVDEKLTPQ----LYILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 13/93 (13%), Positives = 26/93 (27%), Gaps = 4/93 (4%)
Query: 261 WQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQ 320
W+ + + + N + + L L+ G VPD + Q
Sbjct: 286 WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 321 LPFLTELNLKG----TIPNGLIEKQKNGLLSLS 349
L L L+ +++ +S
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 10/59 (16%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 274 PRITSLNLSS---SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+T+++L + ++ D +TL + +D+S N + P L +
Sbjct: 728 YLLTTIDLRFNKLTSLSDDFR--ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)
Query: 274 PRITSLNLSS---SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
++ L+ + T + L L N + DF + + L
Sbjct: 573 VKLGLLDCVHNKVRHL-----EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFS 627
Query: 331 G----TIPNGLIEKQKNGLLSLSVEGNP 354
IPN K + S+ N
Sbjct: 628 HNKLKYIPNIFNAKSVYVMGSVDFSYNK 655
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGYLDGTEV--AVKMLSPSSAQGYKQF---QAEVELLMRI-H 479
+F+ RV+G G + V L T+ A++++ + Q E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 480 HKNLTTLVGYCDEGTNR-GLIYEFMANGNL-----QALLLGEE------ADILSWEGRLR 527
H L L C + +R + E++ G+L + L EE A+I L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 528 IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
E ++RD+K N+LL + K+ D+G+ + G T T GTP Y+ PE
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEI 224
Query: 588 YISNRLTEKSDVYNFGVVLLEIITSKS 614
D + GV++ E++ +S
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY-LDGTEVAVKMLSPSSAQGYK 466
+L + + + + + R + +G +G V G +G VA+K + + + G
Sbjct: 10 MRDLIAELHA------MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 467 Q--FQA---------EVELLMRIHHKNLTTLV-----GYCDEGTNRGLIYEFMANGNLQA 510
E+ LL HH N+ L L+ E M +L
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQ 122
Query: 511 LLLGEEADILSWEGRLRI----------AIEAAKV-HRDVKSTNILLSGKFQAKIADFGL 559
++ + ++S ++ + A V HRD+ NILL+ I DF L
Sbjct: 123 VIHDQR-IVIS-PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 560 SRTFPVEGSGT-HVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSK 613
+R + + T +VT Y PE + T+ D+++ G V+ E+ K
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 19/86 (22%), Positives = 38/86 (44%), Gaps = 6/86 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ L ++ + + P I + L ++ LDLS L P + L L LN+
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNP 354
++P+G+ ++ + L + + NP
Sbjct: 505 QLKSVPDGIFDRLTS-LQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 20/93 (21%), Positives = 37/93 (39%), Gaps = 7/93 (7%)
Query: 266 CSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFL 324
CS ++ + L+LS +G+ ++ L ++ LD ++NL L L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 325 TELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
L++ NG+ + L L + GN
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGN 455
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 18/89 (20%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT-GPVPDFLSQLPFLTELNLKG- 331
+ L + +A I L +++ L++++N + +P++ S L L L+L
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 332 ---TIPNGLIEKQKN---GLLSLSVEGNP 354
+I + LSL + NP
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 19/99 (19%), Positives = 33/99 (33%), Gaps = 11/99 (11%)
Query: 265 NCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFL 318
C P+ P +L+LS + + + + +Q+LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 319 SQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
L L+ L L G ++ G + L L
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSS-LQKLVAVET 110
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
++ L+ S + + +L ++ LD+S+ + + L L L +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 330 --KGTIPNGLIEKQKNGLLSLSVEGN 353
+ + + +N L L +
Sbjct: 456 SFQENFLPDIFTELRN-LTFLDLSQC 480
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/56 (26%), Positives = 24/56 (42%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+++L L+ + I S L+S+Q L NL + L L ELN+
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
++RD+K N++L + KIADFG+ + +G T T GTP Y+ PE
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPEIIAYQPYG 199
Query: 595 EKSDVYNFGVVLLEIITSKS 614
+ D + FGV+L E++ ++
Sbjct: 200 KSVDWWAFGVLLYEMLAGQA 219
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 38/175 (21%)
Query: 424 LRITNNF--ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH 479
LR+ N + R +G+G FG +Y G G EVA+K+ + + Q E ++ +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQ 62
Query: 480 H-KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR-------LRIAI 530
+ T+ EG ++ E LLG D+ ++ R L +A
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLAD 112
Query: 531 EAAK----------VHRDVKSTNILL-SGKFQAKI--ADFGLSRTFPVEGSGTHV 572
+ +HRDVK N L+ GK + DFGL++ + + H+
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 31/81 (38%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG-SGTHVTTTIAGTPGYLDPEYYISNRL 593
V+RD+K NILL KIADFG+ + E G T T GTP Y+ PE + +
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 594 TEKSDVYNFGVVLLEIITSKS 614
D ++FGV+L E++ +S
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQS 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 38/192 (19%), Positives = 68/192 (35%), Gaps = 58/192 (30%)
Query: 405 VAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA 462
VA G + Q SY++ +V+GNG FG VY L G VA+K
Sbjct: 41 VATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAIK------- 85
Query: 463 QGYKQFQA------EVELLMRIHHKNLTTLVGYCDEGTNRG------LIYEFMANGNLQA 510
K Q E++++ ++ H N+ L + + L+ +++ +
Sbjct: 86 ---KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141
Query: 511 LLLGEEADILSWEGRLRIAIEAAKV------------------HRDVKSTNILL-SGKFQ 551
+ + + + K+ HRD+K N+LL
Sbjct: 142 VARH------YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 552 AKIADFGLSRTF 563
K+ DFG ++
Sbjct: 196 LKLCDFGSAKQL 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 32/167 (19%), Positives = 59/167 (35%), Gaps = 53/167 (31%)
Query: 431 ERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQA------EVELLMRIHHKNL 483
+V+GNG FG V+ L + EVA+K K Q E++++ + H N+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 484 TTLVGYCDEGTNRG------LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKV-- 535
L + ++ L+ E++ + +L+ + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYR--------ASRHYAKLKQTMPMLLIKL 145
Query: 536 ------------------HRDVKSTNILL-SGKFQAKIADFGLSRTF 563
HRD+K N+LL K+ DFG ++
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 27/80 (33%), Positives = 35/80 (43%), Gaps = 3/80 (3%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
V+RD+K NILL + + DFGL + S T T GTP YL PE
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLAPEVLHKQPYD 217
Query: 595 EKSDVYNFGVVLLEIITSKS 614
D + G VL E++
Sbjct: 218 RTVDWWCLGAVLYEMLYGLP 237
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/178 (17%), Positives = 59/178 (33%), Gaps = 42/178 (23%)
Query: 431 ERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQ------GYKQFQAEVELLMR 477
+G GGFG +Y + VK+ + Y++ ++
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 478 IHHKNLTTL----VGYCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR------- 525
I + L L G Y FM + G + I +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI---MD--RFGSDLQKIYEANAKRFSRKTV 154
Query: 526 LRIAIEAAK----------VHRDVKSTNILLSGKFQAKI--ADFGLSRTFPVEGSGTH 571
L++++ VH D+K++N+LL+ K ++ D+GL+ + EG
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 1e-07
Identities = 32/206 (15%), Positives = 53/206 (25%), Gaps = 63/206 (30%)
Query: 427 TNNFERV--LGNGGFGTVYHGYLDGTEVAVKML---SPSSAQGYKQ-----FQAEVELLM 476
T +R +G G FG V+ D T VA+K++ P G Q E+ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 477 RIH---------HKNLTTLVGYC------------------------------DEGTNRG 497
+ + L +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 498 LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-----------VHRDVKSTNILL 546
++ EF G L + S I + HRD+ N+LL
Sbjct: 139 IVLEFEFGGI---DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 547 SGKFQAKIADFGLSRTFPVEGSGTHV 572
K+ ++ + G V
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQV 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 7/83 (8%)
Query: 274 PRITSLNLSS---SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
P + LNL + TL ++IL LS +L+ + L + ++L
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 331 G----TIPNGLIEKQKNGLLSLS 349
+ + K L+L+
Sbjct: 509 HNRLTSSSIEALSHLKGIYLNLA 531
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 5/87 (5%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P + L +GI+ + +++ L L +N+++ L L+ +
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 332 ---TIPNGLIEKQKN-GLLSLSVEGNP 354
+ + + LSL++ GN
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGND 190
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 18/100 (18%), Positives = 26/100 (26%), Gaps = 11/100 (11%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
NC P P L S + + S L ++ LDL+ + D
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 318 LSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
L L L + + K L L
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKA-LKHLFFIQT 115
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 5/84 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
R+ +L L+++ + +S +++ L ++ L L L L
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
+I + L L + N
Sbjct: 141 ISSIKLPKGFPTEK-LKVLDFQNN 163
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 18/89 (20%), Positives = 30/89 (33%), Gaps = 8/89 (8%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG---PVPDFLSQLPFLTELN 328
+ + LNLS S + L ++Q L+L N+ + L L L L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 329 LKG----TIPNGLIEKQKNGLLSLSVEGN 353
L +I K + + + N
Sbjct: 483 LSFCDLSSIDQHAFTSLKM-MNHVDLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 14/58 (24%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ L+L+++ ++ ++ + L++++ L LS N S P LT L++KG
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 274 PRITSLNLSSSGIAGDIAPY-ISTLTSIQILDLSNNNLT--GPVPDFLSQLPFLTELNLK 330
P +T L++ + ++ + L +++ LDLS++++ L L L LNL
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 331 G----TIPNGLIEKQKNGLLSLSVEGN 353
++ ++ L L +
Sbjct: 385 YNEPLSLKTEAFKECPQ-LELLDLAFT 410
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 274 PRITSLNLSSSGIA--GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL-- 329
+ L+LS I + L+ +Q L+LS N + + P L L+L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 330 ---KGTIPNGLIEKQKNGLLSLSVEGN 353
K + L L++ +
Sbjct: 410 TRLKVKDAQSPFQNLHL-LKVLNLSHS 435
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 13/58 (22%), Positives = 28/58 (48%), Gaps = 1/58 (1%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ ++LS + + +S L I L+L++N+++ +P L L +NL+
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQ 556
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 9/70 (12%), Positives = 19/70 (27%), Gaps = 6/70 (8%)
Query: 274 PRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ S++ ++L + + L EL+L
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 332 ----TIPNGL 337
+P+GL
Sbjct: 288 THLSELPSGL 297
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 38/175 (21%)
Query: 424 LRITNNF--ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH 479
R+ N F R +G+G FG +Y G EVA+K+ + + + Q E ++ +
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQ 60
Query: 480 -HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR-------LRIAI 530
+ + + EG L+ + LLG D+ ++ R L +A
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLAD 110
Query: 531 EAAK----------VHRDVKSTNILLSGKFQAK---IADFGLSRTFPVEGSGTHV 572
+ +HRD+K N L+ +A I DFGL++ + + H+
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 19/82 (23%), Positives = 37/82 (45%), Gaps = 8/82 (9%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336
L + + D P +S LTS+ +LD+S++ + ++ LP + ++L NG
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY---NG 147
Query: 337 LIEKQKN-----GLLSLSVEGN 353
I L SL+++ +
Sbjct: 148 AITDIMPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 14/59 (23%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332
P++ S++LS +G DI P + TL ++ L++ + + + P L +L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 33/171 (19%), Positives = 62/171 (36%), Gaps = 31/171 (18%)
Query: 431 ERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
+ +G+GGFG +Y + + A ++ Q +E++ R+ K+
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 489 YCDEGTNRGL--IYEF----MANGNLQAL---LLGEE-ADILSWEGR------LRIAIEA 532
+ G+ Y + + + LG + I G L++ I
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160
Query: 533 AK----------VHRDVKSTNILLSGKFQAKI--ADFGLSRTFPVEGSGTH 571
VH D+K+ N+LL K ++ AD+GLS + G+
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 41/230 (17%), Positives = 75/230 (32%), Gaps = 57/230 (24%)
Query: 403 MQVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLS 458
M + S +N F + + +N+ ++G G +G VY Y VA+K ++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 459 PSSAQGYKQFQA---------EVELLMRIHHKNLTTLVGYCDEGTNRG-----LIYEFMA 504
+ F+ E+ +L R+ + L ++ E
Sbjct: 61 -------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA- 112
Query: 505 NGNLQALLLGEEAD---ILSWEGRLRIA---------------IEAAKV-HRDVKSTNIL 545
++D + L I + + HRD+K N L
Sbjct: 113 -----------DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL 161
Query: 546 LSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
L+ K+ DFGL+RT E T++ + + +LT
Sbjct: 162 LNQDCSVKVCDFGLARTINSE-KDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 42/234 (17%), Positives = 73/234 (31%), Gaps = 72/234 (30%)
Query: 406 AKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSS 461
S + + I + +E ++G G +G V Y L+ VA+K +
Sbjct: 37 KPTASMPRPHSDWQ------IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL--- 87
Query: 462 AQGYKQFQA---------EVELLMRIHHKNLTTL--VGYCDEGTNRGLIY---EFM---- 503
+ F+ E+ +L R++H ++ + + + +Y E
Sbjct: 88 ----RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDF 143
Query: 504 -----ANGNLQA---------LLLGE----EADILSWEGRLRIAIEAAKVHRDVKSTNIL 545
L LL+G A IL HRD+K N L
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGIL---------------HRDLKPANCL 188
Query: 546 LSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG----TPGYLDPEYYISNRLTE 595
++ K+ DFGL+RT +G + +LT
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 4/82 (4%)
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL- 593
++RD+K NILL + DFGLS+ F + + GT Y+ P+
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSG 238
Query: 594 -TEKSDVYNFGVVLLEIITSKS 614
+ D ++ GV++ E++T S
Sbjct: 239 HDKAVDWWSLGVLMYELLTGAS 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 9e-07
Identities = 46/340 (13%), Positives = 96/340 (28%), Gaps = 90/340 (26%)
Query: 16 IILEADVWDS--IE-FEDES-TIVT---KEII-HIPQKNFVYVCLVNKGSGTPFISAIEL 67
++L +V ++ F ++T K++ + ++ L +
Sbjct: 248 LVLL-NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT--L------ 298
Query: 68 RPLKNSTYTTESGSLSLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPNSEPINTTSDII 127
T SL ++ + R + LP + + P II
Sbjct: 299 ---------TPDEVKSLLLKY-LDCRPQD-------------LPREVLTTNPR--RLSII 333
Query: 128 SMNDYQGPSTVMQTAVIPTNG-SNSLQLSWEPNDPKFLYYAYLYFSEF-ENVQANNQTRE 185
+ + G +T + + + ++ S +P + S F +
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 186 IIIYINGIDWFG--PFSPLHFAA-------------NTIYSTWPILTAEKIEFSINTTES 230
+I WF + + S I +E +
Sbjct: 394 LI-------WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY----LELKVKLENE 442
Query: 231 STL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGL-----NCSYPE-YDPPRITSLNLSS 283
L I++ Y I + + + D Y + + N +PE R+ L+
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF 502
Query: 284 SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPF 323
+ I D + N +G + + L QL F
Sbjct: 503 --LEQKI-----------RHDSTAWNASGSILNTLQQLKF 529
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 94/660 (14%), Positives = 184/660 (27%), Gaps = 198/660 (30%)
Query: 26 IEFE-DESTIVTKEIIHIPQKNFV--YVCLVNKGSGTPFISAIELRPLKNSTYTTESGSL 82
++FE E K+I+ + + FV + C + +S E+ + S SG+L
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSGTL 65
Query: 83 SLFRRWDIGSRSSETF-RYPDDI----YDRIWLPNSLPNSEPINTTSDIISMNDYQGPST 137
LF W + S+ E ++ +++ Y +L + + +E + + +
Sbjct: 66 RLF--WTLLSKQEEMVQKFVEEVLRINYK--FLMSPI-KTEQRQPSMMTRMYIEQR---- 116
Query: 138 VMQTAVIPTNGSNSLQLSWEPND-PKFLYYAYLYFSEFENVQAN--NQTREIIIYINGID 194
+ L ND F Y + ++ + I+G+
Sbjct: 117 ------------DRLY-----NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 195 WFG----------PFSPLHFAANTIYSTWPILTAEKIEFSINTTESSTLPPILNAYEIYR 244
G + I+ W + + + L
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIF--W-------LNLKNCNSPETVL----------- 199
Query: 245 AKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILD 304
E LQ L Q D + RI S+ + PY + L +L
Sbjct: 200 --EMLQKLLYQIDPNWTS--RSDHSSNIKLRIHSIQAELRRLLKS-KPYENCLL---VLL 251
Query: 305 -LSNNN------------LT---GPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSL 348
+ N LT V DFLS T ++L L + LL
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT-THISLDH-HSMTLTPDEVKSLLLK 309
Query: 349 SVEGNPDLCPEASCTADESNGSRDNKFVVPVVASVVSLCVLVTAMAILW---------SL 399
++ P P T P S+++ + W L
Sbjct: 310 YLDCRPQDLPREVLT------------TNPRRLSIIAE--SIRDGLATWDNWKHVNCDKL 355
Query: 400 RRRMQVAKNG--SFELKNQRFSYSNVLR----ITNNFERVLGNGGFGTVYHGYLDGTEV- 452
++ + N E + + F +V I +L + + ++V
Sbjct: 356 TTIIESSLNVLEPAEYR-KMFDRLSVFPPSAHIP---TILLS------LIWFDVIKSDVM 405
Query: 453 --AVKMLSPSSAQGYKQFQAEVELLMRIH----------------HKNL----TTLVGYC 490
K+ S + + E + I H+++ +
Sbjct: 406 VVVNKLHKYSLVEKQPK-----ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460
Query: 491 DEG----TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAKVHRDVKSTNILL 546
+ Y + + +L+ + E + + L
Sbjct: 461 SDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFR---------------------MVFL 498
Query: 547 SGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL---DPEYYISNRLTEKSDVYNF 602
+F + KI + GS + + Y+ DP+Y RL + + +F
Sbjct: 499 DFRFLEQKIRHDSTAWNAS--GSILNTLQQLKFYKPYICDNDPKY---ERLV--NAILDF 551
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 28/185 (15%), Positives = 53/185 (28%), Gaps = 56/185 (30%)
Query: 431 ERVLGNGGFGTVYHGY----------LDGTEVAVKMLSPSSAQGY----------KQFQA 470
+ G +Y + ++K L + + K Q
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 471 EVEL-LMRIHHKNLTTLVGY-CDEGTNRGLIYEFMANGNLQALLLGEE-ADILSWEGR-- 525
L + T +G+ + R L+ LG L +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHV 155
Query: 526 ------LRIAIEAAK----------VHRDVKSTNILLSGKFQAKI--ADFGLSRTFPVEG 567
L++A VH +V + NI + + Q+++ A +G + +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-- 213
Query: 568 SGTHV 572
SG HV
Sbjct: 214 SGKHV 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 51/279 (18%), Positives = 96/279 (34%), Gaps = 68/279 (24%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI--------HHK 481
R LG G F TV+ ++ T VA+K++ + + E++LL R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 482 NLTTLVGYCDEGTNRGL---------------IYEFMANGN------------LQALLLG 514
++ D ++G + + + LLLG
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 515 EEADILSWEGRLRIAIEAAKVHRDVKSTNILLS------GKFQAKIADFGLSRTFPVEGS 568
D + + +H D+K N+L+ Q KIAD G + +
Sbjct: 144 --LDYMHRRCGI--------IHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW----Y 188
Query: 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT------SKSVIERTHER 622
H T +I T Y PE + +D+++ ++ E+IT T +
Sbjct: 189 DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 623 IHITQWVSFMLGKGDIESIVD-PRLHEDFDINSVWKTVE 660
HI Q + +LG+ + + F+ + + +
Sbjct: 248 DHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 55/271 (20%), Positives = 110/271 (40%), Gaps = 62/271 (22%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY 465
++ + + + +G+G +G+V G +VA+K LS
Sbjct: 12 KQDVNKTAWE------LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS------- 58
Query: 466 KQFQA---------EVELLMRIHHKNLTTLV------GYCDEGTNRGLIYEFMANGNLQA 510
+ FQ+ E+ LL + H+N+ L+ + L+ FM +LQ
Sbjct: 59 RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQK 117
Query: 511 LLLGEEAD---------ILSWEGRLRIAIEAAKV-HRDVKSTNILLSGKFQAKIADFGLS 560
++ + ++ +L + I +A V HRD+K N+ ++ + KI DFGL+
Sbjct: 118 IMGLKFSEEKIQYLVYQML----KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 561 RTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERT 619
R E +G +V T Y PE +S + D+++ G ++ E++T K++ +
Sbjct: 174 RHADAEMTG-YVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 620 HERIHITQWVSFM--LGK---GDIESIVDPR 645
++ Q + G ++ + D
Sbjct: 228 D---YLDQLTQILKVTGVPGTEFVQKLNDKA 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 53/234 (22%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY 465
E+ + + + + +G+G +G V G +VA+K L
Sbjct: 13 RQEVTKTAW------EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------- 59
Query: 466 KQFQA---------EVELLMRIHHKNLTTLV------GYCDEGTNRGLIYEFMANGNLQA 510
+ FQ+ E+ LL + H+N+ L+ D+ T+ L+ FM +L
Sbjct: 60 RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK 118
Query: 511 LLLGEEADILSWEGR-------LRI--AIEAAKV-HRDVKSTNILLSGKFQAKIADFGLS 560
L+ + + L + L+ I AA + HRD+K N+ ++ + KI DFGL+
Sbjct: 119 LM---KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 561 RTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSK 613
R + + +T + T Y PE ++ T+ D+++ G ++ E+IT K
Sbjct: 176 R-----QADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 50/218 (22%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA---------EVELLMRIHH 480
+LG G +G V G VA+K + P F E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKH 68
Query: 481 KNLTTL--VGYCDEGTNRGLIY---EFMANGNLQALLLGEEADILSWEGR-------LRI 528
+N+ T+ + D N +Y E M +L ++ +LS + LR
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI---STQMLSDDHIQYFIYQTLRA 124
Query: 529 --AIEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG------- 578
+ + V HRD+K +N+L++ K+ DFGL+R + T
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 579 TPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSK 613
T Y PE + S + + DV++ G +L E+ +
Sbjct: 185 TRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+T L+LS + + + P ++ L +++L S+N L V ++ LP L EL L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNR 519
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
L+ L+++GN
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 35/166 (21%), Positives = 55/166 (33%), Gaps = 44/166 (26%)
Query: 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQ---------AEVELLMRIH 479
ER+ G G FGTV G G VA+K K Q ++ L +H
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQDLAVLH 77
Query: 480 HKNLTTL--VGYCDEGTNRG-----LIYEFMANGNLQALL--LGEEADILSWE------- 523
H N+ L Y +R ++ E++ L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 524 ----GRLRIAIEAAKV-HRDVKSTNILL-SGKFQAKIADFGLSRTF 563
+ + + V HRD+K N+L+ K+ DFG ++
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 10/85 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
R+ L +S++ + + Y + ++++LDLS+N+L V Q L L L
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 335
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
T+ L +L++ N
Sbjct: 336 IVTLKLSTHH----TLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 7/85 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
++ LNL+ I +I Y + +IQ L + N + P +P LT L L+
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
++P G+ L +LS+ N
Sbjct: 134 DLSSLPRGIFHNTPK-LTTLSMSNN 157
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 12/87 (13%), Positives = 23/87 (26%), Gaps = 7/87 (8%)
Query: 273 PPRITSLNLSSSGIAGDI--APYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
++ D+ TL + +I+ N+ + L + LNL
Sbjct: 24 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83
Query: 331 G----TIPNGLIEKQKNGLLSLSVEGN 353
I + L + N
Sbjct: 84 DLQIEEIDTYAFAYAHT-IQKLYMGFN 109
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 19/85 (22%), Positives = 37/85 (43%), Gaps = 10/85 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
R+ L +S++ + + Y + ++++LDLS+N+L V Q L L L
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
T+ + L +L++ N
Sbjct: 330 IVTLKLSTH----HTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 7/85 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
++ LNL+ I +I Y + +IQ L + N + P +P LT L L+
Sbjct: 69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
++P G+ L +LS+ N
Sbjct: 128 DLSSLPRGIFHNTPK-LTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 11/79 (13%), Positives = 22/79 (27%), Gaps = 5/79 (6%)
Query: 279 LNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----TIP 334
+++ TL + +I+ N+ + L + LNL I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 335 NGLIEKQKNGLLSLSVEGN 353
+ L + N
Sbjct: 86 TYAFAYAHT-IQKLYMGFN 103
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 16/86 (18%), Positives = 36/86 (41%), Gaps = 9/86 (10%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P + ++LS + + I + + ++ L +SNN L + + +P L L+L
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 305
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNP 354
+ + + L +L ++ N
Sbjct: 306 HLLHVERNQPQFDR--LENLYLDHNS 329
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 22/120 (18%), Positives = 41/120 (34%), Gaps = 16/120 (13%)
Query: 248 FLQFLTNQQDAYL----WQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYIST-----LT 298
FL + + Q L + + + P + L L + + + L+
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 299 SIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGNP 354
+Q+L L++N L P S L L L+L + + + L L + N
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN---LEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 21/87 (24%), Positives = 32/87 (36%), Gaps = 8/87 (9%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
++ L L S I L +++ILDL ++ + PD L L EL L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 330 ---KGTIPNGLIEKQKNGLLSLSVEGN 353
+ +G K L L + N
Sbjct: 108 GLSDAVLKDGYFRNLKA-LTRLDLSKN 133
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 8/89 (8%)
Query: 274 PRITSLNLSSSGIAGDIAP--YISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLK 330
+ L L G++ + Y L ++ LDLS N + + +L L ++
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 331 G----TIPNGLIEK-QKNGLLSLSVEGNP 354
+ +E Q L S+ N
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANS 185
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 24/112 (21%), Positives = 41/112 (36%), Gaps = 6/112 (5%)
Query: 247 EFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAG-DIAPYISTLTSIQILDL 305
+ F+ + D +L G ++LS + + DI ++ + +QIL L
Sbjct: 375 TTIHFIPSIPDIFL-SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 306 SNNNLTG-PVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGNPDL 356
+ N + S+ P L +L L N L + L EG L
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGE---NMLQLAWETELCWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 14/83 (16%), Positives = 32/83 (38%), Gaps = 7/83 (8%)
Query: 276 ITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG--- 331
+ L+LS + + + TL +++L+L+ N + + L L LNL
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 332 -TIPNGLIEKQKNGLLSLSVEGN 353
+ + + + ++ N
Sbjct: 327 GELYSSNFYGLPK-VAYIDLQKN 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 14/56 (25%), Positives = 24/56 (42%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
R ++ S + +A + +++ LDLS N L+ L+ L LNL
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 15/91 (16%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
++ +L+LSS+ +A + P + + + L NN L + L L +L+G
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNPDLCPEA 360
+ + +++ + L +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 6/67 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ L+LS + ++ A ++ T +++L+LS+N L D L L L+L
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNY 91
Query: 332 --TIPNG 336
+ G
Sbjct: 92 VQELLVG 98
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 16/84 (19%), Positives = 36/84 (42%), Gaps = 7/84 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
P I +L+ +++ I+ ++ S + + L+NN +T + L+LK
Sbjct: 99 PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
T+ + + L L+++ N
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYN 179
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
++ LN+ S+ I+ DI+ ++ L+ + L L+NN L + + L LT L L
Sbjct: 265 TKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 334 PNGLIE-KQKNGLLSLSVEGNP 354
+ + + S
Sbjct: 323 ITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 17/86 (19%), Positives = 36/86 (41%), Gaps = 11/86 (12%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL---- 329
++T L + ++ I+ DI + LT +++L++ +N ++ L+ L L L L
Sbjct: 243 SQLTWLEIGTNQIS-DI-NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQ 298
Query: 330 -KGTIPNGLIEKQKNGLLSLSVEGNP 354
+ L +L + N
Sbjct: 299 LGNEDMEVI--GGLTNLTTLFLSQNH 322
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 269 PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328
+ + IT L ++ +A I I LT+++ L+L+ N +T P LS L LT L
Sbjct: 39 TQEELESITKLVVAGEKVA-SI-QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94
Query: 329 L 329
+
Sbjct: 95 I 95
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 3/56 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+ L L+ I+ DI+P ++ LT + L+L N+ LS + L L +
Sbjct: 110 TNLRELYLNEDNIS-DISP-LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTV 162
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 11/53 (20%), Positives = 20/53 (37%), Gaps = 4/53 (7%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+L + I I P + L L ++T V +L +T+L +
Sbjct: 3 ATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVV 51
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 11/84 (13%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ LNL+ + I DI+P +S L + L + N +T L L L EL L
Sbjct: 66 TNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDN 121
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
I + + SL++ N
Sbjct: 122 ISDISP--LANLTK-MYSLNLGAN 142
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 13/85 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
+ + I DI P ++ +T + L + NN +T L+ L LT L +
Sbjct: 199 TSLHYFTAYVNQIT-DITP-VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGT-- 252
Query: 334 PNGL-----IEKQKNGLLSLSVEGN 353
N + ++ L L+V N
Sbjct: 253 -NQISDINAVKDLTK-LKMLNVGSN 275
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 18/99 (18%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
++ +L+LSS+ +A + P + + + L NN L + L L +L+G
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNPDLC--PEASCTADE 366
+ + +++ + L E CT
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 14/56 (25%), Positives = 24/56 (42%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
R ++ S + +A + +++ LDLS N L+ L+ L LNL
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ LNL + I D+ + ++ LDLS+N L + +T ++L+
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNP 354
I L + L + GN
Sbjct: 226 LVLIEKAL--RFSQNLEHFDLRGNG 248
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 6/67 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ L+LS + ++ A ++ T +++L+LS+N L D L L L+L
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNY 91
Query: 332 --TIPNG 336
+ G
Sbjct: 92 VQELLVG 98
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 10/61 (16%), Positives = 22/61 (36%), Gaps = 5/61 (8%)
Query: 297 LTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEG 352
+I +++++L + + EL+L G I + L L++
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSS 67
Query: 353 N 353
N
Sbjct: 68 N 68
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 16/84 (19%), Positives = 34/84 (40%), Gaps = 15/84 (17%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
++ LNLSS+ + + +L++++ LDL+NN + L P + L+
Sbjct: 58 TKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
+ G ++ + N
Sbjct: 111 ISRVSCSRG----QGKKNIYLANN 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 20/89 (22%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+T L+LS + ++P ++L+S+Q+L++S+NN L L L+
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNPDLC 357
T ++ + L L++ N C
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 7/88 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKG- 331
+ L+LS +G+ ++ L ++ LD ++NL L L L++
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNPDL 356
NG+ + L L + GN
Sbjct: 137 HTRVAFNGIFNGLSS-LEVLKMAGNSFQ 163
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ L ++ + + P I + L ++ LDLS L P + L L LN+
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
++ + + L L N
Sbjct: 210 NFFSLDTFPYKCLNS-LQVLDYSLN 233
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 11/100 (11%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
+ C PE P L+L + I ++ ++ L+L+ N ++ P
Sbjct: 16 VLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 318 LSQLPFLTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
+ L L L L+ IP G+ N L L + N
Sbjct: 76 FNNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISEN 114
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/89 (25%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ LNLS + I+ I + L +Q + L L P L +L LN+ G
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNPDLC 357
T+ + N L +L ++ NP C
Sbjct: 307 QLTTLEESVFHSVGN-LETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 19/86 (22%), Positives = 38/86 (44%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P + L L+ + ++ + P + L +++ L L +N L + L LT+L++
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNP 354
+ + + + N L SL V N
Sbjct: 115 KIVILLDYMFQDLYN-LKSLEVGDND 139
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 17/84 (20%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
R+ L +S + P ++ L +++ NLT + L +L LNL
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
TI ++ + L + + G
Sbjct: 260 ISTIEGSMLHELLR-LQEIQLVGG 282
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 18/86 (20%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+T L++S + I + Y+ L +++ L++ +N+L S L L +L L+
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNP 354
+IP + L+ L +
Sbjct: 163 NLTSIPTEALSHLHG-LIVLRLRHLN 187
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 7/86 (8%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ L L I I Y L +++L++S+ + LT L++
Sbjct: 176 HGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNP 354
+P + L L++ NP
Sbjct: 235 NLTAVPYLAVRHLVY-LRFLNLSYNP 259
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 63/272 (23%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVY--HGYLDGTEVAVKMLSPSSAQGY 465
EL + + ++ +G+G +G+V G VAVK LS
Sbjct: 17 RQELNKTIW------EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------- 63
Query: 466 KQFQA---------EVELLMRIHHKNLTTLV------GYCDEGTNRGLIYEFMANGNLQA 510
+ FQ+ E+ LL + H+N+ L+ +E + L+ M +L
Sbjct: 64 RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 122
Query: 511 LLLGEEAD----------ILSWEGRLRIAIEAAKV-HRDVKSTNILLSGKFQAKIADFGL 559
++ ++ IL R I +A + HRD+K +N+ ++ + KI DFGL
Sbjct: 123 IVKCQKLTDDHVQFLIYQIL----RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIER 618
+R E +G T Y PE ++ + D+++ G ++ E++T +++
Sbjct: 179 ARHTADEMTGYVATRW------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 619 THERIHITQWVSFM--LGK---GDIESIVDPR 645
T HI Q + +G ++ I
Sbjct: 233 TD---HIDQLKLILRLVGTPGAELLKKISSES 261
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 8/85 (9%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----- 331
SL + +S ++ + P I L ++ LDL P L L LK
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 332 TIPNGLIEKQKNGLLSLSVEGNPDL 356
T+P I + L L + G +L
Sbjct: 268 TLPLD-IHRLTQ-LEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 20/87 (22%), Positives = 31/87 (35%), Gaps = 8/87 (9%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
P +L L S + L+ +Q + + L +PD + Q L L L
Sbjct: 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNP 138
Query: 332 --TIPNGLIEKQKNGLLSLSVEGNPDL 356
+P I L LS+ P+L
Sbjct: 139 LRALPAS-IASLNR-LRELSIRACPEL 163
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 12/66 (18%), Positives = 30/66 (45%), Gaps = 7/66 (10%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG----- 331
+ + ++G+ ++ + ++ L L+ N L +P ++ L L EL+++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 332 TIPNGL 337
+P L
Sbjct: 165 ELPEPL 170
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 37/188 (19%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQA---------EVELLMRIH- 479
+ LG G +G V+ G VAVK + FQ E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSG 67
Query: 480 HKNLTTL--VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGR-------LRI-- 528
H+N+ L V D + L++++M +L A++ A+IL + +++
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI---RANILEPVHKQYVVYQLIKVIK 123
Query: 529 AIEAAKV-HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
+ + + HRD+K +NILL+ + K+ADFGLSR+F T+ +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT--ENFD 181
Query: 588 YISNRLTE 595
LT+
Sbjct: 182 DDQPILTD 189
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 24/85 (28%), Positives = 34/85 (40%), Gaps = 16/85 (18%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+TSL+ +S I D+ I LT + L ++NN+T + LSQ LT L
Sbjct: 40 QLATLTSLDCHNSSIT-DM-TGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLAC-- 92
Query: 332 TIPNGLIEKQKNGLLSLSVEGNPDL 356
N L +L V L
Sbjct: 93 ---------DSNKLTNLDVTPLTKL 108
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 20/59 (33%), Positives = 31/59 (52%), Gaps = 5/59 (8%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
P ++ SLNLS +G+ + + + +LDLS N L P +LP + L+LKG
Sbjct: 252 PSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NPSPD-ELPQVGNLSLKG 305
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 7/89 (7%)
Query: 269 PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVP----DFLSQLPFL 324
++ P + L+++ + + ++ LDLS+N G + P L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 325 TELNL---KGTIPNGLIEKQKNGLLSLSV 350
L L P+G+ + L
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQG 232
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 21/83 (25%), Positives = 32/83 (38%), Gaps = 8/83 (9%)
Query: 263 GLNCSYPEYDPPRITSLNLSSSGIA---GDIAPYISTLTSIQILDLSNNNLTG-PVPDFL 318
GL + P + L L ++G+ G + + +Q LDLS+N+L
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 319 SQLPFLTELNLKG----TIPNGL 337
L LNL +P GL
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGL 272
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 17/97 (17%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
LN P+ P IT+L + + + + L + L++S N LT +P
Sbjct: 45 LNVGESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLTS-LPVL 99
Query: 318 LSQLPFLTELNLKGT-IPNGLIEKQKNGLLSLSVEGN 353
L L+ + T +P +GL L + GN
Sbjct: 100 PPGLLELSIFSNPLTHLPALP-----SGLCKLWIFGN 131
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 16/61 (26%), Positives = 28/61 (45%), Gaps = 4/61 (6%)
Query: 269 PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328
+ D ++T+L GI I + L ++ ++ SNN LT P L L L ++
Sbjct: 41 SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96
Query: 329 L 329
+
Sbjct: 97 M 97
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
+T+L L+ + + DI+P IS L ++ L L NN++ P +S L L L
Sbjct: 287 TALTNLELNENQLE-DISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 334 PNGLIE-KQKNGLLSLSVEGNP 354
+ + + LS N
Sbjct: 343 VSDVSSLANLTNINWLSAGHNQ 364
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
+T L+L+++ I+ ++AP +S LT + L L N ++ P L+ L LT L L
Sbjct: 243 TNLTDLDLANNQIS-NLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 334 PNGLIE-KQKNGLLSLSVEGN 353
+ L L++ N
Sbjct: 299 LEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
+T L L + I+ DI+P +S+LT +Q L NN ++ L+ L + L+
Sbjct: 309 KNLTYLTLYFNNIS-DISP-VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQ 364
Query: 334 PNGLIE-KQKNGLLSLSVEGNP 354
+ L + L +
Sbjct: 365 ISDLTPLANLTRITQLGLNDQA 386
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 11/84 (13%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ SL +++ I+ DI P + LT++ L L+ N L L+ L LT+L+L
Sbjct: 199 TNLESLIATNNQIS-DITP-LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQ 254
Query: 332 --TIPNGLIEKQKNGLLSLSVEGN 353
+ + L L + N
Sbjct: 255 ISNLAP--LSGLTK-LTELKLGAN 275
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 17/54 (31%), Positives = 29/54 (53%), Gaps = 4/54 (7%)
Query: 276 ITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+T +N S++ + DI P + LT + + ++NN + P L+ L LT L L
Sbjct: 70 LTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 14/89 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
+ L+ + G+ IA + L ++ L+LS+N ++G + + P LT LNL G
Sbjct: 42 EELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG-- 97
Query: 334 PNGLIEKQKN--------GLLSLSVEGNP 354
N I+ L SL +
Sbjct: 98 -N-KIKDLSTIEPLKKLENLKSLDLFNCE 124
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/116 (12%), Positives = 38/116 (32%), Gaps = 5/116 (4%)
Query: 219 EKIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLN-----CSYPEYDP 273
+K+ F + + +L ++F + + + +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
I L++ + D++ S L ++ + + N+ + F L L L+L
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 7/70 (10%)
Query: 274 PRITSLNLSSSGIA--GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
P + +L LS + + + TL ++ LD+S N P+PD + LNL
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419
Query: 332 ----TIPNGL 337
+ +
Sbjct: 420 TGIRVVKTCI 429
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 7/94 (7%)
Query: 274 PRITSLNLSSSGIAG-DIAPYISTLTSIQILDLSNNN-LTGPVPDFLSQLPFLTELNLKG 331
+ LNL + + LT++Q L + N + + L L EL +K
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 332 ----TIPNGLIEKQKN-GLLSLSVEGNPDLCPEA 360
+ ++ ++ L+L + + L
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 12/61 (19%), Positives = 22/61 (36%), Gaps = 3/61 (4%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT---GPVPDFLSQLPFLTELNLK 330
++ + + +S + + L S++ LDLS N + P L L L
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 331 G 331
Sbjct: 370 Q 370
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 11/58 (18%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
PR+ L +S + + + S + ++ +S N L +L L ++ L
Sbjct: 451 PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
+ L L SS I I +L S++ LDLS+N+L+ + L L LNL G
Sbjct: 50 ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGNPDL 356
T+ + L +L +
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETF 136
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 24/87 (27%), Positives = 31/87 (35%), Gaps = 7/87 (8%)
Query: 273 PPRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
LNL + I I L ++IL LS N++ + L L L L
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGNP 354
TIPNG L L + NP
Sbjct: 122 NRLTTIPNGAFVYLSK-LKELWLRNNP 147
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 2/59 (3%)
Query: 274 PRITSLNLSSSGIAGDIAPY-ISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ L + S I I L S+ ++L++NNLT D + L L ++L
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/86 (17%), Positives = 29/86 (33%), Gaps = 6/86 (6%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
P + L + I+ A ++ IL L +N L + L L +L+L
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGN 353
++ L +L ++
Sbjct: 91 AQLRSVDPATFHGLGR-LHTLHLDRC 115
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 32/187 (17%), Positives = 58/187 (31%), Gaps = 2/187 (1%)
Query: 145 PTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQANNQTREIIIYINGIDWFGPFSPLHF 204
PTN L L + + +N + + + N + +
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 205 AANTIYSTWPILTAEKIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGL 264
N+ ++ + + + + L L+ + + L+ L+ Q G
Sbjct: 233 TWNSFIRILQLVWHTTVWY--FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 265 NCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFL 324
SY + N + SG S ++ LD SNN LT V + L L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 325 TELNLKG 331
L L+
Sbjct: 351 ETLILQM 357
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 264 LNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDF 317
++ S P+ + T LN+S + I+ I +L+ ++IL +S+N +
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 318 LSQLPFLTELNL 329
L L+L
Sbjct: 65 FKFNQELEYLDL 76
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 13/86 (15%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTI 333
P++ SL L ++ I DI +S LT + L L +N ++ VP L+ L L L L
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK-- 187
Query: 334 PNGL-----IEKQKNGLLSLSVEGNP 354
N + + KN L L +
Sbjct: 188 -NHISDLRALAGLKN-LDVLELFSQE 211
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 8/87 (9%)
Query: 272 DPPRITSLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLK 330
P + L L + G I + +++ L L N L L +LP L +L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 331 G----TIPNGLIEKQKNGLLSLSVEGN 353
+ L EK N L L++ GN
Sbjct: 80 ENRIFGGLDMLAEKLPN-LTHLNLSGN 105
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-- 331
+ L+L + G+ ++ + L ++ L+LS N + G + +LP LT LNL G
Sbjct: 49 VNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 332 -TIPNGLIEKQKNGLL-SLSVEGNP 354
+ L +K L SL +
Sbjct: 107 LKDISTLEPLKKLECLKSLDLFNCE 131
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 10/63 (15%), Positives = 24/63 (38%), Gaps = 7/63 (11%)
Query: 274 PRITSLNLSSSGIAGDIAPYIST---LTSIQILDLSNNNLTG----PVPDFLSQLPFLTE 326
P + L + + + L ++ +D+S LT + D + ++ L
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 327 LNL 329
+N+
Sbjct: 312 INM 314
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVP-DFLSQLPFLTELNLKG 331
+ L +S + IA ++ I L ++++L +SNN +T D L+ L L +L L G
Sbjct: 92 ADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 22/91 (24%), Positives = 38/91 (41%), Gaps = 8/91 (8%)
Query: 269 PEYDPPRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL 327
P+ PP +T L+L + I + L ++ L LS N+++ L+ P L EL
Sbjct: 187 PQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 328 NLKG----TIPNGLIEKQKNGLLSLSVEGNP 354
+L +P GL + + + N
Sbjct: 246 HLNNNKLVKVPGGL--ADHKYIQVVYLHNNN 274
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 20/94 (21%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 265 NCSYPEYDPPRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPF 323
N ++ + + + +LS S I + + S T ++ L L+ N + + L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 324 LTELNLKG----TIPNGLIEKQKNGLLSLSVEGN 353
L +LNL +I + + E L L + N
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDK-LEVLDLSYN 357
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/87 (17%), Positives = 24/87 (27%), Gaps = 8/87 (9%)
Query: 274 PRITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL--- 329
+ L + I L+S+ IL L N + L L L L
Sbjct: 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113
Query: 330 ---KGTIPNGLIEKQKNGLLSLSVEGN 353
+ + + L L + N
Sbjct: 114 NLDGAVLSGNFFKPLTS-LEMLVLRDN 139
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 19/160 (11%), Positives = 44/160 (27%), Gaps = 24/160 (15%)
Query: 103 DIYDRIWLPNSLPNSEPINTT--SDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWE-PN 159
D++ + + L + + + + QT N ++ P
Sbjct: 19 DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERY-----NEDSFGYDIPI 73
Query: 160 DPKFLYYAYLYFSEFENVQANNQTREIIIYING---------IDWFGPFSPLHFAANTIY 210
+ Y L F+E Q+ + + +NG D G +
Sbjct: 74 KEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISI 131
Query: 211 STWPI-----LTAEKIEFSINTTESSTLPPILNAYEIYRA 245
+ ++ + S+ + P + A I +
Sbjct: 132 KKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKG 171
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 38/205 (18%)
Query: 432 RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK---NLTTL 486
+V+G G FG V Y VA+KM+ + + ++Q E+ +L + + N +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 487 VGYCDEGTNRG--------L---IYEFMANGNLQALLLGEEADI-------LSWEGRLRI 528
+ + T R L +YE + Q L L + RI
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221
Query: 529 AIEAAKVHRDVKSTNILL--SGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
+H D+K NILL G+ K+ DFG S + V T I + Y PE
Sbjct: 222 ------IHCDLKPENILLKQQGRSGIKVIDFG-SSCY----EHQRVYTYIQ-SRFYRAPE 269
Query: 587 YYISNRLTEKSDVYNFGVVLLEIIT 611
+ R D+++ G +L E++T
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLT 294
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 13/85 (15%)
Query: 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG- 331
PP + L +S++ + + P + + ++I+D+ NN+L +PD L +
Sbjct: 130 PPLLEYLGVSNNQLE-KL-PELQNSSFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNN 183
Query: 332 ---TIPNGLIEKQKNGLLSLSVEGN 353
+P ++ L ++ + N
Sbjct: 184 QLEELPE--LQNLPF-LTAIYADNN 205
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 8/86 (9%)
Query: 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331
+ R L+L I I +TL +D S+N + D L L L +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 73
Query: 332 ----TIPNGLIEKQKNGLLSLSVEGN 353
I GL + + L L + N
Sbjct: 74 NRICRIGEGLDQALPD-LTELILTNN 98
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 723 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.98 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.98 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.36 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.32 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.19 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.12 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.09 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.05 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.01 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.96 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.95 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.93 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.91 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.88 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.88 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.87 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.86 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.85 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.72 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.71 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.69 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.68 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.64 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.64 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.63 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.63 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.61 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.58 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.58 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.55 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.55 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.54 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.52 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.5 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.5 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.49 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.48 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.48 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.47 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.47 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.47 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.47 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.45 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.45 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.41 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.39 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.38 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.38 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.37 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.37 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.37 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.36 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.34 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.33 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.32 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.29 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.29 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.23 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.22 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.22 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.2 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.2 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.16 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.15 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.12 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.1 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.1 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.09 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.09 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.08 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.07 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.07 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.03 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.01 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.0 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.99 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 97.99 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.97 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 97.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 97.93 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.88 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.87 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 97.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.86 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 97.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.84 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 97.83 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.81 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.81 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.81 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.69 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.68 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.67 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.65 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 97.64 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 97.55 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.53 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.46 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.45 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.36 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.36 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 96.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 96.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.88 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 96.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.67 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.56 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 96.29 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.15 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 95.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.49 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 95.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 94.82 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 94.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 94.57 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 94.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.33 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.95 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 92.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.28 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 91.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.58 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 90.47 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 90.4 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 86.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.8 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 81.37 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=404.51 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=193.1
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|++. +..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3578999999999999863 458999999988777788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCC-------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccC
Q 004935 503 MANGNLQALLLGEE-------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGL 559 (723)
Q Consensus 503 ~~~gsL~~~l~~~~-------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGl 559 (723)
|++|+|.++++... ...++|..++.++.++|. |||||||+||||++++.+||+|||+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGl 204 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEccccc
Confidence 99999999997642 235889888888877765 9999999999999999999999999
Q ss_pred ccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCc
Q 004935 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 560 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
++....... ........||+.|||||.+.+..++.++|||||||+||||+| |+.||...... +.+.... .+..
T Consensus 205 a~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i~-~g~~ 278 (329)
T 4aoj_A 205 SRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDCIT-QGRE 278 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHHHH-HTCC
T ss_pred ceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHHHH-cCCC
Confidence 987643322 223345679999999999999999999999999999999999 89999765432 2222221 1111
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+... ......+.+++.+||+.+|++||||+||++.|+.+.+.
T Consensus 279 -----~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 279 -----LERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----CCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 12234678999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=408.59 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=197.6
Q ss_pred HHHHhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 497 (723)
.+..|.+.||+|+||.||+|.+. ++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34457789999999999999872 4589999997653 334578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEE
Q 004935 498 LIYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~k 553 (723)
||||||++|+|.++|..+. ...++|..++.++.++|. |||||||+||||++++++|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 9999999999999996532 235888888888877765 9999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHH
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~ 632 (723)
|+|||+++....... ........||+.|||||.+.++.++.++|||||||+||||+| |+.||.+.... +.+. .
T Consensus 186 i~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----~~~~-~ 259 (308)
T 4gt4_A 186 ISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVVE-M 259 (308)
T ss_dssp ECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH----HHHH-H
T ss_pred ECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH----HHHH-H
Confidence 999999987643221 223345679999999999999999999999999999999999 89999765432 2222 2
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
+..+.... .+.++...+.+++.+||+.+|++||||+||++.|+..
T Consensus 260 i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222111 1122344678999999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=400.96 Aligned_cols=244 Identities=27% Similarity=0.425 Sum_probs=197.7
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|++. +..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 4678999999999999863 458999999988777788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccC-----------CCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 503 MANGNLQALLLGE-----------EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 503 ~~~gsL~~~l~~~-----------~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
|++|+|.++|+.. ....++|..++.++.++|. |||||||+||||++++.+||+|||+|+
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~ 176 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHH
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccce
Confidence 9999999999753 2346888888888777765 999999999999999999999999998
Q ss_pred ccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIES 640 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (723)
....... ........||+.|||||.+.+..++.++|||||||+||||+| |+.||...... +.+... ..+...
T Consensus 177 ~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i-~~~~~~- 249 (299)
T 4asz_A 177 DVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI-TQGRVL- 249 (299)
T ss_dssp HHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHH-HHTCCC-
T ss_pred ecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH-HcCCCC-
Confidence 7543221 222334568999999999999999999999999999999999 89999765432 222222 122111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.. +......+.+++.+||+.+|++||||+||++.|+++.+
T Consensus 250 ----~~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 250 ----QR----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 11233467899999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=393.50 Aligned_cols=244 Identities=28% Similarity=0.478 Sum_probs=187.4
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||+||+|++.+ .||||+++.. .....++|.+|+++|++++|||||+++|+|.+ +..+||||||++|+
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred EeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 46789999999999999765 6999998754 34556789999999999999999999999865 56899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.++++... ..++|..++.++.++|. |||||||+||||++++++||+|||+|+....... ........
T Consensus 118 L~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~ 195 (307)
T 3omv_A 118 LYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-SQQVEQPT 195 (307)
T ss_dssp HHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------CC
T ss_pred HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc-ceeecccc
Confidence 999997643 34788877777766665 9999999999999999999999999987643222 23344568
Q ss_pred CCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 578 GTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 578 gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
||+.|||||++.+ +.++.++|||||||+||||+||+.||........+.. ....+. ..|.+. ....++
T Consensus 196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~----~~~~~~----~~p~~~-~~~~~~ 266 (307)
T 3omv_A 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF----MVGRGY----ASPDLS-KLYKNC 266 (307)
T ss_dssp CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHHTTC----CCCCST-TSCTTS
T ss_pred cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH----HHhcCC----CCCCcc-cccccc
Confidence 9999999999864 4589999999999999999999999976543222222 222211 112111 112233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
...+.+++.+||+.+|++||||+||++.|+.+
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 45678999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=390.02 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=197.4
Q ss_pred HhhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccC-CceeeEEEEEec-CCceEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHH-KNLTTLVGYCDE-GTNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~-~~~~~l 498 (723)
.+.+.||+|+||.||+|.+.+ +.||||++.... ....+.|.+|+++|++++| ||||+++|+|.+ ++..++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 446789999999999998732 479999998654 3446789999999999965 899999999976 456899
Q ss_pred EEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl 554 (723)
|||||++|+|.++|+... ...++|..++.++.++|. |||||||+||||++++.+||
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi 226 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 226 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEE
Confidence 999999999999997532 245788888777777665 99999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+|+.+..... ........||+.|||||.+.+..++.++|||||||+||||+| |+.||........+...+.
T Consensus 227 ~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~--- 302 (353)
T 4ase_A 227 CDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--- 302 (353)
T ss_dssp CCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH---
T ss_pred CcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH---
Confidence 99999997654332 233455678999999999999999999999999999999998 8999976543322322222
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.+.. +.... .....+.+++.+||+.||++||||+||++.|+++++..
T Consensus 303 -~g~~-----~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 303 -EGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -HTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -cCCC-----CCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2211 11111 12346789999999999999999999999999988643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=383.07 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=185.9
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----ceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT----NRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|+++|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+ ..+||||||++
T Consensus 7 L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 3578999999999999999999999999754322 223455667778899999999999997654 57899999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc------------------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA------------------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a------------------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
|+|.++++.. .++|..+++++.++| .|||||||+||||+.++++||+|||+|+......
T Consensus 86 gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 86 GSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 9999999764 367776666555443 2899999999999999999999999998764332
Q ss_pred CCc-eeeecccCCCccccccccccC------CCCChhhHHHHHHHHHHHHcCCCccccCccc----------ccHHHHHH
Q 004935 568 SGT-HVTTTIAGTPGYLDPEYYISN------RLTEKSDVYNFGVVLLEIITSKSVIERTHER----------IHITQWVS 630 (723)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~SfGvvL~elltg~~p~~~~~~~----------~~~~~~~~ 630 (723)
... .......||+.|||||++.+. .++.++|||||||+||||+||+.|+...... ....+.+.
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 211 122345799999999998754 4678999999999999999998876432211 11112222
Q ss_pred HHhcCCCcccccCCcccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 631 FMLGKGDIESIVDPRLHED-FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
...... ..+|.+... ...+....+.+++.+||+.||++||||+||++.|+++.+.+.
T Consensus 243 ~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 243 KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 222221 122333222 123466778899999999999999999999999998875543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=375.39 Aligned_cols=243 Identities=19% Similarity=0.227 Sum_probs=186.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||.||+|+. +++.||||+++.... +.+|+++|++++|||||++++++.+.+..+||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 46799999999999998 477999999975432 25799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCc--eeeec
Q 004935 509 QALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGT--HVTTT 575 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~--~~~~~ 575 (723)
.+++.... .+++... +..+|+...|||||||+||||+.++ ++||+|||+|+.+....... .....
T Consensus 138 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~ 215 (336)
T 4g3f_A 138 GQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215 (336)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CC
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCc
Confidence 99997542 2343333 3333433449999999999999987 69999999999875432211 12234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|||||.+.+..|+.++|||||||+||||+||+.||............... ..... .+.. ...
T Consensus 216 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~~~~~-----~~~~----~~s 283 (336)
T 4g3f_A 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---PPPIR-----EIPP----SCA 283 (336)
T ss_dssp CCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---CCGGG-----GSCT----TSC
T ss_pred cccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---CCCch-----hcCc----cCC
Confidence 67999999999999999999999999999999999999999876544333332221 10000 1111 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
..+.+++.+||+.||.+|||++|+++.|..+++...+
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 4677999999999999999999999999988866554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=377.49 Aligned_cols=236 Identities=22% Similarity=0.401 Sum_probs=179.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+.+.||+|+||.||+|+. +++.||||++... .....+.|.+|+++|++++|||||++++++.+.+..+||||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3467899999999999998 4779999999754 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCC------HHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILS------WEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~------~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.......++ |..+ +..+|+...|||||||+||||+.++.+||+|||+|+.+... .....
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---~~~~~ 183 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---VELAR 183 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---HHHHH
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---ccccc
Confidence 99999999765433333 3333 33344444499999999999999999999999999876321 12234
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|||||.+.+..|+.++|||||||+||||+||+.||...... +.+...... .. +.+....
T Consensus 184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~-~~-----~~~~~~~---- 249 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----NLVLKIISG-SF-----PPVSLHY---- 249 (350)
T ss_dssp HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHT-CC-----CCCCTTS----
T ss_pred ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcC-CC-----CCCCccC----
Confidence 567999999999999999999999999999999999999999765432 222222211 11 1111222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+||+.||++|||++|+++
T Consensus 250 s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 235779999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.08 Aligned_cols=234 Identities=26% Similarity=0.428 Sum_probs=176.4
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E 501 (723)
|.+.||+|+||.||+|.+. +..||+|++... .....+.|.+|+++|++++|||||+++++|.. ....+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 4567999999999999984 568999998653 34456789999999999999999999999865 345789999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHH----HHHHHHHhcc--ccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCc
Q 004935 502 FMANGNLQALLLGEEA----DILSWE----GRLRIAIEAA--KVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a--~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||++|+|.+++..... ....|. ..+..+|... .|||||||+||||+. ++.+||+|||+|+....
T Consensus 110 y~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----- 184 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----- 184 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-----
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-----
Confidence 9999999999975421 112222 2344444444 599999999999984 78999999999986432
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......||+.|||||.+.+ .|+.++|||||||+||||+||+.||....... ...+ .+..+... +.+....
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~~~-~i~~~~~~----~~~~~~~ 255 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYR-RVTSGVKP----ASFDKVA 255 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHH-HHTTTCCC----GGGGGCC
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HHHH-HHHcCCCC----CCCCccC
Confidence 22345689999999998864 69999999999999999999999997543322 2222 22222111 1111111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+||+.||++|||++|+++
T Consensus 256 ----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 256 ----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 225779999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=378.96 Aligned_cols=236 Identities=20% Similarity=0.284 Sum_probs=183.3
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||.||+|+. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999998 4779999999765444456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCC---CCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCc
Q 004935 509 QALLLGEEA---DILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581 (723)
Q Consensus 509 ~~~l~~~~~---~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~ 581 (723)
.+++....- .+..+ ...+..+|+...|||||||+||||+.++.+||+|||+|+.+.... .......||+.
T Consensus 159 ~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~ 235 (346)
T 4fih_A 159 TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPY 235 (346)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---CCBCCCCSCGG
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC---CcccccccCcC
Confidence 999875421 11122 223344444444999999999999999999999999998764322 23345789999
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHH
Q 004935 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEI 661 (723)
Q Consensus 582 y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 661 (723)
|||||.+.+..|+.++|||||||+||||++|+.||....... ........ . .+.+.. .......+.++
T Consensus 236 YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~-~-----~~~~~~--~~~~s~~~~dl 303 (346)
T 4fih_A 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDN-L-----PPRLKN--LHKVSPSLKGF 303 (346)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHS-S-----CCCCSC--GGGSCHHHHHH
T ss_pred cCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcC-C-----CCCCCc--cccCCHHHHHH
Confidence 999999999999999999999999999999999997653321 11111111 0 111110 11122357799
Q ss_pred HHhccCCCCCCCCCHHHHHH
Q 004935 662 AMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 662 ~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+||+.||++|||++|+++
T Consensus 304 i~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999998875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=379.75 Aligned_cols=237 Identities=20% Similarity=0.284 Sum_probs=185.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|+. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 346899999999999998 477999999987655555678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC---CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 508 LQALLLGEEA---DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 508 L~~~l~~~~~---~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
|.+++....- .+. +....+.++|+...|||||||+||||+.++.+||+|||+|+.+.... ......+||+
T Consensus 235 L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp 311 (423)
T 4fie_A 235 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTP 311 (423)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---CCBCCCEECT
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC---ccccccccCc
Confidence 9999875421 111 22233444444455999999999999999999999999998764332 2334568999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHH
Q 004935 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVE 660 (723)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 660 (723)
.|||||.+.+..|+.++|||||||+||||++|+.||...... +........ . .+.+... ......+.+
T Consensus 312 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~-~-----~~~~~~~--~~~s~~~~d 379 (423)
T 4fie_A 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDN-L-----PPRLKNL--HKVSPSLKG 379 (423)
T ss_dssp TTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHS-C-----CCCCSCT--TSSCHHHHH
T ss_pred CcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcC-C-----CCCCccc--ccCCHHHHH
Confidence 999999999999999999999999999999999999765332 111111111 0 1111110 111235779
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 004935 661 IAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 661 l~~~Cl~~~p~~RPsm~evl~ 681 (723)
++.+||+.||++|||++|+++
T Consensus 380 li~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.90 Aligned_cols=237 Identities=20% Similarity=0.301 Sum_probs=185.3
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.+.||+|+||+||+|+. +++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 34568999999999999998 57799999997532 23356799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 503 MANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|+|.+++..... .+..+.. .+..+|+...|||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus 114 ~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 192 (311)
T 4aw0_A 114 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARAN 192 (311)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-CCCBC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-ccccc
Confidence 999999999975421 1222333 34444444459999999999999999999999999998753322 23345
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..+||+.|||||.+.+..|+.++||||+||+||||+||+.||...... +....... +. ..+.....
T Consensus 193 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~-~~------~~~p~~~s--- 258 (311)
T 4aw0_A 193 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIK-LE------YDFPEKFF--- 258 (311)
T ss_dssp CCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-TC------CCCCTTCC---
T ss_pred CcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHc-CC------CCCCcccC---
Confidence 678999999999999999999999999999999999999999765432 22222211 11 11222222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
..+.+++.+||+.||++|||++|++
T Consensus 259 -~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 259 -PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -HHHHHHHHHHccCCHhHCcChHHHc
Confidence 3567999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.95 Aligned_cols=233 Identities=20% Similarity=0.331 Sum_probs=168.4
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 95 (275)
T 3hyh_A 16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 95 (275)
T ss_dssp EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 4567899999999999997 47799999997543 233567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|+|.+++..... .+..+.. .+..+|+...+||||||+|||+++++++||+|||+|+..... .....
T Consensus 96 -~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~ 170 (275)
T 3hyh_A 96 -GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKT 170 (275)
T ss_dssp -CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred -CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC----CccCC
Confidence 6899999876432 1122223 344444444499999999999999999999999999875322 22345
Q ss_pred ccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..||+.|||||.+.+..+ +.++||||+||+||||+||+.||..... .+..+... .+. +.+....+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~-~~~------~~~p~~~s--- 236 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNIS-NGV------YTLPKFLS--- 236 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HTC------CCCCTTSC---
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-cCC------CCCCCCCC---
Confidence 689999999999998876 5799999999999999999999976432 22222221 111 11111222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.||++|||++|+++
T Consensus 237 -~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 237 -PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 35679999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.13 Aligned_cols=231 Identities=22% Similarity=0.298 Sum_probs=171.3
Q ss_pred HHhhhhccccCcEEEEEEEE-----CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.+.||+|+||.||+|+. .++.||||+++... .....++.+|+++|++++|||||++++++.+.+..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 34568999999999999986 24589999997542 122346889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 501 EFMANGNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|||++|+|.+++..... .+..+. ..+..+|+...|||||||+|||++.++.+||+|||+|+...... ..
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~ 182 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KK 182 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--------CC
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC---cc
Confidence 99999999999976422 122222 33444444445999999999999999999999999998653221 22
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....||+.|||||.+.+..++.++||||+||+||||+||+.||...... +....... +. +.+....
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~-~~------~~~p~~~-- 249 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMILK-AK------LGMPQFL-- 249 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-CC------CCCCTTS--
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHHc-CC------CCCCCcC--
Confidence 34568999999999999999999999999999999999999999765432 22222211 11 1111122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
...+.+++.+||+.||++|||+
T Consensus 250 --s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 250 --SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CHHHHHHHHHHcccCHHHCCCC
Confidence 2357799999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.76 Aligned_cols=236 Identities=20% Similarity=0.296 Sum_probs=166.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------------
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------------ 494 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------------ 494 (723)
+.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 457899999999999998 47799999987544 344567999999999999999999999986543
Q ss_pred ceEEEEEeCCCCCHHHHhccCCC-CCCC------HH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 495 NRGLIYEFMANGNLQALLLGEEA-DILS------WE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~-~~l~------~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
..++|||||++|+|.+++..... .... +. ..+..+|+...|||||||+||||+.++.+||+|||+|+.+
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~ 168 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceec
Confidence 36899999999999999976532 1122 22 2344444445599999999999999999999999999876
Q ss_pred CCCCCCc---------eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc
Q 004935 564 PVEGSGT---------HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 564 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
....... .......||+.|||||.+.+..|+.++|||||||+||||++ ||....+. ...+. ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~~~~-~~~ 241 (299)
T 4g31_A 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VRTLT-DVR 241 (299)
T ss_dssp -----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHHHH-HHH
T ss_pred CCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HHHHH-HHh
Confidence 4332211 11234579999999999999999999999999999999997 66432211 11111 111
Q ss_pred CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 635 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... |.. ..+....+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~-----p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 242 NLKF-----PPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp TTCC-----CHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCC-----CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111 1122234568999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.99 Aligned_cols=260 Identities=43% Similarity=0.763 Sum_probs=219.6
Q ss_pred hhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 431 ERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
.+.||+|+||.||+|.+. ++.||||++........+.+.+|++++++++||||++++++|...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 468999999999999984 6799999998777667788999999999999999999999999999999999999999999
Q ss_pred HHhccCC--CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 510 ALLLGEE--ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 510 ~~l~~~~--~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+++.... ...++|...+.++.+++. +||||||+|||++.++.+||+|||+++....... ........
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~ 202 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ-THLSTVVK 202 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC-CCCBCCCE
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc-cccccccC
Confidence 9997653 234677766666555443 9999999999999999999999999986543221 22233456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc--ccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH--ERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
||+.|+|||.+.+..++.++|||||||+++||+||+.||.... +......|.......+.+..++++.+......+..
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (321)
T 2qkw_B 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESL 282 (321)
T ss_dssp EETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHH
T ss_pred CCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHH
Confidence 8999999999999999999999999999999999999997543 23455666666666777888888888877888889
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
..+.+++.+|++.+|++|||++|+++.|++++..+.
T Consensus 283 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 999999999999999999999999999999886543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.30 Aligned_cols=270 Identities=39% Similarity=0.673 Sum_probs=224.7
Q ss_pred cccCHHHHHHHHHHh--hhhccccCcEEEEEEEE-CCceEEEEEecCCChh-hHHHHHHHHHHHHhccCCceeeEEEEEe
Q 004935 416 QRFSYSNVLRITNNF--ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQ-GYKQFQAEVELLMRIHHKNLTTLVGYCD 491 (723)
Q Consensus 416 ~~~~~~~l~~~t~~f--~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 491 (723)
..+++.++...+.+| .+.||+|+||.||+|.. +++.||||++...... ....|.+|++++++++||||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 467888888777766 47899999999999987 4679999999765422 2346899999999999999999999999
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHH----------HHhc---cccccCCCCCCEEEcCCCcEEEEe
Q 004935 492 EGTNRGLIYEFMANGNLQALLLGEE--ADILSWEGRLRI----------AIEA---AKVHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 492 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~l~i----------~~~~---a~vH~Dlk~~NILl~~~~~~kl~D 556 (723)
..+..++||||+++|+|.+++.... ...++|..+..+ +|.. ..+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998653 234666555444 4444 459999999999999999999999
Q ss_pred ccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcccc----CcccccHHHHHHHH
Q 004935 557 FGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIER----THERIHITQWVSFM 632 (723)
Q Consensus 557 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~----~~~~~~~~~~~~~~ 632 (723)
||+++...... ........||+.|+|||.+.+..++.++|||||||+++||+||+.||.. .........|+...
T Consensus 178 fg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 178 FGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred CccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99998764322 2334456699999999999988999999999999999999999999963 23445677788877
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
........+.+..+......+....+.+++.+|++.+|.+|||++||++.|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 7788888888888888888899999999999999999999999999999998643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.97 Aligned_cols=271 Identities=38% Similarity=0.612 Sum_probs=216.1
Q ss_pred ccccCHHHHHHHHHHhh--------hhccccCcEEEEEEEECCceEEEEEecCCC----hhhHHHHHHHHHHHHhccCCc
Q 004935 415 NQRFSYSNVLRITNNFE--------RVLGNGGFGTVYHGYLDGTEVAVKMLSPSS----AQGYKQFQAEVELLMRIHHKN 482 (723)
Q Consensus 415 ~~~~~~~~l~~~t~~f~--------~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~n 482 (723)
...|++.++.+++.+|. +.||+|+||.||+|..+++.||||++.... ....+.|.+|++++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 35789999999999986 469999999999999999999999987532 334578999999999999999
Q ss_pred eeeEEEEEecCCceEEEEEeCCCCCHHHHhccC-CCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCc
Q 004935 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE-EADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQ 551 (723)
Q Consensus 483 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~ 551 (723)
|+++++++...+..++||||+++|+|.+++... ....+++...+.++.+++ .+||||||+||+++.++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 999999999999999999999999999998743 234567766655554443 399999999999999999
Q ss_pred EEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH
Q 004935 552 AKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 552 ~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~ 631 (723)
+||+|||+++....... ........|++.|+|||.+.+ .++.++||||||++++||++|+.||........+..+...
T Consensus 172 ~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 172 AKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp EEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred EEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence 99999999987643222 223344578999999998764 5899999999999999999999999876554444444333
Q ss_pred HhcC-CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 632 MLGK-GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 632 ~~~~-~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.... ..+...+++.+ ..........+.+++.+|++.+|.+|||+++|++.|+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3222 22344445444 33456677889999999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.34 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=180.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEec------CCceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE------GTNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~l 498 (723)
.+.+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..+|
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 3467899999999999998 57799999997543 3445678999999999999999999998753 367899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
|||||+ |+|.+++.... .++. ...+..+|+...|||||||+|||++.++.+||+|||+|+.+.....
T Consensus 137 vmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp EEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 999996 68999987643 2332 3334455555559999999999999999999999999987643221
Q ss_pred -CceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc--c-C
Q 004935 569 -GTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI--V-D 643 (723)
Q Consensus 569 -~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i--~-d 643 (723)
.........||+.|||||.+.+. .++.++||||+||+++||++|+.||.+......+....... ........ . .
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~-g~p~~~~~~~~~~ 292 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL-GTPSPAVIQAVGA 292 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH-CCCCGGGTC----
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc-CCCChHHhhhhhh
Confidence 12234457899999999998875 46999999999999999999999998765443333332222 11110000 0 0
Q ss_pred C-------ccc--CCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 P-------RLH--EDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~-------~l~--~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. .+. ..... .....+.+++.+||+.||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000 00000 11235679999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=337.34 Aligned_cols=191 Identities=22% Similarity=0.347 Sum_probs=149.3
Q ss_pred HhhhhccccCcEEEEEEEEC-----CceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|+.. ++.||||++..... ..++.+|+++|+++ +||||+++++++.+.++.++||||
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 34678999999999999862 45899999876542 35688999999998 699999999999999999999999
Q ss_pred CCCCCHHHHhccCC-CCC----CCHHHHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCCC-------
Q 004935 503 MANGNLQALLLGEE-ADI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSG------- 569 (723)
Q Consensus 503 ~~~gsL~~~l~~~~-~~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~------- 569 (723)
|++|+|.+++..-. ..+ .+....+..+|+...|||||||+|||++.+ +.+||+|||+|+........
T Consensus 102 ~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 181 (361)
T 4f9c_A 102 LEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181 (361)
T ss_dssp CCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--
T ss_pred CCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccc
Confidence 99999999985421 111 123334455555555999999999999977 79999999999865322110
Q ss_pred ------------------ceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcc
Q 004935 570 ------------------THVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHE 621 (723)
Q Consensus 570 ------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~ 621 (723)
........||+.|+|||.+.+. .++.++||||+||+++||+||+.||....+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp ------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1112345799999999998875 589999999999999999999999965443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=351.72 Aligned_cols=238 Identities=20% Similarity=0.292 Sum_probs=186.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.. +++.||+|++........+.+.+|+++|++++|||||++++++.+.+..+||||||++|
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 4567899999999999998 57799999998777666778999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-----CC----CHHHHHHHHHhccccccCCCCCCEEEcCC--CcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEEAD-----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGK--FQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~-----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~--~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
+|.+++...... +. +....+..+|+...+||||||+|||++.+ +.+||+|||+|+.+... .....
T Consensus 240 ~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~----~~~~~ 315 (573)
T 3uto_A 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKV 315 (573)
T ss_dssp BHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT----SEEEE
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC----Cceee
Confidence 999998654221 12 22333445555555999999999999854 89999999999986432 23345
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|||||.+.+..|+.++||||+||+||||++|+.||........ ..... .... . .++...... .
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~i~-~~~~-~-~~~~~~~~~----s 384 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNVK-SCDW-N-MDDSAFSGI----S 384 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHH-TTCC-C-CCSGGGTTS----C
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHH-hCCC-C-CCcccccCC----C
Confidence 6799999999999999999999999999999999999999976543221 11111 1110 0 011111112 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+||+.||.+|||++|+++
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 35679999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.09 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=183.9
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|...++.||||++.... ....++|.+|++++++++||||+++++++......++||||+++|+
T Consensus 41 i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 35789999999999999999999999997654 3445689999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC-CCCCHHH----------HHHHHHhcc--ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 508 LQALLLGEEA-DILSWEG----------RLRIAIEAA--KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 508 L~~~l~~~~~-~~l~~~~----------~l~i~~~~a--~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|.+++..... ..+++.. .+..+|+.. .+||||||+|||++.++.+||+|||+++..... .....
T Consensus 121 L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~ 197 (309)
T 3p86_A 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST---FLSSK 197 (309)
T ss_dssp HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------------
T ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc---ccccc
Confidence 9999976432 1244433 344455555 699999999999999999999999999864322 12234
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........... ..+... .
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~-----~~~~~~----~ 264 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKR-----LEIPRN----L 264 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCC-----CCCCTT----S
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCC-----CCCCcc----C
Confidence 467899999999999999999999999999999999999999765432 111111111110 111111 2
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
...+.+++.+||+.+|.+|||++++++.|+.++.....
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 23678999999999999999999999999998865443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.87 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=190.0
Q ss_pred hhhhccccCcEEEEEEEEC-----CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|.+. +..||||+++.. .....+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 4578999999999999983 336999999865 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... ..+++...+.++.+++ .+||||||+|||++.++.+||+|||+++............
T Consensus 133 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (325)
T 3kul_A 133 ENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211 (325)
T ss_dssp TTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEEC
T ss_pred CCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeec
Confidence 9999999996542 2355555554444433 3999999999999999999999999998765443323333
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....+|+.|+|||.+.+..++.++|||||||+++||++ |+.||...... +.......... .. ...
T Consensus 212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~~~~------~~----~~~ 277 (325)
T 3kul_A 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEEGYR------LP----APM 277 (325)
T ss_dssp C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHTTCC------CC----CCT
T ss_pred cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHcCCC------CC----CCC
Confidence 44456788999999999999999999999999999999 99999765432 11222111111 01 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.....+.+++.+||+.+|.+|||++++++.|+.++....
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 223467899999999999999999999999999885443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.81 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|... +..||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 3578999999999999984 67999999987777778899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc-------
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT------- 570 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~------- 570 (723)
|.+++.... ..+++...+.++.+++ .+||||||+|||++.++.+||+|||+++.........
T Consensus 94 L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 172 (310)
T 3s95_A 94 LRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172 (310)
T ss_dssp HHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------------
T ss_pred HHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccc
Confidence 999997642 2356655555544443 3999999999999999999999999998764322110
Q ss_pred ----eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc-----cHHHHHHHHhcCCCcccc
Q 004935 571 ----HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI-----HITQWVSFMLGKGDIESI 641 (723)
Q Consensus 571 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~i 641 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|..|+....... ........
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~---------- 242 (310)
T 3s95_A 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR---------- 242 (310)
T ss_dssp -------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----------
T ss_pred ccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----------
Confidence 01124579999999999999999999999999999999999999886432211 11111110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.... .....+.+++.+|++.+|++|||++++++.|+++.....
T Consensus 243 ---~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 ---YCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ---TCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---cCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111 112257799999999999999999999999998875543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=326.73 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=191.9
Q ss_pred hhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
+.+.||+|+||.||+|... +..||||+++... ....+.+.+|+++++++ +||||++++++|...+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 4578999999999999862 2369999997654 34557899999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl 554 (723)
||||+++|+|.+++.... ...+.+...+.++.+++ .+||||||+|||++.++.+||
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 244 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEE
Confidence 999999999999997643 12356655555444443 399999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+
T Consensus 245 ~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~~~~~~---- 318 (370)
T 2psq_A 245 ADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELFKLL---- 318 (370)
T ss_dssp CCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHH----
T ss_pred ccccCCcccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----
Confidence 99999986543221 112233457789999999999999999999999999999999 99999765332 222211
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
..+.. +.. +......+.+++.+||+.+|.+|||++|+++.|+.+++...
T Consensus 319 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 319 KEGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HTTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111 111 11223467899999999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=346.74 Aligned_cols=235 Identities=21% Similarity=0.300 Sum_probs=174.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHH---HHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQ---AEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|+. +++.||||++.+... .....+. .++.+++.++|||||++++++.+.+..+||||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 457899999999999998 577999999964321 1122333 44666777799999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
||++|+|.+++..... .+..+.. .+..+|+...|||||||+||||+.++++||+|||+|+.+... ..
T Consensus 273 y~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-----~~ 347 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KP 347 (689)
T ss_dssp CCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----CC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-----CC
Confidence 9999999999975421 1222333 344444444499999999999999999999999999876432 22
Q ss_pred ecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
...+||+.|||||.+.. ..|+.++|+||+||+||||++|+.||....... ..+..+..... . ..+.....
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~-~------~~~p~~~S- 418 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTM-A------VELPDSFS- 418 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHC-C------CCCCTTSC-
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCC-C------CCCCccCC-
Confidence 34689999999999964 579999999999999999999999997644322 22222222111 1 11112222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+||+.||.+|++ ++||++
T Consensus 419 ---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 419 ---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 35679999999999999998 455543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.41 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=188.3
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----ceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT----NRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|...++.||||++..... ....+..|+.++++++||||+++++++.... ..++||||+++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 357899999999999999999999999975433 3345677999999999999999999997754 36999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
|+|.+++.... ++|...+. .+|+. ..+||||||+|||++.++.+||+|||+++....
T Consensus 107 g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 107 GSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp CBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred CCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 99999997642 45554443 44444 459999999999999999999999999987643
Q ss_pred CCCCceeeecccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCcccc------------cHHHH
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERI------------HITQW 628 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~------------~~~~~ 628 (723)
... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... ....+
T Consensus 184 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 3soc_A 184 GKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262 (322)
T ss_dssp TSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred ccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence 322 122334578999999999876 356678999999999999999999997543211 11122
Q ss_pred HHHHhcCCCcccccCCcccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 629 VSFMLGKGDIESIVDPRLHED-FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
....... .. .+.+... ........+.+++.+||+.+|++|||++||++.|+++.+.
T Consensus 263 ~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 263 QEVVVHK-KK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHTTS-CC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhcc-cC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2211111 11 1111111 1223556789999999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.76 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=179.7
Q ss_pred hhhhccccCcEEEEEEEEC-----CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|++. +..||||+++.. .....++|.+|++++++++||||++++++|...+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 3578999999999999873 447999999765 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... ..+++...+.++.+++ .+||||||+|||++.++.+||+|||+++............
T Consensus 129 ~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 207 (373)
T 2qol_A 129 ENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207 (373)
T ss_dssp TTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred CCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceec
Confidence 9999999997643 2356665555544443 3999999999999999999999999998764332211222
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +..... ..+. ......
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~~~i-~~~~---------~~~~~~ 273 (373)
T 2qol_A 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAV-DEGY---------RLPPPM 273 (373)
T ss_dssp ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHHHHH-HTTE---------ECCCCT
T ss_pred cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH-HcCC---------CCCCCc
Confidence 23345778999999999999999999999999999998 99999755321 111111 1110 011111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.....+.+++.+||+.+|.+||+|++|++.|+.++....
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 233468899999999999999999999999999886543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.71 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=184.9
Q ss_pred HhhhhccccCcEEEEEEEE------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 500 (723)
.+.+.||+|+||.||+|++ +++.||||++........+.|.+|++++++++||||++++++|... ...++||
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 92 (295)
T 3ugc_A 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 92 (295)
T ss_dssp EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEE
T ss_pred hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEE
Confidence 3467899999999999985 4668999999887777778899999999999999999999998553 5589999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++..... .+++...+.++.+ ...+||||||+|||++.++.+||+|||+++.........
T Consensus 93 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (295)
T 3ugc_A 93 EYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171 (295)
T ss_dssp ECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---------
T ss_pred EeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCccee
Confidence 99999999999976532 2454444444333 334999999999999999999999999998765433222
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc-----------ccHHHHHHHHhcCCCcc
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER-----------IHITQWVSFMLGKGDIE 639 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 639 (723)
.......++..|+|||.+.+..++.++||||||++++||+||..|+...... ......+......+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (295)
T 3ugc_A 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-- 249 (295)
T ss_dssp ----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC--
T ss_pred eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC--
Confidence 2334455777899999999999999999999999999999999887543210 000111111111111
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 640 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
...........+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 250 -------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 011112233468899999999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=333.03 Aligned_cols=237 Identities=27% Similarity=0.408 Sum_probs=188.2
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC-ceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT-NRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|...++.||||+++... ..+.|.+|+++|++++||||++++++|.... ..++|||||++|+|
T Consensus 197 ~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 35789999999999999999999999998654 3468999999999999999999999987665 78999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.++.+++. +||||||+|||++.++.+||+|||+++..... .....+
T Consensus 275 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------~~~~~~ 348 (450)
T 1k9a_A 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKL 348 (450)
T ss_dssp HHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------------CC
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------ccCCCC
Confidence 99998765444566555555544443 99999999999999999999999999864221 122357
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++|||||||+||||+| |+.||....... ....+ ..+.. . ..+......
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i----~~~~~-----~----~~p~~~~~~ 414 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV----EKGYK-----M----DAPDGCPPA 414 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHH----HTTCC-----C----CCCTTCCHH
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH----HcCCC-----C----CCCCcCCHH
Confidence 889999999999999999999999999999998 999997654322 22211 11110 0 111123346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=316.66 Aligned_cols=249 Identities=19% Similarity=0.262 Sum_probs=194.6
Q ss_pred ccccCHHHHHHHHHHh------------hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccC
Q 004935 415 NQRFSYSNVLRITNNF------------ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH 480 (723)
Q Consensus 415 ~~~~~~~~l~~~t~~f------------~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H 480 (723)
...++++++..++... .+.||+|+||.||+|.. +++.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 3568888888887642 35799999999999998 477999999987666667789999999999999
Q ss_pred CceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC
Q 004935 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF 550 (723)
Q Consensus 481 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~ 550 (723)
|||+++++++...+..++||||+++|+|.+++... .+++.....++.+++ .+||||||+|||++.++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999998753 356665555554443 39999999999999999
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS 630 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~ 630 (723)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +...
T Consensus 179 ~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~~~ 251 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMK 251 (321)
T ss_dssp CEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH
T ss_pred cEEEeeeeeeeecccCc---cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence 99999999998764322 1234467999999999999999999999999999999999999999754322 1122
Q ss_pred HHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 631 FMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... . .+.+.. .......+.+++.+|++.+|++|||++|+++
T Consensus 252 ~~~~~-~-----~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDS-P-----PPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHS-S-----CCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcC-C-----CCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 1 111111 0112235779999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.05 Aligned_cols=233 Identities=21% Similarity=0.323 Sum_probs=182.8
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||.||+|.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 56899999999999987 5679999999765555567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ++.... +..+|+...+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 105 ~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g 178 (297)
T 3fxz_A 105 TDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVG 178 (297)
T ss_dssp HHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---CCBCCCCS
T ss_pred HHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc---cccCCccC
Confidence 99987642 333333 333444444999999999999999999999999998764332 22345679
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
|+.|+|||.+.+..++.++|||||||+++||++|+.||........... ....+. +.+. ........+
T Consensus 179 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~~~------~~~~--~~~~~~~~~ 246 (297)
T 3fxz_A 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGT------PELQ--NPEKLSAIF 246 (297)
T ss_dssp CGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHHCS------CCCS--CGGGSCHHH
T ss_pred CcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCC------CCCC--CccccCHHH
Confidence 9999999999999999999999999999999999999976543221111 111111 0000 011122357
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+++.+||+.+|++|||++|+++
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhh
Confidence 79999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=321.32 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=189.6
Q ss_pred hhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCc-eEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTN-RGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~-~~lV 499 (723)
+.+.||+|+||.||+|.+ +++.||||+++... ....+.+.+|+++++++ +||||++++++|...+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 357899999999999984 23589999998654 34457799999999999 89999999999987554 8999
Q ss_pred EEeCCCCCHHHHhccCCCC-------------------------------------------------------------
Q 004935 500 YEFMANGNLQALLLGEEAD------------------------------------------------------------- 518 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~------------------------------------------------------------- 518 (723)
|||+++|+|.+++......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 9999999999999764321
Q ss_pred ---CCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccc
Q 004935 519 ---ILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDP 585 (723)
Q Consensus 519 ---~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aP 585 (723)
.+++...+.++.+++ .+||||||+|||++.++.+||+|||+++....... ........+|+.|+||
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAP 264 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--CEECGGGCCH
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccccCCCceeECh
Confidence 155555444444433 39999999999999999999999999987643322 2334456688999999
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHh
Q 004935 586 EYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMA 664 (723)
Q Consensus 586 E~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~ 664 (723)
|.+.+..++.++|||||||+++||+| |+.||............+. .+.. ...... ....+.+++.+
T Consensus 265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~~-----~~~~~~----~~~~l~~li~~ 331 (359)
T 3vhe_A 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTR-----MRAPDY----TTPEMYQTMLD 331 (359)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----HTCC-----CCCCTT----CCHHHHHHHHH
T ss_pred hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----cCCC-----CCCCCC----CCHHHHHHHHH
Confidence 99999999999999999999999998 9999976543332222222 1111 111111 22357899999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 665 CVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 665 Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
|++.+|.+|||++|+++.|+++++..
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999988643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.80 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=195.4
Q ss_pred hhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
+.+.||+|+||.||+|... +..||||++.... ....+++.+|+++++++ +||||++++++|...+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 4578999999999999862 2479999997653 44557899999999999 99999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl 554 (723)
||||+++|+|.+++.... ...+++...+.++.+++. +||||||+|||++.++.+||
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 232 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEE
Confidence 999999999999997643 134666666665555443 99999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+++....... ........+|+.|+|||.+.+..++.++|||||||+++||++ |+.||..... .+......
T Consensus 233 ~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----~~~~~~~~ 307 (382)
T 3tt0_A 233 ADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EELFKLLK 307 (382)
T ss_dssp CSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHH
T ss_pred cccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH
Confidence 99999987643221 122334567889999999999999999999999999999999 9999875432 22222221
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
.+.. +.... .....+.+++.+||+.+|++|||++||++.|+++++.....
T Consensus 308 -~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 308 -EGHR-----MDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp -TTCC-----CCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred -cCCC-----CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 2111 11111 12336789999999999999999999999999999776553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.00 Aligned_cols=237 Identities=18% Similarity=0.310 Sum_probs=187.7
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|..+++.||||++.... ....+.|.+|++++++++||||+++++++... ...++||||+++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 45789999999999999999999999997653 44557899999999999999999999999877 778999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------c--ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------A--KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a--~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+|.+++.......+++...+.++.++ . .+||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------- 165 (271)
T 3kmu_A 94 GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------- 165 (271)
T ss_dssp CBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--------
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc--------
Confidence 999999987655556666655554443 3 48999999999999999999999998765321
Q ss_pred ecccCCCccccccccccCCCCC---hhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 574 TTIAGTPGYLDPEYYISNRLTE---KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~---~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
....+|+.|+|||.+.+..++. ++|||||||+++||++|+.||....... ........+. .+.+...
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-----~~~~~~~- 235 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGMKVALEGL-----RPTIPPG- 235 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----HHHHHHHSCC-----CCCCCTT-
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----HHHHHHhcCC-----CCCCCCC-
Confidence 2346789999999998765544 8999999999999999999997654321 1122221111 1112122
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
....+.+++.+|++.+|++|||++|+++.|+++.
T Consensus 236 ---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 236 ---ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2236789999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=336.71 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=193.4
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.+. +..||||+++.... ..++|.+|+++|++++||||++++++|......++|||||++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 34678999999999999995 66999999976543 3578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+++...+.++.+++. +||||||+|||++.++.+||+|||+++...... .......
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~ 379 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGA 379 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--EECCTTC
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc--eeecCCC
Confidence 9999998765555666666555544443 999999999999999999999999998764221 1222334
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||.+.+..++.++|||||||+||||+| |+.||...... .+.+.+. .+. ....+....
T Consensus 380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~---------~~~~~~~~~ 445 (495)
T 1opk_A 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLE----KDY---------RMERPEGCP 445 (495)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHH----TTC---------CCCCCTTCC
T ss_pred cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH----cCC---------CCCCCCCCC
Confidence 56778999999999999999999999999999999 99998765432 2222221 110 111111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..+.+++.+||+.+|++||||+++++.|+++++.
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 4678999999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=309.12 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=183.3
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHh--ccCCceeeEEEEEec----CCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMR--IHHKNLTTLVGYCDE----GTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|..+++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....++||||+
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 4578999999999999999999999998643 34566777777777 799999999999754 34578999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHH----------HHHHH--------hccccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 504 ANGNLQALLLGEEADILSWEGR----------LRIAI--------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~----------l~i~~--------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
++|+|.+++... .+++... +..+| +...+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 89 EMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp TTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence 999999999653 2444433 44444 34449999999999999999999999999987543
Q ss_pred CCCCce-eeecccCCCccccccccccC------CCCChhhHHHHHHHHHHHHcC----------CCccccCcccccHHHH
Q 004935 566 EGSGTH-VTTTIAGTPGYLDPEYYISN------RLTEKSDVYNFGVVLLEIITS----------KSVIERTHERIHITQW 628 (723)
Q Consensus 566 ~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~SfGvvL~elltg----------~~p~~~~~~~~~~~~~ 628 (723)
...... ......||+.|+|||.+.+. .++.++|||||||++|||+|| +.||............
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~ 245 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh
Confidence 322111 12334799999999999876 456799999999999999999 7887654333222222
Q ss_pred HHHHhcCCCcccccCCcccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 629 VSFMLGKGDIESIVDPRLHE-DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.......... .+.+.. .........+.+++.+||+.+|++|||++||++.|+++
T Consensus 246 ~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 246 MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222221111 111111 12234567889999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.58 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=193.9
Q ss_pred HhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 105 (313)
T 1t46_A 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (313)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence 3467899999999999985 24589999998654 34457899999999999 999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC----------------CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEE
Q 004935 500 YEFMANGNLQALLLGEEA----------------DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~k 553 (723)
|||+++|+|.+++..... ..+++...+.++.+++ .+||||||+||+++.++.+|
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 185 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEE
Confidence 999999999999976432 1356665555544443 39999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHH
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~ 632 (723)
|+|||+++....... ........+++.|+|||.+.+..++.++||||||++++||+| |+.||............+...
T Consensus 186 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 264 (313)
T 1t46_A 186 ICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (313)
T ss_dssp ECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred Ecccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence 999999987654322 223334557789999999999999999999999999999999 999997654433322222211
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.. +.... .....+.+++.+|++.+|.+|||++|+++.|+++++..
T Consensus 265 ~~---------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 265 FR---------MLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CC---------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CC---------CCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 10 01111 12246789999999999999999999999999988643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.92 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=186.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.+. ++.||||+++... ....++|.+|+++|++++||||++++++|...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999994 6799999987653 334457899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++...+.++.++ ..+||||||+|||++.++.+||+|||+++....... .......
T Consensus 198 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~-~~~~~~~ 275 (377)
T 3cbl_A 198 DFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLR 275 (377)
T ss_dssp BHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE-ECCSSCC
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce-eecCCCC
Confidence 9999987532 234555544444433 339999999999999999999999999986432100 0011122
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.++..|+|||.+.+..++.++|||||||++|||+| |+.||...... + +......+... .. +....
T Consensus 276 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~-~~~~~~~~~~~-----~~----~~~~~ 341 (377)
T 3cbl_A 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----Q-TREFVEKGGRL-----PC----PELCP 341 (377)
T ss_dssp EEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----H-HHHHHHTTCCC-----CC----CTTCC
T ss_pred CCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----H-HHHHHHcCCCC-----CC----CCCCC
Confidence 35678999999998999999999999999999998 99998765321 1 11122221110 11 11123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..+.+++.+||+.+|++|||++++++.|+++...
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 4678999999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.25 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=189.4
Q ss_pred HhhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 3467899999999999997 23479999997543 33446799999999999 999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC---------------------CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC
Q 004935 500 YEFMANGNLQALLLGEEA---------------------DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG 548 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~ 548 (723)
|||+++|+|.+++..... ..+++...+.++.+++ .+||||||+|||++.
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC
Confidence 999999999999976432 2356655555544443 399999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHH
Q 004935 549 KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQ 627 (723)
Q Consensus 549 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~ 627 (723)
++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||+++||+| |+.||...........
T Consensus 208 ~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 286 (344)
T 1rjb_A 208 GKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286 (344)
T ss_dssp TTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHH
Confidence 99999999999987644322 233344567889999999999999999999999999999998 9999976544333322
Q ss_pred HHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 628 WVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 628 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.+. .+.. +.. +......+.+++.+||+.+|.+|||+.++++.|+.+++...
T Consensus 287 ~~~----~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 287 LIQ----NGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHH----TTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHh----cCCC-----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 222 1110 111 11123467899999999999999999999999998876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.19 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=193.0
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--ceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--NRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 3578999999999999985 6799999997543 234567889999999999999999999987765 6799999999
Q ss_pred CCCHHHHhccCCC-CCCCHHHHHHHHHhcc----------ccccCCCCCCEEE----cCCCcEEEEeccCccccCCCCCC
Q 004935 505 NGNLQALLLGEEA-DILSWEGRLRIAIEAA----------KVHRDVKSTNILL----SGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 505 ~gsL~~~l~~~~~-~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl----~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+|+|.+++..... ..+++...+.++.+++ .+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-- 170 (319)
T 4euu_A 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170 (319)
T ss_dssp TCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC--
T ss_pred CCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC--
Confidence 9999999976432 2356655555544443 3999999999999 788889999999998764332
Q ss_pred ceeeecccCCCccccccccc--------cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC---Cc
Q 004935 570 THVTTTIAGTPGYLDPEYYI--------SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG---DI 638 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 638 (723)
......||+.|+|||.+. +..++.++|||||||++|||+||+.||..........+.+....... ..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp --CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred --ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 223456899999999986 56789999999999999999999999975543333333333332211 11
Q ss_pred cccc---------CCc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 639 ESIV---------DPR--LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 639 ~~i~---------d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
..+. .+. ............+.+++.+|++.||++|||++|+++...+..-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1100 001 1123345667778899999999999999999999999886653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.45 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=185.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. .+..||+|++... .....+.|.+|+.++++++||||+++++++...+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 457899999999999997 4669999998543 33445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++...+ ..+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 95 g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 170 (294)
T 4eqm_A 95 GPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTN 170 (294)
T ss_dssp SCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----------
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--ccccC
Confidence 999999987542 24444333 33344444999999999999999999999999998764221 12233
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .......... . +..........
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~-~-----~~~~~~~~~~~ 240 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----SIAIKHIQDS-V-----PNVTTDVRKDI 240 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----HHHHHHHSSC-C-----CCHHHHSCTTS
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhcc-C-----CCcchhcccCC
Confidence 456899999999999999999999999999999999999999765432 1111111111 1 11101111122
Q ss_pred HHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhHhh
Q 004935 655 VWKTVEIAMACVSQTSTKRP-TMNQVVMELNESLAIETA 692 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~~~~~~ 692 (723)
...+.+++.+|++.+|.+|| +++++.+.|+.++.....
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 34678999999999999998 999999999988754443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.17 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=186.1
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++|||||++|+|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 4578999999999999995 5689999998654 34678999999999999999999999986 6678999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.++.+ ...+||||||+|||++.++.+||+|||+++...... ........+
T Consensus 270 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~ 347 (454)
T 1qcf_A 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKF 347 (454)
T ss_dssp HHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--HHTTCSSSS
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--eeccCCCcc
Confidence 99997543223444444444333 333999999999999999999999999998753211 111223446
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+....++.++|||||||+||||+| |+.||...... +........... ..+......
T Consensus 348 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~~~~~~----------~~~~~~~~~ 413 (454)
T 1qcf_A 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERGYRM----------PRPENCPEE 413 (454)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHHTCCC----------CCCTTSCHH
T ss_pred cccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCC----------CCCCCCCHH
Confidence 778999999999999999999999999999999 99999765332 222222111111 011122346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+++.+||+.+|++||||++|++.|+++..
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999998763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.18 Aligned_cols=236 Identities=26% Similarity=0.426 Sum_probs=173.7
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCCh----hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSA----QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|...++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 457899999999999999999999999875432 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhcc---ccccCCCCCCEEEcC--------CCcEEEEeccCccccC
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAA---KVHRDVKSTNILLSG--------KFQAKIADFGLSRTFP 564 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a---~vH~Dlk~~NILl~~--------~~~~kl~DfGla~~~~ 564 (723)
++|.+++... .+++... +..+|+.. .+||||||+|||++. ++.+||+|||+++...
T Consensus 91 ~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 167 (271)
T 3dtc_A 91 GPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167 (271)
T ss_dssp EEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred CCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence 9999998643 2344333 33444444 479999999999986 6789999999998653
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
.. ......|++.|+|||.+.+..++.++||||||++++||++|+.||....... ........ ... .
T Consensus 168 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~----~ 233 (271)
T 3dtc_A 168 RT-----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAYGVAMN-KLA----L 233 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHHTS-CCC----C
T ss_pred cc-----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHhhhcC-CCC----C
Confidence 22 1224568999999999999999999999999999999999999997654321 11111111 110 1
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.. .......+.+++.+|++.+|.+|||++|+++.|+++
T Consensus 234 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 PI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 112234678999999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.74 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=181.4
Q ss_pred hhhhccccCcEEEEEEEEC--Cc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD--GT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.+. ++ .||+|.+.... ....++|.+|++++++++||||++++++|.... .++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEe
Confidence 3578999999999999973 33 46888886543 345678999999999999999999999998754 7899999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++..... .+++...+.++. +...+||||||+|||++.++.+||+|||+++....... ...
T Consensus 98 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~ 175 (327)
T 3poz_A 98 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYH 175 (327)
T ss_dssp CTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC----
T ss_pred cCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc-ccc
Confidence 999999999976432 344444444333 33339999999999999999999999999987643322 222
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+. .+.. ....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~----~~~~---------~~~~ 241 (327)
T 3poz_A 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE----KGER---------LPQP 241 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH----TTCC---------CCCC
T ss_pred ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHH----cCCC---------CCCC
Confidence 334557889999999999999999999999999999999 99999765432 2222221 1110 0011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
......+.+++.+||+.+|.+||+|+++++.|+.+.....
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 1223467899999999999999999999999998876443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.57 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=190.3
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|... +..||||++... ......++.+|+.++++++||||+++++++......++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 4678999999999999953 447999999754 34556689999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC-----CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC---cEEEEeccCcccc
Q 004935 502 FMANGNLQALLLGEE-----ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF---QAKIADFGLSRTF 563 (723)
Q Consensus 502 y~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~---~~kl~DfGla~~~ 563 (723)
|+++|+|.+++.... ...+.+...+.++.+++ .+||||||+|||++.++ .+||+|||+++..
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence 999999999997532 23466655555544443 39999999999999554 5999999999854
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........+|+.|+|||.+.+..++.++|||||||+++||+| |+.||...... +...........
T Consensus 235 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~i~~~~~~---- 305 (367)
T 3l9p_A 235 YRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGRM---- 305 (367)
T ss_dssp HHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHTTCCC----
T ss_pred ccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCC----
Confidence 32111 112234567889999999999999999999999999999998 99999765322 222222211110
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.. .......+.+++.+||+.+|.+|||+.+|++.|+.+.+....
T Consensus 306 --~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 306 --DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred --CC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 11 111233578999999999999999999999999998866544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=304.21 Aligned_cols=241 Identities=27% Similarity=0.434 Sum_probs=187.0
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.. +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 457899999999999998 566899999986543 346799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++..... .+++...+.++ |+...+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 93 ~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~ 169 (269)
T 4hcu_A 93 SDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKF 169 (269)
T ss_dssp HHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTC
T ss_pred HHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc--cccccCccc
Confidence 999975432 34444444433 33334999999999999999999999999998653211 112233456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
++.|+|||.+.+..++.++||||||++++||++ |+.||...... +......... ....+ .. ....
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~~~~~~~---~~~~~---~~----~~~~ 235 (269)
T 4hcu_A 170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGF---RLYKP---RL----ASTH 235 (269)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTTC---CCCCC---TT----SCHH
T ss_pred ccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHhcCc---cCCCC---Cc----CCHH
Confidence 778999999999999999999999999999999 99998764332 2222221110 00111 11 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+++.+|++.+|++|||++++++.|+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999998875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.77 Aligned_cols=245 Identities=31% Similarity=0.445 Sum_probs=190.4
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|...+ +.||||+++... ....+.|.+|++++++++||||++++++|...+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 35789999999999999853 689999998654 3445789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC----------------------CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCC
Q 004935 502 FMANGNLQALLLGEEA----------------------DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGK 549 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----------------------~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~ 549 (723)
|+++|+|.+++..... ..+++...+.++.+++ .+||||||+|||++.+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~ 210 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 210 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCC
Confidence 9999999999976421 3466666655554444 3999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQW 628 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~ 628 (723)
+.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 211 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~ 285 (343)
T 1luf_A 211 MVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE----EV 285 (343)
T ss_dssp GCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HH
T ss_pred CeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH----HH
Confidence 9999999999986532211 122234567889999999999999999999999999999999 99999754321 22
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.. ....+.... ... .....+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 286 ~~-~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 286 IY-YVRDGNILA-----CPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HH-HHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HH-HHhCCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 22 222222111 111 1223678999999999999999999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.02 Aligned_cols=239 Identities=26% Similarity=0.442 Sum_probs=179.5
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+.+.||+|+||.||+|...++.||||++.... ..+.|.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeeEeecCCCceEEEEEECCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 35789999999999999999999999997543 3578999999999999999999999887 4579999999999999
Q ss_pred HHhccCCC-CCCCHH----------HHHHHHHh---ccccccCCCCCCEEEcCCCc-EEEEeccCccccCCCCCCceeee
Q 004935 510 ALLLGEEA-DILSWE----------GRLRIAIE---AAKVHRDVKSTNILLSGKFQ-AKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 510 ~~l~~~~~-~~l~~~----------~~l~i~~~---~a~vH~Dlk~~NILl~~~~~-~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++..... ..+.+. ..+..+|+ ...+||||||+|||++.++. +||+|||+++..... ..
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------~~ 161 (307)
T 2eva_A 88 NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MT 161 (307)
T ss_dssp HHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred HHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------cc
Confidence 99986532 123333 33444555 34599999999999998886 799999999765321 22
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ........ .+.. +.+....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~-~~~~-----~~~~~~~---- 229 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVH-NGTR-----PPLIKNL---- 229 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHHHH-TTCC-----CCCBTTC----
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHHHh-cCCC-----CCccccc----
Confidence 3468999999999999999999999999999999999999997543321 11111111 1111 1111122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
...+.+++.+|++.+|++|||++++++.|+.+.+.-
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 235779999999999999999999999999887544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.44 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=189.1
Q ss_pred hhhhccccCcEEEEEEEE------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 500 (723)
+.+.||+|+||.||++.+ +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 357899999999999875 46689999998654 34567799999999999999999999999874 5678999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++.... +++...+.++.++ ..+||||||+|||++.++.+||+|||+++.........
T Consensus 115 e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp CCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred ecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 9999999999997653 4555544444433 33999999999999999999999999998875433222
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc----------cHHHHHHHHhcCCCccc
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI----------HITQWVSFMLGKGDIES 640 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~ 640 (723)
.......++..|+|||.+.+..++.++||||||++++||+||+.||....... .....+......+
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 267 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG---- 267 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT----
T ss_pred ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc----
Confidence 33345568888999999999899999999999999999999999986432110 0000111111111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
............+.+++.+||+.+|.+|||++|+++.|+++.+.-.
T Consensus 268 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 268 -----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 1111122233468899999999999999999999999998875543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.67 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=190.4
Q ss_pred hhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.. ++..||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 357899999999999986 23589999997653 4456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC----------------------CCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCC
Q 004935 502 FMANGNLQALLLGEEA----------------------DILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGK 549 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----------------------~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~ 549 (723)
|+++|+|.+++..... ..+++...+.++.++ ..+||||||+|||++.+
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~ 186 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG 186 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCC
Confidence 9999999999976422 235555444444433 33999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQW 628 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~ 628 (723)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||+++||+| |+.||...... .+...
T Consensus 187 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~ 264 (314)
T 2ivs_A 187 RKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-RLFNL 264 (314)
T ss_dssp TEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHH
T ss_pred CCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 9999999999987643322 122234457788999999999899999999999999999999 99999765432 22222
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+. .+.. +.... .....+.+++.+|++.+|++|||++|+++.|+++++.
T Consensus 265 ~~----~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 265 LK----TGHR-----MERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HH----TTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hh----cCCc-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 1111 11111 1234678999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=310.41 Aligned_cols=233 Identities=23% Similarity=0.387 Sum_probs=181.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. +++.||||++... .....+.+.+|+++|++++||||+++++++...+..++||||+++
T Consensus 19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 357899999999999998 5779999998654 344567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|+|.+++.....- . .+....+..+|+...+||||||+|||++.++.+||+|||+++..... .......
T Consensus 99 ~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~----~~~~~~~ 174 (328)
T 3fe3_A 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKLDAFC 174 (328)
T ss_dssp CBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS----CGGGTTS
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC----Ccccccc
Confidence 9999998654221 1 12223344445555599999999999999999999999999875432 1234567
Q ss_pred CCCccccccccccCCCC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
||+.|+|||.+.+..+. .++|||||||+++||++|+.||..... .+....... +.. .+... ...
T Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~-~~~------~~p~~----~s~ 239 (328)
T 3fe3_A 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLR-GKY------RIPFY----MST 239 (328)
T ss_dssp SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-CCC------CCCTT----SCH
T ss_pred CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCC------CCCCC----CCH
Confidence 99999999999888775 799999999999999999999976532 222222211 111 11111 123
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.+++.+|++.+|.+|||++|+++
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5679999999999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.38 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=192.2
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.||+|+||.||+|...+ ..||+|++.... ....+.+.+|+++++++ +||||++++++|...+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 45789999999999999732 379999997654 34557799999999999 8999999999999999999999
Q ss_pred EeCCCCCHHHHhccCC------------CCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEecc
Q 004935 501 EFMANGNLQALLLGEE------------ADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
||+++|+|.+++.... ...+++...+.++.+ ...+||||||+|||++.++.+||+|||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 209 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccc
Confidence 9999999999986531 223455544444433 333999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
+++....... ........+++.|+|||.+.+..++.++|||||||+++||+| |+.||............+.....
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 285 (333)
T 2i1m_A 210 LARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ--- 285 (333)
T ss_dssp GGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC---
T ss_pred cccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC---
Confidence 9987643322 223334557889999999999999999999999999999999 99999765443333332222111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
+.... .....+.+++.+||+.+|.+|||++|+++.|+++.+.++.
T Consensus 286 ------~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 286 ------MAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp ------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 00111 1123678999999999999999999999999998876544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=328.06 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=183.4
Q ss_pred hhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.+.+ ..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++|||||++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 35789999999999999965 4899999986543 34689999999999999999999999976 678999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.++.+++ .+||||||+|||++.++.+||+|||+++...... ........+
T Consensus 266 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~ 343 (452)
T 1fmk_A 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKF 343 (452)
T ss_dssp HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------------C
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc--eecccCCcc
Confidence 9999754333455555555544443 3999999999999999999999999998764221 112233456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++|||||||+||||+| |+.||...... +...... .+.. . ..+......
T Consensus 344 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~-~~~~-----~----~~~~~~~~~ 409 (452)
T 1fmk_A 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVE-RGYR-----M----PCPPECPES 409 (452)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHH-TTCC-----C----CCCTTSCHH
T ss_pred cccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH-cCCC-----C----CCCCCCCHH
Confidence 789999999999999999999999999999999 99999765322 2222221 1110 0 111123346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+.+++.+||+.+|++|||++++++.|+++...
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 78999999999999999999999999987743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=301.64 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=186.9
Q ss_pred hhhhccccCcEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|...+. .||||++..... ..+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90 (268)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence 457899999999999998654 899999976543 346799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..+++...+.++.+ ...+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 91 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~ 167 (268)
T 3sxs_A 91 LNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKF 167 (268)
T ss_dssp HHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--EEECCSCCC
T ss_pred HHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh--hhcccCCCc
Confidence 99986532 22444444444433 333999999999999999999999999998754322 222334456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
++.|+|||.+.+..++.++||||||++++||+| |+.||....... ........ . ....+. . ....
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~-~--~~~~~~---~----~~~~ 233 (268)
T 3sxs_A 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLKVSQG-H--RLYRPH---L----ASDT 233 (268)
T ss_dssp CGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHTT-C--CCCCCT---T----SCHH
T ss_pred CcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HHHHHHcC-C--CCCCCC---c----ChHH
Confidence 778999999999899999999999999999999 999997554321 11111111 1 011111 1 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
+.+++.+|++.+|++|||++|+++.|+.+.+.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 789999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.70 Aligned_cols=247 Identities=21% Similarity=0.368 Sum_probs=191.3
Q ss_pred hhccccCcEEEEEEEE----CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 432 RVLGNGGFGTVYHGYL----DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.||+|+||.||+|.. .+..||||++.... ....+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 4899999999999986 35589999998753 44567899999999999999999999999 556789999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++...+.++.+++ .+||||||+||+++.++.+||+|||+++...............
T Consensus 95 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 173 (287)
T 1u59_A 95 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173 (287)
T ss_dssp EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred CHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccc
Confidence 9999996532 2355555555444443 3999999999999999999999999998764433222222334
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.+|+.|+|||.+.+..++.++||||||++++||+| |+.||...... +..... ..+.. +.+. ....
T Consensus 174 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~i-~~~~~-----~~~~----~~~~ 239 (287)
T 1u59_A 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI-EQGKR-----MECP----PECP 239 (287)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHH-HTTCC-----CCCC----TTCC
T ss_pred cccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHH-hcCCc-----CCCC----CCcC
Confidence 56889999999998899999999999999999999 99999765432 111111 11111 1111 1223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARL 694 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~~ 694 (723)
..+.+++.+|++.+|.+||++.++++.|++++.......
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 467899999999999999999999999999987766543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.46 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=183.2
Q ss_pred hhhccccCcEEEEEEEECC------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.||+|+||.||+|.... ..||||++.... ......|.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4689999999999998732 259999998653 344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... ..+++...+.++.++ ..+||||||+|||++.++.+||+|||+++............
T Consensus 129 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 207 (333)
T 1mqb_A 129 ENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207 (333)
T ss_dssp TTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------------
T ss_pred CCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccccccc
Confidence 9999999997642 235555554444443 33999999999999999999999999998764332222222
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... +...... .+.. ... ..
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~~~-~~~~-----~~~----~~ 273 (333)
T 1mqb_A 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAIN-DGFR-----LPT----PM 273 (333)
T ss_dssp ---CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH-TTCC-----CCC----CT
T ss_pred CCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHH-CCCc-----CCC----cc
Confidence 33456788999999999999999999999999999999 99999654321 2122221 1110 001 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.....+.+++.+||+.+|++||++.++++.|++++.....
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 2234678999999999999999999999999998865544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=302.57 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=178.4
Q ss_pred HhhhhccccCcEEEEEEEEC-----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|... +..||+|++.... ....+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEec
Confidence 34678999999999999883 2369999987643 344567999999999999999999999984 4678999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++.... ..+++...+.++ |+...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 173 (281)
T 1mp8_A 97 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYK 173 (281)
T ss_dssp CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc--ccc
Confidence 99999999997542 234555444443 33334999999999999999999999999998764321 112
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....+++.|+|||.+.+..++.++||||||++++||++ |+.||....... ....+. .+.. ..+..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~----~~~~-----~~~~~--- 240 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE----NGER-----LPMPP--- 240 (281)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH----TTCC-----CCCCT---
T ss_pred cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHH----cCCC-----CCCCC---
Confidence 233456789999999998999999999999999999997 999997654332 222111 1111 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.....+.+++.+|++.+|++|||+.|+++.|+++++.+++
T Consensus 241 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 241 -NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 2234678999999999999999999999999999877654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.57 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=184.7
Q ss_pred hhhhccccCcEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|...+. .||||++..... ..+++.+|++++++++|+||+++++++...+..++||||+++|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 357899999999999998654 899999986543 246799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..+++...+.++. +...+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 107 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~ 183 (283)
T 3gen_A 107 LNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKF 183 (283)
T ss_dssp HHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--HHSTTSTTS
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc--cccccCCcc
Confidence 99997532 2245444444433 3334999999999999999999999999998653211 111223456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
|+.|+|||.+.+..++.++||||||++++||+| |+.||....... ...... .+. ....... ....
T Consensus 184 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~-~~~-----~~~~~~~----~~~~ 249 (283)
T 3gen_A 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIA-QGL-----RLYRPHL----ASEK 249 (283)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHH-TTC-----CCCCCTT----CCHH
T ss_pred CcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HHHHHh-ccc-----CCCCCCc----CCHH
Confidence 778999999999999999999999999999998 999997654321 111111 110 0011111 1236
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
+.+++.+|++.+|.+|||++++++.|++++..+
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 789999999999999999999999999988654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.75 Aligned_cols=247 Identities=29% Similarity=0.486 Sum_probs=177.3
Q ss_pred HhhhhccccCcEEEEEEEECCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|...+ .||||+++.. .....+.|.+|++++++++|+||+++++++ .....++||||++++
T Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 27 TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 345789999999999998765 5999998754 344567899999999999999999999976 455689999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... ..+++...+.++.+ ...+||||||+|||++.++.+||+|||+++....... .......
T Consensus 105 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~ 182 (289)
T 3og7_A 105 SLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQL 182 (289)
T ss_dssp EHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------
T ss_pred cHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc-ccccccc
Confidence 9999996543 23555544444433 3339999999999999999999999999986543221 2223345
Q ss_pred cCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 577 AGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 577 ~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
.||+.|+|||.+. +..++.++||||||++++||++|+.||........+.+.+.. +... +.+. .....
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~----~~~~-~~~~~ 253 (289)
T 3og7_A 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLS----PDLS-KVRSN 253 (289)
T ss_dssp -CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH----TSCC----CCTT-SSCTT
T ss_pred CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc----cccC----cchh-hcccc
Confidence 6899999999986 567889999999999999999999999765543333332222 1111 1110 11112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
....+.+++.+|++.+|.+|||++++++.|+++++
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 23468899999999999999999999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=333.03 Aligned_cols=242 Identities=20% Similarity=0.360 Sum_probs=184.0
Q ss_pred hccccCcEEEEEEEEC----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLD----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||+|+||.||+|.+. +..||||+++... ....++|.+|+++|++++||||++++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999873 3479999998653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++... ...+++...+.++.+++ .+||||||+|||++.++.+||+|||+++................
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 500 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCC
Confidence 99999754 33466666555555444 39999999999999999999999999987643322112222334
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
+++.|+|||.+.+..++.++|||||||+||||+| |+.||....... +. . .+..+... ..+.....
T Consensus 501 ~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~---~-~i~~~~~~---------~~p~~~~~ 566 (613)
T 2ozo_A 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VM---A-FIEQGKRM---------ECPPECPP 566 (613)
T ss_dssp -CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HH---H-HHHTTCCC---------CCCTTCCH
T ss_pred CccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH---H-HHHcCCCC---------CCCCcCCH
Confidence 6689999999999999999999999999999998 999997654321 11 1 22222110 11112334
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.+.+++.+||+.+|++||++.+|++.|+++....
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 6889999999999999999999999999887544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.27 Aligned_cols=246 Identities=27% Similarity=0.362 Sum_probs=194.8
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|... +..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 4578999999999999995 66899999976543 45789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.......+++...+.++.+++ .+||||||+||+++.++.+||+|||+++...... ........
T Consensus 96 L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~ 173 (288)
T 3kfa_A 96 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173 (288)
T ss_dssp HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS--SEEETTEE
T ss_pred HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc--cccccCCc
Confidence 99999876555566665554444333 3999999999999999999999999998764322 22334455
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
+++.|+|||.+.+..++.++||||||++++||++ |+.||...... ...+.+.. ... ... ......
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~---~~~------~~~----~~~~~~ 239 (288)
T 3kfa_A 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEK---DYR------MER----PEGCPE 239 (288)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHT---TCC------CCC----CTTCCH
T ss_pred cccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhc---cCC------CCC----CCCCCH
Confidence 7789999999999999999999999999999999 99998765432 22222111 100 111 111234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.+.+++.+|++.+|.+|||++++++.|+++++....
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 678999999999999999999999999998876544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.70 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=189.9
Q ss_pred hhhhccccCcEEEEEEEE------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe--cCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD--EGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E 501 (723)
+.+.||+|+||.||++.+ .+..||||++........+.+.+|++++++++|+||+++++++. .....++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 457899999999999985 45689999999887777788999999999999999999999886 4566889999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++..... .+++...+.++.++ ..+||||||+|||++.++.+||+|||+++..........
T Consensus 107 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 185 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185 (327)
T ss_dssp CCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEE
T ss_pred ecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccce
Confidence 9999999999875321 24555544444333 339999999999999999999999999987654433222
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc----------ccHHHHHHHHhcCCCcccc
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER----------IHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~i 641 (723)
......++..|+|||.+.+..++.++|||||||+++||++|+.|+...... ......+......+
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 260 (327)
T 3lxl_A 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG----- 260 (327)
T ss_dssp CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT-----
T ss_pred eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc-----
Confidence 334456888899999999999999999999999999999999998643211 00011111111111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
............+.+++.+|++.+|.+|||++|+++.|+.++.....
T Consensus 261 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 261 ----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred ----cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 11111222334678999999999999999999999999998765543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=307.32 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=193.8
Q ss_pred HHHHHHHHHhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHh--ccCCceeeEEEEEecCC----
Q 004935 421 SNVLRITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMR--IHHKNLTTLVGYCDEGT---- 494 (723)
Q Consensus 421 ~~l~~~t~~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~---- 494 (723)
.+.....+.+.+.||+|+||.||+|..+++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3344445556789999999999999999999999999643 34678889999988 79999999999998776
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHH--------hccccccCCCCCCEEEcCCCcEEEEe
Q 004935 495 NRGLIYEFMANGNLQALLLGEEADILSWEGR----------LRIAI--------EAAKVHRDVKSTNILLSGKFQAKIAD 556 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~--------~~a~vH~Dlk~~NILl~~~~~~kl~D 556 (723)
..++||||+++|+|.+++... .+++... +..+| +...+||||||+|||++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 789999999999999999764 2344333 34444 33449999999999999999999999
Q ss_pred ccCccccCCCCCCce-eeecccCCCccccccccccC------CCCChhhHHHHHHHHHHHHcC----------CCccccC
Q 004935 557 FGLSRTFPVEGSGTH-VTTTIAGTPGYLDPEYYISN------RLTEKSDVYNFGVVLLEIITS----------KSVIERT 619 (723)
Q Consensus 557 fGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~SfGvvL~elltg----------~~p~~~~ 619 (723)
||+++.......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999987643322111 22345799999999998765 234789999999999999999 6777654
Q ss_pred cccc-cHHHHHHHHhcCCCcccccCCcccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 620 HERI-HITQWVSFMLGKGDIESIVDPRLHED-FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 620 ~~~~-~~~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.... ....+.... ..... .+.+... ...+....+.+++.+||+.+|++|||+++|++.|+++.+.+.
T Consensus 271 ~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 271 VPSDPSVEEMRKVV-CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SCSSCCHHHHHHHH-TTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred CcCcccHHHHHHHH-HHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 3222 222322222 22111 1222211 123566788999999999999999999999999999876544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=309.40 Aligned_cols=248 Identities=26% Similarity=0.416 Sum_probs=176.2
Q ss_pred HhhhhccccCcEEEEEEEECCc-----eEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce-----
Q 004935 429 NFERVLGNGGFGTVYHGYLDGT-----EVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR----- 496 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~~-----~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----- 496 (723)
.+.+.||+|+||.||+|..... .||||++... .....++|.+|++++++++||||+++++++......
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 3467899999999999987432 7999999765 334567899999999999999999999999877665
Q ss_pred -EEEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 497 -GLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 497 -~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
++||||+++|+|.+++... ....+++...+.++.++ ..+||||||+|||+++++.+||+|||+++
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~ 185 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence 8999999999999998643 11235555554444433 33999999999999999999999999998
Q ss_pred ccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIES 640 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (723)
....... ........+++.|+|||.+.+..++.++|||||||+++||++ |+.||....... ... ........
T Consensus 186 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~---~~~~~~~~-- 258 (323)
T 3qup_A 186 KIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYN---YLIGGNRL-- 258 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHH---HHHTTCCC--
T ss_pred ccccccc-ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHH---HHhcCCCC--
Confidence 7543221 122234456789999999999999999999999999999999 899987654322 111 11111110
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.. .......+.+++.+|++.+|++|||+.++++.|+++++-..
T Consensus 259 ----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 259 ----KQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ----CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ----CC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 11122467899999999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=314.40 Aligned_cols=258 Identities=17% Similarity=0.213 Sum_probs=190.0
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCChhhH-----------HHHHHHHHHHHhccCCceeeEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSSAQGY-----------KQFQAEVELLMRIHHKNLTTLVGYCD 491 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~~~ 491 (723)
+.+.||+|+||.||+|.+. ++.||||++........ ..+..|+..+++++|+||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 4678999999999999883 35899999876653211 12345566677778999999999987
Q ss_pred cC----CceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEc--CCCcEEEE
Q 004935 492 EG----TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLS--GKFQAKIA 555 (723)
Q Consensus 492 ~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~--~~~~~kl~ 555 (723)
.. ...++||||+ +++|.+++... ...+++...+.++.+++. +||||||+|||++ .++.+||+
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~ 196 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLV 196 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEEC
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEE
Confidence 64 4579999999 99999999764 234666666555555443 9999999999999 88999999
Q ss_pred eccCccccCCCCCCc----eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH
Q 004935 556 DFGLSRTFPVEGSGT----HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 556 DfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~ 631 (723)
|||+++.+....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...............
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 276 (364)
T 3op5_A 197 DYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276 (364)
T ss_dssp CCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred ECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHH
Confidence 999998764322111 1113345999999999999999999999999999999999999999865443333333332
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
.... .+..++++.+... .....+.+++..|++.+|.+||+++++++.|++++......
T Consensus 277 ~~~~-~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 277 RYRE-NIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHH-CHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred Hhhh-hHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2221 2333333333211 12236789999999999999999999999999999765543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.75 Aligned_cols=243 Identities=22% Similarity=0.342 Sum_probs=182.1
Q ss_pred HhhhhccccCcEEEEEEEECC---------ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG---------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|.... ..||+|++........+.|.+|++++++++||||+++++++...+..++|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (289)
T 4fvq_A 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILV 90 (289)
T ss_dssp EEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEE
T ss_pred eeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEE
Confidence 346789999999999998732 46999999876666678899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCc--------EEEEeccCcc
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQ--------AKIADFGLSR 561 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~--------~kl~DfGla~ 561 (723)
|||+++|+|.+++..... .+++...+.++. +...+||||||+|||++.++. +||+|||+++
T Consensus 91 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~ 169 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169 (289)
T ss_dssp EECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCT
T ss_pred EECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccc
Confidence 999999999999976432 244444444333 333499999999999998887 9999999987
Q ss_pred ccCCCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES 640 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (723)
.... .....+++.|+|||.+.+ ..++.++|||||||+++||++|..|+......... ............
T Consensus 170 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~ 239 (289)
T 4fvq_A 170 TVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQFYEDRHQLPA 239 (289)
T ss_dssp TTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTTCCCCC
T ss_pred cccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HHHhhccCCCCC
Confidence 6421 123457889999999987 67999999999999999999966554333221111 111111111111
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhhh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARL 694 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~~ 694 (723)
.. ...+.+++.+||+.+|++|||++|+++.|++++.-..+..
T Consensus 240 ----~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 240 ----PK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp ----CS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred ----CC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 11 1146799999999999999999999999999887555443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.51 Aligned_cols=251 Identities=16% Similarity=0.199 Sum_probs=190.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++..... .+.+.+|+++++++ +|+||+++++++...+..++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 357899999999999996 577999999875432 24688999999999 9999999999999999999999999 99
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCc-----EEEEeccCccccCCCCCCce
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQ-----AKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~-----~kl~DfGla~~~~~~~~~~~ 571 (723)
+|.+++... ...+++...+.++.+++ .+||||||+|||++.++. +||+|||+++..........
T Consensus 90 ~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~ 168 (330)
T 2izr_A 90 SLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168 (330)
T ss_dssp BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCB
T ss_pred CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcc
Confidence 999999764 23456655555544443 399999999999999887 99999999987643322111
Q ss_pred ----eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 572 ----VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 572 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ...+........ ..... ...+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~-~~~~~-~~~~~ 245 (330)
T 2izr_A 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-TLKERYQKIGDT-KRATP-IEVLC 245 (330)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-SHHHHHHHHHHH-HHHSC-HHHHT
T ss_pred ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-cHHHHHHHHHhh-hccCC-HHHHh
Confidence 124567999999999999999999999999999999999999999865432 222211111100 00000 00000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.. .. .+.+++.+|++.+|.+||+++++++.|+++......
T Consensus 246 ~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 246 EN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp TT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11 12 788999999999999999999999999988765544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.58 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=185.3
Q ss_pred HHHHhhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc--cCCceeeEEEEEecC----CceEEE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI--HHKNLTTLVGYCDEG----TNRGLI 499 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~lV 499 (723)
..+.+.+.||+|+||.||+|...++.||||++.... ...+..|.+++..+ +||||+++++++... ...++|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 344456899999999999999999999999986432 34455566666554 999999999999877 678999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhc--------cccccCCCCCCEEEcCCCcEEEEeccCcc
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGR----------LRIAIEA--------AKVHRDVKSTNILLSGKFQAKIADFGLSR 561 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~--------a~vH~Dlk~~NILl~~~~~~kl~DfGla~ 561 (723)
|||+++|+|.+++.... +++... +..+|.. ..+||||||+|||++.++.+||+|||+++
T Consensus 114 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 114 TDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp ECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 99999999999997542 344333 4444444 45999999999999999999999999998
Q ss_pred ccCCCCCCce-eeecccCCCccccccccccCCCCCh------hhHHHHHHHHHHHHcC----------CCccccCccccc
Q 004935 562 TFPVEGSGTH-VTTTIAGTPGYLDPEYYISNRLTEK------SDVYNFGVVLLEIITS----------KSVIERTHERIH 624 (723)
Q Consensus 562 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~------~DV~SfGvvL~elltg----------~~p~~~~~~~~~ 624 (723)
.......... ......||+.|+|||.+.+.....+ +|||||||++|||+|| +.||........
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 7643322111 1234579999999999987766654 9999999999999999 566654332222
Q ss_pred HHHHHHHHhcCCCcccccCCcccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 625 ITQWVSFMLGKGDIESIVDPRLHED-FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 625 ~~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.............. .+.+... ...+....+.+++.+||+.+|++|||+.||++.|+.+.+.+.
T Consensus 271 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 271 SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 22222222222111 1111111 122566778999999999999999999999999999886543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.72 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=189.4
Q ss_pred hhhhccccCcEEEEEEEE-------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCC-ceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGT-NRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-~~~lV 499 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+++++++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 457899999999999985 23589999998654 34456899999999999 7999999999987654 48999
Q ss_pred EEeCCCCCHHHHhccCCCC--------------CCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEE
Q 004935 500 YEFMANGNLQALLLGEEAD--------------ILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~--------------~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
|||+++|+|.+++...... .+++...+.++. +...+||||||+||+++.++.+||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 190 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEC
Confidence 9999999999999765321 245444444433 3334999999999999999999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhc
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLG 634 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 634 (723)
|||+++....... ........+|+.|+|||.+.+..++.++|||||||+++||+| |+.||............+..
T Consensus 191 Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--- 266 (316)
T 2xir_A 191 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--- 266 (316)
T ss_dssp CCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH---
T ss_pred CCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc---
Confidence 9999987643322 223344567889999999999999999999999999999998 99999765433222222211
Q ss_pred CCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 635 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
+.. ...... ....+.+++.+|++.+|.+|||+.|+++.|+++++..
T Consensus 267 -~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 267 -GTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp -TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -Ccc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111 111111 1235789999999999999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.45 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=185.0
Q ss_pred HhhhhccccCcEEEEEEEE------CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC--CceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG--TNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 499 (723)
...+.||+|+||.||+|.+ .++.||||++.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 103 (302)
T 4e5w_A 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 103 (302)
T ss_dssp EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEE
T ss_pred hhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEE
Confidence 3457899999999999984 46699999997543 33457899999999999999999999999876 668999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++..... .+++...+.++. +...+||||||+|||++.++.+||+|||+++........
T Consensus 104 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 182 (302)
T 4e5w_A 104 MEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182 (302)
T ss_dssp EECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCE
T ss_pred EEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcc
Confidence 999999999999954322 244444444333 333499999999999999999999999999876544332
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCc-----------ccccHHHHHHHHhcCCCc
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTH-----------ERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~-----------~~~~~~~~~~~~~~~~~~ 638 (723)
........+|..|+|||.+.+..++.++||||||++++||+||+.|+.... .......... ....+..
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 261 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN-TLKEGKR 261 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH-HHHTTCC
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH-HHhccCC
Confidence 233445668888999999999999999999999999999999999864321 1111111111 1111110
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
..........+.+++.+|++.+|.+|||++++++.|++++
T Consensus 262 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 262 ---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111122346789999999999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.54 Aligned_cols=240 Identities=20% Similarity=0.313 Sum_probs=181.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||.||+|.. ++..||+|++........+.|.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999998 4679999999887767778899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEE--cCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 509 QALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILL--SGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
.+++.... ..+++...+.+ +|+...+||||||+|||+ +.++.+||+|||+++...... .....
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVN 248 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----ccccc
Confidence 99886532 22444444433 333344999999999999 567899999999998764322 22345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||+.|+|||.+.+..++.++|||||||+++||++|+.||........+..+... .... .+...... ..
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---~~~~----~~~~~~~~----~~ 317 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC---RWDL----EDEEFQDI----SE 317 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---CCCS----CSGGGTTS----CH
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCC----ChhhhccC----CH
Confidence 6999999999999899999999999999999999999999765433222222211 1000 01111111 23
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH--HHHHh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVM--ELNES 686 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~--~L~~~ 686 (723)
.+.+++.+|++.+|.+|||++|+++ .+++.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 6789999999999999999999997 55554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.75 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=192.1
Q ss_pred HhhhhccccCcEEEEEEEEC---------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceE
Q 004935 429 NFERVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 497 (723)
.+.+.||+|+||.||+|... +..||||++.... ....+.+.+|+++++++ +||||++++++|...+..+
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 117 (334)
T 2pvf_A 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117 (334)
T ss_dssp EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence 34678999999999999863 3479999997653 34567899999999999 9999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEE
Q 004935 498 LIYEFMANGNLQALLLGEEA--------------DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~k 553 (723)
+||||+++|+|.+++..... ..+++...+.++.+++ .+||||||+|||++.++.+|
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEE
Confidence 99999999999999976432 2356655555544443 39999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHH
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~ 632 (723)
|+|||+++....... ........+++.|+|||.+.+..++.++|||||||+++||++ |+.||..... .+.....
T Consensus 198 L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~ 272 (334)
T 2pvf_A 198 IADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----EELFKLL 272 (334)
T ss_dssp ECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHH
T ss_pred Ecccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----HHHHHHH
Confidence 999999987643221 122234457789999999998899999999999999999999 9999875432 1222211
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
. .+.. +.... .....+.+++.+|++.+|.+|||++|+++.|++++.....
T Consensus 273 ~-~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 273 K-EGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp H-HTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred h-cCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1 1111 11111 1223678999999999999999999999999999876544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.46 Aligned_cols=238 Identities=22% Similarity=0.309 Sum_probs=182.4
Q ss_pred HHHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChh------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQ------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.+.||+|+||.||++... +..||+|++...... ..+.+.+|+++|++++||||+++++++......++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3455689999999999999984 679999998754321 35789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCC----cEEEEeccCccccC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKF----QAKIADFGLSRTFP 564 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~----~~kl~DfGla~~~~ 564 (723)
||||+++|+|.+++.... .+++.....+ +|+...+||||||+|||++.++ .+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999999997542 3444444333 3333349999999999999887 89999999998764
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+ ...... .. . ..+
T Consensus 170 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~~~~-~~-~-~~~ 238 (326)
T 2y0a_A 170 FGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAV-NY-E-FED 238 (326)
T ss_dssp TTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHT-CC-C-CCH
T ss_pred CCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHHhc-CC-C-cCc
Confidence 321 123457999999999999999999999999999999999999999765332211 111111 00 0 000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ....+.+++.+|++.+|.+|||++|+++
T Consensus 239 ~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 239 EYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00011 1235779999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=301.95 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=179.4
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||+++
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 357899999999999998 567999999975432 2346789999999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .++.... +..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 104 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~ 179 (311)
T 3niz_A 104 DLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHE 179 (311)
T ss_dssp EHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC---C---CC
T ss_pred CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc---ccccCC
Confidence 88887765432 2343333 333444444999999999999999999999999998764221 223345
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cccccC------Ccc-
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESIVD------PRL- 646 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i~d------~~l- 646 (723)
.+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+............ .....+ ...
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 68999999999876 56899999999999999999999999876655444443332211110 000000 000
Q ss_pred -cCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 -HEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 -~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ......+.+++.+|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 011235789999999999999999999886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=301.91 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=178.3
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-CceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-TNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|...++.||||++.... ..+.|.+|++++++++||||+++++++... +..++||||+++|+|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 45789999999999999999999999997654 346799999999999999999999997554 578999999999999
Q ss_pred HHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+. .+|+...+||||||+||+++.++.+||+|||+++..... .....+
T Consensus 103 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~------~~~~~~ 176 (278)
T 1byg_A 103 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKL 176 (278)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------------C
T ss_pred HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc------ccCCCc
Confidence 9998754322234433333 333334499999999999999999999999998764321 123357
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
++.|+|||.+.+..++.++||||||++++||+| |+.||....... ... . ...+. .+.... .....
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~---~-~~~~~-----~~~~~~----~~~~~ 242 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVP---R-VEKGY-----KMDAPD----GCPPA 242 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHH---H-HTTTC-----CCCCCT----TCCHH
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---H-HhcCC-----CCCCcc----cCCHH
Confidence 889999999999999999999999999999998 999987653321 111 1 11111 111111 22346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+.+++.+|++.+|.+|||+.|+++.|+++...
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 78999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.07 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=178.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 357899999999999998 467999999875433 23466899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+++.....++ |+...+||||||+|||++.++.+||+|||+++.+..... .......
T Consensus 91 ~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 167 (323)
T 3tki_A 91 ELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKM 167 (323)
T ss_dssp EGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCSC
T ss_pred cHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-ccccCCC
Confidence 9999987542 24444443333 333349999999999999999999999999986543221 2223456
Q ss_pred cCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.||+.|+|||.+.+..+ +.++|||||||+++||++|+.||........... . ....... ..+ .....
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~-~~~~~~~---~~~------~~~~~ 235 (323)
T 3tki_A 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--D-WKEKKTY---LNP------WKKID 235 (323)
T ss_dssp CSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH--H-HHTTCTT---STT------GGGSC
T ss_pred ccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--H-Hhccccc---CCc------cccCC
Confidence 79999999999987775 7799999999999999999999976543321111 1 1111100 000 01122
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|++|||++|+++
T Consensus 236 ~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 236 SAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 35679999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.13 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=188.4
Q ss_pred hhhhccccCcEEEEEEEE------CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--ceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL------DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--NRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 501 (723)
+.+.||+|+||.||++.. +++.||||++........+.|.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 457899999999999985 46699999998877677788999999999999999999999986654 6899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++.... ..+++...+.++.+++ .+||||||+||+++.++.+||+|||+++..........
T Consensus 125 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~ 203 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 203 (326)
T ss_dssp CCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEE
T ss_pred CCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccc
Confidence 999999999997653 2355555544444433 39999999999999999999999999987654332122
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc-----------ccHHHHHHHHhcCCCccc
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER-----------IHITQWVSFMLGKGDIES 640 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 640 (723)
......++..|+|||.+.+..++.++||||||++++||+||+.|+...... ......+...+..+..
T Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 281 (326)
T 2w1i_A 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-- 281 (326)
T ss_dssp CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC--
T ss_pred cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC--
Confidence 223445777899999999888999999999999999999999987632110 0001111111111110
Q ss_pred ccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 641 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
..........+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 282 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 282 -------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp -------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111223468899999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=333.40 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=181.2
Q ss_pred hhccccCcEEEEEEEE----CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYL----DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.+ .+..||||+++... ....++|.+|+++|++++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999976 24589999997643 3346789999999999999999999999964 568899999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... .+++...+.++.++ ..+||||||+|||++.++.+||+|||+++.+............
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 99999997542 35555544444443 3399999999999999999999999999876543322223334
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..+|+.|+|||.+.+..++.++|||||||+|+||++ |+.||...... + +...+..+... .. +...
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~-~~~~i~~~~~~-----~~----p~~~ 597 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----E-VTAMLEKGERM-----GC----PAGC 597 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----H-HHHHHHTTCCC-----CC----CTTC
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----H-HHHHHHcCCCC-----CC----CCCC
Confidence 457789999999999999999999999999999998 99999765432 1 11222222111 11 1122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
...+.+++.+||+.+|++||++++|++.|+++..
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3467899999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.39 Aligned_cols=235 Identities=15% Similarity=0.220 Sum_probs=181.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||++.. ++..||+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 457899999999999998 46699999987554 344678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcC--CCcEEEEeccCccccCCCCCCceeeec
Q 004935 508 LQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSG--KFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|.+++.... ..+++..... .+|+...+||||||+|||++. ++.+||+|||+++..... .....
T Consensus 88 L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 162 (321)
T 1tki_A 88 IFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRL 162 (321)
T ss_dssp HHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT----CEEEE
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC----Ccccc
Confidence 999997542 2244443333 333334499999999999997 789999999999876432 22344
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..+|+.|+|||.+.+..++.++|||||||+++||++|+.||...... +......... .. .++..... ..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~-~~--~~~~~~~~----~s 231 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAE-YT--FDEEAFKE----IS 231 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTC-CC--CCHHHHTT----SC
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHcCC-CC--CChhhhcc----CC
Confidence 57899999999999888999999999999999999999999765432 2222221111 00 00000011 12
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|.+|||+.|+++
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 35789999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.59 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=193.3
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC--ceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT--NRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 4578999999999999984 6799999997543 234567889999999999999999999997765 6799999999
Q ss_pred CCCHHHHhccCCC-CCCCHHHHHHHHHhcc----------ccccCCCCCCEEE----cCCCcEEEEeccCccccCCCCCC
Q 004935 505 NGNLQALLLGEEA-DILSWEGRLRIAIEAA----------KVHRDVKSTNILL----SGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 505 ~gsL~~~l~~~~~-~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl----~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+|+|.+++..... ..+++...+.++.+++ .+||||||+|||+ +.++.+||+|||+++.....
T Consensus 93 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~--- 169 (396)
T 4eut_A 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--- 169 (396)
T ss_dssp TEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---
T ss_pred CCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---
Confidence 9999999976432 2255555544444433 3999999999999 77888999999999876422
Q ss_pred ceeeecccCCCcccccccccc--------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---c
Q 004935 570 THVTTTIAGTPGYLDPEYYIS--------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---I 638 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 638 (723)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.+........ +
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 170 -EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp -GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred -CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 12234568999999999865 56788999999999999999999999765433333333333332211 1
Q ss_pred cccc-----------CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 639 ESIV-----------DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 639 ~~i~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..+. +..............+.+++.+|++.||++||++.|+++.++++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0000 00111223355677788999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.13 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=184.8
Q ss_pred hccccCcEEEEEEEE----CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 433 VLGNGGFGTVYHGYL----DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.||+|+||.||+|.+ .+..||||++.... ....++|.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 899999999999965 24589999997653 23357899999999999999999999999 567789999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+++...+.++.+ ...+||||||+||+++.++.+||+|||+++...............
T Consensus 103 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 180 (291)
T 1xbb_A 103 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180 (291)
T ss_dssp EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence 9999997642 2444444444333 333999999999999999999999999998765433222222334
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.+++.|+|||.+.+..++.++||||||++++||++ |+.||...... +. ...+..+.. +.... ...
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~-~~~~~~~~~-----~~~~~----~~~ 246 (291)
T 1xbb_A 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EV-TAMLEKGER-----MGCPA----GCP 246 (291)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HH-HHHHHTTCC-----CCCCT----TCC
T ss_pred CCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HH-HHHHHcCCC-----CCCCC----CCC
Confidence 56789999999998889999999999999999999 99999764331 11 112222111 11111 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
..+.+++.+|++.+|.+||++.++++.|+++.......
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 46789999999999999999999999999998776553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.82 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=181.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||.||++.. ++..||+|++...... ..+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 3467899999999999998 4679999999764321 3567999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCC----cEEEEeccCccccCCC
Q 004935 501 EFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKF----QAKIADFGLSRTFPVE 566 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~----~~kl~DfGla~~~~~~ 566 (723)
||+++|+|.+++.... .+++... +..+|+...+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~ 172 (361)
T 2yab_A 95 ELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (361)
T ss_dssp ECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence 9999999999997542 3444433 3333444449999999999998876 7999999999876432
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...... .+... .++..
T Consensus 173 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~-~~~~~--~~~~~ 241 (361)
T 2yab_A 173 V----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANIT-AVSYD--FDEEF 241 (361)
T ss_dssp C----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH-TTCCC--CCHHH
T ss_pred C----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-hcCCC--CCchh
Confidence 1 2234579999999999999999999999999999999999999997654321 111111 11100 01111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... ....+.+++.+|+..+|.+|||++|+++
T Consensus 242 ~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 242 FSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 1235779999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.52 Aligned_cols=237 Identities=30% Similarity=0.512 Sum_probs=180.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhh-------HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG-------YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEE
T ss_pred ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEE
Confidence 457899999999999998 56799999986543211 167899999999999999999999986654 6999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhcc--ccccCCCCCCEEEcCCCc-----EEEEeccCcccc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGR----------LRIAIEAA--KVHRDVKSTNILLSGKFQ-----AKIADFGLSRTF 563 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a--~vH~Dlk~~NILl~~~~~-----~kl~DfGla~~~ 563 (723)
||+++|+|.+++.... ..+++... +..+|+.. .+||||||+|||++.++. +||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp ECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 9999999998886543 23444443 44455555 699999999999988776 999999999754
Q ss_pred CCCCCCceeeecccCCCccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYI--SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
.. ......+|+.|+|||.+. ...++.++|||||||+++||++|+.||....... ..........+.
T Consensus 180 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~---- 247 (287)
T 4f0f_A 180 VH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMIREEGL---- 247 (287)
T ss_dssp SS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHHHHHSCC----
T ss_pred cc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHHHhccCC----
Confidence 21 234467899999999984 4567899999999999999999999997654321 111222211111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.+.+.. .....+.+++.+||+.+|.+|||++|+++.|+++
T Consensus 248 -~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 -RPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111222 2234678999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.70 Aligned_cols=247 Identities=22% Similarity=0.394 Sum_probs=182.0
Q ss_pred hhhhccccCcEEEEEEEEC--Cc----eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD--GT----EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.+. +. .||+|.+.... ....+.+.+|+.++++++||||++++++|. ....++|+||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 3578999999999999973 33 38888876443 233456789999999999999999999986 4668899999
Q ss_pred CCCCCHHHHhccCCC-----CCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 503 MANGNLQALLLGEEA-----DILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~-----~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+++|+|.+++..... ..+.| ...+..+|+...+||||||+|||++.++.+||+|||+++....... ....
T Consensus 96 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 174 (325)
T 3kex_A 96 LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-QLLY 174 (325)
T ss_dssp CTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT-CCC-
T ss_pred CCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc-cccc
Confidence 999999999875421 11222 2334444444459999999999999999999999999998654332 2233
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+. .+... ..+..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~----~~~~~--~~~~~------ 241 (325)
T 3kex_A 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLLE----KGERL--AQPQI------ 241 (325)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHHH----TTCBC--CCCTT------
T ss_pred cCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHHH----cCCCC--CCCCc------
Confidence 45568889999999999999999999999999999999 99999765432 1222111 11100 00111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
....+.+++.+||+.+|.+|||++++++.|+.+......
T Consensus 242 -~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~ 280 (325)
T 3kex_A 242 -CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280 (325)
T ss_dssp -BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred -CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 111356899999999999999999999999998765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=309.31 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=183.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.. +++.||+|++..........+.+|+++|++++||||+++++++.+....++||||+++|
T Consensus 54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 3467899999999999998 46699999998776666678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcC--CCcEEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSG--KFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|.+++.... ..+++.....+ +|+...+||||||+|||++. ++.+||+|||+++...... ...
T Consensus 134 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~ 208 (387)
T 1kob_A 134 ELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVK 208 (387)
T ss_dssp BHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEE
T ss_pred cHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc----cee
Confidence 9999987542 23444444333 33333499999999999974 4789999999998764322 223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ......... . ..++..... .
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~-~--~~~~~~~~~----~ 277 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCD-W--EFDEDAFSS----V 277 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCC-C--CCCSSTTTT----S
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCC-C--CCCcccccc----C
Confidence 4579999999999999999999999999999999999999997654321 111111111 0 011111111 2
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+||+.+|.+|||++|+++
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 236789999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=296.25 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=184.6
Q ss_pred hhhhccccCcEEEEEEEECC-----ceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|...+ ..||+|.+... .....+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 35789999999999998732 25999999865 34456789999999999999999999999865 4568999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++++|.+++.... ..+++..... .+|+...+||||||+||+++.++.+||+|||+++...... ....
T Consensus 95 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 171 (281)
T 3cc6_A 95 PYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED--YYKA 171 (281)
T ss_dssp TTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------
T ss_pred CCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc--cccc
Confidence 9999999997532 2244444333 3344444999999999999999999999999998764321 1122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....+++.|+|||.+.+..++.++||||||++++||+| |+.||....... ....+.. ... ......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~---~~~------~~~~~~--- 238 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEK---GDR------LPKPDL--- 238 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHH---TCC------CCCCTT---
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhc---CCC------CCCCCC---
Confidence 34457889999999998999999999999999999998 999997544322 2221111 110 001111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
....+.+++.+|++.+|++|||+.|+++.|+++.+.+..
T Consensus 239 -~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 239 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 223578999999999999999999999999999887653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.72 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=180.9
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.+.||+|+||.||++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 34568899999999999987 57799999987654 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEc---CCCcEEEEeccCccccCCCCCCc
Q 004935 504 ANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
++|+|.+.+..... ++.. ..+..+|+...+||||||+|||++ .++.+||+|||+++......
T Consensus 93 ~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--- 167 (444)
T 3soa_A 93 TGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--- 167 (444)
T ss_dssp BCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC---
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC---
Confidence 99999998876432 3333 233444444459999999999998 46789999999998764322
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......||+.|+|||.+.+..++.++||||+||+++||++|+.||........ ..... .+.. ....+.. ..
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~----~~~i~-~~~~-~~~~~~~-~~- 239 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL----YQQIK-AGAY-DFPSPEW-DT- 239 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHH-HTCC-CCCTTTT-TT-
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH----HHHHH-hCCC-CCCcccc-cc-
Confidence 223446799999999999999999999999999999999999999976543221 11111 1111 0001111 11
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.||++|||+.|+++
T Consensus 240 ---~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 240 ---VTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1235779999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=330.80 Aligned_cols=242 Identities=27% Similarity=0.419 Sum_probs=187.4
Q ss_pred HhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.+.||+|+||.||+|.+.+ ..||||+++.... ..++|.+|+++|++++|+||++++++|.+ +..++|||||++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 346789999999999999965 4899999986543 34689999999999999999999999976 67899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.......+++...+.++.+++ .+||||||+|||+++++.+||+|||+++...... ........
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~ 425 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAK 425 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--HHTTCSTT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--eecccCCc
Confidence 99999754333455555555544443 3999999999999999999999999998753210 11122345
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
++..|+|||.+.+..++.++|||||||+||||+| |+.||...... +...... .+.. . ........
T Consensus 426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~~i~-~~~~-----~----~~~~~~~~ 491 (535)
T 2h8h_A 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVE-RGYR-----M----PCPPECPE 491 (535)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHHHHH-TTCC-----C----CCCTTCCH
T ss_pred CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH-cCCC-----C----CCCCCCCH
Confidence 6788999999999999999999999999999999 89999765322 2222221 1110 0 11112234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.+.+++.+||+.+|++|||++++++.|+++..
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 67899999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.39 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=173.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce----EEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR----GLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----~lV 499 (723)
.+.+.||+|+||.||+|.. +++.||||++.... ......|.+|++++++++||||+++++++...... ++|
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 3467899999999999997 56799999997653 33456789999999999999999999998765544 899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++.... .+++...+. .+|+...+||||||+|||++.++.+||+|||+++........
T Consensus 95 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence 99999999999987532 234443333 333444499999999999999999999999999876443322
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .............. ......
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~---~~~~~~ 245 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPP---SARHEG 245 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCH---HHHSTT
T ss_pred cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCc---ccccCC
Confidence 23334456899999999999999999999999999999999999999765432 22222222211100 000011
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHHhh
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVV-MELNESL 687 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl-~~L~~~~ 687 (723)
....+.+++.+||+.+|.+||++.+++ ..|....
T Consensus 246 ----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 ----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 123577999999999999999766544 4554443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.03 Aligned_cols=242 Identities=28% Similarity=0.385 Sum_probs=186.0
Q ss_pred hhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|...+ ..||||++..... ..+.|.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (279)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCH
Confidence 45789999999999999865 4899999976542 3578999999999999999999999986 4568999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......+++...+.++.++ ..+||||||+||++++++.+||+|||+++...... ........+
T Consensus 95 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~ 172 (279)
T 1qpc_A 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKF 172 (279)
T ss_dssp HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCC
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc--cccccCCCC
Confidence 999875432235555544444433 33999999999999999999999999998764321 122233456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++||||||++++||++ |+.||...... +.......... +.... .....
T Consensus 173 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~------~~~~~----~~~~~ 238 (279)
T 1qpc_A 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLERGYR------MVRPD----NCPEE 238 (279)
T ss_dssp CTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTCC------CCCCT----TCCHH
T ss_pred ccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHHHHhcccC------CCCcc----cccHH
Confidence 788999999998899999999999999999999 89998754322 22222211100 11111 12246
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+.+++.+|++.+|++|||++++++.|+++...
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 78999999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.89 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=180.7
Q ss_pred hhhhccccCcEEEEEEEECC-----ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEe-cCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCD-EGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|...+ ..||+|.+.... ....+.+.+|++++++++||||++++++|. ..+..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 45789999999999998732 258999987643 345678999999999999999999999864 45678999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC-Cce
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-GTH 571 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~ 571 (723)
+++|+|.+++.... ..+++...+.+ +|+...+||||||+|||+++++.+||+|||+++....... ...
T Consensus 109 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 187 (298)
T 3f66_A 109 MKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187 (298)
T ss_dssp CTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-
T ss_pred CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccc
Confidence 99999999997542 22344444333 3334449999999999999999999999999987543211 112
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......+|+.|+|||.+.+..++.++||||||++++||++|. +|+..... ......... +.. ...+ ..
T Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~~~----~~~--~~~~---~~- 256 (298)
T 3f66_A 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQ----GRR--LLQP---EY- 256 (298)
T ss_dssp ----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHHHT----TCC--CCCC---TT-
T ss_pred cccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHhc----CCC--CCCC---cc-
Confidence 233456788999999999999999999999999999999954 55544332 222222111 110 0001 11
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
....+.+++.+|++.+|.+|||++|+++.|++++.
T Consensus 257 ---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 257 ---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12367899999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.54 Aligned_cols=249 Identities=15% Similarity=0.201 Sum_probs=189.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++..... .+.+.+|+++++++ +|+|++.+++++......++||||+ ++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 457899999999999996 577999999865432 24688999999999 8999999999999999999999999 99
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCc-----EEEEeccCccccCCCCCCc-
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQ-----AKIADFGLSRTFPVEGSGT- 570 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~-----~kl~DfGla~~~~~~~~~~- 570 (723)
+|.+++..... .+++...+.++.+++ .+||||||+|||++.++. +||+|||+++.........
T Consensus 91 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (298)
T 1csn_A 91 SLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169 (298)
T ss_dssp BHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred CHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccc
Confidence 99999976432 355555555444443 399999999999987776 9999999998765432211
Q ss_pred ---eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHH--HHHHhcCCCcccccCCc
Q 004935 571 ---HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW--VSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~i~d~~ 645 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||............ +.......... .
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 244 (298)
T 1csn_A 170 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-----E 244 (298)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----H
T ss_pred ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH-----H
Confidence 1234567999999999999999999999999999999999999999765432221111 11111111110 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
+... ....+.+++.+|++.+|++||++++|++.|++++....
T Consensus 245 ~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 245 LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1111 12367899999999999999999999999999886443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.77 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=182.7
Q ss_pred hhhhcccc--CcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNG--GFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+| +||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||||
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 46789999 99999999984 6799999997542 444567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC----
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG---- 569 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~---- 569 (723)
++|+|.+++.......+++.....++. +...+||||||+|||++.++.+||+|||.+.........
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~ 188 (389)
T 3gni_B 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188 (389)
T ss_dssp TTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCB
T ss_pred CCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccc
Confidence 999999999876444455554444433 333399999999999999999999999998754322110
Q ss_pred ceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---------CC-
Q 004935 570 THVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---------GD- 637 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~- 637 (723)
........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+.......... ..
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (389)
T 3gni_B 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268 (389)
T ss_dssp CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------
T ss_pred ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccc
Confidence 111223468899999999987 579999999999999999999999997654433222211110000 00
Q ss_pred ------------ccccc---CCcc------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 638 ------------IESIV---DPRL------HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 638 ------------~~~i~---d~~l------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..... .+.. ...........+.+++.+||+.||++|||++|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 0000 000111123457899999999999999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=306.16 Aligned_cols=238 Identities=23% Similarity=0.381 Sum_probs=181.7
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.+.||+|+||.||+|.. ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 344568899999999999998 4679999999754 334557799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCCC
Q 004935 503 MANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~ 569 (723)
+++|+|.+++.... .+++... +..+|+...+||||||+|||++.+ +.+||+|||+++......
T Consensus 110 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 110 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 99999999887542 2343333 334444444999999999999865 459999999998764221
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +...... .+... ...+.. .
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~-~~~~~-~~~~~~-~- 255 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIK-AGAYD-YPSPEW-D- 255 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HTCCC-CCTTGG-G-
T ss_pred --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-hCCCC-CCcccc-c-
Confidence 223467999999999999989999999999999999999999999764332 1111111 11110 000111 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.+|.+|||+.|+++
T Consensus 256 ---~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 256 ---TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12235779999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.89 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=185.0
Q ss_pred hhhccccCcEEEEEEEE--CCc---eEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce-EEEEEeC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGT---EVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR-GLIYEFM 503 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~---~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV~Ey~ 503 (723)
.+.||+|+||.||+|.. ++. .||+|++.... ....+.|.+|++++++++||||+++++++...+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 47899999999999986 222 69999997644 34567899999999999999999999999776665 9999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC-Ccee
Q 004935 504 ANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-GTHV 572 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~ 572 (723)
.+|+|.+++.... ..+++...+.+ +|+...+||||||+|||++.++.+||+|||+++....... ....
T Consensus 106 ~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 184 (298)
T 3pls_A 106 CHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184 (298)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCC
T ss_pred cCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccccc
Confidence 9999999997642 23444444333 3333349999999999999999999999999986532211 1122
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....+++.|+|||.+.+..++.++||||||++++||++|+.|+............+..... .....
T Consensus 185 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---------~~~~~---- 251 (298)
T 3pls_A 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---------LPQPE---- 251 (298)
T ss_dssp SSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---------CCCCT----
T ss_pred CcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---------CCCCc----
Confidence 23456788999999999999999999999999999999976665444333333332221110 00111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.....+.+++.+|++.+|.+|||++++++.|++++..
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1223678999999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.13 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=179.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. ++..||||++... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 114 (310)
T 2wqm_A 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 114 (310)
T ss_dssp EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecC
Confidence 3467899999999999997 5779999999753 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 504 ANGNLQALLLGE--EADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++|+|.+++... ....+++...+.+ +++...+||||||+||+++.++.+||+|||+++...... .
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~ 191 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---T 191 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC---c
Confidence 999999998642 2233444444333 333344999999999999999999999999998653221 1
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......+++.|+|||.+.+..++.++||||||++++||++|+.||..... .......... ........ ...
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-~~~~~~~~----~~~-- 262 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIE-QCDYPPLP----SDH-- 262 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHHHH-TTCSCCCC----TTT--
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHHhh-cccCCCCc----ccc--
Confidence 22345689999999999999999999999999999999999999865432 2222222221 11111110 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhhhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLK 695 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~~~ 695 (723)
....+.+++.+||+.+|.+|||+++|++.|+++.+..+....
T Consensus 263 --~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 263 --YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 123578999999999999999999999999999877766543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.54 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=180.6
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 445578999999999999998 46799999985321 12357799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccC--CCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCc---EEEEeccCccccC
Q 004935 500 YEFMANGNLQALLLGE--EADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQ---AKIADFGLSRTFP 564 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~--~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~---~kl~DfGla~~~~ 564 (723)
|||+++|+|.+++... ....++.... +..+|+...+||||||+|||++.++. +||+|||+++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 9999999998877543 2222343333 33444444499999999999986654 9999999998764
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... +....... +... .++
T Consensus 185 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i~~-~~~~--~~~ 253 (351)
T 3c0i_A 185 ESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIK-GKYK--MNP 253 (351)
T ss_dssp TTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHHHH-TCCC--CCH
T ss_pred CCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHHHc-CCCC--CCc
Confidence 321 223445799999999999999999999999999999999999999976432 11111111 1110 011
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ....+.+++.+||+.+|++|||+.|+++
T Consensus 254 ~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 RQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11011 1235779999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.33 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=179.6
Q ss_pred hhhhccccCcEEEEEEEE--CCc----eEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGT----EVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.. +++ .||+|.+... .....+.+.+|+.++++++||||++++++|.... .++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence 357899999999999997 333 4688887644 3345678999999999999999999999998755 7899999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++..... .+++...+. .+|+...+||||||+|||++.++.+||+|||+++....... ...
T Consensus 98 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~-~~~ 175 (327)
T 3lzb_A 98 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYH 175 (327)
T ss_dssp CSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------------
T ss_pred cCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc-ccc
Confidence 999999999976432 244443333 33334449999999999999999999999999987643322 222
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....+|+.|+|||.+.+..++.++|||||||+++||++ |+.||...... .+...+. .+.. ... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~----~~~~-----~~~----~ 241 (327)
T 3lzb_A 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE----KGER-----LPQ----P 241 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH----TTCC-----CCC----C
T ss_pred ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH----cCCC-----CCC----C
Confidence 233456789999999999999999999999999999999 99999765432 2222221 1110 001 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
......+.+++.+||+.+|.+||+++|+++.|+++......
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 282 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence 11223578999999999999999999999999998865543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=303.34 Aligned_cols=232 Identities=23% Similarity=0.318 Sum_probs=180.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||+|+++... ......+.+|+++|++++||||+++++++...+..++||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 357899999999999998 46799999997532 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .++. ...+..+|+...+||||||+|||++.++.+||+|||+++...... ....
T Consensus 89 gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~ 163 (337)
T 1o6l_A 89 GGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMK 163 (337)
T ss_dssp TCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---CCBC
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC---Cccc
Confidence 999999987532 2222 233444445555999999999999999999999999998643221 2234
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ . ..+....
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~~---- 228 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILME-E------IRFPRTL---- 228 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-C------CCCCTTS----
T ss_pred ccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHHcC-C------CCCCCCC----
Confidence 567999999999999999999999999999999999999999754321 222222111 1 1111112
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++|+++
T Consensus 229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 23577999999999999999 8888875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=295.39 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=186.5
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.. +++.||+|++..... ..+++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 457899999999999998 566899999986543 346799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..+++...+.++. +...+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 91 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~ 167 (267)
T 3t9t_A 91 SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKF 167 (267)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTC
T ss_pred HHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc--ccccccccc
Confidence 99997642 2344444444433 3334999999999999999999999999998653210 111223456
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++||||||++++||++ |+.||..... .+...... .+.. ...+. .....
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~i~-~~~~--~~~~~-------~~~~~ 233 (267)
T 3t9t_A 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDIS-TGFR--LYKPR-------LASTH 233 (267)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHH-TTCC--CCCCT-------TSCHH
T ss_pred cccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HHHHHHHh-cCCc--CCCCc-------cCcHH
Confidence 778999999998999999999999999999999 8999875432 12222221 1110 00111 11236
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+++.+|++.+|++|||++++++.|+++.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=308.57 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=174.4
Q ss_pred hhhhccccCcEEEEEEEEC--C---ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD--G---TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.+. + ..||||.+.... ....++|.+|+.++++++||||++++++|.. .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 3578999999999999872 2 268999987543 3456789999999999999999999999754 4578999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-ce
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-TH 571 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 571 (723)
+++|+|.+++..... .+++...+.+ +|+...+||||||+|||++.++.+||+|||+++........ ..
T Consensus 173 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 251 (373)
T 3c1x_A 173 MKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251 (373)
T ss_dssp CTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred CCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccccc
Confidence 999999999975432 2344444333 33334499999999999999999999999999865332211 11
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......+++.|+|||.+.+..++.++|||||||++|||+| |.+||...... .....+. .+. ....+ .
T Consensus 252 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~----~~~--~~~~p---~-- 319 (373)
T 3c1x_A 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL----QGR--RLLQP---E-- 319 (373)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHH----TTC--CCCCC---T--
T ss_pred ccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHH----cCC--CCCCC---C--
Confidence 2234457789999999999999999999999999999999 66677654332 2222221 111 00111 1
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.....+.+++.+||+.+|.+|||++|+++.|++++.
T Consensus 320 --~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 320 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122367899999999999999999999999998874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.86 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=172.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 3467899999999999987 467999999875532 234678899999999999999999999999999999999999
Q ss_pred CCHHHHhccC----CCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 506 GNLQALLLGE----EADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 506 gsL~~~l~~~----~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+|.+++... ....+.+... +..+|+...+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~ 163 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV---N 163 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC---C
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc---c
Confidence 5999988643 1223444433 333444444999999999999999999999999998764221 1
Q ss_pred eeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cccc-----cC
Q 004935 572 VTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESI-----VD 643 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i-----~d 643 (723)
......+|+.|+|||.+.+. .++.++|||||||+++||++|+.||........+.......-.... ...+ ..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 22345689999999998764 6899999999999999999999999766543333322222111100 0000 00
Q ss_pred CcccC------------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHE------------DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~------------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+.. .........+.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 000012236789999999999999999998875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.33 Aligned_cols=234 Identities=23% Similarity=0.342 Sum_probs=165.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|... ++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 4578999999999999994 5689999997643 34678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCceeee
Q 004935 508 LQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|.+++.... .+++.....+ +|+...+||||||+|||++. ++.+||+|||+++..... ....
T Consensus 135 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----~~~~ 208 (349)
T 2w4o_A 135 LFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMK 208 (349)
T ss_dssp HHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc----cccc
Confidence 999987542 2444444333 33333499999999999975 889999999999875321 1223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..... ..... ...+ ... +.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~-~~~~~-~~~~-~~~----~~ 278 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRIL-NCEYY-FISP-WWD----EV 278 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHH-TTCCC-CCTT-TTT----TS
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHH-hCCCc-cCCc-hhh----hC
Confidence 457899999999999999999999999999999999999999755432211 11111 11110 0111 111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||+.|+++
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 336789999999999999999999886
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=298.45 Aligned_cols=233 Identities=23% Similarity=0.334 Sum_probs=172.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh--------------------------hHHHHHHHHHHHHhccCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--------------------------GYKQFQAEVELLMRIHHK 481 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------------------------~~~~f~~Ei~~l~~l~H~ 481 (723)
+.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|++++++++||
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 457899999999999988 4679999998754311 135689999999999999
Q ss_pred ceeeEEEEEec--CCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCC
Q 004935 482 NLTTLVGYCDE--GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGK 549 (723)
Q Consensus 482 nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~ 549 (723)
||+++++++.. ....++||||+++|+|.+++... .+++.....++ |+...+||||||+|||++.+
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 173 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC
Confidence 99999999976 56789999999999998865432 34444443333 33334999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCcccccHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHERIHIT 626 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~ 626 (723)
+.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||+++||++|+.||..... .
T Consensus 174 ~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~ 246 (298)
T 2zv2_A 174 GHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI----M 246 (298)
T ss_dssp SCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred CCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----H
Confidence 999999999998764321 2234567999999999997765 47889999999999999999999975432 1
Q ss_pred HHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 627 QWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 627 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....... ...... +. ... ....+.+++.+||+.+|++|||++|+++
T Consensus 247 ~~~~~~~-~~~~~~---~~-~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLHSKIK-SQALEF---PD-QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHH-HCCCCC---CS-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHh-cccCCC---CC-ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2221111 111110 00 111 1235789999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=306.81 Aligned_cols=252 Identities=15% Similarity=0.154 Sum_probs=189.2
Q ss_pred hhhhccccCcEEEEEEEEC----------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceee--------------
Q 004935 430 FERVLGNGGFGTVYHGYLD----------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT-------------- 485 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-------------- 485 (723)
+.+.||+|+||.||+|... ++.||||++... +.+.+|++++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4578999999999999984 568999998754 35889999999999999987
Q ss_pred -EEEEEec-CCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCC--c
Q 004935 486 -LVGYCDE-GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKF--Q 551 (723)
Q Consensus 486 -l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~--~ 551 (723)
+++++.. ....++||||+ +|+|.+++.......+++...+.++.+++. +||||||+|||++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 6777766 77889999999 999999998654445666666555555443 9999999999999998 9
Q ss_pred EEEEeccCccccCCCCCCc----eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcc-cccHH
Q 004935 552 AKIADFGLSRTFPVEGSGT----HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHE-RIHIT 626 (723)
Q Consensus 552 ~kl~DfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~-~~~~~ 626 (723)
+||+|||+++.+....... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ...+.
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 9999999998764322111 112345799999999999999999999999999999999999999986542 22222
Q ss_pred HHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 627 QWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 627 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
......... .....++..... .....+.+++.+|++.+|++|||++++++.|+++++....
T Consensus 280 ~~~~~~~~~--~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 280 KQKQKFVDK--PGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHS--CCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhccCC--hhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 222221111 111111111100 1123678999999999999999999999999998866543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=302.91 Aligned_cols=236 Identities=19% Similarity=0.285 Sum_probs=174.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------------
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------------ 494 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------------ 494 (723)
+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+++|++++||||++++++|.+..
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 457899999999999998 47799999997543 335578999999999999999999999986543
Q ss_pred ---------------------------------------------ceEEEEEeCCCCCHHHHhccCCC-CCCCH------
Q 004935 495 ---------------------------------------------NRGLIYEFMANGNLQALLLGEEA-DILSW------ 522 (723)
Q Consensus 495 ---------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~------ 522 (723)
..++||||+++|+|.+++..... ....+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i 169 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHH
Confidence 27899999999999999986532 22232
Q ss_pred H----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc---------eeeecccCCCccccccccc
Q 004935 523 E----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT---------HVTTTIAGTPGYLDPEYYI 589 (723)
Q Consensus 523 ~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~ 589 (723)
. ..+..+|+...+||||||+|||++.++.+||+|||+++......... .......||+.|+|||.+.
T Consensus 170 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 249 (332)
T 3qd2_B 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249 (332)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhc
Confidence 2 23334444444999999999999999999999999998765432111 1223456999999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCC
Q 004935 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQT 669 (723)
Q Consensus 590 ~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 669 (723)
+..++.++|||||||+++||++|..|+.... .... ....... +. ........+.+++.+|++.+
T Consensus 250 ~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~-~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 250 GNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIIT-DVRNLKF-----PL----LFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHH-HHHTTCC-----CH----HHHHHCHHHHHHHHHHHCSS
T ss_pred CCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHH-HhhccCC-----Cc----ccccCChhHHHHHHHHccCC
Confidence 9999999999999999999999987753211 1111 1111111 00 01122345679999999999
Q ss_pred CCCCCCHHHHHH
Q 004935 670 STKRPTMNQVVM 681 (723)
Q Consensus 670 p~~RPsm~evl~ 681 (723)
|++|||++|+++
T Consensus 314 p~~Rps~~~~l~ 325 (332)
T 3qd2_B 314 PTERPEATDIIE 325 (332)
T ss_dssp GGGSCCHHHHHH
T ss_pred CCcCCCHHHHhh
Confidence 999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.11 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=178.7
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHH--HHhccCCceeeEEEEEec-----CCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVEL--LMRIHHKNLTTLVGYCDE-----GTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|..+++.||||++.... ...+..|.++ +..++|+||+++++++.. ....++||||
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 17 LLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 35789999999999999999999999997543 2344444444 556899999999986532 3356899999
Q ss_pred CCCCCHHHHhccCCCC-------CCCHHHHHHHHHhc---------cccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 503 MANGNLQALLLGEEAD-------ILSWEGRLRIAIEA---------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~-------~l~~~~~l~i~~~~---------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
+++|+|.+++...... ..+....+..+|.. ..+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 ~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 94 YPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173 (336)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccc
Confidence 9999999999765321 11223344555555 5699999999999999999999999999876432
Q ss_pred CC-----CceeeecccCCCcccccccccc-------CCCCChhhHHHHHHHHHHHHcCCCccccCccccc----------
Q 004935 567 GS-----GTHVTTTIAGTPGYLDPEYYIS-------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH---------- 624 (723)
Q Consensus 567 ~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~---------- 624 (723)
.. .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3g2f_A 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253 (336)
T ss_dssp SCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHC
T ss_pred cccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccC
Confidence 11 1112234569999999999876 4567899999999999999999887643321111
Q ss_pred ---HHHHHHHHhcCCCcccccCCcccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 625 ---ITQWVSFMLGKGDIESIVDPRLHED--FDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 625 ---~~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.............. .+.+... ........+.+++.+||+.+|++|||++|+++.|++++..
T Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 254 NHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 01111111111111 1111111 1223556789999999999999999999999999998843
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=301.09 Aligned_cols=235 Identities=22% Similarity=0.268 Sum_probs=175.3
Q ss_pred HHHHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 424 LRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 424 ~~~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
....+...+.||+|+||+||+|.. +++.||||++.... .....++..|+..+.++ +|+||++++++|.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 334445567899999999999998 47799999986542 33445666777777666 99999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
||||+ +++|.+++.... ..++|.....++.+++ .+||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 99999 679988876542 3466666655554443 399999999999999999999999999875322
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.......||+.|+|||.+.+ .++.++|||||||+++||++|..++..... + . .+..+.. .+.+..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~-~-~~~~~~~----~~~~~~ 275 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------W-Q-QLRQGYL----PPEFTA 275 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------H-H-HHTTTCC----CHHHHT
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------H-H-HHhccCC----Cccccc
Confidence 22344569999999998875 799999999999999999999776643211 1 1 1111111 111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ....+.+++.+|++.+|++|||++|+++
T Consensus 276 ~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 276 G----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp T----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 2246789999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.34 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=181.7
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-----hhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCC---
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-----AQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGT--- 494 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~--- 494 (723)
+.+.+.||+|+||.||+|.. +++.||||++.... ......+.+|++++++++ ||||++++++|....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 34567899999999999996 56799999986422 112345677888777764 999999999997755
Q ss_pred --ceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccc
Q 004935 495 --NRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRT 562 (723)
Q Consensus 495 --~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~ 562 (723)
..++||||+. |+|.+++.......+++.....++.+++ .+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred ceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence 4789999998 5999999876555566665555444433 39999999999999999999999999987
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IES 640 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 640 (723)
.... .......+|+.|+|||.+.+..++.++|||||||+++||++|+.||........+............ ...
T Consensus 170 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 170 YSYQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp STTC----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cCCC----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 5422 2234567899999999999999999999999999999999999999776544333333322211100 000
Q ss_pred cc-CC--cccC--C-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IV-DP--RLHE--D-----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~-d~--~l~~--~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. .+ .+.. . ...+....+.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 00 0000 0 00112346789999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.06 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=187.8
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|... +..||||++.... ......|.+|++++++++||||+++++++...+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 4678999999999999864 4589999997653 3445679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC--------CCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 502 FMANGNLQALLLGEE--------ADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 502 y~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
|+++|+|.+++.... ...+++...+.++. +...+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~ 188 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccc
Confidence 999999999986521 12345544444433 333499999999999999999999999999865
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........+++.|+|||.+.+..++.++|||||||+++||++ |+.||..... .+...... .+....
T Consensus 189 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~-~~~~~~-- 260 (322)
T 1p4o_A 189 YETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVM-EGGLLD-- 260 (322)
T ss_dssp GGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHHH-TTCCCC--
T ss_pred ccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----HHHHHHHH-cCCcCC--
Confidence 32211 111223456789999999999999999999999999999999 8888875432 12222222 111111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
... .....+.+++.+|++.+|.+|||+.|+++.|++.+...
T Consensus 261 ---~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 261 ---KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp ---CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ---CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 111 12336789999999999999999999999999887533
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=295.16 Aligned_cols=237 Identities=24% Similarity=0.373 Sum_probs=184.2
Q ss_pred HHHHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec-----------
Q 004935 426 ITNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----------- 492 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----------- 492 (723)
..+...+.||+|+||.||+|... ++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 33445688999999999999984 7799999997654 356789999999999999999998854
Q ss_pred -----CCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEec
Q 004935 493 -----GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADF 557 (723)
Q Consensus 493 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~Df 557 (723)
....++||||+++|+|.+++.......+++...+.++.+++ .+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence 44578999999999999999765444456555544444333 399999999999999999999999
Q ss_pred cCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC
Q 004935 558 GLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 558 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
|+++...... ......+++.|+|||.+.+..++.++||||||++++||++|..|+.... .... ....+.
T Consensus 167 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~-~~~~~~ 235 (284)
T 2a19_B 167 GLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFT-DLRDGI 235 (284)
T ss_dssp TTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHH-HHHTTC
T ss_pred hhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHH-Hhhccc
Confidence 9998764322 1234568999999999999999999999999999999999998875321 1111 111211
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
+ ....+ ..+.+++.+|++.+|.+|||+.|+++.|+.+...
T Consensus 236 ~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 236 I--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp C--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 11122 2467899999999999999999999999877643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=306.41 Aligned_cols=251 Identities=20% Similarity=0.196 Sum_probs=178.2
Q ss_pred hhhhccccCcEEEEEEEEC-----CceEEEEEecCCChh-----------hHHHHHHHHHHHHhccCCceeeEEEEEec-
Q 004935 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSSAQ-----------GYKQFQAEVELLMRIHHKNLTTLVGYCDE- 492 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~- 492 (723)
+.+.||+|+||.||+|... +..||||+....... ..+.+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 4578999999999999984 358999998765421 11346788899999999999999999987
Q ss_pred ---CCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCC--cEEEEec
Q 004935 493 ---GTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKF--QAKIADF 557 (723)
Q Consensus 493 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~--~~kl~Df 557 (723)
....++||||+ +++|.+++.... .+++...+.++.+++ .+||||||+|||++.++ .+||+||
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Df 197 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY 197 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCC
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeC
Confidence 77899999999 999999987643 456655555544443 39999999999999887 9999999
Q ss_pred cCccccCCCCCC----ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh
Q 004935 558 GLSRTFPVEGSG----THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 558 Gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~ 633 (723)
|+++.+...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.................
T Consensus 198 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 277 (345)
T 2v62_A 198 GLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNL 277 (345)
T ss_dssp TTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHH
T ss_pred CCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhh
Confidence 999876432211 1112345799999999999999999999999999999999999999965332222222222111
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
... +...+...... ......+.+++.+||+.+|++||++++|++.|++..
T Consensus 278 ~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 278 LDE-LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHT-TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccc-ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 11100000000 012236789999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.98 Aligned_cols=230 Identities=24% Similarity=0.350 Sum_probs=176.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||+|.. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 356899999999999997 56799999997543 2344679999999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|+|.+++.... ..+++.....++. +...+||||||+|||++.++.+||+|||+++.... ..
T Consensus 138 -g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-------~~ 208 (348)
T 1u5q_A 138 -GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------AN 208 (348)
T ss_dssp -EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------BC
T ss_pred -CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-------CC
Confidence 68888775322 2345554444443 33349999999999999999999999999987532 12
Q ss_pred cccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 575 TIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
...||+.|+|||.+. ...++.++|||||||+++||++|+.||....... .......... +.+...
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----~~~~~~~~~~------~~~~~~-- 276 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNES------PALQSG-- 276 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCC------CCCCCT--
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCC------CCCCCC--
Confidence 356899999999985 5678999999999999999999999997654321 1222211111 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.+|++|||++++++
T Consensus 277 -~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 277 -HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11235679999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.84 Aligned_cols=247 Identities=20% Similarity=0.290 Sum_probs=177.9
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|... ++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 4578999999999999984 679999999755432 246788999999999999999999999999999999999986
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+++... +..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 160 (288)
T 1ob3_A 85 DLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHE 160 (288)
T ss_dssp EHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---cccccc
Confidence 99988875422 2343333 333444444999999999999999999999999998653221 122345
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccc-----ccCCccc-
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IES-----IVDPRLH- 647 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-----i~d~~l~- 647 (723)
.+|+.|+|||.+.+. .++.++|||||||+++||++|+.||........+....+....... ... ..++.+.
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 689999999998764 5899999999999999999999999766543333333322111100 000 0111110
Q ss_pred ------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 ------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..........+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0001112346779999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=303.38 Aligned_cols=245 Identities=24% Similarity=0.290 Sum_probs=169.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEe--------cCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCD--------EGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~--------~~~~~~l 498 (723)
+.+.||+|+||.||+|.. +++.||||++........+.+.+|+.+++++. ||||+++++++. .....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 467899999999999998 67799999997777777788999999999996 999999999994 3345789
Q ss_pred EEEeCCCCCHHHHhccC-CCCCCCHHHH----------HHHHHhcc--ccccCCCCCCEEEcCCCcEEEEeccCccccCC
Q 004935 499 IYEFMANGNLQALLLGE-EADILSWEGR----------LRIAIEAA--KVHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~-~~~~l~~~~~----------l~i~~~~a--~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~ 565 (723)
|+||+. |+|.+++... ....+++... +..+|... .+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190 (337)
T ss_dssp EEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred EEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence 999996 7999888652 2223555444 44445555 69999999999999999999999999987643
Q ss_pred CCCCc---------eeeecccCCCcccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh
Q 004935 566 EGSGT---------HVTTTIAGTPGYLDPEYY---ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 566 ~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~ 633 (723)
..... .......+|+.|+|||.+ .+..++.++|||||||+++||++|+.||...... ......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~- 265 (337)
T 3ll6_A 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGK- 265 (337)
T ss_dssp CC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred cCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----HhhcCc-
Confidence 32111 011234589999999998 5667899999999999999999999999653221 111100
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.. ...... ....+.+++.+||+.+|.+|||++|+++.|+++.+....
T Consensus 266 ----~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 266 ----YS----IPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ----CC----CCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred ----cc----CCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 00 000011 112367899999999999999999999999998865543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.47 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=185.8
Q ss_pred HhhhhccccCcEEEEEEEE--CCc--eEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGT--EVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~--~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|.. ++. .||+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 3467899999999999987 454 45999987543 33456799999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEecc
Q 004935 503 MANGNLQALLLGEE--------------ADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFG 558 (723)
Q Consensus 503 ~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfG 558 (723)
+++|+|.+++.... ...+++...+.++.+++ .+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccC
Confidence 99999999997643 23456555555444433 3999999999999999999999999
Q ss_pred CccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCC
Q 004935 559 LSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 559 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
+++..... .......+++.|+|||.+.+..++.++|||||||+++||+| |+.||..... .+..... ..+.
T Consensus 188 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~~-~~~~ 258 (327)
T 1fvr_A 188 LSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL-PQGY 258 (327)
T ss_dssp CEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHG-GGTC
T ss_pred cCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----HHHHHHh-hcCC
Confidence 99753211 11233456889999999998889999999999999999998 9999975532 2222222 1111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
...... .....+.+++.+|++.+|.+|||++|+++.|+++++....
T Consensus 259 -----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 259 -----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 011111 1224678999999999999999999999999998865544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.69 Aligned_cols=247 Identities=19% Similarity=0.234 Sum_probs=177.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 457899999999999998 46689999997543 33456789999999999999999999999999999999999986
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++.+.+.... ..+++... +..+|+...+||||||+|||++.++.+||+|||+++..... ......
T Consensus 86 -~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 160 (292)
T 3o0g_A 86 -DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---VRCYSA 160 (292)
T ss_dssp -EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC---CSCCCS
T ss_pred -CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc---cccccC
Confidence 5555544322 22343333 33334444499999999999999999999999999876422 122344
Q ss_pred ccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc------cccCCc---
Q 004935 576 IAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE------SIVDPR--- 645 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~i~d~~--- 645 (723)
..+|+.|+|||.+.+.. ++.++|||||||+++||++|+.|+............+.......... ...+..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 57899999999998766 89999999999999999999888644333222222222222111100 000000
Q ss_pred ------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 ------LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 ------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
............+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000011122346779999999999999999999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.80 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=177.0
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC-----ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-----SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
+.+.+.||+|+||.||+|.. ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 33468999999999999998 4568999998643 2344578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCC--------------------------------------CCCC----------CHHHHHHHHHhc
Q 004935 501 EFMANGNLQALLLGEE--------------------------------------ADIL----------SWEGRLRIAIEA 532 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~--------------------------------------~~~l----------~~~~~l~i~~~~ 532 (723)
||+++|+|.+++.... ...+ +....+..+++.
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999999985210 0001 122233444444
Q ss_pred cccccCCCCCCEEEcCCC--cEEEEeccCccccCCCCCC-ceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHH
Q 004935 533 AKVHRDVKSTNILLSGKF--QAKIADFGLSRTFPVEGSG-THVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLL 607 (723)
Q Consensus 533 a~vH~Dlk~~NILl~~~~--~~kl~DfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~ 607 (723)
..+||||||+|||++.++ .+||+|||+++.+...... ........||+.|+|||.+.+ ..++.++|||||||+++
T Consensus 188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 267 (345)
T 3hko_A 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267 (345)
T ss_dssp TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence 449999999999998776 8999999999865432211 112345679999999999875 67899999999999999
Q ss_pred HHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 608 EIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 608 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
||++|+.||..........+ ...... ....+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 268 el~~g~~pf~~~~~~~~~~~----~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 268 LLLMGAVPFPGVNDADTISQ----VLNKKL--CFENPNY-----NVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHSSCSSCCSSHHHHHHH----HHHCCC--CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCChHHHHHH----HHhccc--ccCCccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999976543322222 221110 0001111 112236789999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.68 Aligned_cols=246 Identities=21% Similarity=0.253 Sum_probs=177.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|+||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 457899999999999998 46799999987543 2334779999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++...+.++. +...+||||||+|||++.++.+||+|||++....... .....
T Consensus 118 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 193 (309)
T 2h34_A 118 GVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLG 193 (309)
T ss_dssp CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------------
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc--ccccc
Confidence 999999987532 244444444433 3334999999999999999999999999998654321 12223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-cccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-IESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~i~d~~l~~~~~~~ 653 (723)
...+++.|+|||.+.+..++.++||||||++++||++|+.||...... .+........ .... ....
T Consensus 194 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~----~~~~---- 260 (309)
T 2h34_A 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHINQAIPRPST----VRPG---- 260 (309)
T ss_dssp ---CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHHSCCCCGGG----TSTT----
T ss_pred ccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhccCCCCccc----cCCC----
Confidence 456899999999999999999999999999999999999999764321 1122221111 1111 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhHhh
Q 004935 654 SVWKTVEIAMACVSQTSTKRP-TMNQVVMELNESLAIETA 692 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~~~~~~ 692 (723)
....+.+++.+|++.+|++|| +++++++.|+++++....
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 122577999999999999999 999999999988755543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=305.94 Aligned_cols=227 Identities=24% Similarity=0.315 Sum_probs=172.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|.++++++ +||||+++++++...+..++||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 457899999999999998 46799999997542 23346688999999998 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .++.. ..+..+|+...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 107 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~---~~~~ 181 (353)
T 3txo_A 107 NGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN---GVTT 181 (353)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC---Cccc
Confidence 9999999987542 13332 2344444444599999999999999999999999999864322 2233
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ .. .+....
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~-~~------~~p~~~--- 247 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILND-EV------VYPTWL--- 247 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC-CC------CCCTTS---
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHHHHHcC-CC------CCCCCC---
Confidence 45679999999999999899999999999999999999999997654322 12222111 11 111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
...+.+++.+|++.+|.+||++
T Consensus 248 -~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 248 -HEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -CHHHHHHHHHHTCSSGGGSTTS
T ss_pred -CHHHHHHHHHHhhhCHHHccCC
Confidence 2357799999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.32 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=176.0
Q ss_pred hhhhccccCcEEEEEEEEC-----CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc-----eE
Q 004935 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN-----RG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~ 497 (723)
+.+.||+|+||.||+|... +..||||++... .....+.+.+|++++++++||||+++++++..... .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 3578999999999999873 237999998754 34455779999999999999999999999977653 48
Q ss_pred EEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 498 LIYEFMANGNLQALLLGE----EADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
+||||+++|+|.+++... ....+++...+.++.+++ .+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 999999999999998532 234466665555544443 399999999999999999999999999875
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........+++.|+|||.+.+..++.++||||||++++||++ |+.||....... .... .... ..
T Consensus 198 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~---~~~~-~~---- 267 (313)
T 3brb_A 198 YSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDY---LLHG-HR---- 267 (313)
T ss_dssp --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHH---HHTT-CC----
T ss_pred ccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHH---HHcC-CC----
Confidence 43221 122234457889999999999999999999999999999999 888887654322 2211 1111 10
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.... .....+.+++.+|++.+|.+|||+.++++.|+++++
T Consensus 268 -~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 268 -LKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -CCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 122367899999999999999999999999998875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.00 Aligned_cols=237 Identities=22% Similarity=0.301 Sum_probs=172.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||++.. +++.||||++...... .+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 23 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 3467899999999999998 4679999999764432 356889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCc--EEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQ--AKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~--~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|.+++.... .+++.. .+..+|+...+||||||+|||++.++. +||+|||+++..... ....
T Consensus 102 ~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~----~~~~ 175 (361)
T 3uc3_A 102 ELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPK 175 (361)
T ss_dssp BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc----CCCC
Confidence 9999986532 133332 334444444599999999999987765 999999999753221 1223
Q ss_pred cccCCCccccccccccCCCCCh-hhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEK-SDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~-~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...||+.|+|||.+.+..++.+ +|||||||+++||++|+.||............+........ .+... ..
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~--~~ 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------SIPDD--IR 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------CCCTT--SC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------CCCCc--CC
Confidence 4569999999999988887765 89999999999999999999876554455444443332211 00000 01
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+||+.+|++|||++|+++
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1235779999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.54 Aligned_cols=244 Identities=22% Similarity=0.259 Sum_probs=181.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-----CCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-----HKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||+|.. +++.||||++... ....+.+..|++++++++ ||||+++++++...+..++|||
T Consensus 38 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 3458899999999999998 5679999999743 344567888999999996 9999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcC-----------------------
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSG----------------------- 548 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~----------------------- 548 (723)
|+ +++|.+++.......+++.....++. +...+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (360)
T 3llt_A 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195 (360)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEE
T ss_pred CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccc
Confidence 99 99999999876544455554444433 333399999999999975
Q ss_pred --CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHH
Q 004935 549 --KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHIT 626 (723)
Q Consensus 549 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~ 626 (723)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||........+.
T Consensus 196 ~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 196 TKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp ESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 789999999999864321 234578999999999999999999999999999999999999997654332222
Q ss_pred HHHHHHhcCCC-----------cccccC-Ccc----cCCC-CHH---------------HHHHHHHHHHhccCCCCCCCC
Q 004935 627 QWVSFMLGKGD-----------IESIVD-PRL----HEDF-DIN---------------SVWKTVEIAMACVSQTSTKRP 674 (723)
Q Consensus 627 ~~~~~~~~~~~-----------~~~i~d-~~l----~~~~-~~~---------------~~~~l~~l~~~Cl~~~p~~RP 674 (723)
. +........ ....++ ..+ .... ... ....+.+++.+||+.||++||
T Consensus 270 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 270 M-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp H-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred H-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 1 111111100 000000 000 0000 000 114567999999999999999
Q ss_pred CHHHHHH
Q 004935 675 TMNQVVM 681 (723)
Q Consensus 675 sm~evl~ 681 (723)
|++|+++
T Consensus 349 ta~elL~ 355 (360)
T 3llt_A 349 SPAELLK 355 (360)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.26 Aligned_cols=235 Identities=22% Similarity=0.298 Sum_probs=159.7
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.||+|+||.||+|... ++.||||++... ....+.+|+++++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999984 679999999643 3467889999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCC---cEEEEeccCccccCCCCCCceeeec
Q 004935 509 QALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKF---QAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
.+++.... .+++..... .+|+...+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 94 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 168 (325)
T 3kn6_A 94 FERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKT 168 (325)
T ss_dssp HHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---Ccccc
Confidence 99997642 344444333 33333449999999999998765 89999999998654322 22334
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc---ccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER---IHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
..+|+.|+|||.+.+..++.++|||||||+++||++|+.||...... ....+... .+..+... +......
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCCC------CCSHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCC------CCccccc
Confidence 56899999999999999999999999999999999999999754321 11222222 22222110 0000001
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|.+|||++|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 12346789999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.65 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=169.2
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEec----CCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE----GTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~Ey~~ 504 (723)
+.||+|+||.||++.. +++.||||++... ..+.+|++++.++ +||||+++++++.. ....++|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 5799999999999998 4668999999632 4577889887554 89999999998865 567899999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|+|.+++.......+++.....++.+ ...+||||||+|||++. ++.+||+|||+++..... .
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~----~ 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----N 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC----C
Confidence 999999998765445665555444433 33399999999999997 789999999999865322 1
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc---cHHHHHHHHhcCCCcccccCCcccC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI---HITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .....+. .+... .-.+.. .
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~-~~~~~~-~ 292 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE-FPNPEW-S 292 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC-CCTTTT-T
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc-CCCccc-c
Confidence 2335678999999999999999999999999999999999999997553321 1112111 11110 000110 1
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.....+.+++.+||+.+|++|||+.|+++.
T Consensus 293 ----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 293 ----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122357899999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.75 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=185.8
Q ss_pred ccCHHHHHHHHHHhh-hhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 004935 417 RFSYSNVLRITNNFE-RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRI-HHKNLTTLVGYC 490 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~ 490 (723)
.|...+.....+.+. +.||+|+||.||+|... ++.||||++.... ......+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344444444444444 78999999999999984 7799999987542 23457899999999999 569999999999
Q ss_pred ecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC---CCcEEEEec
Q 004935 491 DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG---KFQAKIADF 557 (723)
Q Consensus 491 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~---~~~~kl~Df 557 (723)
...+..++||||+++|+|.+++.......+++.....++.+++ .+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999998765555566655555544443 399999999999998 789999999
Q ss_pred cCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC
Q 004935 558 GLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD 637 (723)
Q Consensus 558 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 637 (723)
|+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||.............. ....
T Consensus 179 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~ 251 (327)
T 3lm5_A 179 GMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---VNVD 251 (327)
T ss_dssp GGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCC
T ss_pred ccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh---cccc
Confidence 9998764221 22345799999999999999999999999999999999999999976543222111111 1111
Q ss_pred cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 638 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ...........+.+++.+|++.+|.+|||++|+++
T Consensus 252 ~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 Y--------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 01111112335779999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.93 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=186.5
Q ss_pred HhhhhccccCcEEEEEEEE-------CCceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||.||+|.. ++..||||++... ......++.+|+.++++++||||+++++++......++||
T Consensus 33 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (327)
T 2yfx_A 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM 112 (327)
T ss_dssp EEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEE
Confidence 3467899999999999984 3458999999754 3455678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCC-----CCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC---CCcEEEEeccCccc
Q 004935 501 EFMANGNLQALLLGEEA-----DILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG---KFQAKIADFGLSRT 562 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~---~~~~kl~DfGla~~ 562 (723)
||+++|+|.+++..... ..+++...+.++.+++ .+||||||+|||++. +..+||+|||+++.
T Consensus 113 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp ECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred ecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 99999999999976532 3456655555444433 399999999999994 45699999999976
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
...... ........+++.|+|||.+.+..++.++|||||||+++||+| |+.||...... +...... .+..
T Consensus 193 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~-~~~~--- 263 (327)
T 2yfx_A 193 IYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVT-SGGR--- 263 (327)
T ss_dssp HHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHH-TTCC---
T ss_pred cccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHHHh-cCCC---
Confidence 432211 122234567889999999999999999999999999999998 99998754321 2222221 1111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
+.... .....+.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 264 --~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 264 --MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp --CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred --CCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 11111 1223678999999999999999999999999988765543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.08 Aligned_cols=232 Identities=19% Similarity=0.303 Sum_probs=174.9
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|+.. ++.||+|+++... ....+.+..|..++.++ +||||+++++++...+..++||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 3578999999999999984 5689999997542 22334588999999887 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 136 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~---~~~~ 210 (396)
T 4dc2_A 136 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTT 210 (396)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---TCCB
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC---CCcc
Confidence 9999999987532 233333 333444444599999999999999999999999999863222 2234
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc----ccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER----IHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ......+...+..... .+...
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~ 284 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRS 284 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------CCCTT
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------CCCCc
Confidence 4567999999999999999999999999999999999999999643211 1111222222222111 11111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
. ...+.+++.+||+.+|.+||++
T Consensus 285 ~----s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 L----SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp S----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred C----CHHHHHHHHHHhcCCHhHcCCC
Confidence 2 2357799999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.79 Aligned_cols=236 Identities=18% Similarity=0.306 Sum_probs=172.6
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccC--CceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHH--KNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||||++... .....+.+.+|+++|++++| +||+++++++......++||| +.
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CC
Confidence 457899999999999988 4568999998754 34455789999999999976 999999999999999999999 56
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++... +..+|+...+||||||+|||++ ++.+||+|||+++....... .....
T Consensus 92 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~ 167 (343)
T 3dbq_A 92 NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKD 167 (343)
T ss_dssp SEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----------
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc-cccCC
Confidence 889999997643 2344333 3334444449999999999997 57899999999987643321 22234
Q ss_pred cccCCCcccccccccc-----------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 575 TIAGTPGYLDPEYYIS-----------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
...||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ..........
T Consensus 168 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~-------- 236 (343)
T 3dbq_A 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDP-------- 236 (343)
T ss_dssp --CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHCT--------
T ss_pred CCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHHHHhcC--------
Confidence 5679999999999865 67899999999999999999999999754321 1112222211
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
......+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 237 -~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 -NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111112357799999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.67 Aligned_cols=229 Identities=23% Similarity=0.330 Sum_probs=178.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+++. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 357899999999999998 46799999987532 1234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .++... .+..+|+...+||||||+|||++.++.+||+|||+++.... ...
T Consensus 90 gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~------~~~ 161 (318)
T 1fot_A 90 GGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTY 161 (318)
T ss_dssp SCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------CBC
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC------ccc
Confidence 999999997642 233332 23334444449999999999999999999999999987532 123
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ . ..+....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~-~------~~~p~~~---- 226 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNA-E------LRFPPFF---- 226 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHC-C------CCCCTTS----
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC-C------CCCCCCC----
Confidence 457999999999999999999999999999999999999999765332 112222211 1 1111112
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++|+++
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 23577999999999999999 7888774
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.13 Aligned_cols=235 Identities=17% Similarity=0.300 Sum_probs=173.5
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCC--ChhhHHHHHHHHHHHHhcc--CCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIH--HKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++... ++.||||++... .....+.+.+|+++|++++ |+||+++++++...+..++||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 4578999999999999884 668999998654 3445678999999999996 5999999999999999999999 67
Q ss_pred CCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+.+..+. ..+|+...+||||||+|||++ ++.+||+|||+++.+..... .....
T Consensus 139 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~ 214 (390)
T 2zmd_A 139 NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKD 214 (390)
T ss_dssp SEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----------C
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc-cccCC
Confidence 889999997653 34443333 333444449999999999996 57899999999987643221 12234
Q ss_pred cccCCCcccccccccc-----------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 575 TIAGTPGYLDPEYYIS-----------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
...||+.|+|||.+.+ ..++.++|||||||+||||++|+.||...... ...........
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~~~~~~------- 284 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPN------- 284 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHCTT-------
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHHHhCcc-------
Confidence 5679999999999865 46899999999999999999999999754321 12222222211
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+......+.+++.+||+.+|.+|||++|+++
T Consensus 285 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 285 --HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp --SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111235779999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.21 Aligned_cols=230 Identities=20% Similarity=0.288 Sum_probs=175.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 467899999999999998 567999999864321 12357899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++.... ..+|+...+||||||+|||+++++.+||+|||+++..... ....
T Consensus 92 ~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~----~~~~ 165 (336)
T 3h4j_B 92 GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----NFLK 165 (336)
T ss_dssp CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS----BTTC
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC----cccc
Confidence 689988886532 23443333 3333334499999999999999999999999999875422 1223
Q ss_pred cccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...||+.|+|||.+.+..+ +.++|||||||+++||++|+.||........ ...+..... ..+..
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~~--~~p~~ 230 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCVY--VMPDF 230 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSCC--CCCTT
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCCC--CCccc
Confidence 4579999999999988776 7899999999999999999999975432110 001100000 01111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.||.+|||++|+++
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2235779999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.45 Aligned_cols=234 Identities=20% Similarity=0.273 Sum_probs=178.3
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++... ++.||+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999984 5689999986432 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 99 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~----~~~~ 172 (384)
T 4fr4_A 99 GGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQIT 172 (384)
T ss_dssp TEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT----CCBC
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC----Ccee
Confidence 999999997642 233333 333444444499999999999999999999999999876432 2234
Q ss_pred cccCCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 575 TIAGTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
...||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... ............ . ......
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~-~------~~~p~~-- 242 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETT-V------VTYPSA-- 242 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHC-C------CCCCTT--
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhc-c------cCCCCc--
Confidence 5679999999999864 45899999999999999999999999754332 222222222111 0 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPT-MNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPs-m~evl~ 681 (723)
....+.+++.+||+.+|.+||+ ++++.+
T Consensus 243 --~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 --WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1236789999999999999998 555543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.70 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=182.5
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh------hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ------GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.+.||+|+||.||+|.. ++..||||++...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 345578999999999999998 4679999998754321 35789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCC----cEEEEeccCccccC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKF----QAKIADFGLSRTFP 564 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~----~~kl~DfGla~~~~ 564 (723)
||||+++++|.+++.... .+++... +..+|+...+||||||+|||++.++ .+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999999997542 2333333 3333444449999999999999887 79999999998764
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +...... .... ..++
T Consensus 171 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~-~~~~--~~~~ 239 (321)
T 2a2a_A 171 DGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANIT-SVSY--DFDE 239 (321)
T ss_dssp TTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHH-TTCC--CCCH
T ss_pred ccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-hccc--ccCh
Confidence 321 123456899999999999999999999999999999999999999765332 1111111 1100 0111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+... ....+.+++.+|++.+|++|||++|+++
T Consensus 240 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 240 EFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111 1235789999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.98 Aligned_cols=236 Identities=19% Similarity=0.286 Sum_probs=179.9
Q ss_pred HHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|... +..||+|++........+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 344678999999999999985 448999999765555567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCCcee
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
++|.+++.... .+++..... .+|+...+||||||+|||+ +.++.+||+|||++....... .
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~ 164 (277)
T 3f3z_A 91 GELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----M 164 (277)
T ss_dssp CBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----C
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----c
Confidence 99999886532 234443333 3333344999999999999 788999999999998754322 2
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....+|+.|+|||.+.+. ++.++||||||++++||++|+.||......... .... .+.... ......
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~-~~~~~~--~~~~~~---- 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM----LKIR-EGTFTF--PEKDWL---- 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHH-HCCCCC--CHHHHT----
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH----HHHH-hCCCCC--Cchhhh----
Confidence 2345689999999988654 999999999999999999999999765432211 1111 111000 000000
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|.+|||+.++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11236789999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.77 Aligned_cols=235 Identities=23% Similarity=0.332 Sum_probs=169.6
Q ss_pred HhhhhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+++. +++.||+|+++... ......+.+|+++|++++||||+++++++...+..++|
T Consensus 20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 99 (327)
T 3a62_A 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLI 99 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEE
T ss_pred EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEE
Confidence 3457899999999999987 46699999997653 23345688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC----CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 500 YEFMANGNLQALLLGEEA----DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~----~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|||+++|+|.+++..... ... +....+..+|+...+||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 176 (327)
T 3a62_A 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD---GT 176 (327)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC---Cc
Confidence 999999999999875321 111 2223344444444599999999999999999999999999764322 12
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ . ..+....
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~-~------~~~p~~~- 244 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKC-K------LNLPPYL- 244 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHT-C------CCCCTTS-
T ss_pred cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhC-C------CCCCCCC-
Confidence 2345679999999999999999999999999999999999999997654322 12211111 1 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+|++.+|++|| +++|+++
T Consensus 245 ---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 245 ---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 23577999999999999999 5566654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=310.14 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=178.1
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCChh---hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQ---GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|+.. ++.||+|++...... ....+.+|+.++.+++||||++++++|.+.+..++|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 478999999999999984 568999998653211 123488999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... ..+++... +..+|+...|||||||+|||++.++.+||+|||+++...... ......
T Consensus 159 g~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~ 235 (437)
T 4aw2_A 159 GDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSV 235 (437)
T ss_dssp CBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--CEECCS
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC--Cccccc
Confidence 99999997632 22333332 333344444999999999999999999999999998764322 233345
Q ss_pred ccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..||+.|+|||.+. ...++.++|||||||++|||++|+.||............+.... . ..-|......
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-----~~~p~~~~~~ 309 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-R-----FQFPTQVTDV 309 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-H-----CCCCSSCCCS
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-c-----ccCCcccccC
Confidence 67999999999987 46789999999999999999999999976543222222211110 0 0011111112
Q ss_pred CHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTK--RPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~ 681 (723)
...+.+++.+|+..+|++ ||+++|+++
T Consensus 310 ----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 310 ----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 235678999999888888 999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.74 Aligned_cols=235 Identities=25% Similarity=0.369 Sum_probs=177.1
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
.+||+|+||.||+|.. ++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999998 46699999998776666678999999999999999999999999999999999999999999
Q ss_pred HHhccCCC-CCCCHHHH----------HHHHHhccccccCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 510 ALLLGEEA-DILSWEGR----------LRIAIEAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 510 ~~l~~~~~-~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+++..... ..+.+... +..+|+...+||||||+||+++. ++.+||+|||+++...... .......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~ 184 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFT 184 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------CCCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC---CcccccC
Confidence 99976522 22333333 33334444499999999999997 8999999999998753221 1223456
Q ss_pred CCCccccccccccCC--CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 578 GTPGYLDPEYYISNR--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 578 gt~~y~aPE~~~~~~--~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
|++.|+|||.+.+.. ++.++||||||++++||++|+.||........ ......... ..+.+.... .
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~------~~~~~~~~~----~ 252 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFK------VHPEIPESM----S 252 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHC------CCCCCCTTS----C
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhcccc------ccccccccC----C
Confidence 899999999987653 88999999999999999999999975432211 111111100 111222222 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|++|||++|+++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 36779999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=316.42 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=183.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|.. +++.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 57899999999999998 47799999986532 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.......+++.....++ |+...+||||||+|||++.++.+||+|||+++...... ....
T Consensus 269 g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~----~~~~ 344 (576)
T 2acx_A 269 GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKG 344 (576)
T ss_dssp CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC----CEEC
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc----cccc
Confidence 999999976544445555544443 33334999999999999999999999999998764321 2334
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||................... . ..+.... .
T Consensus 345 ~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~------~~~p~~~----s 413 (576)
T 2acx_A 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P------EEYSERF----S 413 (576)
T ss_dssp CCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C------CCCCTTS----C
T ss_pred cCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c------ccCCccC----C
Confidence 579999999999999899999999999999999999999998654433322222222111 1 1111112 2
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
..+.+++.+|++.+|.+|| +++||++
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 3677999999999999999 6677764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.99 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=173.8
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.||+|+||.||+|.. +++.||||++........+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999987 5779999999876655667899999999995 799999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCc---EEEEeccCccccCCCCCC----ce
Q 004935 509 QALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQ---AKIADFGLSRTFPVEGSG----TH 571 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~---~kl~DfGla~~~~~~~~~----~~ 571 (723)
.+++.... .+++... +..+|+...+||||||+|||++.++. +||+|||+++........ ..
T Consensus 99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 176 (316)
T 2ac3_A 99 LSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176 (316)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------------
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccc
Confidence 99987542 2333333 33444444499999999999998766 999999999865422111 11
Q ss_pred eeecccCCCcccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCccccCccccc----------HHHHHHHHhcCC
Q 004935 572 VTTTIAGTPGYLDPEYYIS-----NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH----------ITQWVSFMLGKG 636 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~ 636 (723)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........ ....+......+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 256 (316)
T 2ac3_A 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256 (316)
T ss_dssp -----CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC
T ss_pred ccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc
Confidence 1223458999999999875 5689999999999999999999999975432110 001111111111
Q ss_pred CcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 DIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... . ....... ....+.+++.+|++.||.+|||++|+++
T Consensus 257 ~~~-~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 257 KYE-F-PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCC-C-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccc-c-Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 110 0 0000001 1236789999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.12 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=174.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 44568999999999999998 46699999987543 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccC--CCCCCCHHHHHHHH----------HhccccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCC
Q 004935 505 NGNLQALLLGE--EADILSWEGRLRIA----------IEAAKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 505 ~gsL~~~l~~~--~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+|+|.+++... ....+++.....++ ++...+||||||+|||+ +.++.+||+|||+++.....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--- 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--- 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc---
Confidence 99999988543 12334444444333 33334999999999999 45678999999999875432
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.......+++.|+|||.+. ..++.++||||||++++||++|+.||...... +.............. ....
T Consensus 181 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~----~~~~ 250 (285)
T 3is5_A 181 -EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYKEPNYAV----ECRP 250 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCC------CC
T ss_pred -ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhccCCccccc----ccCc
Confidence 2234456899999999875 56899999999999999999999999764321 111111111110000 0001
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|++|||++|+++
T Consensus 251 ----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 251 ----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1235779999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=299.40 Aligned_cols=238 Identities=13% Similarity=0.170 Sum_probs=185.9
Q ss_pred hhhhccccCcEEEEEEE-------ECCceEEEEEecCCChhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEEE
Q 004935 430 FERVLGNGGFGTVYHGY-------LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.||+|+||.||+|. ..++.||||++..... .++..|++++.+++ |+||+.+++++...+..++|
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 35789999999999994 2567999999986643 46778888888876 99999999999999999999
Q ss_pred EEeCCCCCHHHHhccC---CCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcC-----------CCcEEEE
Q 004935 500 YEFMANGNLQALLLGE---EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSG-----------KFQAKIA 555 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~---~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~-----------~~~~kl~ 555 (723)
||||++|+|.+++... ....+++...+.++.+++. |||||||+|||++. ++.+||+
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 9999999999999742 2345666666555554443 99999999999998 8999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~ 635 (723)
|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus 226 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------- 293 (365)
T 3e7e_A 226 DLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----------- 293 (365)
T ss_dssp CCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----------
T ss_pred eCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----------
Confidence 9999976543222 3344567799999999999999999999999999999999999999864432110
Q ss_pred CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHhhhhH
Q 004935 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKR-PTMNQVVMELNESLAIE 690 (723)
Q Consensus 636 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Psm~evl~~L~~~~~~~ 690 (723)
.....+..... ...+.+++..|++.+|.+| |+++++.+.|++.++..
T Consensus 294 -----~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -----KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 01111111111 2345688999999999999 68999999999988654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.38 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=176.3
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 3578999999999999984 6799999986553 23356789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... .+++... +..+|+...+||||||+||+++.++.+||+|||+++...... .....
T Consensus 87 ~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 161 (311)
T 4agu_A 87 TVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDD 161 (311)
T ss_dssp EHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred chHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc---cccCC
Confidence 99999886542 2343333 333444444999999999999999999999999998754221 22234
Q ss_pred ccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-----------CC-cc--c
Q 004935 576 IAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-----------GD-IE--S 640 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~-~~--~ 640 (723)
..+|+.|+|||.+.+ ..++.++||||||++++||++|+.||.............. .... .. .. .
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK-TLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhcccccccccccccccccccCc
Confidence 568999999999876 5689999999999999999999999976544322222111 1111 00 00 0
Q ss_pred ccCCcccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IVDPRLHED---FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.++.-... ........+.+++.+|++.+|.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001100000 00112345789999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.53 Aligned_cols=232 Identities=20% Similarity=0.310 Sum_probs=176.4
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+++.. ++.||+|++... .....+.+.+|..+++++ +||||+++++++...+..++||||+
T Consensus 13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999984 669999999754 334456788999999998 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .+++.. .+..+|+...+||||||+|||++.++++||+|||+++...... ...
T Consensus 93 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~---~~~ 167 (345)
T 3a8x_A 93 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTT 167 (345)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT---CCB
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC---Ccc
Confidence 9999999987532 233333 3344444445999999999999999999999999998643221 223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc----cHHHHHHHHhcCCCcccccCCcccCC
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI----HITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .....+...+..... .+...
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~ 241 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRS 241 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CCCTT
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CCCCC
Confidence 45679999999999999999999999999999999999999996432110 111122222211111 11111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
....+.+++.+||+.+|.+||++
T Consensus 242 ----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 242 ----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 22357799999999999999996
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=299.87 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=182.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe----cCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD----EGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||++.. +++.||||++........+.+.+|++++++++||||+++++++. .....++|+||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 457899999999999997 57799999997776677788999999999999999999999986 345778999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 504 ANGNLQALLLGE--EADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
++|+|.+++... ....+++...+.++.+++ .+||||||+|||++.++.+||+|||+++..........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~ 192 (317)
T 2buj_A 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192 (317)
T ss_dssp TTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHH
T ss_pred CCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccc
Confidence 999999998752 234456555555444443 39999999999999999999999999876421110000
Q ss_pred ------eeecccCCCccccccccccCC---CCChhhHHHHHHHHHHHHcCCCccccCccc-ccHHHHHHHHhcCCCcccc
Q 004935 572 ------VTTTIAGTPGYLDPEYYISNR---LTEKSDVYNFGVVLLEIITSKSVIERTHER-IHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 572 ------~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SfGvvL~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~i 641 (723)
......||+.|+|||.+.+.. ++.++|||||||+++||++|+.||...... ......... ....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~--- 266 (317)
T 2buj_A 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSI--- 266 (317)
T ss_dssp HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C--C---
T ss_pred ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---cCCC---
Confidence 012235799999999987554 789999999999999999999999643221 112111111 0000
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
+ . .......+.+++.+||+.+|.+|||++++++.|+.+.
T Consensus 267 --~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 267 --P-Q----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --C-C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --C-c----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 0 1112236789999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=289.66 Aligned_cols=235 Identities=23% Similarity=0.381 Sum_probs=179.3
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|... +..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 3578999999999999984 669999998654 344557789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCc---EEEEeccCccccCCCCCCcee
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQ---AKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~---~kl~DfGla~~~~~~~~~~~~ 572 (723)
|+|.+.+.... .+++... +..+|+...+||||||+||+++.++. +||+|||++...... ..
T Consensus 90 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~----~~ 163 (284)
T 3kk8_A 90 GELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EA 163 (284)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS----CB
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC----cc
Confidence 99988876542 2333333 33334444499999999999986655 999999999775422 12
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....+|+.|+|||.+.+..++.++||||||++++||++|+.||........ ..... .+... ...+.. ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~-~~~~~-~~~~~~-~~--- 233 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----YAQIK-AGAYD-YPSPEW-DT--- 233 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HTCCC-CCTTTT-TT---
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH----HHHHH-hcccc-CCchhh-cc---
Confidence 2345789999999999999999999999999999999999999976543211 11111 11110 000110 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|++|||++|+++
T Consensus 234 -~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 234 -VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2235779999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=311.29 Aligned_cols=238 Identities=21% Similarity=0.261 Sum_probs=178.1
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|+.+++.++||||++++++|.+.+..++|||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999984 66899999864221 1123588999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC---CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 506 GNLQALLLGEEAD---IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 506 gsL~~~l~~~~~~---~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
|+|.+++....-. .. +....+..+|+...+||||||+|||++.++.+||+|||+++...... ........|
T Consensus 154 g~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~~g 231 (410)
T 3v8s_A 154 GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVG 231 (410)
T ss_dssp EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--EEECCSCCS
T ss_pred CcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC--cccccCCcC
Confidence 9999998754211 11 12223444444445999999999999999999999999998764321 223345689
Q ss_pred CCccccccccccCC----CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 579 TPGYLDPEYYISNR----LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 579 t~~y~aPE~~~~~~----~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
|+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+....... . -|.. .. .
T Consensus 232 t~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~-----~p~~-~~----~ 300 (410)
T 3v8s_A 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-T-----FPDD-ND----I 300 (410)
T ss_dssp CGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-C-----CCTT-CC----C
T ss_pred CccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-c-----CCCc-cc----c
Confidence 99999999998665 7899999999999999999999997654322222221111000 0 0100 11 1
Q ss_pred HHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTK--RPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~--RPsm~evl~ 681 (723)
...+.+++.+|++.+|.+ ||+++||++
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 235779999999999988 999999886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.49 Aligned_cols=251 Identities=19% Similarity=0.262 Sum_probs=185.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEE-ecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYC-DEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|.. +++.||||++...... .++.+|++++++++|++++..++++ ...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 3467899999999999996 5679999987654322 3588999999999988877766665 6677789999999 9
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCCc--
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGT-- 570 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~~-- 570 (723)
|+|.+++..... .+++...+.++.++ ..+||||||+|||+ +.++.+||+|||+++.........
T Consensus 89 ~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 89 PSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 999999874322 35555554444433 33999999999999 788999999999998765432211
Q ss_pred --eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccc--cH-HHHHHHHhcCCCcccccCCc
Q 004935 571 --HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERI--HI-TQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~--~~-~~~~~~~~~~~~~~~i~d~~ 645 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .. .......... .. +.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-----~~ 241 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-----EV 241 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-----HH
T ss_pred CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh-----hh
Confidence 12235679999999999999999999999999999999999999997643321 11 1111111111 00 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
+.... ...+.+++.+|++.+|++|||++++++.|+++++.....
T Consensus 242 ~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 242 LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 11111 236789999999999999999999999999998766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.23 Aligned_cols=231 Identities=23% Similarity=0.334 Sum_probs=178.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|+. +++.||||+++... ....+.+..|.+++.++ +||||+++++++.+.+..++||||+
T Consensus 21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 357899999999999998 46799999997532 22345688999999987 9999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 101 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~ 175 (345)
T 1xjd_A 101 NGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKT 175 (345)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCB
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC---Ccc
Confidence 9999999987532 233333 3334444444999999999999999999999999998643221 223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ . +.+....
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~~--- 241 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMD-N------PFYPRWL--- 241 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-C------CCCCTTS---
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHhC-C------CCCCccc---
Confidence 4567999999999999999999999999999999999999999765332 111111111 1 1111112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMN-QVV 680 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~-evl 680 (723)
...+.+++.+|++.+|++||++. +++
T Consensus 242 -s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 242 -EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 23577999999999999999997 554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=295.94 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=175.5
Q ss_pred hhhhccccCcEEEEEEEEC---Cc--eEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD---GT--EVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---~~--~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.+. +. .||||+++... ....+.+.+|++++++++||||+++++++.... .++|+|
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 4578999999999999862 22 68999987542 345678999999999999999999999998765 889999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|+|.+++.... ..+++.....+ +|+...+||||||+||+++.++.+||+|||+++..........
T Consensus 101 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 179 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179 (291)
T ss_dssp CCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEE
T ss_pred cccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchh
Confidence 999999999987532 22444444333 3333449999999999999999999999999987654333222
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......++..|+|||.+.+..++.++||||||++++||++ |+.||..... .+........... .....
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~-----~~~~~-- 248 (291)
T 1u46_A 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDKEGER-----LPRPE-- 248 (291)
T ss_dssp C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTSCCC-----CCCCT--
T ss_pred hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHHHHHHHccCCC-----CCCCc--
Confidence 3344567889999999998889999999999999999999 9999976533 2222222222111 01111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.....+.+++.+|++.+|.+|||+.++++.|+++..
T Consensus 249 --~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 249 --DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 123467899999999999999999999999987764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.93 Aligned_cols=229 Identities=21% Similarity=0.289 Sum_probs=178.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 357899999999999998 46799999986532 1234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++..... ++... .+..+|+...+||||||+|||++.++.+||+|||+++..... ..
T Consensus 125 gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~------~~ 196 (350)
T 1rdq_E 125 GGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196 (350)
T ss_dssp TCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------BC
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC------cc
Confidence 9999999975322 33333 333444444499999999999999999999999999875321 23
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +....... +.. .+....
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~-~~~------~~p~~~---- 261 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVS-GKV------RFPSHF---- 261 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-CCC------CCCTTC----
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHHHHHc-CCC------CCCCCC----
Confidence 457899999999999999999999999999999999999999765322 22222211 111 111112
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
...+.+++.+|++.+|.+||+ ++|+++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 235789999999999999998 676654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=290.78 Aligned_cols=232 Identities=25% Similarity=0.411 Sum_probs=176.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E 501 (723)
+.+.||+|+||.||+|... +..||+|++... .....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 3567999999999999984 558999998653 34456789999999999999999999998865 456899999
Q ss_pred eCCCCCHHHHhccCCCCCCCH----------HHHHHHHHhcc--ccccCCCCCCEEEc-CCCcEEEEeccCccccCCCCC
Q 004935 502 FMANGNLQALLLGEEADILSW----------EGRLRIAIEAA--KVHRDVKSTNILLS-GKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~----------~~~l~i~~~~a--~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~ 568 (723)
|+++|+|.+++.... .+++ ...+..+|+.. .+||||||+|||++ .++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 185 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred ecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc--
Confidence 999999999997532 1232 23345555555 69999999999998 7899999999999764321
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......|++.|+|||.+. +.++.++|||||||+++||++|+.||....... ....... .+.... .+..
T Consensus 186 ---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~-~~~~~~----~~~~ 253 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVT-SGVKPA----SFDK 253 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHT-TTCCCG----GGGG
T ss_pred ---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---HHHHHHh-ccCCcc----ccCC
Confidence 223456899999999876 459999999999999999999999997644322 2222221 111111 1111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ....+.+++.+|++.+|.+|||++|+++
T Consensus 254 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 254 V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1235789999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=308.94 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=173.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV 499 (723)
+.+.||+|+||.||+|.. .++.||||++... .....+++.+|+++|++++||||+++++++... ...++|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 357899999999999988 4679999999754 344567889999999999999999999999654 356999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
||||+++ |.+.+... +++. ..+..+|+...+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~E~~~~~-l~~~~~~~----l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--- 217 (464)
T 3ttj_A 146 MELMDAN-LCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--- 217 (464)
T ss_dssp EECCSEE-HHHHHTSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C---
T ss_pred EeCCCCC-HHHHHhhc----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC---
Confidence 9999875 66665432 3333 3344445555599999999999999999999999999875322
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC-------------
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG------------- 636 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------- 636 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||.+......+...+...-...
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp -CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred -cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 223456789999999999999999999999999999999999999976543322222222111000
Q ss_pred ------Ccc-----cccCCcccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 ------DIE-----SIVDPRLHEDF---DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 ------~~~-----~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... ......+.... .......+.+++.+||+.||++|||++|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000000000 0112456889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=292.82 Aligned_cols=237 Identities=23% Similarity=0.357 Sum_probs=178.9
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
.+.+.+.||+|+||.||++.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 344568899999999999998 477999999987655555678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|+|.+++.... .+++.. .+..+|+...+||||||+||++ ++++.+||+|||+++.....
T Consensus 90 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----- 162 (304)
T 2jam_A 90 GGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----- 162 (304)
T ss_dssp SCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----
T ss_pred CccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----
Confidence 999999886532 233333 3334444444999999999999 78899999999999764321
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......|++.|+|||.+.+..++.++|||||||+++||++|+.||....... ...... .+... .......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~-~~~~~--~~~~~~~--- 232 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LFEKIK-EGYYE--FESPFWD--- 232 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHH-HCCCC--CCTTTTT---
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-cCCCC--CCccccc---
Confidence 1233468999999999999999999999999999999999999997653321 111111 11110 0111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|++|||++|+++
T Consensus 233 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 233 -DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12246789999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.72 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=178.3
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||||++++++|...+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 3578999999999999984 6799999986543 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... .+++..... .+|+...+||||||+|||++.++.+||+|||+++...... .....
T Consensus 109 ~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 183 (331)
T 4aaa_A 109 TILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDD 183 (331)
T ss_dssp EHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------------
T ss_pred chHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc---cccCC
Confidence 99998865432 244444333 3333344999999999999999999999999998654321 22334
Q ss_pred ccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh-----------cCCCcccccC
Q 004935 576 IAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML-----------GKGDIESIVD 643 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~i~d 643 (723)
..+++.|+|||.+.+. .++.++|||||||+++||++|+.||........+...+.... ..........
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 5689999999998875 789999999999999999999999976654333222221110 0000111111
Q ss_pred CcccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+..... ......+.+++.+|++.+|.+|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111 112456889999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=289.57 Aligned_cols=250 Identities=19% Similarity=0.258 Sum_probs=186.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEE-ecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYC-DEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++...... +++.+|++++++++|++++..+.++ ......++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 357899999999999996 5779999998765432 4689999999999988877666665 6667789999999 99
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCCc---
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGT--- 570 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~~--- 570 (723)
+|.+++.... ..+++...+.++.++ ..+||||||+|||+ +.++.+||+|||+++.........
T Consensus 90 ~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (296)
T 3uzp_A 90 SLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168 (296)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccc
Confidence 9999997432 235555544444433 33999999999999 488899999999998765432211
Q ss_pred -eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc--ccHH-HHHHHHhcCCCcccccCCcc
Q 004935 571 -HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER--IHIT-QWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 571 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~--~~~~-~~~~~~~~~~~~~~i~d~~l 646 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .... ......... .. +.+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~ 242 (296)
T 3uzp_A 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-----EVL 242 (296)
T ss_dssp CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-----HHH
T ss_pred cccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-ch-----HHH
Confidence 1124567999999999999999999999999999999999999999764322 1111 211111111 00 001
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhhh
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~ 693 (723)
.... ...+.+++.+|++.+|++|||++++++.|+++.......
T Consensus 243 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 243 CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 1111 236789999999999999999999999999988666543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.91 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=179.4
Q ss_pred HHHhhhhccccCcEEEEEEEEC--CceEEEEEecCCCh------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.+.||+|+||.||++... ++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3445689999999999999984 67999999875422 135789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCC----cEEEEeccCccccC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKF----QAKIADFGLSRTFP 564 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~----~~kl~DfGla~~~~ 564 (723)
||||+++++|.+++.... .+++.....++.+ ...+||||||+||+++.++ .+||+|||+++...
T Consensus 86 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999986532 3444444444333 3339999999999999877 89999999998753
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP 644 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 644 (723)
... ......+++.|+|||.+.+..++.++||||||++++||++|+.||........ ..... ..... .++
T Consensus 164 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~--~~~ 232 (283)
T 3bhy_A 164 AGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET----LTNIS-AVNYD--FDE 232 (283)
T ss_dssp ------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHH-TTCCC--CCH
T ss_pred CCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH----HHHhH-hcccC--Ccc
Confidence 221 22345689999999999999999999999999999999999999976543211 11111 11100 001
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ....+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111 1235789999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=287.55 Aligned_cols=238 Identities=20% Similarity=0.314 Sum_probs=180.2
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|+||+++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 3457899999999999998 46799999986442 33457899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|.+++.... .+++.....+ +|+...+||||||+||+++.++.+||+|||++........ ......
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 166 (276)
T 2yex_A 90 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNK 166 (276)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-hhcccC
Confidence 99999987542 2444443333 3333349999999999999999999999999986532221 122334
Q ss_pred ccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..+++.|+|||.+.+..+ +.++||||||++++||++|+.||........... . ....... .. .. . ..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~---~~-~~-~----~~ 234 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--D-WKEKKTY---LN-PW-K----KI 234 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--H-HHTTCTT---ST-TG-G----GS
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--H-hhhcccc---cC-ch-h----hc
Confidence 578999999999987765 7899999999999999999999976543221111 1 1111000 00 00 1 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||++|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 235779999999999999999999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=306.49 Aligned_cols=245 Identities=21% Similarity=0.260 Sum_probs=183.3
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhc------cCCceeeEEEEEecCCceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRI------HHKNLTTLVGYCDEGTNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~~lV~ 500 (723)
.+.+.||+|+||.||+|... ++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..++||
T Consensus 100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 34678999999999999884 569999999754 33446788899999888 5679999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCc--EEEEeccCccccCCCCC
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQ--AKIADFGLSRTFPVEGS 568 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~--~kl~DfGla~~~~~~~~ 568 (723)
||+. ++|.+++.......+++.....++.+++. +||||||+|||++.++. +||+|||+++.....
T Consensus 179 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-- 255 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-- 255 (429)
T ss_dssp CCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--
T ss_pred eccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--
Confidence 9997 69999988765555666665555544443 99999999999999887 999999999764321
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--------Cccc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--------DIES 640 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~ 640 (723)
.....+|+.|+|||.+.+..++.++|||||||+|+||+||+.||........+..++...-... ....
T Consensus 256 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 256 ----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp ----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred ----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 2345789999999999999999999999999999999999999987654433333332210000 0000
Q ss_pred ccC---------------Cc------------cc---CCCC------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 641 IVD---------------PR------------LH---EDFD------INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 641 i~d---------------~~------------l~---~~~~------~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.++ .. +. .... ......+.+++.+||+.||++|||++|+++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 000 00 00 0000 011345789999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.50 Aligned_cols=227 Identities=23% Similarity=0.306 Sum_probs=175.1
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|... ++.||||+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 4578999999999999995 4589999997542 22346788999999988 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 104 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~ 178 (353)
T 2i0e_A 104 NGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTT 178 (353)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCB
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC---ccc
Confidence 9999999987532 233333 3334444444999999999999999999999999998643221 223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... +........ . ..+....
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~~--- 244 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEH-N------VAYPKSM--- 244 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-C------CCCCTTS---
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhC-C------CCCCCCC---
Confidence 4567999999999999999999999999999999999999999765332 222222211 1 1111112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
...+.+++.+|++.+|.+||++
T Consensus 245 -s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 245 -SKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -CHHHHHHHHHHTCSCTTSCTTC
T ss_pred -CHHHHHHHHHHhhcCHHHcCCC
Confidence 2367799999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=311.61 Aligned_cols=233 Identities=23% Similarity=0.372 Sum_probs=180.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+++. +++.||+|++..... .....+..|+++|++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 36799999999999998 467999999965421 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC--CCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEE--ADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~--~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+|.+++.... ...+++.....+ +|+...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~---~~~ 346 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKT 346 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CCB
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC---ccc
Confidence 99999987542 334554444333 333334999999999999999999999999998764322 122
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+........ . ..+....
T Consensus 347 ~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~------~~~p~~~--- 416 (543)
T 3c4z_A 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-A------VTYPDKF--- 416 (543)
T ss_dssp CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-C------CCCCTTS---
T ss_pred ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-c------cCCCccc---
Confidence 34579999999999999999999999999999999999999998654433333333332221 1 1111112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMN 677 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~ 677 (723)
...+.+++.+|++.+|.+||++.
T Consensus 417 -s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 417 -SPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -CHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -CHHHHHHHHHhccCCHhHCCCCc
Confidence 23577999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.08 Aligned_cols=232 Identities=22% Similarity=0.301 Sum_probs=171.6
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++... .......+.+|++++++++||||++++++|...+..++|||||+
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 357899999999999998 4679999998753 23344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCH----------HHHHHHHHh-ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 505 NGNLQALLLGEEADILSW----------EGRLRIAIE-AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~----------~~~l~i~~~-~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+|+|.+++.... .+++ ...+..+|. ...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 232 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~ 306 (446)
T 4ejn_A 232 GGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATM 306 (446)
T ss_dssp SCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--------
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC---Cccc
Confidence 999999986532 2333 334555555 45699999999999999999999999999864322 2223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+|+||++|+.||...... +........ . ..+....
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~~--- 372 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILME-E------IRFPRTL--- 372 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-C------CCCCTTS---
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHhC-C------CCCCccC---
Confidence 4567999999999999999999999999999999999999999765332 112221111 1 1111112
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
...+.+++.+||+.||.+|| +++|+++
T Consensus 373 -~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 373 -GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 23577999999999999999 9988876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=289.10 Aligned_cols=231 Identities=26% Similarity=0.357 Sum_probs=175.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... +..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 3578999999999999984 4589999986432 1234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++... +..+|+...+||||||+|||++.++.+||+|||++...... ...
T Consensus 93 ~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-----~~~ 165 (279)
T 3fdn_A 93 LGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRT 165 (279)
T ss_dssp TEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----------
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-----ccc
Confidence 999999986532 2333333 33334444499999999999999999999999998654321 223
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+++.|+|||.+.+..++.++||||||++++||++|+.||...... +........ . ..+... .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~------~~~~~~----~ 230 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRV-E------FTFPDF----V 230 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHT-C------CCCCTT----S
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HHHHHHHhC-C------CCCCCc----C
Confidence 457899999999999999999999999999999999999999754322 111111111 0 111111 1
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...+.+++.+|++.+|.+|||++|+++.
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2356799999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=309.42 Aligned_cols=231 Identities=23% Similarity=0.340 Sum_probs=179.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 457899999999999998 477999999965321 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++..... .+|+...+||||||+|||++.++.+||+|||+++..... ....
T Consensus 100 gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~----~~~~ 173 (476)
T 2y94_A 100 GGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLR 173 (476)
T ss_dssp SEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT----CCBC
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc----cccc
Confidence 999999997542 244443333 333333499999999999999999999999999876432 1233
Q ss_pred cccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...||+.|+|||.+.+..+ +.++|||||||+++||++|+.||...... ....... .+.. ......
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~-~~~~------~~p~~~--- 239 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKIC-DGIF------YTPQYL--- 239 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHH-TTCC------CCCTTC---
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHh-cCCc------CCCccC---
Confidence 4579999999999988765 68999999999999999999999765332 2122111 1111 011111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|.+|||++|+++
T Consensus 240 -s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 -NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 235779999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=286.82 Aligned_cols=233 Identities=22% Similarity=0.390 Sum_probs=159.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 357899999999999997 577999999864321 224678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... ..+++.....++.+ ...+||||||+||+++.++.+||+|||++....... ....
T Consensus 95 ~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 170 (278)
T 3cok_A 95 NGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHY 170 (278)
T ss_dssp TEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------
T ss_pred CCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC---Ccce
Confidence 999999987642 23454444444333 334999999999999999999999999998754221 1123
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+++.|+|||.+.+..++.++||||||++++||++|+.||........+.. .. .. +..+... .
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~----~~---~~~~~~~----~ 235 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----VV----LA---DYEMPSF----L 235 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CC----SS---CCCCCTT----S
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----Hh----hc---ccCCccc----c
Confidence 45689999999999988999999999999999999999999975432211100 00 00 1111111 2
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||++++++
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 236779999999999999999999886
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=298.27 Aligned_cols=246 Identities=21% Similarity=0.274 Sum_probs=171.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChh--hHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ--GYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 117 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC
Confidence 357899999999999987 5679999999765432 345688999999999999999999999999999999999984
Q ss_pred CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEc-----CCCcEEEEeccCccccCCCCCCc
Q 004935 506 GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLS-----GKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~-----~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
+|.+++..... +++... +..+|+...+||||||+|||++ .++.+||+|||+++..... .
T Consensus 118 -~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~---~ 191 (329)
T 3gbz_A 118 -DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP---I 191 (329)
T ss_dssp -EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------
T ss_pred -CHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc---c
Confidence 99999876532 343333 3333444449999999999994 5556999999999875322 1
Q ss_pred eeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccccc-----
Q 004935 571 HVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESIV----- 642 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i~----- 642 (723)
.......+|+.|+|||.+.+. .++.++|||||||+++||++|+.||........+............ .....
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 223345679999999999875 4899999999999999999999999766544333333322111100 00000
Q ss_pred ---CCcccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 ---DPRLHEDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 ---d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+...... .......+.+++.+|++.||++|||++|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0012246789999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.18 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=176.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEec--CCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDE--GTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....++||||++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 457899999999999987 56799999997544 367899999999997 9999999999987 667899999999
Q ss_pred CCCHHHHhccCCC-CCC----CHHHHHHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCceeeecccC
Q 004935 505 NGNLQALLLGEEA-DIL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 505 ~gsL~~~l~~~~~-~~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
+++|.+++..-.. ... +....+..+|+...+||||||+|||++.++ .+||+|||+++...... ......+
T Consensus 117 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~ 192 (330)
T 3nsz_A 117 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVA 192 (330)
T ss_dssp CCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCS
T ss_pred chhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC----ccccccc
Confidence 9999999864211 111 222334444444459999999999999776 89999999998764322 2234568
Q ss_pred CCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccc-------ccCC------
Q 004935 579 TPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES-------IVDP------ 644 (723)
Q Consensus 579 t~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------i~d~------ 644 (723)
+..|+|||.+.+ ..++.++|||||||+++||++|+.||.......................+ ..++
T Consensus 193 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (330)
T 3nsz_A 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272 (330)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH
T ss_pred cccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhh
Confidence 999999999877 67899999999999999999999999544322111111111111000000 0000
Q ss_pred ----------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 ----------RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ----------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.............+.+++.+|++.||++|||++|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011111112456789999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.05 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=170.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCC--ceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGT--NRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~lV~E 501 (723)
.+.+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++++. ||||+++++++...+ ..++|||
T Consensus 12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence 3457899999999999988 4679999998653 3455677899999999997 999999999997544 6899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC---
Q 004935 502 FMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS--- 568 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 568 (723)
||+ |+|.+++... .+.+. ..+..+|+...+||||||+|||++.++.+||+|||+++.+.....
T Consensus 92 ~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 92 YME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp CCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC
T ss_pred ccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc
Confidence 998 5899988764 23333 334445555559999999999999999999999999986532110
Q ss_pred ---------------CceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH
Q 004935 569 ---------------GTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 569 ---------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~ 632 (723)
.........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.+......+...+. .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~ 246 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG-V 246 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-H
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-h
Confidence 0112334579999999999876 6789999999999999999999999976544333322221 1
Q ss_pred hcCCCccc---ccCC------------------cccCCC------------CHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 004935 633 LGKGDIES---IVDP------------------RLHEDF------------DINSVWKTVEIAMACVSQTSTKRPTMNQV 679 (723)
Q Consensus 633 ~~~~~~~~---i~d~------------------~l~~~~------------~~~~~~~l~~l~~~Cl~~~p~~RPsm~ev 679 (723)
+....... +..+ .....+ .......+.+++.+||+.||++|||++|+
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 11110000 0000 000000 00112367899999999999999999998
Q ss_pred HHH
Q 004935 680 VME 682 (723)
Q Consensus 680 l~~ 682 (723)
++.
T Consensus 327 l~H 329 (388)
T 3oz6_A 327 LKH 329 (388)
T ss_dssp TTS
T ss_pred hCC
Confidence 863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.55 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=178.7
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhh-----HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQG-----YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-----~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.||+|+||.||+|... ++.||||++....... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (346)
T 1ua2_A 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92 (346)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence 34578999999999999984 6799999987543211 2468899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC-----CCCC----HHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 502 FMANGNLQALLLGEEA-----DILS----WEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~-----~~l~----~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|+++ +|.+++..... .... ....+..+|+...+||||||+|||++.++.+||+|||+++...... ..
T Consensus 93 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~ 168 (346)
T 1ua2_A 93 FMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RA 168 (346)
T ss_dssp CCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---CC
T ss_pred cCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc---cc
Confidence 9996 89888875421 1112 2233444555555999999999999999999999999998764322 22
Q ss_pred eecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--cccc---cCC--
Q 004935 573 TTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IESI---VDP-- 644 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~i---~d~-- 644 (723)
.....+|+.|+|||.+.+. .++.++|||||||+++||++|++||........+............ .... .+.
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc
Confidence 3345789999999998764 5899999999999999999999998766543333333332211100 0000 000
Q ss_pred -cccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 -RLHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 -~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.-..... ......+.+++.+|++.+|++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000001 112346889999999999999999999887
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.41 Aligned_cols=226 Identities=22% Similarity=0.332 Sum_probs=176.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 357899999999999987 567999999876531 1234678899999999999999999999999999999
Q ss_pred EEeCCCC-CHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 500 YEFMANG-NLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 500 ~Ey~~~g-sL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
|||+..| +|.+++.... .+++.....++. ....+||||||+|||++.++.+||+|||+++......
T Consensus 108 ~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~- 184 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK- 184 (335)
T ss_dssp EECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC-
Confidence 9999877 9999987643 244444444333 3334999999999999999999999999998764322
Q ss_pred CceeeecccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
......||+.|+|||.+.+..+ +.++|||||||+++||++|+.||....... .....+ .
T Consensus 185 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------~~~~~~--~ 244 (335)
T 3dls_A 185 ---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------EAAIHP--P 244 (335)
T ss_dssp ---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------TTCCCC--S
T ss_pred ---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------hhccCC--C
Confidence 2234568999999999988876 789999999999999999999996532210 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
.. ....+.+++.+|++.+|.+|||++++++.
T Consensus 245 ~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 245 YL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 12357899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=304.02 Aligned_cols=237 Identities=21% Similarity=0.271 Sum_probs=176.4
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.||+|+||.||+++. +++.||||+++.... ...+.+.+|.+++.+++||||+++++++.+.+..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 47899999999999998 477999999975321 1224588999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++..... .+++.. .+..+|+...+||||||+|||++.++++||+|||+++...... ......
T Consensus 146 g~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~--~~~~~~ 222 (412)
T 2vd5_A 146 GDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG--TVRSLV 222 (412)
T ss_dssp CBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--CEECSS
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC--ccccce
Confidence 999999975321 233332 3334444444999999999999999999999999998764322 222344
Q ss_pred ccCCCccccccccc-------cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 576 IAGTPGYLDPEYYI-------SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-------~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
..||+.|+|||.+. ...++.++|||||||++|||++|+.||............+.... . ..-|.+..
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-----~~~p~~~~ 296 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-H-----LSLPLVDE 296 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-H-----CCCC----
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-C-----cCCCcccc
Confidence 67999999999987 35689999999999999999999999976543222222211110 0 00111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKR---PTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~evl~ 681 (723)
.. ...+.+++.+|+. +|.+| |+++|+++
T Consensus 297 ~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 297 GV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 12 2357799999999 99998 58888765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.24 Aligned_cols=237 Identities=22% Similarity=0.395 Sum_probs=169.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--------hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 497 (723)
+.+.+.||+|+||.||+|.. +++.||||++.... ......+.+|+++|++++||||+++++++.. +..+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceE
Confidence 34467899999999999998 45699999986431 1122358899999999999999999999854 5578
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFP 564 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~ 564 (723)
+|||||++|+|.+++.... .+++... +..+|+...+||||||+|||++.+ +.+||+|||+++...
T Consensus 216 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred EEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 9999999999999887543 2444433 333444444999999999999754 459999999998764
Q ss_pred CCCCCceeeecccCCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
.. .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+...+.. +....
T Consensus 294 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----~~~~~- 364 (419)
T 3i6u_A 294 ET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----GKYNF- 364 (419)
T ss_dssp ---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----TCCCC-
T ss_pred CC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----CCCCC-
Confidence 22 22345679999999999863 56888999999999999999999999765544444332221 11100
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+..... ....+.+++.+|++.+|++|||++|+++
T Consensus 365 -~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 365 -IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0111111 1236789999999999999999999886
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=307.90 Aligned_cols=232 Identities=17% Similarity=0.145 Sum_probs=169.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC---ChhhHHHHHHHH---HHHHhccCCceeeEE-------EEEecCCc
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEV---ELLMRIHHKNLTTLV-------GYCDEGTN 495 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~~~~~~~ 495 (723)
.+.||+|+||.||+|.. +++.||||++... .....+.|.+|+ +++++++||||++++ +++...+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 57899999999999996 4779999999743 334567899999 555566899999998 66655532
Q ss_pred -----------------eEEEEEeCCCCCHHHHhccCC-----CCCCCHHHHHHHHH----------hccccccCCCCCC
Q 004935 496 -----------------RGLIYEFMANGNLQALLLGEE-----ADILSWEGRLRIAI----------EAAKVHRDVKSTN 543 (723)
Q Consensus 496 -----------------~~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~----------~~a~vH~Dlk~~N 543 (723)
.++||||+ +|+|.+++.... ...+.+..++.++. +...+||||||+|
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 236 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 78999999 689999987531 11222333333333 3333999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccC-----------CCCChhhHHHHHHHHHHHHcC
Q 004935 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-----------RLTEKSDVYNFGVVLLEIITS 612 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~SfGvvL~elltg 612 (723)
||++.++.+||+|||+++... .......| +.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 237 Ill~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 237 IVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp EEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred EEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 999999999999999998632 22344567 999999999887 899999999999999999999
Q ss_pred CCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhhhh
Q 004935 613 KSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM--ELNESLAI 689 (723)
Q Consensus 613 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~--~L~~~~~~ 689 (723)
+.||........ ...+.. .. ... ...+.+++.+||+.+|++|||+.|+++ .++++.+.
T Consensus 310 ~~Pf~~~~~~~~-------------~~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 310 DLPITKDAALGG-------------SEWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp SCCC------CC-------------SGGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred CCCCcccccccc-------------hhhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999965432111 111111 00 111 236789999999999999999999986 45554433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=300.67 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=178.0
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.||+|+||.||+|... +..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 468999999999999995 679999999765 34455789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHH----------HHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 508 LQALLLGEEADILSWEG----------RLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~----------~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
|.+++.... .+++.. .+..+|+. ..+||||||+|||++.++.+||+|||+++.... ......
T Consensus 118 L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~ 190 (360)
T 3eqc_A 118 LDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSF 190 (360)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-----HC----
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-----ccccCC
Confidence 999987542 233332 33344443 459999999999999999999999999976421 122345
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---------------------
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK--------------------- 635 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------------- 635 (723)
.||+.|+|||.+.+..++.++|||||||+++||++|+.||........ ..........
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL-ELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH-HHHHC--------------------------
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccCCCCCCCcccCCCccccccc
Confidence 789999999999999999999999999999999999999975432111 0000000000
Q ss_pred -----CCcccccC----CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 -----GDIESIVD----PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 -----~~~~~i~d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.++ ..............+.+++.+|++.+|++|||++|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000 00000000012335789999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=301.23 Aligned_cols=239 Identities=23% Similarity=0.313 Sum_probs=180.6
Q ss_pred HhhhhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.||+|+||.||+++. .++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 3467899999999999998 56799999987532 12335678899999999 69999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 004935 499 IYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 568 (723)
||||+++|+|.+++.... .+++... +..+|+...+||||||+|||++.++.+||+|||+++......
T Consensus 137 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 213 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE- 213 (355)
T ss_dssp EECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-
T ss_pred EeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-
Confidence 999999999999987542 2333333 334444444999999999999999999999999998653221
Q ss_pred CceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
........||+.|+|||.+.+ ..++.++|||||||+||||++|+.||...........+........ +.+
T Consensus 214 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~ 285 (355)
T 1vzo_A 214 -TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------PPY 285 (355)
T ss_dssp -GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------CCC
T ss_pred -CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-------CCC
Confidence 122334579999999999986 3478999999999999999999999976554444444443333221 111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRP-----TMNQVVME 682 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~ 682 (723)
... ....+.+++.+||+.+|.+|| +++|+++.
T Consensus 286 ~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 286 PQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred Ccc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 112 223577999999999999999 88888764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=287.87 Aligned_cols=232 Identities=20% Similarity=0.323 Sum_probs=180.8
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||++... ++.||+|++... .....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 3578999999999999984 568999998653 23455678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++...+.+ +|+...+||||||+||+++.++.+||+|||+++...... ....
T Consensus 99 ~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~ 173 (294)
T 2rku_A 99 RRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKK 173 (294)
T ss_dssp TCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT---CCBC
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc---cccc
Confidence 999999886532 2444444333 333334999999999999999999999999998764322 1233
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+++.|+|||.+.+..++.++||||||++++||++|+.||....... ...... ... ..+....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~-~~~------~~~~~~~---- 238 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIK-KNE------YSIPKHI---- 238 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHH-TTC------CCCCTTS----
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHh-hcc------CCCcccc----
Confidence 4568999999999999899999999999999999999999997653221 111111 111 1111111
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 235779999999999999999999887
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=318.15 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=184.6
Q ss_pred HhhhhccccCcEEEEEEEEC-----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|.+. +..||||++.... ....+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 34578999999999999883 2369999987643 344578999999999999999999999985 4568999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++.... ..+++...+.++. +...+||||||+|||++.++.+||+|||+++...... ...
T Consensus 472 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 548 (656)
T 2j0j_A 472 CTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYK 548 (656)
T ss_dssp CTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-------
T ss_pred CCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc--cee
Confidence 99999999997542 2355555444443 3334999999999999999999999999998764321 122
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .......... +.+..
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~~~i~~~~~------~~~~~--- 615 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGER------LPMPP--- 615 (656)
T ss_dssp -----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHHTCC------CCCCT---
T ss_pred ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcCCC------CCCCc---
Confidence 233456789999999998999999999999999999997 999997654321 1111111111 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.....+.+++.+||+.+|++|||+.++++.|+++++.++
T Consensus 616 -~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 616 -NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 223467899999999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=292.09 Aligned_cols=236 Identities=20% Similarity=0.328 Sum_probs=174.5
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|... +..||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4578999999999999994 66999999987766667889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..+++.....++ |+...+||||||+||+++.++.+||+|||++...... ........
T Consensus 103 l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~ 178 (302)
T 2j7t_A 103 VDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---LQKRDSFI 178 (302)
T ss_dssp HHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---HHC-----
T ss_pred HHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc---cccccccc
Confidence 999886532 224444444433 3333499999999999999999999999987543111 11123356
Q ss_pred CCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 578 GTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 578 gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
+++.|+|||.+. ...++.++||||||++++||++|+.|+........ ......... ..... ..
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~-------~~ 246 (302)
T 2j7t_A 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKSDP-PTLLT-------PS 246 (302)
T ss_dssp CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCC-CCCSS-------GG
T ss_pred CChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----HHHHhccCC-cccCC-------cc
Confidence 899999999983 56789999999999999999999999976543211 111111111 11100 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+|++.+|.+|||++++++
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12236789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=287.26 Aligned_cols=232 Identities=25% Similarity=0.401 Sum_probs=182.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 57899999999999987 46799999997553 3446789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++... .+++.....++.+ ...+||||||+||+++.++.+||+|||++....... .......
T Consensus 107 L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~ 180 (303)
T 3a7i_A 107 ALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFV 180 (303)
T ss_dssp HHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---CCBCCCC
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---cccCccC
Confidence 99998653 3455544444333 334999999999999999999999999998754321 1223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+++.|+|||.+.+..++.++||||||++++||++|+.||...... +...... .+. .+.+..... ..
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~-----~~~~~~~~~----~~ 246 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFLIP-KNN-----PPTLEGNYS----KP 246 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHH-HSC-----CCCCCSSCC----HH
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHHhh-cCC-----CCCCccccC----HH
Confidence 899999999999999999999999999999999999999754321 1111111 111 112222222 35
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
+.+++.+|++.+|.+|||+.|+++.
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=289.60 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=180.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEe--cCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCD--EGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 357899999999999998 46799999997543 445567999999999999999999999874 456789999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHHH----------HHHHHhcc-----ccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 504 ANGNLQALLLGE--EADILSWEGR----------LRIAIEAA-----KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~~----------l~i~~~~a-----~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++|+|.+++... ....+++... +..+|+.. .+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169 (279)
T ss_dssp TTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred CCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence 999999998753 2233555444 33444444 699999999999999999999999999875322
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
. .......+++.|+|||.+.+..++.++||||||++++||++|+.||...... +... .+..+... .+
T Consensus 170 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~i~~~~~~-----~~ 236 (279)
T 2w5a_A 170 T---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG-KIREGKFR-----RI 236 (279)
T ss_dssp C---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH-HHHHTCCC-----CC
T ss_pred c---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHH-HHhhcccc-----cC
Confidence 1 1123356899999999999989999999999999999999999999765321 1111 11122111 11
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
... ....+.+++.+|++.+|.+|||++|+++.+.
T Consensus 237 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 237 PYR----YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Ccc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111 2236789999999999999999999998553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=293.12 Aligned_cols=237 Identities=22% Similarity=0.336 Sum_probs=176.7
Q ss_pred HHhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||++... ++.||||++..... .+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 344678999999999999984 66999999976542 245788899888 79999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCC----CcEEEEeccCccccCCCCCCc
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGK----FQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~----~~~kl~DfGla~~~~~~~~~~ 570 (723)
+|+|.+++.... .+++... +..+|+...+||||||+|||+.++ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--- 174 (342)
T 2qr7_A 100 GGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--- 174 (342)
T ss_dssp SCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT---
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC---
Confidence 999999987542 2343333 333444444999999999998543 359999999998764322
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.... +..+... +....
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~-i~~~~~~------~~~~~ 246 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILAR-IGSGKFS------LSGGY 246 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHH-HHHCCCC------CCSTT
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHH-HccCCcc------cCccc
Confidence 2233457899999999998888999999999999999999999999754321 22222222 2222111 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112236779999999999999999999886
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=293.45 Aligned_cols=232 Identities=19% Similarity=0.328 Sum_probs=180.8
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||++... ++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 3578999999999999984 568999998653 33455678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++...+.+ +|+...+||||||+|||++.++.+||+|||+++...... ....
T Consensus 125 ~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 199 (335)
T 2owb_A 125 RRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKK 199 (335)
T ss_dssp TCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT---CCBC
T ss_pred CCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc---cccc
Confidence 999999886532 2444444333 333344999999999999999999999999998764322 1233
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...|++.|+|||.+.+..++.++||||||++++||++|+.||........ ....... . ..+.....
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~-~------~~~~~~~~--- 265 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKN-E------YSIPKHIN--- 265 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHT-C------CCCCTTSC---
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHhcC-C------CCCCccCC---
Confidence 45789999999999999999999999999999999999999976432211 1111111 1 11111122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+|++.+|++|||++|+++
T Consensus 266 -~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 266 -PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 35678999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=300.76 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=172.5
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHH-HHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVEL-LMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|+.. +..||||++.... ....+.+..|..+ ++.++||||+++++++...+..++||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 4678999999999999984 5689999997543 2234556777776 57789999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC----C----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEAD----I----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~----~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|+|.+++.....- . .+....+..+|+...+||||||+|||++.++++||+|||+++...... .....
T Consensus 122 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~---~~~~~ 198 (373)
T 2r5t_A 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---STTST 198 (373)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC---CCCCS
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC---Ccccc
Confidence 999999998753211 1 122233444445555999999999999999999999999998643221 22345
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........ . ..+.... .
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~-~------~~~~~~~----~ 263 (373)
T 2r5t_A 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNK-P------LQLKPNI----T 263 (373)
T ss_dssp BSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHHHS-C------CCCCSSS----C
T ss_pred ccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhc-c------cCCCCCC----C
Confidence 67999999999999999999999999999999999999999765432 222222211 1 1111122 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNE 685 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~ 685 (723)
..+.+++.+|++.+|.+||++.+.++.+.+
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 357799999999999999999765555544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=294.79 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=180.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CC-----ceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HK-----NLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.. +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++...+..++|||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 457899999999999998 4668999999754 334567888999999885 54 49999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhc------------cccccCCCCCCEEEc--CCCcEEEEeccCccccCCCC
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEA------------AKVHRDVKSTNILLS--GKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~------------a~vH~Dlk~~NILl~--~~~~~kl~DfGla~~~~~~~ 567 (723)
|++ |+|.+++.......+++.....++.++ ..+||||||+|||++ .++.+||+|||+++.....
T Consensus 137 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~- 214 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR- 214 (382)
T ss_dssp CCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred cCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-
Confidence 996 599999987654446665554444332 239999999999994 5788999999999876321
Q ss_pred CCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--------C--
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--------D-- 637 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~-- 637 (723)
.....+|+.|+|||.+.+..++.++|||||||+++||+||+.||........+...+...-... .
T Consensus 215 -----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (382)
T 2vx3_A 215 -----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKAR 289 (382)
T ss_dssp -----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHH
T ss_pred -----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHH
Confidence 2345789999999999999999999999999999999999999986654333333222110000 0
Q ss_pred --cccccCCc------------c-------------------------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 004935 638 --IESIVDPR------------L-------------------------HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQ 678 (723)
Q Consensus 638 --~~~i~d~~------------l-------------------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 678 (723)
...+.+.. . .......+...+.+++.+||+.||++|||++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e 369 (382)
T 2vx3_A 290 KFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369 (382)
T ss_dssp HHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHH
Confidence 00000000 0 00012234457899999999999999999999
Q ss_pred HHH
Q 004935 679 VVM 681 (723)
Q Consensus 679 vl~ 681 (723)
+++
T Consensus 370 ~L~ 372 (382)
T 2vx3_A 370 ALQ 372 (382)
T ss_dssp HTT
T ss_pred Hhc
Confidence 875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=296.13 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=172.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV 499 (723)
..+.||+|+||.||+|.. +++.||||++... .....+++.+|++++++++||||+++++++.... ..++|
T Consensus 29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 457899999999999998 4679999998653 3344567899999999999999999999997653 45999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+ +++|.+++... .++.. ..+..+|+...+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 181 (367)
T ss_dssp EECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred EecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc---
Confidence 9999 78999998753 23333 3344444444599999999999999999999999999875321
Q ss_pred ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-----------
Q 004935 570 THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD----------- 637 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 637 (723)
.....+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||........+...+...-....
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 234568999999999887 67999999999999999999999999765433222222221100000
Q ss_pred ------cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 638 ------IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 638 ------~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.......+. .........+.+++.+|++.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000010 001112346789999999999999999999887
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=292.17 Aligned_cols=244 Identities=22% Similarity=0.373 Sum_probs=163.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 357899999999999987 57799999987543 334567899999999999999999999999999999999999999
Q ss_pred CHHHHhccC------CCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC--
Q 004935 507 NLQALLLGE------EADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS-- 568 (723)
Q Consensus 507 sL~~~l~~~------~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 568 (723)
+|.+++... ....+++.....++.++ ..+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 178 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC------
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc
Confidence 999998641 22345555554444333 339999999999999999999999999986543221
Q ss_pred CceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--Cc-ccccCC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--DI-ESIVDP 644 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~-~~i~d~ 644 (723)
.........+|+.|+|||.+.+ ..++.++||||||++++||++|+.||........... ..... .. ....++
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 254 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----TLQNDPPSLETGVQDK 254 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHTSSCCCTTC-----
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH----HhccCCCccccccccc
Confidence 0112234568999999999876 5689999999999999999999999976543322111 11111 01 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...... ...+.+++.+|++.+|.+|||++|+++
T Consensus 255 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 255 EMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 221222 235789999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=290.49 Aligned_cols=235 Identities=23% Similarity=0.389 Sum_probs=171.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEec------CCceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE------GTNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~~lV~ 500 (723)
+.+.||+|+||.||+|.. +++.||||++..... ..+.+.+|+++++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 357899999999999998 577999999875432 346789999999999 89999999999976 46789999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||+++|+|.+++.......++..... ..+|+...+||||||+|||++.++.+||+|||++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--- 183 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--- 183 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc---
Confidence 99999999999976533344443333 33344444999999999999999999999999998653221
Q ss_pred eeeecccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 571 HVTTTIAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
.......+++.|+|||.+. +..++.++|||||||+++||++|+.||......... ...... .......
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~-- 256 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRN-PAPRLKS-- 256 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHS-CCCCCSC--
T ss_pred cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHhhcC-ccccCCc--
Confidence 1223456899999999987 567899999999999999999999999755432111 111111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ....+.+++.+||+.+|.+||+++++++
T Consensus 257 --~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 257 --KK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --cc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1236789999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=295.71 Aligned_cols=234 Identities=23% Similarity=0.381 Sum_probs=177.2
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh--------hhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--------QGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 47899999999999998 477999999875431 1245688999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++.... .+++.....++. +...+||||||+|||++.++.+||+|||++..+....
T Consensus 179 ~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-- 254 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-- 254 (365)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc--
Confidence 99999999999987532 244444443333 3334999999999999999999999999998764322
Q ss_pred ceeeecccCCCcccccccccc------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 570 THVTTTIAGTPGYLDPEYYIS------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...... .+... ...
T Consensus 255 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~-~~~~~-~~~ 326 (365)
T 2y7j_A 255 --KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIM-EGQYQ-FSS 326 (365)
T ss_dssp --CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH-HTCCC-CCH
T ss_pred --ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-hCCCC-CCC
Confidence 2234679999999999863 358899999999999999999999997543221 111111 11110 000
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.. .. ....+.+++.+|++.+|++|||++|+++
T Consensus 327 ~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 327 PEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 11 1235789999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-33 Score=300.80 Aligned_cols=239 Identities=9% Similarity=-0.029 Sum_probs=161.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHHHHHHHhc--cCCceeeEE-------EEEecC--
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMRI--HHKNLTTLV-------GYCDEG-- 493 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~~~~-- 493 (723)
+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 457899999999999997 467999999987543 3445678886655555 599988855 444322
Q ss_pred ---------------CceEEEEEeCCCCCHHHHhccC----CCCC-----------CCHHHHHHHHHhccccccCCCCCC
Q 004935 494 ---------------TNRGLIYEFMANGNLQALLLGE----EADI-----------LSWEGRLRIAIEAAKVHRDVKSTN 543 (723)
Q Consensus 494 ---------------~~~~lV~Ey~~~gsL~~~l~~~----~~~~-----------l~~~~~l~i~~~~a~vH~Dlk~~N 543 (723)
...++|||||+ |+|.+++... .... .+....+..+|+...+||||||+|
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~N 224 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHH
Confidence 33799999999 8999999753 1111 122223444444445999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCccccCcc
Q 004935 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVIERTHE 621 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~~~~~~ 621 (723)
||++.++.+||+|||+++... .......+|+.|+|||.+.+ ..++.++|||||||+|+||+||+.||.....
T Consensus 225 Ill~~~~~~kL~DFG~a~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 225 LFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp EEECTTSCEEECCGGGEEETT------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred EEECCCCCEEEEecceeeecC------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999998652 11224557799999999987 6799999999999999999999999976532
Q ss_pred cccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 622 RIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... ..............+...........+.+++.+||+.+|++|||+.|+++
T Consensus 299 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2100 00000000000111111111122346789999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=305.48 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=186.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccC-CceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH-KNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++...... .++..|+++++.++| +++..+..++...+..++||||+ ++
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 457899999999999997 4779999998754432 358899999999976 56666777778888899999999 99
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCCCc---
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGSGT--- 570 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~~--- 570 (723)
+|.+++.... ..+++...+.++.+++ .|||||||+|||| +.++.+||+|||+++.........
T Consensus 88 sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (483)
T 3sv0_A 88 SLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (483)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccc
Confidence 9999997532 2355555555444443 3999999999999 688999999999998765432211
Q ss_pred -eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH--HHhcCCCcccccCCccc
Q 004935 571 -HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS--FMLGKGDIESIVDPRLH 647 (723)
Q Consensus 571 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~i~d~~l~ 647 (723)
.......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+.. .......+. .+.
T Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----~l~ 241 (483)
T 3sv0_A 167 YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-----ALC 241 (483)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-----HHH
T ss_pred cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-----HHh
Confidence 112356799999999999999999999999999999999999999986543222111111 111000110 011
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
... ...+.+++..||+.+|.+||++++|++.|++++....
T Consensus 242 ~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 242 RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 111 2367899999999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=292.75 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=179.8
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIY 500 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~ 500 (723)
.+.+.||+|+||.||+|.. ++..||||++.... ....+.+.+|++++++++||||+++++++... ...++|+
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 3467899999999999988 46689999997643 34457899999999999999999999999654 3679999
Q ss_pred EeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc
Q 004935 501 EFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
||++ |+|.+++.... +++.... ..+|+...+||||||+|||++.++.+||+|||+++.........
T Consensus 110 e~~~-~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (364)
T 3qyz_A 110 DLME-TDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185 (364)
T ss_dssp ECCS-EEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred cccC-cCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc
Confidence 9998 59999887542 4444333 33334444999999999999999999999999998764332222
Q ss_pred eeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc---cccC---
Q 004935 571 HVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE---SIVD--- 643 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~i~d--- 643 (723)
.......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+...+... ...... .+.+
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-GSPSQEDLNCIINLKA 264 (364)
T ss_dssp CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH-CSCCHHHHHTCCCHHH
T ss_pred ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh-CCCCHHHHHHhhhhhH
Confidence 22244579999999998764 458999999999999999999999997665444333332211 111000 0000
Q ss_pred ------CcccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 ------PRLHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ------~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..-..... ......+.+++.+|++.+|.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 112245789999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=285.83 Aligned_cols=230 Identities=25% Similarity=0.324 Sum_probs=178.7
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|... +..||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 4578999999999999984 5689999986432 1224678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|.+++.... .+++... +..+|+...+||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~ 170 (284)
T 2vgo_A 98 RGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRR 170 (284)
T ss_dssp TEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-----CBC
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-----ccc
Confidence 999999987542 2333333 33334444499999999999999999999999998765321 123
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...+++.|+|||.+.+..++.++||||||++++||++|+.||...... ....... ... ..+....
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~-~~~------~~~~~~~---- 235 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRIV-NVD------LKFPPFL---- 235 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TTC------CCCCTTS----
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----HHHHHHh-ccc------cCCCCcC----
Confidence 456899999999999999999999999999999999999999754322 1111111 111 1111112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|.+|||++++++
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 235779999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=293.72 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=172.7
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhh-HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|.. +++.||||++....... ...+.+|++++++++||||+++++++...+..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 357899999999999998 46799999997544322 1245689999999999999999999999999999999998 5
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++..... .+++... +..+|+...+||||||+|||++.++.+||+|||+++..... .......
T Consensus 85 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~ 160 (324)
T 3mtl_A 85 DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDNE 160 (324)
T ss_dssp EHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------------
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---ccccccc
Confidence 89888875432 2443333 33344444499999999999999999999999999865322 1222345
Q ss_pred cCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccccC---------
Q 004935 577 AGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIVD--------- 643 (723)
Q Consensus 577 ~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~d--------- 643 (723)
.+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+....+ ...... ......
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR-ILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCChHhchhhhcchhhccccc
Confidence 68999999999876 5689999999999999999999999987654333332222 221111 010000
Q ss_pred CcccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PRLHED----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+..... ........+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00012245679999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=296.97 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=179.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc--------CCceeeEEEEEe----cC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH--------HKNLTTLVGYCD----EG 493 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~----~~ 493 (723)
+.+.+.||+|+||.||+|+. +++.||||++... ....+.+.+|++++++++ |+||+++++++. ..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 34467899999999999987 4669999999754 344567899999999996 788999999987 56
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhc-cccccCCCCCCEEEcCCC------------
Q 004935 494 TNRGLIYEFMANGNLQALLLGEEADILSWEG----------RLRIAIEA-AKVHRDVKSTNILLSGKF------------ 550 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~-a~vH~Dlk~~NILl~~~~------------ 550 (723)
...++||||+ +|+|.+.+.......+++.. .+..+|+. ..+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~ 196 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence 6889999999 55666666544333344443 34455555 559999999999999775
Q ss_pred -------------------------------------cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCC
Q 004935 551 -------------------------------------QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593 (723)
Q Consensus 551 -------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 593 (723)
.+||+|||+++..... .....||+.|+|||.+.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSCC
T ss_pred HhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcCCCC
Confidence 7999999999875322 234568999999999999999
Q ss_pred CChhhHHHHHHHHHHHHcCCCccccCccccc-----HHHHHHHHhcCC-------------------CcccccCCcc---
Q 004935 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIH-----ITQWVSFMLGKG-------------------DIESIVDPRL--- 646 (723)
Q Consensus 594 ~~~~DV~SfGvvL~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~-------------------~~~~i~d~~l--- 646 (723)
+.++|||||||+|+||+||+.||........ ....+....... ....+.+...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999975432211 111111111110 0000000000
Q ss_pred ------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 ------HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+....+.+++.+||+.+|++|||++|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01224556678899999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=294.46 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=169.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV 499 (723)
+.+.||+|+||.||+|.. .++.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 357899999999999988 4679999999753 3344567899999999999999999999997654 67999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++ +|.+.+... +++.. .+..+|+...+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~~-~l~~~~~~~----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 180 (371)
T 2xrw_A 109 MELMDA-NLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--- 180 (371)
T ss_dssp EECCSE-EHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred EEcCCC-CHHHHHhhc----cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc---
Confidence 999985 788877543 33333 334444444499999999999999999999999999865321
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHH-----------------
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM----------------- 632 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~----------------- 632 (723)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+...+...
T Consensus 181 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred -cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 12334578999999999999999999999999999999999999997654322111111100
Q ss_pred -hcC-CC-----cccccCCcccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 633 -LGK-GD-----IESIVDPRLHEDF---DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 633 -~~~-~~-----~~~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... .. ............. .......+.+++.+|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 00 0000000000000 1122557889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=300.26 Aligned_cols=244 Identities=17% Similarity=0.254 Sum_probs=173.8
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-------------
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------------- 493 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------------- 493 (723)
.+.+.||+|+||.||+|.. +++.||||++..... ...+|++++++++||||+++++++...
T Consensus 10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 3467899999999999998 567999999875432 234799999999999999999998443
Q ss_pred -------------------------CceEEEEEeCCCCCHHHHhccC--CCCCCCHHHHH----------HHHHhccccc
Q 004935 494 -------------------------TNRGLIYEFMANGNLQALLLGE--EADILSWEGRL----------RIAIEAAKVH 536 (723)
Q Consensus 494 -------------------------~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~l----------~i~~~~a~vH 536 (723)
...++||||++ |+|.+.+... ....+++.... ..+|+...+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H 164 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICH 164 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCcc
Confidence 33789999999 5888777531 22334444433 3334444499
Q ss_pred cCCCCCCEEEc-CCCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCC
Q 004935 537 RDVKSTNILLS-GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKS 614 (723)
Q Consensus 537 ~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~ 614 (723)
|||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999998 68899999999998764322 22345689999999998775 48999999999999999999999
Q ss_pred ccccCcccccHHHHHHHHhcCC---------CcccccCCc-----ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 615 VIERTHERIHITQWVSFMLGKG---------DIESIVDPR-----LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 615 p~~~~~~~~~~~~~~~~~~~~~---------~~~~i~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
||........+.+.+...-... ...+..-+. +...........+.+++.+|++.+|.+|||+.|++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 9987654444444333211110 000000011 11111112234578999999999999999999998
Q ss_pred H
Q 004935 681 M 681 (723)
Q Consensus 681 ~ 681 (723)
+
T Consensus 321 ~ 321 (383)
T 3eb0_A 321 A 321 (383)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=287.31 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=171.5
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe--------------cC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD--------------EG 493 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--------------~~ 493 (723)
..+.||+|+||.||+|... ++.||||++........+++.+|++++++++||||+++++++. ..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3578999999999999984 6799999998777777788999999999999999999999873 34
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEc-CCCcEEEEeccCccc
Q 004935 494 TNRGLIYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLS-GKFQAKIADFGLSRT 562 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~ 562 (723)
...++||||++ |+|.+++... .+.+... +..+|+...+||||||+|||++ +++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred CceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 67889999998 6999998653 2333333 3334444449999999999997 567999999999987
Q ss_pred cCCCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC------
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK------ 635 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 635 (723)
...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||...................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence 6432221222334567899999998865 678999999999999999999999997654322222211110000
Q ss_pred ---CCcccccCCccc-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 ---GDIESIVDPRLH-ED-----FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 ---~~~~~i~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+...+..... .. ........+.+++.+|++.+|++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000000 00 00112346789999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=285.55 Aligned_cols=229 Identities=18% Similarity=0.267 Sum_probs=175.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++||||+
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 93 (289)
T 1x8b_A 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93 (289)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence 3457899999999999998 4779999998764 234557789999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhccCC--CCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcC-------------------CCcE
Q 004935 504 ANGNLQALLLGEE--ADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSG-------------------KFQA 552 (723)
Q Consensus 504 ~~gsL~~~l~~~~--~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~-------------------~~~~ 552 (723)
++|+|.+++.... ...+++.....++.++ ..+||||||+|||++. ...+
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (289)
T 1x8b_A 94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173 (289)
T ss_dssp TTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCE
T ss_pred CCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEE
Confidence 9999999997531 1334544444444333 3399999999999984 4479
Q ss_pred EEEeccCccccCCCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH
Q 004935 553 KIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 553 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~ 631 (723)
||+|||++...... ....+|+.|+|||.+.+. .++.++|||||||+++||++|++++..... ..
T Consensus 174 kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~---- 238 (289)
T 1x8b_A 174 KIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WH---- 238 (289)
T ss_dssp EECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HH----
T ss_pred EEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HH----
Confidence 99999999875422 123589999999999766 567899999999999999999987643311 11
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+..+.. +.+.... ...+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 EIRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111 1122222 236789999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=286.01 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=176.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC----hhhHHHHHHHHHHHHhccCCceeeEEEEE--ecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRIHHKNLTTLVGYC--DEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~lV~E 501 (723)
+.+.||+|+||.||++.. ++..||+|++.... ....+.+.+|++++++++|+||+++++++ .+....++|||
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 457899999999999998 45699999987542 23457799999999999999999999998 44567899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|++++ |.+++.......+++.....++.++ ..+||||||+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~ 166 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA-DD 166 (305)
T ss_dssp CCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS-SC
T ss_pred hccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc-cc
Confidence 99987 7777765544455555554444333 339999999999999999999999999987643222 22
Q ss_pred eeecccCCCccccccccccCC--CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNR--LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
......+++.|+|||.+.+.. .+.++||||||++++||++|+.||..... .+..... ..+.. .+...
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i-~~~~~------~~~~~ 235 (305)
T 2wtk_C 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENI-GKGSY------AIPGD 235 (305)
T ss_dssp EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH-HHCCC------CCCSS
T ss_pred ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHH-hcCCC------CCCCc
Confidence 334556899999999987644 47899999999999999999999975432 2222211 11111 11112
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ...+.+++.+|++.+|.+|||++|+++
T Consensus 236 ~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 236 C----GPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp S----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 235779999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=290.20 Aligned_cols=239 Identities=21% Similarity=0.366 Sum_probs=176.0
Q ss_pred HHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCc
Q 004935 426 ITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN 495 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 495 (723)
..+.+.+.||+|+||.||+|.. +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 3455578999999999999998 456999999875421 12345889999999999999999999987655
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCc---EEEEeccCccc
Q 004935 496 RGLIYEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQ---AKIADFGLSRT 562 (723)
Q Consensus 496 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~---~kl~DfGla~~ 562 (723)
.++||||+++|+|.+++.... .+++... +..+|+...+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 899999999999999987542 2333333 33444444499999999999987654 99999999987
Q ss_pred cCCCCCCceeeecccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE 639 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 639 (723)
.... .......||+.|+|||.+. ...++.++|||||||+++||++|+.||........+...+... ...
T Consensus 167 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~ 238 (322)
T 2ycf_A 167 LGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG----KYN 238 (322)
T ss_dssp CCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT----CCC
T ss_pred cccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC----ccc
Confidence 5321 1223456899999999974 4678999999999999999999999997655443443332211 110
Q ss_pred cccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+..... ....+.+++.+|++.+|++|||+.++++
T Consensus 239 --~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00111111 1236789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=288.86 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=176.0
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|... ++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 4578999999999999984 6799999997643 24678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..+++..... .+|+...+||||||+||+++.++.+||+|||++....... .......
T Consensus 111 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 186 (314)
T 3com_A 111 VSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVI 186 (314)
T ss_dssp HHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB---SCBCCCC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc---cccCccC
Confidence 999986321 2244444333 3334444999999999999999999999999998754321 1223456
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+++.|+|||.+.+..++.++||||||++++||++|+.||....... ........ .. +.+. ........
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~~-----~~~~--~~~~~~~~ 254 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----AIFMIPTN-PP-----PTFR--KPELWSDN 254 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHS-CC-----CCCS--SGGGSCHH
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhcC-CC-----cccC--CcccCCHH
Confidence 8999999999999999999999999999999999999997543221 11111111 10 0110 01111236
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+++.+|++.+|.+|||+.++++
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHh
Confidence 789999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=283.79 Aligned_cols=235 Identities=22% Similarity=0.325 Sum_probs=178.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---------hhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---------AQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 497 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++ ||||+++++++......+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 357899999999999998 46799999997543 122456889999999995 999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+||||+++++|.+++.... .+++.....+ +|+...+||||||+||+++.++.+||+|||+++......
T Consensus 101 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 178 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178 (298)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc
Confidence 9999999999999987532 2444433333 333344999999999999999999999999998764322
Q ss_pred CCceeeecccCCCccccccccc------cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYI------SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
......+++.|+|||.+. ...++.++||||||++++||++|+.||...... ........ +... .
T Consensus 179 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~-~ 248 (298)
T 1phk_A 179 ----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMIMS-GNYQ-F 248 (298)
T ss_dssp ----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-TCCC-C
T ss_pred ----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH----HHHHHHhc-CCcc-c
Confidence 223456899999999885 456889999999999999999999999754322 11111111 1110 0
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.. ......+.+++.+|++.+|.+|||+.|+++
T Consensus 249 ~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GSPEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CTTTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00111 122346789999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.96 Aligned_cols=181 Identities=23% Similarity=0.374 Sum_probs=132.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec-----CCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-----GTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~lV 499 (723)
.+.+.||+|+||.||+|.. +++.||||++... .....+++.+|+++|++++||||+++++++.. ....++|
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 3467899999999999987 4679999998653 34456789999999999999999999999943 3568999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+. |+|.+++.... .+++.. .+..+|+...|||||||+||||+.++.+||+|||+++........
T Consensus 136 ~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 136 LEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp ECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred Eeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence 99985 68999887542 233333 344444444599999999999999999999999999876432211
Q ss_pred c------------------------eeeecccCCCcccccccc-ccCCCCChhhHHHHHHHHHHHHcC
Q 004935 570 T------------------------HVTTTIAGTPGYLDPEYY-ISNRLTEKSDVYNFGVVLLEIITS 612 (723)
Q Consensus 570 ~------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~SfGvvL~elltg 612 (723)
. .......||+.|+|||.+ ....++.++|||||||+|+||++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 0 122345689999999986 456799999999999999999993
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=306.07 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=174.9
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.+.||+|+||.||+|.. .+..||||++.... ......+.+|++++++++||||++++++|......++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 344568899999999999998 46699999987643 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCCC
Q 004935 503 MANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~~ 569 (723)
+++|+|.+++.... .+++.. .+..+|+...+||||||+|||++.. +.+||+|||+++.....
T Consensus 118 ~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--- 192 (494)
T 3lij_A 118 YKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--- 192 (494)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT---
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC---
Confidence 99999998876532 133332 3334444444999999999999764 55999999999876432
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
.......||+.|+|||.+. ..++.++||||+||++|||++|+.||....... ....... +.. ....+.+ ..
T Consensus 193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~-~~~-~~~~~~~-~~ 263 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEK-GKY-TFDSPEW-KN 263 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-TCC-CCCSGGG-TT
T ss_pred -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-CCC-CCCchhc-cc
Confidence 2234457999999999876 569999999999999999999999997654321 1221111 111 0001111 11
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+|++.+|.+|||++|+++
T Consensus 264 ----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 264 ----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1235779999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=302.73 Aligned_cols=243 Identities=19% Similarity=0.274 Sum_probs=172.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E 501 (723)
..+.||+|+||.||+|++ +++.||||++..... .+.+|+++|++++|+||++++++|... ...++|||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 357899999999999999 467999999865432 235799999999999999999998442 23678999
Q ss_pred eCCCCCHHHHhcc--CCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCC
Q 004935 502 FMANGNLQALLLG--EEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 502 y~~~gsL~~~l~~--~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 568 (723)
|+++ +|.+.+.. .....+.+... +..+|+...+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~- 211 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE- 211 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-
Confidence 9986 56655542 12233444433 344444444999999999999965 678999999998764322
Q ss_pred CceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC---------CCc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK---------GDI 638 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~ 638 (723)
......+|+.|+|||.+.+. .++.++|||||||+|+||++|+.||........+.++++..-.. ...
T Consensus 212 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 212 ---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp ---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred ---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 12345689999999998765 79999999999999999999999998765444444433321110 011
Q ss_pred ccccCCcccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 639 ESIVDPRLHE-----DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 639 ~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+...+.+.. .+.......+.+++.+||+.+|.+|||+.|+++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111111110 011122346789999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=281.24 Aligned_cols=231 Identities=24% Similarity=0.346 Sum_probs=170.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence 357899999999999998 47799999986532 1234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++.....+ +|+...+||||||+||+++.++.+||+|||++...... ....
T Consensus 95 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~ 168 (276)
T 2h6d_A 95 GGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLR 168 (276)
T ss_dssp SCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------
T ss_pred CCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC----ccee
Confidence 999999986542 2344433333 33333499999999999999999999999999875322 1223
Q ss_pred cccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
...+++.|+|||.+.+..+ +.++||||||++++||++|+.||..... ........ .+. ..+....
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~------~~~~~~~--- 234 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIR-GGV------FYIPEYL--- 234 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HCC------CCCCTTS---
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhh-cCc------ccCchhc---
Confidence 4568999999999987765 6899999999999999999999975432 12122111 111 0111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.+|.+|||++|+++
T Consensus 235 -~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 235 -NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 235779999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=286.81 Aligned_cols=244 Identities=18% Similarity=0.262 Sum_probs=181.9
Q ss_pred HhhhhccccCcEEEEEEEE---CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCc------eeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL---DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN------LTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|.. +++.||||++... ....+.+.+|++++++++|++ ++++++++...+..++|
T Consensus 17 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv 95 (339)
T 1z57_A 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95 (339)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence 4467899999999999987 4668999999754 334567899999999997665 99999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcC-------------------CC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSG-------------------KF 550 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~-------------------~~ 550 (723)
|||+ +++|.+++.......+++.....++.+ ...+||||||+|||++. ++
T Consensus 96 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~ 174 (339)
T 1z57_A 96 FELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174 (339)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred EcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence 9999 889999998765444555544444333 33399999999999987 66
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS 630 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~ 630 (723)
.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||........... +.
T Consensus 175 ~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~~ 247 (339)
T 1z57_A 175 DIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM-ME 247 (339)
T ss_dssp CEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH-HH
T ss_pred CceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HH
Confidence 8999999999864321 2345789999999999999999999999999999999999999976543322222 11
Q ss_pred HHhcCCC--------ccccc-C-------------------Cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 631 FMLGKGD--------IESIV-D-------------------PRLH--EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 631 ~~~~~~~--------~~~i~-d-------------------~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
.....-. ..... . ..+. ..........+.+++.+|++.||.+|||++|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 1111100 00000 0 0000 011223456788999999999999999999987
Q ss_pred H
Q 004935 681 M 681 (723)
Q Consensus 681 ~ 681 (723)
+
T Consensus 328 ~ 328 (339)
T 1z57_A 328 K 328 (339)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-33 Score=296.88 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=183.0
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChh-----------------hHHHHHHHHHHHHhccCCceeeEEEEEec
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQ-----------------GYKQFQAEVELLMRIHHKNLTTLVGYCDE 492 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~-----------------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 492 (723)
+.+.||+|+||.||+|..+++.||||++...... ..+.|.+|++++++++||||+++++++..
T Consensus 35 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 4578999999999999998889999998643211 12789999999999999999999999999
Q ss_pred CCceEEEEEeCCCCCHHHH------hccCCCCCCCHHHHHH----------HHHh-ccccccCCCCCCEEEcCCCcEEEE
Q 004935 493 GTNRGLIYEFMANGNLQAL------LLGEEADILSWEGRLR----------IAIE-AAKVHRDVKSTNILLSGKFQAKIA 555 (723)
Q Consensus 493 ~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~l~----------i~~~-~a~vH~Dlk~~NILl~~~~~~kl~ 555 (723)
.+..++||||+++|+|.++ +.......+++..... .+|+ ...+||||||+||+++.++.+||+
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~ 194 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLS 194 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEe
Confidence 9999999999999999998 5543344555555444 3444 445999999999999999999999
Q ss_pred eccCccccCCCCCCceeeecccCCCccccccccccC-CCCC-hhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHh
Q 004935 556 DFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTE-KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 556 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~ 633 (723)
|||+++..... ......++..|+|||.+.+. .++. ++|||||||+++||++|+.||..........+ ..
T Consensus 195 dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~i- 265 (348)
T 2pml_X 195 DFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN---NI- 265 (348)
T ss_dssp CCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH---HH-
T ss_pred ccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HH-
Confidence 99999875322 33456789999999999877 6666 99999999999999999999976544222222 11
Q ss_pred cCCCccccc------CCccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 634 GKGDIESIV------DPRLH---EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 634 ~~~~~~~i~------d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+...... .+... ..........+.+++.+|++.+|.+|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111000 00000 0000122346789999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=307.33 Aligned_cols=237 Identities=25% Similarity=0.332 Sum_probs=180.9
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
.+.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 445568999999999999998 46799999986542 3346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEE---cCCCcEEEEeccCccccCCCCC
Q 004935 502 FMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILL---SGKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 568 (723)
|+++|+|.+++..... +++... +..+|+...+||||||+|||+ +.++.+||+|||+++......
T Consensus 107 ~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 183 (484)
T 3nyv_A 107 VYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183 (484)
T ss_dssp CCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence 9999999998875432 333333 333444444999999999999 567899999999998764321
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......||+.|+|||.+.+ .++.++||||+||++|||++|+.||........ ..... .+... .-.+..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~-~~~~~-~~~~~~-- 251 (484)
T 3nyv_A 184 ---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----LKKVE-KGKYT-FELPQW-- 251 (484)
T ss_dssp ---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HCCCC-CCSGGG--
T ss_pred ---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHH-cCCCC-CCCccc--
Confidence 2234569999999999866 699999999999999999999999976543221 11111 11110 000111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|.+|||++|+++
T Consensus 252 ---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 252 ---KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 112235779999999999999999999886
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=304.69 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=178.3
Q ss_pred HHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
..+.+.+.||+|+||.||+|.. +++.||||++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 3455678999999999999998 46799999986432 2235678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEc---CCCcEEEEeccCccccCCCCC
Q 004935 502 FMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~ 568 (723)
|+++|+|.+.+.... .+++.. .+..+|+...+||||||+|||++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (486)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence 999999998886532 233333 33344444449999999999995 4567999999999875422
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.......||+.|+|||.+.+ .++.++||||+||++|||++|+.||........ ..... .+.... -.+.. .
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~-~~~~~~-~~~~~-~ 247 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVE-TGKYAF-DLPQW-R 247 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HTCCCS-CSGGG-G
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH-hCCCCC-CCccc-C
Confidence 22334579999999999875 599999999999999999999999976543221 11111 111100 00111 1
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.+|.+|||+.|+++
T Consensus 248 ----~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 248 ----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ----GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12235779999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=297.42 Aligned_cols=185 Identities=24% Similarity=0.358 Sum_probs=143.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV 499 (723)
.+.+.||+|+||.||+|.. +++.||||++... .....+++.+|+++|++++|+||+++++++... ...++|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 3467899999999999998 4668999999754 344567899999999999999999999999766 568999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||++ |+|.+++.... .+++... +..+|+...+||||||+|||++.++.+||+|||+++........
T Consensus 109 ~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 185 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185 (432)
T ss_dssp EECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------
T ss_pred EecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccc
Confidence 99997 59999987642 2444433 33444444499999999999999999999999999876432211
Q ss_pred c-------------------eeeecccCCCcccccccc-ccCCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 570 T-------------------HVTTTIAGTPGYLDPEYY-ISNRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 570 ~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
. .......||+.|+|||.+ ....++.++|||||||+++||++|..|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 0 123456789999999986 5667999999999999999999865544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=284.92 Aligned_cols=235 Identities=21% Similarity=0.259 Sum_probs=163.3
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHH-HHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYK-QFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~-~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|.. +++.||||++.... ..... .+.++...++.++||||+++++++...+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 357899999999999998 67799999997653 22233 34555556888899999999999999999999999998
Q ss_pred CCHHHHhccC--CCCCCCHHHH----------HHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 506 GNLQALLLGE--EADILSWEGR----------LRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 506 gsL~~~l~~~--~~~~l~~~~~----------l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|+|.+++... ....+++... +..+|+. ..+||||||+||+++.++.+||+|||+++..... ..
T Consensus 90 ~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 165 (290)
T 3fme_A 90 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VA 165 (290)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc----cc
Confidence 4888777542 2233444443 3444444 5599999999999999999999999999875432 12
Q ss_pred eecccCCCcccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 573 TTTIAGTPGYLDPEYY----ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~----~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.....+|+.|+|||.+ .+..++.++|||||||+++||+||+.||...... ............ +....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~------~~~~~ 236 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQVVEEPS------PQLPA 236 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---HHHHHHHHHSCC------CCCCT
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---HHHHHHHhccCC------CCccc
Confidence 2334689999999996 4567899999999999999999999999753321 111222222211 11111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|++|||++|+++
T Consensus 237 ---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 ---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111235789999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=288.82 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=177.0
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEec--------CCceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDE--------GTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~~~~~ 497 (723)
+.+.||+|+||.||+|.. +++.||||++..... .....+.+|++++++++||||+++++++.. .+..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 457899999999999998 467999999865432 234578899999999999999999999977 34688
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
+||||+++ +|.+.+..... .+++.....++ |+...+||||||+|||++.++.+||+|||+++......
T Consensus 101 lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 178 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178 (351)
T ss_dssp EEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCS
T ss_pred EEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccc
Confidence 99999985 77777655322 24444443333 33334999999999999999999999999998764322
Q ss_pred C-CceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---ccccc
Q 004935 568 S-GTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIV 642 (723)
Q Consensus 568 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~ 642 (723)
. .........||+.|+|||.+.+ ..++.++|||||||+++||+||+.||........+... ........ ....-
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~ 257 (351)
T 3mi9_A 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI-SQLCGSITPEVWPNVD 257 (351)
T ss_dssp SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCTTTSTTGG
T ss_pred cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCChhhccccc
Confidence 1 1122344578999999999876 45899999999999999999999999876543332222 22211110 00000
Q ss_pred CCccc--------CCCCH-HH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 DPRLH--------EDFDI-NS------VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d~~l~--------~~~~~-~~------~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+. ..... +. ...+.+++.+|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 258 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp GCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000 00001 11 234779999999999999999999887
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=287.73 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=178.9
Q ss_pred hhhhccccCcEEEEEEEE---CCceEEEEEecCCC--hhhHHHHHHHHHHHHhc---cCCceeeEEEEEe-----cCCce
Q 004935 430 FERVLGNGGFGTVYHGYL---DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRI---HHKNLTTLVGYCD-----EGTNR 496 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~~~~~ 496 (723)
+.+.||+|+||.||+|.. +++.||||++.... ......+.+|+.+++++ +||||++++++|. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 457899999999999998 35689999986432 11223566788777766 8999999999987 55678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 497 GLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++||||++ |+|.+++.......+++.....++.++ ..+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred EEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC
Confidence 99999998 699999987654446665554444443 3399999999999999999999999999865321
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC--ccc-ccC
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD--IES-IVD 643 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-i~d 643 (723)
.......+++.|+|||.+.+..++.++|||||||+++||++|+.||........+...+........ ... ...
T Consensus 174 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 174 ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp ----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 1223456899999999999999999999999999999999999999866543333332222111100 000 000
Q ss_pred Cc--c-------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 644 PR--L-------HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 644 ~~--l-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
++ + ...........+.+++.+|++.+|.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0 00111122346779999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=295.74 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=160.4
Q ss_pred hhhccccCcEEEEEEEEC----CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEe--cCCceEEEEEeCC
Q 004935 431 ERVLGNGGFGTVYHGYLD----GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCD--EGTNRGLIYEFMA 504 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~Ey~~ 504 (723)
.++||+|+||.||+|... +..||||++..... ...+.+|+++|++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 357999999999999963 56899999975532 246889999999999999999999994 4678899999998
Q ss_pred CCCHHHHhccC-------CCCCCCHHHHH----------HHHHhccccccCCCCCCEEE----cCCCcEEEEeccCcccc
Q 004935 505 NGNLQALLLGE-------EADILSWEGRL----------RIAIEAAKVHRDVKSTNILL----SGKFQAKIADFGLSRTF 563 (723)
Q Consensus 505 ~gsL~~~l~~~-------~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl----~~~~~~kl~DfGla~~~ 563 (723)
+ +|.+++... ....+++.... ..+|+...+||||||+|||+ +.++.+||+|||+++..
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 5 787776521 11124444433 33344444999999999999 67889999999999876
Q ss_pred CCCCCCceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCccc---------ccHHHHHHHHh
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHER---------IHITQWVSFML 633 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~---------~~~~~~~~~~~ 633 (723)
..............||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ..+...+. .+
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~-~~ 261 (405)
T 3rgf_A 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN-VM 261 (405)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH-HH
T ss_pred CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH-hh
Confidence 4322222233456789999999998874 5899999999999999999999999654321 11112111 11
Q ss_pred cCCC---cccccC------------CcccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 634 GKGD---IESIVD------------PRLHEDFD---------INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 634 ~~~~---~~~i~d------------~~l~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... ...+.. ........ ......+.+++.+||+.||.+|||++|+++
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110 000000 00000000 001235779999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=294.88 Aligned_cols=244 Identities=22% Similarity=0.295 Sum_probs=168.5
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCC-----------hhhHHHHHHHHHHHHhccCCceeeEEEEEec-----C
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSS-----------AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-----G 493 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~-----------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~ 493 (723)
.+.||+|+||.||+|.. ++..||||++.... ....+.+.+|++++++++||||+++++++.. .
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 57899999999999987 56699999986432 1224789999999999999999999999843 3
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 494 TNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
...++||||++ |+|.+++.... ..+++.....++ |+...+||||||+|||++.++.+||+|||+++..
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred ceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 45799999998 68888876542 234544443333 3333499999999999999999999999999754
Q ss_pred CCCCCCceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc---
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE--- 639 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 639 (723)
... .......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+...+.. .......
T Consensus 185 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 259 (362)
T 3pg1_A 185 TAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV-VGTPKIEDVV 259 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHH
T ss_pred ccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCChHHhh
Confidence 322 22334568999999999876 67899999999999999999999999765433222222221 1111100
Q ss_pred --------cccCCccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 --------SIVDPRLH-------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 --------~i~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.+...+. ..........+.+++.+|++.+|++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000000 0001112345789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=291.94 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=176.7
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|...+ .||+|++.... ....+.|.+|+.++++++|+||+++++++...+..++|+||+++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred EeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 35789999999999999865 59999987542 2233568899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCC--Cceeeec
Q 004935 508 LQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGS--GTHVTTT 575 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~ 575 (723)
|.+++.... ..+++...+. .+|+...+||||||+|||++ ++.+||+|||+++....... .......
T Consensus 116 L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 193 (319)
T 2y4i_B 116 LYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193 (319)
T ss_dssp HHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccccc
Confidence 999997643 2234333333 33344449999999999998 67999999999876532111 1112233
Q ss_pred ccCCCcccccccccc---------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 576 IAGTPGYLDPEYYIS---------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~---------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
..|++.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ...... ..+.........+
T Consensus 194 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~~~~~ 268 (319)
T 2y4i_B 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIWQM-GTGMKPNLSQIGM 268 (319)
T ss_dssp CSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHHHH-HTTCCCCCCCSSC
T ss_pred CCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHh-ccCCCCCCCcCCC
Confidence 468999999999864 35788999999999999999999999754322 111111 1111111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
...+.+++.+|++.+|.+|||++++++.|+++......
T Consensus 269 --------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 269 --------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp --------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred --------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 12467999999999999999999999999998866544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=297.36 Aligned_cols=245 Identities=18% Similarity=0.260 Sum_probs=172.3
Q ss_pred HhhhhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc------eEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN------RGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~lV~E 501 (723)
.+.+.||+|+||.||+|+. .+..||+|++..... ...+|++++++++||||+++++++..... .++|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 3467899999999999998 455799998865432 22479999999999999999999855433 789999
Q ss_pred eCCCCCHHHHhcc-CCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEc-CCCcEEEEeccCccccCCCCCC
Q 004935 502 FMANGNLQALLLG-EEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLS-GKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 502 y~~~gsL~~~l~~-~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|++++.+...... .....+++.. .+..+|+...+||||||+|||++ .++.+||+|||+++......
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-- 196 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-- 196 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--
Confidence 9998655443321 1122333333 34444444459999999999999 79999999999998763322
Q ss_pred ceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-------------
Q 004935 570 THVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK------------- 635 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 635 (723)
......+|+.|+|||.+.+. .++.++|||||||+++||++|+.||........+...++..-..
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 197 --PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp --CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred --CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 22345689999999998765 58999999999999999999999998765443443333321110
Q ss_pred -CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 -GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 -~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+....+...+.......+.+++.+||+.+|.+|||+.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000000111112346889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.15 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=174.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCce------EEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNR------GLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~------~lV 499 (723)
+.+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 357899999999999988 4679999999764 333457889999999999999999999999877665 999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||++ |+|.+++... +++.... ..+|+...+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~e~~~-~~l~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---- 196 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGME----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---- 196 (371)
T ss_dssp EECCC-EEHHHHTTSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred Ecccc-ccHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc----
Confidence 99998 5888887543 4444333 333444449999999999999999999999999986532
Q ss_pred ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-c-ccc-----
Q 004935 570 THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-I-ESI----- 641 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~i----- 641 (723)
......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+.......-.... . ..+
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 2234578999999999887 67999999999999999999999999765433333222221111000 0 000
Q ss_pred ------cCCcccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 ------VDPRLHED---FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+....... ........+.+++.+|++.+|++|||++|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000 00112346789999999999999999999886
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=293.37 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=160.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV 499 (723)
+.+.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 357899999999999987 4679999998753 334567889999999999999999999998654 567999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+||+ +++|.+++... .+++.... ..+|+...+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~---- 184 (367)
T 2fst_X 113 THLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---- 184 (367)
T ss_dssp EECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------
T ss_pred eccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc----
Confidence 9999 68998888653 34444433 334444449999999999999999999999999986532
Q ss_pred ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC---cccccCC-
Q 004935 570 THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD---IESIVDP- 644 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~i~d~- 644 (723)
......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||.+......+....+. ..... +..+...
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~-~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSES 261 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCHHHHTTCCCHH
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCHHHHHHhhhHH
Confidence 1234578999999999877 67899999999999999999999999765443322222221 11110 0000000
Q ss_pred ------ccc--CCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 645 ------RLH--EDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 645 ------~l~--~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+. ..... .....+.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 00010 11235789999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=305.17 Aligned_cols=234 Identities=24% Similarity=0.312 Sum_probs=174.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCCh-------------hhHHHHHHHHHHHHhccCCceeeEEEEEecCC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA-------------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT 494 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 494 (723)
+.+.||+|+||.||+|... +..||||++..... ...+.+.+|+++|++++||||+++++++.+..
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4578999999999999984 56899999875431 23467899999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCC---cEEEEeccCcc
Q 004935 495 NRGLIYEFMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKF---QAKIADFGLSR 561 (723)
Q Consensus 495 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~---~~kl~DfGla~ 561 (723)
..++||||+++|+|.+++.... .+++.... ..+|+...+||||||+|||++.++ .+||+|||+++
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 197 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCE
Confidence 9999999999999999886532 24444333 333333449999999999998775 69999999998
Q ss_pred ccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 562 TFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
..... .......||+.|+|||.+. ..++.++||||+||+++||++|+.||...... +...... .+...
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~-~~~~~-- 265 (504)
T 3q5i_A 198 FFSKD----YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKVE-KGKYY-- 265 (504)
T ss_dssp ECCTT----SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCC--
T ss_pred EcCCC----CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCCCC--
Confidence 76432 1233457999999999876 46999999999999999999999999765432 2222211 11110
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+...... ....+.+++.+|++.+|.+|||++|+++
T Consensus 266 ~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 266 FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000011 1235789999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.01 Aligned_cols=238 Identities=24% Similarity=0.324 Sum_probs=168.7
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec-------------C
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-------------G 493 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------------~ 493 (723)
.+.+.||+|+||.||+|.. +++.||||++... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 3457899999999999997 5679999998643 3445779999999999999999999998865 3
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 494 TNRGLIYEFMANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
...++||||+++|+|.+++.... ..+++.. .+..+|+...+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 166 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred CceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence 56789999999999999997542 2233333 233344444499999999999999999999999999875
Q ss_pred CCCCC-----------CceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH
Q 004935 564 PVEGS-----------GTHVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 564 ~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~ 631 (723)
..... .........+++.|+|||.+.+. .++.++|||||||+++||++ |+...... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~---~~~~~~ 240 (303)
T 1zy4_A 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER---VNILKK 240 (303)
T ss_dssp TC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHHHHH
T ss_pred ccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---HHHHHh
Confidence 42210 01122345689999999998764 68999999999999999998 44322111 111111
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ... ..+...........+.+++.+|++.+|.+|||++++++
T Consensus 241 ~~-~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 241 LR-SVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH-STT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc-ccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 111 11112222333446789999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=285.89 Aligned_cols=237 Identities=20% Similarity=0.276 Sum_probs=156.0
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHH-HHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVE-LLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||.||+|... ++.||||++.... .....++..|+. +++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 568999999999999984 7799999997653 334456666766 67778999999999999999999999999985
Q ss_pred CHHHHhcc---CCCCCCCHHHHH----------HHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 507 NLQALLLG---EEADILSWEGRL----------RIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 507 sL~~~l~~---~~~~~l~~~~~l----------~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+|.+++.. .....+++.... ..+++. ..+||||||+|||++.++.+||+|||+++...... .
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~ 181 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----A 181 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc----c
Confidence 88777653 123334444433 334443 45999999999999999999999999998753221 2
Q ss_pred eecccCCCcccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 573 TTTIAGTPGYLDPEYY----ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~----~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
.....||+.|+|||.+ .+..++.++|||||||+++||++|+.||....... +.... +.....+.+..
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~------~~~~~~~~~~~ 252 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQ------VVKGDPPQLSN 252 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CC------CCCSCCCCCCC
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHH------HhcCCCCCCCC
Confidence 2334689999999998 45678999999999999999999999997543211 00000 00001111211
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.........+.+++.+||+.+|.+|||+.++++
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111122346789999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.29 Aligned_cols=236 Identities=18% Similarity=0.300 Sum_probs=171.5
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCC--ChhhHHHHHHHHHHHHhcc--CCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIH--HKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||++.. +++.||||++... .....+.+.+|++++++++ |+||+++++++...+..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 357899999999999988 4668999998654 3445678999999999997 5999999999999999999999 67
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|.+++.... .+++.....+ +|+...+||||||+|||+++ +.+||+|||+++....... .....
T Consensus 111 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~-~~~~~ 186 (313)
T 3cek_A 111 NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT-SVVKD 186 (313)
T ss_dssp SEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------------
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc-ccccc
Confidence 889999997643 3444444333 33344499999999999975 7999999999987643221 12223
Q ss_pred cccCCCcccccccccc-----------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccC
Q 004935 575 TIAGTPGYLDPEYYIS-----------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 643 (723)
...|++.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ............
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~------ 257 (313)
T 3cek_A 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNH------ 257 (313)
T ss_dssp ---CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHCTTS------
T ss_pred CCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHHHHHHHhccc------
Confidence 4568999999999875 46888999999999999999999999754322 112222222111
Q ss_pred CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 644 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
...........+.+++.+||+.+|.+||+++|+++.
T Consensus 258 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 258 ---EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111112367899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=290.12 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=163.3
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc-------eEEEEE
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN-------RGLIYE 501 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-------~~lV~E 501 (723)
.+.||+|+||.||+|... +..||||++..... ....+.+|++.+++++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 578999999999999984 67999999865432 22456788899999999999999999865433 789999
Q ss_pred eCCCCCHHHHhcc--CCCCCCCHHH----------HHHHHH--hccccccCCCCCCEEEcC-CCcEEEEeccCccccCCC
Q 004935 502 FMANGNLQALLLG--EEADILSWEG----------RLRIAI--EAAKVHRDVKSTNILLSG-KFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 502 y~~~gsL~~~l~~--~~~~~l~~~~----------~l~i~~--~~a~vH~Dlk~~NILl~~-~~~~kl~DfGla~~~~~~ 566 (723)
|+++ +|.+.+.. .....+.+.. .+..+| +...+||||||+|||++. ++.+||+|||+++.....
T Consensus 107 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~ 185 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185 (360)
T ss_dssp CCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred cccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence 9997 44443332 1222233222 233344 444499999999999997 899999999999876432
Q ss_pred CCCceeeecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC---------
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--------- 636 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 636 (723)
. ......||+.|+|||.+.+.. ++.++|||||||+++||++|+.||........+...++......
T Consensus 186 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 186 E----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp S----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred C----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence 2 223456899999999987654 89999999999999999999999987654433333333211110
Q ss_pred --CcccccCC------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 --DIESIVDP------RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 --~~~~i~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+. .............+.+++.+||+.+|.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 0001111223557889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=289.17 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=176.2
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 501 (723)
+.+.||+|+||.||+|... ++.||||++.... ......+.+|++++++++||||+++++++... ...++|+|
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 3578999999999999984 7799999997543 34456789999999999999999999998654 67899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHH----------HHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRL----------RIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l----------~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|++ |+|.+++... .+++.... ..+|+...+||||||+|||++.++.+||+|||+++..........
T Consensus 95 ~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 170 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170 (353)
T ss_dssp CCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccccc
Confidence 998 5999988753 24444333 333444449999999999999999999999999987643221110
Q ss_pred -------eeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC----cc
Q 004935 572 -------VTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD----IE 639 (723)
Q Consensus 572 -------~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 639 (723)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+..... ...... ..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 249 (353)
T 2b9h_A 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG-IIGTPHSDNDLR 249 (353)
T ss_dssp ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCSTTTTT
T ss_pred CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCchhcccc
Confidence 1223468999999998764 6789999999999999999999999976543322222221 111110 00
Q ss_pred cccCCc-------cc--CCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 SIVDPR-------LH--EDF-----DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 ~i~d~~-------l~--~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+..+. +. ... .......+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00 000 0112346789999999999999999999886
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=313.88 Aligned_cols=227 Identities=23% Similarity=0.302 Sum_probs=176.1
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|... ++.||||+++... ....+.+..|.+++..+ +|++|+.+++++.+.+..++||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 4578999999999999984 5689999987532 22345688999999988 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++.... .+++... +..+|+...|||||||+||||+.++++||+|||+++...... ...
T Consensus 425 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~---~~~ 499 (674)
T 3pfq_A 425 NGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTT 499 (674)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT---CCB
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC---ccc
Confidence 9999999997542 2333333 333344444999999999999999999999999998643222 223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+||||++|+.||...... +........ . ..+...
T Consensus 500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~---- 564 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEH-N------VAYPKS---- 564 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHSS-C------CCCCTT----
T ss_pred ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----HHHHHHHhC-C------CCCCcc----
Confidence 4567999999999999999999999999999999999999999765432 222222211 1 111112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTM 676 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm 676 (723)
....+.+++.+||+.+|++||++
T Consensus 565 ~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 565 MSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCHHHHHHHHHHccCCHHHCCCC
Confidence 22357899999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=286.88 Aligned_cols=239 Identities=19% Similarity=0.229 Sum_probs=152.8
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~ 505 (723)
++||+|+||.||+|... ++.||||++.... +........++.++|+||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999984 7799999986532 122223334566799999999999876 4457899999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCcee
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|+|.+++.......+++.....++.+++ .+||||||+|||++. ++.+||+|||+++..... .
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~ 185 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----A 185 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-----c
Confidence 9999999876555566665555554443 399999999999986 455999999999865321 2
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....+|+.|+|||.+.+..++.++|||||||+++||++|+.||.............. ....+.. .+......
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~ 258 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIRLGQY------GFPNPEWS 258 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTTST
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-hhhcccc------ccCchhhc
Confidence 2345689999999999888899999999999999999999999975433211111111 0000000 00000011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHh
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM--ELNES 686 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~--~L~~~ 686 (723)
.....+.+++.+|++.+|.+|||++|+++ .+++.
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 12346789999999999999999999997 44443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=284.02 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=180.5
Q ss_pred HhhhhccccCcEEEEEEEEC--C-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCc------eeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD--G-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN------LTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|... + ..||||+++.. ....+.+.+|++++++++|++ ++.+++++...+..++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv 100 (355)
T 2eu9_A 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA 100 (355)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence 44678999999999999983 3 58999999754 334567889999999998766 99999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEE-------------------cCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILL-------------------SGKF 550 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl-------------------~~~~ 550 (723)
|||+ +++|.+++.......+++.....++.+++ .+||||||+|||+ +.++
T Consensus 101 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 179 (355)
T 2eu9_A 101 FELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179 (355)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred Eecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCC
Confidence 9999 66777777665444566655555444443 3999999999999 6788
Q ss_pred cEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHH
Q 004935 551 QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS 630 (723)
Q Consensus 551 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~ 630 (723)
.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||........+... .
T Consensus 180 ~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~ 252 (355)
T 2eu9_A 180 SIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM-E 252 (355)
T ss_dssp CEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-H
T ss_pred cEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H
Confidence 9999999999864322 23457899999999999999999999999999999999999999765443222221 1
Q ss_pred HHhcCCC--------cccc-cCC-------------------cc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 631 FMLGKGD--------IESI-VDP-------------------RL--HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 631 ~~~~~~~--------~~~i-~d~-------------------~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
.....-. .... ... .+ ...........+.+++.+||+.||++|||++|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 1111100 0000 000 00 0011223455788999999999999999999997
Q ss_pred H
Q 004935 681 M 681 (723)
Q Consensus 681 ~ 681 (723)
+
T Consensus 333 ~ 333 (355)
T 2eu9_A 333 L 333 (355)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.16 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=173.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc------eEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN------RGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~lV 499 (723)
+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..... .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 357899999999999998 47799999997643 3345678999999999999999999999987654 4999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||++ |+|.+++... +++..... .+|+...+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~e~~~-~~l~~~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---- 178 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGLK----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---- 178 (353)
T ss_dssp EECCS-EEGGGTTTSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred ecccc-CCHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC----
Confidence 99998 5888877542 44444333 33444449999999999999999999999999986432
Q ss_pred ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC------------
Q 004935 570 THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG------------ 636 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------ 636 (723)
......+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+....+..-...
T Consensus 179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 1234568999999999877 6789999999999999999999999976543322222222110000
Q ss_pred -----CcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 637 -----DIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 637 -----~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.+.....+.+. .........+.+++.+|++.+|++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000110 011122346789999999999999999999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=294.20 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=169.1
Q ss_pred hhhccccCcEEEEE-EEECCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGTVYH-GYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~-~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||+||. +..+++.||||++... ..+.+.+|+++|+++ +||||+++++++...+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 46899999999964 4457889999998643 235678999999987 89999999999999999999999996 699
Q ss_pred HHHhccCCCC--C---------CCHHHH----HHHHHhccccccCCCCCCEEEcCC-------------CcEEEEeccCc
Q 004935 509 QALLLGEEAD--I---------LSWEGR----LRIAIEAAKVHRDVKSTNILLSGK-------------FQAKIADFGLS 560 (723)
Q Consensus 509 ~~~l~~~~~~--~---------l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~-------------~~~kl~DfGla 560 (723)
.+++...... . +.+..+ +..+|+...+||||||+|||++.+ +.+||+|||++
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 9999764211 1 113333 334444444999999999999754 48999999999
Q ss_pred cccCCCCCCc-eeeecccCCCcccccccccc-------CCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHH
Q 004935 561 RTFPVEGSGT-HVTTTIAGTPGYLDPEYYIS-------NRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSF 631 (723)
Q Consensus 561 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~ 631 (723)
+......... .......||+.|+|||.+.+ ..++.++|||||||+++||+| |+.||....... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~ 253 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRG 253 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHT
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcC
Confidence 8764332111 11234579999999999865 568999999999999999999 999996543211 111111
Q ss_pred HhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 632 MLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 632 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. .. +.+...........+.+++.+|++.+|.+|||+.||++
T Consensus 254 ~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 254 IF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 11 11111123345567889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=286.75 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=182.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-----------CCceeeEEEEEecCC-
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-----------HKNLTTLVGYCDEGT- 494 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~~~- 494 (723)
.+.+.||+|+||.||+|.. +++.||||++... ....+.+.+|++++++++ |+||+++++++...+
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 100 (373)
T 1q8y_A 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100 (373)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence 3467899999999999997 5679999999754 334567899999999886 899999999987644
Q ss_pred ---ceEEEEEeCCCCCHHHHhccCCCCCCCHHH----------HHHHHHhc-cccccCCCCCCEEEc------CCCcEEE
Q 004935 495 ---NRGLIYEFMANGNLQALLLGEEADILSWEG----------RLRIAIEA-AKVHRDVKSTNILLS------GKFQAKI 554 (723)
Q Consensus 495 ---~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~-a~vH~Dlk~~NILl~------~~~~~kl 554 (723)
..++||||+ +++|.+++.......+++.. .+..+|+. ..+||||||+|||++ ..+.+||
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl 179 (373)
T 1q8y_A 101 NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179 (373)
T ss_dssp TEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred CCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEE
Confidence 788999999 88999999765444344433 34445554 569999999999994 4458999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc------ccHHHH
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER------IHITQW 628 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~------~~~~~~ 628 (723)
+|||+++..... .....+|+.|+|||.+.+..++.++|||||||+++||+||+.||...... ..+.+.
T Consensus 180 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 180 ADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp CCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred cccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 999999875322 23346899999999999999999999999999999999999999754321 111111
Q ss_pred HHHHhcCC-------------------CcccccCCcc---------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 629 VSFMLGKG-------------------DIESIVDPRL---------HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 629 ~~~~~~~~-------------------~~~~i~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
.. ....- ....+..... ...........+.+++.+||+.||++|||++|++
T Consensus 254 ~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 254 IE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 11 11110 0000000000 0123455677889999999999999999999998
Q ss_pred H--HHHHhhhhH
Q 004935 681 M--ELNESLAIE 690 (723)
Q Consensus 681 ~--~L~~~~~~~ 690 (723)
+ .+++....+
T Consensus 333 ~hp~f~~~~~~~ 344 (373)
T 1q8y_A 333 NHPWLKDTLGME 344 (373)
T ss_dssp TCGGGTTCTTCT
T ss_pred hChhhhcccCcc
Confidence 7 444444333
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=276.91 Aligned_cols=238 Identities=26% Similarity=0.333 Sum_probs=178.2
Q ss_pred HHHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 426 ITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 426 ~t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
..+.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 3445568999999999999998 46799999986532 2345789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEcCC---CcEEEEeccCccccCCCCC
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLSGK---FQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~~~---~~~kl~DfGla~~~~~~~~ 568 (723)
|+++++|.+++.... .+++...+.++.+ ...+||||||+||+++.+ +.+||+|||+++......
T Consensus 102 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 102 LYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 999999998886432 2444444444333 333999999999999754 479999999998754321
Q ss_pred CceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccC
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 648 (723)
......+++.|+|||.+.+ .++.++||||||++++||++|+.||...... +...... .+..... .+.. .
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~-~~~~-~ 247 (287)
T 2wei_A 179 ---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVE-TGKYAFD-LPQW-R 247 (287)
T ss_dssp ---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCC-SGGG-T
T ss_pred ---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCCCCCC-chhh-h
Confidence 1223457889999998865 4899999999999999999999999765432 1122111 1111100 0100 1
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 649 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ....+.+++.+|++.+|++|||+.|+++
T Consensus 248 ~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 248 T----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 1235789999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=290.80 Aligned_cols=235 Identities=27% Similarity=0.393 Sum_probs=168.0
Q ss_pred hhhccccCcEE-EEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 431 ERVLGNGGFGT-VYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 431 ~~~lG~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.+.||+|+||+ ||++..+++.||||++..... ..+.+|+++|+++ +||||+++++++.+....++||||++ |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 46899999998 566667889999999976443 2357899999999 89999999999999999999999997 599
Q ss_pred HHHhccCCC-----CCCCHHH----HHHHHHhccccccCCCCCCEEEcC-----CCcEEEEeccCccccCCCCCCceeee
Q 004935 509 QALLLGEEA-----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSG-----KFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 509 ~~~l~~~~~-----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~-----~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
.+++..... ....+.. .+..+|+...+||||||+|||++. ...+||+|||+++.............
T Consensus 105 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 184 (432)
T 3p23_A 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184 (432)
T ss_dssp HHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----------
T ss_pred HHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeecc
Confidence 999976532 1223333 344455555599999999999943 34688999999987653322222334
Q ss_pred cccCCCccccccccc---cCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 575 TIAGTPGYLDPEYYI---SNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~---~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
...||+.|+|||.+. ...++.++|||||||+++||+| |+.||...... ............ .+. .
T Consensus 185 ~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-----~~~~~~~~~~~~-----~~~--~ 252 (432)
T 3p23_A 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----QANILLGACSLD-----CLH--P 252 (432)
T ss_dssp -CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-----HHHHHTTCCCCT-----TSC--T
T ss_pred ccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-----HHHHHhccCCcc-----ccC--c
Confidence 567999999999987 4567889999999999999999 88898543221 111111111111 011 1
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.......+.+++.+|++.+|.+|||++||++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1223445779999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=281.70 Aligned_cols=227 Identities=23% Similarity=0.377 Sum_probs=170.3
Q ss_pred HHHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChh------hHHHHHHHHHHHHhc----cCCceeeEEEEEecCC
Q 004935 427 TNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQ------GYKQFQAEVELLMRI----HHKNLTTLVGYCDEGT 494 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~~ 494 (723)
.+.+.+.||+|+||.||+|.. +++.||||++...... ....+.+|+.++.++ +|+||+++++++...+
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~ 111 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence 345568999999999999988 5669999999765321 223467899999999 8999999999999999
Q ss_pred ceEEEEEe-CCCCCHHHHhccCCCCCCCHHHHHHHHHh----------ccccccCCCCCCEEEc-CCCcEEEEeccCccc
Q 004935 495 NRGLIYEF-MANGNLQALLLGEEADILSWEGRLRIAIE----------AAKVHRDVKSTNILLS-GKFQAKIADFGLSRT 562 (723)
Q Consensus 495 ~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~ 562 (723)
..++|+|| +++++|.+++.... .+++...+.++.+ ...+||||||+||+++ .++.+||+|||+++.
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 99999999 89999999987532 2454444444333 3339999999999999 889999999999987
Q ss_pred cCCCCCCceeeecccCCCccccccccccCCCC-ChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 563 FPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT-EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
.... ......++..|+|||.+.+..+. .++|||||||+++||++|+.||..... ... ..
T Consensus 190 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~---~~------ 249 (312)
T 2iwi_A 190 LHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE---AE------ 249 (312)
T ss_dssp CCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH---TC------
T ss_pred cccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh---hc------
Confidence 6432 12345689999999998877764 589999999999999999999864321 111 00
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+... ....+.+++.+|++.+|++|||++|+++
T Consensus 250 --~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 250 --LHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --cCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111 2235779999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=273.92 Aligned_cols=234 Identities=22% Similarity=0.281 Sum_probs=156.1
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhH-HHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGY-KQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~-~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||.||+|.. +++.||||++..... ... +.+.++..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 56899999999999998 477999999976532 223 33455556788889999999999999999999999999 44
Q ss_pred CHHHHhccCCCCCCCHHH----------HHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 507 NLQALLLGEEADILSWEG----------RLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~----------~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
.+..+.... ...+++.. .+..+|+. ..+||||||+||+++.++.+||+|||+++...... ....
T Consensus 109 ~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~ 183 (318)
T 2dyl_A 109 CAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK----AKDR 183 (318)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------
T ss_pred cHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc----cccc
Confidence 555554421 12233333 34444543 45999999999999999999999999997653221 2234
Q ss_pred ccCCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 576 IAGTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 576 ~~gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
..+++.|+|||.+. ...++.++|||||||+++||++|+.||...... .+.......... +.+...
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~------~~~~~~- 253 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQEEP------PLLPGH- 253 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHHSCC------CCCCSS-
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHHHHhccCC------CCCCcc-
Confidence 56899999999984 456899999999999999999999999754322 122222222211 111110
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+||+.+|.+||+++++++
T Consensus 254 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 254 -MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011235779999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=299.79 Aligned_cols=256 Identities=24% Similarity=0.284 Sum_probs=184.7
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEec------CCceEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE------GTNRGL 498 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~l 498 (723)
+.+.+.||+|+||.||+|.. +++.||||++... .....+.|.+|++++++++||||+++++++.. .+..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 44568999999999999987 4679999998765 44556789999999999999999999999765 677899
Q ss_pred EEEeCCCCCHHHHhccCCC-CCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCc---EEEEeccCccccC
Q 004935 499 IYEFMANGNLQALLLGEEA-DILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQ---AKIADFGLSRTFP 564 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~~-~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~---~kl~DfGla~~~~ 564 (723)
||||+++|+|.+++..... ..+++. ..+..+|+...+||||||+||+++.++. +||+|||+++...
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~ 175 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTT
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccc
Confidence 9999999999999976421 123322 2334444444499999999999997664 9999999998764
Q ss_pred CCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc----cc
Q 004935 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI----ES 640 (723)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 640 (723)
... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ...|.......... .+
T Consensus 176 ~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 176 QGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ---PVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp SCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH---HHHSSTTCC------CCSCC
T ss_pred ccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc---hhhhhhhhhcccchhhhhhh
Confidence 322 22446789999999999999999999999999999999999999965421 11111111000000 00
Q ss_pred ccC------Cc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHHhhhhH
Q 004935 641 IVD------PR--LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQ-----VVMELNESLAIE 690 (723)
Q Consensus 641 i~d------~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e-----vl~~L~~~~~~~ 690 (723)
... .. ............+.+++.+|++.||++|||+++ +.+.++++++..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000 00 111223345677899999999999999999988 567777776544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=282.41 Aligned_cols=225 Identities=24% Similarity=0.384 Sum_probs=173.1
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh------hhHHHHHHHHHHHHhcc--CCceeeEEEEEecCCceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA------QGYKQFQAEVELLMRIH--HKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++...+..++
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l 125 (320)
T 3a99_A 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125 (320)
T ss_dssp EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence 3467899999999999987 567999999865421 12245778999999996 5999999999999999999
Q ss_pred EEEeCCC-CCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEc-CCCcEEEEeccCccccCCC
Q 004935 499 IYEFMAN-GNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLS-GKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 499 V~Ey~~~-gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~ 566 (723)
|+||+.. ++|.+++.... .+++... +..+++...+||||||+|||++ +++.+||+|||+++.....
T Consensus 126 v~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~ 203 (320)
T 3a99_A 126 ILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203 (320)
T ss_dssp EEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred EEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence 9999986 89999987532 2343333 3333444449999999999999 7899999999999876422
Q ss_pred CCCceeeecccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
......||+.|+|||.+.+..+ +.++|||||||+++||++|+.||..... ... . .. .
T Consensus 204 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~----~-~~------~ 261 (320)
T 3a99_A 204 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR----G-QV------F 261 (320)
T ss_dssp -----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----C-CC------C
T ss_pred -----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc----c-cc------c
Confidence 2234568999999999987766 6889999999999999999999864321 111 0 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+.... ...+.+++.+||+.+|++|||++|+++
T Consensus 262 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112 235779999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=300.56 Aligned_cols=227 Identities=19% Similarity=0.270 Sum_probs=174.1
Q ss_pred HhhhhccccCcEEEEEEEE---CCceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCc-----eEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL---DGTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTN-----RGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~lV 499 (723)
.+.+.||+|+||.||+|.+ +++.||||++... .......|.+|++++++++||||+++++++...+. .++|
T Consensus 83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv 162 (681)
T 2pzi_A 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162 (681)
T ss_dssp EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence 4467899999999999997 4679999998754 34455679999999999999999999999987665 6999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhcc----------ccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIAIEAA----------KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a----------~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++++|.+++.. .++|...+.++.+++ .|||||||+|||++.+ .+||+|||+++.....
T Consensus 163 ~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--- 234 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--- 234 (681)
T ss_dssp EECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---
T ss_pred EEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---
Confidence 999999999987754 466666555554443 3999999999999986 8999999999875322
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
....||++|+|||.+.+. ++.++|||||||+|+||++|..|+....... +. ...
T Consensus 235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------~~-------~~~ 288 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------LP-------EDD 288 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------CC-------TTC
T ss_pred ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------cc-------ccc
Confidence 345699999999998765 4899999999999999999998876432110 00 000
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhh
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRP-TMNQVVMELNESLAI 689 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~~~ 689 (723)
........+.+++.+|++.+|.+|| +++++...|...+..
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0011224678999999999999999 577777777776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=271.87 Aligned_cols=224 Identities=12% Similarity=0.121 Sum_probs=163.8
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|... ++.||||++.... ....+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 34 ~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 113 (286)
T 3uqc_A 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWI 113 (286)
T ss_dssp EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEec
Confidence 34678999999999999985 6799999997653 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC--CCCCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 504 ANGNLQALLLGEEA--DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 504 ~~gsL~~~l~~~~~--~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
++++|.+++..... +...+. ..+..+|+...+||||||+|||++.++.+||+++|
T Consensus 114 ~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------------- 174 (286)
T 3uqc_A 114 RGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------- 174 (286)
T ss_dssp CEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------------
T ss_pred CCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------------
Confidence 99999999965321 111222 23344444444999999999999999999998543
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
|++ .++.++|||||||++|||+||+.||........+.. ... .+... +.............
T Consensus 175 ----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----~~~--~~~~~--~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----AER--DTAGQ--PIEPADIDRDIPFQ 235 (286)
T ss_dssp ----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----CCB--CTTSC--BCCHHHHCTTSCHH
T ss_pred ----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----HHH--HhccC--CCChhhcccCCCHH
Confidence 222 368899999999999999999999976543211100 000 00000 00000001112345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
+.+++.+||+.||.+| |+.|+++.|+++...+.
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 7899999999999999 99999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=276.55 Aligned_cols=224 Identities=17% Similarity=0.127 Sum_probs=156.3
Q ss_pred hhhccccCcEEEEEEEEC--CceEEEEEecCCCh---hhHHHHHHHHHHHHhccC-Cc----------eee---------
Q 004935 431 ERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHH-KN----------LTT--------- 485 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H-~n----------Iv~--------- 485 (723)
.+.||+|+||.||+|.+. ++.||||++..... ...+.|.+|+.+++.++| +| ++.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 468999999999999984 77999999884332 235779999999999977 21 111
Q ss_pred --EEEEEec-----CCceEEEEEeCCCCCHHHHhc-----cCCCCCCCHHHHHHHHHh----------ccccccCCCCCC
Q 004935 486 --LVGYCDE-----GTNRGLIYEFMANGNLQALLL-----GEEADILSWEGRLRIAIE----------AAKVHRDVKSTN 543 (723)
Q Consensus 486 --l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~l~i~~~----------~a~vH~Dlk~~N 543 (723)
+..++.. ....+++|++ .+++|.+++. ......+.+..++.++.+ ...+||||||+|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~N 241 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241 (413)
T ss_dssp --------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccce
Confidence 1111111 1234556665 4679999884 222333444444444333 334999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCceeeecccCCCcccccccc----------ccCCCCChhhHHHHHHHHHHHHcCC
Q 004935 544 ILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY----------ISNRLTEKSDVYNFGVVLLEIITSK 613 (723)
Q Consensus 544 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~SfGvvL~elltg~ 613 (723)
||++.++.+||+|||+++... .......| +.|+|||.+ ....++.++|||||||++|||+||+
T Consensus 242 ILl~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 242 IVLDQRGGVFLTGFEHLVRDG------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp EEECTTCCEEECCGGGCEETT------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred EEEecCCeEEEEeccceeecC------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999988642 12344567 999999999 5556889999999999999999999
Q ss_pred CccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 614 SVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 614 ~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.||........ ...++... ... ...+.+++.+||+.+|++||++.++++
T Consensus 315 ~Pf~~~~~~~~-------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 315 LPNTDDAALGG-------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCCCTTGGGSC-------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcchhhh-------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99975432111 11111100 111 246789999999999999999888854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=261.44 Aligned_cols=209 Identities=19% Similarity=0.265 Sum_probs=156.3
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHH-HhccCCceeeEEEEEec----CCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELL-MRIHHKNLTTLVGYCDE----GTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~ 504 (723)
+.||+|+||.||++.. +++.||||++... ..+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999998 5679999998642 4577899988 55599999999999876 677899999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|+|.+++.......+++.....++.++ ..+||||||+|||++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------
Confidence 9999999987654456655554444443 3399999999999998 7899999999986532
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
+..++.++|||||||+++||++|+.||........ .......+..... ...
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~~~~~~~~~~~~~--~~~ 222 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGMKTRIRMGQY--EFP 222 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCC--SSC
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------hHHHHHHHhhccc--cCC
Confidence 23467899999999999999999999965432110 0000011100000 011
Q ss_pred ----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 ----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|.+|||++|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112346789999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=263.69 Aligned_cols=233 Identities=15% Similarity=0.132 Sum_probs=164.5
Q ss_pred HHHhhhhccccCcEEEEEEEECCceEEEEEecCCC--------hhhHHHHHHHHHHHHhcc---------CCceeeEEEE
Q 004935 427 TNNFERVLGNGGFGTVYHGYLDGTEVAVKMLSPSS--------AQGYKQFQAEVELLMRIH---------HKNLTTLVGY 489 (723)
Q Consensus 427 t~~f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~---------H~nIv~l~g~ 489 (723)
.+.+.+.||+|+||.||+|+.+++.||||++.... ....+.+.+|++++++++ |+||+++.+.
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred cchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 45567899999999999999999999999997542 223477899999999886 8888888776
Q ss_pred Ee------------------------------cCCceEEEEEeCCCCCHHHHhccCCC---CC----CCHHHHHHHHH-h
Q 004935 490 CD------------------------------EGTNRGLIYEFMANGNLQALLLGEEA---DI----LSWEGRLRIAI-E 531 (723)
Q Consensus 490 ~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~---~~----l~~~~~l~i~~-~ 531 (723)
+. ..+..++||||+++|++.+.+.+... .+ .+....+..+| +
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 180 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS 180 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 42 26789999999999976665543211 11 12233445555 5
Q ss_pred ccccccCCCCCCEEEcCCC--------------------cEEEEeccCccccCCCCCCceeeecccCCCccccccccccC
Q 004935 532 AAKVHRDVKSTNILLSGKF--------------------QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591 (723)
Q Consensus 532 ~a~vH~Dlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 591 (723)
...+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||.+.+.
T Consensus 181 ~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCSGGGCCC
T ss_pred CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccChhhhcCC
Confidence 5569999999999999887 899999999987532 134689999999999876
Q ss_pred CCCChhhHHHHHHH-HHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCC
Q 004935 592 RLTEKSDVYNFGVV-LLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTS 670 (723)
Q Consensus 592 ~~~~~~DV~SfGvv-L~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p 670 (723)
. +.++||||+|++ ..++++|..||...... .............. ..............+.+++.+||+.+
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHHHHhccC-
Confidence 6 899999998777 77788999998532100 00111111111100 11111112345667899999999966
Q ss_pred CCCCCHHHHH
Q 004935 671 TKRPTMNQVV 680 (723)
Q Consensus 671 ~~RPsm~evl 680 (723)
|++|++
T Consensus 324 ----sa~e~l 329 (336)
T 2vuw_A 324 ----SATDLL 329 (336)
T ss_dssp ----SHHHHH
T ss_pred ----CHHHHH
Confidence 888877
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-24 Score=242.59 Aligned_cols=180 Identities=15% Similarity=0.091 Sum_probs=119.9
Q ss_pred hccccCcEEEEEEEE--CCceEEEEEecCCC----------hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 433 VLGNGGFGTVYHGYL--DGTEVAVKMLSPSS----------AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
..+.|+.|.+.++.. -|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.+.+..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 355666766665443 57899999996542 12346799999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC-C----CCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 500 YEFMANGNLQALLLGEEA-D----ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~-~----~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|||++||+|.+++..... . ..+....|..+|+...|||||||+||||++++++||+|||+|+...... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---SWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC---cccc
Confidence 999999999999986532 1 1233444555666666999999999999999999999999998764322 2234
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
...||++|+|||.+.+ .+..++|+||+|++++++.++..++
T Consensus 398 t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 398 NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 5679999999999865 4677899999999988887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-22 Score=224.26 Aligned_cols=180 Identities=12% Similarity=0.145 Sum_probs=137.1
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCCh--------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSA--------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.||+|+||.||+|...+..+++|+...... ...++|.+|++++++++||||+++..++...+..++||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 46899999999999988899999998754321 1234689999999999999999766677678888999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCc----eeee
Q 004935 503 MANGNLQALLLGEEADILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT----HVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~----~~~~ 574 (723)
+++|+|.+++.. .+.+..+ +..+|+...+||||||+|||++. ++||+|||+++......... ....
T Consensus 421 ~~ggsL~~~l~~----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~ 494 (540)
T 3en9_A 421 INGKLAKDVIED----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK 494 (540)
T ss_dssp CCSEEHHHHSTT----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHH----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence 999999999976 3444444 45555555599999999999999 99999999999864221100 0123
Q ss_pred cccCCCcccccccccc--CCCCChhhHHHHHHHHHHHHcCCCcc
Q 004935 575 TIAGTPGYLDPEYYIS--NRLTEKSDVYNFGVVLLEIITSKSVI 616 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~--~~~~~~~DV~SfGvvL~elltg~~p~ 616 (723)
...||+.|+|||.+.. ..|+..+|+|+..+-.++-+.++.++
T Consensus 495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5679999999999976 66888899999999988888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=173.77 Aligned_cols=135 Identities=16% Similarity=0.121 Sum_probs=101.3
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCCh------------------hhHHHHHHHHHHHHhccCCceeeEEEEEe
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA------------------QGYKQFQAEVELLMRIHHKNLTTLVGYCD 491 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 491 (723)
.+.||+|+||.||+|.. +++.||||+++.... .....+.+|+++|++++| +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence 37899999999999999 467999999975322 134578999999999994 55555443
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCCCCCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 492 EGTNRGLIYEFMANGNLQALLLGEEADILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 492 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
. +..++||||+++|+|.+ +.. .....+ ...+..+|+...+||||||+|||++ ++.+||+|||+++..
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~---- 242 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---- 242 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET----
T ss_pred c-cceEEEEEecCCCcHHH-cch--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC----
Confidence 3 56799999999999998 432 222223 3344555555559999999999999 999999999998743
Q ss_pred CCceeeecccCCCccccccccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYI 589 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~ 589 (723)
..++|||++.
T Consensus 243 ------------~~~~a~e~l~ 252 (282)
T 1zar_A 243 ------------GEEGWREILE 252 (282)
T ss_dssp ------------TSTTHHHHHH
T ss_pred ------------CCCCHHHHHH
Confidence 2467888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.3e-14 Score=145.39 Aligned_cols=127 Identities=23% Similarity=0.267 Sum_probs=92.3
Q ss_pred hhhccccCcEEEEEEEE--CCce--EEEEEecCCChh------------------------hHHHHHHHHHHHHhccCCc
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTE--VAVKMLSPSSAQ------------------------GYKQFQAEVELLMRIHHKN 482 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~H~n 482 (723)
.+.||+|+||.||+|.. +|+. ||||+++..... ....+.+|+++|.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46899999999999998 7888 999997643211 1136889999999998875
Q ss_pred e--eeEEEEEecCCceEEEEEeCCC-C----CHHHHhccC-CCCCC----CHHHHHHHHH-hccccccCCCCCCEEEcCC
Q 004935 483 L--TTLVGYCDEGTNRGLIYEFMAN-G----NLQALLLGE-EADIL----SWEGRLRIAI-EAAKVHRDVKSTNILLSGK 549 (723)
Q Consensus 483 I--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~-~~~~l----~~~~~l~i~~-~~a~vH~Dlk~~NILl~~~ 549 (723)
+ ...+++ +..+|||||+.+ | +|.++.... ..... +....+..+| ....+||||||+|||++.
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID- 206 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence 4 444443 367899999952 4 777765431 11222 2334455566 566699999999999998
Q ss_pred CcEEEEeccCcccc
Q 004935 550 FQAKIADFGLSRTF 563 (723)
Q Consensus 550 ~~~kl~DfGla~~~ 563 (723)
.++|+|||+|...
T Consensus 207 -~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 -KVYFIDMGQAVTL 219 (258)
T ss_dssp -SEEECCCTTCEET
T ss_pred -cEEEEECcccccC
Confidence 9999999999764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-13 Score=161.08 Aligned_cols=124 Identities=25% Similarity=0.355 Sum_probs=95.1
Q ss_pred cchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcC
Q 004935 233 LPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG 312 (723)
Q Consensus 233 lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g 312 (723)
+|+.+..+..++.+++..+...+..|..+.. .+.|+.|+|++|+|+|.||.+|++|++|+.|||++|+|+|
T Consensus 624 ~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~---------l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g 694 (768)
T 3rgz_A 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS---------MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694 (768)
T ss_dssp CCCSCSSSBCCCEEECCSSCCBSCCCGGGGG---------CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred CchhhhccccccEEECcCCcccccCCHHHhc---------cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccC
Confidence 3444444455555555555444444432222 2578999999999999999999999999999999999999
Q ss_pred CCCccCCCCCCCcEEEccCCCCCCchhhc--ccCccccccCCCCCCCCCC--CCCCC
Q 004935 313 PVPDFLSQLPFLTELNLKGTIPNGLIEKQ--KNGLLSLSVEGNPDLCPEA--SCTAD 365 (723)
Q Consensus 313 ~iP~~l~~l~~L~~l~l~~n~~~g~~p~~--~~~~~~l~~~~n~~lc~~~--~c~~~ 365 (723)
.||..++++++|+.|+|++|.++|.||.. +..+...+|.||+++|+.+ .|...
T Consensus 695 ~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp CCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred cCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 99999999999999999999999999974 3355667899999999864 56543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=123.96 Aligned_cols=147 Identities=13% Similarity=0.114 Sum_probs=93.4
Q ss_pred eEEEEEecCCCCCCCccCCCCCCCceEecCCCCC-Ccccc-CccccccCCCCCCchhhhhhceeccCCCCceEEeeC-CC
Q 004935 83 SLFRRWDIGSRSSETFRYPDDIYDRIWLPNSLPN-SEPIN-TTSDIISMNDYQGPSTVMQTAVIPTNGSNSLQLSWE-PN 159 (723)
Q Consensus 83 ~~~~r~~~g~~~~~~~rypdD~~dR~W~~~~~~~-~~~~~-t~~~i~~~~~~~~P~~v~~tA~~~~~~~~~~~~~w~-~~ 159 (723)
+...|.|||+.. +. |..+|.|.++.... ....+ ....+........|+.|||||..... +++|. |.
T Consensus 5 ~~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~-----~~tY~f~v 73 (174)
T 2jwp_A 5 KVIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED-----SFGYDIPI 73 (174)
T ss_dssp HEEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS-----CEEEEEEC
T ss_pred cEEEEEECCCCC---cc---CCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC-----CeEEEEEe
Confidence 357899999863 22 67899999885421 11111 11111112224458899999976432 56777 77
Q ss_pred CCccceEEEeeeecccccccCCcceEEEEEEcCccccCCccccee-----------eeE------EEEeeeeecccceEE
Q 004935 160 DPKFLYYAYLYFSEFENVQANNQTREIIIYINGIDWFGPFSPLHF-----------AAN------TIYSTWPILTAEKIE 222 (723)
Q Consensus 160 ~~~~~y~~~lhF~e~~~~~~~~~~R~f~i~ln~~~~~~~~~p~~l-----------~~~------~~~~~~p~~~~~~~~ 222 (723)
+++..|.|+|||||+.... ...|+|+|++||......+++... ..+ .+.+.++. ..+.++
T Consensus 74 ~~~G~Y~VrLhF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~-~~g~L~ 150 (174)
T 2jwp_A 74 KEEGEYVLVLKFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVST-FTGKLS 150 (174)
T ss_dssp CSCEEEEEEEEEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEE-CCSEEE
T ss_pred CCCeEEEEEEEEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecc-cCCeEE
Confidence 7778899999999998533 367999999999887665654311 011 00111122 456788
Q ss_pred EEEEcCCCCCcchhhhhhhhhhh
Q 004935 223 FSINTTESSTLPPILNAYEIYRA 245 (723)
Q Consensus 223 lsl~~~~~s~lPp~inale~~~~ 245 (723)
|++.+.. .-.|+|||+|+++.
T Consensus 151 I~f~p~~--~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 151 VEFVKGY--YDNPKVCALFIMKG 171 (174)
T ss_dssp EEEECSS--SCSSSEEEEEEESS
T ss_pred EEEeccC--CCCcEEEEEEEEeC
Confidence 9998742 23599999998763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.3e-12 Score=137.45 Aligned_cols=129 Identities=9% Similarity=0.088 Sum_probs=86.3
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCCCh--------------hhHH--------HHHHHHHHHHhccCCcee--
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA--------------QGYK--------QFQAEVELLMRIHHKNLT-- 484 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~--------------~~~~--------~f~~Ei~~l~~l~H~nIv-- 484 (723)
+.+.||+|++|.||+|.. +|+.||||+++.... .... ...+|...|.++.+.++.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 356899999999999997 577999999764210 0001 124567777777655442
Q ss_pred eEEEEEecCCceEEEEEeCCCCCHHHHhccCCCC--CCCHHHHHHHHHhccccccCCCCCCEEEcCCC----------cE
Q 004935 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEAD--ILSWEGRLRIAIEAAKVHRDVKSTNILLSGKF----------QA 552 (723)
Q Consensus 485 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~--~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~----------~~ 552 (723)
..+++ ...+|||||+++++|.++....... ..+....+..+|+...|||||||.|||+++++ .+
T Consensus 179 ~p~~~----~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 179 EPIAQ----SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTP 254 (397)
T ss_dssp CEEEE----ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred eeeec----cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccce
Confidence 22222 2347999999999987764322111 11233445556666669999999999998876 38
Q ss_pred EEEeccCccc
Q 004935 553 KIADFGLSRT 562 (723)
Q Consensus 553 kl~DfGla~~ 562 (723)
.|+||+-+..
T Consensus 255 ~iID~~Q~V~ 264 (397)
T 4gyi_A 255 IIIXFPQMVS 264 (397)
T ss_dssp EECCCTTCEE
T ss_pred EEEEeCCccc
Confidence 9999997654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=5.2e-11 Score=140.88 Aligned_cols=81 Identities=25% Similarity=0.400 Sum_probs=73.6
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCc---ccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGL---LSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~---~~l~~ 350 (723)
+.|+.|||++|+|+|.||.+|++|++|+.|+|++|+|+|.||..+++|++|+.|||++|.++|.+|..+..+ ..+.+
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 578999999999999999999999999999999999999999999999999999999999999999887654 34556
Q ss_pred CCCC
Q 004935 351 EGNP 354 (723)
Q Consensus 351 ~~n~ 354 (723)
++|.
T Consensus 712 s~N~ 715 (768)
T 3rgz_A 712 SNNN 715 (768)
T ss_dssp CSSE
T ss_pred cCCc
Confidence 6663
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.12 E-value=5.6e-11 Score=124.89 Aligned_cols=150 Identities=15% Similarity=0.232 Sum_probs=99.8
Q ss_pred ccccccCCc---ceEEEEEEcCccccC--CcccceeeeEEEEeeeeecccceEEEEEE--cCCCCCcchhhhhhhhhhhh
Q 004935 174 FENVQANNQ---TREIIIYINGIDWFG--PFSPLHFAANTIYSTWPILTAEKIEFSIN--TTESSTLPPILNAYEIYRAK 246 (723)
Q Consensus 174 ~~~~~~~~~---~R~f~i~ln~~~~~~--~~~p~~l~~~~~~~~~p~~~~~~~~lsl~--~~~~s~lPp~inale~~~~~ 246 (723)
|.++.|... .|+-.+.+.+..+.+ .+++. +.. ......+.+. ....+.+|+.+..+..++.+
T Consensus 38 w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~-l~~----------l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L 106 (313)
T 1ogq_A 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LAN----------LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106 (313)
T ss_dssp STTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-GGG----------CTTCSEEEEEEETTEESCCCGGGGGCTTCSEE
T ss_pred CcceEeCCCCCCceEEEEECCCCCccCCcccChh-HhC----------CCCCCeeeCCCCCcccccCChhHhcCCCCCEE
Confidence 899998643 688888888877665 33321 110 1223335554 34455677777777777777
Q ss_pred ccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCC-CCc
Q 004935 247 EFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP-FLT 325 (723)
Q Consensus 247 ~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~-~L~ 325 (723)
.+..+...+..+..+. ..++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+++++ +|+
T Consensus 107 ~Ls~n~l~~~~p~~~~---------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~ 177 (313)
T 1ogq_A 107 YITHTNVSGAIPDFLS---------QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177 (313)
T ss_dssp EEEEECCEEECCGGGG---------GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred ECcCCeeCCcCCHHHh---------CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCc
Confidence 7655544332222111 125678888888888888888888888888888888888888888888877 788
Q ss_pred EEEccCCCCCCchhhccc
Q 004935 326 ELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 326 ~l~l~~n~~~g~~p~~~~ 343 (723)
.|+|++|.++|.+|..+.
T Consensus 178 ~L~L~~N~l~~~~~~~~~ 195 (313)
T 1ogq_A 178 SMTISRNRLTGKIPPTFA 195 (313)
T ss_dssp EEECCSSEEEEECCGGGG
T ss_pred EEECcCCeeeccCChHHh
Confidence 888888888777776554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.1e-11 Score=136.30 Aligned_cols=69 Identities=22% Similarity=0.294 Sum_probs=45.4
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC-Cchhhccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN-GLIEKQKN 343 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~-g~~p~~~~ 343 (723)
.++|+.|+|++|.|+| +|+.++.+++|+.|+|++|+|++ +|..++.+++|+.|+|++|.+. +.+|..+.
T Consensus 190 l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 190 FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp CTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred CCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 3567777777777775 44457777777777777777774 6666677777777777777666 44554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.05 E-value=9.2e-11 Score=123.26 Aligned_cols=103 Identities=25% Similarity=0.398 Sum_probs=86.7
Q ss_pred cccccCCCcee--ecCccCCCCCCCCCceEEEEcCCCcccc--cCcccccCCCCCCeeeCcC-CcCcCCCCccCCCCCCC
Q 004935 250 QFLTNQQDAYL--WQGLNCSYPEYDPPRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSN-NNLTGPVPDFLSQLPFL 324 (723)
Q Consensus 250 ~~~~~~~~~~~--w~g~~c~~~~~~~~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~L~ls~-N~l~g~iP~~l~~l~~L 324 (723)
..|....++|. |.|+.|.... ...+++.|+|++|+++| .+|+.|+++++|++|+|++ |+++|.+|..++++++|
T Consensus 25 ~~W~~~~~~C~~~w~gv~C~~~~-~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L 103 (313)
T 1ogq_A 25 SSWLPTTDCCNRTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103 (313)
T ss_dssp TTCCTTSCTTTTCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTC
T ss_pred cCCCCCCCCCcCCCcceEeCCCC-CCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCC
Confidence 34556678898 9999997422 12589999999999999 9999999999999999995 99999999999999999
Q ss_pred cEEEccCCCCCCchhhcccC---ccccccCCC
Q 004935 325 TELNLKGTIPNGLIEKQKNG---LLSLSVEGN 353 (723)
Q Consensus 325 ~~l~l~~n~~~g~~p~~~~~---~~~l~~~~n 353 (723)
++|+|++|.+++.+|..+.. +..+.+.+|
T Consensus 104 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 135 (313)
T 1ogq_A 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp SEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred CEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence 99999999999999887654 334455555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.7e-10 Score=133.48 Aligned_cols=32 Identities=16% Similarity=0.196 Sum_probs=26.8
Q ss_pred eecc---cccccCCcceEEEEEEcCccccCCcccc
Q 004935 171 FSEF---ENVQANNQTREIIIYINGIDWFGPFSPL 202 (723)
Q Consensus 171 F~e~---~~~~~~~~~R~f~i~ln~~~~~~~~~p~ 202 (723)
+|.| .++.|+...||..+.+.+..+.|.+++.
T Consensus 66 ~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~ 100 (636)
T 4eco_A 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100 (636)
T ss_dssp GGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGG
T ss_pred cccccCCCCeEEcCCCCEEEEEecCcccCCcCChH
Confidence 4778 9999976689999999999888777664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.01 E-value=6.6e-10 Score=105.59 Aligned_cols=100 Identities=24% Similarity=0.227 Sum_probs=83.5
Q ss_pred eeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 259 YLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 259 ~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|.|+.+.|+... ..++.++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..+..+++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 567777777532 23468999999999999988999999999999999999999777777899999999999999
Q ss_pred CCCCchhhccc---CccccccCCCCCCCC
Q 004935 333 IPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 333 ~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
.+++..+..+. .+..+.+.+|+..|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 99987775444 456678889987764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.7e-10 Score=130.57 Aligned_cols=99 Identities=21% Similarity=0.318 Sum_probs=84.6
Q ss_pred ccccCCCceee---cCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCC-------------------
Q 004935 251 FLTNQQDAYLW---QGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNN------------------- 308 (723)
Q Consensus 251 ~~~~~~~~~~w---~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N------------------- 308 (723)
+|....++|.| .||.|+.. .+++.|+|++|+|+|.||++|++|++|++|+|++|
T Consensus 59 ~W~~~~~~c~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~ 134 (636)
T 4eco_A 59 NWNFNKELDMWGAQPGVSLNSN----GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMS 134 (636)
T ss_dssp CCCCSSCGGGTTCCTTEEECTT----CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCC
T ss_pred CCCCCCCcccccCCCCeEEcCC----CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCch
Confidence 45566889999 99999743 48999999999999999999999999999999988
Q ss_pred -----------------------------------------------------------cCcCCCCccCCCCCCCcEEEc
Q 004935 309 -----------------------------------------------------------NLTGPVPDFLSQLPFLTELNL 329 (723)
Q Consensus 309 -----------------------------------------------------------~l~g~iP~~l~~l~~L~~l~l 329 (723)
+|+| ||..++++++|++|+|
T Consensus 135 ~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~L 213 (636)
T 4eco_A 135 DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYM 213 (636)
T ss_dssp HHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEE
T ss_pred HHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEEC
Confidence 5567 9999999999999999
Q ss_pred cCCCCCCc-----------------hhhccc--Cc---cccccCCCC
Q 004935 330 KGTIPNGL-----------------IEKQKN--GL---LSLSVEGNP 354 (723)
Q Consensus 330 ~~n~~~g~-----------------~p~~~~--~~---~~l~~~~n~ 354 (723)
++|.++|. +|..+. ++ ..+.+.+|.
T Consensus 214 s~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 214 GNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp ESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred cCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence 99999996 888766 44 345556654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=106.26 Aligned_cols=84 Identities=24% Similarity=0.301 Sum_probs=57.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|+|++.+|..|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++.+|..+. .+..+.+
T Consensus 54 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (192)
T 1w8a_A 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEe
Confidence 4677777777777777777777777777777777777777776677777777777777777776665544 3344556
Q ss_pred CCCCCCC
Q 004935 351 EGNPDLC 357 (723)
Q Consensus 351 ~~n~~lc 357 (723)
.+|+-.|
T Consensus 134 ~~N~l~c 140 (192)
T 1w8a_A 134 ASNPFNC 140 (192)
T ss_dssp TTCCBCC
T ss_pred CCCCccC
Confidence 6666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=9.2e-10 Score=109.30 Aligned_cols=127 Identities=18% Similarity=0.185 Sum_probs=92.1
Q ss_pred EEEEcCCCCCcch--hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 223 FSINTTESSTLPP--ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 223 lsl~~~~~s~lPp--~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
+.+..+.-..+++ .+..+..++.+.+..+....-.+..+ ...++|+.|+|++|+|++..|..|+.|++|
T Consensus 37 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~---------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 107 (220)
T 2v70_A 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF---------EGASGVNEILLTSNRLENVQHKMFKGLESL 107 (220)
T ss_dssp EECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTT---------TTCTTCCEEECCSSCCCCCCGGGGTTCSSC
T ss_pred EEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHh---------CCCCCCCEEECCCCccCccCHhHhcCCcCC
Confidence 4444433334432 35666666766655443322111111 123689999999999998888889999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
+.|+|++|+|++..|..+..+++|+.|+|++|.+++..|..+. ++..+.+.+|+-.|.
T Consensus 108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 108 KTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 9999999999999999999999999999999999998887665 345567788876663
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.93 E-value=8.7e-10 Score=130.67 Aligned_cols=121 Identities=11% Similarity=0.080 Sum_probs=76.7
Q ss_pred cchhhhhhhhhhhhccccccccCC-CceeecCc--------cCCCCC-CCCCceEEEEcCCCcccccCcccccCCCCCCe
Q 004935 233 LPPILNAYEIYRAKEFLQFLTNQQ-DAYLWQGL--------NCSYPE-YDPPRITSLNLSSSGIAGDIAPYISTLTSIQI 302 (723)
Q Consensus 233 lPp~inale~~~~~~~~~~~~~~~-~~~~w~g~--------~c~~~~-~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~ 302 (723)
+|+.+..+..++.+.+..+...+. .+..|... ...... ...++|+.|+|++|++.|.+|..|++|++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 788888888888887776655541 11122110 011000 02356788888888888888888888888888
Q ss_pred eeCcCCc-CcC-CCCccCCCCC-------CCcEEEccCCCCCCchhh--ccc---CccccccCCCC
Q 004935 303 LDLSNNN-LTG-PVPDFLSQLP-------FLTELNLKGTIPNGLIEK--QKN---GLLSLSVEGNP 354 (723)
Q Consensus 303 L~ls~N~-l~g-~iP~~l~~l~-------~L~~l~l~~n~~~g~~p~--~~~---~~~~l~~~~n~ 354 (723)
|+|++|+ |+| .||..+++++ +|+.|+|++|.++ .+|. .+. ++..|.+.+|.
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~ 584 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNK 584 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSC
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCC
Confidence 8888887 777 7777665554 7777788777777 6666 443 33344455553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.3e-09 Score=112.12 Aligned_cols=116 Identities=14% Similarity=0.152 Sum_probs=77.9
Q ss_pred EEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
.+.+..+.-..+|..+..+..++.+.+..+...+ .+..+ ...++|+.|+|++|++.|.+|..++.+++|+
T Consensus 187 ~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l---------~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 187 SLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAI---------HHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGG---------GGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred EEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-Cchhh---------ccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 3555554444677777777666666654443322 11111 1125678888888888888888888888888
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccc
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLS 347 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~ 347 (723)
.|+|++|++.|.+|..++++++|+.|+|++|.+.|.+|..+..+..
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 8888888888888887888888888888888888888777665443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.8e-09 Score=114.99 Aligned_cols=100 Identities=23% Similarity=0.254 Sum_probs=82.0
Q ss_pred eeecCccCCCC-C-------CCCCceEEEEcCC-CcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEc
Q 004935 259 YLWQGLNCSYP-E-------YDPPRITSLNLSS-SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329 (723)
Q Consensus 259 ~~w~g~~c~~~-~-------~~~~~l~~l~ls~-n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l 329 (723)
|.|..+.|+.. . ....+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 66777777754 1 1224699999996 9999888889999999999999999999999999999999999999
Q ss_pred cCCCCCCchhhccc--CccccccCCCCCCCC
Q 004935 330 KGTIPNGLIEKQKN--GLLSLSVEGNPDLCP 358 (723)
Q Consensus 330 ~~n~~~g~~p~~~~--~~~~l~~~~n~~lc~ 358 (723)
++|.+++..+..+. .+..|.+.+|+-.|.
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 99999986655443 256677888887763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-09 Score=114.96 Aligned_cols=122 Identities=15% Similarity=0.125 Sum_probs=60.2
Q ss_pred eEEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeec----------------------CccCCCC-CCCCCce
Q 004935 220 KIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQ----------------------GLNCSYP-EYDPPRI 276 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~----------------------g~~c~~~-~~~~~~l 276 (723)
...+.+..+.-..+|+.+..+..++.+.+..+...+..+..+. .+..-.. -...++|
T Consensus 129 L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L 208 (328)
T 4fcg_A 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNL 208 (328)
T ss_dssp CSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTC
T ss_pred CCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCC
Confidence 4456666655557777777777777776655433333321111 1100000 0012345
Q ss_pred EEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc
Q 004935 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK 342 (723)
Q Consensus 277 ~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~ 342 (723)
+.|+|++|++++ +|+.++++++|+.|+|++|++.|.+|..++++++|+.|+|++|.+.+.+|..+
T Consensus 209 ~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~ 273 (328)
T 4fcg_A 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273 (328)
T ss_dssp CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence 555555555553 44445555555555555555555555555555555555555555555555433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.1e-09 Score=129.71 Aligned_cols=89 Identities=17% Similarity=0.290 Sum_probs=76.6
Q ss_pred cCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeC-cCCcCcCC---------------------------
Q 004935 262 QGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDL-SNNNLTGP--------------------------- 313 (723)
Q Consensus 262 ~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~l-s~N~l~g~--------------------------- 313 (723)
.|+.|+. ..+++.|+|++|+|+|.||++|++|++|+.|+| ++|+|+|.
T Consensus 315 ~GV~C~~----~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~ 390 (876)
T 4ecn_A 315 PGVDLDN----NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390 (876)
T ss_dssp TTEEECT----TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHH
T ss_pred CceEecC----CCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhh
Confidence 9999974 258999999999999999999999999999999 88877776
Q ss_pred -------------------------------------------------CCccCCCCCCCcEEEccCCCCCC--------
Q 004935 314 -------------------------------------------------VPDFLSQLPFLTELNLKGTIPNG-------- 336 (723)
Q Consensus 314 -------------------------------------------------iP~~l~~l~~L~~l~l~~n~~~g-------- 336 (723)
||..+++|++|+.|+|++|.++|
T Consensus 391 ~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~ 470 (876)
T 4ecn_A 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470 (876)
T ss_dssp HTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCS
T ss_pred hhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccc
Confidence 89999999999999999999999
Q ss_pred ---------chhhccc--C---ccccccCCCC
Q 004935 337 ---------LIEKQKN--G---LLSLSVEGNP 354 (723)
Q Consensus 337 ---------~~p~~~~--~---~~~l~~~~n~ 354 (723)
.+|..+. + +..|.+.+|.
T Consensus 471 ~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred ccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 4887764 3 3445555653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.1e-09 Score=106.64 Aligned_cols=127 Identities=19% Similarity=0.272 Sum_probs=90.5
Q ss_pred EEEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcc-cccCCCC
Q 004935 222 EFSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAP-YISTLTS 299 (723)
Q Consensus 222 ~lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~-~~~~l~~ 299 (723)
.+.+..+.-..+|+ .+..+..++.+.+..+....-.+..+. ..++|+.|+|++|+|++ ||+ .|..|++
T Consensus 36 ~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~---------~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~ 105 (220)
T 2v9t_B 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---------GLRSLNSLVLYGNKITE-LPKSLFEGLFS 105 (220)
T ss_dssp EEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTT---------TCSSCCEEECCSSCCCC-CCTTTTTTCTT
T ss_pred EEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhh---------CCcCCCEEECCCCcCCc-cCHhHccCCCC
Confidence 34554444444544 566667777776654433322221121 23689999999999994 554 4789999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
|+.|+|++|+|++..|..+..+++|+.|+|++|.+++..+..+. .+..+.+.+|+..|.
T Consensus 106 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 106 LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999999999998899999999999999999999987776544 445677888887663
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.2e-09 Score=105.18 Aligned_cols=104 Identities=19% Similarity=0.093 Sum_probs=84.5
Q ss_pred ccccCCCceeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCC
Q 004935 251 FLTNQQDAYLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFL 324 (723)
Q Consensus 251 ~~~~~~~~~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L 324 (723)
.+..+...|+|.++.|+... ..+++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..+..+..+++|
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 90 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90 (229)
T ss_dssp CCCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc
Confidence 34566778999999998642 245789999999999999889999999999999999999976555678999999
Q ss_pred cEEEccCCCCCCchhhccc---CccccccCCCC
Q 004935 325 TELNLKGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 325 ~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
+.|+|++|.+++..+..+. .+..|.+.+|.
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 123 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNK 123 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCc
Confidence 9999999999987665443 44455566653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.5e-09 Score=100.16 Aligned_cols=86 Identities=22% Similarity=0.252 Sum_probs=72.8
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Cccccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLS 349 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~ 349 (723)
++.|+.|+|++|+|++.+|..|++|++|+.|+|++|+|++..|..+.++++|+.|+|++|.+++..+..+. ++..+.
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 46899999999999998899999999999999999999986566678999999999999999987665444 455677
Q ss_pred cCCCCCCCC
Q 004935 350 VEGNPDLCP 358 (723)
Q Consensus 350 ~~~n~~lc~ 358 (723)
+.+|+-.|.
T Consensus 112 L~~N~~~c~ 120 (174)
T 2r9u_A 112 LYNNPWDCE 120 (174)
T ss_dssp CCSSCBCTT
T ss_pred eCCCCcccc
Confidence 888887663
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.86 E-value=3.2e-09 Score=102.97 Aligned_cols=111 Identities=18% Similarity=0.180 Sum_probs=87.9
Q ss_pred EEEEEcCCCCCcchh--hhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 222 EFSINTTESSTLPPI--LNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~--inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
.+.+..+.-+.+|+. +..+..++.+.+..+...+..+..+. ..++|+.|+|++|+|++..|..|+.+++
T Consensus 33 ~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 103 (192)
T 1w8a_A 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE---------GASHIQELQLGENKIKEISNKMFLGLHQ 103 (192)
T ss_dssp EEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTT---------TCTTCCEEECCSCCCCEECSSSSTTCTT
T ss_pred EEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcC---------CcccCCEEECCCCcCCccCHHHhcCCCC
Confidence 455555555566653 77888888887765544333222111 2368999999999999999989999999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ 341 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~ 341 (723)
|+.|+|++|+|++.+|..+..+++|+.|+|++|.+++..+..
T Consensus 104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~ 145 (192)
T 1w8a_A 104 LKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp CCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred CCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch
Confidence 999999999999999999999999999999999999887643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.5e-09 Score=104.99 Aligned_cols=127 Identities=16% Similarity=0.168 Sum_probs=92.0
Q ss_pred EEEEEcCCCCC-cchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESST-LPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~-lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.+.|..+.-.. .|..+..+..++.+.+..+....-.+..+ ...++|+.|+|++|+|++..+..|+.|++|
T Consensus 44 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~---------~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 114 (229)
T 3e6j_A 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF---------DSLTQLTVLDLGTNQLTVLPSAVFDRLVHL 114 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---------TTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred EEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc---------ccCCCcCEEECCCCcCCccChhHhCcchhh
Confidence 35555533333 35567777777777765543322111101 124689999999999997666678999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
+.|+|++|+|+ .||..+..+++|+.|+|++|.+++..+..+. .+..+.+.+|+..|.
T Consensus 115 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 115 KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 99999999999 8999999999999999999999987665443 455677888887764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=9e-09 Score=99.88 Aligned_cols=85 Identities=28% Similarity=0.290 Sum_probs=70.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++..+..+. .+..+.+
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI 133 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence 4788999999999987778899999999999999999988888899999999999999999876654443 4556778
Q ss_pred CCCCCCCC
Q 004935 351 EGNPDLCP 358 (723)
Q Consensus 351 ~~n~~lc~ 358 (723)
.+|+..|.
T Consensus 134 ~~N~~~C~ 141 (193)
T 2wfh_A 134 GANPLYCD 141 (193)
T ss_dssp CSSCEECS
T ss_pred CCCCeecC
Confidence 88887663
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=4.6e-09 Score=107.02 Aligned_cols=81 Identities=7% Similarity=0.018 Sum_probs=66.3
Q ss_pred hhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 431 ERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
...++.|+.+.||+....++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||+++.+|.
T Consensus 19 ~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp EECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred EeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 4567778889999998888899999987532122346889999999994 677888999999888999999999999998
Q ss_pred HH
Q 004935 510 AL 511 (723)
Q Consensus 510 ~~ 511 (723)
+.
T Consensus 99 ~~ 100 (263)
T 3tm0_A 99 EE 100 (263)
T ss_dssp HH
T ss_pred hc
Confidence 75
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.5e-08 Score=102.61 Aligned_cols=86 Identities=19% Similarity=0.216 Sum_probs=66.4
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Cccccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLS 349 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~ 349 (723)
.++|+.|+|++|+|++..|..++.+++|+.|+|++|+|++..|..++.+++|+.|+|++|.+++..+..+. .+..+.
T Consensus 106 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 185 (251)
T 3m19_A 106 LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185 (251)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEE
Confidence 35788888888888865555678888888888888888876666788888888888888888877665443 445667
Q ss_pred cCCCCCCCC
Q 004935 350 VEGNPDLCP 358 (723)
Q Consensus 350 ~~~n~~lc~ 358 (723)
+.+|+-.|.
T Consensus 186 l~~N~~~c~ 194 (251)
T 3m19_A 186 LFGNQFDCS 194 (251)
T ss_dssp CCSCCBCTT
T ss_pred eeCCceeCC
Confidence 778876663
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.5e-08 Score=100.39 Aligned_cols=112 Identities=15% Similarity=0.109 Sum_probs=87.6
Q ss_pred eEEEEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCC
Q 004935 220 KIEFSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLT 298 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~ 298 (723)
...+.+..+.-..+|+ .+..+..++.+.+..+....-.+..+. ..++|+.|+|++|+|++..|..|+.|+
T Consensus 59 L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 129 (220)
T 2v70_A 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFK---------GLESLKTLMLRSNRITCVGNDSFIGLS 129 (220)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGT---------TCSSCCEEECTTSCCCCBCTTSSTTCT
T ss_pred CCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhc---------CCcCCCEEECCCCcCCeECHhHcCCCc
Confidence 3446665544445554 677777788777765544433322222 236899999999999999999999999
Q ss_pred CCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 299 SIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 299 ~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
+|+.|+|++|+|++..|..+..+++|+.|+|++|.+++..+.
T Consensus 130 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 130 SVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred cCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 999999999999999999999999999999999999987654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.72 E-value=2.5e-08 Score=95.10 Aligned_cols=95 Identities=22% Similarity=0.205 Sum_probs=72.8
Q ss_pred eeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 259 YLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 259 ~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|.|.++.|+..+ ..++.|+.|+|++|++++..+..++++++|+.|+|++|+|++..|..++.+++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 678888887532 23468899999999998655566789999999999999998766677788999999999999
Q ss_pred CCCCchhhccc---CccccccCCC
Q 004935 333 IPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 333 ~~~g~~p~~~~---~~~~l~~~~n 353 (723)
.+++..+..+. .+..+.+.+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CccccCHHHhhCCcccCEEECcCC
Confidence 98877665433 4445566666
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.72 E-value=3.2e-08 Score=97.01 Aligned_cols=126 Identities=17% Similarity=0.171 Sum_probs=85.9
Q ss_pred EEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 223 FSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 223 lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
+.+....-..+|+ .+..+..++.+.+..+....-.+.. -...++|+.|+|++|++++..+..++++++|+
T Consensus 33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 103 (208)
T 2o6s_A 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV---------FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLK 103 (208)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh---------cCCCCCcCEEECCCCcCCccCHhHhcCccCCC
Confidence 4444433334444 4566777777766544222111100 01236899999999999965556689999999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLC 357 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc 357 (723)
.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. ++..+.+.+|+..|
T Consensus 104 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 104 ELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred EEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 999999999977777788999999999999998876664433 45566777887655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=3e-08 Score=96.18 Aligned_cols=95 Identities=24% Similarity=0.276 Sum_probs=78.5
Q ss_pred eeecCccCCCC------CCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 259 YLWQGLNCSYP------EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 259 ~~w~g~~c~~~------~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|.|..+.|+.. ...++.|+.|+|++|+|+ .||..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45566666643 224568999999999998 89999999999999999999999988889999999999999999
Q ss_pred CCCCchhhcccC---ccccccCCCC
Q 004935 333 IPNGLIEKQKNG---LLSLSVEGNP 354 (723)
Q Consensus 333 ~~~g~~p~~~~~---~~~l~~~~n~ 354 (723)
.+++..|..+.+ +..+.+.+|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~ 113 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGND 113 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCC
Confidence 999988766553 4455666664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.71 E-value=3e-08 Score=101.64 Aligned_cols=129 Identities=17% Similarity=0.177 Sum_probs=88.9
Q ss_pred EEEEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 221 IEFSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 221 ~~lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
..+.+..+.-..+|+ .+..+..++.+.+..+......+.. -...++|+.|+|++|++++..|..++.+++
T Consensus 88 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 158 (272)
T 3rfs_A 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV---------FDKLTNLTYLNLAHNQLQSLPKGVFDKLTN 158 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHH---------hccCCCCCEEECCCCccCccCHHHhccCcc
Confidence 345555533334444 3566777777666544322211100 012367999999999999766677899999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
|+.|+|++|++++..|..++.+++|+.|+|++|.+++..|..+. .+..+.+.+|+..|.
T Consensus 159 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 159 LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 99999999999987777788999999999999999987775443 455667788876654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.69 E-value=4.1e-08 Score=93.58 Aligned_cols=84 Identities=25% Similarity=0.282 Sum_probs=50.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|+|++..+..++.+++|+.|+|++|+|++..|..+.++++|+.|+|++|.+++..+..+. .+..+.+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 131 (177)
T 2o6r_A 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEe
Confidence 4566667777766644444466667777777777777665555566666777777776666654443222 3344455
Q ss_pred CCCCCCC
Q 004935 351 EGNPDLC 357 (723)
Q Consensus 351 ~~n~~lc 357 (723)
.+|+-.|
T Consensus 132 ~~N~~~~ 138 (177)
T 2o6r_A 132 HTNPWDC 138 (177)
T ss_dssp CSSCBCC
T ss_pred cCCCeec
Confidence 5555433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.68 E-value=3.8e-08 Score=101.96 Aligned_cols=129 Identities=19% Similarity=0.128 Sum_probs=90.4
Q ss_pred eEEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 220 KIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
...+.+..+.-..+|..+..+..++.+.+..+....-.+..+. ..++|+.|+|++|+|++..|..|..+++
T Consensus 79 L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 149 (290)
T 1p9a_G 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR---------GLGELQELYLKGNELKTLPPGLLTPTPK 149 (290)
T ss_dssp CCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTT---------TCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred CCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHc---------CCCCCCEEECCCCCCCccChhhcccccC
Confidence 3345555555557787777777777776655433322211111 2357999999999999766666889999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
|+.|+|++|+|++..+..+.++++|+.|+|++|.++. +|..+. .+..+.+.+|+..|.
T Consensus 150 L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccCc
Confidence 9999999999996555567889999999999999884 555443 344567788888774
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.2e-08 Score=115.16 Aligned_cols=86 Identities=21% Similarity=0.158 Sum_probs=78.4
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc----Ccccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN----GLLSL 348 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~----~~~~l 348 (723)
.++|+.|+|++|+|++.+|..|++|++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++..|..+. .+..+
T Consensus 493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence 46899999999999999999999999999999999999999999999999999999999999999888764 34567
Q ss_pred ccCCCCCCCC
Q 004935 349 SVEGNPDLCP 358 (723)
Q Consensus 349 ~~~~n~~lc~ 358 (723)
..++||..|.
T Consensus 573 ~L~~Np~~C~ 582 (635)
T 4g8a_A 573 NLTQNDFACT 582 (635)
T ss_dssp ECTTCCBCCS
T ss_pred EeeCCCCccc
Confidence 8899999884
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3e-08 Score=109.42 Aligned_cols=129 Identities=19% Similarity=0.209 Sum_probs=92.1
Q ss_pred EEEEEEcCC-CCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 221 IEFSINTTE-SSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 221 ~~lsl~~~~-~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
..+.+..+. .+.+|..+..+..++.+.+..+...+..+..+. ..++|+.|+|++|++++..|..++++++
T Consensus 278 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 348 (455)
T 3v47_A 278 KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW---------GLTHLLKLNLSQNFLGSIDSRMFENLDK 348 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT---------TCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred eEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhc---------CcccCCEEECCCCccCCcChhHhcCccc
Confidence 345555422 233455666777777776654433322221111 2368999999999998888889999999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. .+..+.+.+|+-.|.
T Consensus 349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 99999999999998899999999999999999999886654433 456677888887664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.6e-08 Score=101.69 Aligned_cols=128 Identities=18% Similarity=0.145 Sum_probs=88.8
Q ss_pred EEEEEcCCCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.+.+..+.-..+ |..+..+..++.+.+..+....-.+.. -...++|+.|+|++|++++..+..++.+++|
T Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 179 (285)
T 1ozn_A 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT---------FRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179 (285)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT---------TTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred EEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH---------hccCCCccEEECCCCcccccCHHHhcCcccc
Confidence 344444332333 445666666666665443222111100 1124689999999999997666679999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. .+..+.+.+|+..|.
T Consensus 180 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 9999999999999999999999999999999999987665444 445677788876663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.63 E-value=5.9e-08 Score=95.05 Aligned_cols=96 Identities=23% Similarity=0.210 Sum_probs=73.7
Q ss_pred ceeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccC
Q 004935 258 AYLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331 (723)
Q Consensus 258 ~~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~ 331 (723)
.|.|.++.|+..+ ..+++|+.|+|++|++++..+..++.+++|+.|+|++|+|++..+..+..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 3789999997532 2346799999999999966556688999999999999999976666778899999999999
Q ss_pred CCCCCchhhccc---CccccccCCC
Q 004935 332 TIPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 332 n~~~g~~p~~~~---~~~~l~~~~n 353 (723)
|.+++..+..+. .+..+.+.+|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N 110 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTN 110 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcCCccCHhHhcCccCCCEEEcCCC
Confidence 998876654433 4445555555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.63 E-value=4.8e-08 Score=92.58 Aligned_cols=66 Identities=21% Similarity=0.188 Sum_probs=59.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++|+.|+|++|+|++..|..|+.|++|++|+|++|+|++..|..+.++++|+.|+|++|.++...+
T Consensus 54 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 54 TQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 589999999999996666668999999999999999998777789999999999999999987654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.62 E-value=3.1e-08 Score=115.89 Aligned_cols=112 Identities=11% Similarity=0.072 Sum_probs=91.3
Q ss_pred eEEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 220 KIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
...|.|..+.-..+|+.+..+..++.|.+..+... ..+..+.+ .++|+.|+|++|.|+ .||..|++|++
T Consensus 226 L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~---------l~~L~~L~Ls~N~l~-~lp~~~~~l~~ 294 (727)
T 4b8c_D 226 WHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKN---------LSNLRVLDLSHNRLT-SLPAELGSCFQ 294 (727)
T ss_dssp CCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG---------GTTCCEEECTTSCCS-SCCSSGGGGTT
T ss_pred CcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhC---------CCCCCEEeCcCCcCC-ccChhhcCCCC
Confidence 34466666666678888888888888887666444 33322211 257999999999999 89999999999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~ 343 (723)
|+.|+|++|+|+ .||..|++|++|+.|+|++|.++|.+|..+.
T Consensus 295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 295 LKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp CSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred CCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence 999999999997 8999999999999999999999999987764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.61 E-value=6.3e-08 Score=95.91 Aligned_cols=81 Identities=23% Similarity=0.168 Sum_probs=65.6
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC---cccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG---LLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~---~~~l~~ 350 (723)
++|+.|+|++|++++..|..|++|++|+.|+|++|+|++..+..+..+++|+.|+|++|.+++..|..+.. +..+.+
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 57899999999999888899999999999999999999555555788999999999999999887766543 444556
Q ss_pred CCCC
Q 004935 351 EGNP 354 (723)
Q Consensus 351 ~~n~ 354 (723)
.+|.
T Consensus 136 ~~N~ 139 (220)
T 2v9t_B 136 YDNK 139 (220)
T ss_dssp CSSC
T ss_pred CCCc
Confidence 6664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.60 E-value=8.9e-08 Score=96.83 Aligned_cols=124 Identities=19% Similarity=0.179 Sum_probs=88.0
Q ss_pred EEEEEcCCCCCcc-hhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESSTLP-PILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~lP-p~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.+.+..+.-..++ ..+..+..++.+.+..+......+..+ ...++|+.|+|++|+|++..|..|+.+++|
T Consensus 39 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 109 (251)
T 3m19_A 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF---------DDLTELGTLGLANNQLASLPLGVFDHLTQL 109 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT---------TTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred EEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh---------ccCCcCCEEECCCCcccccChhHhcccCCC
Confidence 3555553333343 457777777777765543333221111 123689999999999997777788999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
+.|+|++|+|++..|..+..+++|+.|+|++|.+++..+..+. ++..+.+.+|.
T Consensus 110 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 110 DKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 9999999999977777789999999999999999987765544 44456666664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=1.5e-08 Score=93.66 Aligned_cols=97 Identities=16% Similarity=0.203 Sum_probs=65.5
Q ss_pred CcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCc
Q 004935 232 TLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT 311 (723)
Q Consensus 232 ~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~ 311 (723)
.+|+.+..+..++.+.+..+.... + ..-...++|+.|+|++|++++.+|..++.+++|+.|+|++|+++
T Consensus 33 ~~~~~~~~l~~L~~L~l~~n~l~~--------~---~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~ 101 (149)
T 2je0_A 33 KLEGLTDEFEELEFLSTINVGLTS--------I---ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101 (149)
T ss_dssp BCCSCCTTCTTCCEEECTTSCCCC--------C---TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred HHHHHHhhcCCCcEEECcCCCCCC--------c---hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence 566666666666666554332221 1 00112357888888888888778887788888888888888887
Q ss_pred C-CCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 312 G-PVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 312 g-~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
+ ..|..++.+++|+.|+|++|.+++..+
T Consensus 102 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 102 DLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp SHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 6 345777888888888888887776544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.58 E-value=9.5e-08 Score=90.93 Aligned_cols=67 Identities=19% Similarity=0.167 Sum_probs=58.1
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
.++|+.|+|++|+|++-.+..|++|++|+.|+|++|+|++..|..+..+++|+.|+|++|.+....+
T Consensus 56 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 56 LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 3689999999999997444557999999999999999997666679999999999999999986543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5.4e-08 Score=110.41 Aligned_cols=78 Identities=27% Similarity=0.365 Sum_probs=60.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCch-hhcccC---ccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLI-EKQKNG---LLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~-p~~~~~---~~~l~ 349 (723)
++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|++ || .+++|++|+.|+|++|.+++.+ |..+.. +..+.
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 46888888888888 788888888888888888888886 77 7888888888888888888876 666553 34455
Q ss_pred cCCCC
Q 004935 350 VEGNP 354 (723)
Q Consensus 350 ~~~n~ 354 (723)
+.+|+
T Consensus 540 L~~N~ 544 (567)
T 1dce_A 540 LQGNS 544 (567)
T ss_dssp CTTSG
T ss_pred ecCCc
Confidence 66664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.55 E-value=9.7e-08 Score=97.70 Aligned_cols=62 Identities=24% Similarity=0.237 Sum_probs=26.6
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
+|+.|+|++|++++..+..|+.+++|+.|+|++|++++..|..+.++++|+.|+|++|.+++
T Consensus 134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence 44444444444443222234444444444444444444333334444444444444444443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.55 E-value=1.6e-07 Score=96.06 Aligned_cols=123 Identities=17% Similarity=0.138 Sum_probs=82.2
Q ss_pred EEEEEcCCCCCcchh-hhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESSTLPPI-LNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~-inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.+.+..+.-..+|+. +..+..++.+.+..+....-.+.. -...++|+.|+|++|++++..|..|+.+++|
T Consensus 65 ~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 135 (270)
T 2o6q_A 65 LLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGV---------FDQLVNLAELRLDRNQLKSLPPRVFDSLTKL 135 (270)
T ss_dssp EEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTT---------TTTCSSCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred EEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhH---------cccccCCCEEECCCCccCeeCHHHhCcCcCC
Confidence 355544433445543 355666666655433222111100 0123579999999999998777788999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n 353 (723)
+.|+|++|+|++..+..+..+++|+.|+|++|.+++..+..+. .+..+.+.+|
T Consensus 136 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 136 TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 9999999999976666788999999999999988886665443 3445556666
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.54 E-value=1.6e-07 Score=91.26 Aligned_cols=121 Identities=19% Similarity=0.123 Sum_probs=73.2
Q ss_pred EEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
.+.+..+.. +.++.+..+..++.+.+..+......+..+. ..++|+.|+|++|++++.+|..++.+++|+
T Consensus 70 ~L~l~~n~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~---------~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 139 (197)
T 4ezg_A 70 DLTINNIHA-TNYNPISGLSNLERLRIMGKDVTSDKIPNLS---------GLTSLTLLDISHSAHDDSILTKINTLPKVN 139 (197)
T ss_dssp EEEEESCCC-SCCGGGTTCTTCCEEEEECTTCBGGGSCCCT---------TCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred EEEccCCCC-CcchhhhcCCCCCEEEeECCccCcccChhhc---------CCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence 355555422 2334555666666665544333221121111 235788888888888887888888888888
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh-cccCccccccCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK-QKNGLLSLSVEGN 353 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~-~~~~~~~l~~~~n 353 (723)
.|+|++|++.+.+| .+..+++|+.|+|++|.+++..+. .+.++..+.+.+|
T Consensus 140 ~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 140 SIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC
T ss_pred EEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCc
Confidence 88888887555676 577888888888888887764321 1223444455555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.54 E-value=5.8e-08 Score=91.62 Aligned_cols=98 Identities=18% Similarity=0.198 Sum_probs=76.2
Q ss_pred CCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcC
Q 004935 231 STLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNL 310 (723)
Q Consensus 231 s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l 310 (723)
+.+|..+..+..++.+.+..+..... ..-...++|+.|+|++|++++.+|..++++++|+.|+|++|++
T Consensus 39 ~~i~~~~~~l~~L~~L~l~~n~l~~~-----------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 107 (168)
T 2ell_A 39 GKIEGLTAEFVNLEFLSLINVGLISV-----------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107 (168)
T ss_dssp TBCSSCCGGGGGCCEEEEESSCCCCC-----------SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSC
T ss_pred hhHHHHHHhCCCCCEEeCcCCCCCCh-----------hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCcc
Confidence 36777777777777776654432221 0111346899999999999999999999999999999999999
Q ss_pred cCC-CCccCCCCCCCcEEEccCCCCCCchh
Q 004935 311 TGP-VPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 311 ~g~-iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++. .+..+..+++|+.|+|++|.+++..+
T Consensus 108 ~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 108 KDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred CcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 974 33789999999999999999987655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.6e-07 Score=86.52 Aligned_cols=66 Identities=23% Similarity=0.266 Sum_probs=42.8
Q ss_pred CceEEEEcCCCccc-ccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc
Q 004935 274 PRITSLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ 341 (723)
Q Consensus 274 ~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~ 341 (723)
++++.|+|++|+++ |.+|..++.+++|+.|+|++|++++. ..++++++|+.|+|++|.+++.+|..
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~ 83 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVL 83 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHH
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHH
Confidence 45666666666666 66666666666666666666666654 55666666666666666666655544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=8.1e-08 Score=110.17 Aligned_cols=84 Identities=23% Similarity=0.178 Sum_probs=59.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc----Cccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN----GLLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~----~~~~l~ 349 (723)
++|+.|+|++|++++.+|..+++|++|+.|+|++|++++.+|..++++++|+.|+|++|.++ .+|..+. .+..+.
T Consensus 473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~ 551 (606)
T 3vq2_A 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFN 551 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEE
T ss_pred CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEE
Confidence 56777777777777777777777777777777777777777777777777777777777777 3444332 244566
Q ss_pred cCCCCCCCC
Q 004935 350 VEGNPDLCP 358 (723)
Q Consensus 350 ~~~n~~lc~ 358 (723)
+.+|+..|.
T Consensus 552 l~~N~~~c~ 560 (606)
T 3vq2_A 552 LTNNSVACI 560 (606)
T ss_dssp CCSCCCCCS
T ss_pred ccCCCcccC
Confidence 777777664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.50 E-value=9.4e-08 Score=96.77 Aligned_cols=72 Identities=13% Similarity=0.077 Sum_probs=56.3
Q ss_pred cccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCce--eeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 435 GNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL--TTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 435 G~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+.|..+.||+.... +..+++|+..... ...+..|+++++.+++.++ .+++++....+..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 35566999999774 5679999976542 2457899999999965554 55888888888889999999998874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.50 E-value=1e-07 Score=99.31 Aligned_cols=84 Identities=21% Similarity=0.163 Sum_probs=56.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC----ccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG----LLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~----~~~l~ 349 (723)
++|+.|+|++|++++..|..++.+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++..|..+.. +..+.
T Consensus 175 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~ 254 (306)
T 2z66_A 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254 (306)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEE
T ss_pred cCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEE
Confidence 46777777777777766777777777777777777777666666777777777777777777766654432 33455
Q ss_pred cCCCCCCC
Q 004935 350 VEGNPDLC 357 (723)
Q Consensus 350 ~~~n~~lc 357 (723)
+.+|+-.|
T Consensus 255 L~~N~~~~ 262 (306)
T 2z66_A 255 LTQNDFAC 262 (306)
T ss_dssp CTTCCEEC
T ss_pred ccCCCeec
Confidence 56665444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.8e-07 Score=90.77 Aligned_cols=119 Identities=15% Similarity=0.172 Sum_probs=85.0
Q ss_pred EEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
.+.+..+.-..+| .+..+..++.+.+..+ ...+...+ ...++|+.|+|++|++++..|..++.|++|+
T Consensus 48 ~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n--~~~~~~~l---------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 48 YITLANINVTDLT-GIEYAHNIKDLTINNI--HATNYNPI---------SGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp EEEEESSCCSCCT-TGGGCTTCSEEEEESC--CCSCCGGG---------TTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred EEeccCCCccChH-HHhcCCCCCEEEccCC--CCCcchhh---------hcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3455554444555 4666666676665544 11111111 1236899999999999999999999999999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n 353 (723)
.|+|++|++++.+|..++++++|+.|+|++|...+.+| .+. .+..+.+.+|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD 169 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTB
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCC
Confidence 99999999999999999999999999999998444444 232 3445555555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.4e-07 Score=107.14 Aligned_cols=75 Identities=23% Similarity=0.310 Sum_probs=63.3
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVE 351 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~ 351 (723)
.|+.|+|++|+|++ ||. |++|++|+.|+|++|+|+ .||..+++|++|+.|+|++|.+++ +| .+. ++..|.++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999997 787 999999999999999999 899999999999999999999998 56 444 34455666
Q ss_pred CCC
Q 004935 352 GNP 354 (723)
Q Consensus 352 ~n~ 354 (723)
+|.
T Consensus 517 ~N~ 519 (567)
T 1dce_A 517 NNR 519 (567)
T ss_dssp SSC
T ss_pred CCC
Confidence 664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.48 E-value=1.7e-07 Score=103.06 Aligned_cols=87 Identities=18% Similarity=0.144 Sum_probs=76.6
Q ss_pred CCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
..++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. .+..+
T Consensus 205 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 284 (440)
T 3zyj_A 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284 (440)
T ss_dssp TCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEE
T ss_pred CCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEE
Confidence 346899999999999999899999999999999999999999999999999999999999999987665543 45667
Q ss_pred ccCCCCCCCC
Q 004935 349 SVEGNPDLCP 358 (723)
Q Consensus 349 ~~~~n~~lc~ 358 (723)
.+.+|+..|.
T Consensus 285 ~L~~Np~~Cd 294 (440)
T 3zyj_A 285 HLHHNPWNCN 294 (440)
T ss_dssp ECCSSCEECS
T ss_pred EcCCCCccCC
Confidence 8899998874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.2e-07 Score=108.69 Aligned_cols=84 Identities=24% Similarity=0.237 Sum_probs=69.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|++++.+|..|+.+++|+.|+|++|++++.+|..+.++++| .|+|++|.+++..|..+. .+..+.+
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 578889999999988888888999999999999999998888888888888 899999988887776543 5566778
Q ss_pred CCCCCCCC
Q 004935 351 EGNPDLCP 358 (723)
Q Consensus 351 ~~n~~lc~ 358 (723)
.+|+..|.
T Consensus 555 ~~N~~~c~ 562 (606)
T 3t6q_A 555 RQNPLDCT 562 (606)
T ss_dssp TTCCEECS
T ss_pred CCCCcccc
Confidence 88887663
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.47 E-value=1.8e-07 Score=103.20 Aligned_cols=87 Identities=21% Similarity=0.161 Sum_probs=76.5
Q ss_pred CCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
..++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+..+. ++..+
T Consensus 216 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 295 (452)
T 3zyi_A 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295 (452)
T ss_dssp TCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEE
T ss_pred ccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEE
Confidence 346899999999999999999999999999999999999999999999999999999999999977665443 45667
Q ss_pred ccCCCCCCCC
Q 004935 349 SVEGNPDLCP 358 (723)
Q Consensus 349 ~~~~n~~lc~ 358 (723)
.+.+|+..|.
T Consensus 296 ~L~~Np~~Cd 305 (452)
T 3zyi_A 296 HLHHNPWNCD 305 (452)
T ss_dssp ECCSSCEECS
T ss_pred EccCCCcCCC
Confidence 8899988774
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.47 E-value=4.7e-08 Score=116.76 Aligned_cols=84 Identities=20% Similarity=0.130 Sum_probs=76.0
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccccccCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEG 352 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~ 352 (723)
.++|+.|+|++|+|++.+|..|+.|++|+.|+|++|+|++..|..+. ++|+.|+|++|.+++.+|..+.++..+.+.+
T Consensus 479 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~ 556 (844)
T 3j0a_A 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITH 556 (844)
T ss_dssp BCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEE
T ss_pred cccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecC
Confidence 47899999999999998888899999999999999999987776665 8999999999999999999888888889999
Q ss_pred CCCCCC
Q 004935 353 NPDLCP 358 (723)
Q Consensus 353 n~~lc~ 358 (723)
|+..|.
T Consensus 557 Np~~C~ 562 (844)
T 3j0a_A 557 NKFICE 562 (844)
T ss_dssp ECCCCS
T ss_pred CCcccc
Confidence 998883
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-07 Score=101.97 Aligned_cols=127 Identities=19% Similarity=0.193 Sum_probs=80.2
Q ss_pred EEEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.|.|..+.-..+|+ .+..+..++.|.+..+....-.+..+ ...++|+.|+|++|+|++..|..|+.|++|
T Consensus 68 ~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 138 (361)
T 2xot_A 68 SLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLF---------SDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT---------TTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred EEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHh---------CCCcCCCEEECCCCcccEECHHHhCCcccC
Confidence 34554443344443 45666666666654443222111111 123578888888888888778888888888
Q ss_pred CeeeCcCCcCcCCCCcc-C---CCCCCCcEEEccCCCCCCchhhcccCc-----cccccCCCCCCCC
Q 004935 301 QILDLSNNNLTGPVPDF-L---SQLPFLTELNLKGTIPNGLIEKQKNGL-----LSLSVEGNPDLCP 358 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~-l---~~l~~L~~l~l~~n~~~g~~p~~~~~~-----~~l~~~~n~~lc~ 358 (723)
+.|+|++|+|++ +|.. + ..+++|+.|+|++|.+++..+..+..+ ..+.+.+|+..|.
T Consensus 139 ~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 139 QKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 888888888886 5544 3 568888888888888887554443332 3467778877663
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.47 E-value=3.3e-07 Score=93.77 Aligned_cols=111 Identities=19% Similarity=0.116 Sum_probs=79.5
Q ss_pred hhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCC
Q 004935 235 PILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPV 314 (723)
Q Consensus 235 p~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~i 314 (723)
+.+..+..++.+.+..+... ++.... -...++|+.|+|++|++++..|..++++++|+.|+|++|++++..
T Consensus 79 ~~l~~l~~L~~L~L~~n~l~--------~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 149 (272)
T 3rfs_A 79 SALKELTNLTYLILTGNQLQ--------SLPNGV-FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP 149 (272)
T ss_dssp GGGTTCTTCCEEECTTSCCC--------CCCTTT-TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred hhhcCCCCCCEEECCCCccC--------ccChhH-hcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccC
Confidence 35556666666665443222 221110 012368999999999999777777899999999999999999877
Q ss_pred CccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCC
Q 004935 315 PDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 315 P~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
|..++.+++|+.|+|++|.+++..+..+. .+..+.+.+|.
T Consensus 150 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 150 KGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred HHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 77889999999999999999987765443 44555666664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.2e-07 Score=107.80 Aligned_cols=86 Identities=19% Similarity=0.269 Sum_probs=63.0
Q ss_pred CCceEEEEcCCCccc-ccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 273 PPRITSLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
.++|+.|+|++|.++ |.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|++|.+++..|..+. .+..+
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 357778888888877 67777788888888888888888877777788888888888888887776665443 34455
Q ss_pred ccCCCCCCCC
Q 004935 349 SVEGNPDLCP 358 (723)
Q Consensus 349 ~~~~n~~lc~ 358 (723)
.+.+|+-.|.
T Consensus 524 ~l~~N~~~~~ 533 (570)
T 2z63_A 524 WLHTNPWDCS 533 (570)
T ss_dssp ECCSSCBCCC
T ss_pred EecCCcccCC
Confidence 6677766553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-07 Score=99.67 Aligned_cols=97 Identities=18% Similarity=0.066 Sum_probs=72.3
Q ss_pred Ccchhhhhhhhhhhhcccc-ccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcC
Q 004935 232 TLPPILNAYEIYRAKEFLQ-FLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNL 310 (723)
Q Consensus 232 ~lPp~inale~~~~~~~~~-~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l 310 (723)
.+|+ |..+..++.|.+.. +...+-.+..+. ..++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|
T Consensus 23 ~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~---------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 92 (347)
T 2ifg_A 23 SLHH-LPGAENLTELYIENQQHLQHLELRDLR---------GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (347)
T ss_dssp TTTT-SCSCSCCSEEECCSCSSCCEECGGGSC---------SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred ccCC-CCCCCCeeEEEccCCCCCCCcChhHhc---------cccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcc
Confidence 4676 77777677776653 333322221121 236899999999999999999999999999999999999
Q ss_pred cCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 311 TGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 311 ~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++..|..+..++ |+.|+|++|.+.....
T Consensus 93 ~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 93 ESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred ceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 975555555555 9999999999986543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.45 E-value=8.2e-08 Score=112.35 Aligned_cols=109 Identities=21% Similarity=0.234 Sum_probs=80.4
Q ss_pred cchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcC
Q 004935 233 LPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG 312 (723)
Q Consensus 233 lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g 312 (723)
.|..+..+..++.|.+..+... ..+..+. ..++|+.|+|++|.|+ .||+.|++|++|++|+|++|+|+
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---------~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIF---------KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGG---------GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhc---------CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 4556666777777776554333 2221111 2357999999999999 99999999999999999999999
Q ss_pred CCCccCCCCCCCcEEEccCCCCCCchhhcccC---ccccccCCCC
Q 004935 313 PVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG---LLSLSVEGNP 354 (723)
Q Consensus 313 ~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~---~~~l~~~~n~ 354 (723)
.||..+++|++|+.|+|++|.++ .+|..+.. +..|.+.+|.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 89999999999999999999997 67776654 4455666665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.7e-07 Score=98.67 Aligned_cols=122 Identities=16% Similarity=0.117 Sum_probs=78.8
Q ss_pred EEEEcCCCCCcchh-hh-hhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 223 FSINTTESSTLPPI-LN-AYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 223 lsl~~~~~s~lPp~-in-ale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
|.|..+.-..+|+. +. .+..++.+.+..+....-.+..+ ...++|+.|+|++|+|++..+..|..|++|
T Consensus 44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~---------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 114 (361)
T 2xot_A 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF---------VPVPNLRYLDLSSNHLHTLDEFLFSDLQAL 114 (361)
T ss_dssp EECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT---------TTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred EECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc---------cCCCCCCEEECCCCcCCcCCHHHhCCCcCC
Confidence 44444333444443 22 55666666654443222111111 123578899999999887666778889999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc------cCccccccCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK------NGLLSLSVEGN 353 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~------~~~~~l~~~~n 353 (723)
+.|+|++|++++..|..+..+++|+.|+|++|.+++..+..+ ..+..|.+.+|
T Consensus 115 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N 173 (361)
T 2xot_A 115 EVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred CEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence 999999999988888888889999999999988887544332 23444555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2.2e-07 Score=87.59 Aligned_cols=80 Identities=25% Similarity=0.361 Sum_probs=57.1
Q ss_pred CCCceEEEEcCCCccc-ccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Cccc
Q 004935 272 DPPRITSLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLS 347 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~ 347 (723)
.+++|+.|+|++|+++ |.||..++.+++|+.|+|++|++++. ..++.+++|+.|+|++|.+++.+|..+. .+..
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3457788888888887 77877778888888888888887765 6677778888888888887776555432 4444
Q ss_pred cccCCC
Q 004935 348 LSVEGN 353 (723)
Q Consensus 348 l~~~~n 353 (723)
+.+.+|
T Consensus 100 L~Ls~N 105 (168)
T 2ell_A 100 LNLSGN 105 (168)
T ss_dssp EECBSS
T ss_pred EeccCC
Confidence 555555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=3e-07 Score=103.97 Aligned_cols=96 Identities=22% Similarity=0.178 Sum_probs=68.3
Q ss_pred ceeecCccCCCC--------CCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEc
Q 004935 258 AYLWQGLNCSYP--------EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329 (723)
Q Consensus 258 ~~~w~g~~c~~~--------~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l 329 (723)
.|.|.|+ |.-. ...+++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..++++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4667776 5421 112357888888888888777778888888888888888888877778888888888888
Q ss_pred cCCCCCCchhhccc---CccccccCCCC
Q 004935 330 KGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 330 ~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
++|.+++..|..+. .+..+...+|.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCc
Confidence 88888877766444 33444555553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.38 E-value=4.6e-07 Score=93.74 Aligned_cols=80 Identities=26% Similarity=0.274 Sum_probs=47.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|+|++..|..|+.|++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++..+..+. ++..+.+
T Consensus 100 ~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 179 (290)
T 1p9a_G 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179 (290)
T ss_dssp TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEEC
Confidence 4566666666666655555666666666666666666655555566666666677666666654433222 3334444
Q ss_pred CCC
Q 004935 351 EGN 353 (723)
Q Consensus 351 ~~n 353 (723)
.+|
T Consensus 180 ~~N 182 (290)
T 1p9a_G 180 QEN 182 (290)
T ss_dssp CSS
T ss_pred CCC
Confidence 444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.38 E-value=1.9e-07 Score=97.66 Aligned_cols=129 Identities=17% Similarity=0.169 Sum_probs=71.7
Q ss_pred EEEEEEc-CCCCCcchhh--hhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCC
Q 004935 221 IEFSINT-TESSTLPPIL--NAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTL 297 (723)
Q Consensus 221 ~~lsl~~-~~~s~lPp~i--nale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l 297 (723)
..+.+.. ...+.+|..+ ..+..++.+.+..+...+. +..+.++.- ..+++|+.|+|++|++++..|..|+++
T Consensus 98 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~----~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQ----WLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp CEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT----TCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHH----hhcCCCcEEEeeCCCCccchHHHhccC
Confidence 3455555 3334556554 5666666666554443332 211111100 012467777777777776666777777
Q ss_pred CCCCeeeCcCCcCcCC--CCccC--CCCCCCcEEEccCCCCCC--chhhcc----cCccccccCCCC
Q 004935 298 TSIQILDLSNNNLTGP--VPDFL--SQLPFLTELNLKGTIPNG--LIEKQK----NGLLSLSVEGNP 354 (723)
Q Consensus 298 ~~L~~L~ls~N~l~g~--iP~~l--~~l~~L~~l~l~~n~~~g--~~p~~~----~~~~~l~~~~n~ 354 (723)
++|+.|+|++|+++|. +|..+ +++++|+.|+|++|.+++ .++..+ ..+..+.+++|.
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 7777777777777665 33344 677777777777777764 222221 244555555553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=4.9e-07 Score=92.59 Aligned_cols=63 Identities=24% Similarity=0.210 Sum_probs=35.7
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..+..++++++|+.|+|++|.+++
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence 355555555555555555555555555555555555555444455555555555555555554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.37 E-value=2.5e-07 Score=96.28 Aligned_cols=82 Identities=20% Similarity=0.180 Sum_probs=68.0
Q ss_pred CCceEEEEcCCCcccc-cCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 273 PPRITSLNLSSSGIAG-DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
.++|+.|+|++|.+++ .+|..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+..+. .+..+
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 3689999999999988 6788899999999999999999998899999999999999999999886654443 44556
Q ss_pred ccCCCC
Q 004935 349 SVEGNP 354 (723)
Q Consensus 349 ~~~~n~ 354 (723)
.+.+|.
T Consensus 229 ~L~~N~ 234 (306)
T 2z66_A 229 DYSLNH 234 (306)
T ss_dssp ECTTSC
T ss_pred ECCCCC
Confidence 666664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=5.6e-07 Score=92.64 Aligned_cols=123 Identities=12% Similarity=0.085 Sum_probs=74.8
Q ss_pred EEEEEcCC-CCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 222 EFSINTTE-SSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 222 ~lsl~~~~-~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
.+.+..+. -..+ |..+..+..++.+.+..+......+.. -...++|+.|+|++|++++..+..++.+++
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 154 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL---------FRGLAALQYLYLQDNALQALPDDTFRDLGN 154 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhH---------hhCCcCCCEEECCCCcccccCHhHhccCCC
Confidence 34444432 2333 455666666666655443222211100 012357888888888887655566788888
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC---ccccccCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG---LLSLSVEGN 353 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~---~~~l~~~~n 353 (723)
|+.|+|++|++++..+..+..+++|+.|+|++|.+++..|..+.. +..+.+.+|
T Consensus 155 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 888888888888665666777888888888888887776665543 334445555
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.7e-07 Score=103.98 Aligned_cols=63 Identities=24% Similarity=0.210 Sum_probs=32.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|+|++-.|..|++|++|++|+|++|+|++..|..+++|++|+.|+|++|.+++
T Consensus 100 ~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~ 162 (635)
T 4g8a_A 100 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 162 (635)
T ss_dssp TTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcccc
Confidence 345555555555554333445555555555555555554444445555555555555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.35 E-value=1.2e-07 Score=105.78 Aligned_cols=32 Identities=16% Similarity=0.101 Sum_probs=26.1
Q ss_pred hhHHHHHHHHHHHHhccCCceeeEEEEEecCC
Q 004935 463 QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT 494 (723)
Q Consensus 463 ~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 494 (723)
.+.++|..|++.+++++|+|+|+++|||....
T Consensus 321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 321 QGSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred ccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 34578999999999999999999999997654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.35 E-value=5.5e-07 Score=103.11 Aligned_cols=80 Identities=21% Similarity=0.176 Sum_probs=54.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccccccCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGN 353 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~n 353 (723)
++|+.|+|++|.|++..|..|++|++|+.|+|++|+|++..|..++++++|+.|+|++|.+++..+..+..+..+.+.+|
T Consensus 123 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 56777888888777433333577788888888888887777777777788888888877777654444444444444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=8e-07 Score=93.59 Aligned_cols=62 Identities=21% Similarity=0.291 Sum_probs=30.7
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
+|+.|+|++|.+++..|..++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+++.
T Consensus 217 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred CCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCcc
Confidence 4445555555555444444555555555555555554 4444444555555555555544443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.8e-07 Score=100.52 Aligned_cols=113 Identities=13% Similarity=0.132 Sum_probs=87.3
Q ss_pred ceEEEEEEcCCCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCC
Q 004935 219 EKIEFSINTTESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTL 297 (723)
Q Consensus 219 ~~~~lsl~~~~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l 297 (723)
....+.+..+.-..+ |..+..+..++.+.+..+......+..+. ..++|+.|+|++|++++.+|..|+.+
T Consensus 300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE---------NLDKLEVLDLSYNHIRALGDQSFLGL 370 (455)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGT---------TCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhc---------CcccCCEEECCCCcccccChhhcccc
Confidence 344566666444444 45777788888887765544332222221 23689999999999999999999999
Q ss_pred CCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 298 TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 298 ~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++.+|.
T Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 9999999999999986667789999999999999999998884
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=5.5e-07 Score=103.17 Aligned_cols=114 Identities=11% Similarity=0.103 Sum_probs=73.2
Q ss_pred EEEEEEcCCCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 221 IEFSINTTESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 221 ~~lsl~~~~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
..+.+..+.-..+ |..+..+..++.+.+..+......+..+. ..++|+.|+|++|++++..|..+++|++
T Consensus 59 ~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~---------~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 129 (606)
T 3vq2_A 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFS---------GLTSLENLVAVETKLASLESFPIGQLIT 129 (606)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSST---------TCTTCCEEECTTSCCCCSSSSCCTTCTT
T ss_pred cEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcC---------CcccCCEEEccCCccccccccccCCCCC
Confidence 3355544333333 34556666666666544433322222111 2356888888888888766677888888
Q ss_pred CCeeeCcCCcCcC-CCCccCCCCCCCcEEEccCCCCCCchhhccc
Q 004935 300 IQILDLSNNNLTG-PVPDFLSQLPFLTELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 300 L~~L~ls~N~l~g-~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~ 343 (723)
|++|+|++|++++ .+|..++++++|+.|+|++|.+++..|..+.
T Consensus 130 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 174 (606)
T 3vq2_A 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174 (606)
T ss_dssp CCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred CCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh
Confidence 8888888888875 6788888888888888888888776665443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.32 E-value=4.8e-07 Score=103.62 Aligned_cols=123 Identities=15% Similarity=0.225 Sum_probs=87.9
Q ss_pred EEEEcCCCCCcchh-hhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 223 FSINTTESSTLPPI-LNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 223 lsl~~~~~s~lPp~-inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
+.+....-+.+|+. +..+..++.+.+..+......+..+ ...++|+.|+|++|.+++..|..|++|++|+
T Consensus 56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 126 (597)
T 3oja_B 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF---------AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126 (597)
T ss_dssp EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTT---------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHh---------cCCCCCCEEECCCCcCCCCCHHHHcCCCCCC
Confidence 44444334445554 5667777777665443322111111 1246899999999999998888899999999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC---ccccccCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG---LLSLSVEGNP 354 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~---~~~l~~~~n~ 354 (723)
+|+|++|+|++..|..++++++|+.|+|++|.+++..|..+.. +..|.+.+|.
T Consensus 127 ~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182 (597)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCC
Confidence 9999999999655556799999999999999999988876653 4445566663
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.3e-07 Score=93.01 Aligned_cols=67 Identities=18% Similarity=0.279 Sum_probs=41.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcC-CCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|++++..+..++++++|+.|+|++|++++ .+|..++++++|+.|+|++|.+++..+.
T Consensus 100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 456666666666665555456666666666666666665 3566666666666666666666654443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1e-06 Score=92.72 Aligned_cols=95 Identities=22% Similarity=0.240 Sum_probs=75.5
Q ss_pred ceeecCccCCCC------CCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccC
Q 004935 258 AYLWQGLNCSYP------EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331 (723)
Q Consensus 258 ~~~w~g~~c~~~------~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~ 331 (723)
.|.|..+.|+.. ...++.++.|+|++|++++..+..|+++++|++|+|++|++++..|..++++++|+.|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 356777777642 22456899999999999987777899999999999999999998899999999999999999
Q ss_pred CCCCCchhhcc-cCccccccCCC
Q 004935 332 TIPNGLIEKQK-NGLLSLSVEGN 353 (723)
Q Consensus 332 n~~~g~~p~~~-~~~~~l~~~~n 353 (723)
|.++. +|..+ ..+..+.+.+|
T Consensus 110 n~l~~-l~~~~~~~L~~L~l~~n 131 (330)
T 1xku_A 110 NQLKE-LPEKMPKTLQELRVHEN 131 (330)
T ss_dssp SCCSB-CCSSCCTTCCEEECCSS
T ss_pred CcCCc-cChhhcccccEEECCCC
Confidence 99874 44333 34555555555
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=8.2e-07 Score=98.59 Aligned_cols=85 Identities=26% Similarity=0.289 Sum_probs=71.7
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. .+..+.+
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 5799999999999987778899999999999999999998899999999999999999999887665543 4556778
Q ss_pred CCCCCCCC
Q 004935 351 EGNPDLCP 358 (723)
Q Consensus 351 ~~n~~lc~ 358 (723)
.+|+-.|.
T Consensus 328 ~~N~l~c~ 335 (477)
T 2id5_A 328 DSNPLACD 335 (477)
T ss_dssp CSSCEECS
T ss_pred cCCCccCc
Confidence 88887664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=1e-06 Score=99.00 Aligned_cols=67 Identities=18% Similarity=0.218 Sum_probs=45.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcC--CCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG--PVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+|..++++++|+.|+|++|.+++.+|.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~ 392 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence 466677777777776667667777777777777777765 5666666667777777777766665554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=6e-07 Score=93.74 Aligned_cols=76 Identities=25% Similarity=0.319 Sum_probs=36.5
Q ss_pred ceEEEEcCCCcccccCcccccCC---CCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC-chhhcccCcccccc
Q 004935 275 RITSLNLSSSGIAGDIAPYISTL---TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG-LIEKQKNGLLSLSV 350 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l---~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g-~~p~~~~~~~~l~~ 350 (723)
+|+.|+|++|+|++.+|+.++.+ ++|+.|+|++|+|+ .||..+. ++|+.|+|++|.+++ +.+..+..+..+.+
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L 301 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLTL 301 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEEC
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEEC
Confidence 44555555555555555544444 35555555555555 4454443 455555555555554 23333333344444
Q ss_pred CCC
Q 004935 351 EGN 353 (723)
Q Consensus 351 ~~n 353 (723)
.+|
T Consensus 302 ~~N 304 (310)
T 4glp_A 302 DGN 304 (310)
T ss_dssp SST
T ss_pred cCC
Confidence 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.29 E-value=3.1e-06 Score=96.09 Aligned_cols=67 Identities=22% Similarity=0.193 Sum_probs=42.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcC--CCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTG--PVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+|..++++++|+.|+|++|.+++.+|.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 421 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh
Confidence 456666666666666666666666666666666666665 3445566666666666666666654443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.28 E-value=1e-06 Score=92.89 Aligned_cols=95 Identities=21% Similarity=0.181 Sum_probs=75.2
Q ss_pred eeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 259 YLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 259 ~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|.|..+.|+... ..++.++.|+|++|++++..|..|+++++|+.|+|++|++++..|..++++++|+.|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 567777776432 23468999999999999877889999999999999999999988999999999999999999
Q ss_pred CCCCchhhcc-cCccccccCCCC
Q 004935 333 IPNGLIEKQK-NGLLSLSVEGNP 354 (723)
Q Consensus 333 ~~~g~~p~~~-~~~~~l~~~~n~ 354 (723)
.++. +|..+ ..+..+.+.+|.
T Consensus 113 ~l~~-l~~~~~~~L~~L~l~~n~ 134 (332)
T 2ft3_A 113 HLVE-IPPNLPSSLVELRIHDNR 134 (332)
T ss_dssp CCCS-CCSSCCTTCCEEECCSSC
T ss_pred cCCc-cCccccccCCEEECCCCc
Confidence 9884 44333 345556666653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.28 E-value=7e-07 Score=95.34 Aligned_cols=78 Identities=12% Similarity=0.188 Sum_probs=58.3
Q ss_pred hhccccCcEEEEEEEECCceEEEEEec--CCC-hhhHHHHHHHHHHHHhcc--CCceeeEEEEEecC---CceEEEEEeC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLS--PSS-AQGYKQFQAEVELLMRIH--HKNLTTLVGYCDEG---TNRGLIYEFM 503 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~Ey~ 503 (723)
+.|+.|.++.||+....++.+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 468899999999999888899999876 432 123457889999999997 45678899998776 4589999999
Q ss_pred CCCCHH
Q 004935 504 ANGNLQ 509 (723)
Q Consensus 504 ~~gsL~ 509 (723)
++..+.
T Consensus 124 ~G~~l~ 129 (359)
T 3dxp_A 124 SGRVLW 129 (359)
T ss_dssp CCBCCC
T ss_pred CCeecC
Confidence 988773
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.27 E-value=4.8e-07 Score=94.57 Aligned_cols=62 Identities=26% Similarity=0.261 Sum_probs=30.4
Q ss_pred CceEEEEcCCCcccc--cCccc-ccCCCCCCeeeCcCCcCcCCCC-ccCCCCCCCcEEEccCCCCC
Q 004935 274 PRITSLNLSSSGIAG--DIAPY-ISTLTSIQILDLSNNNLTGPVP-DFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g--~ip~~-~~~l~~L~~L~ls~N~l~g~iP-~~l~~l~~L~~l~l~~n~~~ 335 (723)
++|+.|+|++|++++ .+|.. +.++++|+.|+|++|++++.+| ..+..+++|+.|+|++|.++
T Consensus 201 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 345555555555552 23322 2445555555555555555544 23334555555555555554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=8e-07 Score=106.10 Aligned_cols=125 Identities=14% Similarity=0.113 Sum_probs=87.9
Q ss_pred eEEEEEEcC-CCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCccc--cc
Q 004935 220 KIEFSINTT-ESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPY--IS 295 (723)
Q Consensus 220 ~~~lsl~~~-~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~--~~ 295 (723)
...+.+..+ ..+.+ |..+..+..++.+.+..+......+..+. ..++|+.|+|++|++++.+|.. |+
T Consensus 50 L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~---------~l~~L~~L~Ls~n~l~~~~~~~~~~~ 120 (844)
T 3j0a_A 50 LQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ---------GLFHLFELRLYFCGLSDAVLKDGYFR 120 (844)
T ss_dssp CSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC---------SCSSCCCEECTTCCCSSCCSTTCCCS
T ss_pred CeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc---------CCcccCEeeCcCCCCCcccccCcccc
Confidence 344666554 34455 55677777777777665544333332222 2357899999999999888876 89
Q ss_pred CCCCCCeeeCcCCcCcCCCC-ccCCCCCCCcEEEccCCCCCCchhhccc-----CccccccCCC
Q 004935 296 TLTSIQILDLSNNNLTGPVP-DFLSQLPFLTELNLKGTIPNGLIEKQKN-----GLLSLSVEGN 353 (723)
Q Consensus 296 ~l~~L~~L~ls~N~l~g~iP-~~l~~l~~L~~l~l~~n~~~g~~p~~~~-----~~~~l~~~~n 353 (723)
+|++|+.|+|++|++++..| ..+++|++|+.|+|++|.+++..|..+. .+..+.+.+|
T Consensus 121 ~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n 184 (844)
T 3j0a_A 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184 (844)
T ss_dssp SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCS
T ss_pred ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCC
Confidence 99999999999999988765 5788999999999999998887776543 3444555555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-06 Score=93.19 Aligned_cols=99 Identities=23% Similarity=0.210 Sum_probs=78.2
Q ss_pred CCCceeecCccCCCC--------CCCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcE
Q 004935 255 QQDAYLWQGLNCSYP--------EYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTE 326 (723)
Q Consensus 255 ~~~~~~w~g~~c~~~--------~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~ 326 (723)
....|.|.|+ |.-. ...+++|+.|+|++|++++..+..++++++|+.|+|++|++++..|..++++++|++
T Consensus 26 ~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 26 ASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp -CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 3456888887 4321 123458999999999999766668999999999999999999988999999999999
Q ss_pred EEccCCCCCCchhhccc---CccccccCCCC
Q 004935 327 LNLKGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 327 l~l~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
|+|++|.+++..+..+. ++..+.+.+|.
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 135 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 135 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCC
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCC
Confidence 99999999986655343 45566667764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.1e-06 Score=99.79 Aligned_cols=85 Identities=27% Similarity=0.345 Sum_probs=74.1
Q ss_pred CCceEEEEcCCCcccccCcc-cccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc----ccCccc
Q 004935 273 PPRITSLNLSSSGIAGDIAP-YISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ----KNGLLS 347 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~----~~~~~~ 347 (723)
.++|+.|+|++|+++ .||+ .|++|++|+.|+|++|+|++..|..+.++++|+.|+|++|.+++..|.. +..+..
T Consensus 535 l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 613 (680)
T 1ziw_A 535 LSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613 (680)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSE
T ss_pred CCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCE
Confidence 468999999999999 6776 5899999999999999999766667789999999999999999988763 446777
Q ss_pred cccCCCCCCCC
Q 004935 348 LSVEGNPDLCP 358 (723)
Q Consensus 348 l~~~~n~~lc~ 358 (723)
+.+.+|+..|.
T Consensus 614 l~l~~N~~~c~ 624 (680)
T 1ziw_A 614 LDMRFNPFDCT 624 (680)
T ss_dssp EECTTCCCCBC
T ss_pred EEccCCCcccC
Confidence 88999999986
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.3e-06 Score=96.42 Aligned_cols=83 Identities=22% Similarity=0.189 Sum_probs=67.4
Q ss_pred CCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
.++.++.|+|++|++++..|..|++|++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. ++..|
T Consensus 73 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 152 (452)
T 3zyi_A 73 IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL 152 (452)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEE
T ss_pred CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEE
Confidence 456889999999999988888899999999999999999988888899999999999999988876655443 34455
Q ss_pred ccCCCC
Q 004935 349 SVEGNP 354 (723)
Q Consensus 349 ~~~~n~ 354 (723)
.+.+|.
T Consensus 153 ~L~~N~ 158 (452)
T 3zyi_A 153 WLRNNP 158 (452)
T ss_dssp ECCSCC
T ss_pred ECCCCC
Confidence 566654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.3e-06 Score=94.19 Aligned_cols=66 Identities=18% Similarity=0.263 Sum_probs=34.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCc-cCCCCCCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPD-FLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|++++..|..|+++++|+.|+|++|+++ .+|. .++++++|+.|+|++|.+++..|.
T Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~ 159 (390)
T 3o6n_A 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDD 159 (390)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChh
Confidence 34555555555555544455555555555555555555 2333 235555555555555555554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.22 E-value=8.3e-07 Score=84.36 Aligned_cols=60 Identities=22% Similarity=0.192 Sum_probs=38.9
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
+|+.|+|++|+|++. +.++.+++|+.|+|++|+|++..|..++.+++|+.|+|++|.++.
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 102 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc
Confidence 566777777777653 566677777777777777764333334667777777777776643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.22 E-value=1e-06 Score=88.17 Aligned_cols=64 Identities=14% Similarity=0.212 Sum_probs=35.6
Q ss_pred CceEEEEcCC-CcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCc---EEEccCC-CCCCchh
Q 004935 274 PRITSLNLSS-SGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLT---ELNLKGT-IPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~-n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~---~l~l~~n-~~~g~~p 339 (723)
++|+.|+|++ |++++..|..|+++++|+.|+|++|++++ +|. ++.+++|+ .|+|++| .+++..+
T Consensus 80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~ 148 (239)
T 2xwt_C 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPV 148 (239)
T ss_dssp TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECT
T ss_pred cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCc
Confidence 3556666665 56654444455566666666666666654 554 55555555 5666655 5544333
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.20 E-value=9.1e-07 Score=93.25 Aligned_cols=66 Identities=24% Similarity=0.238 Sum_probs=43.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
++|+.|+|++|++++..|..++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|.+++..+.
T Consensus 217 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp TTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChh
Confidence 45666677777666655556666677777777777666 6666666666777777776666654433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.4e-06 Score=96.05 Aligned_cols=77 Identities=22% Similarity=0.352 Sum_probs=51.4
Q ss_pred CCceEEEEcCCCcccccCcccccCC-----------------CCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTL-----------------TSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l-----------------~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+++|+.|+|++|+++| ||+.+.+| ++|++|+|++|++++ +| .++++++|+.|+|++|.++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~ 166 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence 3456666666666665 55433221 467788888888876 77 4788888888888888887
Q ss_pred CchhhcccCccccccCCC
Q 004935 336 GLIEKQKNGLLSLSVEGN 353 (723)
Q Consensus 336 g~~p~~~~~~~~l~~~~n 353 (723)
+ +|.....+..+.+.+|
T Consensus 167 ~-lp~~~~~L~~L~L~~n 183 (454)
T 1jl5_A 167 K-LPDLPPSLEFIAAGNN 183 (454)
T ss_dssp C-CCCCCTTCCEEECCSS
T ss_pred c-cCCCcccccEEECcCC
Confidence 6 5555555556666655
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.5e-06 Score=92.04 Aligned_cols=122 Identities=15% Similarity=0.104 Sum_probs=83.3
Q ss_pred EEEEEcCCCCCcch-hhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCccc-ccCCCC
Q 004935 222 EFSINTTESSTLPP-ILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPY-ISTLTS 299 (723)
Q Consensus 222 ~lsl~~~~~s~lPp-~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~-~~~l~~ 299 (723)
.+.+..+.-..+|+ .+..+..++.+.+..+......+..+ ...++|+.|+|++|+++ .+|+. ++++++
T Consensus 73 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~ 142 (390)
T 3o6n_A 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF---------QNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142 (390)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT---------TTCTTCCEEECCSSCCC-CCCTTTTTTCTT
T ss_pred EEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh---------cCCCCCCEEECCCCccC-cCCHHHhcCCCC
Confidence 34554433334443 56666666666654332222111101 12468999999999999 56665 699999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccccccCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGN 353 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~n 353 (723)
|+.|+|++|++++..|..+.++++|+.|+|++|.+++.-...+..+..+.+.+|
T Consensus 143 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 999999999999888888999999999999999998764444545555555555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.3e-06 Score=97.98 Aligned_cols=123 Identities=16% Similarity=0.072 Sum_probs=85.7
Q ss_pred eEEEEEEcCCCCCcc-hhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCC
Q 004935 220 KIEFSINTTESSTLP-PILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLT 298 (723)
Q Consensus 220 ~~~lsl~~~~~s~lP-p~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~ 298 (723)
...+.+..+.-..+| ..+..+..++.+.+..+...+..+..+. ..++|+.|+|++|+++ .||.. .++
T Consensus 23 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~-~lp~~--~l~ 90 (520)
T 2z7x_B 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK---------FNQELEYLDLSHNKLV-KISCH--PTV 90 (520)
T ss_dssp CSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGT---------TCTTCCEEECCSSCCC-EEECC--CCC
T ss_pred ccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhh---------cccCCCEEecCCCcee-ecCcc--ccC
Confidence 344666664444444 5777788888777665543332222221 2357899999999998 68887 899
Q ss_pred CCCeeeCcCCcCcC-CCCccCCCCCCCcEEEccCCCCCCchhhcccCc--cccccCCCC
Q 004935 299 SIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGL--LSLSVEGNP 354 (723)
Q Consensus 299 ~L~~L~ls~N~l~g-~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~--~~l~~~~n~ 354 (723)
+|++|+|++|++++ .+|..++++++|+.|+|++|.+++.....+..+ ..+...+|.
T Consensus 91 ~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~ 149 (520)
T 2z7x_B 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149 (520)
T ss_dssp CCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECT
T ss_pred CccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeeccc
Confidence 99999999999988 688999999999999999998887443444444 555555553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-06 Score=98.67 Aligned_cols=110 Identities=15% Similarity=0.182 Sum_probs=72.6
Q ss_pred EEEEEEcCCCCCc-chhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 221 IEFSINTTESSTL-PPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 221 ~~lsl~~~~~s~l-Pp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
..+.+..+.-..+ |..+..+..++.+.+..+...+..+..+ ...++|+.|+|++|++++..|..|++|++
T Consensus 29 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~---------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 99 (549)
T 2z81_A 29 KSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF---------YSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99 (549)
T ss_dssp CEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT---------TTCTTCCEEECTTSCCCSCCHHHHTTCTT
T ss_pred cEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc---------cccccCCEEECCCCccCccCHHHhccCCC
Confidence 3455555333333 4556677777777665443322211111 12357888888888888777777888888
Q ss_pred CCeeeCcCCcCcC-CCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 300 IQILDLSNNNLTG-PVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 300 L~~L~ls~N~l~g-~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
|++|+|++|++++ .+|..++++++|+.|+|++|.+.+.+|
T Consensus 100 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140 (549)
T ss_dssp CCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred CcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC
Confidence 8888888888887 567778888888888888887555555
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.5e-06 Score=94.63 Aligned_cols=67 Identities=18% Similarity=0.199 Sum_probs=42.8
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++.++.|+|++|++++..|..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 97 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL 97 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCT
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCc
Confidence 3456666666666666656666666666666666666666666666666666666666666655433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.7e-06 Score=98.20 Aligned_cols=68 Identities=19% Similarity=0.234 Sum_probs=64.7
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
.++|+.|+|++|++++.+|..++++++|+.|+|++|+|++..|..+.++++|+.|+|++|.+++.+|.
T Consensus 469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 46899999999999999999999999999999999999999888999999999999999999998875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=2.4e-06 Score=97.86 Aligned_cols=81 Identities=21% Similarity=0.033 Sum_probs=65.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|++++..|..|++|++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+. ++..+.+
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 5788899999998888888889999999999999999888888888899999999998888886555554 3344555
Q ss_pred CCCC
Q 004935 351 EGNP 354 (723)
Q Consensus 351 ~~n~ 354 (723)
.+|.
T Consensus 137 ~~n~ 140 (606)
T 3t6q_A 137 GSNH 140 (606)
T ss_dssp CSSC
T ss_pred CCCc
Confidence 5553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.12 E-value=2.3e-06 Score=81.21 Aligned_cols=63 Identities=24% Similarity=0.177 Sum_probs=54.6
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCc--cCCCCCCCcEEEccCCCCCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPD--FLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~--~l~~l~~L~~l~l~~n~~~g 336 (723)
.++|+.|+|++|+|++..|..++.+++|+.|+|++|+++ .+|. .+..+++|+.|+|++|.++.
T Consensus 63 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp CSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred CCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC
Confidence 468999999999999643344599999999999999994 6887 89999999999999999874
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.6e-06 Score=89.23 Aligned_cols=58 Identities=21% Similarity=0.131 Sum_probs=23.8
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+|+.|+|++|++++. | ....+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++
T Consensus 170 ~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 170 TLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp TCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred cCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc
Confidence 344444444444432 1 12224444444444444442 2223444444444444444444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.2e-06 Score=97.27 Aligned_cols=125 Identities=19% Similarity=0.145 Sum_probs=88.6
Q ss_pred eEEEEEEcC-CCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCC
Q 004935 220 KIEFSINTT-ESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLT 298 (723)
Q Consensus 220 ~~~lsl~~~-~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~ 298 (723)
...+.+..+ ..+..|..+..+..++.+.+..+....-.+..+ ...++|+.|+|++|++++..|..|++|+
T Consensus 51 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---------~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 121 (680)
T 1ziw_A 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF---------AFCTNLTELHLMSNSIQKIKNNPFVKQK 121 (680)
T ss_dssp CSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTT---------TTCTTCSEEECCSSCCCCCCSCTTTTCT
T ss_pred CcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhh---------ccCCCCCEEECCCCccCccChhHccccC
Confidence 334555543 333445667777777777665432221111001 1236899999999999877778899999
Q ss_pred CCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc-----cCccccccCCC
Q 004935 299 SIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK-----NGLLSLSVEGN 353 (723)
Q Consensus 299 ~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~-----~~~~~l~~~~n 353 (723)
+|++|+|++|++++..|..++++++|+.|+|++|.+++..+..+ ..+..+.+.+|
T Consensus 122 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181 (680)
T ss_dssp TCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred CCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCC
Confidence 99999999999999999999999999999999999998877643 23455666666
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.09 E-value=3e-06 Score=84.73 Aligned_cols=78 Identities=22% Similarity=0.173 Sum_probs=49.2
Q ss_pred CceE-EEEcCCCcccccCcccccCCCCCCeeeCcCCc-CcCCCCccCCCC-CCCcEEEccCCCCCCchhhcccCcccccc
Q 004935 274 PRIT-SLNLSSSGIAGDIAPYISTLTSIQILDLSNNN-LTGPVPDFLSQL-PFLTELNLKGTIPNGLIEKQKNGLLSLSV 350 (723)
Q Consensus 274 ~~l~-~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~iP~~l~~l-~~L~~l~l~~n~~~g~~p~~~~~~~~l~~ 350 (723)
++|+ .|+|++|+++ .||+.....++|+.|+|++|+ +++..|..+..+ ++|+.|+|++|.+++..+..+..+..+..
T Consensus 155 ~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l 233 (239)
T 2xwt_C 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIA 233 (239)
T ss_dssp BSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEEC
T ss_pred hcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeec
Confidence 4667 7777777777 666655444677777777773 775445566677 77777777777776544333444444444
Q ss_pred CC
Q 004935 351 EG 352 (723)
Q Consensus 351 ~~ 352 (723)
.+
T Consensus 234 ~~ 235 (239)
T 2xwt_C 234 RN 235 (239)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.4e-06 Score=95.76 Aligned_cols=77 Identities=19% Similarity=0.128 Sum_probs=54.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC-chhhccc---Cccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG-LIEKQKN---GLLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g-~~p~~~~---~~~~l~ 349 (723)
++|+.|+|++|++++..|..|++|++|++|+|++|+|+ .||.. .+++|+.|+|++|.+++ .+|..+. ++..+.
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 56778888888888777777888888888888888877 57766 77788888888887776 3444444 333444
Q ss_pred cCCC
Q 004935 350 VEGN 353 (723)
Q Consensus 350 ~~~n 353 (723)
..+|
T Consensus 153 L~~n 156 (562)
T 3a79_B 153 LSAA 156 (562)
T ss_dssp EECS
T ss_pred cCCC
Confidence 4444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-06 Score=87.54 Aligned_cols=64 Identities=30% Similarity=0.426 Sum_probs=55.6
Q ss_pred CceEEEEcCCCcccc--cCcccccCCCCCCeeeCcCCcCcCCCCccCCCCC--CCcEEEccCCCCCCchh
Q 004935 274 PRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP--FLTELNLKGTIPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~--~L~~l~l~~n~~~g~~p 339 (723)
++|+.|+|++|+|++ .||..++.|++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 689999999999999 7888899999999999999999975 3455555 99999999999988665
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.07 E-value=4.7e-06 Score=88.16 Aligned_cols=80 Identities=20% Similarity=0.188 Sum_probs=55.1
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh-cccCccccccC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK-QKNGLLSLSVE 351 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~-~~~~~~~l~~~ 351 (723)
.++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..++++++|+.|+|++|.+++..|. .+..+..+.+.
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~ 341 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFA 341 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSS
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehh
Confidence 35677778887777763 4577777788888888887777777777777888888888777776662 22244455555
Q ss_pred CCC
Q 004935 352 GNP 354 (723)
Q Consensus 352 ~n~ 354 (723)
+|+
T Consensus 342 ~N~ 344 (347)
T 4fmz_A 342 NQV 344 (347)
T ss_dssp CC-
T ss_pred hhc
Confidence 553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.07 E-value=4.6e-06 Score=91.57 Aligned_cols=82 Identities=21% Similarity=0.119 Sum_probs=55.9
Q ss_pred CCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccc
Q 004935 272 DPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSL 348 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l 348 (723)
.++.++.|+|++|++++..|..|++|++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+. ++..|
T Consensus 62 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 141 (440)
T 3zyj_A 62 ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKEL 141 (440)
T ss_dssp CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEE
T ss_pred CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCcee
Confidence 345677777777777777777777777777777777777776667777777777777777777765544333 33344
Q ss_pred ccCCC
Q 004935 349 SVEGN 353 (723)
Q Consensus 349 ~~~~n 353 (723)
.+.+|
T Consensus 142 ~L~~N 146 (440)
T 3zyj_A 142 WLRNN 146 (440)
T ss_dssp ECCSC
T ss_pred eCCCC
Confidence 45555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.03 E-value=5e-06 Score=95.11 Aligned_cols=68 Identities=21% Similarity=0.284 Sum_probs=59.7
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGL 345 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~ 345 (723)
.++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .||..+.++++|+.|+|++|.+++.+|..+..+
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 468999999999998 6887 6788999999999999 889999999999999999999999888766543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.01 E-value=8e-06 Score=92.27 Aligned_cols=110 Identities=15% Similarity=0.138 Sum_probs=73.3
Q ss_pred eEEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 220 KIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
...+.+..+.-..+| ..+..++.+.+..+...+ .+ . ...+|+.|+|++|+|++ ||. .+++
T Consensus 82 L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~-ip-------~-----l~~~L~~L~Ls~N~l~~-lp~---~l~~ 141 (571)
T 3cvr_A 82 ITVLEITQNALISLP---ELPASLEYLDACDNRLST-LP-------E-----LPASLKHLDVDNNQLTM-LPE---LPAL 141 (571)
T ss_dssp CSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CC-------C-----CCTTCCEEECCSSCCSC-CCC---CCTT
T ss_pred CCEEECcCCCCcccc---cccCCCCEEEccCCCCCC-cc-------h-----hhcCCCEEECCCCcCCC-CCC---cCcc
Confidence 344666665555677 334555555554432222 11 1 11278999999999998 887 6889
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCccccccCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGNP 354 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~n~ 354 (723)
|+.|+|++|+|++ ||. .+++|+.|+|++|.+++ +|.-..++..|.+++|.
T Consensus 142 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 142 LEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELPESLEALDVSTNL 191 (571)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred ccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cchhhCCCCEEECcCCC
Confidence 9999999999987 886 57889999999999888 55521245556666663
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.6e-06 Score=94.28 Aligned_cols=66 Identities=12% Similarity=0.200 Sum_probs=49.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCC-------CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSI-------QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG 344 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L-------~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~ 344 (723)
++|+.|+|++|+|+ .||. |.. +| +.|+|++|+|+ .||..+.++++|+.|+|++|.+++.+|..+..
T Consensus 180 ~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 180 ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 56788888888887 7777 554 66 88888888888 58887878888888888888888887776554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.99 E-value=1.4e-05 Score=91.13 Aligned_cols=60 Identities=32% Similarity=0.448 Sum_probs=43.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++|+|++. +.|+.|++|+.|+|++|+|++..| +..|++|+.|+|++|.+++.
T Consensus 131 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 131 PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp TTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 5677777777777764 567777777777777777776655 77777777777777777764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=97.99 E-value=1.5e-05 Score=82.28 Aligned_cols=58 Identities=29% Similarity=0.397 Sum_probs=29.7
Q ss_pred ceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 275 RITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
+|+.|+|++|++++. +.++.+++|+.|+|++|++++..| +..+++|+.|+|++|.+++
T Consensus 135 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 135 QLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 455555555555542 345555555555555555554333 4555555555555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.97 E-value=1.5e-05 Score=80.97 Aligned_cols=116 Identities=17% Similarity=0.213 Sum_probs=80.7
Q ss_pred eEEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCC
Q 004935 220 KIEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTS 299 (723)
Q Consensus 220 ~~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~ 299 (723)
...+.+..+.-+.+|+ +..+..++.+.+..+....-.. . .. ++|+.|+|++|++++ + +.++.+++
T Consensus 65 L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l~~-----~------~~-~~L~~L~L~~N~l~~-~-~~l~~l~~ 129 (263)
T 1xeu_A 65 LKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNLNG-----I------PS-ACLSRLFLDNNELRD-T-DSLIHLKN 129 (263)
T ss_dssp CCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCCTT-----C------CC-SSCCEEECCSSCCSB-S-GGGTTCTT
T ss_pred CCEEECCCCccCCChh-hccCCCCCEEECCCCccCCcCc-----c------cc-CcccEEEccCCccCC-C-hhhcCccc
Confidence 3446666655566777 7777777777665443322111 0 11 589999999999997 4 46999999
Q ss_pred CCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCC
Q 004935 300 IQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNP 354 (723)
Q Consensus 300 L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~ 354 (723)
|+.|+|++|++++. | .++.+++|+.|+|++|.+++. ..+. .+..+.+.+|+
T Consensus 130 L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 130 LEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp CCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred ccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 99999999999974 5 688999999999999999886 2222 33344555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.97 E-value=5.9e-06 Score=85.89 Aligned_cols=174 Identities=18% Similarity=0.178 Sum_probs=103.2
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCc--eeeEEEEEecCC---ceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKN--LTTLVGYCDEGT---NRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~~~ 505 (723)
+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +...+..+...+ ..++|||++++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 357899999999863 67899986532 34567899999999884 332 345555544433 34789999999
Q ss_pred CCHHHHhc-----------------------cCCC---C---CCC-HHHH------HH----------------H----H
Q 004935 506 GNLQALLL-----------------------GEEA---D---ILS-WEGR------LR----------------I----A 529 (723)
Q Consensus 506 gsL~~~l~-----------------------~~~~---~---~l~-~~~~------l~----------------i----~ 529 (723)
.+|.+... .... . ... |... +. - +
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 87754211 0000 0 111 2110 00 0 0
Q ss_pred Hhc--------cccccCCCCCCEEEcC--CCcEEEEeccCccccCCCCCCceeeecccCCCcc---cccccccc-----C
Q 004935 530 IEA--------AKVHRDVKSTNILLSG--KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY---LDPEYYIS-----N 591 (723)
Q Consensus 530 ~~~--------a~vH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~ 591 (723)
+.. ..+|+|+++.||++++ ...+.|.||+.+....... ........ ..|+.... +
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-------Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-------DFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-------HHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-------HHHHHHhhccccCHHHHHHHHHHcC
Confidence 111 1299999999999998 4567899999887532110 00000011 12221110 1
Q ss_pred C---------CCChhhHHHHHHHHHHHHcCCCccc
Q 004935 592 R---------LTEKSDVYNFGVVLLEIITSKSVIE 617 (723)
Q Consensus 592 ~---------~~~~~DV~SfGvvL~elltg~~p~~ 617 (723)
. .....+.|+++.+++++.+|+.++.
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 1123689999999999999998764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.2e-06 Score=86.52 Aligned_cols=63 Identities=17% Similarity=0.171 Sum_probs=40.7
Q ss_pred CceEEEEcCCCcccccCc----ccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIA----PYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip----~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|.+++.+| ..+..+++|+.|+|++|++++..|..++.+++|+.|+|++|.+.+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 183 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLG 183 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCH
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCcc
Confidence 456666666666666555 334556666666666666666666666666667777776666554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.93 E-value=6.2e-06 Score=87.60 Aligned_cols=58 Identities=21% Similarity=0.303 Sum_probs=31.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCc--cCCCCCCCcEEEccCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPD--FLSQLPFLTELNLKGT 332 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~--~l~~l~~L~~l~l~~n 332 (723)
++|+.|+|++|++++..+..++++++|++|+|++|++++ +|. .+.++++|+.|+|++|
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEES
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCC
Confidence 355556666665553222235555566666666665552 333 4555556666665555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=2.2e-05 Score=81.77 Aligned_cols=77 Identities=21% Similarity=0.323 Sum_probs=50.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc-ccCccccccCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ-KNGLLSLSVEG 352 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~-~~~~~~l~~~~ 352 (723)
++|+.|+|++|++++. |+ ++.+++|+.|+|++|++++ +|. +..+++|+.|+|++|.+++..+.. +..+..+.+.+
T Consensus 129 ~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~ 204 (308)
T 1h6u_A 129 SNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN 204 (308)
T ss_dssp TTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTT
T ss_pred CCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccC
Confidence 5677777777777753 33 7777777777777777775 333 777777777777777777654421 22344455555
Q ss_pred CC
Q 004935 353 NP 354 (723)
Q Consensus 353 n~ 354 (723)
|.
T Consensus 205 N~ 206 (308)
T 1h6u_A 205 NQ 206 (308)
T ss_dssp SC
T ss_pred Cc
Confidence 53
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.88 E-value=2.2e-05 Score=86.46 Aligned_cols=18 Identities=33% Similarity=0.525 Sum_probs=7.2
Q ss_pred CCCCCCCcEEEccCCCCC
Q 004935 318 LSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 318 l~~l~~L~~l~l~~n~~~ 335 (723)
++++++|+.|+|++|.++
T Consensus 191 ~~~l~~L~~L~l~~N~l~ 208 (454)
T 1jl5_A 191 LQNLPFLTAIYADNNSLK 208 (454)
T ss_dssp CTTCTTCCEEECCSSCCS
T ss_pred ccCCCCCCEEECCCCcCC
Confidence 333444444444444333
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.7e-05 Score=90.40 Aligned_cols=62 Identities=29% Similarity=0.422 Sum_probs=37.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++|+.|+|++|+|++ + +.++.|++|+.|+|++|+|++. ..++.|++|+.|+|++|.+++..|
T Consensus 109 ~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 109 KKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp TTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 456666666666664 2 3466666666666666666653 445666666666666666666555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.87 E-value=1.4e-05 Score=83.34 Aligned_cols=117 Identities=15% Similarity=0.298 Sum_probs=75.3
Q ss_pred EEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
.+.+..+.-..+|+ +..+..++.+.+..+....-.+ . ...++|+.|+|++|++++ +|+ ++.+++|+
T Consensus 111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-----l------~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~ 176 (308)
T 1h6u_A 111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP-----L------AGLTNLQYLSIGNAQVSD-LTP-LANLSKLT 176 (308)
T ss_dssp EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-----G------GGCTTCCEEECCSSCCCC-CGG-GTTCTTCC
T ss_pred EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc-----c------cCCCCccEEEccCCcCCC-Chh-hcCCCCCC
Confidence 34444444444544 5555656655554332222111 1 123579999999999986 555 89999999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc-ccCccccccCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ-KNGLLSLSVEGNP 354 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~-~~~~~~l~~~~n~ 354 (723)
.|+|++|++++..| +..+++|+.|+|++|.+++..|.. +..+..+.+.+|+
T Consensus 177 ~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~ 228 (308)
T 1h6u_A 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEE
T ss_pred EEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCe
Confidence 99999999986544 788999999999999998866521 1133444555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.9e-06 Score=87.85 Aligned_cols=63 Identities=25% Similarity=0.359 Sum_probs=44.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCch
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLI 338 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~ 338 (723)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..| +..+++|+.|+|++|.+++..
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~ 96 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL 96 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc
Confidence 357777777777777666677777777777777777776554 677777777777777766543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.86 E-value=4.5e-05 Score=87.18 Aligned_cols=72 Identities=19% Similarity=0.232 Sum_probs=42.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccC---cccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNG---LLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~---~~~l~~ 350 (723)
++|+.|+|++|+|++ || ..+++|+.|+|++|+|+ .||. .+++|+.|+|++|.++ .+|..+.. +..+.+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 456666666666664 55 44566666666666666 4555 4566667777777666 44544432 233445
Q ss_pred CCCC
Q 004935 351 EGNP 354 (723)
Q Consensus 351 ~~n~ 354 (723)
.+|+
T Consensus 292 ~~N~ 295 (622)
T 3g06_A 292 EGNP 295 (622)
T ss_dssp CSCC
T ss_pred cCCC
Confidence 5554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=97.85 E-value=2.1e-05 Score=81.12 Aligned_cols=118 Identities=21% Similarity=0.235 Sum_probs=80.7
Q ss_pred EEEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 221 IEFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 221 ~~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
..+.+..+.-..+++ +..+..++.+.+..+....-. + -...++|+.|+|++|++++ + +.++.|++|
T Consensus 71 ~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~-----~------l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L 136 (291)
T 1h6t_A 71 TKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLS-----S------LKDLKKLKSLSLEHNGISD-I-NGLVHLPQL 136 (291)
T ss_dssp CEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGG-----G------GTTCTTCCEEECTTSCCCC-C-GGGGGCTTC
T ss_pred CEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCCh-----h------hccCCCCCEEECCCCcCCC-C-hhhcCCCCC
Confidence 345555544455666 667777776665544322210 1 1123689999999999987 3 578999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc-ccCccccccCCCC
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ-KNGLLSLSVEGNP 354 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~-~~~~~~l~~~~n~ 354 (723)
+.|+|++|++++. ..++.+++|+.|+|++|.+++..|.. +..+..+...+|.
T Consensus 137 ~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 137 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCc
Confidence 9999999999975 57889999999999999998876621 1234445566663
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=4.2e-05 Score=77.74 Aligned_cols=75 Identities=17% Similarity=0.122 Sum_probs=55.7
Q ss_pred ccccCcE-EEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCCCHH
Q 004935 434 LGNGGFG-TVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANGNLQ 509 (723)
Q Consensus 434 lG~G~~g-~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 509 (723)
+..|..| .||+.... +..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 68987663 457899986533 3457889999999884 334678899999999999999999998775
Q ss_pred HH
Q 004935 510 AL 511 (723)
Q Consensus 510 ~~ 511 (723)
+.
T Consensus 109 ~~ 110 (272)
T 4gkh_A 109 QV 110 (272)
T ss_dssp HH
T ss_pred cc
Confidence 54
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=97.83 E-value=3.6e-07 Score=88.76 Aligned_cols=60 Identities=17% Similarity=0.161 Sum_probs=36.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|+++ .||..++.+++|+.|+|++|++++ +| .++.+++|+.|+|++|.+++
T Consensus 70 ~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp TTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 35666666666665 566656666666666666666664 44 45556666666666666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.82 E-value=3.9e-05 Score=84.60 Aligned_cols=59 Identities=22% Similarity=0.258 Sum_probs=33.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCch
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLI 338 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~ 338 (723)
++|+.|+|++|++++ +| ++++++|+.|+|++|+|++ +| ++++++|+.|+|++|...+.+
T Consensus 106 ~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~ 164 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL 164 (457)
T ss_dssp TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC
T ss_pred CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc
Confidence 456666666666665 33 5666666666666666665 33 556666666666666444433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.81 E-value=2.4e-05 Score=79.48 Aligned_cols=59 Identities=24% Similarity=0.376 Sum_probs=38.7
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++|++++ +|+ +++|++|+.|+|++|++++ +|.... ++|+.|+|++|.+++.
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~ 121 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDT 121 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBS
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCCC
Confidence 467777777777765 333 7777777777777777765 444322 6777777777777663
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.81 E-value=3e-05 Score=85.69 Aligned_cols=62 Identities=24% Similarity=0.210 Sum_probs=41.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++|+.|+|++|++++..| ++.+++|+.|+|++|++++. ..+.++++|+.|+|++|.+++..|
T Consensus 309 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 466666677666666544 66666777777777766654 356667777777777777776665
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.81 E-value=3e-05 Score=85.50 Aligned_cols=78 Identities=27% Similarity=0.267 Sum_probs=45.5
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCC-------CCcEEEccCCCCCCchhhcc-cCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLP-------FLTELNLKGTIPNGLIEKQK-NGL 345 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~-------~L~~l~l~~n~~~g~~p~~~-~~~ 345 (723)
++|+.|+|++|+|+| || ++.+++|+.|+|++|+|+|..+..+.+|. +|+.|++++|.+.|.+|... ..+
T Consensus 212 ~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L 288 (457)
T 3bz5_A 212 IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKI 288 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTC
T ss_pred CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccC
Confidence 567777777777776 55 67777777777777777765444444443 34455555555555555321 233
Q ss_pred cccccCCCC
Q 004935 346 LSLSVEGNP 354 (723)
Q Consensus 346 ~~l~~~~n~ 354 (723)
..+...+|.
T Consensus 289 ~~L~Ls~n~ 297 (457)
T 3bz5_A 289 KELDVTHNT 297 (457)
T ss_dssp CCCCCTTCT
T ss_pred CEEECCCCc
Confidence 444455553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.69 E-value=6.3e-05 Score=83.08 Aligned_cols=62 Identities=29% Similarity=0.388 Sum_probs=32.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
++|+.|+|++|++++. |+ ++.+++|+.|+|++|++++..| ++.+++|+.|+|++|.+++..|
T Consensus 265 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 265 TKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp TTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred CCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence 3455555555555542 22 5555555555555555554333 4555555555555555555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.68 E-value=2.3e-05 Score=83.13 Aligned_cols=94 Identities=16% Similarity=0.132 Sum_probs=70.8
Q ss_pred eeecCccCCCC------CCCCCceEEEEcCCCcccccCcc-cccCCCCCCeeeCcCCcCcCCCCc-cCCCCCCCcE-EEc
Q 004935 259 YLWQGLNCSYP------EYDPPRITSLNLSSSGIAGDIAP-YISTLTSIQILDLSNNNLTGPVPD-FLSQLPFLTE-LNL 329 (723)
Q Consensus 259 ~~w~g~~c~~~------~~~~~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~-l~l 329 (723)
|.|..+.|+.. ...++.++.|+|++|+|+ .||+ .|++|++|+.|+|++|++.+.||. .+.+|++|+. +.+
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 56777888743 224468999999999999 5665 699999999999999999988885 5688888776 566
Q ss_pred cCCCCCCchhhcccCc---cccccCCC
Q 004935 330 KGTIPNGLIEKQKNGL---LSLSVEGN 353 (723)
Q Consensus 330 ~~n~~~g~~p~~~~~~---~~l~~~~n 353 (723)
++|.+++..|..+..+ ..+...+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n 114 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNT 114 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred cCCcccccCchhhhhcccccccccccc
Confidence 7888888777665533 33444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.67 E-value=9.3e-06 Score=87.38 Aligned_cols=81 Identities=20% Similarity=0.203 Sum_probs=62.9
Q ss_pred CceEEEEcCCCccc----ccCcccccCCCCCCeeeCcCCcCcCC----CCccC--CCCCCCcEEEccCCCCCC----chh
Q 004935 274 PRITSLNLSSSGIA----GDIAPYISTLTSIQILDLSNNNLTGP----VPDFL--SQLPFLTELNLKGTIPNG----LIE 339 (723)
Q Consensus 274 ~~l~~l~ls~n~l~----g~ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l--~~l~~L~~l~l~~n~~~g----~~p 339 (723)
++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++. +|..+ +++++|+.|+|++|.+++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 57888999999987 77888888889999999999988876 67766 448889999999998887 466
Q ss_pred hcc----cCccccccCCCC
Q 004935 340 KQK----NGLLSLSVEGNP 354 (723)
Q Consensus 340 ~~~----~~~~~l~~~~n~ 354 (723)
..+ ..+..+.+.+|.
T Consensus 296 ~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHHHHCTTCCEEECTTSB
T ss_pred HHHHhcCCCceEEEccCCc
Confidence 544 345556666653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.65 E-value=7.7e-06 Score=87.30 Aligned_cols=66 Identities=24% Similarity=0.179 Sum_probs=46.6
Q ss_pred ceEEEEcCCCcccccCcccccCC-----CCCCeeeCcCCcCcCCCCccCCCC-----CCCcEEEccCCCCCCchhh
Q 004935 275 RITSLNLSSSGIAGDIAPYISTL-----TSIQILDLSNNNLTGPVPDFLSQL-----PFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~ip~~~~~l-----~~L~~L~ls~N~l~g~iP~~l~~l-----~~L~~l~l~~n~~~g~~p~ 340 (723)
+|+.|+|++|++++..+..++.+ ++|+.|+|++|++++..+..++.+ ++|+.|+|++|.+++..+.
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 127 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSS 127 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHH
Confidence 57777777777777777776665 777777777777777766644433 6777777777777665543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=97.64 E-value=9.3e-05 Score=78.05 Aligned_cols=78 Identities=21% Similarity=0.276 Sum_probs=54.0
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Cccccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLS 349 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~ 349 (723)
.++|+.|+|++|.+++ + +.+..+++|+.|+|++|++++. | .+..+++|+.|+|++|.+++..|..+. .+..+.
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 3577788888887775 3 4677778888888888887763 3 467778888888888887777665543 334455
Q ss_pred cCCCC
Q 004935 350 VEGNP 354 (723)
Q Consensus 350 ~~~n~ 354 (723)
..+|+
T Consensus 318 L~~n~ 322 (347)
T 4fmz_A 318 LSQNH 322 (347)
T ss_dssp CCSSS
T ss_pred ccCCc
Confidence 55654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.57 E-value=1.5e-05 Score=83.80 Aligned_cols=63 Identities=27% Similarity=0.316 Sum_probs=48.0
Q ss_pred CceEEEEcCCCccccc-CcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC-CCCC
Q 004935 274 PRITSLNLSSSGIAGD-IAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT-IPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n-~~~g 336 (723)
++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++.+|..++++++|+.|+|++| .+++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~ 157 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCH
Confidence 5677778887777766 7777777778888888877777777777777777888888777 5665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=97.55 E-value=3.9e-06 Score=81.29 Aligned_cols=60 Identities=22% Similarity=0.256 Sum_probs=54.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|++++ +| .++++++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+++
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~ 107 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc
Confidence 478999999999997 88 9999999999999999998 789888888999999999999987
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.53 E-value=2.4e-05 Score=84.09 Aligned_cols=64 Identities=22% Similarity=0.360 Sum_probs=49.5
Q ss_pred CceEEEEcCCCccc--c---cCcccccCCCCCCeeeCcCCcCc----CCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIA--G---DIAPYISTLTSIQILDLSNNNLT----GPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~--g---~ip~~~~~l~~L~~L~ls~N~l~----g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++|+++ | .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 46788888888887 3 34457788888888888888886 67787788888888888888887765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.46 E-value=2.9e-05 Score=78.57 Aligned_cols=78 Identities=26% Similarity=0.373 Sum_probs=58.6
Q ss_pred EEcCCCc---ccccCcccccCCCCCCeeeCcCCcCcC--CCCccCCCCCCCcEEEccCCCCCCchh-hccc--Ccccccc
Q 004935 279 LNLSSSG---IAGDIAPYISTLTSIQILDLSNNNLTG--PVPDFLSQLPFLTELNLKGTIPNGLIE-KQKN--GLLSLSV 350 (723)
Q Consensus 279 l~ls~n~---l~g~ip~~~~~l~~L~~L~ls~N~l~g--~iP~~l~~l~~L~~l~l~~n~~~g~~p-~~~~--~~~~l~~ 350 (723)
++++.|. +.+.++-...+|++|+.|+||+|+|++ .+|..+..+++|+.|+|++|.+++.-. ..+. .+..|.+
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L 227 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 227 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEEC
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEc
Confidence 5667773 444444444689999999999999999 788888899999999999999998621 1122 5566778
Q ss_pred CCCCCCC
Q 004935 351 EGNPDLC 357 (723)
Q Consensus 351 ~~n~~lc 357 (723)
.+|+ +|
T Consensus 228 ~~Np-l~ 233 (267)
T 3rw6_A 228 DGNS-LC 233 (267)
T ss_dssp TTST-TG
T ss_pred cCCc-Cc
Confidence 8887 44
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00021 Score=75.72 Aligned_cols=81 Identities=21% Similarity=0.160 Sum_probs=65.6
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCc-cCCCCCCCcEEEccCCCCCCchhhcccCccccccCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPD-FLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEG 352 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~~~ 352 (723)
..++.|+|++|+|+ .||+.+...++|+.|+|++|+.-+.||. .+..+++|+.|+|++|.++...+..+.++..|...+
T Consensus 154 ~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~ 232 (350)
T 4ay9_X 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232 (350)
T ss_dssp SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTT
T ss_pred hhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhcc
Confidence 46899999999998 6888888889999999997666668886 578999999999999999976555566666666555
Q ss_pred CCC
Q 004935 353 NPD 355 (723)
Q Consensus 353 n~~ 355 (723)
+..
T Consensus 233 ~~~ 235 (350)
T 4ay9_X 233 TYN 235 (350)
T ss_dssp CTT
T ss_pred CCC
Confidence 443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.36 E-value=4.6e-05 Score=80.01 Aligned_cols=69 Identities=22% Similarity=0.186 Sum_probs=56.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCC-CCccCCCCCCCcEEEccCCCCCCchhhccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGP-VPDFLSQLPFLTELNLKGTIPNGLIEKQKN 343 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~-iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~ 343 (723)
+.++.|+|++|.+++.+|. +.++++|+.|+|++|++++. +|..+.++++|+.|+|++|.+++.++..+.
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~ 139 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 139 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh
Confidence 5678888888888876655 56788899999999888876 888888888999999988888877776554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.33 E-value=6.8e-05 Score=79.84 Aligned_cols=67 Identities=28% Similarity=0.255 Sum_probs=59.5
Q ss_pred CceEEEEcCCCcccccCc----ccccCCC-CCCeeeCcCCcCcCCCCccCCCC-----CCCcEEEccCCCCCCchhh
Q 004935 274 PRITSLNLSSSGIAGDIA----PYISTLT-SIQILDLSNNNLTGPVPDFLSQL-----PFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip----~~~~~l~-~L~~L~ls~N~l~g~iP~~l~~l-----~~L~~l~l~~n~~~g~~p~ 340 (723)
..|+.|+|++|++++.-+ ..+.+++ +|+.|+|++|++++..+..++.+ ++|+.|+|++|.+++..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~ 98 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSD 98 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHH
Confidence 469999999999998777 7788999 89999999999999988888775 9999999999999877665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0019 Score=66.87 Aligned_cols=74 Identities=19% Similarity=0.135 Sum_probs=56.0
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCC---ceeeEEEEEe-cCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK---NLTTLVGYCD-EGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~gs 507 (723)
+.++.|....||+. ++.+++|+-. .......+.+|+++|+.+.+. .+...+.++. ..+..++||||+++.+
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 35788888899988 6788999853 233456789999999999753 3566777774 4556789999999988
Q ss_pred HHH
Q 004935 508 LQA 510 (723)
Q Consensus 508 L~~ 510 (723)
+.+
T Consensus 100 l~~ 102 (306)
T 3tdw_A 100 LGE 102 (306)
T ss_dssp CHH
T ss_pred Cch
Confidence 765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00016 Score=79.36 Aligned_cols=81 Identities=20% Similarity=0.142 Sum_probs=57.1
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeCcCCcCcCCCCccCCC-----CCCCcEEEccCCCCCC----chhh
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDLSNNNLTGPVPDFLSQ-----LPFLTELNLKGTIPNG----LIEK 340 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~-----l~~L~~l~l~~n~~~g----~~p~ 340 (723)
++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++..+..+++ .++|+.|+|++|.+++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 4788888888888875 6777777888888888888887765554443 6788888888888875 5555
Q ss_pred cc---cCccccccCCCC
Q 004935 341 QK---NGLLSLSVEGNP 354 (723)
Q Consensus 341 ~~---~~~~~l~~~~n~ 354 (723)
.+ ..+..+.+.+|.
T Consensus 393 ~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 393 TLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHCCCCCEEECCSSS
T ss_pred HHHhCCCccEEECCCCC
Confidence 43 244555666663
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0019 Score=69.53 Aligned_cols=73 Identities=15% Similarity=0.209 Sum_probs=49.3
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCCh-------hhHHHHHHHHHHHHhccC--Cc-eeeEEEEEecCCceEEE
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-------QGYKQFQAEVELLMRIHH--KN-LTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~n-Iv~l~g~~~~~~~~~lV 499 (723)
+.||.|..+.||++.. .++.++||....... ....++..|.++|+.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 4689999999999965 457899998654321 122456789999988743 33 3455544 34456899
Q ss_pred EEeCCCC
Q 004935 500 YEFMANG 506 (723)
Q Consensus 500 ~Ey~~~g 506 (723)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0023 Score=65.57 Aligned_cols=73 Identities=23% Similarity=0.231 Sum_probs=53.5
Q ss_pred hhccccCcEEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccC---CceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH---KNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+|.|..+.||+..+ +|+.|.+|+...........|..|++.|+.+.. -.+.+.+++. ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 4589999999999998 567999998765544434568899999998842 2344555542 3478999998765
Q ss_pred H
Q 004935 508 L 508 (723)
Q Consensus 508 L 508 (723)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00017 Score=79.21 Aligned_cols=80 Identities=16% Similarity=0.169 Sum_probs=58.4
Q ss_pred CceEEEEcCCCcccccCcccccCC-----CCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCchhhccc-
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTL-----TSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGLIEKQKN- 343 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l-----~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~- 343 (723)
++|+.|+|++|.+++..+..++.. ++|+.|+|++|++++. +|..+..+++|+.|+|++|.+++..+..+.
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 578889999998887666555443 6889999999988876 677777888899999988888765444322
Q ss_pred -------CccccccCCC
Q 004935 344 -------GLLSLSVEGN 353 (723)
Q Consensus 344 -------~~~~l~~~~n 353 (723)
.+..+...+|
T Consensus 364 ~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHTSTTCCCCEEECTTS
T ss_pred HHcCCCCceEEEECCCC
Confidence 4455566665
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0038 Score=64.72 Aligned_cols=74 Identities=19% Similarity=0.161 Sum_probs=61.0
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhcc---CCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH---HKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.|+.|....+|+...+++.+++|+.... ....|..|.+.|+.+. ...+.+.++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 35788999999999888889999987643 3467899999999884 35688899998888889999999998765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00036 Score=74.54 Aligned_cols=81 Identities=22% Similarity=0.147 Sum_probs=55.2
Q ss_pred CceEEEEcCCCcccc----cCcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCchhhc----
Q 004935 274 PRITSLNLSSSGIAG----DIAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGLIEKQ---- 341 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~~p~~---- 341 (723)
+.|+.|+|++|+|+. .++..+..+++|++|+|++|+|+.. ++..+...++|+.|+|++|.++......
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 468888888888865 3556667788888888888888742 4556667778888888888887532221
Q ss_pred c---cCccccccCCCC
Q 004935 342 K---NGLLSLSVEGNP 354 (723)
Q Consensus 342 ~---~~~~~l~~~~n~ 354 (723)
+ ..+..+.+++|.
T Consensus 235 L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 235 AREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHCSSCCEEECTTSS
T ss_pred HHhCCCCCEEeccCCC
Confidence 1 244555666653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.004 Score=65.12 Aligned_cols=72 Identities=15% Similarity=0.232 Sum_probs=43.2
Q ss_pred hccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCC--ceeeEEE------EEecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK--NLTTLVG------YCDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~Ey~~ 504 (723)
.|+.|..+.||+...+++.+++|+.... ..++..|+.+++.+... .+.+++. +....+..++++||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4556778899999888778999998752 13344556666655311 2233332 1123566789999999
Q ss_pred CCCH
Q 004935 505 NGNL 508 (723)
Q Consensus 505 ~gsL 508 (723)
+..+
T Consensus 115 G~~~ 118 (346)
T 2q83_A 115 GRPF 118 (346)
T ss_dssp CBCC
T ss_pred CccC
Confidence 8654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0015 Score=69.04 Aligned_cols=78 Identities=4% Similarity=-0.008 Sum_probs=55.6
Q ss_pred hhc-cccCcEEEEEEEEC--------CceEEEEEecCCC---hhhHHHHHHHHHHHHhccC---CceeeEEEEEecC---
Q 004935 432 RVL-GNGGFGTVYHGYLD--------GTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHH---KNLTTLVGYCDEG--- 493 (723)
Q Consensus 432 ~~l-G~G~~g~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~--- 493 (723)
+.| +.|....+|+.... ++.+++|+..... ......+.+|+.+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78888999998765 6689999865432 1012457889999988843 3567788888665
Q ss_pred CceEEEEEeCCCCCHH
Q 004935 494 TNRGLIYEFMANGNLQ 509 (723)
Q Consensus 494 ~~~~lV~Ey~~~gsL~ 509 (723)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0046 Score=55.10 Aligned_cols=56 Identities=23% Similarity=0.312 Sum_probs=44.6
Q ss_pred EEEcCCCccc-ccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 278 SLNLSSSGIA-GDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 278 ~l~ls~n~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
.++.++++|+ -.||..|- ++|+.|+|++|+|+.--+..+..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6788899997 57776532 46899999999999655556788999999999988764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00084 Score=71.64 Aligned_cols=69 Identities=17% Similarity=0.145 Sum_probs=56.9
Q ss_pred CceEEEEcCCCcccc----cCcccccCCCCCCeeeCcCCcCcC----CCCccCCCCCCCcEEEccCCCCCCchhhcc
Q 004935 274 PRITSLNLSSSGIAG----DIAPYISTLTSIQILDLSNNNLTG----PVPDFLSQLPFLTELNLKGTIPNGLIEKQK 342 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~L~ls~N~l~g----~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~ 342 (723)
+.|+.|+|++|+|+. .|+..+..+++|+.|+|++|+++. .++..+...++|+.|+|++|.++......+
T Consensus 183 ~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 183 TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp SSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred CCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 579999999999986 357778889999999999999985 355556678999999999999886554443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.00078 Score=76.45 Aligned_cols=61 Identities=15% Similarity=0.237 Sum_probs=27.5
Q ss_pred ceEEEEcCCC--cccccCcccccC-CCCCCeeeCcCCcCcC-CCCccCCCCCCCcEEEccCCCCC
Q 004935 275 RITSLNLSSS--GIAGDIAPYIST-LTSIQILDLSNNNLTG-PVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 275 ~l~~l~ls~n--~l~g~ip~~~~~-l~~L~~L~ls~N~l~g-~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+|+.|+|+.+ .+++..+..++. +++|+.|+|++|++++ .+|..+..+++|+.|+|++|.++
T Consensus 437 ~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 437 KLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp TCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred CCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 4455555422 244444444332 4445555555555444 23333444455555555555443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0018 Score=61.56 Aligned_cols=64 Identities=13% Similarity=0.225 Sum_probs=41.8
Q ss_pred CceEEEEcCCCcccc----cCcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEc--cCCCCCCc
Q 004935 274 PRITSLNLSSSGIAG----DIAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNL--KGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l--~~n~~~g~ 337 (723)
+.|+.|+|++|++.. .|...+...++|+.|+|++|+++.. |...+...++|+.|+| ++|.+...
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 357777777777754 2444555567777777777777643 4555666677777777 66776643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.016 Score=62.80 Aligned_cols=72 Identities=11% Similarity=0.134 Sum_probs=46.3
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCC----h-----hhHHHHHHHHHHHHh-ccCCceeeEEEEEecCCceEEEEE
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSS----A-----QGYKQFQAEVELLMR-IHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----~-----~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.||.|..+.||+...+++.++||...+.. . .....+..|+..+.. ..+..+.+++.+. .+..++|||
T Consensus 40 ~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e 117 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMR 117 (420)
T ss_dssp EECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEEC
T ss_pred EEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEe
Confidence 458889999999998777799999533210 0 122344444443322 2334566777665 466789999
Q ss_pred eC-CC
Q 004935 502 FM-AN 505 (723)
Q Consensus 502 y~-~~ 505 (723)
|+ ++
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.82 E-value=0.015 Score=60.24 Aligned_cols=74 Identities=8% Similarity=0.041 Sum_probs=44.8
Q ss_pred hccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCce--eeEEEE------EecCCceEEEEEeCC
Q 004935 433 VLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL--TTLVGY------CDEGTNRGLIYEFMA 504 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~------~~~~~~~~lV~Ey~~ 504 (723)
.|+.|....+|+...+++.+++|+..... ...++..|+.++..+....+ .+++.. ....+..+++++|++
T Consensus 29 ~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred ccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 46678888999998877789999987631 12345678888877743222 233321 112345689999999
Q ss_pred CCCH
Q 004935 505 NGNL 508 (723)
Q Consensus 505 ~gsL 508 (723)
+..+
T Consensus 107 G~~~ 110 (322)
T 2ppq_A 107 GMWL 110 (322)
T ss_dssp CBCC
T ss_pred CcCC
Confidence 8653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.0017 Score=68.85 Aligned_cols=65 Identities=17% Similarity=0.234 Sum_probs=52.0
Q ss_pred CCceEEEEcCCCcccccCccccc---CCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYIS---TLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~---~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
.|+|+.|+|++|.++...+..+. .+++|++|+|+.|+|++. ++..+..+++|+.|+|++|.++..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 47899999999999876665554 578999999999999874 555556789999999998887654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=95.32 E-value=0.002 Score=73.06 Aligned_cols=63 Identities=11% Similarity=0.134 Sum_probs=36.3
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeCcCCcCc----CCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDLSNNNLT----GPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~ls~N~l~----g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|.+++. ++..+.++++|+.|+|++|+++ +.++..+.++++|+.|+|++|.+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~ 234 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH
Confidence 3566666666666554 4444555666666666666665 3344444556666666666655554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.31 E-value=0.012 Score=62.54 Aligned_cols=71 Identities=17% Similarity=0.260 Sum_probs=44.4
Q ss_pred hccccCcEEEEEEEEC---------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCc-eeeEEEEEecCCceEEEEEe
Q 004935 433 VLGNGGFGTVYHGYLD---------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN-LTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 502 (723)
.|..|-...+|+.... ++.+++|+.... ......+.+|.++++.+...+ ..++++++.+ .+|+||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4556777788998764 368999986432 223456779999998884333 3566776654 399999
Q ss_pred CCCCCH
Q 004935 503 MANGNL 508 (723)
Q Consensus 503 ~~~gsL 508 (723)
+++.+|
T Consensus 132 i~G~~l 137 (379)
T 3feg_A 132 IPSRPL 137 (379)
T ss_dssp CSEEEC
T ss_pred ecCccC
Confidence 997655
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.24 E-value=0.012 Score=64.04 Aligned_cols=71 Identities=15% Similarity=0.253 Sum_probs=49.4
Q ss_pred hhccccCcEEEEEEEEC---------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEE
Q 004935 432 RVLGNGGFGTVYHGYLD---------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 501 (723)
+.|+.|....+|+.... ++.+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 35778888999999874 36899999854211 2455689999998854444 567776543 38999
Q ss_pred eCCCCCH
Q 004935 502 FMANGNL 508 (723)
Q Consensus 502 y~~~gsL 508 (723)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.011 Score=60.81 Aligned_cols=70 Identities=6% Similarity=0.096 Sum_probs=45.0
Q ss_pred hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEEeC-CCCCH
Q 004935 432 RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYEFM-ANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gsL 508 (723)
+.|+.|....+|+. +.+++|+....... ......|+.+++.+....+ .++++++ .+..++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 45788989999998 67889988754221 1223568888887753333 3555543 33457899999 55444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.0037 Score=70.84 Aligned_cols=63 Identities=16% Similarity=0.174 Sum_probs=38.6
Q ss_pred CceEEEEcCCCcccccCcccccC-CCCCCeeeCcCCcCcCCCCccC-CCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYIST-LTSIQILDLSNNNLTGPVPDFL-SQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~-l~~L~~L~ls~N~l~g~iP~~l-~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 3566666655 566555555555 6667777777776665544444 4566777777777666443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.73 E-value=0.0059 Score=57.98 Aligned_cols=62 Identities=21% Similarity=0.263 Sum_probs=51.4
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeC--cCCcCcCC----CCccCCCCCCCcEEEccCCCCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDL--SNNNLTGP----VPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~l--s~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+.|+.|+|++|+++.. |...+...++|+.|+| ++|.++.. +-..+...++|+.|+|++|.+.
T Consensus 93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4699999999999874 6778888999999999 88999855 3445566789999999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=94.57 E-value=0.035 Score=49.24 Aligned_cols=39 Identities=21% Similarity=0.384 Sum_probs=33.8
Q ss_pred CCCceEEEEcCCCcccccCcc-cccCCCCCCeeeCcCCcCc
Q 004935 272 DPPRITSLNLSSSGIAGDIAP-YISTLTSIQILDLSNNNLT 311 (723)
Q Consensus 272 ~~~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~ 311 (723)
.+++++.|+|++|+|+. ||+ .|..|++|+.|+|++|.+.
T Consensus 29 lp~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 29 FPVDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CCTTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCcCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCee
Confidence 45689999999999995 654 5899999999999999875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=94.31 E-value=0.005 Score=69.68 Aligned_cols=60 Identities=27% Similarity=0.352 Sum_probs=43.6
Q ss_pred CceEEEEcCCC-ccccc-CcccccCCCCCCeeeCcCCcCcCCCCccCC----CCCCCcEEEccCCC
Q 004935 274 PRITSLNLSSS-GIAGD-IAPYISTLTSIQILDLSNNNLTGPVPDFLS----QLPFLTELNLKGTI 333 (723)
Q Consensus 274 ~~l~~l~ls~n-~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~----~l~~L~~l~l~~n~ 333 (723)
++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+. .+++|+.|+|++|.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA 195 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence 47888888888 55543 455556788888888888888776554443 56688888888775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.80 E-value=0.053 Score=59.23 Aligned_cols=72 Identities=15% Similarity=0.228 Sum_probs=48.3
Q ss_pred hhccccCcEEEEEEEECC--ceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEEeCCCCCH
Q 004935 432 RVLGNGGFGTVYHGYLDG--TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.|+.|-...+|+....+ ..+++|+....... ..+...|..+++.+...++ .++++++.. .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457788889999999876 78999987543211 1122689999999965555 467777632 369999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.33 E-value=0.14 Score=53.03 Aligned_cols=74 Identities=12% Similarity=0.063 Sum_probs=40.3
Q ss_pred hccccCcEE-EEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccC--CceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 433 VLGNGGFGT-VYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH--KNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 433 ~lG~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
.|+.|.... +|+.... ++.+++|....... ..+..|+.+++.+.. -.+.+++.++... .+++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 354454444 6677664 67788877554321 234567777777642 2345677665433 3789999987666
Q ss_pred HHH
Q 004935 509 QAL 511 (723)
Q Consensus 509 ~~~ 511 (723)
.+.
T Consensus 100 ~~~ 102 (333)
T 3csv_A 100 TEV 102 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.28 E-value=0.07 Score=55.23 Aligned_cols=72 Identities=13% Similarity=0.133 Sum_probs=46.2
Q ss_pred ccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCc--eeeEEEE-----EecCCceEEEEEeCCC
Q 004935 434 LGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKN--LTTLVGY-----CDEGTNRGLIYEFMAN 505 (723)
Q Consensus 434 lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~-----~~~~~~~~lV~Ey~~~ 505 (723)
++ |....||+...+ |+.+++|+...... ....+..|..++..+.... +++++.. ....+..++++||+++
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 777889988764 45799999874321 2356777888888874322 3334432 1123455789999987
Q ss_pred CC
Q 004935 506 GN 507 (723)
Q Consensus 506 gs 507 (723)
..
T Consensus 112 ~~ 113 (328)
T 1zyl_A 112 RQ 113 (328)
T ss_dssp EE
T ss_pred CC
Confidence 54
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.95 E-value=0.071 Score=56.34 Aligned_cols=71 Identities=17% Similarity=0.193 Sum_probs=44.4
Q ss_pred hccccCcEEEEEEEECC----------ceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEE
Q 004935 433 VLGNGGFGTVYHGYLDG----------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 501 (723)
.|+.|....+|+....+ +.+++|+...... ...+...|.++++.+...++ .++++.. ..++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 56778788999988754 6888988765322 11234678888888854443 4566544 2378999
Q ss_pred eCCCCCH
Q 004935 502 FMANGNL 508 (723)
Q Consensus 502 y~~~gsL 508 (723)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=92.50 E-value=0.17 Score=47.18 Aligned_cols=61 Identities=15% Similarity=0.093 Sum_probs=41.5
Q ss_pred CCCcEEEEEcCeEE-EEEec---CCCCccEEEEEEEe-------------cCCCcEEEEEEecCCCCcceeeeeeeeC
Q 004935 10 KPPSFDIILEADVW-DSIEF---EDESTIVTKEIIHI-------------PQKNFVYVCLVNKGSGTPFISAIELRPL 70 (723)
Q Consensus 10 ~~p~Fd~~~~~~~w-~~v~~---~~~~~~~~~e~i~~-------------~~~~~~~vCl~~~~~~~Pfis~lel~~l 70 (723)
...+||+++++..- .-.++ .....+++.++.+. ..++.+.|.|.+...+.||||+||+.+-
T Consensus 94 ~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 94 QQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKG 171 (174)
T ss_dssp SSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEESS
T ss_pred CCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEEeC
Confidence 45689999999653 33343 12234566666554 3566788999864466799999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=91.92 E-value=0.17 Score=52.49 Aligned_cols=56 Identities=21% Similarity=0.277 Sum_probs=45.6
Q ss_pred CceEEEEcCCCcccccCcc-cccCCCCCCeeeCcCCcCcCCCCccCCCCCCCc-EEEccC
Q 004935 274 PRITSLNLSSSGIAGDIAP-YISTLTSIQILDLSNNNLTGPVPDFLSQLPFLT-ELNLKG 331 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~-~l~l~~ 331 (723)
++|+.|+|++|+++ .||+ .|.+|++|+.|+|++| ++---+..+.++++|+ .|+|++
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 47999999999988 5665 5899999999999998 6643345688899999 999887
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.58 E-value=0.47 Score=49.40 Aligned_cols=68 Identities=12% Similarity=0.137 Sum_probs=43.5
Q ss_pred cccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccC---CceeeEEEE------EecCCceEEEEEeCCC
Q 004935 435 GNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH---KNLTTLVGY------CDEGTNRGLIYEFMAN 505 (723)
Q Consensus 435 G~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~------~~~~~~~~lV~Ey~~~ 505 (723)
|.|....||+...+++.+++|+...... ..|+.++..+.. +.+.+.+.. ....+..++||+|+++
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999987666999998765442 356666666532 223444432 2234667899999998
Q ss_pred CCH
Q 004935 506 GNL 508 (723)
Q Consensus 506 gsL 508 (723)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=90.47 E-value=0.25 Score=51.07 Aligned_cols=66 Identities=14% Similarity=0.076 Sum_probs=53.2
Q ss_pred CceEEEEcCCCcccccCc-ccccCCCCCC-eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc
Q 004935 274 PRITSLNLSSSGIAGDIA-PYISTLTSIQ-ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK 342 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip-~~~~~l~~L~-~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~ 342 (723)
.+|+.|+|++| ++ .|+ ..|.+|++|+ .|+|.+ +++-.-+..+.++++|+.|+|++|.++..-+..+
T Consensus 250 ~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF 317 (329)
T 3sb4_A 250 KYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELF 317 (329)
T ss_dssp TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTT
T ss_pred CCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhh
Confidence 47999999998 66 466 4599999999 999998 7774445789999999999999988876544433
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=90.40 E-value=0.059 Score=50.37 Aligned_cols=62 Identities=16% Similarity=0.140 Sum_probs=45.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCc-CcCCCCccCCCC----CCCcEEEccCCC-CC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNN-LTGPVPDFLSQL----PFLTELNLKGTI-PN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~iP~~l~~l----~~L~~l~l~~n~-~~ 335 (723)
.+|+.||||++.++-.=-..+..|++|+.|+|+++. ++..-=..|+++ ++|+.|+|+++. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 479999999998876545567889999999999984 664333345554 479999998863 54
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=86.48 E-value=0.27 Score=46.77 Aligned_cols=64 Identities=13% Similarity=0.258 Sum_probs=41.4
Q ss_pred CceEEEEcCCC-cccc----cCcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSS-GIAG----DIAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n-~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
+.|+.|+|++| ++.. .|-..+..-+.|+.|+|++|++... |-..|..-+.|+.|+|++|.+...
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~ 113 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 113 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence 46778888875 6542 2445566667788888888887622 223333456788888888877654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.80 E-value=0.8 Score=49.21 Aligned_cols=71 Identities=11% Similarity=0.225 Sum_probs=47.4
Q ss_pred hccccCcEEEEEEEEC---------CceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEEe
Q 004935 433 VLGNGGFGTVYHGYLD---------GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey 502 (723)
.+..|-...+|+.... +..+++|+....... ..+..+|.++++.+...++ .++++.+. .++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4666777889998876 578999997554321 1234678888888853333 45555432 3789999
Q ss_pred CCCCCH
Q 004935 503 MANGNL 508 (723)
Q Consensus 503 ~~~gsL 508 (723)
+++.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=81.37 E-value=0.52 Score=44.77 Aligned_cols=59 Identities=19% Similarity=0.265 Sum_probs=45.3
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n 332 (723)
..|+.|+|++|++... |...+..=+.|+.|+|++|+++.. |=..|..-+.|+.|+|++|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 4699999999999843 344555678999999999999844 2334555677999999865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 723 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-60
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLV 487
+ +G+G FGTVY G G VAVKML+ + + Q + F+ EV +L + H N+ +
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
GY ++ ++ +L L E + IA + A+ +HR
Sbjct: 71 GYSTAP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY---ISNRLT 594
D+KS NI L KI DFGL+ SG+H ++G+ ++ PE N +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKS-RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
+SDVY FG+VL E++T + + R I V + P L + N
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------RGYLSPDLSKVRS-NC 238
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688
+ C+ + +RP Q++ + E LA
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASI-ELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-56
Identities = 57/292 (19%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+ +G G FG V+ G G EVAVK+ S + +AE+ + + H+N+ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 490 CDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------- 534
++ L+ ++ +G+L L ++ EG +++A+ A
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 535 -------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV-TTTIAGTPGYLDPE 586
HRD+KS NIL+ IAD GL+ + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 587 YYISN------RLTEKSDVYNFGVVLLEIIT------SKSVIERTHERIHITQWVSFMLG 634
+ +++D+Y G+V EI + + + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 635 KGDIESIVDPRLHEDFDINSVWKTV-EIAMACVSQTSTKRPTMNQVVMELNE 685
K E + P + + + + +I C R T ++ L++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 28/268 (10%)
Query: 429 NFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
F + +G+G FG V+ GY + +VA+K + A + F E E++M++ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G C E L++EFM +G L L + + + E L + ++ + +HR
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+ + N L+ K++DFG++R +T + PE + +R + KS
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 598 DVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657
DV++FGV++ E+ + + + + +S + PRL
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKPRLAST-------H 230
Query: 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685
+I C + RP ++++ +L E
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 68/267 (25%), Positives = 107/267 (40%), Gaps = 28/267 (10%)
Query: 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
LG G FG V+ GY T+VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
+ +I E+M NG+L L L+ L +A + A+ +HRD
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+++ NIL+S KIADFGL+R + + PE T KSD
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 599 VYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658
V++FG++L EI+T + + Q + + + E+
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----ERGYRMVRPDNCPEEL-------- 239
Query: 659 VEIAMACVSQTSTKRPTMNQVVMELNE 685
++ C + RPT + + L +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 429 NFERVLGNGGFGTVYHGYLDGT------EVAVKMLSPSSAQGYK-QFQAEVELLMRIHHK 481
++V+G G FG VY G L + VA+K L + + F E ++ + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
N+ L G + +I E+M NG L E+ S + + A
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
VHRD+ + NIL++ K++DFGLSR + T+ T+ + PE
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 592 RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
+ T SDV++FG+V+ E++T + + L ++ ++
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYG-------------ERPYWELSNHEVMKAINDGFRLPTP 235
Query: 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ ++ M C Q +RP +V L++
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 7e-53
Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 32/267 (11%)
Query: 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGY 489
+ +G G FG V G G +VAVK + + + F AE ++ ++ H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 68
Query: 490 C-DEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
+E ++ E+MA G+L L +L + L+ +++ + VHRD
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+ + N+L+S AK++DFGL++ T + PE + + KSD
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 599 VYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658
V++FG++L EI + V + V K D P ++
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVY----------- 230
Query: 659 VEIAMACVSQTSTKRPTMNQVVMELNE 685
E+ C + RP+ Q+ +L
Sbjct: 231 -EVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 28/268 (10%)
Query: 429 NFERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
F + LG G FG V +G +VA+KM+ S +F E +++M + H+ L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
G C + +I E+MANG L L + L + + + +HR
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 538 DVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKS 597
D+ + N L++ + K++DFGLSR + + PE + ++ + KS
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 598 DVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657
D++ FGV++ EI + + + ++ L + + +++
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVY---------- 231
Query: 658 TVEIAMACVSQTSTKRPTMNQVVMELNE 685
I +C + + +RPT ++ + +
Sbjct: 232 --TIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 4e-52
Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 43/299 (14%)
Query: 418 FSYSNVLRITNNF-----------ERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPS- 460
F++ + F E+V+G G FG V G+L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 461 SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADIL 520
+ + + F +E ++ + H N+ L G + T +I EFM NG+L + L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 521 SWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGT 570
+ + + A VHRD+ + NIL++ K++DFGLSR + S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 571 HVTTTIA--GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW 628
T+ + + PE + T SDV+++G+V+ E+++ +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
+ D RL D S ++ + C + RP Q+V L++ +
Sbjct: 246 I-----------EQDYRLPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 6e-52
Identities = 66/269 (24%), Positives = 102/269 (37%), Gaps = 28/269 (10%)
Query: 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTL 486
+ LG G +G VY G VAVK L + + ++F E ++ I H NL L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
+G C +I EFM GNL L +S L +A + + +H
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEK 596
RD+ + N L+ K+ADFGLSR G + PE N+ + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 597 SDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656
SDV+ FGV+L EI T + + + +++ +
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------------LLEKDYRMERPEGCPE 243
Query: 657 KTVEIAMACVSQTSTKRPTMNQVVMELNE 685
K E+ AC + RP+ ++
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-52
Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 28/270 (10%)
Query: 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVG 488
E LG G FG V+ G T VA+K L P + + F E +++ ++ H+ L L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 489 YCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRD 538
E ++ E+M+ G+L L GE L + +A + A VHRD
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 138
Query: 539 VKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSD 598
+++ NIL+ K+ADFGL+R +E + + PE + R T KSD
Sbjct: 139 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 599 VYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658
V++FG++L E+ T V + V + P E
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPECPESL-------- 243
Query: 659 VEIAMACVSQTSTKRPTMNQVVMELNESLA 688
++ C + +RPT + L +
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-51
Identities = 69/292 (23%), Positives = 125/292 (42%), Gaps = 35/292 (11%)
Query: 412 ELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYLD-----GTEVAVKMLSPSSAQG-Y 465
+++ S + +F V+G G FG VYHG L AVK L+ + G
Sbjct: 16 AVQHVVIGPS---SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 466 KQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG-LIYEFMANGNLQALLLGEEADILSWEG 524
QF E ++ H N+ +L+G C ++ +M +G+L+ + E + + +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKD 131
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV-EGSGTHVT 573
+ ++ AK VHRD+ + N +L KF K+ADFGL+R E H
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFML 633
T ++ E + + T KSDV++FGV+L E++T + ++ ++L
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG---APPYPDVNTFDITVYLL 248
Query: 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ P D E+ + C + RP+ +++V ++
Sbjct: 249 ---QGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-51
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 41/272 (15%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTT 485
F+ +G G F TVY G EVA L + ++F+ E E+L + H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 486 LVGYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
+ L+ E M +G L+ L + ++ + + K
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 535 -----VHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K NI ++G KI D GL+ + GTP ++ PE
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFAKAVIGTPEFMAPEM- 184
Query: 589 ISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648
+ E DVY FG+ +LE+ TS+ I + V+ + + + P +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 243
Query: 649 DFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680
EI C+ Q +R ++ ++
Sbjct: 244 -----------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 51/270 (18%), Positives = 104/270 (38%), Gaps = 30/270 (11%)
Query: 431 ERVLGNGGFGTVYHGYL----DGTEVAVKMLSPSSAQG-YKQFQAEVELLMRIHHKNLTT 485
+ LG G FG+V G +VA+K+L + + ++ E +++ ++ + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 486 LVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------V 535
L+G C + L+ E G L L+G+ + + + + + V
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 536 HRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
HRD+ + N+LL + AKI+DFGLS+ + S + + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 596 KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655
+SDV+++GV + E ++ + + + ++ +G P +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----QGKRMEC-PPECPPEL----- 241
Query: 656 WKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
+ C RP V +
Sbjct: 242 ---YALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 2e-50
Identities = 77/300 (25%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGY-KQFQAEVELLMR 477
NN E R +G G FG V+ T VAVKML ++ FQ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL----------------------LGE 515
+ N+ L+G C G L++E+MA G+L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 516 EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPV 565
LS +L IA + A VHRD+ + N L+ KIADFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY- 191
Query: 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHI 625
A ++ PE NR T +SDV+ +GVVL EI + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 626 TQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
+V G+I + + N + + C S+ RP+ + L
Sbjct: 252 IYYVR----DGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 47/225 (20%), Positives = 91/225 (40%), Gaps = 23/225 (10%)
Query: 427 TNNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGY-KQFQAEVELLMRIHHK 481
++FE LG G G V+ G +A K++ Q E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
+ G + E M G+L +L ++A + + +++I K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
+HRDVK +NIL++ + + K+ DFG+S + + GT Y+ PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQG 177
Query: 591 NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635
+ +SD+++ G+ L+E+ + I + + + G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-49
Identities = 60/271 (22%), Positives = 109/271 (40%), Gaps = 32/271 (11%)
Query: 431 ERVLGNGGFGTVYHGYL----DGTEVAVKMLSPSSAQGY--KQFQAEVELLMRIHHKNLT 484
++ LG+G FGTV GY VAVK+L + + AE ++ ++ + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
++G C+ + L+ E G L L ++ + + + + + +
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
VHRD+ + N+LL + AKI+DFGLS+ + + T + PE + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
KSDV++FGV++ E + R + +T ML KG+ +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGERMGC-PAGCPREM---- 239
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
++ C + RP V + L
Sbjct: 240 ----YDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 48/297 (16%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRI-HH 480
F + LG G FG V VAVKML PS+ ++ +E+++L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALL----------------LGEEADILSWEG 524
N+ L+G C G +I E+ G+L L + ++ L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
L + + AK +HRD+ + NILL+ KI DFGL+R S V
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK-NDSNYVVKG 205
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634
++ PE + T +SDV+++G+ L E+ + + M
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG------------SSPYPGMPV 253
Query: 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691
++ ++ + +I C KRPT Q+V + + ++ T
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-48
Identities = 73/334 (21%), Positives = 127/334 (38%), Gaps = 56/334 (16%)
Query: 397 WSLRRRMQVAKNGSFELKNQRFSYSNVLRIT-NNFE--RVLGNGGFGTVYHGYLDGT--- 450
+ + + N F + + + Y N E +VLG+G FG V + G
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 451 ----EVAVKMLSPSSAQGY-KQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFMA 504
+VAVKML + + +E++++ ++ H+N+ L+G C LI+E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 505 NGNLQALLLG---------------------EEADILSWEGRLRIAIEAAK--------- 534
G+L L E+ ++L++E L A + AK
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
VHRD+ + N+L++ KI DFGL+R S V ++ PE
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653
T KSDV+++G++L EI + + ++ D
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPV------------DANFYKLIQNGFKMDQPFY 291
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
+ + I +C + S KRP+ + L L
Sbjct: 292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-48
Identities = 61/275 (22%), Positives = 94/275 (34%), Gaps = 32/275 (11%)
Query: 430 FERVLGNGGFGTVYHGYLD-----GTEVAVKMLSP---SSAQGYKQFQAEVELLMRIHHK 481
LG+G FG V G D VAVK L P S + F EV + + H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
NL L G + ++ E G+L L + R A++ A+
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+ + N+LL+ + KI DFGL R P + + PE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 592 RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
+ SD + FGV L E+ T I + + +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI----- 244
Query: 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686
+ + C + RPT + L E+
Sbjct: 245 -------YNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 42/277 (15%)
Query: 429 NFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKN 482
++E +G G +G DG + K L S + +EV LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 483 LTTLVGYCDEGTNRGL--IYEFMANGNLQALL--LGEEADILSWEGRLRIAIEAAK---- 534
+ + TN L + E+ G+L +++ +E L E LR+ +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 535 -----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+HRD+K N+ L GK K+ DFGL+R T GTP Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVGTPYYM 181
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643
PE EKSD+++ G +L E+ + + ++ + +G I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRRI-P 235
Query: 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680
R ++ EI ++ RP++ +++
Sbjct: 236 YRYSDEL--------NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-47
Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 47/289 (16%)
Query: 429 NFERVLGNGGFGTVYHGYLDGT----EVAVKMLSP-SSAQGYKQFQAEVELLMRI-HHKN 482
F+ V+G G FG V + + A+K + +S ++ F E+E+L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALL--------------LGEEADILSWEGRLRI 528
+ L+G C+ L E+ +GNL L A LS + L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 529 AIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578
A + A+ +HRD+ + NIL+ + AKIADFGLSR V T
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----KTMGRL 188
Query: 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI 638
++ E + T SDV+++GV+L EI++ + + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------- 239
Query: 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
RL + + + ++ C + +RP+ Q+++ LN L
Sbjct: 240 --PQGYRLEKPLNCDDEVY--DLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 37/308 (12%)
Query: 423 VLRITNN----FERVLGNGGFGTVYHGYLDGT------EVAVKMLSPS-SAQGYKQFQAE 471
+LRI +VLG+G FGTVY G VA+K L + S + K+ E
Sbjct: 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 472 VELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIE 531
++ + + ++ L+G C T + LI + M G L + E D + + L ++
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQ 119
Query: 532 AAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
AK VHRD+ + N+L+ KI DFGL++ +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGKVPIK 178
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641
++ E + T +SDV+++GV + E++T S +I SI
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------------SEISSI 225
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETARLKAAGKEY 701
++ I + C + RP ++++E ++ L G E
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 702 ESKDSIES 709
S
Sbjct: 286 MHLPSPTD 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-46
Identities = 61/280 (21%), Positives = 104/280 (37%), Gaps = 33/280 (11%)
Query: 430 FERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSSAQGYKQ-FQAEVELLMRIHHKNL 483
R +G G FG V+ G VA+K ++ ++ F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
L+G E +I E G L++ L L + A + +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
VHRD+ + N+L+S K+ DFGLSR E S + + ++ PE R
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653
T SDV+ FGV + EI+ + V + G+ + P
Sbjct: 187 TSASDVWMFGVCMWEILMHG----VKPFQGVKNNDVIGRIENGERLPM-PPNCPPTL--- 238
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETAR 693
+ C + ++RP ++ +L+ L E A+
Sbjct: 239 -----YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-46
Identities = 64/266 (24%), Positives = 100/266 (37%), Gaps = 37/266 (13%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLT 484
R LG G FG VY +A+K+L + A Q + EVE+ + H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
L GY + T LI E+ G + L ++ + E A
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRD+K N+LL + KIADFG S P + TT+ GT YL PE
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
EK D+++ GV+ E + K E + + + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFPDFVTEGA-------- 231
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQVV 680
++ + ++RP + +V+
Sbjct: 232 ----RDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 1e-45
Identities = 55/267 (20%), Positives = 100/267 (37%), Gaps = 40/267 (14%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG---YKQFQAEVELLMRIHHKNLTTL 486
R +G+G FG VY + VA+K +S S Q ++ EV L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 487 VGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VH 536
G L+ E+ L + ++ L + A + +H
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 537 RDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS---NRL 593
RDVK+ NILLS K+ DFG + + GTP ++ PE ++ +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMAPEVILAMDEGQY 191
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653
K DV++ G+ +E+ K + + + + + + + ++ E F
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNESPALQSGHWSEYF--- 243
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVV 680
+C+ + RPT ++
Sbjct: 244 -----RNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 420 YSNVLRITN-----NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEV 472
Y +V R N LG+G FG VY A K++ S + + + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 473 ELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEA 532
++L H N+ L+ N ++ EF A G + A++L E L+ + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQT 119
Query: 533 AK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
+HRD+K+ NIL + K+ADFG+S + GTP +
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT---RTIQRRDSFIGTPYW 176
Query: 583 LDPEYYISNRL-----TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD 637
+ PE + K+DV++ G+ L+E+ + + V + K +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRVLLKIAKSE 231
Query: 638 IESIVDP-RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
++ P R +F + C+ + R T +Q+
Sbjct: 232 PPTLAQPSRWSSNF--------KDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-45
Identities = 50/268 (18%), Positives = 99/268 (36%), Gaps = 31/268 (11%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGY-KQFQAEVELLMRIHHKN 482
+++ + LG G +G V VAVK++ A + + E+ + ++H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ G+ EG + L E+ + G L + E + R +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
HRD+K N+LL + KI+DFGL+ F + + + GT Y+ PE
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 593 L-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
E DV++ G+VL ++ + ++ + + +D
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP----- 236
Query: 652 INSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + + + + R T+ +
Sbjct: 237 -------LALLHKILVENPSARITIPDI 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 40/284 (14%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQGYK-QFQAEVELLMRIHHK 481
R LG G FG VY G T VA+K ++ +++ + +F E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------LGEEADILSWEGRLRIAIEAA 533
++ L+G +G +I E M G+L++ L S +++A E A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 534 K----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
VHRD+ + N +++ F KI DFG++R E ++
Sbjct: 144 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWM 202
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643
PE T SDV++FGVVL EI T + + ++V +G + D
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPD 258
Query: 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
N E+ C RP+ +++ + E +
Sbjct: 259 ---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 53/282 (18%), Positives = 107/282 (37%), Gaps = 32/282 (11%)
Query: 412 ELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQ 467
E+ + S +V + +G G GTVY G EVA++ ++ +
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 468 FQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLR 527
E+ ++ + N+ + G ++ E++A G+L ++ D
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAA 120
Query: 528 IAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577
+ E + +HRD+KS NILL K+ DFG E +T+
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMV 177
Query: 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD 637
GTP ++ PE K D+++ G++ +E+I + + +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---------- 227
Query: 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
I + P L ++++++ + C+ KR + ++
Sbjct: 228 IATNGTPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (388), Expect = 8e-42
Identities = 58/316 (18%), Positives = 116/316 (36%), Gaps = 34/316 (10%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK 481
+ ++++ LG G FG V+ G A K + + + E++ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
L L ++ +IYEFM+ G L + +E + +S + + + K
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 535 ---VHRDVKSTNILLSGKF--QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
VH D+K NI+ + K + K+ DFGL+ GT + PE
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAE 198
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649
+ +D+++ GV+ +++ S ++ + S +++ + ED
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS---CDWNMDDSAFSGISED 255
Query: 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQVVME--LNESLAIETARLKAAGKEYESKDSI 707
+ + R T++Q + L A + + + +DSI
Sbjct: 256 G--------KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
Query: 708 ESISVNQHSELSPLAR 723
++ L PL R
Sbjct: 308 KTKYDAWPEPLPPLGR 323
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 1e-41
Identities = 60/281 (21%), Positives = 114/281 (40%), Gaps = 35/281 (12%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQG---YKQFQAEVELLMR 477
+++ +E +LG GG V+ +VAVK+L A+ Y +F+ E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 478 IHHKNLTTLVGYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAA 533
++H + + + T G ++ E++ L+ ++ ++ + + + +A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADAC 121
Query: 534 K----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYL 583
+ +HRDVK NI++S K+ DFG++R G+ T + GT YL
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 584 DPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643
PE + + +SDVY+ G VL E++T + Q V S
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---EDPIPPSARH 238
Query: 644 PRLHEDFDINSVWKTVEIAMACVSQTSTKRP-TMNQVVMEL 683
L D D + + +++ R T ++ +L
Sbjct: 239 EGLSADLD--------AVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 49/295 (16%)
Query: 430 FERVLGNGGFGTVYHGYL---------DGTEVAVKMLSP-SSAQGYKQFQAEVELLMRI- 478
+ LG G FG V T+VAVKML ++ + +E+E++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 479 HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL--------------LGEEADILSWEG 524
HKN+ L+G C + +I E+ + GNL+ L + LS +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 525 RLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574
+ A + A+ +HRD+ + N+L++ KIADFGL+R TT
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTT 195
Query: 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG 634
++ PE T +SDV++FGV+L EI T + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK------- 248
Query: 635 KGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689
++ D N + + C ++RPT Q+V +L+ +A+
Sbjct: 249 ------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 47/292 (16%)
Query: 430 FERVLGNGGFGTVYHGYL-------DGTEVAVKMLSPSSAQG-YKQFQAEVELLMRI-HH 480
+ LG G FG V VAVKML + ++ +E+++L+ I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 481 KNLTTLVGYC-DEGTNRGLIYEFMANGNLQALLLGEE--------------ADILSWEGR 525
N+ L+G C G +I EF GNL L + D L+ E
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 526 LRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575
+ + + AK +HRD+ + NILLS K KI DFGL+R +
Sbjct: 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGD 195
Query: 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK 635
++ PE T +SDV++FGV+L EI + + + + I + L +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---LGASPYPGVKIDEEFCRRLKE 252
Query: 636 GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
G D E + + C ++RPT +++V L L
Sbjct: 253 GTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-40
Identities = 46/265 (17%), Positives = 85/265 (32%), Gaps = 33/265 (12%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSA---QGYKQFQAEVELLMRIHHKNLT 484
F ++LG G F TV E A+K+L E +++ R+ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
L + + NG L + + E
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLT 594
+HRD+K NILL+ +I DFG ++ E + GT Y+ PE
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSAC 188
Query: 595 EKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654
+ SD++ G ++ +++ +E + + + D P+
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKIIKLEYDFPEKFFPKA-------- 237
Query: 655 VWKTVEIAMACVSQTSTKRPTMNQV 679
++ + +TKR ++
Sbjct: 238 ----RDLVEKLLVLDATKRLGCEEM 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 3e-38
Identities = 54/272 (19%), Positives = 102/272 (37%), Gaps = 35/272 (12%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY-KQFQAEVELLMRIHH 480
I + ++ VLG G F V VA+K ++ + +G + E+ +L +I H
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
N+ L + G + LI + ++ G L + E + R+ +
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 535 ----VHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
VHRD+K N+L + I+DFGLS+ V +T GTPGY+ PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPGYVAPEV 180
Query: 588 YISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647
++ D ++ GV+ ++ ++ + + + + +S +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAEYEFDSPYWDDIS 237
Query: 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + + + KR T Q
Sbjct: 238 DSA--------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (358), Expect = 1e-37
Identities = 45/270 (16%), Positives = 95/270 (35%), Gaps = 32/270 (11%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHK 481
+ + ++ LG+G FG V+ G K ++ + E+ ++ ++HH
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
L L ++ LI EF++ G L + E+ +S + +A +
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 535 ---VHRDVKSTNILLSGKF--QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
VH D+K NI+ K KI DFGL+ + + T + PE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVD 201
Query: 590 SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649
+ +D++ GV+ +++ S + + + + + + +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 650 FDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + + KR T++
Sbjct: 259 A--------KDFIKNLLQKEPRKRLTVHDA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 2e-36
Identities = 49/283 (17%), Positives = 96/283 (33%), Gaps = 31/283 (10%)
Query: 424 LRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH 479
LR+ N + R +G+G FG +Y G G EVA+K+ + Q E ++ +
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----- 534
+ +C + ++ + +L+ L + S + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYI 119
Query: 535 -----VHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGSGTHV----TTTIAGTPGY 582
+HRDVK N L+ I DFGL++ + + H+ + GT Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV 642
++ + + D+ + G VL+ + ++ K S
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---MSTP 236
Query: 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNE 685
L + + + C S +P + +
Sbjct: 237 IEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 6e-36
Identities = 35/264 (13%), Positives = 87/264 (32%), Gaps = 31/264 (11%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
LG G FG V+ K + + E+ +L H+N+ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67
Query: 488 GYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHR 537
+ +I+EF++ ++ + A L+ + + + H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 538 DVKSTNILLS--GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTE 595
D++ NI+ KI +FG +R + P Y PE + + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 596 KSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655
+D+++ G ++ +++ + + I ++ + + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN---AEYTFDEEAFKEISIEA----- 234
Query: 656 WKTVEIAMACVSQTSTKRPTMNQV 679
++ + + R T ++
Sbjct: 235 ---MDFVDRLLVKERKSRMTASEA 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 54/295 (18%), Positives = 115/295 (38%), Gaps = 41/295 (13%)
Query: 422 NVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY-KQFQAEVELLM 476
V + + +G G +G V Y ++ VA+K +SP Q Y ++ E+++L+
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADI-----LSWEGRLRIAIE 531
R H+N+ + T + ++ L+ + + LS + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTH----LMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 532 AAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
+ +HRD+K +N+LL+ KI DFGL+R + T T T
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 582 YLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFM--LGKGDI 638
Y PE ++++ T+ D+++ G +L E+++++ + H + + + + D+
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 639 ESIVDPRLHEDFDINSVWKTV--------------EIAMACVSQTSTKRPTMNQV 679
I++ + V ++ ++ KR + Q
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (329), Expect = 2e-34
Identities = 54/278 (19%), Positives = 95/278 (34%), Gaps = 45/278 (16%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY---------KQFQAEVELLMRI 478
+ +LG G V E AVK++ + + + EV++L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 479 H-HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--- 534
H N+ L + T L+++ M G L L E LS + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVIC 124
Query: 535 -------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
VHRD+K NILL K+ DFG S + GTP YL PE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSYLAPEI 180
Query: 588 YISNRL------TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641
+ ++ D+++ GV++ ++ + + + +S G S
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---GNYQFGSP 237
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ ++ + KR T +
Sbjct: 238 EWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 3e-34
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 25/204 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQ---FQAEVELLMRIHH 480
+F+ R LG G FG V+ +G A+K+L KQ E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ + G + +I +++ G L L ++ A E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYIS 590
++RD+K NILL KI DFG ++ P VT T+ GTP Y+ PE +
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYTLCGTPDYIAPEVVST 175
Query: 591 NRLTEKSDVYNFGVVLLEIITSKS 614
+ D ++FG+++ E++ +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 54/269 (20%), Positives = 91/269 (33%), Gaps = 36/269 (13%)
Query: 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVELLMR-IHHKNL 483
++LG G FG V+ A+K L + E +L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 484 TTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK--------- 534
T + N + E++ G+L + + A E
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 535 -VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL 593
V+RD+K NILL KIADFG+ + G T T GTP Y+ PE + +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653
D ++FGV+L E++ +S E + S + ++
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYPRWLEKEA------- 230
Query: 654 SVWKTVEIAMACVSQTSTKRPTMNQVVME 682
++ + + KR + + +
Sbjct: 231 -----KDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 52/291 (17%), Positives = 101/291 (34%), Gaps = 40/291 (13%)
Query: 425 RITNNFE--RVLGNGGFGTVYHGY---LDGTEVAVKMLSPSSAQG--YKQFQAEVELLMR 477
R +E +G G +G V+ G VA+K + + + EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 478 I---HHKNLTTLVGYCDEGTNRGLIYEFM----ANGNLQALLLGEEADILSWEGRLRIAI 530
+ H N+ L C + + +L L + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 531 EAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580
+ + VHRD+K NIL++ Q K+ADFGL+R + S T++ T
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTL 179
Query: 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIES 640
Y PE + + D+++ G + E+ K + + + + + + + G+ +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 641 IVDPRLHEDFDINSVWKTVEIAMACVSQTS------------TKRPTMNQV 679
D L + + +E + + + KR +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 1e-33
Identities = 41/288 (14%), Positives = 93/288 (32%), Gaps = 39/288 (13%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HH 480
+ +++ R +G G FG ++ G L+ +VA+K S Q + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGC 60
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ + + EG + L+ + + G LL S + A +
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 535 ----VHRDVKSTNILLSGKF-----QAKIADFGLSRTFPVEGSGTHV----TTTIAGTPG 581
V+RD+K N L+ + DFG+ + + + H+ ++GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER--IHITQWVSFMLGKGDIE 639
Y+ ++ + + D+ G V + + + + + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 640 SIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687
+ E+F + + P + + ++ L
Sbjct: 239 ELC-AGFPEEFY--------KYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 55/272 (20%), Positives = 98/272 (36%), Gaps = 49/272 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGY------KQFQAEVELLMRIH-- 479
+LG+GGFG+VY G D VA+K + + + EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----- 534
+ L+ + + + LI E + E L E + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHC 126
Query: 535 -----VHRDVKSTNILLSG-KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYY 588
+HRD+K NIL+ + + K+ DFG V T GT Y PE+
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-----DTVYTDFDGTRVYSPPEWI 181
Query: 589 ISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647
+R + V++ G++L +++ E E I +G + R+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-----------RGQV--FFRQRVS 228
Query: 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + C++ + RPT ++
Sbjct: 229 SEC--------QHLIRWCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 55/279 (19%), Positives = 96/279 (34%), Gaps = 36/279 (12%)
Query: 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG-----YKQFQAEVELLMRIHHKNLT 484
LG G F TVY VA+K + + E++LL + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 485 TLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK---------- 534
L+ +N L+++FM ++ + + +L+ + +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 535 VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL- 593
+HRD+K N+LL K+ADFGL+++F GS T T Y PE R+
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 594 TEKSDVYNFGVVLLEIITSK------------SVIERTHERIHITQWVSFMLGKGDIESI 641
D++ G +L E++ + I T QW +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 642 VDPRLHEDFDINSVWKT-VEIAMACVSQTSTKRPTMNQV 679
P + ++ +++ R T Q
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 2e-32
Identities = 50/278 (17%), Positives = 98/278 (35%), Gaps = 41/278 (14%)
Query: 426 ITNNFE---RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-H 479
I ++++ +VLG G G V + + A+KML + + EVEL R
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQ 63
Query: 480 HKNLTTLVGYCDEGTNRG----LIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK- 534
++ +V + ++ E + G L + + + I +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 535 ---------VHRDVKSTNILLSGKFQ---AKIADFGLSRTFPVEGSGTHVTTTIAGTPGY 582
HRDVK N+L + K K+ DFG ++ S TT TP Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYY 179
Query: 583 LDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVS-FMLGKGDIESI 641
+ PE + + D+++ GV++ ++ H + +G+ + +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ E+ + + T+R T+ +
Sbjct: 240 EWSEVSEEV--------KMLIRNLLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-32
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 37/283 (13%)
Query: 429 NFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKN 482
NF+ +G G +G VY L G VA+K + + E+ LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L+ L++EF+ + +L+ + + + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNR 592
+HRD+K N+L++ + K+ADFGL+R F G T T Y PE + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 593 -LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651
+ D+++ G + E++T +++ E + + LG D D+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-TLGTPDEVVWPGVTSMPDYK 237
Query: 652 INSVWKT---------------VEIAMACVSQTSTKRPTMNQV 679
+ + + KR +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 54/278 (19%), Positives = 96/278 (34%), Gaps = 41/278 (14%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG------YKQFQAEVELL 475
+ + ++ LG+G F V G + A K + + + + EV +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 476 MRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK- 534
I H N+ TL + T+ LI E +A G L E + L+ E +
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNG 125
Query: 535 ---------VHRDVKSTNILLS----GKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPG 581
H D+K NI+L K + KI DFGL+ + I GTP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTPE 181
Query: 582 YLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641
++ PE L ++D+++ GV+ +++ S ++ + + E
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNYEFEDE 238
Query: 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
+ + + KR T+
Sbjct: 239 YFSNTSALA--------KDFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 52/207 (25%), Positives = 78/207 (37%), Gaps = 23/207 (11%)
Query: 425 RIT-NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPS---SAQGYKQFQAEVELLM 476
++T N+F+ ++LG G FG V G A+K+L + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 477 RIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-- 534
H LT L + E+ G L L + + E E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 535 --------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPE 586
V+RD+K N++L KI DFGL + +G+ T GTP YL PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEYLAPE 175
Query: 587 YYISNRLTEKSDVYNFGVVLLEIITSK 613
N D + GVV+ E++ +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (311), Expect = 2e-31
Identities = 52/240 (21%), Positives = 85/240 (35%), Gaps = 24/240 (10%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAEVE---LLMR 477
N+F R++G GGFG VY G A+K L QG E L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 478 IHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALL----LGEEADILSWEGRLRIAIEAA 533
+ + I + M G+L L + EAD+ + + + +E
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 534 K----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYI 589
V+RD+K NILL +I+D GL+ F GT GY+ PE
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-----SKKKPHASVGTHGYMAPEVLQ 178
Query: 590 SNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHE 648
+D ++ G +L +++ S + + + ++ P L
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (301), Expect = 8e-31
Identities = 51/282 (18%), Positives = 98/282 (34%), Gaps = 35/282 (12%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL-DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKN 482
+ +G G +G VY G A+K + E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 483 LTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK-------- 534
+ L L++E + + L + E L ++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR 119
Query: 535 --VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN- 591
+HRD+K N+L++ + + KIADFGL+R F G T T Y P+ + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 592 RLTEKSDVYNFGVVLLEIITSKSV------------IERTHERIHITQW--VSFMLGKGD 637
+ + D+++ G + E++ + I R + W V+ +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 638 IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQV 679
++ +P E F +++ + +R T Q
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-30
Identities = 53/293 (18%), Positives = 107/293 (36%), Gaps = 41/293 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG--YKQFQAEVELLMRIHHK 481
+ +E +G G FG V+ G +VA+K + + + E+++L + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 482 NLTTLVGYCDEGTNRG--------LIYEFMANGNLQALLLGEEADILSWEGR-------- 525
N+ L+ C + L+++F + L LS R
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 526 LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTF-PVEGSGTHVTTTIAGTPGYLD 584
L +HRD+K+ N+L++ K+ADFGL+R F + S + T T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 585 PEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG--KGDIESI 641
PE + R D++ G ++ E+ T +++ E+ + ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 642 VDPRLHEDFDINSVWKT---------------VEIAMACVSQTSTKRPTMNQV 679
+ L+E ++ K +++ + +R +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 1e-29
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 28/233 (12%)
Query: 398 SLRRRMQVAKNGSFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVA 453
S++ + AK LK N ++ + F+ + LG G FG V G A
Sbjct: 14 SVKEFLAKAKEDF--LKKWETPSQNTAQL-DQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 454 VKMLSPSSAQGYKQ---FQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNLQA 510
+K+L KQ E +L ++ L L + +N ++ E++A G + +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 511 LLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLS 560
L S A + ++RD+K N+L+ + ++ DFG +
Sbjct: 131 HL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 561 RTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
+ T T+ GTP L PE +S + D + GV++ E+
Sbjct: 189 KRVK------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-29
Identities = 51/309 (16%), Positives = 100/309 (32%), Gaps = 49/309 (15%)
Query: 405 VAKNGSFELKNQRFSYSNVLRITNNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA 462
VA G + Q SY+ +V+GNG FG VY L G VA+K +
Sbjct: 7 VATPGQGPDRPQEVSYT--------DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK- 57
Query: 463 QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRG------LIYEFMANGNLQALL-LGE 515
+ E++++ ++ H N+ L + + L+ +++ +
Sbjct: 58 ---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 516 EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGK-FQAKIADFGLSRTFP 564
L + + HRD+K N+LL K+ DFG ++
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 565 VEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIH 624
G + I + + T DV++ G VL E++ + +
Sbjct: 175 ---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 625 ITQWVSFM--------------LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTS 670
+ + + + + I + F + + + + + T
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 671 TKRPTMNQV 679
T R T +
Sbjct: 292 TARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 48/284 (16%), Positives = 95/284 (33%), Gaps = 37/284 (13%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHK 481
+E +G G +GTV+ VA+K + E+ LL + HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 482 NLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------- 534
N+ L L++EF + L E + K
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 535 ---VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISN 591
+HRD+K N+L++ + K+A+FGL+R F G + T Y P+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 592 R-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650
+ + D+++ G + E+ + + ++ + + +LG E D+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 651 DINSVWKTVEIAMACVSQTS---------------TKRPTMNQV 679
++ + V + + +R + +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 7e-26
Identities = 45/230 (19%), Positives = 100/230 (43%), Gaps = 21/230 (9%)
Query: 428 NNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKN 482
++++ R LG G + V+ + +V VK+L P K+ + E+++L + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 483 LTTLVGYCDEGTNR--GLIYEFMANGNLQALLLG-EEADILSWEGRLRIAIEAAK----V 535
+ TL + +R L++E + N + + L + DI + + A++ +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 536 HRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRL- 593
HRDVK N+++ + + ++ D+GL+ + + + PE + ++
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFY----HPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 594 TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVD 643
D+++ G +L +I K H+ ++ +LG D+ +D
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 410 SFELKNQRFSYSNVLRITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--SAQ 463
S E+ + F+ + ++ + +G+G G V Y + VA+K LS +
Sbjct: 5 SVEVGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 58
Query: 464 GYKQFQAEVELLMRIHHKNLTTLVGYC------DEGTNRGLIYEFMANGNLQALLLGEEA 517
K+ E+ L+ ++HKN+ +L+ +E + L+ E M Q + + +
Sbjct: 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 118
Query: 518 DILSWEGR-----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572
+ +S+ ++ A +HRD+K +NI++ KI DFGL+RT + +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFM 174
Query: 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK 613
T T Y PE + E D+++ G ++ E++ K
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-24
Identities = 55/290 (18%), Positives = 102/290 (35%), Gaps = 43/290 (14%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIH 479
+ + + +G+G +G V G +VA+K L S K+ E+ LL +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE--EADILSWEGRLRIAIEAAK--- 534
H+N+ L+ +F LG+ + + L + + + K
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 535 -------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
+HRD+K N+ ++ + KI DFGL+R E T T Y PE
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEV 189
Query: 588 YISN-RLTEKSDVYNFGVVLLEIITSKS------------VIERTHERIHITQWVSFMLG 634
++ R T+ D+++ G ++ E+IT K+ I +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 635 KGDIESIVDPRLHEDFDINSVWKTV-----EIAMACVSQTSTKRPTMNQV 679
+ P L + D S+ + + + +R T +
Sbjct: 250 EAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 428 NNFE--RVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLM 476
NFE +VLG G +G V+ G A+K+L ++ A+ + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 477 RI-HHKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGE----EADILSWEGRLRIAIE 531
I L TL T LI +++ G L L E ++ + G + +A+E
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 532 AAK----VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
++RD+K NILL + DFGLS+ F T GT Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYDFCGTIEYMAPDI 201
Query: 588 YISNR--LTEKSDVYNFGVVLLEIITSK 613
+ D ++ GV++ E++T
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 2e-22
Identities = 42/207 (20%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 426 ITNNFE--RVLGNGGFGTVYHGY--LDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIH 479
+ ++ +G+G +G+V + G VAVK LS S K+ E+ LL +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 480 HKNLTTLVGYCDEGT-----NRGLIYEFMANGNLQALLLGE---EADILSWEGRLRIAIE 531
H+N+ L+ N + + +L ++ + + + ++ ++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 532 AA----KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEY 587
+HRD+K +N+ ++ + KI DFGL+R T T Y PE
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DDEMTGYVATRWYRAPEI 189
Query: 588 YISNR-LTEKSDVYNFGVVLLEIITSK 613
++ + D+++ G ++ E++T +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.2 bits (212), Expect = 1e-18
Identities = 48/260 (18%), Positives = 93/260 (35%), Gaps = 47/260 (18%)
Query: 430 FERVLGNGGFGTVYHGY--LDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLV 487
R LG G F TV+ ++ T VA+K++ + + E++LL R++ + T
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 75
Query: 488 GYC---------------DEGTNRGLIYEFMANGNLQALLLGE-----EADILSWEGRLR 527
G + +++E + L + E + +L
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 528 IAIEAAK-----VHRDVKSTNILLS------GKFQAKIADFGLSRTFPVEGSGTHVTTTI 576
+ ++ +H D+K N+L+ Q KIAD G + + T
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD------EHYTNS 189
Query: 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK------SVIERTHERIHITQWVS 630
T Y PE + +D+++ ++ E+IT T + HI Q +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 631 FMLGKGDIESIVDPRLHEDF 650
+LG+ + + + F
Sbjct: 250 -LLGELPSYLLRNGKYTRTF 268
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 2e-14
Identities = 29/153 (18%), Positives = 46/153 (30%), Gaps = 27/153 (17%)
Query: 432 RVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA----------QGYKQFQAEVELLMRIHH 480
+++G G V++ Y E VK G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 481 KNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK------ 534
+ L L G +Y + N L L+ +E + E + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 535 ----VHRDVKSTNILLSGKFQAKIADFGLSRTF 563
VH D+ N+L+S + I DF S
Sbjct: 121 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 19/105 (18%), Positives = 31/105 (29%), Gaps = 24/105 (22%)
Query: 261 WQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQ 320
+ L+L ++ I G + ++ L + L++S NNL G +P
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN 289
Query: 321 LPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGNPDLC--PEASCT 363
L N LC P +CT
Sbjct: 290 LQRFDVSAY---------------------ANNKCLCGSPLPACT 313
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 5e-08
Identities = 32/219 (14%), Positives = 78/219 (35%), Gaps = 21/219 (9%)
Query: 128 SMNDYQGPSTVMQTAVIPTNGSNSLQLSWEPNDPKFLYYAYLYFSEFENVQANNQTREII 187
+ T ++ I +N + + + + + + L S+ + E+
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELS 225
Query: 188 IYINGIDWFGPFSP------LHFAANTIYSTWPILTAEKI-EFSINTTESSTLPPILN-- 238
+ N + G + L A N I + P+ K+ E + + S + P+
Sbjct: 226 LNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLT 285
Query: 239 -AYEIYRAKEFLQFLTNQQDAYLWQGLNCSY-------PEYDPPRITSLNLSSSGIAGDI 290
+ + L+ ++ + L + P ++ L +++ ++
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-- 343
Query: 291 APYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
++ LT+I L +N ++ P L+ L +T+L L
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 4/60 (6%)
Query: 269 PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELN 328
+ D ++T+L GI I + L ++ ++ SNN LT P L L L ++
Sbjct: 39 SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 25/99 (25%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 261 WQGLNCSY------PEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPV 314
+ + CS P+ PP L+L ++ I L ++ L L NN ++
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 315 PDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGN 353
P + L L L L L EK L L V N
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN 110
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 276 ITSLNLSSSGIAGDIAPYI-STLTSIQILDLSNNNLTG----PVPDFLSQLPFLTELNLK 330
I SL++ ++ + L Q++ L + LT + L P L ELNL+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 331 G 331
Sbjct: 64 S 64
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 21/101 (20%), Positives = 35/101 (34%), Gaps = 13/101 (12%)
Query: 265 NCSYPEYDPPRITSLNLSSSGI----AGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQ 320
C + L L+ + +A + S++ LDLSNN L L +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 321 -----LPFLTELNLKGTIPNGLIEKQKNGLLSLSVEGNPDL 356
L +L L E+ ++ L +L + P L
Sbjct: 420 SVRQPGCLLEQLVLYD---IYWSEEMEDRLQAL-EKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 9/61 (14%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 274 PRITSLNLSSSGI----AGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+ + L G+ DI+ + ++ L+L +N L + Q +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86
Query: 330 K 330
+
Sbjct: 87 Q 87
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 24/166 (14%), Positives = 51/166 (30%), Gaps = 9/166 (5%)
Query: 162 KFLYYAYLYFSEFENVQANNQTREIIIYINGIDWFGPFSPLHFAANTIYSTWPILTAEKI 221
L L + V+ N +I N + P L + + + I +
Sbjct: 43 TTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPL 102
Query: 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNL 281
N T + + + + L L + +S +
Sbjct: 103 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQV 162
Query: 282 SSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTEL 327
+ ++ LT+++ LD+S+N ++ L++L L L
Sbjct: 163 TDL-------KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 14/53 (26%), Positives = 19/53 (35%), Gaps = 3/53 (5%)
Query: 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+N + + P + IL LS N L L LT+LNL
Sbjct: 13 LEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 8/41 (19%), Positives = 13/41 (31%), Gaps = 2/41 (4%)
Query: 297 LTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG--TIPN 335
+ ILD+S + L L L + +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 240
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 7e-04
Identities = 18/78 (23%), Positives = 30/78 (38%), Gaps = 10/78 (12%)
Query: 260 LWQGLNCSYPEYDPPRI--------TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLT 311
LWQ L+ + P + S + +A + S +Q +DLSN+ +
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIE 59
Query: 312 G-PVPDFLSQLPFLTELN 328
+ LSQ L L+
Sbjct: 60 VSTLHGILSQCSKLQNLS 77
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 16/68 (23%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 288 GDIAPYISTLTSIQILDLSN-NNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLL 346
D L +Q L LS ++ L ++P L L + G +P+G ++ K L
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP 249
Query: 347 SLSVEGNP 354
L + +
Sbjct: 250 HLQINCSH 257
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 8/38 (21%), Positives = 18/38 (47%), Gaps = 2/38 (5%)
Query: 292 PYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNL 329
+++L ++ + L NN ++ P L+ L + L
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.004
Identities = 12/96 (12%), Positives = 29/96 (30%), Gaps = 5/96 (5%)
Query: 237 LNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPR-ITSLNLSSSGIAGDIAP-YI 294
L+ + L L + + + L L ++ + A +
Sbjct: 27 LSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPL 86
Query: 295 STLTSIQILDLSNNNLTGP---VPDFLSQLPFLTEL 327
+ + +L+L N+L LP ++ +
Sbjct: 87 VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 723 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.67 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.34 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.3 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.67 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.39 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.23 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.16 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.12 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.1 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.08 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.07 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 97.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.57 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.54 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.51 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.51 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.3 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.27 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.25 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.2 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.16 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 96.92 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.87 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 96.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 96.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 95.8 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 95.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 94.01 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 93.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.75 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 92.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 91.59 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 91.08 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 80.22 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-45 Score=379.38 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=194.4
Q ss_pred ccCHHHHHHHHHHhh-----------hhccccCcEEEEEEEEC--Cc---eEEEEEecCC-ChhhHHHHHHHHHHHHhcc
Q 004935 417 RFSYSNVLRITNNFE-----------RVLGNGGFGTVYHGYLD--GT---EVAVKMLSPS-SAQGYKQFQAEVELLMRIH 479 (723)
Q Consensus 417 ~~~~~~l~~~t~~f~-----------~~lG~G~~g~Vy~~~~~--~~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~ 479 (723)
.++|+++.+++.+|. +.||+|+||.||+|.+. ++ .||||.+... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 467778888888773 57999999999999983 22 5899998764 4455678999999999999
Q ss_pred CCceeeEEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCC
Q 004935 480 HKNLTTLVGYCDEGTNRGLIYEFMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGK 549 (723)
Q Consensus 480 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~ 549 (723)
|||||+++|+|...+..++|||||++|+|.+++.... ..++|..++.++.++|. +||||||+||||+.+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 164 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC
Confidence 9999999999999999999999999999999887543 34778777777666655 999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCce--eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTH--VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHIT 626 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~ 626 (723)
+++||+|||+++.+........ ......+|+.|+|||.+.+..++.++|||||||+||||+| |+.||......
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---- 240 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---- 240 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999987653322111 1223457899999999999999999999999999999998 89999765432
Q ss_pred HHHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 627 QWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 627 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
+.+.......+. ..+.+....+.+++.+||+.+|++||||+||++.|+++++.+.
T Consensus 241 ~~~~~i~~~~~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 241 DVINAIEQDYRL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp HHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHHHHcCCCC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 222222211111 1112233467899999999999999999999999999886543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=370.82 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=186.8
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|+..+ .||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||||++|+
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp CCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 35789999999999998765 6999998754 34556789999999999999999999999865 56899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++..... .+++..++.++.++|. |||||||+||||+.++.+||+|||+|+....... ........
T Consensus 90 L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~ 167 (276)
T d1uwha_ 90 LYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLS 167 (276)
T ss_dssp HHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------------CC
T ss_pred HHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC-cccccccc
Confidence 9999975432 4677777666666554 9999999999999999999999999987643322 23334567
Q ss_pred CCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 578 GTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 578 gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
||+.|+|||.+.+ ..++.++|||||||+||||+||+.||........+...+...... |.+. ....+.
T Consensus 168 gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------p~~~-~~~~~~ 238 (276)
T d1uwha_ 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--------PDLS-KVRSNC 238 (276)
T ss_dssp CCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC--------CCGG-GSCTTC
T ss_pred cCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--------Ccch-hccccc
Confidence 9999999999864 358999999999999999999999997654432222222221111 1111 111123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
...+.+++.+||+.+|++||||+|+++.|+.+.+
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3467899999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=369.00 Aligned_cols=242 Identities=25% Similarity=0.437 Sum_probs=182.1
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.+. ++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++|||||++|+|
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 4578999999999999994 5689999997644 3347899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.... ..++|..++.++.++|. +||||||+|||+++++.+||+|||+++...... ........|
T Consensus 88 ~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~g 164 (263)
T d1sm2a_ 88 SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKF 164 (263)
T ss_dssp HHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------------
T ss_pred HHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC--ceeecceec
Confidence 99987543 34677777766666654 999999999999999999999999998764322 122334578
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
|+.|+|||.+.+..++.++|||||||++|||+|+..|+........+.+.+.. .. ....|. .....+
T Consensus 165 t~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~---~~~~p~-------~~~~~l 231 (263)
T d1sm2a_ 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GF---RLYKPR-------LASTHV 231 (263)
T ss_dssp CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TC---CCCCCT-------TSCHHH
T ss_pred CcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cC---CCCCcc-------ccCHHH
Confidence 99999999999999999999999999999999965544333222222222221 11 111121 122467
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.+++.+||+.+|++||||+||++.|+++++
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=368.02 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=186.4
Q ss_pred hhhhccccCcEEEEEEEECC------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLDG------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.++||+|+||.||+|.+.+ ..||||+++... .....+|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 36789999999999998732 269999997653 34456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
|.+|++.+++.... ..++|..++.++.+++. +||||||+||||+.++.+||+|||+++.+.........
T Consensus 91 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~ 169 (283)
T d1mqba_ 91 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169 (283)
T ss_dssp CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred cccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceE
Confidence 99999999876543 34777777777666654 99999999999999999999999999986544333333
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
.....||+.|+|||.+.+..++.++|||||||+||||+||+.|+........+.+ .. ..+. +...+.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---~i-~~~~---------~~~~~~ 236 (283)
T d1mqba_ 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---AI-NDGF---------RLPTPM 236 (283)
T ss_dssp ----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HH-HTTC---------CCCCCT
T ss_pred eccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---HH-hccC---------CCCCch
Confidence 4456789999999999999999999999999999999997766544332222222 21 1211 111122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
+....+.+++.+||+.+|++||||+||++.|+.+++..
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 23346889999999999999999999999999888654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=368.22 Aligned_cols=241 Identities=29% Similarity=0.409 Sum_probs=190.9
Q ss_pred hhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.+.+ +.||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+|
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred EeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence 45789999999999999964 589999997654 335789999999999999999999998865 567999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......++|..++.++.+++. +||||||+||||++++.+||+|||+|+.+.... ........|
T Consensus 95 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~g 172 (272)
T d1qpca_ 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKF 172 (272)
T ss_dssp HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCC
T ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc--cccccccCC
Confidence 99887655455788888777777665 999999999999999999999999999864321 233345678
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKT 658 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 658 (723)
|+.|+|||.+.++.++.++|||||||+||||+||+.|+........+.+. .. .+. .+..... ....+
T Consensus 173 t~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~---i~-~~~-----~~~~p~~----~~~~l 239 (272)
T d1qpca_ 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---LE-RGY-----RMVRPDN----CPEEL 239 (272)
T ss_dssp CTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH-TTC-----CCCCCTT----CCHHH
T ss_pred cccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH---HH-hcC-----CCCCccc----ChHHH
Confidence 99999999999999999999999999999999976665443322222222 21 111 1111111 22367
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 659 VEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 659 ~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
.+++.+||+.+|++||||+||++.|++..
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 89999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-44 Score=370.27 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=195.8
Q ss_pred HhhhhccccCcEEEEEEEEC--CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYLD--GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.+. ++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|||||++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 34678999999999999984 66899999876543 4578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.......+++..++.++.+++. +||||||+||||++++.+||+|||+|+...... .......
T Consensus 99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~ 176 (287)
T d1opja_ 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGA 176 (287)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS--SEEETTE
T ss_pred chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC--ceeeccc
Confidence 9999998776667787777666665554 999999999999999999999999998764322 2333445
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.|++.|+|||.+.+..++.++|||||||++|||++|+.|+........+.+.+ ..+. .+.. +.....
T Consensus 177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~-----~~~~----~~~~~~ 243 (287)
T d1opja_ 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDY-----RMER----PEGCPE 243 (287)
T ss_dssp EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTC-----CCCC----CTTCCH
T ss_pred cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCC-----CCCC----CccchH
Confidence 68899999999999999999999999999999999877765443322222222 1111 0111 112234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.+.+++.+||+.+|++||||+||++.|+.+.+
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 67899999999999999999999999987754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=362.16 Aligned_cols=243 Identities=21% Similarity=0.367 Sum_probs=192.1
Q ss_pred hccccCcEEEEEEEEC----CceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 433 VLGNGGFGTVYHGYLD----GTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 433 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.||+|+||.||+|.+. +..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999873 3379999997654 4456789999999999999999999999965 56899999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++.... ..+++..++.++.++|. +||||||+||||+.++.+||+|||+++.+..............
T Consensus 95 L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~ 173 (285)
T d1u59a_ 95 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173 (285)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSC
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccc
Confidence 999986542 34677777777666654 9999999999999999999999999998754433233334556
Q ss_pred CCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 578 GTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 578 gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+.. +.... ....
T Consensus 174 gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~----~i~~~~~-----~~~p~----~~~~ 239 (285)
T d1u59a_ 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA----FIEQGKR-----MECPP----ECPP 239 (285)
T ss_dssp CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHH----HHHTTCC-----CCCCT----TCCH
T ss_pred cCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHH----HHHcCCC-----CCCCC----cCCH
Confidence 8999999999999999999999999999999998 89999765432 1222 2222221 11111 2234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.+.+++.+||+.+|++||||.+|++.|+.+.....
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 67899999999999999999999999998765433
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=363.83 Aligned_cols=239 Identities=24% Similarity=0.388 Sum_probs=185.3
Q ss_pred hhccccCcEEEEEEEEC----CceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 432 RVLGNGGFGTVYHGYLD----GTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.||+|+||.||+|.+. ++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999873 2479999997543 3345689999999999999999999999965 467899999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
|+|.+++.... .+++...+.++.++|. |||||||+||||+.++.+||+|||+++.+............
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 99999987643 3667766666665554 99999999999999999999999999976544332333345
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.. ..+..+.. +.... ..
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~-~~i~~~~~-----~~~p~----~~ 235 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT-AMLEKGER-----MGCPA----GC 235 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH-HHHHTTCC-----CCCCT----TC
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHH-HHHHcCCC-----CCCCc----cc
Confidence 678999999999999999999999999999999998 89999765322 211 22222211 11111 22
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
...+.+++.+||+.+|++||||++|++.|++..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 346789999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=365.28 Aligned_cols=242 Identities=27% Similarity=0.436 Sum_probs=189.6
Q ss_pred HhhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|+..+ ..||||++.... ......|.+|+.+|.++ +|||||+++++|.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 356899999999999998732 269999987543 33446799999999998 899999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCC---------------------CCCCHHHHHHHHHhccc----------cccCCCCCCEEEcC
Q 004935 500 YEFMANGNLQALLLGEEA---------------------DILSWEGRLRIAIEAAK----------VHRDVKSTNILLSG 548 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~ 548 (723)
||||++|+|.++++.... ..++|...+.++.+++. |||||||+|||++.
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc
Confidence 999999999999976421 24677777666666554 99999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHH
Q 004935 549 KFQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQ 627 (723)
Q Consensus 549 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~ 627 (723)
++.+||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||+||||+| |+.||........+.+
T Consensus 200 ~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 200 GKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp TTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987654332 233445668999999999999999999999999999999998 8999976554333333
Q ss_pred HHHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 004935 628 WVSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELN 684 (723)
Q Consensus 628 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~ 684 (723)
.+. .+. .+. .+......+.+++.+||+.+|++||||+||++.|.
T Consensus 279 ~~~----~~~-----~~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 279 LIQ----NGF-----KMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH----TTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHh----cCC-----CCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 222 111 011 11122346789999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=351.38 Aligned_cols=239 Identities=26% Similarity=0.416 Sum_probs=190.1
Q ss_pred hhhhccccCcEEEEEEEEC-CceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLD-GTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
|.+.||+|+||.||+|++. ++.||||+++.... ..++|.+|++++++++||||++++|+|.+.+..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 4678999999999999995 45899999986543 346899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++..... .+.+..++.++.++|. +||||||+|||+++++.+||+|||+++....... .......+
T Consensus 87 ~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~ 163 (258)
T d1k2pa_ 87 LNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKF 163 (258)
T ss_dssp HHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--CCCCCSCC
T ss_pred HHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc--eeecccCC
Confidence 998765432 3455555555555544 9999999999999999999999999987654322 23334678
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +... .+..+. ....|. .....
T Consensus 164 t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~-~i~~~~--~~~~p~-------~~~~~ 229 (258)
T d1k2pa_ 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAE-HIAQGL--RLYRPH-------LASEK 229 (258)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHH-HHHTTC--CCCCCT-------TCCHH
T ss_pred CCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HHHH-HHHhCC--CCCCcc-------cccHH
Confidence 999999999999999999999999999999998 79899765432 2122 222221 111121 12246
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
+.+++.+||+.+|++|||++++++.|.++
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 78999999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=358.37 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=188.4
Q ss_pred HHhhhhccccCcEEEEEEEECC-ceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYLDG-TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
..+.+.||+|+||.||+|++.+ +.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 3456789999999999999955 489999997554 345789999999999999999999999954 5678999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|..++.......++|..++.++.++|. +||||||+||||+.++++||+|||+++...... .......
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~--~~~~~~~ 174 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGA 174 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC--ceeeccc
Confidence 9999988765556888888888777765 999999999999999999999999998764322 2233446
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||+.|+|||++..+.++.++|||||||+||||+||+.|+........+...+. . +. .+..... ...
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~-~~-----~~~~~~~----~~~ 241 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R-GY-----RMPCPPE----CPE 241 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-TC-----CCCCCTT----SCH
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---h-cC-----CCCCCcc----cCH
Confidence 789999999999999999999999999999999997776654433222222222 1 11 1111122 233
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 657 KTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.+.+++.+||+.+|++||||++|+++|++...
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 67899999999999999999999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=354.88 Aligned_cols=237 Identities=20% Similarity=0.289 Sum_probs=179.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
+.+.||+|+||.||+|+. +++.||||++..... ...++|.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 457899999999999998 467999999976532 33467999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|.+++.... .+++... +..+|+...+||||||+|||+++++.+||+|||+|+....... .......
T Consensus 89 ~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~-~~~~~~~ 165 (271)
T d1nvra_ 89 ELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKM 165 (271)
T ss_dssp EGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCCC
T ss_pred cHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc-cccccce
Confidence 9999987542 2333333 3333444449999999999999999999999999987643322 2233456
Q ss_pred cCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 577 AGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
.||+.|+|||.+.+..+ +.++|||||||+||||+||+.||............ ........ +. .. ...
T Consensus 166 ~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~----~~-~~----~~s 233 (271)
T d1nvra_ 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYL----NP-WK----KID 233 (271)
T ss_dssp CSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTS----TT-GG----GSC
T ss_pred eeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCC----Cc-cc----cCC
Confidence 79999999999988876 57899999999999999999999765443222111 11111100 00 01 112
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+||+.+|++|||++|+++
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 234 SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 35678999999999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=353.79 Aligned_cols=237 Identities=27% Similarity=0.418 Sum_probs=184.4
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEEeCCCCCH
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYEFMANGNL 508 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL 508 (723)
+.+.||+|+||.||+|.++++.||||+++... ..++|.+|++++++++||||++++|+|.+ .+..++||||+++|+|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 46789999999999999999999999997653 34679999999999999999999999865 4568999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 509 QALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 509 ~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
.+++.......++|..++.++.+++. +||||||+|||++.++.+||+|||+++..... .....+
T Consensus 89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------~~~~~~ 162 (262)
T d1byga_ 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKL 162 (262)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------------C
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC------Cccccc
Confidence 99997654455788877777777665 99999999999999999999999999875321 223467
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHH
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWK 657 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~ 657 (723)
+..|+|||.+.+..++.++|||||||++|||+| |+.|+...... .+...+. .+. .+.+.. .....
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-~~~~~i~----~~~-----~~~~~~----~~~~~ 228 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE----KGY-----KMDAPD----GCPPA 228 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHT----TTC-----CCCCCT----TCCHH
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH----cCC-----CCCCCc----cCCHH
Confidence 889999999999999999999999999999998 67777654332 3333222 111 111212 22246
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 658 TVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 658 l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
+.+++.+||+.||.+||||++++++|+++..
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=359.17 Aligned_cols=237 Identities=21% Similarity=0.317 Sum_probs=184.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+++|+
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 357899999999999997 477999999976555556789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC---CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccCCC
Q 004935 508 LQALLLGEEA---DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAGTP 580 (723)
Q Consensus 508 L~~~l~~~~~---~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 580 (723)
|.+++....- .+..+.. .+..+|+...|||||||+|||++.++++||+|||+|+.+.... .......||+
T Consensus 104 L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~ 180 (293)
T d1yhwa1 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTP 180 (293)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---CCBCCCCSCG
T ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc---ccccccccCC
Confidence 9998875421 1222222 3334444444999999999999999999999999998764332 2334567999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHHHHHH
Q 004935 581 GYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVWKTVE 660 (723)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 660 (723)
.|+|||.+.+..++.++|||||||++|||+||+.||........+.. ....+. +.+. ........+.+
T Consensus 181 ~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~------~~~~--~~~~~s~~~~~ 248 (293)
T d1yhwa1 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGT------PELQ--NPEKLSAIFRD 248 (293)
T ss_dssp GGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHHCS------CCCS--SGGGSCHHHHH
T ss_pred CccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH----HHhCCC------CCCC--CcccCCHHHHH
Confidence 99999999999999999999999999999999999976543222211 111111 0110 11112235779
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 004935 661 IAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 661 l~~~Cl~~~p~~RPsm~evl~ 681 (723)
++.+||+.||.+|||++|+++
T Consensus 249 li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=357.22 Aligned_cols=246 Identities=27% Similarity=0.455 Sum_probs=190.0
Q ss_pred HhhhhccccCcEEEEEEEECC---c--eEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEec-CCceEEEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLDG---T--EVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE-GTNRGLIYE 501 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~---~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 501 (723)
+|.++||+|+||+||+|.+.. + .||||+++.. .....++|.+|+++|++++||||++++|+|.. ....++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999999832 2 5899999754 45566889999999999999999999999875 457899999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC-c
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG-T 570 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 570 (723)
||++|+|.+++.... ....+..++.++.++|. +||||||+||||++++.+||+|||+++........ .
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999987643 33556666666666554 99999999999999999999999999876433221 1
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.|+........+...+. .+. ....|.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~--~~~~p~----- 257 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGR--RLLQPE----- 257 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTC--CCCCCT-----
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCC--CCCCcc-----
Confidence 223345689999999999999999999999999999999998888765443333333222 111 111111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
.....+.+++.+||+.+|++||+|+||++.|+++++
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122367899999999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-42 Score=358.11 Aligned_cols=243 Identities=31% Similarity=0.461 Sum_probs=191.6
Q ss_pred hhhhccccCcEEEEEEEECC-------ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG-------TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|+..+ +.||||+++... ....++|.+|+++|++++||||++++++|...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 35789999999999998742 589999997654 3446789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC----------------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCC
Q 004935 502 FMANGNLQALLLGEE----------------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGK 549 (723)
Q Consensus 502 y~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~ 549 (723)
|+++|+|.+++.... ...++|..++.++.++|. |||||||+|||||.+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~ 176 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCC
Confidence 999999999986431 124778888777777665 999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHH
Q 004935 550 FQAKIADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQW 628 (723)
Q Consensus 550 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~ 628 (723)
+.+||+|||+|+.+..... ........+++.|+|||.+.+..++.++|||||||++|||++|. +||...... +.
T Consensus 177 ~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~----e~ 251 (301)
T d1lufa_ 177 MVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE----EV 251 (301)
T ss_dssp GCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HH
T ss_pred CcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH----HH
Confidence 9999999999987643322 23334567889999999999999999999999999999999996 466544322 22
Q ss_pred HHHHhcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 004935 629 VSFMLGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESL 687 (723)
Q Consensus 629 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~ 687 (723)
... +..+.... ... ..+..+.+++.+||+.+|++||||.||++.|++++
T Consensus 252 ~~~-v~~~~~~~-----~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 252 IYY-VRDGNILA-----CPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH-HHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH-HHcCCCCC-----CCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 222 22222211 111 22236789999999999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=350.48 Aligned_cols=231 Identities=27% Similarity=0.368 Sum_probs=181.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4567899999999999998 46699999986432 223567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 504 ANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
++|+|.+++..... +++.. .+..+|+...|||||||+|||++.++.+||+|||+|+..... ..
T Consensus 89 ~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-----~~ 161 (263)
T d2j4za1 89 PLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RR 161 (263)
T ss_dssp TTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-----CC
T ss_pred CCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-----cc
Confidence 99999999875322 33332 333344444499999999999999999999999999875422 22
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++|||||||+||||+||+.||...... +...... ... +.+....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~-~~~------~~~p~~~--- 227 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRIS-RVE------FTFPDFV--- 227 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TTC------CCCCTTS---
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHH-cCC------CCCCccC---
Confidence 4567999999999999999999999999999999999999999754322 2122111 111 1111112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+||+.||++|||++|+++
T Consensus 228 -s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 -TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 235778999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=349.41 Aligned_cols=234 Identities=26% Similarity=0.423 Sum_probs=175.6
Q ss_pred hhhhccccCcEEEEEEEEC--CceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec----CCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD--GTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE----GTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E 501 (723)
|.+.||+|+||+||+|... +..||+|.+... .....+.|.+|+++|++++|||||++++++.. ....++|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 4568999999999999984 568999998654 34455679999999999999999999999864 345789999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHH----HHHHHHHhcc--ccccCCCCCCEEEc-CCCcEEEEeccCccccCCCCCCc
Q 004935 502 FMANGNLQALLLGEEA----DILSWE----GRLRIAIEAA--KVHRDVKSTNILLS-GKFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a--~vH~Dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~ 570 (723)
|+++|+|.+++..... ....|. ..+..+|+.. .+||||||+|||++ +++.+||+|||+|+....
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----- 167 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----- 167 (270)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-----
T ss_pred CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-----
Confidence 9999999999875421 112222 2333444443 49999999999997 578999999999986432
Q ss_pred eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 571 HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
.......||+.|+|||.+.+ .++.++|||||||+||||++|+.||........+ .+ .+..+... +.+....
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~-~i~~~~~~----~~~~~~~ 238 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YR-RVTSGVKP----ASFDKVA 238 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HH-HHTTTCCC----GGGGGCC
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH---HH-HHHcCCCC----cccCccC
Confidence 12345679999999998865 6999999999999999999999999754332222 22 22221111 1111111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+||+.+|++|||++|+++
T Consensus 239 ----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 239 ----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 225779999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=353.92 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=189.0
Q ss_pred hhhhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----ceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT----NRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~Ey~~~ 505 (723)
+.+.||+|+||.||+|+++|+.||||+++..... ...+..|+..+.+++||||++++|+|...+ ..++|||||++
T Consensus 7 l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 3578999999999999999999999999644321 122344555666789999999999997654 57899999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhccc------------------cccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEAAK------------------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~a~------------------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
|+|.+++++. .++|..++.+++++|. |||||||+||||++++.+||+|||+++......
T Consensus 86 g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 86 GSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 9999999764 4778877777766543 899999999999999999999999998765433
Q ss_pred CCc-eeeecccCCCccccccccccCC------CCChhhHHHHHHHHHHHHcCCCccccCccc----------ccHHHHHH
Q 004935 568 SGT-HVTTTIAGTPGYLDPEYYISNR------LTEKSDVYNFGVVLLEIITSKSVIERTHER----------IHITQWVS 630 (723)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SfGvvL~elltg~~p~~~~~~~----------~~~~~~~~ 630 (723)
... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+...... ........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 211 1234567999999999987542 677999999999999999999877432211 11122222
Q ss_pred HHhcCCCcccccCCcccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 631 FMLGKGDIESIVDPRLHEDF-DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 631 ~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.....+. .+|.+.... ..+....+.+++.+||+.+|++||||.||++.|+++.+-+..
T Consensus 243 ~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 243 KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 2222211 122222211 234566788999999999999999999999999988876654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=352.42 Aligned_cols=235 Identities=24% Similarity=0.390 Sum_probs=170.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEec--CCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--GTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|+. +++.||||++.... ....+.|.+|+++|++++|||||++++++.+ .+..++||||+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 457899999999999998 46799999987653 3445679999999999999999999999864 45678999999
Q ss_pred CCCCHHHHhccC--CCCCCCHHH------H----HHHHHhcc-----ccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 504 ANGNLQALLLGE--EADILSWEG------R----LRIAIEAA-----KVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 504 ~~gsL~~~l~~~--~~~~l~~~~------~----l~i~~~~a-----~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++|+|.+++... ....+++.. + +..+|+.. .|||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 ~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 999999998642 122333333 3 33333322 389999999999999999999999999876432
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcc
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRL 646 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 646 (723)
........||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +... .+..+... .+
T Consensus 168 ---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~-~i~~~~~~-----~~ 234 (269)
T d2java1 168 ---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG-KIREGKFR-----RI 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH-HHHHTCCC-----CC
T ss_pred ---CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHH-HHHcCCCC-----CC
Confidence 22334567999999999999999999999999999999999999999765332 1111 12222211 11
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..... ..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12222 35779999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=354.18 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=182.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
+.+.||+|+||.||+|+. ++..||||++........+.|.+|+++|++++|||||++++++.+.+..++|||||++|+
T Consensus 16 i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 457899999999999998 466999999987766667889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
|.+++..... .+++.. .+..+|+...+||||||+|||++.++.+||+|||+|+..... ........
T Consensus 96 L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---~~~~~~~~ 171 (288)
T d2jfla1 96 VDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQRRDSFI 171 (288)
T ss_dssp HHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---HHHHTCCC
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC---cccccccc
Confidence 9998764321 233333 333344444499999999999999999999999999765321 11223467
Q ss_pred CCCccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 578 GTPGYLDPEYYI-----SNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 578 gt~~y~aPE~~~-----~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
||+.|+|||.+. ...++.++|||||||+||||+||+.||........+.+... . .. +.+. ...
T Consensus 172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~----~-~~-----~~~~--~~~ 239 (288)
T d2jfla1 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----S-EP-----PTLA--QPS 239 (288)
T ss_dssp SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH----S-CC-----CCCS--SGG
T ss_pred cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----C-CC-----CCCC--ccc
Confidence 999999999984 45689999999999999999999999976554332222211 1 11 1110 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.||++|||++|+++
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12336789999999999999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=345.60 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=181.8
Q ss_pred HhhhhccccCcEEEEEEEECC-----ceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYLDG-----TEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||.||+|.+.. ..||||.++... ....+.|.+|+++|++++|||||+++|+|. .+..++||||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence 346789999999999998732 368999987543 344567999999999999999999999996 4678999999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+++|+|.+++.... ..+++...+.++.+++. +||||||+||+++.++.+||+|||+++.+.... ...
T Consensus 89 ~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~--~~~ 165 (273)
T d1mp8a_ 89 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYK 165 (273)
T ss_dssp CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred ccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc--cee
Confidence 99999999876543 24566666665555543 999999999999999999999999998764322 223
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....||+.|+|||.+.+..++.++|||||||++|||+| |++||...... .+...+. .+.. +.+..
T Consensus 166 ~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~----~~~~-----~~~~~--- 232 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIE----NGER-----LPMPP--- 232 (273)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH----TTCC-----CCCCT---
T ss_pred ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHH----cCCC-----CCCCC---
Confidence 345568999999999999999999999999999999998 88888765443 2222222 2111 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIETA 692 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~ 692 (723)
.....+.+++.+||+.+|++|||++||++.|+.+++.+++
T Consensus 233 -~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 233 -NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence 2234678999999999999999999999999999887765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=348.73 Aligned_cols=242 Identities=26% Similarity=0.369 Sum_probs=179.4
Q ss_pred hhhhccccCcEEEEEEEEC---C--ceEEEEEecCC---ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD---G--TEVAVKMLSPS---SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---~--~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|++. + ..||||++... .....++|.+|+++|++++||||++++|+|.+ ...++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 4578999999999999873 2 27999998754 23445789999999999999999999999976 46789999
Q ss_pred eCCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCce
Q 004935 502 FMANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
|+++|++.+++..+. ..+++..++.++.++|. +||||||+||||+.++.+||+|||+++..........
T Consensus 91 ~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~ 169 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169 (273)
T ss_dssp CCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEE
T ss_pred eecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcce
Confidence 999999998876542 23667666666665554 9999999999999999999999999998755444333
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDF 650 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 650 (723)
......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +........+.. +....
T Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~~~~~~-----~~~~~-- 238 (273)
T d1u46a_ 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGER-----LPRPE-- 238 (273)
T ss_dssp C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCC-----CCCCT--
T ss_pred ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHHhCCCC-----CCCcc--
Confidence 3445568889999999999999999999999999999998 89999755332 222222222211 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 004935 651 DINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNES 686 (723)
Q Consensus 651 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~ 686 (723)
.....+.+++.+||+.+|++||||+||++.|+++
T Consensus 239 --~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 --DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223678999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-41 Score=349.32 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=182.5
Q ss_pred HhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecC-CceEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEG-TNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~~l 498 (723)
.+.+.||+|+||.||+|... ++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... ...++
T Consensus 16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i 95 (299)
T d1ywna1 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 95 (299)
T ss_dssp EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence 34678999999999999872 2479999997643 44567788999988887 789999999998664 46899
Q ss_pred EEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl 554 (723)
|||||++|+|.+++.... ...+++...+.++.+++. |||||||+||||++++.+||
T Consensus 96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl 175 (299)
T d1ywna1 96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 175 (299)
T ss_dssp EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEE
Confidence 999999999999997542 234677766666655544 99999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++|||+||. +||........+...+.
T Consensus 176 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~--- 251 (299)
T d1ywna1 176 CDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--- 251 (299)
T ss_dssp CC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH---
T ss_pred ccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Confidence 99999987643332 22334567999999999999999999999999999999999975 56765443322222222
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.+.. +..... ....+.+++.+||+.+|++||||+||++.|+++++..
T Consensus 252 -~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 252 -EGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp -HTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -cCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2211 111111 2236789999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=353.16 Aligned_cols=243 Identities=29% Similarity=0.431 Sum_probs=188.2
Q ss_pred hhhhccccCcEEEEEEEEC--Cc--eEEEEEecCC-ChhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEEEEeC
Q 004935 430 FERVLGNGGFGTVYHGYLD--GT--EVAVKMLSPS-SAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
+.+.||+|+||.||+|++. +. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+.+..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 4578999999999999983 33 5888888654 334556799999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhccC--------------CCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccC
Q 004935 504 ANGNLQALLLGE--------------EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGL 559 (723)
Q Consensus 504 ~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGl 559 (723)
++|+|.++++.. ....++|..++.++.++|. +||||||+|||++.++.+||+|||+
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~ 173 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccc
Confidence 999999999754 2356788888777777665 9999999999999999999999999
Q ss_pred ccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCC-ccccCcccccHHHHHHHHhcCCCc
Q 004935 560 SRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKS-VIERTHERIHITQWVSFMLGKGDI 638 (723)
Q Consensus 560 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~ 638 (723)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..+.... +..+.
T Consensus 174 a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----~~~~~~~-i~~~~- 243 (309)
T d1fvra_ 174 SRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEK-LPQGY- 243 (309)
T ss_dssp EESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH-GGGTC-
T ss_pred cccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----HHHHHHH-HHhcC-
Confidence 98653221 1234468999999999999999999999999999999999765 554432 2222222 22221
Q ss_pred ccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhH
Q 004935 639 ESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIE 690 (723)
Q Consensus 639 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~ 690 (723)
.+.... .....+.+++.+||+.+|++||||+||++.|+.+++..
T Consensus 244 ----~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 244 ----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111111 22346789999999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=355.37 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=181.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.||+|+||+||+|+. +++.||+|+++... ....+++.+|+++|++++|||||+++++|.+.++.++|||||++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 47899999999999998 46799999997653 3345679999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCC--------CCCHHHHHHHHHhc-cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecccC
Q 004935 508 LQALLLGEEAD--------ILSWEGRLRIAIEA-AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIAG 578 (723)
Q Consensus 508 L~~~l~~~~~~--------~l~~~~~l~i~~~~-a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~g 578 (723)
|.+++.+...- ..+....+..+|+. ..+||||||+|||+++++++||+|||+|+..... ......|
T Consensus 91 L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-----~~~~~~G 165 (322)
T d1s9ja_ 91 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVG 165 (322)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-----TC---CC
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-----ccccccC
Confidence 99999754221 11233344555543 4599999999999999999999999999875321 2234689
Q ss_pred CCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-------------ccccc---
Q 004935 579 TPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-------------IESIV--- 642 (723)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~i~--- 642 (723)
|+.|+|||.+.+..++.++||||+||+++||++|+.||...........+......... .....
T Consensus 166 T~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T d1s9ja_ 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245 (322)
T ss_dssp SSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------
T ss_pred CccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccc
Confidence 99999999999999999999999999999999999999764322110000000000000 00000
Q ss_pred ----------------CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHH
Q 004935 643 ----------------DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM--ELNE 685 (723)
Q Consensus 643 ----------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~--~L~~ 685 (723)
.+.+.. ......+.+++.+||+.||.+|||++|+++ .+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 246 PPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000 001235779999999999999999999987 3543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-40 Score=351.59 Aligned_cols=237 Identities=19% Similarity=0.283 Sum_probs=185.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|+. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 34568899999999999998 4779999999887777778899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHH----------HHHhccccccCCCCCCEEEcC--CCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEEADILSWEGRLR----------IAIEAAKVHRDVKSTNILLSG--KFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~----------i~~~~a~vH~Dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+|.+++..... .+++..... .+|+...|||||||+|||++. ++.+||+|||+++.+... ...
T Consensus 108 g~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~----~~~ 182 (350)
T d1koaa2 108 GELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSV 182 (350)
T ss_dssp CBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT----SCE
T ss_pred CCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc----ccc
Confidence 999999865422 244443333 333333499999999999964 578999999999876432 223
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-CCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-GDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~i~d~~l~~~~~~ 652 (723)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +........ .... +....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~----~~~~~---- 250 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSCDWNMD----DSAFS---- 250 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSC----CGGGG----
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC----ccccc----
Confidence 4567999999999999999999999999999999999999999755332 222221111 1111 11111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.||++|||++|+++
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11235779999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=351.78 Aligned_cols=238 Identities=20% Similarity=0.299 Sum_probs=179.7
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 34568999999999999998 46799999986432 22346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 503 MANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+++|+|.+++..... .+..+.. .+..+|+...|||||||+|||+++++.+||+|||+|+.+..... .....
T Consensus 90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~ 168 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARAN 168 (288)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc-ccccc
Confidence 999999998875421 1122222 33333444449999999999999999999999999987643322 22334
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++||||+||+||||+||+.||...... +...... .+. ..+.....
T Consensus 169 ~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~-~~~------~~~p~~~s--- 234 (288)
T d1uu3a_ 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKII-KLE------YDFPEKFF--- 234 (288)
T ss_dssp -CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-TTC------CCCCTTCC---
T ss_pred cccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHHHHH-cCC------CCCCccCC---
Confidence 567999999999999999999999999999999999999999765322 1111111 111 11112222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 235 -PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 35679999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=346.67 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=184.8
Q ss_pred hhhhccccCcEEEEEEEEC--Cc----eEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYLD--GT----EVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
+.+.||+|+||.||+|.+. ++ .||+|+++.. .....++|.+|+++|++++|||||+++|+|.++ ..++++||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEe
Confidence 4579999999999999873 32 5999998754 344567899999999999999999999999865 56788999
Q ss_pred CCCCCHHHHhccCCCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+.+|+|.+++... ...+++..++.++.++|. |||||||+||||+.++.+||+|||+++....... ...
T Consensus 92 ~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~ 169 (317)
T d1xkka_ 92 MPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYH 169 (317)
T ss_dssp CTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC----
T ss_pred ccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc-ccc
Confidence 9999999987764 334666666666655553 9999999999999999999999999998654332 223
Q ss_pred eecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 573 TTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
.....||+.|+|||.+.++.++.++|||||||+||||+| |+.||...... .+...+.. +.. +. .+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~~----~~~-----~~----~p 235 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK----GER-----LP----QP 235 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHHH----TCC-----CC----CC
T ss_pred ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc----CCC-----CC----CC
Confidence 344568999999999999999999999999999999999 78888755432 23332221 110 01 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
......+.+++.+||+.+|.+||||+|+++.|+.+...
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 12234678999999999999999999999999887644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=345.27 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=194.3
Q ss_pred HhhhhccccCcEEEEEEEEC-------CceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 499 (723)
.+.+.||+|+||.||+|++. ++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+....++|
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv 105 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence 34678999999999999862 3489999998654 34556799999999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHhccCC----------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEE
Q 004935 500 YEFMANGNLQALLLGEE----------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAK 553 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~k 553 (723)
||||++|+|.++++... ...+++..++.++.+++. |||||||+|||++.++.+|
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~k 185 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEE
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCccc
Confidence 99999999999987542 124677776666666554 9999999999999999999
Q ss_pred EEeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcC-CCccccCcccccHHHHHHHH
Q 004935 554 IADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITS-KSVIERTHERIHITQWVSFM 632 (723)
Q Consensus 554 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg-~~p~~~~~~~~~~~~~~~~~ 632 (723)
|+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+|+ ++|+........+.+.+...
T Consensus 186 i~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 186 ICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp ECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred ccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999998754332 3444567789999999999999999999999999999999995 55554443332333333221
Q ss_pred hcCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 633 LGKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 633 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
.. + ..+......+.+++.+||+.+|.+||||++|+++|++.++.
T Consensus 265 ~~---------~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 265 FR---------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp CC---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 1 11111224678999999999999999999999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-40 Score=345.93 Aligned_cols=230 Identities=23% Similarity=0.348 Sum_probs=178.1
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
..+.||+|+||.||+|+. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 357899999999999997 46689999987653 2344679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 505 NGNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|+|..++... ..+++.....++.++ ..|||||||+||||+.++.+||+|||+|+.... ..
T Consensus 99 ~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------~~ 169 (309)
T d1u5ra_ 99 GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------AN 169 (309)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------BC
T ss_pred CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-------CC
Confidence 99998766543 234554444443333 339999999999999999999999999987532 23
Q ss_pred cccCCCcccccccccc---CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 575 TIAGTPGYLDPEYYIS---NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~---~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....... .. +.+...
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----~~~i~~~-~~-----~~~~~~-- 237 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQN-ES-----PALQSG-- 237 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHS-CC-----CCCSCT--
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhC-CC-----CCCCCC--
Confidence 4579999999999864 4589999999999999999999999975543221 1111111 11 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.....+.+++.+||+.||.+|||++|+++
T Consensus 238 -~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 -HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11235779999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=346.94 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=192.6
Q ss_pred hhhhccccCcEEEEEEEEC-------CceEEEEEecCC-ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYLD-------GTEVAVKMLSPS-SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|.+. +..||||+++.. .......|.+|++++++++||||++++|+|...+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999873 358999999764 34455679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccC--------CCCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEEEeccCcccc
Q 004935 502 FMANGNLQALLLGE--------EADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKIADFGLSRTF 563 (723)
Q Consensus 502 y~~~gsL~~~l~~~--------~~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl~DfGla~~~ 563 (723)
||++|+|.+++... ....++|..++.++.++|. +||||||+|||+++++++||+|||+++.+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~ 183 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceec
Confidence 99999999988643 2234677777777666654 99999999999999999999999999876
Q ss_pred CCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCC-CccccCcccccHHHHHHHHhcCCCccccc
Q 004935 564 PVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSK-SVIERTHERIHITQWVSFMLGKGDIESIV 642 (723)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 642 (723)
..... ........+|+.|+|||.+.+..++.++|||||||+||||+||+ .|+.... ..+...... .+....
T Consensus 184 ~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~----~~~~~~~i~-~~~~~~-- 255 (308)
T d1p4oa_ 184 YETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFVM-EGGLLD-- 255 (308)
T ss_dssp GGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHHHH-TTCCCC--
T ss_pred cCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH-hCCCCC--
Confidence 43322 22233446899999999999999999999999999999999985 5665432 233333222 222111
Q ss_pred CCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 004935 643 DPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLA 688 (723)
Q Consensus 643 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~ 688 (723)
... .....+.+++.+||+.+|++||||++|++.|++.++
T Consensus 256 ---~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 256 ---KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---Ccc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 122468899999999999999999999999988765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=347.83 Aligned_cols=237 Identities=23% Similarity=0.345 Sum_probs=167.0
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh-hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA-QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 34568999999999999998 467899999976542 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEc---CCCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|+|.+++.... .+++... +..+|+...+||||||+|||+. +++.+||+|||+|+..... .
T Consensus 91 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~----~ 164 (307)
T d1a06a_ 91 GGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----S 164 (307)
T ss_dssp SCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred CCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC----C
Confidence 999999997642 2343333 3334444449999999999994 5789999999999865322 2
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......||+.|+|||.+.+..++.++|||||||+||||++|+.||....... ....... +... .+......
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~-~~~~--~~~~~~~~-- 235 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILK-AEYE--FDSPYWDD-- 235 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHT-TCCC--CCTTTTTT--
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhc-cCCC--CCCccccC--
Confidence 2344679999999999999999999999999999999999999997653321 1111111 1110 01111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+||+.||++|||++|+++
T Consensus 236 --~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 236 --ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2235789999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.7e-40 Score=348.25 Aligned_cols=238 Identities=20% Similarity=0.277 Sum_probs=185.7
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
+.+.+.||+|+||.||+|.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 34568999999999999998 4779999999877766677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEc--CCCcEEEEeccCccccCCCCCCceee
Q 004935 506 GNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLS--GKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
|+|.+++..... .++.. ..+..+|+...|||||||+||||+ .++.+||+|||+|+.+... ...
T Consensus 111 g~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~----~~~ 185 (352)
T d1koba_ 111 GELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD----EIV 185 (352)
T ss_dssp CBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT----SCE
T ss_pred ChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC----Cce
Confidence 999988765422 23332 333444444449999999999998 6789999999999886432 233
Q ss_pred ecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHH
Q 004935 574 TTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 653 (723)
....||+.|+|||.+.+..++.++||||+||+||||+||+.||........ ....... ... ..+.....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~-~~~--~~~~~~~~---- 254 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRC-DWE--FDEDAFSS---- 254 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHC-CCC--CCSSTTTT----
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhC-CCC--CCcccccC----
Confidence 456789999999999999999999999999999999999999976543221 1111111 100 01111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
....+.+++.+||+.||.+|||++|+++
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2235779999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-40 Score=342.11 Aligned_cols=245 Identities=29% Similarity=0.435 Sum_probs=189.3
Q ss_pred hhhhccccCcEEEEEEEECC---------ceEEEEEecCCC-hhhHHHHHHHHHHHHhc-cCCceeeEEEEEecCCceEE
Q 004935 430 FERVLGNGGFGTVYHGYLDG---------TEVAVKMLSPSS-AQGYKQFQAEVELLMRI-HHKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 498 (723)
+.+.||+|+||.||+|+..+ ..||||+++... .....++.+|+..+.++ +|||||+++++|.+.+..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 45789999999999998622 369999997754 34557899999999998 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHhccc----------cccCCCCCCEEEcCCCcEEE
Q 004935 499 IYEFMANGNLQALLLGEE--------------ADILSWEGRLRIAIEAAK----------VHRDVKSTNILLSGKFQAKI 554 (723)
Q Consensus 499 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~~a~----------vH~Dlk~~NILl~~~~~~kl 554 (723)
|||||++|+|.+++..+. ...+++...+.++.+++. |||||||+|||++.++.+||
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl 176 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 176 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEe
Confidence 999999999999997543 234677777766666554 99999999999999999999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHc-CCCccccCcccccHHHHHHHHh
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIIT-SKSVIERTHERIHITQWVSFML 633 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~ellt-g~~p~~~~~~~~~~~~~~~~~~ 633 (723)
+|||+++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |++||...... + +...+
T Consensus 177 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~-~~~~i 250 (299)
T d1fgka_ 177 ADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E-LFKLL 250 (299)
T ss_dssp CSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H-HHHHH
T ss_pred ccchhhcccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----H-HHHHH
Confidence 99999997754332 233445678999999999999999999999999999999998 67777654321 1 11222
Q ss_pred cCCCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 004935 634 GKGDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAI 689 (723)
Q Consensus 634 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~ 689 (723)
..+.. +..... ....+.+++.+||+.+|++|||+.||++.|++++++
T Consensus 251 ~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 251 KEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22211 111111 223678999999999999999999999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=341.02 Aligned_cols=237 Identities=23% Similarity=0.308 Sum_probs=181.4
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh------hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEE
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA------QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 499 (723)
+.+.+.||+|+||.||+|+. +++.||||++..... ...+.|.+|+++|++++|||||++++++.+.+..++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34567899999999999998 467999999865321 2357899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcCCC----cEEEEeccCccccCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSGKF----QAKIADFGLSRTFPV 565 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~~~----~~kl~DfGla~~~~~ 565 (723)
||||++|+|.+++.... .+++... +..+|+...+||||||+|||++.++ .+||+|||+++....
T Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 99999999999987542 2333333 3334444449999999999998776 599999999987643
Q ss_pred CCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCc
Q 004935 566 EGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPR 645 (723)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 645 (723)
. .......+|+.|+|||.+.+..++.++|||||||+||||+||+.||........ ..... ..... ..+.
T Consensus 170 ~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~-~~~~~--~~~~ 238 (293)
T d1jksa_ 170 G----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----LANVS-AVNYE--FEDE 238 (293)
T ss_dssp S----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-TTCCC--CCHH
T ss_pred C----ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH----HHHHH-hcCCC--CCch
Confidence 2 223456789999999999999999999999999999999999999976543221 11111 11100 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... ....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 239 YFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 1235679999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-39 Score=336.92 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=178.6
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----ceEEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT----NRGLI 499 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 499 (723)
.+.+.||+|+||.||+|.. +++.||||+++... ....+.|.+|+++|++++||||+++++++...+ ..++|
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 4567899999999999997 47799999997643 334567999999999999999999999986644 37899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+++|+|.+++.... .+++...+.++ |+...+||||||+|||++.++..+|+|||.++........
T Consensus 90 mE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred EECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence 99999999999886542 24444433333 3333399999999999999999999999999876443333
Q ss_pred ceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCC
Q 004935 570 THVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHED 649 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~ 649 (723)
........||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +............. ......
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~~~~~~~~~~---~~~~~~ 240 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPP---SARHEG 240 (277)
T ss_dssp -----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCG---GGTSSS
T ss_pred ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH----HHHHHHHhcCCCCC---chhccC
Confidence 33445667999999999999999999999999999999999999999765332 22222222221110 011111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhh
Q 004935 650 FDINSVWKTVEIAMACVSQTSTKRP-TMNQVVMELNESL 687 (723)
Q Consensus 650 ~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~ 687 (723)
....+.+++.+|++.||++|| |++++++.|..+.
T Consensus 241 ----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 241 ----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 223677999999999999999 8999998887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-39 Score=336.67 Aligned_cols=232 Identities=22% Similarity=0.318 Sum_probs=181.0
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 3467899999999999998 47799999986432 233567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCC----CCHH----HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEADI----LSWE----GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~~~----l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|+|..++....... ..+. ..+..+|+...|||||||+|||++.++.+||+|||+|+..... ...
T Consensus 87 ~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~------~~~ 160 (316)
T d1fota_ 87 EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYT 160 (316)
T ss_dssp CSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCC
T ss_pred CCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc------ccc
Confidence 9999999887653321 1222 2333444444499999999999999999999999999876422 234
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++||||+||+||||+||+.||...... +........ . ..+....+
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~-~------~~~p~~~s---- 225 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNA-E------LRFPPFFN---- 225 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHC-C------CCCCTTSC----
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----HHHHHHHcC-C------CCCCCCCC----
Confidence 67999999999999999999999999999999999999999765432 222222111 1 11111122
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
..+.+++.+|++.+|.+|| |++|+++
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 3567999999999999996 8888875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=339.81 Aligned_cols=235 Identities=23% Similarity=0.312 Sum_probs=182.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||.||+|+. +++.||||+++... ....+++.+|+.+|++++||||+++++++.+.+..++|||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 3467899999999999998 57799999997532 223567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC----CCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeec
Q 004935 504 ANGNLQALLLGEEA----DILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTT 575 (723)
Q Consensus 504 ~~gsL~~~l~~~~~----~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 575 (723)
++|+|.+++..... .+..+ ...+..+|+...|||||||+|||++.++.+||+|||+|+...... .....
T Consensus 88 ~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~---~~~~~ 164 (337)
T d1o6la_ 88 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKT 164 (337)
T ss_dssp TTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---CCBCC
T ss_pred CCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC---ccccc
Confidence 99999999876422 12222 333444455555999999999999999999999999998754322 22345
Q ss_pred ccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHH
Q 004935 576 IAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSV 655 (723)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 655 (723)
..||+.|+|||.+.+..++.++||||+||+||||++|+.||...... +...... .+. ..+.....
T Consensus 165 ~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i~-~~~------~~~p~~~s---- 229 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELIL-MEE------IRFPRTLS---- 229 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCC------CCCCTTSC----
T ss_pred ceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHHHHh-cCC------CCCCccCC----
Confidence 67999999999999999999999999999999999999999765432 1122111 111 11112222
Q ss_pred HHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 656 WKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 656 ~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+||+.||++||+ ++|+++
T Consensus 230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 35679999999999999995 667665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=331.99 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=177.5
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhh-----HHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQG-----YKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
++||+|+||+||+|+. +++.||||+++...... .+.+.+|+++|++++|||||++++++...++.++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999998 46799999987543221 2468999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
++++..+...... .+..|.. .+..+|+...+||||||+|||++.++.+||+|||+++...... ......
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---~~~~~~ 160 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQ 160 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---CCCCCS
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc---ccccce
Confidence 9888877654321 2223333 3444445455999999999999999999999999998764332 222345
Q ss_pred cCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCC-------cc--
Q 004935 577 AGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDP-------RL-- 646 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~-------~l-- 646 (723)
.||+.|+|||.+... .++.++|||||||+++||+||+.||....+...+....+.. .........+. ..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL-GTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSSSTTSSTTCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhc-CCCChhhccchhccchhhhhcc
Confidence 789999999998754 57999999999999999999999997665443333333221 11110000000 00
Q ss_pred cCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 HEDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 ~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...... .....+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000111 11246789999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-38 Score=325.50 Aligned_cols=235 Identities=22% Similarity=0.312 Sum_probs=179.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---------hhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---------QGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---------~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 497 (723)
+.+.||+|+||+||+|+. +++.||||+++.... ...+.+.+|+.+|++++ ||||+++++++.+.+..+
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 467899999999999998 567999999875421 12346889999999997 999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCHHHHHHH----------HHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADILSWEGRLRI----------AIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEG 567 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~l~i----------~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 567 (723)
||||||++|+|.+++.... .+++.....+ +|+...+||||||+|||++.++.+||+|||+++......
T Consensus 87 ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 164 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC
Confidence 9999999999999997542 2444443333 333333999999999999999999999999998764322
Q ss_pred CCceeeecccCCCcccccccccc------CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc
Q 004935 568 SGTHVTTTIAGTPGYLDPEYYIS------NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI 641 (723)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 641 (723)
......||+.|+|||.+.+ ..++.++||||+||+|+||+||+.||......... .... .+...
T Consensus 165 ----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----~~i~-~~~~~-- 233 (277)
T d1phka_ 165 ----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----RMIM-SGNYQ-- 233 (277)
T ss_dssp ----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHH-HTCCC--
T ss_pred ----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----HHHH-hCCCC--
Confidence 2345679999999999863 34788999999999999999999999865432211 1111 11111
Q ss_pred cCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
+...........+.+++.+||+.+|++|||++||++
T Consensus 234 ----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 ----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001011112236789999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=334.76 Aligned_cols=234 Identities=19% Similarity=0.249 Sum_probs=174.4
Q ss_pred hhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhc-cCCceeeEEEEEec----CCceEEEEEeCC
Q 004935 432 RVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRI-HHKNLTTLVGYCDE----GTNRGLIYEFMA 504 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~Ey~~ 504 (723)
+.||+|+||.||+|+. +++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5699999999999997 4679999998643 4578899987665 89999999999865 466899999999
Q ss_pred CCCHHHHhccCCCCCCCHHHH----------HHHHHhccccccCCCCCCEEEcC---CCcEEEEeccCccccCCCCCCce
Q 004935 505 NGNLQALLLGEEADILSWEGR----------LRIAIEAAKVHRDVKSTNILLSG---KFQAKIADFGLSRTFPVEGSGTH 571 (723)
Q Consensus 505 ~gsL~~~l~~~~~~~l~~~~~----------l~i~~~~a~vH~Dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~~ 571 (723)
+|+|.+++.......+++... +..+|+...+||||||+|||++. ++.+||+|||+|+......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---- 168 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---- 168 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC----
Confidence 999999998654444544433 33344444499999999999985 4679999999998764322
Q ss_pred eeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCC
Q 004935 572 VTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFD 651 (723)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 651 (723)
......||+.|+|||.+.+..++.++|||||||+||||+||+.||........... +......+. ..+.....
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~~i~~~~------~~~~~~~~ 241 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQ------YEFPNPEW 241 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCS------SSCCTTHH
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-HHHHHhcCC------CCCCCccc
Confidence 23456799999999999999999999999999999999999999976543221111 111111111 00111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 652 INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 652 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
......+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122346789999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-38 Score=338.69 Aligned_cols=235 Identities=22% Similarity=0.298 Sum_probs=173.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCCh---hhHHHHHHH---HHHHHhccCCceeeEEEEEecCCceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA---QGYKQFQAE---VELLMRIHHKNLTTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 501 (723)
+.+.||+|+||.||+|+. +++.||||++..... .....+.+| +++++.++|||||++++++.+.+..++|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 467899999999999998 477999999864321 122334444 666777789999999999999999999999
Q ss_pred eCCCCCHHHHhccCCC----CCCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 502 FMANGNLQALLLGEEA----DILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 502 y~~~gsL~~~l~~~~~----~~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
||++|+|.+++..... .+..+.. .+..+|+...|||||||+|||++.++.+||+|||+|+.+... ..
T Consensus 88 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-----~~ 162 (364)
T d1omwa3 88 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KP 162 (364)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-----CC
T ss_pred ecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-----cc
Confidence 9999999999875422 1222222 334444444499999999999999999999999999876432 22
Q ss_pred ecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCH
Q 004935 574 TTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDI 652 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 652 (723)
....||+.|+|||.+.. ..++.++|||||||+||||+||+.||....... .....+ ...... +.+.....
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~-~~~~~~------~~~~~~~s- 233 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR-MTLTMA------VELPDSFS- 233 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHH-HSSSCC------CCCCSSSC-
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-hcccCC------CCCCCCCC-
Confidence 34579999999999875 568999999999999999999999997654322 222111 111111 11112222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 653 NSVWKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 653 ~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
..+.+++.+||+.||++||| ++|+++
T Consensus 234 ---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 234 ---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 35789999999999999999 466654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=329.91 Aligned_cols=235 Identities=14% Similarity=0.220 Sum_probs=181.4
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.+.||+|+||.||+|.. +++.||||+++.... ....+.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 3467899999999999998 466999999987653 3456889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCH----------HHHHHHHHhccccccCCCCCCEEEcCC--CcEEEEeccCccccCCCCCCceeee
Q 004935 507 NLQALLLGEEADILSW----------EGRLRIAIEAAKVHRDVKSTNILLSGK--FQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~----------~~~l~i~~~~a~vH~Dlk~~NILl~~~--~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
+|.+++..... .++. ...+..+|+...+||||||+|||++.+ ..+||+|||+++.... .....
T Consensus 87 ~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~----~~~~~ 161 (321)
T d1tkia_ 87 DIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP----GDNFR 161 (321)
T ss_dssp BHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT----TCEEE
T ss_pred cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc----CCccc
Confidence 99999975432 2332 233444444445999999999999854 5899999999987532 22334
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-CCcccccCCcccCCCCHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK-GDIESIVDPRLHEDFDIN 653 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~i~d~~l~~~~~~~ 653 (723)
...+|+.|+|||.+.+..++.++||||+||++|||++|+.||........ ....... ..... ......
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~----~~~~~~--- 230 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMNAEYTFDE----EAFKEI--- 230 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCH----HHHTTS---
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCh----hhccCC---
Confidence 46789999999999999999999999999999999999999976543221 1211111 01110 000111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 654 SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 654 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+.+++.+|++.||.+|||++|+++
T Consensus 231 -s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 -SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 235679999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-38 Score=332.23 Aligned_cols=231 Identities=21% Similarity=0.271 Sum_probs=179.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMA 504 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 504 (723)
+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+++|++++|||||++++++......++|+||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 357899999999999998 47799999986432 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC----CCCCH----HHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 505 NGNLQALLLGEEA----DILSW----EGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 505 ~gsL~~~l~~~~~----~~l~~----~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+|+|.+++..... .+..+ ...+..+|+...|||||||+|||++.++.+||+|||+|+..... ....
T Consensus 125 ~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~------~~~~ 198 (350)
T d1rdqe_ 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTL 198 (350)
T ss_dssp TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------BCCC
T ss_pred ccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc------cccc
Confidence 9999999865422 11222 23344444444499999999999999999999999999876321 2346
Q ss_pred cCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHHHH
Q 004935 577 AGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINSVW 656 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 656 (723)
.||+.|+|||.+.+..++.++|||||||+||||+||+.||...... ....... .+. +...... ..
T Consensus 199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~-~~~------~~~p~~~----s~ 263 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIV-SGK------VRFPSHF----SS 263 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCC------CCCCTTC----CH
T ss_pred cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHHh-cCC------CCCCccC----CH
Confidence 7999999999999999999999999999999999999999765322 2222111 111 1111112 23
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004935 657 KTVEIAMACVSQTSTKRP-----TMNQVVM 681 (723)
Q Consensus 657 ~l~~l~~~Cl~~~p~~RP-----sm~evl~ 681 (723)
.+.+++.+||+.||.+|+ |++|+++
T Consensus 264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 577999999999999994 8888875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=332.97 Aligned_cols=235 Identities=22% Similarity=0.321 Sum_probs=179.0
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCC---hhhHHHHHHHHHHHH-hccCCceeeEEEEEecCCceEEEEEe
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS---AQGYKQFQAEVELLM-RIHHKNLTTLVGYCDEGTNRGLIYEF 502 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV~Ey 502 (723)
.+.+.||+|+||+||+|+. +++.||||+++... ....+.+..|..++. .++|||||++++++.+++..++||||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence 3568999999999999998 57799999997432 223456777777765 68999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCC----CCCHHH----HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 503 MANGNLQALLLGEEAD----ILSWEG----RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~----~l~~~~----~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
|++|+|.+++.....- +..+.. .+..+|+...+||||||+|||+++++.+||+|||+++...... ....
T Consensus 85 ~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---~~~~ 161 (320)
T d1xjda_ 85 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTN 161 (320)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBC
T ss_pred cCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc---cccc
Confidence 9999999999754321 222222 3334444444999999999999999999999999998754322 2334
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCcccCCCCHHH
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLHEDFDINS 654 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 654 (723)
...||+.|+|||.+.+..++.++|||||||++|||+||+.||.+.... +...... .+. +.+....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~-~~~------~~~p~~~---- 226 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIR-MDN------PFYPRWL---- 226 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCC------CCCCTTS----
T ss_pred ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCC------CCCCccC----
Confidence 567999999999999999999999999999999999999999765432 1111111 111 1121122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 004935 655 VWKTVEIAMACVSQTSTKRPTMN-QVVM 681 (723)
Q Consensus 655 ~~~l~~l~~~Cl~~~p~~RPsm~-evl~ 681 (723)
...+.+++.+||+.+|++|||++ |+++
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 23577999999999999999996 6653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=320.67 Aligned_cols=247 Identities=19% Similarity=0.277 Sum_probs=177.7
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANG 506 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 506 (723)
.+.||+|+||+||+|.. +++.||||+++.... ...+++.+|+++|++++|||||++++++.+.++.++||||+.++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence 47899999999999998 477999999965432 23468999999999999999999999999999999999999865
Q ss_pred CHHHHhccCCCCCCCHHHHHHHH----------HhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeecc
Q 004935 507 NLQALLLGEEADILSWEGRLRIA----------IEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTI 576 (723)
Q Consensus 507 sL~~~l~~~~~~~l~~~~~l~i~----------~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 576 (723)
+.+++.......+++.....++ |+...|||||||+|||++.++.+||+|||+|+...... ......
T Consensus 87 -~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~ 162 (298)
T d1gz8a_ 87 -LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHE 162 (298)
T ss_dssp -HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---BCTTCC
T ss_pred -hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc---ccceee
Confidence 4444443333445555444443 33334999999999999999999999999998764322 223445
Q ss_pred cCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCc--cccc-CCcccCC---
Q 004935 577 AGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDI--ESIV-DPRLHED--- 649 (723)
Q Consensus 577 ~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~i~-d~~l~~~--- 649 (723)
.||+.|+|||.+.... ++.++||||+||++|||++|+.||........+............. .... .+.....
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence 7999999999877665 5889999999999999999999998665433333333222111110 0000 0000000
Q ss_pred ---CC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 650 ---FD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 650 ---~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.. ......+.+++.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 011246789999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-36 Score=313.91 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=177.7
Q ss_pred hhhccccCcEEEEEEEE-CCceEEEEEecCCCh--hhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCCCC
Q 004935 431 ERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA--QGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 507 (723)
.+.||+|+||+||+|+. +++.||||++..... ...++|.+|+.+|++++||||+++++++...+..++++||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 46899999999999998 467999999976532 235789999999999999999999999999999999999999887
Q ss_pred HHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 508 LQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 508 L~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
+..+..... .++.. ..++.+|+...|||||||+|||++.++.+||+|||.+....... .......
T Consensus 87 ~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~ 161 (286)
T d1ob3a_ 87 KKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEI 161 (286)
T ss_dssp HHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------
T ss_pred HHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc---cccceec
Confidence 777765432 23333 33444444444999999999999999999999999998764322 2233456
Q ss_pred CCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCccccc--------CCccc-
Q 004935 578 GTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIV--------DPRLH- 647 (723)
Q Consensus 578 gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~--------d~~l~- 647 (723)
+++.|+|||.+.+. .++.++||||+||+++||++|+.||........+.+........ ...... +....
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTCCTTCCC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC-Chhhccchhhhhhccccccc
Confidence 89999999998765 56899999999999999999999997665443333332221111 100000 00000
Q ss_pred ------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 ------EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..........+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011112346779999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=314.92 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=173.6
Q ss_pred hhhhccccCcEEEEEEEEC---CceEEEEEecCCC--hhhHHHHHHHHHHHHhc---cCCceeeEEEEEec-----CCce
Q 004935 430 FERVLGNGGFGTVYHGYLD---GTEVAVKMLSPSS--AQGYKQFQAEVELLMRI---HHKNLTTLVGYCDE-----GTNR 496 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~~~ 496 (723)
+.+.||+|+||+||+|+.. ++.||||+++... ......+.+|+.+|+.+ +||||++++++|.. ....
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence 3578999999999999973 4479999986432 12223566788877766 79999999999853 3467
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 004935 497 GLIYEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVE 566 (723)
Q Consensus 497 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~ 566 (723)
++++||+++|.+....... ...+++. ..+..+|+...|||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~- 168 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 168 (305)
T ss_dssp EEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG-
T ss_pred EEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc-
Confidence 8999999998776554432 2223333 233344444449999999999999999999999999986532
Q ss_pred CCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc-------
Q 004935 567 GSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE------- 639 (723)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 639 (723)
........||+.|+|||.+.+..++.++||||+||+++||+||+.||........+..............
T Consensus 169 ---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 169 ---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp ---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 2233456799999999999999999999999999999999999999987654433333333221111000
Q ss_pred -cccC----CcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 640 -SIVD----PRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 640 -~i~d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
.... +.............+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000011112235678999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=320.85 Aligned_cols=227 Identities=24% Similarity=0.375 Sum_probs=171.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCCh------hhHHHHHHHHHHHHhcc--CCceeeEEEEEecCCceEE
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSA------QGYKQFQAEVELLMRIH--HKNLTTLVGYCDEGTNRGL 498 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~l 498 (723)
.+.+.||+|+||.||+|+. +++.||||++..... ....++.+|+.+|++++ |||||++++++.+.+..++
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence 3467899999999999998 467999999864321 12234778999999996 8999999999999999999
Q ss_pred EEEeCCC-CCHHHHhccCCC----CCCCHH----HHHHHHHhccccccCCCCCCEEEcCC-CcEEEEeccCccccCCCCC
Q 004935 499 IYEFMAN-GNLQALLLGEEA----DILSWE----GRLRIAIEAAKVHRDVKSTNILLSGK-FQAKIADFGLSRTFPVEGS 568 (723)
Q Consensus 499 V~Ey~~~-gsL~~~l~~~~~----~~l~~~----~~l~i~~~~a~vH~Dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 568 (723)
||||+.+ +++.+++..... .+..|. ..+..+|+...+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 v~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-- 164 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164 (273)
T ss_dssp EEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--
T ss_pred EEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc--
Confidence 9999986 678887764321 112222 23344444444999999999999854 79999999999875322
Q ss_pred CceeeecccCCCccccccccccCCC-CChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 569 GTHVTTTIAGTPGYLDPEYYISNRL-TEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
......||+.|+|||.+.+..+ +.++||||+||+||||+||+.||..... ..+ +. ..+.
T Consensus 165 ---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~-----~~------~~~~ 224 (273)
T d1xwsa_ 165 ---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-----GQ------VFFR 224 (273)
T ss_dssp ---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----CC------CCCS
T ss_pred ---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-----cc------cCCC
Confidence 2345679999999999987776 5679999999999999999999964321 111 11 0111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...+ ..+.+++.+|++.||++|||++|+++
T Consensus 225 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 225 QRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2222 35779999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-35 Score=306.51 Aligned_cols=250 Identities=16% Similarity=0.221 Sum_probs=186.3
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccC-CceeeEEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH-KNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|+. +++.||||++..... ...+.+|++.++.+.| +|++.+++++..+...++||||+ +
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 3467899999999999997 467999999865432 2457889999999965 89999999999999999999999 6
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHH----------hccccccCCCCCCEEEcC-----CCcEEEEeccCccccCCCCCCc
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAI----------EAAKVHRDVKSTNILLSG-----KFQAKIADFGLSRTFPVEGSGT 570 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~----------~~a~vH~Dlk~~NILl~~-----~~~~kl~DfGla~~~~~~~~~~ 570 (723)
|+|.+++..... .+++...+.++. +...+||||||+|||++. ++.+||+|||+|+.........
T Consensus 85 ~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 85 PSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 899998865432 345444444433 333399999999999974 5689999999999864332211
Q ss_pred ----eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHH--HHHHhcCCCcccccCC
Q 004935 571 ----HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQW--VSFMLGKGDIESIVDP 644 (723)
Q Consensus 571 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~i~d~ 644 (723)
.......||+.|+|||.+.+..++.++|||||||+++||+||+.||............ +..........
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~----- 238 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR----- 238 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----
T ss_pred ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH-----
Confidence 1233467999999999999999999999999999999999999999765433222221 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 645 RLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 645 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
.+....+ ..+.+++..|++.+|++||+++.+.+.|+++++...
T Consensus 239 ~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 239 ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1112222 357789999999999999999999999999875443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=314.99 Aligned_cols=244 Identities=19% Similarity=0.251 Sum_probs=171.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceeeEEEEEecC------CceEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG------TNRGLIYE 501 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E 501 (723)
..++||+|+||+||+|+. +++.||||++..... .+.+|+++|++++|+||+++++++... .+.+||||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 357899999999999998 467999999976532 235799999999999999999998543 34689999
Q ss_pred eCCCCCHHHHhcc-CCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCC
Q 004935 502 FMANGNLQALLLG-EEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 502 y~~~gsL~~~l~~-~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~ 569 (723)
||++|.+..+... .....+++.. .+..+|+...+||||||+|||++.++ .+||+|||+++......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-- 177 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-- 177 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc--
Confidence 9997755444332 1222344333 33344444449999999999999775 89999999998764322
Q ss_pred ceeeecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcC-------------
Q 004935 570 THVTTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGK------------- 635 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 635 (723)
......||..|+|||.+.+ ..++.++||||+||+++||++|+.||........+...++..-..
T Consensus 178 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred --ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 2334579999999998775 568999999999999999999999997665433333332211100
Q ss_pred -CCcccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 -GDIESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 -~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
..........+...........+.+++.+|++.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000111111122335789999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-35 Score=307.62 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=177.5
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCceee-EEEEEecCCceEEEEEeCCC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLTT-LVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~ 505 (723)
.+.+.||+|+||.||+|++ +++.||||++...... +++..|++++++++|+|++. +.++..+.+..++||||+.
T Consensus 10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~- 86 (299)
T d1ckia_ 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG- 86 (299)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-
T ss_pred EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-
Confidence 3567899999999999998 4679999998765432 45889999999998776555 4555577788899999995
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHhc----------cccccCCCCCCEEEc---CCCcEEEEeccCccccCCCCCCc--
Q 004935 506 GNLQALLLGEEADILSWEGRLRIAIEA----------AKVHRDVKSTNILLS---GKFQAKIADFGLSRTFPVEGSGT-- 570 (723)
Q Consensus 506 gsL~~~l~~~~~~~l~~~~~l~i~~~~----------a~vH~Dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~~~-- 570 (723)
|+|.+.+.... ..+++...+.++.++ ..|||||||+|||++ .+..+||+|||+|+.+.......
T Consensus 87 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 87 PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 56666554332 234554444444433 339999999999986 35679999999999875432211
Q ss_pred --eeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHH---HhcCCCcccccCCc
Q 004935 571 --HVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSF---MLGKGDIESIVDPR 645 (723)
Q Consensus 571 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~i~d~~ 645 (723)
.......||+.|+|||.+.+..++.++|||||||+++||+||+.||............... .... .. +.
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~ 239 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-----EV 239 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH-----HH
T ss_pred eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch-----hH
Confidence 1234567999999999999999999999999999999999999999765433222211111 1110 00 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhHh
Q 004935 646 LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVMELNESLAIET 691 (723)
Q Consensus 646 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~ 691 (723)
+.... ...+.+++..|++.+|++||+++++.+.|++++..+.
T Consensus 240 ~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 240 LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 11111 2357899999999999999999999999998875443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-35 Score=308.28 Aligned_cols=252 Identities=18% Similarity=0.223 Sum_probs=174.5
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEec--------CCceE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDE--------GTNRG 497 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~~~~~ 497 (723)
+.+.||+|+||+||+|+. +++.||||++.... ....+++.+|+++|++++|+||+++++.+.. .+..+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 357899999999999998 46799999986442 2345678999999999999999999998855 34678
Q ss_pred EEEEeCCCCCHHHHhccCCCCC--------CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEADI--------LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~~~--------l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+||||++++.+........... .++...+..+|+...+||||||+|||++.++.+||+|||+++........
T Consensus 94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence 9999999887776554332211 12334445555555599999999999999999999999999876432211
Q ss_pred -ceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC--CcccccCCc
Q 004935 570 -THVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG--DIESIVDPR 645 (723)
Q Consensus 570 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~i~d~~ 645 (723)
........||+.|+|||.+.+. .++.++||||+||+++||++|+.||........+....+...... .........
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 1122335699999999998765 689999999999999999999999976554333333222221111 000000000
Q ss_pred c--------cCCCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 646 L--------HEDFDIN-------SVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 646 l--------~~~~~~~-------~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. ....... ....+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 0001111 1234568999999999999999999885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=311.85 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=174.4
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC-hhhHHHHHHHHHHHHhccCCceeeEEEEEecCC----ceEEEEEe
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS-AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT----NRGLIYEF 502 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~Ey 502 (723)
..+.||+|+||+||+|.. +++.||||++.... ....+++++|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 357899999999999998 47799999997643 445678999999999999999999999996543 23566677
Q ss_pred CCCCCHHHHhccCCCCCCCHHH----------HHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCcee
Q 004935 503 MANGNLQALLLGEEADILSWEG----------RLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHV 572 (723)
Q Consensus 503 ~~~gsL~~~l~~~~~~~l~~~~----------~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 572 (723)
+.+|+|.+++.... +++.. .+..+|+...|||||||+|||+++++.+||+|||+++...........
T Consensus 92 ~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~ 168 (345)
T d1pmea_ 92 LMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168 (345)
T ss_dssp CCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred ecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcccee
Confidence 88999999997542 33333 334444444499999999999999999999999999876433222223
Q ss_pred eecccCCCcccccccccc-CCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccc----------
Q 004935 573 TTTIAGTPGYLDPEYYIS-NRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESI---------- 641 (723)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i---------- 641 (723)
.....||+.|+|||.+.. ..++.++||||+||+++||++|+.||............... .........
T Consensus 169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCHHHHHTCCCHHHHH
T ss_pred eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh-ccCCChhhhhhhhhhhhhc
Confidence 345679999999999854 56789999999999999999999999765432222111111 111000000
Q ss_pred ---cCCcccCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004935 642 ---VDPRLHEDFDI-----NSVWKTVEIAMACVSQTSTKRPTMNQVVME 682 (723)
Q Consensus 642 ---~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~ 682 (723)
..+.. ..... .....+.+++.+|++.||.+|||++|+++.
T Consensus 248 ~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 248 YLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000 011357799999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=314.11 Aligned_cols=241 Identities=23% Similarity=0.325 Sum_probs=181.9
Q ss_pred HHhhhhccccCcEEEEEEEE-----CCceEEEEEecCCC----hhhHHHHHHHHHHHHhccC-CceeeEEEEEecCCceE
Q 004935 428 NNFERVLGNGGFGTVYHGYL-----DGTEVAVKMLSPSS----AQGYKQFQAEVELLMRIHH-KNLTTLVGYCDEGTNRG 497 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~ 497 (723)
+.+.+.||+|+||+||+|+. +++.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 44568999999999999986 35689999986432 2234568899999999976 89999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCC----CCCCHHHH----HHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 498 LIYEFMANGNLQALLLGEEA----DILSWEGR----LRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 498 lV~Ey~~~gsL~~~l~~~~~----~~l~~~~~----l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
+++|||.+|+|.+++..... ....+..+ +..+|+...+||||||+|||++.++.+||+|||+++.+....
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~-- 183 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-- 183 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG--
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc--
Confidence 99999999999999875432 12223333 334444444999999999999999999999999998764322
Q ss_pred ceeeecccCCCccccccccccC--CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcccccCCccc
Q 004935 570 THVTTTIAGTPGYLDPEYYISN--RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIESIVDPRLH 647 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~ 647 (723)
........|++.|+|||.+.+. .++.++|||||||+|+||+||+.||.............+...... +.+.
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------~~~~ 256 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------PPYP 256 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------CCCC
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------CCCc
Confidence 2223456799999999998764 478899999999999999999999987765555444444332221 1111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004935 648 EDFDINSVWKTVEIAMACVSQTSTKRPT-----MNQVVM 681 (723)
Q Consensus 648 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~ 681 (723)
. +....+.+++.+|++.+|.+||| ++|+++
T Consensus 257 ~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred c----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 22346789999999999999995 677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=306.78 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=172.8
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEecCC------ceEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGT------NRGLI 499 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~lV 499 (723)
..+.||+|+||+||+|.. +++.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 357899999999999998 4779999999754 3344568899999999999999999999997654 46999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCHH----------HHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 500 YEFMANGNLQALLLGEEADILSWE----------GRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 500 ~Ey~~~gsL~~~l~~~~~~~l~~~----------~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
|||+ +.+|..+..... ++.. ..+..+|+...+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~e~~-~~~l~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---- 173 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---- 173 (346)
T ss_dssp EECC-SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred Eecc-cccHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC----
Confidence 9999 557877765432 3333 334444444449999999999999999999999999987532
Q ss_pred ceeeecccCCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCC-------C----
Q 004935 570 THVTTTIAGTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKG-------D---- 637 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~---- 637 (723)
......||+.|+|||.+.+. .++.++||||+||+++||++|+.||........+........... .
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 12456799999999998764 578999999999999999999999976644333322222111100 0
Q ss_pred ------cccccCCcccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 004935 638 ------IESIVDPRLHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVME--LNESL 687 (723)
Q Consensus 638 ------~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~--L~~~~ 687 (723)
..+.....+.. ........+.+++.+|++.||++|||++|+++. |+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 001112356799999999999999999999873 55443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=300.13 Aligned_cols=249 Identities=17% Similarity=0.202 Sum_probs=180.9
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecCCceEEEEEeCCC
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEGTNRGLIYEFMAN 505 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 505 (723)
..+.||+|+||+||+|++ +++.||||+++... ....+++.+|+.+|++++||||++++++|...+..++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 357899999999999998 46689999986543 33467899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC----CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeeeccc
Q 004935 506 GNLQALLLGEEAD----IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 506 gsL~~~l~~~~~~----~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
++|..++...... .. +....+..+|+...+||||||+|||++.++.+||+|||.++...... .......
T Consensus 86 ~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~---~~~~~~~ 162 (292)
T d1unla_ 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEV 162 (292)
T ss_dssp EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC---SCCCSCC
T ss_pred cccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC---ccceeec
Confidence 9998887654221 11 22233444444444999999999999999999999999998764332 2233446
Q ss_pred CCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCCcc------cccCC----cc
Q 004935 578 GTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGDIE------SIVDP----RL 646 (723)
Q Consensus 578 gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~i~d~----~l 646 (723)
++..|+|||.+.... ++.++||||+||+++||++|+.||............+.......... ...+. ..
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 778999999987665 68999999999999999999999755443333333222222211000 00000 00
Q ss_pred -----cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 647 -----HEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 647 -----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
...........+.+++.+|++.||.+|||++|+++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011112235678999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-34 Score=304.07 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=173.9
Q ss_pred HhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEec--CCceEEEEEeC
Q 004935 429 NFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDE--GTNRGLIYEFM 503 (723)
Q Consensus 429 ~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~Ey~ 503 (723)
.+.+.||+|+||+||+|+. +++.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 3467899999999999998 47799999997654 367899999999995 9999999999874 45689999999
Q ss_pred CCCCHHHHhccCC-CCC----CCHHHHHHHHHhccccccCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCceeeeccc
Q 004935 504 ANGNLQALLLGEE-ADI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKF-QAKIADFGLSRTFPVEGSGTHVTTTIA 577 (723)
Q Consensus 504 ~~gsL~~~l~~~~-~~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~ 577 (723)
++|+|..+...-. ..+ .+....+..+|+...+||||||+|||++.++ .+||+|||+|+...... ......
T Consensus 115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~----~~~~~~ 190 (328)
T d3bqca1 115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRV 190 (328)
T ss_dssp CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC----CCCSCC
T ss_pred CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC----cccccc
Confidence 9999987653211 111 1223334444444559999999999999655 68999999998764322 234567
Q ss_pred CCCccccccccccC-CCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc---------CCC------cccc
Q 004935 578 GTPGYLDPEYYISN-RLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG---------KGD------IESI 641 (723)
Q Consensus 578 gt~~y~aPE~~~~~-~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~------~~~i 641 (723)
+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............+...+. ... ....
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 270 (328)
T d3bqca1 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270 (328)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred cCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence 89999999998765 4799999999999999999999999755432211111111110 000 0000
Q ss_pred cCC-------c-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 642 VDP-------R-LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 642 ~d~-------~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... . ............+.+++.+|++.||++|||++|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 000001112235789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-34 Score=302.64 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=167.5
Q ss_pred hhhccccCcEEEEEEEE--CCceEEEEEecCC--ChhhHHHHHHHHHHHHhccCCceeeEEEEEec------CCceEEEE
Q 004935 431 ERVLGNGGFGTVYHGYL--DGTEVAVKMLSPS--SAQGYKQFQAEVELLMRIHHKNLTTLVGYCDE------GTNRGLIY 500 (723)
Q Consensus 431 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~lV~ 500 (723)
.+.||+|+||+||+|.+ +++.||||++... .....+++.+|+.+|++++||||+++++++.. ..+.++||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 46899999999999998 4779999999754 33445678999999999999999999999853 46789999
Q ss_pred EeCCCCCHHHHhccCCC--CC----CCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceeee
Q 004935 501 EFMANGNLQALLLGEEA--DI----LSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVTT 574 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~--~~----l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 574 (723)
||+.++.+... ...-. .+ .+....+..+|+...+||||||+|||++.++.+|++|||+++.... .....
T Consensus 102 Ey~~~~l~~~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~----~~~~~ 176 (355)
T d2b1pa1 102 ELMDANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 176 (355)
T ss_dssp ECCSEEHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred eccchHHHHhh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc----ccccc
Confidence 99987655544 32211 11 1222334444444459999999999999999999999999887532 22334
Q ss_pred cccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhc-------------------C
Q 004935 575 TIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLG-------------------K 635 (723)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~-------------------~ 635 (723)
...+|+.|+|||.+.+..++.++||||+||+++||++|+.||.................. .
T Consensus 177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (355)
T d2b1pa1 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256 (355)
T ss_dssp ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTS
T ss_pred cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcC
Confidence 567899999999999999999999999999999999999999765433222222221110 0
Q ss_pred CCc-----ccccCCcccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 636 GDI-----ESIVDPRLHED---FDINSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 636 ~~~-----~~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
... ........... ........+.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000001010 11223556789999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.7e-33 Score=295.97 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=172.2
Q ss_pred hhhhccccCcEEEEEEEE--CCceEEEEEecCCC--hhhHHHHHHHHHHHHhccCCceeeEEEEEecC-----CceEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSS--AQGYKQFQAEVELLMRIHHKNLTTLVGYCDEG-----TNRGLIY 500 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~ 500 (723)
..+.||+|+||+||+|+. +++.||||+++... ....+++.+|+++|++++|||+|++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 357899999999999997 47799999997543 34456789999999999999999999998543 3457778
Q ss_pred EeCCCCCHHHHhccCCCC---CC----CHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCCceee
Q 004935 501 EFMANGNLQALLLGEEAD---IL----SWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSGTHVT 573 (723)
Q Consensus 501 Ey~~~gsL~~~l~~~~~~---~l----~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 573 (723)
+|+.+|+|.+++....-. +. +....+..+|+...+||||||+|||++.++.+|++|||++.... ...
T Consensus 102 ~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~------~~~ 175 (348)
T d2gfsa1 102 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEM 175 (348)
T ss_dssp EECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT------GGG
T ss_pred EeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC------ccc
Confidence 889999999998654211 11 22233444444455999999999999999999999999997642 223
Q ss_pred ecccCCCccccccccccCC-CCChhhHHHHHHHHHHHHcCCCccccCcccccHHHHHHHHhcCCC-ccc---------cc
Q 004935 574 TTIAGTPGYLDPEYYISNR-LTEKSDVYNFGVVLLEIITSKSVIERTHERIHITQWVSFMLGKGD-IES---------IV 642 (723)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~-~~~~~DV~SfGvvL~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------i~ 642 (723)
....|++.|+|||...+.. ++.++||||+||+++||++|+.||.............+....... ... ..
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 3457889999999877654 689999999999999999999999765443222222222111100 000 00
Q ss_pred C--CcccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004935 643 D--PRLHEDFD-----INSVWKTVEIAMACVSQTSTKRPTMNQVVM 681 (723)
Q Consensus 643 d--~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~ 681 (723)
. +.. .... ......+.+++.+|++.||++|||++|+++
T Consensus 256 ~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 256 QSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000 0000 011235679999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.3e-29 Score=271.26 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=172.5
Q ss_pred HHhhhhccccCcEEEEEEEE--CCceEEEEEecCCChhhHHHHHHHHHHHHhcc-----------CCceeeEEEEEec--
Q 004935 428 NNFERVLGNGGFGTVYHGYL--DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-----------HKNLTTLVGYCDE-- 492 (723)
Q Consensus 428 ~~f~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~-- 492 (723)
+.+.+.||+|+||+||+|+. +++.||||+++.... ..+.+.+|++++++++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 34568999999999999998 577999999976532 3467889999998885 5789999988754
Q ss_pred CCceEEEEEeCCCCCHH-HHhccCCCCCCCH----------HHHHHHHHh-ccccccCCCCCCEEEcCCC------cEEE
Q 004935 493 GTNRGLIYEFMANGNLQ-ALLLGEEADILSW----------EGRLRIAIE-AAKVHRDVKSTNILLSGKF------QAKI 554 (723)
Q Consensus 493 ~~~~~lV~Ey~~~gsL~-~~l~~~~~~~l~~----------~~~l~i~~~-~a~vH~Dlk~~NILl~~~~------~~kl 554 (723)
.....++++++..+... ..........+.. ...+..+|. ...+||||||+|||++.++ .+++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence 34566777776655433 3333232222322 223334444 3359999999999998654 4999
Q ss_pred EeccCccccCCCCCCceeeecccCCCccccccccccCCCCChhhHHHHHHHHHHHHcCCCccccCccc------ccHHHH
Q 004935 555 ADFGLSRTFPVEGSGTHVTTTIAGTPGYLDPEYYISNRLTEKSDVYNFGVVLLEIITSKSVIERTHER------IHITQW 628 (723)
Q Consensus 555 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SfGvvL~elltg~~p~~~~~~~------~~~~~~ 628 (723)
+|||.+..... ......||+.|+|||.+.+..++.++||||+||+++||++|+.||...... ..+...
T Consensus 174 ~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 174 ADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp CCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999986532 223467999999999999999999999999999999999999998654321 111111
Q ss_pred HHHHhcCC------------------Cc-ccccCCc---------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004935 629 VSFMLGKG------------------DI-ESIVDPR---------LHEDFDINSVWKTVEIAMACVSQTSTKRPTMNQVV 680 (723)
Q Consensus 629 ~~~~~~~~------------------~~-~~i~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl 680 (723)
+. .+... .. ..+.... ............+.+++.+|++.||.+|||++|++
T Consensus 248 ~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 248 IE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11 11100 00 0000000 01122345667889999999999999999999998
Q ss_pred HH--HHHhhhhHh
Q 004935 681 ME--LNESLAIET 691 (723)
Q Consensus 681 ~~--L~~~~~~~~ 691 (723)
+. +++....+.
T Consensus 327 ~Hp~f~~~~~~~~ 339 (362)
T d1q8ya_ 327 NHPWLKDTLGMEE 339 (362)
T ss_dssp TCGGGTTCTTCTT
T ss_pred cCcccCCCCCccc
Confidence 73 555554433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.67 E-value=9e-18 Score=161.43 Aligned_cols=161 Identities=17% Similarity=0.203 Sum_probs=106.6
Q ss_pred hhhhccccCcEEEEEEEE-CCceEEEEEecCCCh------------------hhHHHHHHHHHHHHhccCCceeeEEEEE
Q 004935 430 FERVLGNGGFGTVYHGYL-DGTEVAVKMLSPSSA------------------QGYKQFQAEVELLMRIHHKNLTTLVGYC 490 (723)
Q Consensus 430 f~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 490 (723)
+.+.||+|+||.||+|.. +|+.||||+++.... .....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 357899999999999997 577999998754211 0123456788999999999999988663
Q ss_pred ecCCceEEEEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHhccccccCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 004935 491 DEGTNRGLIYEFMANGNLQALLLGEEA-DILSWEGRLRIAIEAAKVHRDVKSTNILLSGKFQAKIADFGLSRTFPVEGSG 569 (723)
Q Consensus 491 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~~a~vH~Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 569 (723)
..+++|||+++..+.++...... -..+....+..+|....+||||||+|||++++ .++|+|||+|+........
T Consensus 84 ----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~ 158 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158 (191)
T ss_dssp ----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH
T ss_pred ----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH
Confidence 23799999998766543211100 01123334455555555999999999999965 5899999999765322110
Q ss_pred ceeeecccCCCccccc--c---ccccCCCCChhhHHHHHHHH
Q 004935 570 THVTTTIAGTPGYLDP--E---YYISNRLTEKSDVYNFGVVL 606 (723)
Q Consensus 570 ~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DV~SfGvvL 606 (723)
.|... + .....+|..++|+||..--+
T Consensus 159 -----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 -----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred -----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 11110 0 01235678899999975433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.34 E-value=6.8e-13 Score=137.01 Aligned_cols=88 Identities=26% Similarity=0.369 Sum_probs=77.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc--ccCccccccC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ--KNGLLSLSVE 351 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~--~~~~~~l~~~ 351 (723)
+.++.|++++|.++|.+| .++.+++|+.|+|++|+|+|.||..+++|++|++|+|++|.++|.+|.. +..+..+.+.
T Consensus 221 ~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~ 299 (313)
T d1ogqa_ 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299 (313)
T ss_dssp SCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTC
T ss_pred cccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhC
Confidence 578899999999998765 6999999999999999999999999999999999999999999999963 3355667889
Q ss_pred CCCCCCCC--CCC
Q 004935 352 GNPDLCPE--ASC 362 (723)
Q Consensus 352 ~n~~lc~~--~~c 362 (723)
+|+.+|+. ++|
T Consensus 300 ~N~~l~g~plp~c 312 (313)
T d1ogqa_ 300 NNKCLCGSPLPAC 312 (313)
T ss_dssp SSSEEESTTSSCC
T ss_pred CCccccCCCCCCC
Confidence 99999975 455
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.30 E-value=5.2e-13 Score=137.89 Aligned_cols=96 Identities=25% Similarity=0.415 Sum_probs=83.6
Q ss_pred ccccccCCCce--eecCccCCCCCCCCCceEEEEcCCCcccc--cCcccccCCCCCCeeeCcC-CcCcCCCCccCCCCCC
Q 004935 249 LQFLTNQQDAY--LWQGLNCSYPEYDPPRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSN-NNLTGPVPDFLSQLPF 323 (723)
Q Consensus 249 ~~~~~~~~~~~--~w~g~~c~~~~~~~~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~L~ls~-N~l~g~iP~~l~~l~~ 323 (723)
+.+|..+.|+| .|.||+|+..+ ...+|+.|+|++|+++| .||++|++|++|++|+|++ |+|+|.||.++++|++
T Consensus 24 l~sW~~~~d~C~~~w~gv~C~~~~-~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~ 102 (313)
T d1ogqa_ 24 LSSWLPTTDCCNRTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102 (313)
T ss_dssp GTTCCTTSCTTTTCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTT
T ss_pred CCCCCCCCCCCCCcCCCeEEeCCC-CcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccc
Confidence 45677788998 59999998532 33589999999999999 6899999999999999996 9999999999999999
Q ss_pred CcEEEccCCCCCCchhhcccCc
Q 004935 324 LTELNLKGTIPNGLIEKQKNGL 345 (723)
Q Consensus 324 L~~l~l~~n~~~g~~p~~~~~~ 345 (723)
|++|+|++|.+.+..+..+...
T Consensus 103 L~~L~Ls~N~l~~~~~~~~~~~ 124 (313)
T d1ogqa_ 103 LHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CSEEEEEEECCEEECCGGGGGC
T ss_pred cchhhhccccccccccccccch
Confidence 9999999999999887765543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.72 E-value=8.1e-09 Score=97.74 Aligned_cols=84 Identities=24% Similarity=0.301 Sum_probs=59.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|++++.++..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|.+++..|..+. ++..+.+
T Consensus 54 ~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L 133 (192)
T d1w8aa_ 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred ceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccc
Confidence 4677777777777777777777777777777777777766666777777777777777777776555443 3445566
Q ss_pred CCCCCCC
Q 004935 351 EGNPDLC 357 (723)
Q Consensus 351 ~~n~~lc 357 (723)
.+|+..|
T Consensus 134 ~~N~~~~ 140 (192)
T d1w8aa_ 134 ASNPFNC 140 (192)
T ss_dssp TTCCBCC
T ss_pred ccccccc
Confidence 6666555
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.67 E-value=1.8e-08 Score=95.34 Aligned_cols=96 Identities=22% Similarity=0.237 Sum_probs=79.3
Q ss_pred eeecCccCCCCC------CCCCceEEEEcCCCcccccCc-ccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccC
Q 004935 259 YLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIA-PYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331 (723)
Q Consensus 259 ~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~ 331 (723)
|.|..+.|+..+ ..++.++.|+|++|+|++.++ ..|+++++|+.|+|++|++++..+..+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 567778887532 245689999999999998775 5589999999999999999999999999999999999999
Q ss_pred CCCCCchhhcccC---ccccccCCCC
Q 004935 332 TIPNGLIEKQKNG---LLSLSVEGNP 354 (723)
Q Consensus 332 n~~~g~~p~~~~~---~~~l~~~~n~ 354 (723)
|.+++..|..+.+ +..|.+.+|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~ 113 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQ 113 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred ccccccCHHHHhCCCcccccccCCcc
Confidence 9999877766554 4455666664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=8.6e-08 Score=95.44 Aligned_cols=127 Identities=19% Similarity=0.133 Sum_probs=90.0
Q ss_pred EEEEEcCCCCCcchhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCCC
Q 004935 222 EFSINTTESSTLPPILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSIQ 301 (723)
Q Consensus 222 ~lsl~~~~~s~lPp~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~ 301 (723)
.+.+..+.-...|+.+..+..++.+.+..+....-.... .....++..|++++|.+++-.|..+..+++|+
T Consensus 81 ~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~---------~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~ 151 (266)
T d1p9ag_ 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA---------LRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (266)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSST---------TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccccccccccccccccccccccccccccccceeeccc---------cccccccccccccccccceeccccccccccch
Confidence 355544444455666666666666654333222111111 11235789999999999966666788899999
Q ss_pred eeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCCCCCCC
Q 004935 302 ILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGNPDLCP 358 (723)
Q Consensus 302 ~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n~~lc~ 358 (723)
.|+|++|+|++..|..+..+++|+.|+|++|.++ .+|..+. .+..+...|||..|.
T Consensus 152 ~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred hcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 9999999999888888999999999999999998 5776544 345577889998884
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=9.3e-08 Score=86.92 Aligned_cols=85 Identities=24% Similarity=0.265 Sum_probs=69.7
Q ss_pred CceEEEEcCCCc-ccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc--Ccccccc
Q 004935 274 PRITSLNLSSSG-IAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN--GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~-l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~--~~~~l~~ 350 (723)
++|+.|+|++|+ |+.--+..|.+|++|+.|+|++|+|+..-|..+..+++|+.|+|++|.++..-+..+. .+..+.+
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L 110 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEEC
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcccccccccc
Confidence 588999998775 7754456799999999999999999987788899999999999999999864444332 4556788
Q ss_pred CCCCCCCC
Q 004935 351 EGNPDLCP 358 (723)
Q Consensus 351 ~~n~~lc~ 358 (723)
.+|+..|.
T Consensus 111 ~~Np~~C~ 118 (156)
T d2ifga3 111 SGNPLHCS 118 (156)
T ss_dssp CSSCCCCC
T ss_pred CCCcccCC
Confidence 99988774
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.50 E-value=9.7e-08 Score=83.17 Aligned_cols=78 Identities=27% Similarity=0.371 Sum_probs=62.7
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh-hccc---Cccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE-KQKN---GLLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p-~~~~---~~~~l~ 349 (723)
+.|+.|+|++|+|+ .||+.++.+++|+.|+|++|++++ +| .++++++|+.|++++|.++.... ..+. .+..+.
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence 47899999999998 689999999999999999999985 56 48999999999999999886432 2222 445566
Q ss_pred cCCCC
Q 004935 350 VEGNP 354 (723)
Q Consensus 350 ~~~n~ 354 (723)
+.+|+
T Consensus 97 l~~N~ 101 (124)
T d1dcea3 97 LQGNS 101 (124)
T ss_dssp CTTSG
T ss_pred CCCCc
Confidence 77775
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.7e-07 Score=94.22 Aligned_cols=85 Identities=24% Similarity=0.222 Sum_probs=74.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---Ccccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~ 350 (723)
++|+.|+|++|+|++-.|..|.++++|+.|+|++|++++..|..+..+++|+.|++++|.+.+..|..+. .+..+.+
T Consensus 153 ~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l 232 (284)
T d1ozna_ 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred cchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEe
Confidence 5789999999999987788899999999999999999999999999999999999999999998877665 3556778
Q ss_pred CCCCCCCC
Q 004935 351 EGNPDLCP 358 (723)
Q Consensus 351 ~~n~~lc~ 358 (723)
++|+-.|.
T Consensus 233 ~~N~l~C~ 240 (284)
T d1ozna_ 233 NDNPWVCD 240 (284)
T ss_dssp CSSCEECS
T ss_pred cCCCCCCC
Confidence 88987763
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.34 E-value=3.7e-07 Score=79.32 Aligned_cols=73 Identities=23% Similarity=0.296 Sum_probs=60.0
Q ss_pred EEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhccc---CccccccCCC
Q 004935 277 TSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 277 ~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~---~~~~l~~~~n 353 (723)
+.|+|++|+++ .+| .+++|++|++|||++|+|+ .+|..++.+++|+.|+|++|.+++. |. +. .+..+...+|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-Cc-cccccccCeEECCCC
Confidence 36999999998 565 5999999999999999998 6899999999999999999999875 32 33 3445556665
Q ss_pred C
Q 004935 354 P 354 (723)
Q Consensus 354 ~ 354 (723)
.
T Consensus 76 ~ 76 (124)
T d1dcea3 76 R 76 (124)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=8.6e-07 Score=80.32 Aligned_cols=61 Identities=23% Similarity=0.136 Sum_probs=54.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
++|+.|+|++|+|+.--|..|..+++|+.|+|++|+|+ .||..+....+|+.|+|++|.+.
T Consensus 56 ~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 68999999999999766778999999999999999999 77777666678999999999886
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.16 E-value=1.6e-06 Score=87.57 Aligned_cols=95 Identities=25% Similarity=0.244 Sum_probs=73.7
Q ss_pred eeecCccCCCCC------CCCCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 259 YLWQGLNCSYPE------YDPPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 259 ~~w~g~~c~~~~------~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
|.|.++.|+..+ ..++.++.|+|++|+++.--+.+|.+|++|+.|++++|.++...|..+.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 788999998531 23578999999999999544457999999999999999999888889999999999999999
Q ss_pred CCCCchhhcccCccccccCCC
Q 004935 333 IPNGLIEKQKNGLLSLSVEGN 353 (723)
Q Consensus 333 ~~~g~~p~~~~~~~~l~~~~n 353 (723)
.++.........+..+....|
T Consensus 90 ~l~~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 90 QLKELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp CCSBCCSSCCTTCCEEECCSS
T ss_pred ccCcCccchhhhhhhhhcccc
Confidence 988643322223334444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=1.8e-06 Score=85.49 Aligned_cols=63 Identities=21% Similarity=0.228 Sum_probs=58.8
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
.+.++.|++++|+|++..|..|+.+++|+.|+|++|+|+ .||..+..+++|+.|+|+||.+.-
T Consensus 147 l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 368999999999999887888999999999999999999 999999999999999999998874
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=2e-06 Score=78.40 Aligned_cols=77 Identities=22% Similarity=0.184 Sum_probs=44.2
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh---cccCcccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK---QKNGLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~---~~~~~~~l~~ 350 (723)
.+++.|+|++|+++ .||..+..+++|+.|||++|+++ .++ .+..+++|+.|+|++|.++...+. .+..+..+..
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 35666666666665 45555566666666666666666 343 356666666666666666553331 1223444455
Q ss_pred CCC
Q 004935 351 EGN 353 (723)
Q Consensus 351 ~~n 353 (723)
.+|
T Consensus 95 ~~N 97 (162)
T d1a9na_ 95 TNN 97 (162)
T ss_dssp CSC
T ss_pred ccc
Confidence 554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=1.2e-06 Score=87.82 Aligned_cols=110 Identities=15% Similarity=0.041 Sum_probs=80.1
Q ss_pred EEEEEcCCCCCcc-hhhhhhhhhhhhccccccccCCCceeecCccCCCCCCCCCceEEEEcCCCcccccCcccccCCCCC
Q 004935 222 EFSINTTESSTLP-PILNAYEIYRAKEFLQFLTNQQDAYLWQGLNCSYPEYDPPRITSLNLSSSGIAGDIAPYISTLTSI 300 (723)
Q Consensus 222 ~lsl~~~~~s~lP-p~inale~~~~~~~~~~~~~~~~~~~w~g~~c~~~~~~~~~l~~l~ls~n~l~g~ip~~~~~l~~L 300 (723)
.+.+....-+.+| ..+..+..++.+.+..+....-.+..+. ..++|+.|+|++|++++..|..|.++++|
T Consensus 133 ~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~---------~l~~L~~l~l~~N~l~~i~~~~f~~l~~L 203 (284)
T d1ozna_ 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR---------GLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203 (284)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT---------TCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred hhhhccccccccChhHhccccchhhcccccCcccccchhhhc---------cccccchhhhhhccccccChhHhhhhhhc
Confidence 3444443334444 3455555555555443322221111111 23689999999999999999999999999
Q ss_pred CeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh
Q 004935 301 QILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK 340 (723)
Q Consensus 301 ~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~ 340 (723)
+.||+++|++++..|..++.+++|+.|+|++|.+.+..+.
T Consensus 204 ~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred ccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 9999999999998889999999999999999999876553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.07 E-value=2.8e-06 Score=85.72 Aligned_cols=82 Identities=20% Similarity=0.224 Sum_probs=65.3
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcc---------cC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQK---------NG 344 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~---------~~ 344 (723)
+.++.|++++|.+++..|..+.++++|+.|+|++|+|+ .||..+.++++|+.|+|++|.++..-...+ ..
T Consensus 195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~ 273 (305)
T d1xkua_ 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273 (305)
T ss_dssp TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCC
T ss_pred ccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCC
Confidence 46889999999999888888999999999999999998 689999999999999999999885422221 23
Q ss_pred ccccccCCCCCC
Q 004935 345 LLSLSVEGNPDL 356 (723)
Q Consensus 345 ~~~l~~~~n~~l 356 (723)
+..+.+.+|+-.
T Consensus 274 L~~L~L~~N~~~ 285 (305)
T d1xkua_ 274 YSGVSLFSNPVQ 285 (305)
T ss_dssp CSEEECCSSSSC
T ss_pred CCEEECCCCcCc
Confidence 344567777643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=4.7e-06 Score=75.75 Aligned_cols=61 Identities=21% Similarity=0.233 Sum_probs=45.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|+++ .|+ .|..|++|+.|+|++|+++..-|..+..+++|+.|+|++|.++.
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccc
Confidence 46788888888887 453 57788888888888888875444445678888888888887765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.75 E-value=2.2e-05 Score=76.93 Aligned_cols=74 Identities=8% Similarity=0.052 Sum_probs=56.6
Q ss_pred CcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhcc-CCceeeEEEEEecCCceEEEEEeCCCCCHHHH
Q 004935 438 GFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIH-HKNLTTLVGYCDEGTNRGLIYEFMANGNLQAL 511 (723)
Q Consensus 438 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 511 (723)
+.+.||+...+++.+.||+...........+.+|...+..+. +--+.+++.++...+..++||+++++.++.+.
T Consensus 26 s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 26 SPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 346899998888889999987554433445788888888774 43456788888888889999999999877543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.70 E-value=1.7e-05 Score=82.21 Aligned_cols=76 Identities=22% Similarity=0.226 Sum_probs=60.6
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhc-ccCccccccCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQ-KNGLLSLSVEG 352 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~-~~~~~~l~~~~ 352 (723)
+.++.|+|++|++++. + .+..+++|+.|+|++|+|++ +| .++++++|+.|+|++|.+++..|-. +..+..+...+
T Consensus 307 ~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~ 382 (384)
T d2omza2 307 KNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLND 382 (384)
T ss_dssp TTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCC
T ss_pred cccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCC
Confidence 5789999999999974 4 38999999999999999985 55 6899999999999999999877632 22344445544
Q ss_pred C
Q 004935 353 N 353 (723)
Q Consensus 353 n 353 (723)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.57 E-value=4.3e-05 Score=73.19 Aligned_cols=63 Identities=17% Similarity=0.333 Sum_probs=52.1
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchh
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIE 339 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p 339 (723)
.++|+.|++++|.+++.. .+++|++|+.|+|++|++++ +|. ++++++|+.|+|++|.+++..|
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred ccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc
Confidence 357899999999987533 38899999999999999986 554 7889999999999999887544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.54 E-value=3.6e-05 Score=72.90 Aligned_cols=59 Identities=27% Similarity=0.406 Sum_probs=44.0
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
+.++.++++.|.+++ ++.++.+++|+.|++++|++++ ++. ++++++|+.|+|++|.++.
T Consensus 134 ~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCB
T ss_pred ccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCCC
Confidence 567788888888764 4457778888888888888875 433 7778888888888887764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.51 E-value=3e-05 Score=80.17 Aligned_cols=56 Identities=21% Similarity=0.425 Sum_probs=50.8
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGT 332 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n 332 (723)
.++|+.|+|++|+|++ +| .+++|++|+.|+|++|+|++-+| +.+|++|+.|+|++|
T Consensus 328 l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 328 LTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 4689999999999985 55 79999999999999999998766 899999999999987
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.51 E-value=7e-05 Score=70.13 Aligned_cols=60 Identities=32% Similarity=0.416 Sum_probs=48.5
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
.++|+.|++++|++.. + +.+..+++|+.|++++|++++ +| .++++++|+.|+|++|.++.
T Consensus 127 l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 127 LTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC
T ss_pred hhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC
Confidence 3578899999998873 4 468888999999999999886 33 37888999999999988876
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.30 E-value=7.5e-05 Score=71.43 Aligned_cols=55 Identities=24% Similarity=0.415 Sum_probs=48.1
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccC
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG 331 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~ 331 (723)
.++|+.|+|++|++++ ||+ +++|++|+.|+|++|++++ ||. +.++++|+.|+|++
T Consensus 172 l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 172 LSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred cccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 3689999999999986 554 9999999999999999996 553 89999999999974
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.27 E-value=0.00025 Score=66.84 Aligned_cols=60 Identities=28% Similarity=0.395 Sum_probs=30.4
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|++++|.+.. .+.+..+++|+.+++++|.+++ +..+.++++|+.+++++|.+++.
T Consensus 112 ~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 112 KKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp TTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred ccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 345555555555431 2245555555555555555543 22344555555555555555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.27 E-value=0.00016 Score=73.41 Aligned_cols=67 Identities=21% Similarity=0.319 Sum_probs=49.8
Q ss_pred CCceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCcccc
Q 004935 273 PPRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSL 348 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l 348 (723)
+++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .||.. +++|+.|+|++|.++. +|.....+..+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~~~~L~~L 349 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCCCTTCCEE
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCccccccCee
Confidence 468999999999988 68854 567888999999998 68864 4678899999998774 55433333333
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.25 E-value=0.0001 Score=71.55 Aligned_cols=72 Identities=15% Similarity=0.113 Sum_probs=51.3
Q ss_pred ccccC-cEEEEEEEECCc-eEEEEEecCCChhhHHHHHHHHHHHHhccCC--ceeeEEEEEecCCceEEEEEeCCCCCH
Q 004935 434 LGNGG-FGTVYHGYLDGT-EVAVKMLSPSSAQGYKQFQAEVELLMRIHHK--NLTTLVGYCDEGTNRGLIYEFMANGNL 508 (723)
Q Consensus 434 lG~G~-~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL 508 (723)
+..|. -+.||+...++. .+.+|....... ..+..|+..++.+... .+.++++++.+.+..++||+++++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33444 367999988655 678888765543 2467788888777433 356678888888889999999987655
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.20 E-value=0.0003 Score=65.56 Aligned_cols=60 Identities=25% Similarity=0.391 Sum_probs=35.1
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++|++++ +++ +++|++|+.|++++|.+. .+| .+.+++.|+.|++++|.....
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~ 121 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI 121 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC
T ss_pred CCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccc
Confidence 356666666666664 232 666666666666666655 233 255666666666666655543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.16 E-value=5.2e-06 Score=78.22 Aligned_cols=61 Identities=16% Similarity=0.155 Sum_probs=40.8
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
++|+.|+|++|+++ .||..+..+++|+.|+|++|+++. ++ .+.++++|+.|+|++|.++..
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~ 130 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNW 130 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCH
T ss_pred ccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhccc
Confidence 36777777777776 566656666677777777777763 33 356677777777777776653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.92 E-value=0.00024 Score=68.29 Aligned_cols=94 Identities=15% Similarity=0.172 Sum_probs=64.4
Q ss_pred eeecCccCCCC------CCCCCceEEEEcCCCcccccCcc-cccCCCCCCeeeCcCCcCcCCCCc-cCCCCCCCcEEEcc
Q 004935 259 YLWQGLNCSYP------EYDPPRITSLNLSSSGIAGDIAP-YISTLTSIQILDLSNNNLTGPVPD-FLSQLPFLTELNLK 330 (723)
Q Consensus 259 ~~w~g~~c~~~------~~~~~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~ 330 (723)
|....+.|+.. ...++.++.|+|++|.++. ||+ .|.+|++|++|+|++|.+...+|. .+..++.++.|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 33445566532 2234579999999999984 554 689999999999999999887765 56789999999875
Q ss_pred -CCCCCCchhhccc---CccccccCCC
Q 004935 331 -GTIPNGLIEKQKN---GLLSLSVEGN 353 (723)
Q Consensus 331 -~n~~~g~~p~~~~---~~~~l~~~~n 353 (723)
.|.+....+..+. ++..+.+.+|
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~ 113 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNT 113 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred ccccccccccccccccccccccccchh
Confidence 4566655554433 3333444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.87 E-value=7.3e-05 Score=67.56 Aligned_cols=62 Identities=29% Similarity=0.362 Sum_probs=31.7
Q ss_pred CceEEEEcCCCcccc--cCcccccCCCCCCeeeCcCCcCcCCCCc-cCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAG--DIAPYISTLTSIQILDLSNNNLTGPVPD-FLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g 336 (723)
+.|+.|+|++|+|+. .++..+..|++|+.|||++|+++. ++. ...+...|+.|+|+||.+..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence 355666666666653 123345556666666666666552 322 11223345556666655544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=96.84 E-value=4e-05 Score=71.90 Aligned_cols=77 Identities=22% Similarity=0.232 Sum_probs=58.2
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCCCchhh-cccCccccccCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEK-QKNGLLSLSVEG 352 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~-~~~~~~~l~~~~ 352 (723)
++|+.|+|++|+++ .|+ .|..|++|+.|+|++|+++ .||.....+++|+.|+|++|.++..-+. .+..+..+.+.+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l~~~~~l~~L~~L~L~~ 124 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSN 124 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCHHHHHHHHHSSEEEESE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 47899999999998 675 5999999999999999997 6787666677899999999998864221 112344455554
Q ss_pred C
Q 004935 353 N 353 (723)
Q Consensus 353 n 353 (723)
|
T Consensus 125 N 125 (198)
T d1m9la_ 125 N 125 (198)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.69 E-value=0.00066 Score=67.05 Aligned_cols=77 Identities=27% Similarity=0.386 Sum_probs=61.4
Q ss_pred CceEEEEcCCC-cccccCcccccCCCCCCeeeCcC-CcCcCCCCccCCCCCCCcEEEccCCCCCCchhhcccCcccccc
Q 004935 274 PRITSLNLSSS-GIAGDIAPYISTLTSIQILDLSN-NNLTGPVPDFLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLSV 350 (723)
Q Consensus 274 ~~l~~l~ls~n-~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~~ 350 (723)
++|+.|+|++| .+++..+..++++++|++|+|++ +++++.....++++++|+.|+++|+...+.++.-...+..+..
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i 253 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSEE
T ss_pred ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccccc
Confidence 58999999985 68888899999999999999999 6788887788999999999999998666655543333344443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=96.56 E-value=0.0013 Score=66.24 Aligned_cols=54 Identities=26% Similarity=0.418 Sum_probs=23.2
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccCCCCC
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+.|+.|+|++|+|+ .||..+ .+|+.|++++|+++ .|+.. .+.|++|+|++|.+.
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~ 111 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE 111 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc
Confidence 34444455544444 444332 23444444444444 22211 023555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.37 E-value=0.003 Score=65.22 Aligned_cols=74 Identities=16% Similarity=0.200 Sum_probs=47.9
Q ss_pred hhccccCcEEEEEEEEC--CceEEEEEecCCC-------hhhHHHHHHHHHHHHhcc-C--CceeeEEEEEecCCceEEE
Q 004935 432 RVLGNGGFGTVYHGYLD--GTEVAVKMLSPSS-------AQGYKQFQAEVELLMRIH-H--KNLTTLVGYCDEGTNRGLI 499 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-------~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV 499 (723)
+.||.|....||+.... ++.++||.-.+.. .....+...|.+.|+.+. + ..+.+++.++ .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 46899999999999863 4589999754311 112234556888887663 2 3455666553 4556899
Q ss_pred EEeCCCCC
Q 004935 500 YEFMANGN 507 (723)
Q Consensus 500 ~Ey~~~gs 507 (723)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998644
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.15 E-value=0.00028 Score=63.54 Aligned_cols=70 Identities=26% Similarity=0.269 Sum_probs=52.0
Q ss_pred ccccCcccccCCCCCCeeeCcCCcCcCC--CCccCCCCCCCcEEEccCCCCCCchhhc---ccCccccccCCCCC
Q 004935 286 IAGDIAPYISTLTSIQILDLSNNNLTGP--VPDFLSQLPFLTELNLKGTIPNGLIEKQ---KNGLLSLSVEGNPD 355 (723)
Q Consensus 286 l~g~ip~~~~~l~~L~~L~ls~N~l~g~--iP~~l~~l~~L~~l~l~~n~~~g~~p~~---~~~~~~l~~~~n~~ 355 (723)
+...++....++++|++|+||+|+++.- ++..+..+++|+.|+|++|.++..-+.. ...+..+.+.||+-
T Consensus 53 ~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl 127 (162)
T d1koha1 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127 (162)
T ss_dssp HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTT
T ss_pred HhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCc
Confidence 3344555567899999999999999953 3455778999999999999998754322 23456677888864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.80 E-value=0.0054 Score=58.24 Aligned_cols=74 Identities=23% Similarity=0.163 Sum_probs=52.9
Q ss_pred CceEEEEcCCCcccccCcccccCCCCCCee-eCcCCcCcCCCCc-cCCCCCCCcEEEccCCCCCCchhhcccCccccc
Q 004935 274 PRITSLNLSSSGIAGDIAPYISTLTSIQIL-DLSNNNLTGPVPD-FLSQLPFLTELNLKGTIPNGLIEKQKNGLLSLS 349 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~L-~ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~~p~~~~~~~~l~ 349 (723)
..++.|++++|+++ .|+....++++++.+ ++++|+|+ .||. .+.++++|+.|+|++|.++...+..+.++..|.
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 228 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEE
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccc
Confidence 47888999999998 566666666666555 57778887 5654 578899999999999988854343444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.0012 Score=65.13 Aligned_cols=63 Identities=29% Similarity=0.371 Sum_probs=54.8
Q ss_pred CCceEEEEcCCCccccc-CcccccCCCCCCeeeCcCCcCcCCCCccCCCCCCCcEEEccC-CCCC
Q 004935 273 PPRITSLNLSSSGIAGD-IAPYISTLTSIQILDLSNNNLTGPVPDFLSQLPFLTELNLKG-TIPN 335 (723)
Q Consensus 273 ~~~l~~l~ls~n~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~-n~~~ 335 (723)
+.+|+.|||+++.+++. ++.-+.++++|++|+|+++++++..+..++++++|+.|+|++ +.++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it 109 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence 45899999999998865 455578999999999999999999999999999999999998 4555
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.29 E-value=0.0017 Score=67.72 Aligned_cols=61 Identities=15% Similarity=0.208 Sum_probs=27.7
Q ss_pred ceEEEEcCCCccccc----Cccccc-CCCCCCeeeCcCCcCcC----CCCccCCCCCCCcEEEccCCCCC
Q 004935 275 RITSLNLSSSGIAGD----IAPYIS-TLTSIQILDLSNNNLTG----PVPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~----ip~~~~-~l~~L~~L~ls~N~l~g----~iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
.|+.|+|++|+++.. ++..+. ..+.|++|+|++|+|+. .|+..+..+++|++|+|++|.++
T Consensus 341 ~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred chhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 355555555555432 233332 23445555555555542 13333444455555555555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.56 E-value=0.027 Score=56.11 Aligned_cols=67 Identities=13% Similarity=0.140 Sum_probs=43.8
Q ss_pred EEEEEEEE-CCceEEEEEecCCChhhHHHHHHHHHHHHhccCCcee--eEEE-----EEecCCceEEEEEeCCCCC
Q 004935 440 GTVYHGYL-DGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNLT--TLVG-----YCDEGTNRGLIYEFMANGN 507 (723)
Q Consensus 440 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l~g-----~~~~~~~~~lV~Ey~~~gs 507 (723)
-.||+... +|..+++|+.++... ..+++..|.+.+..|....+. ..+. .....+..+.+++++++..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999988 566899999876532 346788899988887533321 1111 1133456778999988643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=94.01 E-value=0.0081 Score=60.44 Aligned_cols=63 Identities=21% Similarity=0.339 Sum_probs=44.3
Q ss_pred ceEEEEcCCCccccc-----CcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCc
Q 004935 275 RITSLNLSSSGIAGD-----IAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 275 ~l~~l~ls~n~l~g~-----ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
.++.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.+++.
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 577888888877632 345567778888888888877633 444566777888888888877654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.97 E-value=0.0087 Score=62.10 Aligned_cols=63 Identities=32% Similarity=0.437 Sum_probs=48.6
Q ss_pred CceEEEEcCCCccccc----Cccccc-CCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYIS-TLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~-~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g 336 (723)
++|+.|||++|.++.. +...+. ...+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 55 ~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 55 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 5799999999998632 233332 235799999999999854 56778889999999999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.75 E-value=0.024 Score=58.18 Aligned_cols=71 Identities=15% Similarity=0.249 Sum_probs=48.8
Q ss_pred hhccccCcEEEEEEEECC---------ceEEEEEecCCChhhHHHHHHHHHHHHhccCCce-eeEEEEEecCCceEEEEE
Q 004935 432 RVLGNGGFGTVYHGYLDG---------TEVAVKMLSPSSAQGYKQFQAEVELLMRIHHKNL-TTLVGYCDEGTNRGLIYE 501 (723)
Q Consensus 432 ~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 501 (723)
+.|+.|-.-.+|+...+. ..|.+++..... ......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 357778888999998742 357777765322 23456789999998854444 477777753 68999
Q ss_pred eCCCCCH
Q 004935 502 FMANGNL 508 (723)
Q Consensus 502 y~~~gsL 508 (723)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=92.77 E-value=0.016 Score=58.18 Aligned_cols=63 Identities=16% Similarity=0.097 Sum_probs=49.7
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeCcCCcCcCCCCccC----C--CCCCCcEEEccCCCCCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDLSNNNLTGPVPDFL----S--QLPFLTELNLKGTIPNG 336 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~iP~~l----~--~l~~L~~l~l~~n~~~g 336 (723)
++|+.|+|++|.++.. +...+..+++|+.|+|++|++++.-...+ . ..+.|+.|+|++|.++.
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 5799999999998753 56778899999999999999986522222 2 24679999999998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.72 E-value=0.064 Score=52.76 Aligned_cols=61 Identities=3% Similarity=0.079 Sum_probs=35.8
Q ss_pred cCHHHHHHHHHHhh-------hhccccCcEEEEEEEECCceEEEEEecCCChhhHHHHHHHHHHHHhccC
Q 004935 418 FSYSNVLRITNNFE-------RVLGNGGFGTVYHGYLDGTEVAVKMLSPSSAQGYKQFQAEVELLMRIHH 480 (723)
Q Consensus 418 ~~~~~l~~~t~~f~-------~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H 480 (723)
++.+|+......+. +.|..|---+.|+...+++.+++|+...... .++...|++++..+.+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~--~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--KNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC--HHHHHHHHHHHHhhhh
Confidence 34555555554441 2344566678899988888899999865422 2345567777777743
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=91.59 E-value=0.032 Score=49.58 Aligned_cols=64 Identities=13% Similarity=0.269 Sum_probs=44.1
Q ss_pred CceEEEEcCCC-ccccc----CcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSSS-GIAGD----IAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~n-~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
+.|+.|+|+++ .++.. +-..+...+.|+.|+|++|.++.. +-..|...+.|+.|+|++|.++..
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~ 87 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 87 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchH
Confidence 57888888864 45432 334566778888888888888632 223445567888888888877754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=91.08 E-value=0.039 Score=49.00 Aligned_cols=62 Identities=18% Similarity=0.244 Sum_probs=48.1
Q ss_pred CceEEEEcCCCccccc----CcccccCCCCCCeeeCcCCcCcCC----CCccCCCCCCCcEEEccCCCCC
Q 004935 274 PRITSLNLSSSGIAGD----IAPYISTLTSIQILDLSNNNLTGP----VPDFLSQLPFLTELNLKGTIPN 335 (723)
Q Consensus 274 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~n~~~ 335 (723)
+.|+.|+|++|.+... +...+...+.|+.|+|++|+++.. +=..+..-++|+.|+|++|...
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 4699999999999743 334566779999999999999854 2224667789999999988654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=80.22 E-value=0.25 Score=43.17 Aligned_cols=64 Identities=22% Similarity=0.319 Sum_probs=45.4
Q ss_pred CceEEEEcCC-Cccccc----CcccccCCCCCCeeeCcCCcCcCCCC----ccCCCCCCCcEEEccCCCCCCc
Q 004935 274 PRITSLNLSS-SGIAGD----IAPYISTLTSIQILDLSNNNLTGPVP----DFLSQLPFLTELNLKGTIPNGL 337 (723)
Q Consensus 274 ~~l~~l~ls~-n~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~iP----~~l~~l~~L~~l~l~~n~~~g~ 337 (723)
+.|+.|+|++ +.++.. +-..+...++|+.|+|++|+++..-- ..+...++|+.|++++|.++..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 6889999987 456432 33455678889999999998874422 2345578899999988877644
|